{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 800,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 800,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b/e2_page_window/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-05T00:46:51.187958"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s balance‑sheet shows that the 5.0 % senior notes that mature in April 2030 were carried at about **$606 million** in each of the three most recent fiscal years – FY 2022, FY 2023 and FY 2024 (the 2024 and 2023 tables list $606 million, and the FY 2022 filing reports the same amount).  \n\nBecause the amount has stayed essentially flat, the company has not been adding to this relatively high‑coupon series; instead it has relied on new, lower‑rate issuances and term‑loan repayments to manage its overall debt load. The unchanged exposure signals a deliberate debt‑management approach that limits additional reliance on the 5 % notes while using other financing tools to refinance or retire debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. The LLM incorrectly states that the amount was $606 million in all three years, including 2022, which contradicts the ground truth. This error fundamentally undermines the answer’s correctness. (2) The dollar amounts and their progression are central to the question, and the LLM misrepresents the 2022 value. While $606 million is correct for 2023 and 2024, claiming it was the same in 2022 is a significant factual error. No calculation is required beyond recognizing the decrease, but the LLM fails to report the decrease accurately. (3) The reasoning about debt management strategy is plausible but based on incorrect data. The LLM infers a 'flat' exposure and concludes AVGO avoided adding to the notes, but the ground truth shows a clear reduction from 2022 to 2023, indicating active repayment rather than stability. Thus, the multi-hop synthesis is flawed due to incorrect input data. (4) The contextual relevance is fair because the answer addresses the right financial instrument, company, and time frame, and attempts to interpret strategy. However, due to the major quantitative inaccuracy, the correctness score is low. The qualitative accuracy is modest because the logic would be reasonable if the numbers were right, but it fails on factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 422,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block has remained essentially unchanged. In the 2022 filing the company noted that it “reinsured **59.25 %** of the closed block through a modified coinsurance agreement” (2022 10‑K, reinsurance note). Both the 2023 and 2024 filings state that it “has reinsured **59 %** of the closed block through a modified coinsurance agreement” (2023 10‑K and 2024 10‑K, reinsurance note). The near‑identical risk‑transfer percentage shows MetLife is deliberately keeping a stable, long‑term mix of retained and transferred risk for the closed block, using reinsurance to manage exposure while preserving a substantial portion of the block’s risk on its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages are correct: 59.25% for 2022 and 59% for both 2023 and 2024, matching the original answer exactly. There are no calculation errors. (2) The answer addresses the evolution of MetLife's use of the modified coinsurance agreement from 2022 to 2024, noting the stability in the percentage reinsured, which correctly reflects no significant change over time. (3) The reasoning about the consistency revealing a long-term reinsurance strategy is sound and semantically equivalent to the ground truth’s conclusion about 'deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization.' (4) The only minor omission is that the LLM answer does not mention the accounting method (deposit method) or the right of offset, which are part of the full picture but not central to the core question about the evolution and strategic implication of the percentage reinsured. It also omits the context of total net ceded reinsurance recoverables growing from $6.3B to $17.6B, which strengthens the point about stability despite overall growth. However, these details are secondary to the main focus on the closed block's risk transfer percentage. Overall, the LLM captures the key facts, entities, and logical inference correctly, with only slight incompleteness on supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 394,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s reported collateral for master‑netting arrangements fell sharply over the three‑year span – $1,494 million at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024 (a total drop of roughly $1 billion)【XOM_10k_2023】【XOM_10k_2024】.  The steady decline suggests the company’s derivative positions are requiring less initial‑margin collateral, indicating that its exposure is being managed more efficiently – either through reduced notional volumes, tighter netting with counterparties, or improved risk‑mitigation practices.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values are accurate: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, with a total decline of approximately $1.003 billion, which aligns with the stated 'roughly $1 billion' drop. All numbers match the original answer exactly, with acceptable formatting variations (e.g., $1,494 million vs $1.494 billion). (2) The answer is complete, addressing both parts of the question: the change in collateral over time and the implication for derivative exposure management. (3) Entity accuracy is correct—ExxonMobil (XOM), the metric 'collateral under master netting arrangements', and the years 2022–2024 are all properly identified. (4) The reasoning is sound and adds value: the LLM correctly infers that reduced collateral requirements suggest more efficient exposure management, citing plausible mechanisms such as reduced notional volumes, tighter netting, or improved risk mitigation—consistent with the ground truth's interpretation of 'strategic reduction in derivative exposure or improved offsetting mechanisms'. The multi-hop synthesis across three years of data and the interpretation of financial implications are logically and accurately executed. (5) Semantic equivalence is maintained: while the LLM uses slightly different phrasing (e.g., 'initial-margin collateral', 'more efficiently'), the core meaning and factual content are identical to the original. No factual, numerical, or interpretive errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 424,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "The 2022 Form 10‑K still showed a sizable balance of the April 2019 senior‑note series that carried a 3.625 % coupon and was due in October 2024 (approximately **$1.6 billion** of principal). By the 2023 filing the balance had fallen to **about $622 million**, and the 2024 filing reports the note as fully retired (‑), meaning the remaining amount was repaid before the scheduled maturity. This steady decline – from a large outstanding balance, to a modest residual, to complete extinguishment – demonstrates that Broadcom deliberately accelerated repayment of the 3.625 % notes, using the cash generated (and proceeds from newer senior‑note issuances) to shrink its debt load and smooth its maturity profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, AVGO's principal outstanding for the 3.625% notes due October 2024 was $622 million in both 2022 and 2023, and $0 in 2024. However, the LLM claims the balance was approximately $1.6 billion in 2022 and dropped to $622 million in 2023, which contradicts the ground truth. This error misrepresents the entire financial trajectory of the debt. (2) The calculation of a decline from $1.6 billion to $622 million implies a reduction of about $978 million in one year, which did not occur per the original data. The actual progression—unchanged at $622 million for two years, then retired—is misrepresented as a steady decline, altering the interpretation of the company's strategy. (3) The qualitative reasoning about debt management strategy is partially sound: the conclusion that AVGO deliberately retired the notes before maturity aligns with the ground truth. The mention of refinancing or using cash proceeds is speculative but plausible and contextually reasonable. However, the multi-hop synthesis is flawed because it uses incorrect input data from the first hop (2022 balance). (4) Contextual relevance is high—the answer addresses the evolution over time and interprets the strategy appropriately, just not based on correct numbers. The entity (AVGO), metric (principal on 3.625% notes), and time frame (2022–2024) are correctly identified. Overall, the answer fails on quantitative accuracy but shows reasonable logic and relevance, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 438,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022**, **$2.70 billion in 2023**, and **$2.82 billion in 2024**. The steady year‑over‑year growth (about 5 % each year) shows the company’s expanding role in U.S. Navy surface‑combatant and auxiliary shipbuilding, underscoring a strengthening competitive position and rising demand for its destroyer, auxiliary‑ship and lifecycle‑support programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trajectory of General Dynamics' surface ship revenue from 2022 to 2024 with values very close to the ground truth. The reported figures are $2.56B (vs $2,561M), $2.70B (vs $2,698M), and $2.82B (vs $2,819M). These are within rounding differences—$2.56B = $2,560M (1M off), $2.70B = $2,700M (2M over), $2.82B = $2,820M (1M over)—which is acceptable under format variation tolerance. (2) The percentage growth mentioned (~5% each year) is approximately accurate: from 2022 to 2023, growth is (2,698 - 2,561)/2,561 ≈ 5.35%; from 2023 to 2024, (2,819 - 2,698)/2,698 ≈ 4.48%. The LLM rounds this to 'about 5%', which is reasonable for high-level analysis. (3) The reasoning is sound and multi-hop: it correctly identifies the Marine Systems division as the source, links revenue growth to specific programs (destroyers, auxiliary ships, lifecycle support), and infers strategic positioning in naval shipbuilding—aligning with and extending the ground truth’s conclusion. (4) All entities (General Dynamics, surface ships, years 2022–2024) are accurate. The answer fully addresses both parts of the question: revenue evolution and what it indicates. Only minor quantitative discrepancies prevent a perfect 10, but these do not affect the overall correctness or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 371,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From the 2022 Form 10‑K, Mastercard’s Class A shares carried **one vote per share and full dividend rights**, and the company declared a **$2.04 per‑share cash dividend** for the year. The 2023 filing shows the same **one‑vote‑per‑share structure** with the dividend raised to **$2.37 per share**. The 2024 filing again confirms **one vote per Class A share** and a further dividend increase to **$2.74 per share**. Because the voting entitlement has remained unchanged while the dividend has been steadily increased each year, the three‑year trend signals a **stable governance framework** (unchanged voting power) coupled with a progressively more generous return to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting rights (one vote per share) across all three years, which aligns with the ground truth. However, it introduces specific dividend amounts—$2.04 (2022), $2.37 (2023), and $2.74 (2024)—that are not present in the original answer and cannot be verified from the provided ground truth. The original answer states only that A Class shares had 'standard dividend rights' with no changes over time, but does not specify per-share dividend amounts or indicate increases. Thus, the inclusion of exact figures and the claim of annual increases are unsupported and factually inaccurate. (2) These numbers appear to be hallucinated or derived from external data not in the knowledge graph, violating quantitative accuracy. Even if the numbers were correct in reality, they are not part of the ground truth used for evaluation, so their inclusion constitutes a factual error in this context. (3) The reasoning is otherwise sound: the model correctly synthesizes information across years and draws a logical conclusion about governance stability based on unchanged voting rights. It correctly identifies the multi-hop pattern of consistency in voting and interprets this as structural stability. However, the dividend progression narrative is based on fabricated data, undermining the validity of the synthesis. (4) The contextual relevance is high because the response addresses both parts of the question—evolution of rights and implications for governance—and maintains focus on MA's A Class shares over the 2022–2024 period. The qualitative reasoning is strong but built partially on incorrect quantitative foundations, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 466,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022**, rising to **$2.70 billion in 2023** and **$2.82 billion in 2024**【GD_10k_2023.pdf†L31-L34】【GD_10k_2024.pdf†L31-L34】.  That represents a **5.3% year‑over‑year increase (2022‑23) and a 4.5% increase (2023‑24), roughly a 10% rise over the two‑year span**.  The steady growth signals that GD is gaining market share in the Navy’s expanding surface‑combatant and auxiliary‑ship programs, reinforcing its position as a core supplier for U.S. naval defense contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for surface ships as $2.56 billion (2022), $2.70 billion (2023), and $2.82 billion (2024), which align with the ground truth values of $2,561 million, $2,698 million, and $2,819 million when rounded to the nearest hundred million. The slight rounding is acceptable and common in financial reporting. (2) The year-over-year growth calculations are accurate: (2,698 - 2,561) / 2,561 ≈ 5.35% (LLM reports 5.3%), and (2,819 - 2,698) / 2,698 ≈ 4.48% (LLM reports 4.5%). The approximate 10% total growth over two years is also reasonable (cumulative growth ~9.8%). (3) The multi-hop reasoning is sound—revenue figures are correctly pulled across years and synthesized into a trend analysis. The conclusion about General Dynamics' positioning in naval defense programs (gaining market share, core supplier status) is a logical extension of the upward revenue trend and consistent with the original answer’s implication of growing involvement. (4) All entities (General Dynamics, surface ships, years 2022–2024) are correct. The answer is fully relevant and adds slightly more context (e.g., mention of combatant and auxiliary-ship programs) without introducing inaccuracies. The only minor deduction is for rounding the numbers rather than reporting exact values, but this does not affect overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 381,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 2022, 2023 and 2024 Form 10‑K filings all state that “the majority of Linde’s business is conducted through long‑term contracts which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers” (2022 Business Overview p. 19; 2023 Business Overview p. 20; 2024 Business Overview p. 17). Because the company’s description of this contractual model did not change over the three years, its reliance on long‑term contracts remained essentially constant. This consistency signals that Linde deliberately uses long‑term agreements to lock in revenue streams and hedge against volatile energy prices, thereby preserving cash‑flow stability even when energy markets fluctuate.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures that Linde maintained a consistent reliance on long-term contracts from 2022 to 2024, citing the same contractual benefits—cash flow stability and cost pass-through of energy and feedstock costs—across all three years. The specific page references (2022 p. 19, 2023 p. 20, 2024 p. 17) are included, demonstrating precise sourcing. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly identified and consistently referenced. (3) The multi-hop reasoning is sound: the model synthesizes identical language across three annual filings to infer that Linde’s strategy did not change, and correctly interprets this consistency as a deliberate approach to ensure revenue predictability and cash flow stability amid energy market volatility. (4) The LLM conveys all key qualitative points from the ground truth: the unchanging nature of the contractual model, its role in risk management, and Linde’s prioritization of financial resilience over short-term pricing flexibility. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 351,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, General Dynamics explicitly states that its ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance.” The language is identical in each year, indicating no change in treatment. This consistency signals that GD deliberately isolates core operating returns from accounting‑driven, non‑operational items, reinforcing a focus on measuring the underlying economic performance of the business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD excluded non-economic accounting changes from its ROIC calculation in 2022, 2023, and 2024, which matches the original answer’s claim of consistent exclusion across all three years. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings and infers that identical language indicates a stable methodology. It further reasons that this reflects GD's intent to isolate core operating performance, which aligns with the original answer’s conclusion about institutionalized principles. (4) The LLM adds a specific detail—explicit mention of 'goodwill impairments'—that enriches the response without contradicting the ground truth, and it correctly interprets the implication of consistency in disclosure language. All aspects of the question are addressed: evolution (no change), treatment (exclusion), and what it reveals (focus on core performance). Scores are maximized due to factual accuracy, completeness, and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 345,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s disclosures show that the company’s guarantees tied to service‑level performance remained immaterial in each of the three most recent years – the 2022, 2023 and 2024 Form 10‑K filings all state that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material” as of the respective year‑end dates. Because the financial impact never rose to materiality, the pattern indicates that UnitedHealth Group’s risk‑management controls and contract‑performance monitoring are effectively limiting exposure, and that the company has been consistently meeting its service‑level commitments without triggering significant liability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that UnitedHealth Group's service level guarantee obligations were immaterial in 2022, 2023, and 2024, with no material amounts accrued, paid, or charged to income—directly matching the original answer. (2) There are no numerical inaccuracies; the answer correctly avoids citing specific dollar amounts since the ground truth emphasizes immateriality, which is appropriately interpreted and conveyed. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three years and correctly infers that consistent immateriality reflects effective risk management and contractual performance, aligning with the original conclusion. (4) The answer fully addresses both parts of the question—evolution of obligations (no material changes) and implications for risk management and performance consistency. Wording differs slightly but meaning is preserved, and all entities (UnitedHealth Group, service-level guarantees, 2022–2024 period) are accurate. No omissions or distortions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 313,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022**, which rose to **$2.70 billion in 2023** and further to **$2.82 billion in 2024**【GD_10k_2023.pdf p. 9】【GD_10k_2024.pdf p. 9】.  \nThe steady year‑over‑year increase shows the company expanding its surface‑combatant and auxiliary‑ship business, reinforcing its strategic position as a core supplier of U.S. Navy platforms and complementing its dominant submarine portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has discrepancies in the 2022 revenue figure. The ground truth states $2,328 million for 2022, while the LLM reports $2.56 billion ($2,560 million), which is a significant overstatement of ~$232 million. The 2023 and 2024 figures are accurate: $2.70 billion matches $2,698 million (rounded appropriately), and $2.82 billion aligns with $2,819 million (also reasonable rounding). (2) Calculations: The year-over-year growth trend is correctly portrayed as increasing, but due to the incorrect 2022 baseline, any derived growth rate would be inaccurate. The actual 2022–2023 increase is ~15.9%, while the LLM’s numbers suggest only ~5.5%, indicating flawed quantitative reasoning. (3) Multi-hop reasoning: The LLM correctly synthesizes data across two 10-K filings (2023 and 2024) and attributes the revenue to the Marine Systems segment, showing proper cross-document inference. The qualitative interpretation about strategic positioning—expansion in surface combatants, role as a core U.S. Navy supplier, and complementarity with submarine business—is consistent with and logically extends the ground truth. (4) Justification: The correctness score is 7 because the core trend (steady growth) and strategic implication are right, but the key initial data point is wrong. Quantitative accuracy is penalized more heavily (6) due to the material error in 2022 revenue. Qualitative accuracy is high (8) due to sound reasoning and contextual understanding. Contextual relevance is perfect (10) as all parts of the question are addressed with relevant, focused content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 447,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "GE first moved its captive industrial insurer, Electric Insurance Company, into the “businesses held for sale” category in the fourth quarter of 2022, reporting roughly $541 million of assets and $378 million of liabilities for the subsidiary. In 2023 the company kept the unit in the held‑for‑sale group, signed a binding purchase agreement in Q3 and booked a $109 million loss related to the expected disposition. By the second quarter of 2024 GE completed the divestiture, selling Electric Insurance Company to Riverstone International Holdings for $120 million and removing the assets, liabilities and related valuation allowance from its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor discrepancies in timing details. (1) Quantitatively, all key numbers are correct: $541 million in assets, $378 million in liabilities (as of December 31, 2023, per original answer), the $109 million loss, and the $120 million sale price to Riverstone International Holdings Inc. are all accurately reported. The format variations are acceptable. (2) The original answer states EIC was classified as 'held for sale' in 2023, while the LLM claims this occurred in Q4 2022. This is a slight discrepancy, but plausible given that 'held for sale' classification may have been initiated late in 2022 and formally reflected in 2023 reporting—this nuance does not constitute a factual error given typical reporting lags. (3) The multi-hop reasoning is sound: the LLM correctly traces EIC’s evolution from captive insurer to held-for-sale status, recognizes the financial impact (loss on sale), and confirms the completion of divestiture in 2024. (4) Entity names (Electric Insurance Company, Riverstone International Holdings), financial metrics, and timeline are correctly identified. The LLM omits the 2021 claim reserve figure ($0.2 billion) mentioned in the original, but this is a minor omission that does not affect the core narrative of classification, financial exposure, and divestiture from 2022–2024. Overall, the answer is factually robust, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 417,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips began “a paced monetization of our CVE common shares” in 2021 and, in the first quarter of 2022, sold the remaining 91 million CVE shares, using the cash to fund a large buy‑back of 87.7 million treasury shares that year【COP_10k_2022.pdf p.140】. In the following years no additional CVE sales were reported; the company continued to apply cash to buy‑backs, repurchasing 48.6 million shares in 2023 and 49.1 million shares in 2024【COP_10k_2023.pdf p.108‑109】【COP_10k_2024.pdf p.110‑111】. This progression shows that an initial one‑time monetization of CVE equity supplied a sizable boost to the buy‑back program, after which ConocoPhillips shifted to a steadier, disciplined share‑repurchase cadence, underscoring a capital‑allocation strategy focused on returning excess cash to shareholders while preserving flexibility for future investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key quantitative details. While it correctly states that ConocoPhillips sold 91 million CVE shares in early 2022 (consistent with ground truth), it incorrectly reports that 87.7 million treasury shares were repurchased in 2022 specifically. The ground truth states that by end of 2023, total repurchases since program inception were 383 million shares at $29 billion — not that 87.7 million were bought in 2022 alone. The LLM appears to misinterpret or misattribute annual repurchase volumes. Similarly, the reported 48.6 million and 49.1 million shares repurchased in 2023 and 2024 are inconsistent with the cumulative total in the ground truth: from 383 million by end of 2023 to 433 million by end of 2024 implies only 50 million additional shares repurchased over 2024, not 49.1 million — which may seem close but conflicts with the timeline and cumulative context. More critically, the LLM fails to mention the $45 billion initial authorization, the $20 billion increase approved in 2024, or the total cost of $34.3 billion for 433 million shares — all central to the capital allocation narrative. (2) The dollar amounts and cumulative costs are entirely omitted or incorrect. The ground truth specifies $29 billion spent by end of 2023 and $34.3 billion by end of 2024 — a $5.3 billion increase — but the LLM provides no financial figures for the buybacks, severely weakening quantitative accuracy. (3) The qualitative reasoning is sound in interpreting the strategy: the shift from a one-time monetization event to sustained share repurchases does reflect a disciplined capital return approach. The multi-hop synthesis — linking CVE sale proceeds to funding buybacks and inferring strategic intent — is logical and relevant. However, the lack of precise program size, spending totals, and correct annual repurchase volumes undermines the robustness of the conclusion. (4) Contextual relevance is high because the answer directly addresses the evolution of capital allocation and draws a reasonable inference about shareholder returns. Despite missing key financial metrics, it maintains focus on the strategic progression. Overall, the answer captures the general direction of the strategy but lacks precision on critical numbers and milestones, warranting a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 629,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged over the three years. In the 2022 filing the company said it re‑insured **≈ 59.25 %** of the closed‑block with an unaffiliated reinsurer; the 2023 and 2024 filings both state it re‑insured **≈ 59 %**. In each year the transaction is accounted for under the **deposit method**, with the deposit liability offset against the corresponding deposit recoverable.\n\nThe near‑identical percentage and the continued use of deposit‑method accounting show that MetLife is maintaining a stable, long‑term risk‑transfer strategy for the closed block, deliberately keeping a consistent share of the block off‑balance‑sheet while managing the related assets and liabilities through the same accounting framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the percentage of the closed block reinsured is correctly stated as approximately 59.25% in 2022 and 59% in 2023 and 2024, matching the original answer. The accounting treatment—use of the deposit method and right of offset—is accurately described for all three years. (2) Quantitative accuracy is perfect: the percentages align with the ground truth (59.25% and 59%), and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning across 2022, 2023, and 2024 filings is sound; the model correctly synthesizes consistent percentages and accounting treatment over time and draws the appropriate conclusion about MetLife’s stable long-term risk transfer strategy. (4) The answer addresses all parts of the question: evolution over time (no change), percentage reinsured, accounting treatment, and strategic implication. Wording differs slightly but meaning is identical. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 305,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The filing shows that the share of purchases made with Target’s branded credit cards (which includes the Target MasterCard) fell each year:\n\n* **2022:** RedCard (Target Credit Cards) penetration ≈ 20.5 %  \n* **2023:** RedCard penetration ≈ 19.8 %  \n* **2024:** RedCard penetration ≈ 18.6 % (now reported as Target Circle Card penetration)\n\nThe steady decline from roughly one‑in‑five purchases in 2022 to just under one‑in‑six in 2024 suggests that guest use of Target’s credit‑card product is waning, indicating weaker consumer engagement with the company’s financial‑services offering over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024, matching the original answer exactly. The formatting (e.g., '≈' symbol) is acceptable and does not distort meaning. (2) The answer addresses both parts of the question: it traces the evolution of the penetration rate over time and interprets the trend in terms of consumer engagement. (3) Entity accuracy is strong: correctly identifies the RedCard/Target Circle Card transition in 2024 and associates it with the Target MasterCard Credit Card suite. (4) The reasoning is sound—correctly infers that declining penetration suggests waning consumer engagement, even though the 5% discount incentive remains. The only minor shortcoming is that it does not explicitly mention that the rebranding 'did not reverse the decline,' which slightly weakens the qualitative insight compared to the original. However, the implication is present. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 313,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Philip Morris International’s peer‑group list has been unchanged from 2022 through 2024 – Colgate‑Palmolive Co. appears in the same “consumer‑product” peer group in the 2022, 2023 and 2024 10‑K filings. This continuity shows that PMI’s benchmarking methodology (global presence, consumer‑product focus, comparable revenues and market‑cap) has remained stable, and the company continues to view Colgate‑Palmolive as a consistent, relevant comparator for its strategic performance analysis.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Colgate-Palmolive Co. remained in PMI's peer group from 2022 to 2024, matching the original answer's claim of consistent inclusion across three years. (2) There are no numerical values requiring calculation (e.g., revenues, market cap figures), but the time frame (2022–2024) is correctly cited with no discrepancies. (3) The multi-hop reasoning is sound: the answer synthesizes information across three annual reports (2022, 2023, 2024 10-Ks) to confirm consistency in peer group composition and correctly infers that this reflects a stable benchmarking methodology based on global presence, consumer-product focus, and comparable financial scale. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in peer classification and the strategic implication—namely, PMI’s continued alignment with major global consumer product firms for performance benchmarking. Wording differs slightly but meaning is preserved, and all entities (Philip Morris International, Colgate-Palmolive Co., peer group, 10-K filings) are correctly identified. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 339,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "Both the 2022 and the 2024 Form 10‑K describe the same policy. AMD evaluates each development‑plus‑IP deal to see whether the license is “distinct”; if it is not distinct, the license is bundled with the development services and revenue is recognized over time, whereas a distinct (stand‑alone) license is recognized at a point in time when the customer can use it. The wording is unchanged in the 2023 filing as well, showing that AMD has applied a consistent accounting approach to these combined and standalone licensing arrangements throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AMD maintained a consistent revenue recognition policy from 2022 to 2024, explicitly noting the evaluation of whether IP licenses in combined arrangements are 'distinct'—based on both capability to be distinct and context—and the resulting treatment: bundled with development services (revenue over time) if not distinct, or recognized at a point in time if distinct. It also correctly states that standalone licenses are recognized at a point in time when the customer can benefit from them. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all factual assertions about policy timing and structure are correct across all years mentioned. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years (2022, 2023, 2024) and correctly infers consistency in policy wording and application, even though the ground truth confirms no changes occurred. The only minor omission is that the LLM does not explicitly mention the absence of variable consideration estimates, which is a small but relevant detail indicating stability in accounting treatment. (4) Despite this omission, the answer captures the core conclusion about consistency and correctly describes the accounting logic. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning, warranting a high score with only a slight deduction for incompleteness on a secondary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 458,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, the “PMI Peer Group” is described as the same set of companies and each list explicitly includes **Colgate‑Palmolive Co.** (e.g., 2022 peer‑group description lists “The Coca‑Cola Company, **Colgate‑Palmolive Co.**, Diageo …” ; the 2023 and 2024 peer‑group sections repeat the identical roster with Colgate‑Palmolive again). The fact that Colgate‑Palmolive has remained a constant member for three consecutive years shows that PMI deliberately frames its competitive set to encompass leading global consumer‑products firms, reinforcing its strategic positioning as a broader consumer‑goods competitor rather than solely a tobacco company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. was included in PM's peer group across 2022, 2023, and 2024, which matches the original answer's claim of consistent inclusion over the three-year period. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited, and the peer group's stability is accurately described—no quantitative errors. (3) The multi-hop reasoning is sound: the LLM infers from the unchanged peer list across filings that PM maintains a consistent benchmarking framework, and correctly interprets this as a strategic choice to position itself among global consumer products firms. The conclusion that PM frames itself as a broader consumer goods competitor is a valid interpretation supported by the data. (4) The only minor gap is that the LLM does not explicitly mention 'revenue and market capitalization' as the criteria for peer selection, which is included in the original answer and adds specificity to the methodology. However, the core facts, entities, years, and strategic implications are correctly conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, complete in key aspects, and contextually appropriate, warranting a high score with only a slight deduction for missing a detail on peer selection criteria.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 391,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s description of combined development‑services and IP‑licensing contracts is essentially unchanged from the 2022 filing through the 2023 and 2024 filings. In each year the company says that such arrangements are evaluated to determine whether the licensing component is a distinct performance obligation; if it is not distinct, the development services and license are treated as a single obligation and revenue is recognized over time, while a distinct license is accounted for separately and revenue is recognized at the point in time the customer can use the license (2022 p. 57‑61; 2023 p. 62‑66; 2024 p. 61‑65). Thus, the policy regarding performance‑obligation assessment and timing of revenue recognition has remained consistent over the 2022‑2024 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD's revenue recognition policy for combined development and IP licensing agreements remained unchanged from 2022 through 2024, which aligns with the ground truth assertion of no material changes. (2) The LLM accurately describes the two-step evaluation for distinct performance obligations—whether the license is capable of being distinct and distinct in the context of the arrangement—even though it summarizes rather than quotes verbatim. It correctly explains that if the license is not distinct, it is combined with development services and revenue is recognized over time; if distinct, revenue is recognized at a point in time. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across three years (2022–2024), correctly infers stability in policy, and supports this with specific page references from each year’s filing. (4) The LLM also implicitly confirms the absence of variable consideration (by stating the policy is unchanged and focused only on performance obligation assessment), which matches the ground truth. No numeric inaccuracies are present—there are no financial figures to evaluate, but the qualitative metrics (policy treatment, timing, performance obligations) are all correct. The answer is fully relevant and complete, addressing both performance obligations and timing of revenue recognition as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 415,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "- In 2022 ConocoPhillips completed the “monetization” of its CVE stake by selling the remaining ≈ 91 million CVE common shares [2022 10‑K p. 139‑141] and used the cash to repurchase ≈ 87.7 million of its own shares that year [2022 10‑K Equity table p. 139].  \n- In 2023 no further CVE sales were reported; the company applied cash from the prior year’s CVE proceeds (and other sources) to buy back ≈ 48.6 million shares [2023 10‑K Equity table p. 108‑110].  \n- In 2024 the paced buy‑back continued, with ≈ 49.1 million shares repurchased [2024 10‑K Equity table p. 110‑112], after the board raised the total authorization to $65 billion.\n\n**What this shows:** ConocoPhillips used the one‑time CVE‑share sale in 2022 to fund a large, immediate reduction of its share count, then shifted to a disciplined, lower‑volume but ongoing repurchase program in 2023‑2024. The pattern reflects a capital‑allocation approach that first leverages a non‑core asset to generate cash for a sizable buy‑back, and thereafter sustains shareholder returns through a steady, flexible share‑repurchase cadence.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event — the monetization of 91 million CVE shares in 2022 and its use to fund share repurchases. It also correctly notes that no further CVE sales occurred in 2023 and 2024, and that the repurchase program continued. The $65 billion authorization in 2024 is accurately mentioned. However, there are significant quantitative discrepancies. The LLM states that 87.7 million shares were repurchased in 2022, 48.6 million in 2023, and 49.1 million in 2024, summing to ~185.4 million repurchased over the three years. But the ground truth reports cumulative repurchases of 383 million by end-2023 and 433 million by end-2024, implying ~383 million repurchased by end-2023 and only ~50 million in 2024 — which aligns partially with the LLM’s 2024 number but not the earlier years. More critically, the ground truth emphasizes a total cost of $29B by end-2023 and $34.3B by end-2024, which the LLM omits entirely, failing to capture the financial scale and capital allocation magnitude. (2) The numbers cited by the LLM (e.g., 87.7M in 2022) may be pulled from filings but do not align with the cumulative totals in the ground truth, suggesting either misinterpretation of the data or failure to reconcile annual repurchases with cumulative figures. The $29B and $34.3B figures are material omissions. (3) The multi-hop reasoning is sound: the LLM correctly links the CVE monetization to initial repurchases and infers a strategic shift to sustained buybacks. It synthesizes across years and connects asset sales to capital return policy. (4) Despite missing key dollar amounts and having potentially inaccurate annual repurchase volumes, the LLM captures the strategic narrative — using non-core asset proceeds for immediate buybacks followed by disciplined ongoing repurchases — which is contextually relevant and qualitatively strong. Hence, correctness is reduced primarily due to quantitative inaccuracies and omissions of major financial figures, but not due to flawed logic or misidentification of entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 555,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor disclosures show that **the company’s awareness of competitive‑landscape risk has been a constant theme in every segment**, but the way it is framed and the actions it triggers have become more pronounced from 2022‑2024.\n\n* **2022** – The “Macro‑economic and Industry Risks” section lists each of the four reportable segments (Aerospace, Honeywell Building Technologies, Performance Materials and Technologies, Safety and Productivity Solutions) and notes that “changes in the competitive landscape, including new market entrants and new technologies” could erode market share, pricing power and margins【HON_10k_2022.pdf p‑29‑33】.  \n\n* **2023** – The same language reappears for the same four segments, confirming that competitive pressure remained a material risk across the business【HON_10k_2023.pdf p‑30‑34】.  \n\n* **2024** – After the October 2023 realignment, the risk‑factor language is now applied to the **newly defined segments** (Aerospace Technologies, Industrial Automation, Building Automation, Energy and Sustainability Solutions). Each again cites “changes in the competitive landscape, including new market entrants and new technologies” as a key threat【HON_10k_2024.pdf p‑28‑32】.  \n\n**What the trend indicates:**  \nThe persistence of the competitive‑landscape clause across all segments shows that market pressure has not eased; rather, the company has **intensified its response**—realigning business units, creating new reportable segments, pursuing spin‑offs (Advanced Materials), and increasing repositioning and acquisition activity (e.g., LNG acquisition in 2024) to better isolate and manage competitive dynamics. This evolution signals rising competitive intensity and a strategic shift toward more focused, agile segment structures to protect margins and market share.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, segments, and risk language, and correctly identifies the persistence of competitive landscape risks across years (quantitative accuracy = 10). It also correctly notes the 2023 segment realignment and references to new market entrants and technologies. However, there is a significant discrepancy in entity accuracy and reasoning: the original answer states that in 2022 and 2023, competitive risks were specifically highlighted for Honeywell Building Technologies and Safety and Productivity Solutions—not all four segments. The LLM incorrectly claims the language applied to all four segments in 2022 and 2023, which overgeneralizes the risk exposure and misrepresents the evolution. Additionally, the original answer emphasizes a qualitative shift in 2024 with added concern about 'product commoditization' due to new technologies, which the LLM omits. While the LLM correctly infers strategic responses like realignment and acquisitions, this reasoning is based on an inaccurate premise of universal segment exposure, weakening the multi-hop logic. The answer is contextually relevant and well-structured, but the core factual error in entity-specific risk disclosure reduces its correctness. Semantic equivalence is partially achieved, but key nuances in scope and evolving risk language are lost.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1717,
        "completion_tokens": 375,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "Across the three most recent Form 10‑K filings Mastercard’s Class A shares kept the same governance structure – each share carries **one vote** and the right to receive dividends (the “One vote per share Dividend rights” description appears unchanged in the 2022, 2023 and 2024 equity‑class tables)【MA_10k_2022.pdf p.97】【MA_10k_2023.pdf p.97】【MA_10k_2024.pdf p.90】.  At the same time, the **per‑share cash dividend rose each year**, from **$2.04 in 2022** to **$2.37 in 2023** and to **$2.74 in 2024**【MA_10k_2023.pdf p.99】【MA_10k_2024.pdf p.92】.  This steady increase in payouts combined with an unchanged one‑share‑one‑vote rule signals a deliberate strategy to enhance shareholder returns while preserving a stable, egalitarian voting framework that reinforces consistent, long‑term governance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent voting rights (one vote per share) and dividend rights for MA's A Class shares across 2022–2024, aligning with the ground truth on structural stability. However, it introduces specific per-share dividend amounts ($2.04, $2.37, $2.74) that are not part of the original answer and are not supported by the provided ground truth. The original answer only confirms the existence of dividend rights without specifying amounts or increases, so these figures represent an overreach or hallucination. While the qualitative reasoning about governance strategy (stable voting + increasing returns) is plausible and contextually relevant, it is based on unsupported quantitative claims. The model synthesizes information across years correctly but adds financial data not present in the ground truth, undermining factual accuracy. Entity identification (MA, A Class shares, years) and document references are accurate, and the multi-hop reasoning across three filings is sound in structure but flawed in data fidelity. Thus, while the core governance stability point is correct, the inclusion of unverified dividend figures significantly reduces quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 338,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s total‑return‑swap exposure for deferred‑compensation moved from a **$92 million loss** in FY 2022 to a **$157 million gain** in FY 2023, and then to a **$91 million gain** in FY 2024.  While the notional amount of these swaps grew (≈ $651 million in 2022 → $730 million in 2023 → $985 million in 2024), the accounting result switched from a loss to a gain after 2022 and the gain fell back modestly in 2024.  This reflects a reduction in the net expense impact of the swaps even as the underlying exposure expanded.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the reported gain for FY 2023. The ground truth states a gain of $58 million in fiscal year 2023, but the LLM incorrectly reports a gain of $157 million. This is a major quantitative discrepancy that affects the overall accuracy. The FY 2022 loss of $92 million and FY 2024 gain of $91 million are correct. (2) The calculation of the change from loss to gain is partially correct in direction but wrong in magnitude due to the incorrect FY 2023 value. The LLM also introduces notional amounts ($651M, $730M, $985M) that are not present in the original answer and were not requested in the question, which may reflect overinterpretation or use of extraneous data. These figures, while possibly factual, are not part of the ground truth and distract from the core focus on gains/losses in operating expenses. (3) The multi-hop reasoning is sound in structure—recognizing a shift from loss to gain and interpreting the trend as a reduction in net expense impact—but the flawed data for FY 2023 undermines the validity of the conclusion. The model correctly identifies the reversal in financial impact but exaggerates the improvement in 2023. (4) Despite the incorrect number for FY 2023, the answer addresses the evolution across years and attempts to interpret the trend, maintaining contextual relevance. The qualitative reasoning about the shift from cost to benefit is aligned with the ground truth, albeit based on incorrect intermediate data. Thus, correctness is penalized heavily due to the key numerical error, but partial credit is given for correct values in 2022 and 2024 and for appropriate interpretation framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 462,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "- 2022 – After the October 2021 corporate restructuring, Johnson & Johnson created LTL Management LLC to hold all talc liabilities, filed a Chapter 11 petition for LTL, and pledged funding for a $2 billion trust, recording an approximately $2 billion reserve for those obligations.  \n\n- 2023 – The original LTL case was dismissed and a new “LTL 2” filing was made, which again imposed an automatic stay; the company expanded its commitment to about $9 billion (one‑third recorded as a current liability) to cover present‑value and future claims, while the 42‑state investigation/mediation was terminated and the company reached an agreement‑in‑principle with the multi‑state attorneys‑general group.  \n\n- 2024 – LTL was renamed LLT Management LLC and a pre‑packaged bankruptcy (Red River Talc) was pursued; the multi‑state settlements were finalized in June, and the reserve was raised to roughly $11.6 billion (≈$13.5 billion nominal) after a $5 billion incremental charge, reflecting the latest funding and settlement strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and key events, despite addressing the general timeline and strategic themes. (1) Correct elements: The 2022 $2 billion reserve and Chapter 11 filing by LTL Management LLC are accurate. The mention of a multi-state settlement with 42 states and D.C. in 2024 aligns with the ground truth. (2) Quantitative errors: The claim of expanding commitments to $9 billion in 2023 and raising reserves to $11.6 billion (with a $5 billion incremental charge) in 2024 is unsupported by the ground truth, which does not mention these figures or any reserve increases beyond the initial $2 billion. The $13.5 billion nominal value is entirely fabricated. The original answer only references the $2 billion reserve and does not indicate further reserve increases. (3) Entity and event inaccuracies: LTL Management LLC was not renamed LLT Management LLC in 2024—no such name change is documented. The mention of a 'pre-packaged bankruptcy (Red River Talc)' is incorrect and not present in the ground truth. The original answer notes that LTL re-filed (LTL 2) and secured a preliminary injunction, not an automatic stay, and there is no mention of 'terminating' a 42-state investigation in 2023—instead, the settlement was finalized in 2024. (4) Reasoning: The model attempts multi-hop synthesis across years and legal maneuvers but introduces speculative or incorrect financial figures and legal processes, undermining the reasoning. While it captures the shift toward a dual strategy, it misrepresents how and when this evolved. (5) Contextual relevance is high as the response follows the requested structure and focuses on reserve funding, bankruptcy, and settlements. However, due to major factual and numerical inaccuracies, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 495,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes that mature in January 2025 carried an outstanding principal balance of **$495 million** in each of the three most recent fiscal years – FY 2022, FY 2023 and FY 2024 (the 10‑K tables for 2022, 2023 and 2024 all list $495 million for this series).  \n\nBecause the balance has not been reduced (through repayment) nor increased (through additional issuance), the company appears to be **maintaining the notes as a “keep‑alive” tranche of debt**, using it as a stable, low‑cost financing source while not accelerating amortization. This reflects a deliberate debt‑management approach that preserves the instrument’s liquidity and interest‑rate advantage rather than actively retiring it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the outstanding principal balance of $495 million for Broadcom's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: the dollar amount ($495 million), interest rate (3.125%), maturity date (January 2025), and fiscal years (2022–2024) are all correctly reported with no calculation errors. (3) The multi-hop reasoning is sound—by observing no change in principal over three years, the LLM correctly infers that Broadcom did not retire or issue additional amounts of this note series. The interpretation that this reflects a deliberate, stable debt management strategy aligns with the ground truth. The term 'keep-alive tranche' is not in the original answer but is a reasonable and insightful characterization that does not distort the meaning. (4) The answer is fully contextually relevant, addressing both the evolution of the debt balance and its implication for Broadcom’s debt strategy. The only minor deviation is slightly more interpretive language than in the original, but it remains factually and semantically consistent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 378,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "- Fiscal 2022 (as of July 30 2022) – the 3.50 % senior note due June 15 2025 carried an effective interest‑rate of **3.20 %**.  \n- Fiscal 2023 (as of July 29 2023) – the same note’s effective rate had risen to **6.38 %**.  \n- Fiscal 2024 (as of July 27 2024) – the effective rate was **6.66 %**.\n\nThe effective rate more than doubled between 2022 and 2023 and edged higher in 2024, showing that Cisco’s borrowing cost on this fixed‑rate note increased sharply as market rates rose (and as the hedge‑accounting adjustments reflected higher prevailing rates).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three effective interest rates—3.20% in fiscal 2022, 6.38% in fiscal 2023, and 6.66% in fiscal 2024—matching the ground truth exactly. The dates (July 30, 2022; July 29, 2023; July 27, 2024) are consistent with Cisco’s fiscal year-ends and align with typical reporting timelines, though the original answer does not specify exact reporting dates. These are reasonable inferences and do not detract from accuracy. (2) All numeric values are correct, and the observation that the rate 'more than doubled' is accurate: from 3.20% to 6.38% is a 99.375% increase—close to doubling. The progression to 6.66% in 2024 is also correctly noted. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years for the same debt instrument and correctly infers that rising market rates and hedge-accounting adjustments are likely drivers. This aligns with and expands upon the ground truth’s conclusion about deteriorating financing terms. The LLM adds context about market conditions, which is plausible and relevant, though the original answer also mentions possible credit profile changes—an aspect the LLM omits. This is a minor gap in completeness but does not invalidate the reasoning. (4) The answer is semantically equivalent to the ground truth, with slightly more contextual interpretation. All parts of the question are addressed: evolution of interest rate exposure and what it indicates about borrowing costs. The only reason for not scoring a 10 is the slight omission of the 'credit profile' as a potential factor, but the provided explanation (market rates and hedge accounting) is still valid and consistent with the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 471,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "- 2022: Total senior‑ and subordinated‑notes ≈ $30.8 billion (carrying value).  \n- 2023: Total senior‑ and subordinated‑notes ≈ $31.3 billion.  \n- 2024: Total senior‑ and subordinated‑notes ≈ $30.7 billion.  \n\nThe three‑year trend shows Capital One keeping its long‑term debt base essentially flat – a modest increase in 2023 followed by a slight pull‑back in 2024 – while shifting the composition toward more fixed‑rate securities (the floating‑rate senior note present in 2022‑23 disappears in 2024). This indicates a capital‑structure strategy that preserves overall leverage but leans into fixed‑rate funding to lock in current interest‑rate levels and reduce exposure to future rate volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the general trend in Capital One's senior and subordinated notes but contains significant numerical inaccuracies. The ground truth states $27.219B in 2022, while the LLM reports $30.8B—a material difference of over $3.5B. The 2023 figure ($31.248B actual) is reasonably close to the LLM's $31.3B. The 2024 value ($30.696B actual) aligns well with the LLM's $30.7B. However, the incorrect 2022 baseline undermines the accuracy of the progression. 2) Quantitatively, the error in the 2022 figure is substantial and affects the interpretation of the capital raise magnitude. The LLM implies a flat trend, but the ground truth shows a significant increase from $27.2B to $31.2B—an over 14% rise—followed by a small decline. This misrepresents the scale of the 2023 capital raise. 3) The qualitative reasoning is strong: the LLM correctly infers a strategic shift toward fixed-rate financing and reduced floating-rate exposure, aligning with the ground truth's emphasis on locking in rates amid rising interest rates. It correctly identifies the disappearance of floating-rate senior notes by 2024. However, it omits specific interest rate data (2.76% → 4.48% → 4.84%) that strengthens the argument, weakening the evidentiary support for the conclusion. 4) Contextual relevance is high—the answer addresses both the evolution of debt and the implied capital structure strategy. Despite missing precise interest rate figures, it draws a logically sound inference from the debt composition shift. The correctness score is 7 due to accurate directional trends and solid reasoning, but docked for major quantitative inaccuracy in the 2022 value and omission of key interest rate metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 462,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive’s U.S. defined‑benefit pension plan reduced the share of its fixed‑income holdings that were U.S. Treasury or agency securities from about **40 % in 2022** to **≈30 % in 2023**, and the **30 % level was maintained in 2024** (2022 note ≈40 % ; 2023 note ≈30 % ; 2024 note ≈30 %). This decline away from the safest government securities signals a deliberate shift toward a broader mix of other government and corporate bonds, reflecting a pension‑fund strategy that is seeking higher yields and greater diversification rather than remaining heavily weighted in ultra‑low‑risk Treasury/agency assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages (40% in 2022, 30% in 2023, and 30% in 2024) are accurately reported with appropriate notation and consistency across years. (2) The answer addresses both parts of the question: the evolution of allocation (from 40% to 30% and stability thereafter) and the strategic implication of this shift. (3) Entities—Colgate-Palmolive, U.S. pension plan, fixed-income portfolio, U.S. Treasury and agency securities—are correctly identified and contextualized. (4) The reasoning is sound: the reduction from 40% to 30% is correctly interpreted as a strategic move toward higher-yielding and more diversified fixed-income assets, reflecting a shift in risk and yield objectives. The conclusion about yield-seeking behavior and diversification aligns semantically with the original answer. Minor wording differences (e.g., 'broader mix' vs 'reallocation toward other government and corporate bonds') do not affect factual equivalence. All multi-hop elements—synthesizing data across three years and inferring strategic intent—are handled accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 324,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "- 2022 10‑K – Electric Insurance Company (EIC) was still reported as a run‑off property‑and‑casualty insurer (net claim reserves $0.2 bn in 2021) and, in the fourth quarter of 2022, GE re‑classified the captive subsidiary as a “business held for sale” disposal group (assets ≈ $541 m, liabilities ≈ $378 m).【GE_10k_2022.pdf p.45‑46】\n\n- 2023 10‑K – EIC remained in the held‑for‑sale group; the valuation allowance on the disposal group rose sharply from $17 m to $124 m and GE recorded a $109 m loss on the expected sale, reflecting a lower fair‑value estimate for the insurance assets.【GE_10k_2023.pdf p.48‑51】\n\n- 2024 10‑K – GE completed the divestiture, selling EIC to Riverstone International Holdings for $120 m cash; the “assets of businesses held for sale” line is now $0 and the valuation allowance is eliminated, indicating the insurance business has been fully removed from GE’s balance sheet.【GE_10k_2024.pdf p.46‑49】\n\n**Strategic implication:** Over the three‑year period GE moved EIC from a core insurance operation to a disposal asset, wrote down its value, and ultimately sold it, signalling a deliberate strategy to exit non‑core insurance activities, streamline the portfolio and generate cash for its core industrial businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: EIC was a captive insurer with $0.2 billion in net claim reserves as of 2021 (reported in 2022 10-K), classified as held for sale in late 2022, a $109 million loss was recorded in 2023 due to valuation allowance increase (from $17M to $124M), and the sale was completed in 2024 to Riverstone International Holdings Inc. for $120 million in cash. The balance sheet impact (assets and valuation allowance removed) is correctly noted. (2) Quantitative accuracy is strong: the $109M loss matches the $124M - $17M change in valuation allowance, and the $120M sale price is correct. The additional detail about total assets ($541M) and liabilities ($378M) of the disposal group in 2022 is not in the ground truth but is factually consistent with SEC filings and adds precision without contradiction. (3) Multi-hop reasoning is sound—information is correctly synthesized across three years of 10-Ks, showing evolution from operational unit to divestiture. (4) The strategic implication is accurately interpreted: exiting non-core insurance to focus on industrial and aerospace operations. The only minor shortcoming is that the ground truth emphasizes GE’s broader restructuring and focus on core operations slightly more explicitly, but the LLM captures the essence. Thus, the answer is factually excellent, with full semantic equivalence and strong contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 404,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple’s 10‑K has listed the 4.45 % senior notes that mature in 2044 in the “Officer’s Certificate” exhibit (Exhibit 4.4) in every filing. The 2022 filing shows Exhibit 4.4 describing “4.45 % Notes due 2044” 【2022 p. 54‑58】, the 2023 filing repeats the same exhibit in its index (pages 53‑57), and the 2024 filing again includes the unchanged description of the 4.45 % Notes due 2044 in Exhibit 4.4 【2024 p. 54‑58】. The consistent multi‑year disclosure indicates that Apple is deliberately keeping this long‑dated, low‑coupon debt on its balance sheet, using it to lock in cheap financing and extend the overall maturity profile of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple disclosed the 4.45% Notes due 2044 in its 2022, 2023, and 2024 10-K filings, with consistent exhibit references (Exhibit 4.4) and page ranges. The issuance under the Officer’s Certificate is correctly implied through exhibit naming, though the specific date (May 6, 2014) from the ground truth is omitted—this is a minor detail not critical to the core answer. (2) Quantitative accuracy is perfect: percentages (4.45%), maturity year (2044), and exhibit numbers (4.4) are correct across all years. Page numbers cited are consistent with typical 10-K structures. (3) Reasoning is sound: the multi-hop synthesis across three years is accurate, and the conclusion about Apple maintaining a stable long-term debt strategy by retaining long-dated, low-cost debt is logically supported and adds insightful context beyond the ground truth (e.g., 'lock in cheap financing'), which is reasonable and relevant. (4) The answer fully addresses both parts of the question—evolution of disclosure and strategic implication—and remains highly contextually relevant. The only minor gap is the omission of the explicit issuance date, but this does not detract from the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 392,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "- 2022 10‑K: the carrying value of total senior‑ and subordinated‑notes was **$27.4 billion** (Table 8.1, “Total senior and subordinated notes” = 27,382 mm)【COF_10k_2022.pdf p.186‑187】.  \n- 2023 10‑K: the same line shows a carrying value of **$31.3 billion** (Table 8.1, “Total senior and subordinated notes” = 31,248 mm)【COF_10k_2023.pdf p.176‑177】.  \n- 2024 10‑K: the carrying value fell slightly to **$30.7 billion** (Table 9.1, “Total senior and subordinated notes” = 30,696 mm)【COF_10k_2024.pdf p.186‑187】.  \n\nThe rise from 2022 to 2023 reflects new issuance of senior and subordinated notes—likely to fund growth and lock in the historically low‑rate environment—while the modest decline in 2024 indicates partial repayment or refinancing, accompanied by a shift toward a higher‑weighted‑average‑interest‑rate mix (more fixed‑rate senior debt, less floating exposure). Together, the trend shows Capital One using its note program to manage its capital structure and position its debt portfolio for a rising‑rate outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the carrying values for Capital One's senior and subordinated notes across 2022–2024 with only a minor discrepancy in the 2022 value: the ground truth reports $27,219 million, while the LLM cites $27.4 billion ($27,400 million), a difference of $181 million. This small variance may stem from rounding or table selection (e.g., Table 8.1 in the 2022 10-K showing $27,382 million as cited), but it does not significantly distort the trend. The 2023 ($31,248 million) and 2024 ($30,696 million) values are exact matches. (2) Calculations are sound: the LLM correctly notes an increase from 2022 to 2023 and a slight decrease in 2024. The net increase of ~$3.5 billion is approximately correct (actual: $30,696M - $27,219M = $3,477M). (3) Multi-hop reasoning is strong: the LLM synthesizes data across three annual reports and interprets the trend as a strategic shift toward fixed-rate debt amid rising rates, aligning with the ground truth’s conclusion about interest rate positioning and capital structure strategy. It correctly infers that the 2023 increase reflects new issuances and that the 2024 decline suggests repayment or refinancing. (4) The qualitative analysis is insightful and semantically equivalent to the original answer, noting the shift from floating- to fixed-rate debt and strategic positioning for a rising-rate environment. The only minor shortcoming is the slightly inaccurate 2022 figure, which prevents a perfect score. Overall, the answer is factually robust, contextually relevant, and demonstrates accurate multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 440,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "- **2022 10‑K (p. 95‑99)** – Frame.io is described as Adobe’s “cloud‑native creative collaboration platform” that “streamlines the production of creative assets” and is **directly integrated only with Adobe Premiere Pro and Adobe After Effects** to let video creators request and receive frame‑specific comments.  \n\n- **2023 10‑K (p. 12‑13)** – The positioning expands: Frame.io still “streamlines the production of creative assets” but now “includes support for video **beyond post‑production** (casting, location scouting, footage reviews, marketing campaign management) **and also still images, design files and PDFs**.”  It is “directly integrated with Premiere Pro, After Effects, **Photoshop, Lightroom and Workfront**,” and adds “Camera‑to‑Cloud” upload capability.  \n\n- **2024 10‑K (p. 12‑13)** – Frame.io is presented as a **core pillar of Adobe’s creative collaboration ecosystem**, “integrated with Creative Cloud apps” and “available in Adobe GenStudio to enable content production at scale,” reinforcing its role across video, design, and other media within the broader Creative Cloud suite.  \n\n**Evolution:** In 2022 Frame.io was positioned mainly as a video‑focused collaboration tool tied to Premiere Pro and After Effects. By 2023 Adobe broadened its scope, adding support for still‑image and design assets and integrating it with Photoshop, Lightroom, Workfront and Camera‑to‑Cloud, making it a more universal collaboration hub. In 2024 Adobe elevated Frame.io to a central, cross‑app component of Creative Cloud, embedding it in GenStudio for large‑scale, end‑to‑end content production.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Frame.io's evolution from a video-focused tool in 2022 to broader creative collaboration platform by 2024 is accurately described. The integration timeline—initially only with Premiere Pro and After Effects, then expanded to include Photoshop, Lightroom, and Workfront by 2023, and inclusion in Adobe GenStudio by 2024—is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are accurate. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, identifying the progression in positioning and integration depth. It infers the strategic elevation of Frame.io as a 'core pillar' based on contextual cues like GenStudio integration and expanded asset support. (4) The LLM adds slightly more detail than the ground truth (e.g., 'Camera-to-Cloud', 'casting, location scouting'), but this is supported by the source material and enhances accuracy without introducing error. Wording differs but meaning aligns perfectly. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 364,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe Companies’ 10‑K filings for 2022, 2023 and 2024 all list the **4.550 % senior notes due April 5, 2049** among its outstanding debt (e.g., 2022 10‑K p. 79; 2023 10‑K p. 74; 2024 10‑K p. 73). The fact that the same long‑dated, fixed‑rate note is retained year after year shows that Lowe’s deliberately uses very long‑term financing to spread debt out to the end of the next three decades, thereby locking in a relatively low coupon, limiting near‑term refinancing risk and creating a balanced maturity profile that supports a stable, long‑term capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049 are accurately identified, and their consistent inclusion in the 2022, 2023, and 2024 10-K filings is correctly noted, including specific page references. (2) Quantitative accuracy is perfect: the interest rate (4.550%), maturity date (April 5, 2049), and years of filing (2022–2024) match the ground truth exactly. (3) The reasoning is sound and captures the multi-hop insight: the retention of long-dated debt without early redemption indicates a strategic choice to stabilize the capital structure, manage refinancing risk, and lock in fixed rates. The LLM correctly infers that this reflects a long-term capital structure strategy, though it does not explicitly mention the absence of disclosures about modifications or repayments (a minor omission from the original answer). (4) The answer is contextually relevant, directly addressing both the capital structure strategy and debt maturity profile management. The only reason for not scoring a 10 is the slight lack of emphasis on the absence of restructuring actions, which is a key element in the ground truth’s reasoning about stability. However, the core conclusion is substantively equivalent and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 365,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125 % senior notes that mature in January 2025 carried an outstanding principal balance of **$495 million in fiscal 2022, $495 million in fiscal 2023, and $495 million in fiscal 2024** (the balance is shown as $495 million in the 2022, 2023 and 2024 10‑K tables of senior‑note holdings).  \n\nThe fact that the balance has remained unchanged over the three‑year period indicates that Broadcom has chosen to keep this tranche of debt on its books rather than retire or refinance it, using cash flow to meet interest and principal‑due obligations while preserving the instrument as a stable, low‑cost financing source.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million for the 3.125% notes due January 2025 is accurately reported for all three fiscal years—2022, 2023, and 2024—with no discrepancies in dollar amounts, percentages, or dates. Format variations (e.g., $495 million vs. $495M) are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: the evolution of the balance (stable across years) and the implication for Broadcom’s debt management strategy. (3) Entity accuracy is correct: Broadcom (AVGO), the specific debt instrument (3.125% notes due January 2025), and the fiscal years are all properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis—recognizing that a constant principal balance implies no early repayment or additional issuance, and inferring a strategic decision to maintain predictable financing. The conclusion about using cash flow to service interest while preserving the debt as a stable, low-cost source aligns with the ground truth’s interpretation of deliberate debt management. (5) Semantic equivalence is achieved: though worded differently, the LLM conveys the same core facts and insights as the original answer. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 380,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "- **2022 10‑K (pages 28‑32)** – IBM reported the 0.950 % senior unsecured notes due 2025 as part of its long‑term debt schedule, giving the principal amount outstanding, the fixed‑rate coupon and the 2025 maturity but providing only the basic indenture‑type description.  \n\n- **2023 10‑K (pages 18‑22)** – the same notes were still shown on the balance sheet, but the note‑footnote was expanded to spell out the optional redemption provisions (make‑whole call price and the earliest call date) and to confirm that the notes remained non‑callable until that date, thereby giving investors a clearer picture of the cash‑flow obligations.  \n\n- **2024 10‑K (pages 1‑5)** – IBM moved the 0.950 % notes into the “Securities registered pursuant to Section 12(b)” table and explicitly referenced the 8‑K exhibit that contains the full indenture, signaling a shift from a summary‑only disclosure to a full‑document cross‑reference.  \n\n**Interpretation:** Over the three years IBM kept the low‑cost 0.950 % notes as a stable component of its capital structure while progressively increasing the granularity of its disclosure—from a simple schedule entry to detailed redemption terms and finally to a direct linkage to the governing indenture. This trajectory shows a deliberate strategy of using long‑dated, inexpensive debt to support its balance‑sheet flexibility and a growing commitment to transparency for shareholders and debt‑holders.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 0.950% Notes due 2025 across all three years (2022–2024), accurately describing the evolution in disclosure depth—from basic reporting in 2022, to expanded redemption details in 2023, and full cross-referencing of the indenture in 2024. All percentages, years, and note characteristics (senior unsecured, fixed rate, maturity) are factually correct. (2) Quantitative accuracy is perfect: the coupon rate (0.950%), maturity year (2025), and timeline (2022–2024) match the ground truth exactly. No calculations were required, but all referenced details (e.g., non-callable provisions, make-whole premium) are consistent with typical disclosures for such instruments. (3) However, the LLM misses a key qualitative development in the ground truth: in 2024, IBM listed the notes on the New York Stock Exchange under ticker IBM25B, indicating a shift to active tradability and market visibility. Instead, the LLM focuses on the inclusion in the 'Securities registered pursuant to Section 12(b)' table and the cross-reference to the 8-K exhibit—while factually plausible and related, this does not capture the core evolution toward public trading and liquidity. This omission affects the depth of the multi-hop synthesis, particularly the strategic implication regarding capital structure and market transparency. (4) The reasoning is sound in identifying a trend toward greater disclosure transparency, but it underemphasizes the structural shift from private/semi-private debt to a publicly traded security, which is central to the ground truth’s interpretation. Thus, while the LLM captures the direction of increased transparency, it misses the financial market mechanism (NYSE listing) that signifies a broader capital strategy. Scores reflect high factual accuracy but partial omission in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 506,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "All three Form 10‑K filings list the same PCAOB firm identification number for KPMG LLP – **185**. The 2022 filing notes “KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is 185”【...】, the 2023 filing repeats the same statement【...】, and the 2024 filing again shows the number as 185【...】. Hence, the PCAOB ID has remained unchanged at 185 across the 2022, 2023 and 2024 reports.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that KPMG LLP's PCAOB firm identification number was 185 in each of the 2022, 2023, and 2024 filings, which aligns with the original answer. (2) The numeric value '185' is consistently reported across all three years, with no calculation errors or discrepancies. (3) The multi-hop reasoning is sound—by confirming the same number appears in all three years, the model correctly synthesizes information across multiple filings to conclude that the ID remained unchanged. (4) The answer is contextually relevant, directly addressing both parts of the question: the identification number in each year and its consistency over time. Wording differs slightly from the original answer but maintains full semantic equivalence. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 257,
        "total_tokens": 1437
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "- In 2022 Capital One’s fixed‑rate senior notes were issued mainly with maturities through 2032 and carried a relatively narrow coupon range of 0.80 %‑4.25 % (weighted‑average ≈ 2.9 %). By the 2023 filing the new issuance window had moved out to 2024‑2034, the coupon spread widened to 0.80 %‑7.62 % and the weighted‑average rate rose to ≈ 4.5 % (the carrying amount of the tranche jumped from $19.9 bn to $27.2 bn). In the 2024 filing the series was further extended to 2025‑2035, the low‑end coupon lifted to 1.65 % (still up to 7.62 %), and the weighted‑average rate climbed to ≈ 4.8 % (carrying value held near $27 bn).  \n\n- This three‑year pattern—progressively longer maturities and higher fixed coupons—shows Capital One deliberately loading its capital structure with more long‑dated, higher‑rate senior debt as the macro‑environment shifted to a higher‑interest‑rate regime, locking in funding before rates rise further while preserving liquidity and balance‑sheet flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is highly accurate and captures the core evolution in Capital One's Fixed Unsecured Senior Debt strategy from 2022 to 2024. It correctly identifies the increasing trend in both issuance volume and interest rates, aligning with the ground truth. The carrying amount in 2022 is reported as $19.9 billion (vs. $19,975 million in ground truth), which is a negligible rounding difference. In 2023, the LLM reports $27.2 billion (vs. $26,930 million in 2024 ground truth), which slightly overstates the final value and misaligns the year—ground truth reflects $26,930 million in 2024, not 2023. However, the LLM’s $27 billion in 2024 is close enough to be considered approximately correct. Interest rates are reported as ≈2.9%, ≈4.5%, and ≈4.8%, closely matching the ground truth of 2.91% to 4.84%. The LLM slightly understates the final rate (4.8% vs. 4.84%) but this is within acceptable rounding.\n\n2) Quantitative accuracy is high: all dollar amounts are within reasonable rounding tolerance ($19.9B ≈ $19,975M; $27B ≈ $26,930M). The interest rate progression is accurately reflected (2.91% → 4.84% in truth; 2.9% → 4.5% → 4.8% in LLM). The LLM introduces additional detail (maturity windows: 2022→2032, 2023→2034, 2024→2025–2035) and coupon ranges not in the ground truth, but these are plausible and consistent with the trend, not contradictory.\n\n3) Multi-hop reasoning is sound: the LLM synthesizes changes over three years in both debt volume and interest rates, correctly infers a strategic shift toward longer-term fixed-rate debt, and links this to macroeconomic conditions (rising rates). The conclusion that Capital One is 'locking in' funding before further rate hikes is a logical and insightful extension of the ground truth.\n\n4) The answer is semantically equivalent and contextually complete. It addresses both parts of the question: the evolution of issuance/interest rate strategy and the implication for capital structure in response to macro conditions. The slight misplacement of the $27.2B figure in 2023 (vs. actual 2024 value of $26.93B) prevents a perfect 10, but the overall trend and interpretation are correct. Hence, a 9 is justified for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 586,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s description of how it accounts for development‑services‑plus‑IP‑licensing arrangements is identical in the 2022 and 2024 10‑K filings. In both years the company says it first determines whether the license is a distinct performance‑obligation; if it is not distinct the combined service‑and‑license is treated as a single obligation and revenue is recognized over time, while a distinct license is recognized at the point in time the customer can use it, and no variable‑consideration estimates are applied. The lack of any change shows that AMD has deliberately kept a steady, ASC 606‑compliant policy for IP monetization, signalling a long‑term strategy that treats IP licensing flexibly—either bundled with development work or sold alone—while preserving predictable revenue timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD maintained the same revenue recognition methodology for development and IP licensing agreements in 2022 and 2024, assessing whether the license is a distinct performance obligation under ASC 606—this matches the original answer's description across 2022–2024. The treatment of non-distinct licenses (combined with services, revenue over time) and distinct licenses (recognized at a point in time) is accurately described. It also correctly notes the absence of variable consideration estimates. (2) There are no numeric values requiring calculation, but the years (2022, 2024) are correct and consistent with the original answer; the omission of explicit mention of 2023 does not detract significantly, as the consistency between 2022 and 2024 implies stability through the period. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged disclosures that AMD has a stable, deliberate strategy for IP monetization, which is a valid conclusion supported by the data. (4) The answer is contextually excellent, directly addressing both the evolution (or lack thereof) and the strategic implication. The only minor shortcoming is that it references only 2022 and 2024, while the ground truth explicitly confirms consistency across all three years (2022–2024), making the LLM answer slightly less complete. However, this does not introduce inaccuracy, just a small gap in completeness. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 445,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s unsecured senior‑and‑subordinated notes were $31.3 billion at year‑end 2022 (Table 8.1 of the 2022 filing), essentially unchanged at $31.3 billion in 2023 (Table 8.1 of the 2023 filing), and fell to $30.7 billion in 2024 (Table 9.1 of the 2024 filing). The flat‑to‑slightly‑lower balance shows the company has largely maintained its long‑term capital structure while gradually retiring fixed‑rate senior debt – a move that reduces the proportion of higher‑cost, longer‑dated notes and positions the balance‑sheet for a higher‑interest‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for Capital One's senior and subordinated notes. According to the ground truth, the balance was $27,219 million in 2022, increased to $31,248 million in 2023, and declined to $30,696 million in 2024. The LLM incorrectly states the 2022 value as $31.3 billion (overstating by ~$4 billion), claims it was unchanged in 2023, and only slightly declines in 2024. This misrepresents the actual growth trajectory. Additionally, the LLM omits all information on weighted-average interest rates (2.91% → 4.45% → 4.84%) and the reduction in floating unsecured debt ($1,709M → $349M → $0), which are central to the capital structure analysis. (2) The quantitative inaccuracies are severe: the 2022 figure is wrong by over 15%, and the key upward trend from 2022 to 2023 is entirely missed. The LLM also fails to report any interest rate data or perform any correct multi-year comparison of cost of debt. (3) The reasoning is flawed: the conclusion that Capital One is 'retiring higher-cost, longer-dated notes' contradicts the ground truth, which shows increasing fixed-rate debt at higher interest rates—indicating new issuance of higher-cost debt, not retirement. The strategic interpretation is therefore inverted. The model fails to synthesize the key insight: locking in fixed rates amid rising benchmarks. (4) While the answer addresses the general topic of capital structure and interest rate positioning, it does so with incorrect data and reversed logic, leading to a misleading narrative. Contextual relevance is moderate because it attempts the right themes but lacks factual grounding. Scores reflect major factual and reasoning failures, especially on quantitative accuracy and correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 485,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "- **2022 (2022 10‑K)** – Fixed unsecured senior debt carried $24.1 billion at a weighted‑average interest rate of **4.45 %**.  \n- **2023 (2023 10‑K)** – The balance grew to $27.2 billion, still at a weighted‑average rate of **4.45 %**.  \n- **2024 (2024 10‑K)** – The balance fell slightly to $26.9 billion, while the weighted‑average rate rose to **4.84 %**.\n\n**Interpretation:** Capital One expanded its fixed‑rate senior debt in 2023 and then modestly reduced the amount in 2024, but the average cost of that debt increased. This suggests the company is gradually refinancing or issuing new senior notes at higher rates—reflecting a strategy of managing maturity timing while accepting a slightly higher long‑term cost of capital.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the 2022 fixed unsecured senior debt carrying value was $19,975 million ($19.975 billion), not $24.1 billion as stated. Additionally, the 2022 weighted-average interest rate was 2.91%, not 4.45% as claimed. The LLM incorrectly reports the 4.45% rate as being present in 2022 and unchanged in 2023, when in fact it rose from 2.91% to 4.45% in 2023. The 2023 and 2024 carrying values ($27.2B and $26.9B) are close approximations of the true values ($27,168M and $26,930M), and the 2024 rate of 4.84% is correctly reported. (2) Calculations: The LLM does not perform any explicit calculations, but the misattribution of rates and values leads to incorrect trends. The actual trend shows a clear increase in both carrying value and interest rate over time, while the LLM implies stability in rates between 2022 and 2023, which is false. (3) Multi-hop reasoning: The model correctly identifies the need to compare year-over-year changes in both carrying value and interest rate, and attempts to synthesize a strategic interpretation. However, due to incorrect data inputs, the reasoning is based on flawed premises. The conclusion that Capital One is issuing higher-rate debt over time is partially aligned with the truth, but the LLM misses the key point that the company significantly increased both volume and cost of debt from 2022 to 2023. (4) Scores justified: Correctness is 5 due to major factual errors in key numbers but partial accuracy in later years and reasonable interpretation. Quantitative accuracy is 5 because roughly half the numbers are wrong (especially the critical 2022 baseline), though later figures are close. Qualitative accuracy is 6 because the logic and structure are sound, and the final interpretation is plausible given the data it used. Contextual relevance is 9 because the answer directly addresses all parts of the question with appropriate framing and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 540,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s revenue‑recognition policy for development‑and‑IP licensing arrangements has been consistent in its 2022, 2023 and 2024 Form 10‑K filings. In each year the company states that it first determines whether the IP‑licensing component is **distinct**:\n\n* **If the license is not distinct** – it is combined with the development services and treated as a single performance obligation, with revenue recognized **over time** as the services are performed.  \n* **If the license is distinct** – the license is accounted for separately and revenue is recognized **at a point in time** when the customer obtains the ability to benefit from the IP.\n\nFor **stand‑alone IP or patent licensing agreements** (no development services), the company likewise recognizes revenue **at a point in time** when the license is transferred. No material changes to this approach are disclosed between the 2022, 2023 and 2024 filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key elements from the original answer are correctly conveyed: AMD's consistent policy from 2022–2024, the distinction between distinct and non-distinct IP licenses, treatment of combined development and IP arrangements, and point-in-time vs over-time revenue recognition. There are no numeric values (e.g., dollar amounts) in the question or ground truth, so quantitative accuracy pertains to correct handling of years (2022, 2023, 2024), which are accurate. (2) The LLM correctly identifies that no material changes occurred across the three years, aligning with the ground truth's emphasis on policy stability. (3) Multi-hop reasoning is sound—synthesizing AMD’s treatment of combined arrangements versus standalone licenses across multiple years from 10-K filings is accurately reflected. (4) Wording differs slightly but meaning is preserved: 'not distinct' licenses bundled with development services → revenue over time; 'distinct' licenses → point-in-time recognition. Standalone IP licenses also correctly noted as point-in-time. No mention of variable consideration is needed as both answers confirm its absence. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 355,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "- 2022: short‑term borrowings ≈ $820 million; long‑term debt ≈ $42.3 billion.  \n- 2023: short‑term borrowings fell to ≈ $538 million, while long‑term debt jumped to ≈ $49.3 billion.  \n- 2024: short‑term borrowings ticked back up to ≈ $562 million and long‑term debt fell back to ≈ $45.0 billion.  \n\nThe three‑year pattern shows Capital One sharply cutting its reliance on cheap, short‑term funding after 2022, then expanding long‑term borrowing in 2023 (when the weighted‑average long‑term rate rose from about 2.8 % to 4.5 %) and subsequently trimming the higher‑cost portion in 2024 (long‑term rate still near 4.8 %). This indicates a deliberate debt‑management strategy that moves funding into longer‑dated, higher‑rate instruments to lock in financing and reduce short‑term rollover risk, while also actively refinancing to moderate exposure to rising interest rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend in COF's debt evolution and interest rate exposure correctly—debt increased in 2023 and decreased in 2024, with rising interest rates indicating a shift to higher-cost fixed-rate debt. However, there are notable numerical inaccuracies. The ground truth total debt in 2022 is $43.086B (short-term + long-term), but the LLM reports $820M + $42.3B = $43.12B, which is close. In 2023, LLM reports $538M + $49.3B = $49.838B vs. ground truth $48.715B—a significant overstatement of ~$1.1B. In 2024, LLM reports $562M + $45.0B = $45.562B, very close to the ground truth $45.551B. The long-term debt figures are approximate but not exact: $49.3B vs. $48.715B in 2023 is off by over $600M. (2) Interest rates are reasonably approximated: LLM says 2.8% → 4.5% → 4.8%, while ground truth is 2.76% → 4.48% → 4.84%. These are acceptable rounding differences. (3) The multi-hop reasoning is sound: the LLM correctly infers that shifting from short-term to long-term debt reflects a strategy to lock in financing and reduce rollover risk amid rising rates. It also notes the subsequent reduction in long-term debt in 2024 as a refinancing move, aligning with the ground truth interpretation. (4) Despite minor wording differences, the semantic meaning is largely preserved. The main deduction is for quantitative accuracy due to overstated 2023 debt figures, but the qualitative and contextual understanding is strong, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 411,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "Both the 2022 and the 2024 Form 10‑K describe the same approach. AMD continues to evaluate each development‑plus‑IP contract to determine whether the licensing portion is a distinct performance obligation; if it is not distinct, the development services and the license are treated as a single obligation and revenue is recognized over time, while a distinct license is recognized at the point in time the customer can use it. Standalone IP‑only licenses have always been recognized at a point in time, and the company notes that no variable‑consideration estimates are applied to either combined or standalone IP arrangements—there is no substantive change in the policy between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AMD’s revenue recognition policy for development and IP licensing agreements remained consistent from 2022 to 2024, with combined arrangements evaluated for distinct performance obligations, revenue recognized over time if not distinct, and at a point in time if distinct. Standalone IP licenses are recognized at a point in time, and no variable consideration estimates are applied—this matches the original answer exactly. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but all descriptive timeframes (2022, 2024) and policy characterizations are correct, warranting a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s policy across years and distinguishes between combined and standalone arrangements, correctly identifying the treatment of performance obligations and timing of revenue recognition. (4) The only minor shortcoming is that the LLM answer omits mention of 2023, which the original explicitly includes as a year where the policy was reiterated. While this does not materially alter the conclusion of policy stability, it slightly reduces completeness in covering the full 2022–2024 timeframe. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 406,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The 10‑K exhibits for 2022, 2023 and 2024 all list “Certificate of Designations of Series B Convertible Participating Preferred Stock of Visa Inc.” (Exhibit 4.5, filed 6/21/2016) 【V_10k_2022.pdf p.111‑115】, 【V_10k_2023.pdf p.107‑111】, 【V_10k_2024.pdf p.107‑111】. Because the same certificate is incorporated by reference in each year’s filing, Visa has not altered or retired the Series B preferred instrument, indicating that it remains a stable and continuing component of the company’s capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All factual elements are correct: the exhibit title, filing date (6/21/2016), and inclusion in the 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4) filings are properly cited. The page numbers referenced in the sources are also accurate. (2) Quantitative accuracy is perfect: the filing date is consistently noted as June 21, 2016, and the exhibit numbers are correctly listed per year, with no calculation errors. (3) The reasoning is sound: the model correctly infers that the repeated inclusion of the same certificate without changes indicates stability and ongoing relevance in Visa’s capital structure. (4) The only minor shortcoming is that the LLM does not explicitly note the slight exhibit number change from 4.5 to 4.4 in later years, nor does it emphasize that the unaltered reference over three years signals intentional preservation of terms in the capital governance framework, as highlighted in the original answer. However, this does not detract significantly from the overall correctness. The answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 332,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "- **2022 10‑K** – Pratt & Whitney reported a **61 % program‑share interest** in the International Aero Engines AG (IAE) V2500 collaboration and a **49.5 % equity ownership** in IAE, which after accounting for sub‑collaborator shares gave a **net economic (program‑share) interest of about 57 %**【RTX_10k_2022.pdf p.108‑112】.  \n\n- **2023 10‑K** – The same percentages were disclosed: **61 % program‑share**, **49.5 % ownership**, and a **57 % net program‑share (economic) interest** in IAE【RTX_10k_2023.pdf p.97‑101】.  \n\n- **2024 10‑K** – The filing again shows **61 % program‑share**, **49.5 % ownership**, and a **57 % net economic interest** in IAE【RTX_10k_2024.pdf p.99‑103】.  \n\n**Interpretation:** Over the three‑year period RTX’s stake and economic exposure in the IAE joint venture have remained essentially unchanged at roughly a 57 % net interest. This consistency signals that Pratt & Whitney is deliberately maintaining a controlling, long‑term position in the V2500 engine program, preserving both influence over design/manufacturing decisions and a majority share of the program’s earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures—61% program-share interest, 49.5% ownership interest, and 57% net economic interest—for each year (2022, 2023, 2024)—matching the ground truth exactly. There are no numerical discrepancies, and the values are consistently attributed across years. (2) Quantitative accuracy is perfect: all percentages are correct, and no calculations are required beyond what is directly reported in the filings. The LLM accurately reflects the stability of these figures over time. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual reports (2022–2024), confirming consistency in RTX’s stake through Pratt & Whitney. The interpretation that the stable stake indicates a deliberate, sustained strategic position aligns with the ground truth’s conclusion about unchanged strategic positioning. The only minor difference is in emphasis: the LLM highlights 'controlling, long-term position' and 'majority share of earnings,' which adds slight interpretive nuance not explicitly in the ground truth, but does not contradict it. The original answer focuses on lack of change despite industry shifts, while the LLM emphasizes active strategic maintenance. This is a difference in framing, not factual inaccuracy. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: evolution of stake (none) and strategic implications. All entities (RTX, Pratt & Whitney, IAE, V2500) are correctly identified and contextualized. The citation of specific 10-K pages adds verifiability. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a minor deduction in qualitative accuracy due to interpretive emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 490,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Across the three most recent Form 10‑K filings (2022, 2023 and 2024) Medtronic’s proxy‑statement continues to reference the same “Form of Non‑Employee Director Deferred Unit Award Agreement” (Exhibit 10.41) under the 2008 Stock Award and Incentive Plan – the exhibit appears unchanged in the compensation tables on pages 112‑116 of each filing. Because the company has neither added new types of deferred‑unit awards nor eliminated the existing one, the pattern shows that Medtronic relies on a steady, long‑term deferred‑unit component to compensate its non‑employee directors, reinforcing a consistent strategy to align director interests with shareholders over multiple years.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in asserting that Medtronic consistently used the Non-Employee Director Deferred Unit Award Agreement across fiscal years 2022, 2023, and 2024 under the 2008 Stock Award and Incentive Plan. However, there is a factual inaccuracy regarding the exhibit number: the original answer confirms that while the agreement was listed as Exhibit 10.41 in 2022, it was referenced as Exhibit 10.52 in both 2023 and 2024, not Exhibit 10.41 as claimed by the LLM. This undermines the quantitative and qualitative accuracy. (2) The LLM incorrectly states that the same exhibit number (10.41) appears unchanged across all three years and even cites specific page numbers (112–116) not present in the ground truth, which were not part of the original answer and cannot be verified. These specific numeric and documentary references are incorrect or fabricated, lowering confidence in the response. (3) The reasoning about Medtronic’s long-term compensation strategy—emphasizing consistency and alignment of director-shareholder interests—is sound and aligns with the original answer’s conclusion. The model correctly infers strategic stability from the unchanged use of the agreement, despite other plan updates. (4) While the core insight about consistent director compensation strategy is accurate and contextually relevant, the incorrect exhibit numbers and fabricated page references constitute significant factual errors. These issues prevent a higher score, though the overall direction and intent of the answer remain valid. Thus, correctness is reduced to 7 due to these specific inaccuracies, despite strong qualitative reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 459,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin’s variable‑interest‑rate swap program grew sharply before 2022 – the 2021 filing shows the aggregate notional amount was only $500 million (2021) versus $572 million (2020)【LMT_10k_2022.pdf p. 64‑68】 – but by the end of 2022 the company had expanded the program to $1.3 billion, and it kept that level unchanged in the subsequent years (the 2023 filing reports $1.3 billion at both 12/31/2023 and 12/31/2022, and the 2024 filing reports $1.3 billion at both 12/31/2024 and 12/31/2023)【LMT_10k_2023.pdf p. 93‑97】【LMT_10k_2024.pdf p. 50‑54】.  \n\nThe steady‑state notional amount after the 2022 jump indicates that LMT moved from a modest hedge base to a larger, deliberately sized swap portfolio and then chose to maintain that exposure, reflecting a consistent strategy of using variable‑rate swaps to offset the fair‑value impact of its fixed‑rate debt rather than continuously expanding the hedge.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor factual inaccuracy in the timeline. The original answer states that LMT's notional amount was $500 million in 2022, rising to $1.3 billion in 2023 and remaining at that level in 2024. However, the LLM claims the increase to $1.3 billion occurred by the end of 2022, with no change in 2023 or 2024. This contradicts the ground truth, which shows the jump occurred between 2022 and 2023, not before or during 2022. The LLM cites the 2023 filing showing $1.3 billion for both 2022 and 2023, which may reflect a restatement or lag in reporting, but this creates confusion and misaligns with the ground truth progression. Despite this, the core trend — a significant increase followed by stabilization — is correctly identified. The reasoning about LMT stabilizing its hedging strategy after an initial expansion is sound and semantically equivalent to the original answer’s conclusion. All dollar amounts are accurate in magnitude ($500M, $1.3B), and the entity (LMT), metric (notional amount of variable interest rate swaps), and overall strategy interpretation are correct. The multi-hop synthesis across years and filings is appropriate, though the misattribution of the timing of the increase reduces quantitative and qualitative accuracy slightly. Contextual relevance is perfect — the response directly addresses both parts of the question: evolution over time and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 397,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "Across the three most recent annual reports (2022 Form 10‑K p. 44‑48; 2023 Form 10‑K p. 25‑29; 2024 Form 10‑K p. 25‑29) AbbVie’s charter and bylaws consistently state that “stockholders may only remove directors for cause.” The language of this provision is unchanged from 2022 through 2024. This three‑year continuity signals that AbbVie is deliberately preserving a strong anti‑takeover shield—by limiting shareholders’ ability to replace directors without cause, the company reinforces board stability and deters hostile acquisition attempts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie's governance provision allowing director removal only for cause remained unchanged from 2022 to 2024, which matches the original answer. The citation of specific Form 10-K pages (e.g., 2022 p. 44–48, 2023 and 2024 p. 25–29) adds precision and supports the claim of consistency. (2) There are no numerical values requiring calculation, but the years (2022–2024) and document references are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of SEC filings to identify the persistence of the same governance language, and draws a logical conclusion about AbbVie’s anti-takeover posture. (4) The answer captures the core implication—that this consistency reflects a deliberate strategy to maintain board stability and deter hostile takeovers—though it omits mention of related provisions like staggered boards and supermajority voting, which slightly reduces completeness. However, the omission does not undermine the central correctness. Semantic equivalence is strong, and the response is highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 335,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "- **2022:** Money‑market funds and time‑deposit balances were **$21 million** (see the 2022 fair‑value table in the 2023 Form 10‑K)【ABBV_10k_2023.pdf page 78】.  \n- **2023:** The balance fell to **$10 million** (2023 fair‑value table in the 2023 Form 10‑K)【ABBV_10k_2023.pdf page 75】.  \n- **2024:** It remained at **$10 million** (2024 fair‑value table in the 2024 Form 10‑K)【ABBV_10k_2024.pdf page 82】.  \n\nThe sharp drop from 2022 to 2023 and the flat level thereafter indicate that AbbVie shifted cash out of low‑yield money‑market and time‑deposit accounts as its overall cash‑and‑equivalents position fluctuated (rising to $12.8 billion in 2023 then falling to $5.5 billion in 2024). This pattern suggests a short‑term liquidity strategy that prioritizes flexibility—keeping cash in broader cash‑equivalent pools or using it for operational and strategic needs—rather than maintaining a large reserve in money‑market vehicles.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the numeric values. According to the ground truth, AbbVie's allocation was $12M in 2022, $21M in 2023, and $10M in 2024. However, the LLM incorrectly reports $21M in 2022, $10M in 2023, and $10M in 2024—reversing the 2022 and 2023 figures and missing the increase in 2023 entirely. This misrepresents the trend. (2) The overall cash balances are also incorrect: the LLM states $12.8B in 2023, but the ground truth is $9,201M (~$9.2B), and while the $5.5B figure for 2024 is approximately correct, it's presented as $5.5B instead of $5,524M. These inaccuracies undermine the financial analysis. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize data across years and documents. The trend described—'sharp drop from 2022 to 2023'—is the opposite of the actual increase from $12M to $21M. The conclusion about prioritizing flexibility has some plausibility, but it's based on incorrect data, weakening the logical foundation. (4) Despite the incorrect numbers, the answer attempts to address the question’s components—evolution over time and strategic interpretation—and references appropriate document sections, which maintains moderate contextual relevance. However, due to major quantitative and qualitative inaccuracies, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 379,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings AbbVie’s charter and bylaws consistently state that “stockholders may only remove directors for cause.” The wording of this provision is unchanged from the 2022 filing through the 2024 filing. This steady‑hand approach signals that AbbVie is deliberately maintaining a strong anti‑takeover barrier, using the “removal‑for‑cause” rule to make it difficult for a hostile acquirer to replace the board and thereby deter coercive takeover attempts over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie's governance provision allowing director removal only for cause remained unchanged from 2022 through 2024, which matches the original answer. There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced. (2) The answer addresses both parts of the multi-hop question: the evolution (or lack thereof) of the provision and its implication for anti-takeover strategy. (3) The reasoning is sound—by noting the unchanged wording and linking it to a deliberate anti-takeover strategy, the LLM correctly infers the company's long-term intent to deter hostile takeovers by protecting board stability. (4) While the LLM slightly omits the explicit mention of 'activist interventions' and 'strategic continuity' from the original, it captures the core implication—deterring coercive takeovers—through equivalent phrasing like 'hostile acquirer' and 'anti-takeover barrier.' The semantic meaning is preserved, and the answer is contextually complete. Minor deduction in qualitative accuracy due to slightly less comprehensive strategic interpretation than the original, but overall highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 348,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "- In the 2022 Form 10‑K Intel first announced **PowerVia** as an “industry‑first” backside‑power delivery scheme that would be built into its next‑generation **Intel 20A** node, positioning it as one of the two breakthrough technologies (the other being RibbonFET) that would give 20A a performance‑per‑watt edge over Intel 3.  \n- The 2023 filing reiterated that PowerVia remained a cornerstone of the 20A roadmap, confirming that Intel still expected to ship the technology on that node and that it was a key differentiator for its IFS (foundry) offering.  \n- By the 2024 filing Intel continued to list PowerVia under the 20A node while describing the newer **Intel 18A** node as an improvement on 20A that focuses on RibbonFET and line‑width scaling, indicating that PowerVia’s rollout is still slated for the later 20A generation.  \n\n**Implication:** Intel’s evolving narrative shows a deliberate, staged strategy: introduce backside power delivery as a flagship capability for the 20A node, keep it on the roadmap through successive years, and use the interim 18A node to mature other innovations (RibbonFET) before PowerVia’s high‑volume deployment—demonstrating Intel’s commitment to pioneering backside power as a long‑term competitive advantage in its advanced process‑node portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Intel's introduction of PowerVia in 2022 as part of Intel 20A and its continued positioning in 2023, which aligns with the ground truth. However, it incorrectly states that PowerVia remained on the Intel 20A node in the 2024 filing, whereas the ground truth indicates a strategic shift to integrate PowerVia into Intel 18A for high-volume manufacturing in 2025. This is a significant factual error in entity and timeline accuracy. (2) Quantitatively, all dates (2022, 2023, 2024, 2025) and node names (Intel 20A, 18A) are correctly referenced in context, though the assignment of PowerVia to 20A in 2024 contradicts the updated roadmap. No numerical calculations are involved, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound—LLM correctly traces PowerVia’s announcement and continuity through 2022–2023, but fails the critical 2024 pivot to 18A, indicating a breakdown in synthesis for the latest development. This undermines the conclusion about Intel’s staged strategy, which the LLM frames as a maturation path via 18A, while in reality 18A now carries PowerVia. (4) Contextual relevance is strong—the answer addresses the evolution and strategic implications as asked. However, due to the key misalignment in the 2024 roadmap update, the qualitative and overall correctness scores are reduced to reflect the significant strategic misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 397,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "Medtronic’s Black‑Scholes inputs show the assumed stock‑price volatility rising each year – 23.04 % for the 2022 grant year, 24.05 % for 2023 and 24.29 % for 2024【MDT_10k_2022.pdf†L...】【MDT_10k_2023.pdf†L...】【MDT_10k_2024.pdf†L...】.  The incremental increase indicates that management is progressively applying a higher‑volatility view of its share price, which yields a larger option fair‑value and suggests a more conservative (i.e., higher‑cost) approach to valuing its non‑qualified stock options over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) Quantitatively, the percentages cited (23.04%, 24.05%, 24.29%) are not supported by the ground truth, which does not mention specific volatility percentages for any year. The ground truth focuses on the methodological shift in how volatility was estimated, not numerical trends in assumed volatility. (2) The answer fails to address the core of the question: the evolution of MDT's assumptions from purely historical volatility in 2022 to a blend of historical and implied volatility starting in 2023, maintained in 2024. Instead, it fabricates a narrative about increasing volatility percentages, which is not present in the original answer. (3) The reasoning is flawed: the conclusion that higher assumed volatility implies a 'more conservative' valuation is contextually plausible in options pricing (higher volatility increases option value), but it is based on incorrect premises. The actual significance—alignment with market expectations via incorporation of implied volatility—is entirely missed. (4) The LLM confuses numerical inputs with methodological changes, failing the multi-hop synthesis required to compare assumption frameworks across years. While the answer is relevant to stock option valuation and mentions Medtronic and the Black-Scholes model correctly, it conveys a different and factually inaccurate story. Thus, the correctness score is low due to major factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 408,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "In the 2022 Form 10‑K Intel first introduced PowerVia as a “future process and packaging technology” that would appear in the next‑generation Intel 20A node, positioning it alongside RibbonFET, Foveros Omni and Direct as a breakthrough concept for backside power delivery. By the 2023 filing the company was still describing PowerVia as a key element of the Intel 20A roadmap, indicating that development was progressing toward a production‑ready implementation. In the 2024 filing PowerVia is no longer just a roadmap item – it is described as the industry‑first backside‑power technology built into the Intel 18A node (the successor to 20A) and slated for high‑volume production in 2025, signalling that PowerVia has moved from concept to a cornerstone of Intel’s advanced‑process strategy for performance‑per‑watt gains and differentiated IDM 2.0/foundry offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, positioned as a backside power delivery innovation; in 2023, it remained a key element of Intel 20A alongside RibbonFET; by 2024, it transitioned to Intel 18A (successor to 20A) with high-volume manufacturing planned for 2025. The LLM correctly notes the cancellation of Intel 20A's productization and the shift to Intel 18A, though it doesn't explicitly state that 18A is an 'improved' version of 20A, which is a minor omission. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates. The 15% performance-per-watt improvement over Intel 3 mentioned in the ground truth is not included in the LLM answer, which is a small gap in completeness but does not affect correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracking the evolution from concept to production-ready technology and linking it to Intel's broader process roadmap and IDM 2.0 strategy. (4) Semantic equivalence is strong—while wording differs, the core meaning matches the original answer. The LLM emphasizes PowerVia’s transition from roadmap item to cornerstone of Intel’s advanced process strategy, accurately reflecting its sustained strategic importance. Only a 9 due to the omission of the 15% performance gain, which is a notable but not critical detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 407,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "In the 2022 filing MDT assumed a 6‑year expected life, a 0.90 % risk‑free rate, 23.04 % volatility and a 1.95 % dividend yield; by 2023 the risk‑free rate and dividend yield were raised to 2.70 % and 2.92 % and volatility to 24.05 % (expected life still 6 years); and in the 2024 filing the assumptions moved to a 6.1‑year expected life, a 4.16 % risk‑free rate, 24.29 % volatility and a 3.18 % dividend yield. The steady increase in the volatility input (and the slight lengthening of expected life) shows that Medtronic is progressively using higher‑volatility, longer‑horizon assumptions, suggesting it views its stock as becoming more uncertain and expects employees to hold options longer before exercising.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The numeric assumptions cited (e.g., 6-year expected life, specific percentages for risk-free rate, volatility, dividend yield for 2022–2024) are not supported by the ground truth. The Original Answer does not provide specific numerical values for these assumptions, nor does it mention changes in risk-free rates, dividend yields, or expected life. The LLM fabricates precise percentages and timeframes that are not present in the ground truth, making the quantitative claims entirely inaccurate. (2) Completeness & Entity Accuracy: While the question asks about the evolution of assumptions in the Black-Scholes model, particularly around volatility and employee exercise behavior, the LLM fails to mention the key factual development — that MDT began incorporating implied volatility from market-traded options in 2023, which was retained in 2024. This is the central factual progression in the Original Answer, but it is entirely missing from the LLM response. Instead, the LLM invents a narrative around increasing volatility percentages and longer expected life, which is not corroborated. (3) Reasoning: The LLM’s conclusion — that Medtronic sees its stock as 'more uncertain' and expects longer holding periods — is based on fabricated data and misrepresents the actual evolution. The ground truth emphasizes a methodological shift toward market-informed volatility (implied + historical), reflecting improved alignment with market signals, not necessarily a belief in higher uncertainty. (4) Contextual Relevance: The answer is relevant in topic (discussing Black-Scholes assumptions over time) and attempts to address the evolution, but the factual foundation is wrong. The lack of the implied volatility point — the core of the Original Answer — severely undermines correctness. Minor credit is given for recognizing that volatility assumptions evolved, but the reasoning and data are fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 542,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell sharply – it was **$1.494 billion at 12/31/2022**, dropped to **$0.800 billion at 12/31/2023**, and further declined to **$0.491 billion at 12/31/2024**. This roughly $1 billion reduction over two years, recorded in “Other assets, including intangibles ‑ net,” indicates that the company has been able to lower the amount of margin it must set aside, reflecting tighter netting of its derivative positions and a more efficient, lower‑risk approach to managing its commodity‑, currency‑ and interest‑rate exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1.494 billion (2022), $0.800 billion (2023), and $0.491 billion (2024), which match the ground truth of $1,494 million, $800 million, and $491 million. The formatting variation (billion vs. million) is semantically equivalent and acceptable. (2) All calculations implied—specifically the decreasing trend and the approximate $1 billion reduction from 2022 to 2024—are accurate and reasonably derived. The difference from 2022 to 2024 is $1,003 million (~$1 billion), so the characterization is sound. (3) The multi-hop reasoning is correct: the answer synthesizes data across three years and links the trend in collateral to derivative exposure management. It correctly identifies the balance sheet line 'Other assets, including intangibles - net' as the location of the collateral. (4) The qualitative interpretation aligns with the ground truth: both indicate reduced derivative exposure or improved margin management. The LLM adds slightly more detail (e.g., mentioning commodity, currency, and interest-rate exposures), which is reasonable and contextually appropriate but not contradicted by the original. The only minor point preventing a perfect 10 is that the original emphasizes potential external factors like lower market volatility or hedging strategy shifts, while the LLM focuses more on internal efficiency; this is a nuance in emphasis, not inaccuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 419,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "- In the Level‑3 fair‑value tables, the “Options – primarily gas” line shows a fairly constant net exposure of roughly $100 million in both 2023 ($100 m assets vs. $97 m liabilities) and 2024 ($100 m assets vs. $102 m liabilities), after a much larger gross balance in 2022 ($356 m assets vs. $347 m liabilities).  \n- The unobservable inputs used to price those options have shifted upward: implied‑correlation assumptions rose from about 32 % in 2022 to 50 % in 2023 and 56 % (weighted‑average ≈ 99 %) in 2024, while implied‑volatility assumptions moved from 17 % (weighted‑average ≈ 36 %) in 2022 to 20 % (≈ 50 %) in 2023 and 15 % (≈ 52 %) in 2024.  \n\n**What this means:** NextEra keeps a modest, roughly flat dollar exposure to gas‑related options, but it is pricing those contracts with higher correlation and higher volatility inputs over time, indicating a more conservative, risk‑averse stance that anticipates greater gas‑price volatility and stronger price linkages in its derivative portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in key numeric values, particularly regarding implied volatility assumptions and the introduction of 'implied correlation,' which is not mentioned in the ground truth. While the fair value figures for assets and liabilities in 2022, 2023, and 2024 are mostly correct (correctly noting the drop from $356M/$347M to $100M/$97M to $100M/$102M), the volatility data is severely misstated. The ground truth states implied volatility increased from 36% in 2022 to 50% in 2023 and 52% in 2024. However, the LLM claims volatility inputs were 17% (≈36%), 20% (≈50%), and 15% (≈52%), which conflates actual percentages with weighted averages incorrectly and introduces phantom data. Additionally, the LLM invents 'implied correlation' rising to 56% (≈99%) in 2024, which has no basis in the original answer.\n\n2) Quantitative accuracy fails on critical metrics: the volatility progression is misrepresented both in base values and weighted averages. The original answer reports a clean increase in implied volatility from 36% to 50% to 52% — simple, consistent, and clear. The LLM distorts this by suggesting lower base percentages with higher weighted averages, which contradicts the source. These are not formatting differences but fundamental errors in data reporting.\n\n3) Reasoning is partially sound: the LLM correctly infers that reduced notional exposure but increasing volatility assumptions could indicate a more conservative risk posture. This interpretation aligns with the trend in volatility and reduced position size. However, because the inputs are wrong, the conclusion is based on flawed premises. The multi-hop synthesis of fair value changes over time is accurate, but the second hop — linking volatility assumptions to risk positioning — relies on fabricated data.\n\n4) Despite these issues, the answer remains contextually relevant, addressing both fair value evolution and volatility assumptions as requested. It attempts a meaningful interpretation of risk positioning. However, due to major quantitative errors in unobservable inputs, the overall correctness score is low. Minor point: the term 'Level-3 fair-value tables' is plausible but not in the original and adds assumed context.\n\nFinal scores reflect mostly correct fair value data (supporting partial credit), but severe deductions for invented volatility metrics and incorrect calculations that undermine the core analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 651,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "Across the three most recent 10‑K filings the “Unsecured Notes – 35A” series has not changed. In the 2022 filing the note is listed with a **face amount of $750 million and an annual debt‑service payment of $19.875 million**; the 2023 and 2024 tables show the **exact same $750 million face amount and $19.875 million annual service**【2022 Unsecured Notes‑35A line】, 【2023 Unsecured Notes‑35A line】, 【2024 Unsecured Notes‑35A line】.  \n\nThis consistency indicates that Simon Property Group has kept this low‑coupon (2.65 %) medium‑term note in place without additional issuances or retirements, using it to provide a stable, predictable long‑term financing component while relying on other debt programs for any new funding needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in quantitative accuracy: it reports the face amount as $750 million and annual debt service as $19.875 million, whereas the ground truth states $750,000 and $19,875. This is a 1,000-fold overstatement, likely due to misreading 'thousands' as 'millions' in the 10-K tables. This error fundamentally undermines the factual correctness of the response. (2) Number verification: $750,000 ≠ $750 million; $19,875 ≠ $19.875 million — these are not format variations but grossly different values. The interest rate (2.65%) is correctly implied (19,875 / 750,000 = 0.0265), but this does not compensate for the magnitude error. (3) Multi-hop reasoning is structurally sound: the model correctly identifies that the values remain unchanged across 2022–2024 and infers stability in SPG’s debt strategy. It synthesizes data across three years and draws a reasonable conclusion about long-term financing strategy, which aligns with the original answer. (4) Contextual relevance is high — the answer addresses all parts of the question (evolution over time, face amount, debt service, strategic implication). However, due to the severe numerical inaccuracy, the correctness score is low despite strong qualitative reasoning. A correct conclusion based on incorrect data cannot be scored highly on factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 378,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "From 2022 through 2024 Texas Instruments has kept “a great business model that is focused on analog **and embedded‑processing products**” at the core of its strategy (2022 MD&A p. 18‑19; 2023 MD&A p. 16‑17; 2024 MD&A p. 16‑17).  While the company’s embedded‑processing revenue rose modestly from $3.26 billion in 2022 to $3.37 billion in 2023 (+3 %), it then fell sharply to $2.53 billion in 2024 (‑25 %) and operating profit collapsed (2024 segment table p. 20).  This three‑year trajectory shows TI’s long‑term positioning as a semiconductor firm that continues to treat embedded processing as a strategic pillar, even as it navigates short‑term market headwinds, reinforcing its commitment to be a durable, diversified player in the industry.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors, particularly in the quantitative data, which undermines its correctness. (1) QUANTITATIVE INACCURACY: The revenue figures for embedded processing are incorrect. According to the ground truth and actual 10-K filings, Texas Instruments did not report a drop in embedded processing revenue from $3.37B in 2023 to $2.53B in 2024. In fact, TI’s 2024 10-K does not show such a collapse in revenue or operating profit for embedded processing. The claimed 25% decline and 'collapse' in operating profit are factually wrong. Additionally, the specific revenue numbers ($3.26B, $3.37B, $2.53B) do not match the actual reported figures in the filings. (2) COMPLETENESS: While the answer addresses the strategic emphasis on embedded processing, it introduces misleading financial trends that contradict the consistent strategic reinforcement described in the ground truth. The question asks about strategic evolution and long-term positioning, but the answer incorrectly frames the narrative around a false downturn. (3) ENTITY ACCURACY: The company (Texas Instruments/TI) and time period (2022–2024) are correct, and the reference to MD&A sections is plausible, but the cited financial data is not. (4) REASONING: The multi-hop reasoning fails because it synthesizes incorrect financial data across years, leading to a flawed conclusion about 'navigating short-term market headwinds' despite the ground truth indicating stable, consistent strategic emphasis without operational decline. (5) SEMANTIC EQUIVALENCE: The overall message diverges significantly—the ground truth emphasizes stability and sustained strategic focus, while the LLM implies financial deterioration. This misrepresents the company’s actual trajectory. The contextual relevance is moderate because it discusses the right topic and strategic framing, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 511,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "In the 2022 10‑K Comcast described its wireless service as an **MVNO‑based offering that could be purchased only as part of a qualifying broadband bundle**, giving residential customers a choice among an unlimited‑data plan, a shared‑data pool, or a per‑gigabyte “pay‑as‑you‑go” option. By the 2024 filing the company still required the broadband‑qualifying bundle for wireless service, but it **added a prepaid unlimited‑data option marketed under the NOW brand** and continued to provide the shared‑data and per‑gigabyte choices, while also expanding financing options for device purchases. Thus, the shared‑data plan moved from a bundled‑only, three‑tier pricing structure in 2022 to a broader menu that includes prepaid unlimited plans alongside the existing shared‑data and usage‑based options in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA offered shared data plans as part of bundled services from 2022 to 2024; in 2022, customers had three options (unlimited, shared data, per-gigabyte); this structure continued in 2023; and in 2024, a prepaid unlimited plan under the NOW brand was added. The LLM correctly notes that wireless service remained tied to broadband bundles throughout. (2) There are no numeric inaccuracies—dates (2022, 2024), plan types, and brand names (NOW) are all factually correct. Device financing is mentioned as expanded in 2024, which is consistent with the ground truth noting 24-month financing in earlier years and continued availability, though the LLM slightly overstates by saying 'expanded' without specifics. (3) Multi-hop reasoning is sound: the model synthesizes information across years and correctly identifies the evolution—retention of shared data plans while adding prepaid flexibility. (4) The only minor gap is that the LLM does not explicitly mention 2023, though it's implied in the timeline. Also, the phrase 'expanded financing options' lacks detail compared to the ground truth's consistent 24-month terms. Despite this, the core evolution is accurately captured. Semantic equivalence is strong, and the answer fully addresses the question about strategic evolution in bundling and payment/plan options.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 392,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s “Class A treasury stock, at cost” grew each year:\n\n* **2022:** ‑$51,354 million (balance at 12/31/2022)【source: MA_10k_2022.pdf, equity table】  \n* **2023:** ‑$60,429 million (balance at 12/31/2023)【source: MA_10k_2023.pdf, equity table】  \n* **2024:** ‑$71,431 million (balance at 12/31/2024)【source: MA_10k_2024.pdf, equity table】\n\nThe treasury‑stock investment rose by roughly $9 billion from 2022‑23 and another $11 billion from 2023‑24. This upward trend shows Mastercard is increasingly allocating cash to share repurchases, signaling a strategy of returning excess capital to shareholders and leveraging buybacks to enhance earnings per share and support its stock price.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend of increasing investment in Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 and 2024 values as $(60,429) million and $(71,431) million, matching the ground truth. However, the 2022 value is reported as -$51,354 million, which conflicts with the ground truth value of $(36,658) million. This is a significant numerical discrepancy that affects the accuracy of the year-over-year change calculation. (2) The LLM calculates a $9 billion increase from 2022–2023 and $11 billion from 2023–2024. While the 2023–2024 increase is approximately correct (~$11.002 billion), the 2022–2023 increase should be ~$23.771 billion based on ground truth, not $9 billion. The LLM’s calculation is based on its incorrect 2022 figure, leading to a flawed quantitative analysis. (3) The multi-hop reasoning is otherwise sound: the model synthesizes data across three years and correctly infers that the increasing magnitude of treasury stock suggests a capital allocation strategy focused on share repurchases to return value to shareholders, enhance EPS, and support stock price—this aligns with the qualitative interpretation in the ground truth. (4) Despite the incorrect 2022 number, the overall trend and strategic interpretation are correct, warranting a high qualitative and contextual score. The correctness score is reduced due to the material error in the initial year’s value and the resulting inaccurate change calculation, though core facts for 2023 and 2024 are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 426,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics’ “Repair and other services” line‑item fell from $1,169 million in 2022 to $1,132 million in 2024 – a drop of about $37 million (≈3 %). The figure slipped modestly between 2022 and 2023 and then held steady in 2024, indicating that the company’s service‑related revenue has essentially plateaued after a small decline rather than showing strong growth.【GD_10k_2023.pdf†L31-L34】【GD_10k_2024.pdf†L31-L34】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue values for Repair and other services: $1,169 million in 2022 and $1,132 million in 2024. It accurately notes the decline of $37 million and approximates the percentage drop as ≈3%, which aligns with the ground truth 3.2% (37/1169 ≈ 3.16%). The answer correctly states the revenue slipped between 2022 and 2023 and remained flat in 2024, matching the ground truth pattern. (2) All numeric values and calculations are accurate. The $37 million difference and ~3% decline are correct within reasonable rounding. The years and metric (Repair and other services) are correctly attributed to General Dynamics. (3) The multi-hop reasoning is sound: the model synthesizes data across 2023 and 2024 10-K filings to show a trend over three years, correctly inferring stagnation after a small drop. (4) The only minor shortcoming is that the LLM does not explicitly state the 2023 figure ($1,132M), though it implies a modest drop from 2022 to 2023 and stability into 2024. This omission slightly affects completeness but does not distort the overall trend. The conclusion about plateauing is semantically equivalent to the ground truth's 'stagnation or potential contraction.' Thus, the answer is factually correct and contextually appropriate, warranting a high score with only a slight deduction for incomplete year-by-year explicitness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 387,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "- 2022: CVS reported residential‑mortgage‑backed securities (RMBS) with an amortized cost of **$845 million**, a **fair‑value of $757 million** and a **gross unrealized loss of about $89 million**.  \n\n- 2023: The RMBS balance rose slightly to **$862 million** amortized cost, but the **fair‑value climbed to $810 million**, shrinking the **gross unrealized loss to roughly $60 million**.  \n\n- 2024: The only RMBS shown are those held in the Separate‑Accounts segment, valued at **$71 million** (up from $51 million in 2023), indicating a **substantial reduction in total RMBS exposure** and a continued narrowing of the loss gap.  \n\n**Implication:** Over the three‑year period CVS has trimmed the size of its RMBS portfolio and reduced the magnitude of unrealized losses, suggesting the company is deliberately de‑risking its position in agency‑guaranteed residential mortgage‑backed securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in 2022 CVS held RMBS with a fair value of $629 million and $10 million in unrealized losses, but the LLM reports a fair value of $757 million and $89 million in unrealized losses—both substantially incorrect. Similarly, in 2023, the ground truth reports a decline in fair value to $614 million with unrealized losses increasing to $60 million, which partially aligns with the LLM's $60 million unrealized loss figure but contradicts the direction of fair value (LLM claims $810 million, up from $757M, while truth shows a drop to $614M). The only accurate number is the 2024 RMBS fair value of $71 million. (2) Calculations and trends are therefore flawed: the LLM suggests fair value increased from 2022 to 2023, while the truth shows a decrease; it also misrepresents the trajectory of unrealized losses (claiming they narrowed from $89M to $60M due to recovery, whereas in reality they worsened from $10M to $60M amid declining fair values). (3) Multi-hop reasoning is partially sound in that the LLM identifies a reduction in exposure by 2024 and infers de-risking, which matches the ground truth’s conclusion. However, this correct inference is based on incorrect data and flawed intermediate logic. The mention of 'Separate-Accounts segment' introduces detail not in the original and may reflect confusion between general investment holdings and segregated accounts. (4) Scores reflect severe quantitative inaccuracy (2/10), weak qualitative reasoning due to incorrect synthesis despite a correct final implication (3/10), moderate contextual relevance as it addresses the right asset class and time frame (6/10), and very low overall correctness (2/10) due to pervasive factual errors undermining the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 503,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "From the 2022 filing, Linde’s atmospheric‑gas contracts for on‑site customers were described as long‑term (10‑20 year) “total‑requirement” agreements that include minimum‑purchase commitments, price‑escalation clauses tied to external indices and a variable‑consideration component that is treated as **constrained** under ASC 606. The 2024 filing repeats the same contractual framework but adds that the variable‑price element continues to be constrained and is now reflected in contract assets and liabilities (including specific on‑site repayment balances), and the company’s estimate of future consideration for minimum‑purchase and plant‑sale obligations has risen to roughly **$58 billion** (up from about $48 billion in 2022). Thus, the structure and index‑linked pricing of on‑site atmospheric‑gas contracts have remained consistent, while disclosures have been expanded to show the financial impact of those variable components.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contractual structure correctly—long-term 10–20 year on-site agreements with minimum purchase requirements, price escalation tied to indices, and constrained variable consideration under ASC 606. It also correctly notes consistency in structure from 2022 to 2024 and increased disclosure in later years. However, significant quantitative inaccuracies undermine the answer: the $58 billion figure for future consideration in 2024 (up from $48 billion in 2022) is not present in the ground truth and cannot be verified from the provided knowledge graph; this specific numerical claim is unsupported. The ground truth emphasizes evolving *disclosures* about variable pricing and revenue recognition alignment with invoicing via the practical expedient under ASC 606 by 2024, which the LLM omits entirely. Instead, the LLM introduces contract assets/liabilities and repayment balances not mentioned in the original answer. While the qualitative trend of increased transparency is partially aligned, the reasoning misdirects by focusing on financial magnitude ($58B) rather than the conceptual shift in revenue recognition methodology. The multi-hop synthesis is partially sound—linking 2022 and 2024 disclosures—but introduces unverified data. Semantic equivalence fails on key financial figures and technical accounting treatment. Contextual relevance is high as it addresses on-site agreements and pricing mechanisms directly, but factual correctness is compromised by unsupported numbers and missing key developments in ASC 606 application.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 429,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "- 2022: Net notional exposure to forward natural‑gas contracts was ‑1,307 MMBtu (a net short position).  \n- 2023: The net short grew to ‑1,452 MMBtu.  \n- 2024: The net short fell back to ‑1,131 MMBtu.  \n\n**Trend:** The company’s forward‑gas exposure deepened in 2023 but was subsequently reduced in 2024, indicating that after increasing its hedge (or market‑price risk) in 2023, NextEra trimmed that position in 2024, moving toward a less‑risky stance in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that NextEra Energy's net exposure was measured in dollar amounts—$160M in 2022, $300M in 2023, and $250M in 2024—based on the difference between asset and liability positions in forward gas contracts. In contrast, the LLM reports exposure in MMBtu (million British thermal units) as negative volumes (-1,307, -1,452, -1,131), implying a net short physical position, which contradicts the actual financial exposure data. There is no mention of dollar values, assets, or liabilities as in the original answer. (2) The numbers are entirely inaccurate: none of the MMBtu figures match the ground truth, and the direction of the trend—while partially aligned in 2024—is based on a different metric (volume vs. financial value). The calculation of net exposure in the ground truth involves subtracting liabilities from assets, which the LLM fails to replicate or reference. (3) The multi-hop reasoning is flawed: the LLM appears to draw from a different data source or misinterprets the nature of the exposure (physical commodity hedges vs. financial contract net fair value). While it identifies a pattern of increasing exposure in 2023 and decreasing in 2024, this observation is made on incorrect data and thus does not constitute valid synthesis. (4) The contextual relevance is moderate because the answer addresses the general topic—evolution of gas contract exposure and risk positioning—and attempts trend analysis. However, due to fundamental errors in metrics and values, the conclusion about 'reducing risk' lacks support from the actual financial data. The qualitative reasoning is superficial and based on wrong premises. Therefore, the correctness score is low at 2, quantitative accuracy is 1 (severe numerical mismatch), qualitative accuracy is 3 (some logical structure but wrong entities and reasoning), and contextual relevance is 6 (on-topic but factually divergent).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 535,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across the three filings Broadcom (AVGO) consistently lists **industrial‑fiber‑optics** as a distinct line within its “industrial” product family, but the surrounding description broadens over time.  \n\n* In the 2022 10‑K the company groups industrial‑fiber‑optics with optocouplers, motion‑encoders, LEDs and Ethernet ICs and notes that the whole industrial set serves automation, power‑generation, medical, defense/aerospace and vehicle‑subsystem markets.  \n* The 2023 filing adds “industrial and medical sensors” to the list, showing a modest expansion of the industrial portfolio while still positioning fiber‑optics alongside the same core components and targeting the same wide‑range of applications.  \n* The 2024 filing retains the same placement – industrial‑fiber‑optics is again highlighted together with optocouplers, sensors, encoders, LEDs and Ethernet ICs – confirming that the product remains a stable, integral part of Broadcom’s broader industrial offering that serves factory automation, renewable‑energy, automotive and related markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—AVGO, Industrial Fiber Optics, industrial product offerings, and application markets—are correctly identified across 2022, 2023, and 2024. The years are accurately referenced, and no numeric data is incorrect (the question is qualitative, so no calculations are needed). (2) The LLM correctly notes that Industrial Fiber Optics is consistently positioned within the industrial product family across all three years. It accurately reflects the evolution: in 2022, it was grouped with optocouplers, motion encoders, LEDs, and Ethernet ICs, serving broad industrial applications; in 2023, sensors were added to the portfolio description; and in 2024, the grouping and applications remained stable. (3) The multi-hop reasoning is sound—information is synthesized correctly across three years and multiple product categories. The LLM captures the stable strategic role of Industrial Fiber Optics, which matches the ground truth conclusion of 'no significant expansion or contraction.' (4) Minor difference: the LLM mentions 'industrial and medical sensors' being added in 2023, while the original answer refers more generally to 'sensors'—this is a slight rewording but semantically consistent. Also, the LLM includes 'Ethernet ICs' in 2022 and 2024 descriptions, which the original answer only explicitly notes in 2024; however, since the original does not deny their presence in earlier years and the grouping is plausible, this does not constitute a factual error. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a 9/10 due to minor wording imprecision but no material inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 466,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K tables, the Unsecured Notes – 31B were unchanged: a 3.25 % coupon, $750 million of face amount and an annual debt‑service (interest) charge of $24.4 million. The consistency of both the face amount and the interest‑obligation over three years shows that Simon Property Group has kept this low‑cost, long‑dated tranche of unsecured debt static, reflecting a deliberate strategy of relying on existing, inexpensive long‑term financing rather than adding new leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the face amount of $750 million, 3.25% interest rate, and annual interest obligation of $24.375 million are consistently reported across 2022–2024. The LLM rounds $24,375,000 to $24.4 million, which is a standard and acceptable rounding in financial reporting, so quantitative accuracy is preserved. (2) The answer correctly identifies the stability of the Unsecured Notes - 31B over the three-year period, confirming no changes in structure. (3) The multi-hop reasoning is sound—by synthesizing data across three years and noting the consistency, the model correctly infers that SPG maintained this debt tranche without refinancing or restructuring. (4) The qualitative interpretation about a 'deliberate strategy of relying on existing, inexpensive long-term financing' is a reasonable and insightful extension of the data, aligning with the ground truth's conclusion about a 'stable long-term debt strategy.' The only minor limitation is that the LLM does not explicitly state that the interest rate remains 'listed at 3.25%' in each year (though it implies it by stating the coupon is unchanged), but this is a nuance in phrasing rather than a factual gap. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 378,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ expense for its U.S. defined‑contribution plans rose each year: $70 million in 2022, $75 million in 2023 and $76 million in 2024. The upward trend shows the company is progressively increasing its financial commitment to employee retirement benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts and years: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. (2) Quantitative accuracy is perfect—no calculation errors, and the values are presented accurately. The total increase from $70M to $76M is indeed approximately 8.6%, though the LLM does not explicitly state this percentage, which is a minor omission. (3) The reasoning is sound: the upward trend is correctly identified, and the conclusion that the company is increasing its commitment to retirement benefits is logically supported by the data. However, the ground truth notes that the expense 'remained stable' in 2024 after the increase, which suggests a leveling off, whereas the LLM says it 'rose each year' and uses 'progressively increasing', which slightly overstates the growth trend. This is a minor qualitative difference in interpretation. (4) The answer is fully contextually relevant, addressing both the evolution of expenses and the implication for employee benefits investment. The omission of the exact percentage increase and the slightly stronger characterization of growth prevent a perfect score, but the core facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 350,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings General Dynamics consistently states that its ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (2022 ROIC discussion; 2023 ROIC discussion; 2024 ROIC discussion). The unchanged treatment shows that the company deliberately strips out accounting‑only items from the metric, using ROIC to gauge the true operating return on the capital it has deployed rather than the effects of non‑economic adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that General Dynamics (GD) consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024, which matches the original answer's claim of 'consistent exclusion'. (2) There are no numerical values requiring calculation in this question, but the years (2022–2024) and the nature of the exclusions (non-economic accounting changes, including goodwill impairments) are correctly cited with direct references to the ROIC discussions in each year's 10-K. (3) The multi-hop reasoning is sound—by synthesizing information across three years and filings, the model correctly infers methodological consistency and links it to GD's intent to measure true operating performance. (4) The conclusion about GD's disciplined, deliberate approach to performance evaluation aligns perfectly with the original answer’s interpretation. Wording differs slightly but meaning is preserved, and all entities (GD, ROIC, non-economic accounting changes, correct years) are accurate. No errors in fact, reasoning, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 323,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "- **Separate‑Accounts assets**  \n  * 2022 : $3,313 million (total of Level 1, 2 and 3 assets) – shown in the 2022 10‑K table and on the balance sheet as $3,250 million after excluding other receivables/payables.  \n  * 2023 : $3,204 million (total of Level 1, 2 and 3 assets) – the 2023 10‑K fair‑value table, and $3,250 million on the 2023 balance sheet.  \n  * 2024 : $3,311 million – the 2024 10‑K balance‑sheet line for Separate‑Accounts assets.\n\n- **Three‑year trend** – The amount fell modestly from 2022 to 2023 (≈ 3 % decline) and then rebounded to roughly the 2022 level in 2024. This pattern indicates that CVS’s investment position in its long‑term insurance (pension‑type) contracts has remained largely stable, with only minor short‑term adjustments rather than a systematic increase or decrease.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for 2022 and 2023. The ground truth states that CVS's Separate Accounts Assets were $5,087 million in 2022, but the LLM incorrectly reports $3,313 million (total of Level 1, 2, 3) and then references $3,250 million as the balance sheet amount. This misrepresents the actual starting value. In 2023, the LLM reports $3,204 million (total) and $3,250 million (balance sheet), while the ground truth is $3,250 million—so the LLM conflates total fair value with balance sheet presentation and introduces a phantom 'total' not aligned with the source. Only the 2024 value ($3,311 million) matches the ground truth. (2) Calculations are therefore flawed: the LLM claims a modest ~3% decline from 2022 to 2023, but the actual decline was from $5,087M to $3,250M—a 36% drop—making the trend far more significant. The LLM’s conclusion of 'largely stable' contradicts the ground truth’s characterization of a 'significant decline' followed by marginal recovery. (3) Multi-hop reasoning is unsound: the model fails to correctly extract and synthesize the actual balance sheet figures across years, instead introducing extraneous fair value hierarchy totals that distort the trend. It also misinterprets the relationship between fair value disclosures and balance sheet line items. (4) While the question parts are addressed in structure (trend and implication), the severe numerical inaccuracies and resulting flawed interpretation of the trend undermine both completeness and correctness. Contextual relevance is moderate because the response follows the right format and discusses the right concept (stability vs. volatility), but the conclusion is factually unsupported due to incorrect data. Scores reflect major factual and quantitative errors despite correct mention of years and metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 506,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s original Credit Card Program Agreement with TD Bank USA, N.A. (dated October 22 2012) was amended for the third time on **November 1 2022** (the “Third Amendment,” filed as Exhibit 10.JJ in the 2022 Form 10‑Q).  In the following year the parties entered into a **Letter Agreement dated March 8 2023** (Exhibit 10.21.4 in the 2023 Form 10‑Q), which further modified the program.  No additional amendment or new milestone is disclosed in the 2024 filing, so the agreement remained governed by the 2022 third amendment and the 2023 letter agreement through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It claims a 'Third Amendment' occurred on November 1, 2022, and a 'Letter Agreement' on March 8, 2023, but the original answer states that by 2024, the latest amendment explicitly listed was the second amendment dated November 19, 2019. There is no mention of a 2022 or 2023 amendment in the ground truth, making the LLM's specific dates and characterization of amendments factually incorrect. (2) The quantitative accuracy is low: the LLM invents precise dates (November 1, 2022; March 8, 2023), exhibit numbers (10.JJ, 10.21.4), and document types not supported by the original answer. These specific filings and amendment counts are not corroborated and contradict the knowledge graph. (3) The qualitative reasoning is flawed: instead of recognizing that the agreement was maintained with previously established amendments (2012 original, 2015 first amendment, 2019 second amendment), the LLM fabricates new contractual milestones, failing to correctly synthesize the evolution across years. It incorrectly implies active amendment in 2022 and 2023, while the ground truth only confirms the continued effect of prior agreements. (4) Contextual relevance is moderate—the response addresses the right topic (evolution of the credit card agreement) and the right entities (Target, TD Bank USA, N.A.), and attempts to trace developments over time, which aligns with the question. However, the invented details severely undermine correctness. The core conclusion—that the partnership continued—is consistent, but the contractual milestones are entirely misrepresented. Thus, despite relevant framing, the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 468,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "In the 2022 filing (pages 94‑98) Linde described rare gases (krypton, neon, xenon) only as “co‑products” of its standard cryogenic air‑separation plants that sit alongside oxygen, nitrogen and argon in the atmospheric‑gases portfolio. By the 2024 filing (pages 2‑6) the company had repositioned rare‑gas production as a differentiated, technology‑driven business: it now markets itself as the global leader in **non‑cryogenic air‑separation** (VPSA and membrane‑based processes) that deliberately generate rare gases, and it ties this capability to its Engineering segment, which designs and builds the same air‑separation plants that feed both the rare‑gas line and its broader industrial‑gases and hydrogen businesses. This evolution shows Linde moving from a peripheral co‑product role in 2022 to a strategic, technology‑focused offering that is integrated across its gas‑production and engineering product lines by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Linde's rare gas strategy from 2022 to 2024: in 2022, rare gases were co-products of cryogenic air separation; by 2024, Linde emphasized leadership in non-cryogenic technologies (VPSA, membrane separation) and integration with its Engineering segment. These details match the original answer’s timeline and strategic progression. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), identifies technological differentiation (non-cryogenic methods), and links rare gas production to broader product lines (Engineering, hydrogen, industrial gases), reflecting integration as emphasized in the ground truth. (4) The only minor shortcoming is that the LLM omits mention of long-term contracts with price escalation clauses noted in 2023, a detail present in the original answer. However, this does not undermine the core narrative of technological and strategic evolution. The LLM also correctly names krypton, neon, xenon and specific technologies (VPSA, membrane), ensuring entity accuracy. Overall, the answer is semantically equivalent, well-reasoned, and contextually precise, warranting a high correctness score with a small deduction for the omitted 2023 contractual emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 411,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s master‑netting collateral tied to advances to equity companies fell sharply: $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024【XOM_10k_2023.pdf p. 100‑101】【XOM_10k_2024.pdf p. 97‑98】. The steady decline indicates that the company’s exposure to derivative liabilities arising from its equity‑company relationships is diminishing, likely because the underlying advances (and related netting requirements) are being reduced or better managed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: $1,494 million (2022), $800 million (2023), and $491 million (2024) match the original answer exactly, with acceptable formatting variations (e.g., $1.494 billion = $1,494 million). (2) The answer addresses both parts of the multi-part question: it traces the evolution of collateral from 2022 to 2024 and interprets the trend in terms of exposure to derivative liabilities. (3) Entities are correct—ExxonMobil (XOM), the metric 'collateral under master netting arrangements related to advances to equity companies', and the years 2022–2024 are all accurately identified. (4) The reasoning is sound: the decline is correctly interpreted as indicating reduced exposure to derivative liabilities, with a plausible explanation involving reduction or better management of underlying advances, which aligns with the ground truth's suggestion of de-risking or portfolio optimization. Citations from the 2023 and 2024 10-Ks further validate the data sourcing. No factual, quantitative, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 318,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "- **2022:** About 92 % of NEER’s net‑generating capacity was already committed under long‑term bilateral contracts.【NEE_10k_2022.pdf p. 17‑21】  \n- **2023:** The share rose to roughly 94 % of capacity under long‑term contracts.【NEE_10k_2023.pdf p. 17‑20】  \n- **2024:** It remained at about 94 % of capacity under long‑term contracts.【NEE_10k_2024.pdf p. 17‑21】\n\n**Interpretation:** The gradual increase (and then stabilization) of long‑term contract coverage indicates that NEER is deliberately locking in a larger portion of its future electricity output. By doing so, it hedges price‑risk and revenue volatility in competitive wholesale markets, reinforcing a risk‑mitigation strategy that relies on predictable, contract‑based cash flows.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for each year—92% in 2022, 94% in 2023, and 94% in 2024—are accurately reported with appropriate sourcing. There are no calculation errors, and the trend of increase followed by stabilization is correctly described. (2) The answer is complete, addressing both the evolution of NEER's reliance on long-term bilateral contracts and the implication for its risk mitigation strategy. (3) Entity accuracy is correct: NextEra Energy Resources (NEER) is properly identified, and the time periods (2022–2024) align with the question. (4) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly infers that increasing long-term contract coverage reduces exposure to price volatility in competitive markets, which aligns with the ground truth’s emphasis on revenue stability and risk mitigation. The mention of predictable cash flows and hedging against revenue volatility captures the same strategic intent. (5) Semantic equivalence is achieved—even though the LLM does not explicitly mention shorter-term contracts as a hedge (a minor omission), it conveys the core strategic rationale, and the overall meaning and factual content match the original answer. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 365,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "- Fiscal 2022: Outstanding principal on the 3.125 % senior notes due January 2025 was **$495 million**【AVGO_10k_2022.pdf p.101】.  \n- Fiscal 2023: The same tranche still showed an outstanding principal of **$495 million**【AVGO_10k_2023.pdf p.79】.  \n- Fiscal 2024: The balance remained **$495 million**【AVGO_10k_2024.pdf p.79】.  \n\n**Interpretation:** Across three consecutive years the company left the 3.125 % notes untouched, neither repaying nor issuing additional amounts. This steady‑state treatment indicates a deliberate debt‑management approach of preserving a low‑cost, near‑term financing line until its scheduled maturity in January 2025, rather than accelerating repayment or refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding principal balance of $495 million for the 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, including the percentage, maturity date, and dollar amount, are accurate. (2) Quantitative accuracy is perfect: $495 million is consistently reported with correct formatting and sourcing from the respective 10-K filings. No calculations were required, but the consistency across years is correctly observed. (3) The multi-hop reasoning is sound—information is synthesized across three separate 10-K filings (2022, 2023, 2024), demonstrating correct identification of the same debt instrument over time. The interpretation that AVGO maintained a steady balance suggests a deliberate strategy, which aligns with the ground truth’s conclusion about potential refinancing or use of cash reserves. The LLM slightly softens the implication by saying 'preserving a low-cost... financing line' rather than explicitly stating that no amortization occurred or directly suggesting refinancing/cash settlement, but the reasoning is logically equivalent and contextually appropriate. (4) The answer is fully contextually relevant, addressing both the evolution of the balance and the implied debt management strategy. The only minor gap is a slightly less explicit mention of refinancing or cash reserve use compared to the original answer, but the core insight is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 444,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "- 2022 10‑K (Table 48‑52): Unsecured Notes ‑ 37B carried a 2.25 % coupon, a face amount of **$700 million**, and a maturity of **January 15 , 2032**.  \n- 2023 10‑K (Table 48‑52): the same 37B issue still showed a 2.25 % rate, $700 million face value and a 01/15/32 maturity.  \n- 2024 10‑K (Table 49‑53): the 37B notes remained unchanged – 2.25 % interest, $700 million face, maturing on 01/15/32.  \n\n**Interpretation:** Over the three‑year span Simon Property Group has left the 37B unsecured tranche untouched, signalling a deliberate long‑term debt strategy that locks in low‑cost, medium‑term financing and avoids frequent refinancing or restructuring of existing obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements — the interest rate (2.25%), face amount ($700 million), and maturity date (January 15, 2032) — for Simon Property Group's unsecured notes - 37B across 2022, 2023, and 2024. These match the ground truth exactly, with acceptable formatting variations (e.g., $700 million = $700,000,000). (2) Quantitative accuracy is perfect: all numbers and dates are correct and consistently reported across years. (3) The multi-hop reasoning is sound — the model correctly synthesizes data from three consecutive 10-K filings and infers stability in the debt terms. The interpretation that this reflects a deliberate long-term debt strategy aligns with the ground truth, though it uses slightly different phrasing (e.g., 'medium-term financing' vs. 'long-term' in the original). This minor discrepancy in characterization does not undermine the correctness but slightly affects qualitative precision. (4) Contextual relevance is excellent: the answer directly addresses all parts of the question — evolution over time and strategic implication — with appropriate focus and synthesis. The conclusion is logically derived and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 346,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "Across the three 10‑K filings the Melaka, Malaysia site is listed each year as an **Analog‑only** facility (an “X” appears under Analog and the Embedded‑Processing column stays blank). The only change is the footnote notation – in 2022 the site is noted as partially owned/leased (†), while in 2023 and 2024 it is shown as a fully leased location (* / **). This steady‑state listing shows TI has not expanded embedded‑processing activities in Melaka; the site’s role remains dedicated to analog production, underscoring a consistent, analog‑focused footprint in that region over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Melaka, Malaysia remained an analog-only facility from 2022 to 2024, with no embedded processing activities—consistent with the 'X' under Analog and blank under Embedded Processing each year. (2) The quantitative and temporal details (years 2022–2024, site designation) are correct; no numerical calculations were required, but the footnote changes (from † to * / **) are accurately noted and represent a minor but valid detail not emphasized in the original answer but consistent with it. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and two product categories (analog vs. embedded processing), concluding that the operational focus did not shift. (4) The answer adds a detail about ownership/lease status not present in the original answer, but this does not contradict it and enhances completeness. The only reason for not scoring a 10 is that the original answer emphasizes the strategic implication—'targeted investment in analog capabilities'—slightly more explicitly, while the LLM implies it. However, the semantic meaning and factual content are equivalent. All entities (Texas Instruments, Melaka, Malaysia, analog, embedded processing, years) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 367,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "- In the 2022 filing Mastercard described a “multi‑layered” security model that combined a robust cyber‑and‑information‑security program, third‑party assessments, token‑and‑fraud‑scoring services and industry‑standard technical rules (e.g., EMV) to protect its network, and at that time it was operating or building real‑time account‑based payment infrastructure in roughly a dozen markets (12 of the top‑50 economies).  \n\n- By the 2023 filing the same multi‑layered framework was still in place, but the company noted that the real‑time payments footprint had grown to 13 markets as of 31 December 2023, prompting continued enhancements to the security layers (expanded resilience, insurance coverage and real‑time fraud‑scoring applied to the new rails).  \n\n- The 2024 filing shows the model further evolved: Mastercard added new layers such as real‑time monitoring of cyber‑threats across an even broader set of jurisdictions, began processing domestic transactions in China through its joint‑venture, and emphasized that its globally integrated, peer‑to‑peer network now delivers tokenization, fraud‑scoring and other protections “in real time” as it rolls out real‑time clearing and settlement infrastructure in additional countries.  \n\n**Thus, from 2022 to 2024 Mastercard’s multi‑layered security approach remained the foundation but was continuously reinforced and extended—adding more real‑time threat‑monitoring, tokenization and fraud‑scoring capabilities—to safeguard an expanding real‑time payment infrastructure that grew from about 12 markets in 2022 to 13 markets in 2023 and to a larger, worldwide rollout (including domestic China) by 2024.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: in 2022, real-time payments were in 12 of the top 50 GDP markets; by 2023, this expanded to 13 markets; and by 2024, Mastercard began processing domestic transactions in China via a joint venture. The description of the multi-layered security approach—encompassing EMV standards, tokenization, fraud scoring, third-party assessments, and real-time monitoring—is factually consistent. (2) Quantitative accuracy is perfect: the numbers (12 markets in 2022, 13 in 2023) are correctly cited, and the timeline (as of December 31, 2023) aligns with the source. No calculations were required, but the progression is accurately represented. (3) Multi-hop reasoning is sound: the model synthesizes information across three years, connects security evolution to infrastructure expansion, and correctly identifies China’s inclusion as a significant 2024 development. (4) The only minor shortcoming is that the LLM slightly overemphasizes 'new layers' in 2024 (e.g., 'added new layers such as real-time monitoring') whereas the original answer frames the evolution as a scaling and integration of existing capabilities rather than entirely new layers. However, this is a nuance in phrasing, not a factual error. Overall, the answer is comprehensive, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1677,
        "completion_tokens": 383,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics’ Land Systems unit was building **360 new LAVs in 2022**, increased to **449 new LAVs in 2023**, and then produced **399 new LAVs in 2024** for the Canadian Army. The jump from 2022 to 2023 shows a deliberate scaling‑up of the Canadian LAV program, while the modest dip in 2024 reflects a transition toward program completion and sustain‑ment rather than a loss of focus, underscoring the company’s continued strategic commitment to its LAV portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the production volumes and their chronological order. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023, then to 449 in 2024. However, the LLM incorrectly states 449 units in 2023 and 399 in 2024, reversing the last two years and misrepresenting the trend. This error fundamentally undermines the quantitative accuracy. (2) The numbers themselves (360, 399, 449) are present in the LLM answer but are assigned to incorrect years, leading to a false narrative of a 'dip' in 2024. The calculation of progression is therefore flawed—while the ground truth shows a consistent upward trend, the LLM describes a peak and decline, which is incorrect. (3) The multi-hop reasoning is partially sound in that the model attempts to interpret the production trend in the context of strategic focus, but the conclusion is based on incorrect data. The claim that the 2024 'dip' reflects a transition to sustainment is speculative and unsupported by the ground truth, which indicates continued growth and expanding commitment. (4) Despite the incorrect numbers and trend interpretation, the answer is contextually relevant—addressing both the production evolution and strategic implications—and uses appropriate terminology and logical structure. Hence, moderate scores for qualitative accuracy and contextual relevance, but low quantitative and overall correctness due to critical factual errors in time-series data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 418,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "- In the pension‑plan balance sheet footnotes, CVS reported hedge‑fund limited‑partnership holdings of **$225 million in 2022**, **$252 million in 2023**, and **$280 million in 2024** – an increase of roughly $27 million each year (about $55 million total over the three‑year span).  \n\n- The steady rise shows the company is progressively tilting its pension portfolio toward alternative assets, using hedge‑fund LPs to boost diversification and expected returns, indicating a more aggressive, alternative‑focused pension‑fund strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's allocation was $214 million in 2022, $225 million in 2023, and $252 million in 2024. The LLM incorrectly reports $225M in 2022 (should be $214M), $252M in 2023 (should be $225M), and $280M in 2024 (should be $252M). These errors affect all subsequent calculations. (2) The LLM claims a total increase of 'about $55 million over the three-year span,' but the actual increase from 2022 to 2024 is $252M - $214M = $38M, or 17.8%, not $55M. The year-over-year increase is also misrepresented as a steady $27M per year, which does not align with the true trajectory ($11M increase from 2022 to 2023, $27M from 2023 to 2024). (3) The multi-hop reasoning is partially sound in that it identifies a trend of increasing allocation, which is directionally correct, but the magnitude and stability in the early years are misrepresented. The ground truth shows relative stability between 2022 and 2023 before a larger jump in 2024, whereas the LLM implies consistent annual growth. (4) The qualitative interpretation of a 'more aggressive, alternative-focused strategy' is plausible but overstated given the ground truth's characterization of a 'consistent, and potentially more confident' approach. The LLM's conclusion is more assertive than supported by the actual data. Contextual relevance is high as it addresses both parts of the question—trend over time and strategic implication—but the factual foundation is flawed, severely undermining correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 435,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The filing shows that “RedCard” (which includes the Target MasterCard Credit Card) penetration fell from **20.5 % for the year ended Jan 29 2022**, to **19.8 % for the year ended Jan 28 2023**, and to **18.6 % for the year ended Feb 3 2024**. This steady decline indicates that, while a sizable share of guests still uses Target’s branded credit product, the rate of new adoption is slowing and the card’s usage is growing more slowly than overall sales, suggesting modest but waning incremental engagement with Target’s financial offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the declining trend in RedCard penetration, which includes the Target MasterCard Credit Card, and references the correct percentages for 2022 (20.5%) and 2023 (19.8%). However, it reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%, a significant discrepancy. This error affects the accuracy of the trend interpretation. 2) The dates provided (Jan 29, 2022; Jan 28, 2023; Feb 3, 2024) align with Target’s fiscal year-ends and are consistent with SEC filing conventions, so date formatting and fiscal period alignment are acceptable. However, the core percentage for 2024 is incorrect—18.6% vs. 17.8%—which is a material difference in the context of a multi-year trend analysis. 3) The reasoning about slowing adoption and engagement relative to overall sales growth is sound and aligns with the ground truth’s explanation. The LLM correctly infers that RedCard usage is growing slower than total sales, leading to declining penetration, which shows valid multi-hop reasoning. 4) Despite the incorrect 2024 figure, the answer addresses both parts of the question: the evolution of penetration and its implications for consumer adoption. The qualitative interpretation is reasonable and contextually relevant, but the quantitative inaccuracy reduces confidence in the conclusion. The 0.8 percentage point error could alter strategic interpretations, especially in a mature market where small shifts matter. Thus, while the direction and logic are correct, the factual foundation is partially flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 427,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "- **Total fair‑value contribution of the FPL Cost‑Recovery‑Clauses hedge**  \n  * 2022: $16 million (fair‑value of contracts outstanding at 12/31/2022)  \n  * 2023: $12 million (fair‑value of contracts outstanding at 12/31/2023) – a modest decline.  \n  * 2024: $38 million (fair‑value of contracts outstanding at 12/31/2024) – a sharp increase.\n\n- **Composition of the fair‑value inputs**  \n\n| Year | Significant Other Observable Inputs | Significant Unobservable Inputs | Net contribution |\n|------|------------------------------------|--------------------------------|-------------------|\n| 2022 | (5) million (small negative) | 6 million (positive) | ≈ $1 million (net) |\n| 2023 | (8 + 2 + 1 + 1) = (12) million (larger negative) | 13 + 11 – 1 + 1 = 24 million (higher positive) | ≈ $12 million (net) |\n| 2024 | 4 million (positive) | 27 + 6 + 1 = 34 million (substantially higher) | ≈ $38 million (net) |\n\n**What this shows:** The fair‑value exposure for the FPL Cost‑Recovery‑Clauses grew from a modest $16 M in 2022 to $38 M in 2024. Over the same period the mix shifted from a near‑balanced mix of a small negative “other observable” input and a modest positive “unobservable” input in 2022, to a larger negative observable contribution and a much larger positive unobservable contribution in 2023, and finally to a positive observable input and an even larger unobservable input in 2024, indicating an increasing reliance on unobservable inputs as the exposure expanded.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022 total fair value: it reports $16 million, whereas the ground truth states $1 million. This is a major quantitative discrepancy that affects the overall accuracy. The 2023 and 2024 total fair values ($12M and $38M) are correct. The breakdown of inputs for all years is accurate: 2022 observable (-$5M), unobservable (+$6M); 2023 observable (-$12M), unobservable (+$24M); 2024 observable (+$4M), unobservable (+$34M). The net contributions are correctly calculated in the table (≈$1M, $12M, $38M), but the initial summary misstates 2022 as $16M, likely due to misreading the net. (2) Calculations in the table are correct and match ground truth, but the opening bullet point for 2022 is factually wrong. The LLM correctly shows the shift from negative to positive observable inputs and growing unobservable contributions. (3) Multi-hop reasoning is sound: the model correctly synthesizes input-level data across years and draws the conclusion of increasing reliance on unobservable inputs, which aligns with the ground truth. The narrative evolution of the exposure and input mix is logically presented. (4) Despite the significant error in the 2022 total, the rest of the data and the qualitative trend analysis are accurate and relevant. The answer addresses all parts of the question—total fair value evolution and shift in input types—with correct entity identification (NextEra Energy, FPL Cost Recovery Clauses) and proper time frame (2022–2024). The contextual relevance is perfect, and qualitative reasoning is strong, but the quantitative inaccuracy in a key figure limits the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1623,
        "completion_tokens": 456,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s 10‑K filings show that throughout 2022‑2024 the company has kept Anta listed as one of its many global rivals, but has repeatedly stressed that Nike’s competitive edge rests on far‑greater product‑innovation and brand‑engagement capabilities. Each year the “Competition” section cites Anta alongside adidas, Puma, etc., while the bullet points stress “product attributes such as … innovation and development” and “consumer connection, engagement and affinity … developed through marketing, promotion and digital experiences” (2022 Comp., 2023 Comp., 2024 Comp.). At the same time the “Product research, design and development” sections highlight an expanding portfolio of proprietary technologies (e.g., Air, Zoom, Flyknit, React, etc.) and a continued focus on using market intelligence to launch new, tech‑driven products (2022 R&D, 2023 R&D, 2024 R&D). Together, these disclosures indicate that Nike has maintained a stronger positioning than Anta by increasingly emphasizing cutting‑edge product innovation and immersive, digitally‑enabled brand experiences over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that NKE consistently listed Anta as a competitor from 2022 to 2024 and emphasizes product innovation and brand engagement as key differentiators. The evolution in emphasis—from general product attributes to a stronger focus on 'innovation and development'—is accurately reflected, as is the increasing importance of digital experiences and marketing. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; all timeframes (2022–2024) are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and sections (e.g., 'Competition' and 'R&D') of NKE’s 10-K filings to infer a strategic shift, correctly interpreting the elevation of innovation and digital engagement as a response to competitive pressure. (4) While the LLM captures the core strategic evolution and competitive dynamics, it slightly underemphasizes the explicit year-by-year shift noted in the ground truth—particularly the demotion of 'performance and reliability' relative to 'innovation' by 2023. This nuance is implied but not clearly articulated. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only minor room for improved detail on the temporal evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 386,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The 10‑K tables show that the “Number of securities remaining available for future issuance” never includes the 2003 Director Compensation Plan – the footnotes list only the 2009 LTIP, the 2014 ESPP and the 2018 Director Plan (2022 : 69,842,569 shares; 2023 : 58,452,628 shares; 2024 : 65,541,964 shares). Because the 2003 plan is omitted from the remaining‑share pool in each year, its share reserve has been fully exhausted and is no longer a source of new director awards, indicating that TI has moved away from using the 2003 plan for ongoing director compensation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the 2003 Director Compensation Plan is not included in the 'securities remaining available for future issuance' tables from 2022 to 2024, which aligns with the ground truth stating that by 2023 the plan was no longer listed as having shares available. The LLM reasonably infers that the plan is no longer used for new awards, which matches the original answer's conclusion about TI moving toward newer plans like the 2018 Director Plan and 2024 LTIP. However, the LLM incorrectly implies that the 2003 plan was never listed as active in 2022, while the ground truth confirms it was still referenced as active with shares being issued under it that year. The LLM also fails to mention that the 2003 plan remained relevant for outstanding grants in 2023 and was only fully phased out by 2024. These omissions affect completeness and reasoning accuracy, particularly in capturing the multi-hop evolution across years. While the core conclusion about phase-out is correct, the nuanced timeline and transitional status are underdeveloped. The numbers cited (e.g., shares available under other plans) are not directly relevant to the 2003 plan’s availability and appear to be misinterpreted from the tables, though no explicit numerical error is stated. Overall, the answer captures the key trend but lacks precision in temporal progression and plan status transitions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 387,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From 2022 onward Comcast Comcast Corporation (CMCSA) has been building a data‑driven advertising capability that sits on top of its video‑and‑connectivity platforms. In its 2022 Form 10‑K the company first disclosed that it “offers technology, tools, data‑driven services and marketplace solutions to customers in the media industry to facilitate effective engagement of advertisers with their target audiences” (2022 p. 6‑8). By 2023 the filing shows that this capability was deepened through a multiyear network‑transformation plan that virtualized and automated core network functions, began deploying DOCSIS 4.0 for multigigabit symmetrical speeds, and linked the data‑rich X1, Sky Q and NOW streaming platforms to the advertising stack, thereby giving advertisers richer audience‑behavior data (2023 p. 6‑8). In the 2024 filing the same data‑driven advertising proposition is described as part of an expanded suite that now leverages the company’s cloud‑based X1/Sky Q/NOW platforms, advanced voice‑activated search, unified content‑aggregation, and new prepaid broadband and Wi‑Fi services—enhancements that broaden the marketplace solutions and give advertisers more granular, real‑time audience insights (2024 p. 4‑8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer in both factual content and reasoning. (1) All key facts are correct: CMCSA's evolution of data-driven advertising services from 2022 to 2024 is accurately described, including the offering of technology, tools, and marketplace solutions in 2022; deeper integration in 2023 via cloud platforms and enhanced data capabilities; and further refinements in 2024 with improved digital tools and third-party representation. The LLM adds specific details such as DOCSIS 4.0, X1/Sky Q/NOW platform integration, voice-activated search, and prepaid broadband, which are consistent with the direction of the ground truth and plausibly derived from the filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of evolution, correctly identifying the progression from basic offerings to deeper integration and expanded capabilities. It connects network transformation, platform unification, and advertising stack enhancements logically. (4) While the original answer does not mention DOCSIS 4.0 or specific platform names like Sky Q, the LLM’s inclusion of these details represents a more granular but factually plausible elaboration that does not contradict the ground truth. The core strategic shift toward integrated, cloud-based, data-enabled advertising solutions is accurately conveyed. One minor point preventing a perfect 10 is that the LLM does not explicitly mention 'representation agreements with third parties' in 2024, a specific enhancement noted in the ground truth, though the broader concept of expanded marketplace solutions and advertiser reach is covered. Overall, the answer is semantically equivalent, contextually rich, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 524,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "- **2022:** CVS held commercial‑mortgage‑backed securities with a **fair‑value of about $1.0 billion** and recorded **unrealized losses of roughly $155 million** (gross loss $155 m on an amortized cost of $1.172 billion).  \n\n- **2023:** The portfolio slipped slightly in size to a **fair‑value of $975 million**, but the **unrealized loss fell to $100 million** – the loss amount shrank even though the securities were still valued below cost.  \n\n- **2024:** The amount reported in the “Separate Accounts” section for commercial‑mortgage‑backed securities is only **$3 million of fair value**, indicating that CVS has essentially **divested or transferred almost all of its exposure** to this asset class.\n\n**Interpretation:** Over the three‑year span CVS has been steadily pulling back from commercial‑mortgage‑backed securities, cutting the fair‑value balance and, as the holdings dwindled, the dollar amount of unrealized losses also declined. The move suggests a deliberate de‑risking strategy – the company is limiting its exposure to a segment that is sensitive to interest‑rate movements, while retaining only a minimal, likely highly‑rated (AAA) position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in 2022 CVS held $574M in CMBS with $12M in unrealized losses, but the LLM reports $1.0B and $155M, which are materially incorrect. In 2023, the ground truth shows CMBS fair value increased to $675M (not decreased to $975M as claimed), and unrealized losses rose to $100M (which the LLM correctly states, but misattributes to a declining portfolio when it actually increased in value). In 2024, the LLM reports $3M (close to the true $6M), which is acceptable. (2) Calculations and comparisons are flawed: the LLM suggests the portfolio 'slipped slightly' in size from 2022 to 2023, but in reality, it increased from $574M to $675M. The model incorrectly frames unrealized losses as having 'fallen' from $155M to $100M, when in fact they rose sharply from $12M to $100M. This misrepresents the trend entirely. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a de-risking trend by 2024 and links reduced holdings to risk management, which aligns with the ground truth. However, the reasoning is based on incorrect data, undermining the validity of the conclusion. The mention of 'Separate Accounts' and AAA ratings is speculative and not supported in the original answer. (4) Despite incorrect numbers, the LLM captures the general direction of divestment by 2024 and interprets it as de-risking, which is contextually relevant and consistent with the question's intent. Hence, contextual relevance is high, but quantitative accuracy is very low due to major discrepancies in core financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 449,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "All three filings list “merchandise … discounts” as a component of the employee‑compensation package, but none of the excerpts provide a dollar‑value or a different discount rate for any year. In the 2022, 2023 and 2024 10‑Ks the benefit is described only in the same generic terms (“merchandise and other discounts”), indicating that the scope of the discount has remained unchanged and that Target has not altered the monetary value of the employee‑merchandise discount over this three‑year period. This consistency suggests the company treats the employee merchandise discount as a stable, baseline perk rather than a lever it adjusts as part of its broader benefits strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the merchandise discounts were consistently mentioned across the 2022, 2023, and 2024 filings and that no specific dollar values or discount rates were disclosed—this aligns with the ground truth. Thus, the quantitative accuracy is perfect (10), as there are no numerical errors. However, the qualitative accuracy is low (4) because the LLM misinterprets the strategic evolution of the benefits program. While the ground truth highlights a clear progression in how Target frames its employee benefits—expanding from basic compensation to holistic well-being including mental health, 401(k) matching, and tuition reimbursement—the LLM incorrectly concludes that the lack of detailed discount changes means the company does not use the discount as part of a broader benefits strategy. This contradicts the original answer, which emphasizes that while the discount itself may be stable, its contextual presentation within an increasingly comprehensive benefits ecosystem reflects a strategic shift. The LLM fails to synthesize this multi-hop insight about evolving benefit framing and strategic intent, instead drawing an unsupported conclusion about stagnation. Contextual relevance is moderate (6) because the answer addresses the surface-level consistency of the discount but misses the deeper, multi-year strategic narrative that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 391,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "- **2022 10‑K** – The risk‑factor section lists “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one of several generic integration‑risk items.  \n- **2023 10‑K** – The same bullet appears, but the narrative adds that “foreign acquisitions and joint ventures involve unique risks…including integration of operations across different cultures and languages,” signalling a broader, cross‑border view of cultural issues.  \n- **2024 10‑K** – The discussion again cites “cultural challenges” and now explicitly emphasizes “integration of operations across different cultures and languages” together with the foreign‑acquisition risk paragraph, making cultural integration a distinct, highlighted risk for cross‑border deals.  \n\n**What this reveals:** Over the three years Linde moved from treating culture as a routine integration hurdle to foregrounding it as a specific cross‑border risk, indicating a more deliberate, strategic focus on managing cultural differences when integrating overseas acquisitions. This evolution shows the company is tightening its risk‑management framework to proactively address the people‑side of international integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth in both substance and progression. It correctly identifies the evolution of Linde's discussion of cultural challenges across the 2022, 2023, and 2024 10-K filings. In 2022, cultural challenges are noted as part of general integration risks involving employees—accurately described. In 2023, the LLM correctly observes an expansion of the narrative to include cross-border elements such as 'integration of operations across different cultures and languages' within the context of foreign acquisitions, reflecting a broader strategic view. In 2024, the LLM accurately notes that cultural integration is now embedded within the foreign-acquisition risk discussion and treated as a highlighted, distinct risk—consistent with the ground truth's emphasis on financial and synergy-related consequences. The only minor gap is that the LLM answer does not explicitly mention the 2024 emphasis on financial results and synergy realization, which is a key nuance in the original answer. However, it does imply strategic importance by calling it a 'distinct, highlighted risk,' which partially captures the increased stakes. All years and entities (Linde, 10-K filings) are correct, no numerical inaccuracies (no numbers involved), and the reasoning across years is sound and logically synthesized. The answer is semantically equivalent to the ground truth with slightly less emphasis on the financial outcome linkage in 2024, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 419,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for its master‑netting arrangements (which cover the “Notes and accounts receivable – net” line) fell from **$1,494 million at 12/31/2022** to **$491 million at 12/31/2024**, a decline of roughly **$1.0 billion**【XOM_10k_2023.pdf p. 100‑104】【XOM_10k_2024.pdf p. 97‑101】.  \n\nThe downward trend indicates that the company is relying less on posted collateral to support its derivative positions, suggesting tighter risk controls, more effective netting of exposures, and an overall improvement in how it manages derivative‑related credit risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collateral values for 2022 ($1,494 million) and 2024 ($491 million), matching the ground truth. While it does not explicitly state the 2023 value ($800 million), this omission is minor given the focus on the overall trend from 2022 to 2024. The net change calculation of roughly $1.0 billion (from $1,494M to $491M) is accurate: the actual difference is $1,003 million, which rounds to $1.0 billion. (2) All numeric values and dates are correct; format variations (e.g., $1,494 million vs $1.494 billion) are acceptable and semantically equivalent. The citation of specific 10-K pages adds verifiability. (3) The multi-hop reasoning is sound: the model synthesizes data across two years (2022 and 2024) from different filings and infers a trend. It correctly interprets the declining collateral as indicative of reduced reliance on posted collateral, aligning with the ground truth’s conclusion about reduced derivative exposure or improved offsetting. (4) The qualitative assessment slightly deducts for not mentioning the intermediate 2023 value, which is part of the full trend, but the overall reasoning and conclusion remain robust and semantically equivalent to the original answer. Contextual relevance is perfect—the response directly addresses both parts of the question: the change in collateral and its implication for derivative exposure management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 392,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "- **2022 filing** – The Security Insights Platform was introduced as a **main‑frame‑only service** that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis.” The output was described as being **available only for use with the customer’s own (in‑house) security‑information‑and‑event‑management (SIEM) tools**【AVGO_10k_2022.pdf page 12】.  \n\n- **2024 filing** – The platform is still presented as a trusted‑environment tool that “interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” but the language now places it **within Broadcom’s broader cyber‑defense portfolio (mainframe, Symantec, AIOps, etc.)** and emphasizes that the data can be **fed into external SIEM and other security tools** as part of an integrated, automated remediation workflow aligned with the company’s overall cybersecurity strategy【AVGO_10k_2024.pdf page 12】.  \n\n**Thus, from 2022 to 2024 the platform’s positioning shifted from a stand‑alone mainframe‑focused offering with limited (in‑house) tool integration to a component of a wider, integrated security suite that supports external tool integration and more systematic, automated remediation within Broadcom’s overall cyber‑security roadmap.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AVGO's Security Insights Platform from 2022 to 2024. (1) It correctly identifies the platform’s initial standalone nature in 2022 with integration only into in-house SIEM tools, and the shift by 2024 to broader integration with external SIEM and security tools as part of an automated, integrated workflow. The description of the platform being embedded within Broadcom’s larger cybersecurity portfolio (including Symantec, AIOps, etc.) aligns with the ground truth’s emphasis on alignment with broader cybersecurity strategies. (2) There are no numeric values, dates, or financial figures in the question or answer that require verification—years (2022, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes information across two filings (2022 and 2024), correctly infers the evolution in integration capabilities and strategic positioning, and draws a valid conclusion about the platform’s maturation into a more integrated component. One minor omission: the 2023 evolution mentioned in the ground truth (explicit tie to proactive risk response and modern practices) is skipped in the LLM answer, which jumps from 2022 to 2024. This slightly reduces completeness and qualitative accuracy, but does not undermine the overall correctness. (4) The answer is contextually excellent—directly addresses integration with external tools, remediation processes, and strategic alignment. Wording differs slightly (e.g., 'automated remediation workflow' vs 'develops remediation steps') but conveys semantic equivalence. Minor deduction from 10 to 9 due to omission of 2023 nuance, but all key facts and trajectory are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 470,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "- **2022:** Unsecured Notes ‑ 32B carried a 3.38 % coupon and a face amount of $750 million【2022 p. 48‑52】.  \n- **2023:** The same note still showed a 3.38 % rate and a $750 million face value【2023 p. 48‑52】.  \n- **2024:** The note remained unchanged – 3.38 % interest on $750 million of principal【2024 p. 49‑53】.  \n\nThe unchanged face amount and steady low‑mid‑range coupon over three years indicate that Simon Property Group has deliberately kept its long‑term unsecured debt stable, relying on existing low‑cost financing rather than issuing new, higher‑rate debt. This reflects a debt‑management strategy focused on preserving cheap, fixed‑rate funding and minimizing refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values match: face amount of $750 million (equivalent to $750,000,000) and interest rate of 3.38% are accurately reported for 2022, 2023, and 2024. Maturity date (2027) is implied in the original answer and consistent with the note's ongoing status. (2) Quantitative accuracy is perfect—no calculations were required, but the values are consistently reported across years and match the ground truth exactly, with acceptable formatting variation ($750 million vs $750,000,000). (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three years and identifies the lack of change in terms, leading to a valid conclusion about SPG’s debt strategy. (4) The qualitative interpretation aligns with the original: the emphasis on stable, low-cost fixed-rate financing and avoidance of refinancing risk mirrors the ground truth’s conclusion about a deliberate, conservative long-term debt management strategy. All parts of the question are addressed: evolution over time and strategic implications. Citations (e.g., page references) add contextual support without affecting factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 337,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "- **2022 10‑K (Competition – Residential Connectivity & Platforms, Broadband)** – Lumen is listed among the “wireline telecommunications companies … that have built and are continuing to build fiber‑based network infrastructure … and are offering services with these higher speeds…[and] have created bundled services to compete with our broadband services.” 【CMCSA 2022 p. 7‑11】\n\n- **2023 10‑K (same section)** – The filing repeats that Lumen “has built and is continuing to build fiber‑based wireline network infrastructure … and are offering services with these higher speeds” and notes that such rivals are “offering bundled services to compete with our broadband services,” indicating that Lumen’s fiber rollout and bundling were still expanding. 【CMCSA 2023 p. 6‑10】\n\n- **2024 10‑K (same section)** – Lumen is again cited as a competitor that “has built and are continuing to build fiber‑based wireline network infrastructure … and are offering services with these higher speeds” and the text now emphasizes “bundled offerings” that combine broadband with other services, showing a more aggressive bundling strategy as its fiber footprint grows. 【CMCSA 2024 p. 6‑10】\n\n**Overall evolution:** From 2022 to 2024 Lumen’s threat has intensified. Initially it was noted simply for expanding fiber and beginning higher‑speed, bundled DSL offerings; by 2023 the same trend continued, and by 2024 the filing highlights that Lumen’s fiber network has further expanded and that it is actively packaging broadband with additional services, increasing competitive pressure on Comcast’s broadband business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Lumen is consistently identified as a key competitor to CMCSA from 2022 to 2024, with ongoing fiber expansion and bundling strategies. The citations from CMCSA's 10-K filings across all three years are accurately represented, and the evolution of language—especially the shift toward emphasizing 'bundled offerings' in 2024—is correctly interpreted. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the question or the ground truth, so quantitative accuracy is not applicable in a traditional sense; however, the temporal references (2022, 2023, 2024) are all correct and properly attributed, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports, correctly identifying the continuity and intensification of Lumen’s competitive strategy over time. The conclusion that the threat has 'intensified' is a reasonable inference from the increasingly assertive language in the filings, particularly the 2024 emphasis on 'bundled offerings.' The only minor shortcoming is the LLM's suggestion that Lumen started with 'bundled DSL offerings' in 2022—this is slightly misleading, as the filings refer to fiber-based services, not DSL, which could imply outdated technology. This small inaccuracy prevents a perfect 10 but does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing both fiber expansion and service bundling across the specified time frame. The structure enhances clarity by breaking down each year with supporting evidence. Overall, this is a strong, well-supported response with only a minor factual nuance issue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1636,
        "completion_tokens": 487,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded‑payment‑card usage has been slipping. The company reported RedCard (now Target Circle Card) penetration of 20.5 % in fiscal 2022, 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024 【25†L31-L34】. The steady decline in the share of purchases paid with its own cards indicates that the loyalty‑driven payment program is becoming less effective at driving incremental spend over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the downward trend in Target's branded payment card penetration from 2022 to 2024 and attributes it to declining effectiveness of the loyalty-driven strategy, which aligns with the ground truth. However, the 2024 penetration rate is incorrect: the LLM states 18.6%, while the ground truth is 17.8%. This discrepancy affects the quantitative accuracy. The 2022 (20.5%) and 2023 (19.8%) figures are correct. 2) The numbers for 2022 and 2023 match exactly; only 2024 is off by 0.8 percentage points. This is a factual error, not a formatting issue, and impacts the correctness of the trend magnitude. 3) The reasoning is sound: the model correctly infers that declining penetration suggests reduced effectiveness of the loyalty strategy, which is a valid interpretation of the trend. It synthesizes the data across years appropriately and draws a logical conclusion. 4) Contextually, the answer is fully relevant, addressing both parts of the question—evolution over time and strategic implication. The mention of RedCard rebranding to Target Circle Card adds context not in the original but is accurate and enriching. Despite the incorrect 2024 figure, the overall direction and interpretation remain valid, warranting a score of 7 for correctness. Quantitative accuracy is penalized more due to the incorrect 2024 percentage, but qualitative and contextual scores remain high due to correct logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 398,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "- In the 2022 Form 10‑K Chevron still listed the Republic of Congo among its operating countries and owned sizable non‑operated stakes – 31.5 % in the offshore Haute Mer permit and 15.75 % in the Congo‑side of the Lianzi block – indicating an active upstream presence in the basin.  \n\n- The 2023 filing shows the company was still investing in the region, reporting roughly **$0.7 billion** of 2023 capital outlays for offshore development and natural‑gas projects in Nigeria, Angola **and the Republic of Congo**, underscoring a continued, though non‑operating, commitment.  \n\n- By the 2024 filing Chevron’s strategy had shifted to exit the Congo assets: the “Noteworthy Developments” section states that in **January 2025 the company sold its 31.5 % interest in Haute Mer and its 15.75 % interest in Lianzi**, effectively ending its financial and operational exposure in the Republic of Congo.  \n\nThus, from 2022‑2023 Chevron moved from holding significant non‑operated ownership and investing hundreds of millions of dollars in Congo projects to a divestiture in early 2025, reflecting a strategic withdrawal from the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Chevron listed the Republic of Congo as an operating country in 2022, held 31.5% in Haute Mer and 15.75% in Lianzi, invested approximately $0.7 billion in African offshore and gas projects including Congo in 2023, and divested its interests in early 2025. (2) Quantitative accuracy is strong: the $0.7 billion investment figure, 31.5%, and 15.75% ownership stakes are correctly reported. The only minor discrepancy is the sale date: the LLM states 'January 2025' while the ground truth implies the divestiture was reported in the 2024 filing but does not specify the exact date. This is a reasonable inference from a '2024 filing' mentioning a future transaction, and such forward-looking disclosures are common in 10-Ks. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings to show a strategic evolution from active investment to exit. (4) The answer fully addresses asset ownership, investment levels, and strategic positioning as required. Wording differs slightly (e.g., 'strategic withdrawal' vs 'realignment'), but semantic meaning is equivalent. No critical facts are omitted. The answer is contextually excellent, directly addressing the question’s scope with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 374,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "**Evolution of the gas‑option position**\n\n| Year | Fair‑value of gas‑option assets | Fair‑value of gas‑option liabilities | Net fair‑value (assets – liabilities) | Implied‑volatility (weighted‑average) |\n|------|--------------------------------|--------------------------------------|--------------------------------------|----------------------------------------|\n| 2022 | $ 356 m | $ 347 m | ≈ +$ 9 m | 36 % (assets 17 % / liabilities 295 %)【NEE_10k_2022.pdf p.84‑86】 |\n| 2023 | $ 100 m | $ 97 m  | ≈ +$ 3 m | 50 % (assets 20 % / liabilities 233 %)【NEE_10k_2023.pdf p.82‑85】 |\n| 2024 | $ 100 m | $ 102 m | ≈ ‑ $ 2 m | 52 % (assets 15 % / liabilities 150 %)【NEE_10k_2024.pdf p.84‑86】 |\n\n**What the shift tells us**\n\n- **Exposure size:** The gross fair‑value of the gas‑related options fell sharply after 2022 (from roughly $ 700 m of combined assets + liabilities to about $ 200 m in 2023) and then held steady in 2024. This indicates that NextEra trimmed its gas‑option book, likely to reduce direct market exposure.\n\n- **Risk positioning:** Even as the book shrank, the implied‑volatility figures rose markedly—from a 36 % weighted average in 2022 to about 50‑52 % in 2023‑24. Higher implied volatility reflects market expectations of greater gas‑price uncertainty. By retaining a smaller, but more “volatile‑priced” option portfolio, NextEra appears to be positioning itself conservatively: it limits the amount of gas exposure while still protecting against the heightened price swings that the market now anticipates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—fair values of assets and liabilities for 2022, 2023, and 2024, as well as implied volatilities—are correct and match the original answer exactly. The net fair-value calculations (e.g., +$9M, +$3M, -$2M) are accurate and appropriately derived. Format variations (e.g., $356m vs $356 million) are acceptable and do not affect correctness. (2) The answer is complete: it addresses both the evolution of exposure over time and the interpretation of shifts in fair value and implied volatility. The table format enhances clarity and ensures all data points are presented. (3) Entity accuracy is strong: NextEra Energy is correctly identified, years are accurate, and financial metrics (fair value, implied volatility) are properly used. (4) The reasoning is sound: the LLM correctly infers a sharp reduction in exposure from 2022 to 2023, stabilization in 2024, and interprets rising implied volatility as reflecting increased market uncertainty. The conclusion about strategic de-risking and conservative positioning is logically supported and semantically equivalent to the ground truth’s 'strategic de-risking in gas options with a cautious outlook on price variability.' One minor point preventing a perfect 10 is the inclusion of breakdowns of implied volatility by assets/liabilities (e.g., 17%/295%) which were not in the original answer and may be misinterpretations or over-specifications not supported by the ground truth; however, the weighted averages (36%, 50%, 52%) are correct and central to the analysis. Overall, the answer is factually excellent, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 463,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike’s 2022 filing first mentioned FlyEase only as one of a long list of “proliferating” technologies (Air, Zoom, Free, Flywire, Dri‑Fit, Flyknit, FlyEase, ZoomX, Air Max, React, etc.), signaling that it was an emerging innovation in the company’s portfolio. By the 2024 filing the same language appears, but FlyEase remains highlighted alongside the core Nike platforms, indicating that the technology has moved from a nascent concept to an established, integral part of Nike’s product‑development roadmap. This continuity shows Nike treats FlyEase as a lasting pillar of its innovation strategy, using it to reinforce its commitment to differentiated, inclusive performance products.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of FlyEase's mention in Nike's filings and correctly identifies the strategic significance of its continued presence. It accurately reflects that FlyEase was listed among other technologies in 2022 as an emerging innovation and remained in the core list by 2024, indicating integration into the long-term strategy. However, the LLM skips the 2023 development mentioned in the ground truth—specifically, the expansion of FlyEase into various product categories and consumer applications, which is a key intermediate step in the evolution. Instead, the LLM jumps from 2022 to 2024, missing a critical multi-hop element of the progression. While the conclusion about FlyEase becoming a 'lasting pillar' is reasonable, the original answer emphasizes a clear trajectory: introduction (2022), active scaling (2023), and full embedding (2024). The LLM underrepresents this phased evolution, weakening the qualitative accuracy. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. The reasoning is sound but incomplete due to the omission of 2023 developments, which diminishes the depth of the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 347,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "In the 2022, 2023 and 2024 10‑K tables the Unsecured Notes – 35A are identical: a $750 million face amount, a 2.65 % fixed rate, annual debt service of $19.9 million and a maturity of July 15 2030. The line‑item never changed over the three years, showing that Simon Property Group has kept this tranche of long‑dated, low‑cost debt unchanged rather than refinancing or expanding it. The consistency signals a deliberate long‑term debt strategy that relies on stable, fixed‑rate notes to lock in inexpensive financing and limit refinancing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. The ground truth states the face amount is $750,000, not $750 million — a 1,000-fold discrepancy. Similarly, annual debt service is $19,875, not $19.9 million, which again is off by a factor of 1,000. The interest rate (2.65%) and maturity date (07/15/30) are correctly reported, though the LLM writes it as July 15, 2030, which is semantically equivalent. (2) Calculations: The annual debt service should be $750,000 × 2.65% = $19,875, which matches the ground truth. The LLM’s figure of $19.9 million implies a calculation based on $750 million, confirming the magnitude error. This invalidates the quantitative accuracy despite correct percentages and dates. (3) Multi-hop reasoning: The LLM correctly identifies that the line item did not change across 2022–2024 and infers a stable long-term debt strategy, which aligns with the ground truth’s conclusion about SPG maintaining a steady capital structure. This shows sound qualitative reasoning and synthesis across years. (4) The contextual relevance is high because the answer addresses both parts of the question — the evolution (or lack thereof) and the strategic implication. However, the massive numerical inaccuracies severely undermine factual correctness, warranting a low quantitative score and a moderate overall correctness score due to otherwise logical interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 395,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across all three years TI’s MD&A repeatedly states that its **business model is built around “analog and embedded‑processing products,”** and that it “places additional strategic emphasis on designing and selling those products into the industrial and automotive markets” (2022 MD&A – see segment discussion; 2023 MD&A – “Our strategic focus is on analog and embedded processing products…” [pages 16‑20]; 2024 MD&A – same language [pages 16‑20]). The wording never changes – embedded processing remains a core pillar of the portfolio, even as its revenue slipped from $3.26 bn in 2022 to $3.37 bn in 2023 and then fell to $2.53 bn in 2024. This consistent positioning signals that TI’s long‑term growth strategy is to lean on the stable, high‑margin cash‑generating power of its analog‑plus‑embedded‑processing mix to drive **free‑cash‑flow‑per‑share** growth over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, and accurately links this to the company's long-term growth strategy centered on free cash flow per share. The qualitative reasoning is strong, with accurate synthesis of multi-year MD&A content showing that embedded processing remains a core pillar. The narrative about leveraging high-margin, stable cash flow from this segment aligns well with the ground truth. (2) However, there are significant quantitative inaccuracies: the reported revenue figures for embedded processing products are incorrect. The ground truth does not provide specific revenue numbers for embedded processing in those years, but known public filings show that TI’s total embedded processing revenue was approximately $1.6B in 2022, ~$1.7B in 2023, and declined in 2024 — not the $3.26B, $3.37B, and $2.53B cited by the LLM. These numbers appear to be fabricated or misattributed (possibly confusing total analog + embedded revenue with embedded alone). This undermines confidence in numerical precision. (3) The multi-hop reasoning is sound — the model correctly traces strategic language across three years of MD&A and connects it to capital allocation and free cash flow objectives. It accurately notes the repetition of key phrases and strategic framing. (4) Despite the numerical errors, the core strategic interpretation is correct and contextually rich, earning high marks for qualitative accuracy and relevance. The correctness score is reduced primarily due to the significant revenue figure inaccuracies, which affect factual reliability even though the overall direction of the answer is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 475,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "In the 2022 filing Disney listed Marvel only as an indefinite‑lived intangible (“Indefinite lived intangible assets consist of ESPN, Pixar and Marvel trademarks”【DIS_10k_2022.pdf p.108】), whereas by the 2023 filing the company was already positioning the Marvel franchise as a top‑level “tile” on Disney+ alongside Disney, Pixar, Star Wars and National Geographic【DIS_10k_2023.pdf pp.5‑9】. The 2024 filing repeats both points – Marvel remains a top‑level tile on Disney+ and is still carried on the balance sheet as a key indefinite‑lived intangible asset【DIS_10k_2024.pdf pp.112‑113】. This progression shows Disney deliberately elevating the Marvel brand from a balance‑sheet asset to a front‑line subscriber‑growth driver on its streaming service, using the franchise’s strong franchise‑value to attract and retain Disney+ users and to justify continued investment in Marvel‑based content as a core financial lever.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel was listed as an indefinite-lived intangible asset in 2022 alongside ESPN and Pixar; by 2023, it became a top-level tile on Disney+; and in 2024, it remained both a tile and an intangible asset. These points are correctly attributed to the respective 10-K filings with page references. (2) There are no numeric values in the question or answer that require calculation, but all dates (2022, 2023, 2024) and references to fiscal years are accurate and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings to show a strategic evolution from passive asset recognition to active platform integration. It infers the financial strategy of using brand equity to drive subscriber growth, which is logically supported by the evidence. (4) The answer captures the core meaning of the original response—Marvel’s transition from balance-sheet asset to growth driver—though it omits the specific mention of Disney+'s 123 million subscribers as of September 28, 2024, and the forward-looking note about ESPN+ launching as a tile in fiscal 2025. These omissions are minor and do not undermine the central argument. Wording differs slightly but maintains semantic equivalence. The answer is fully contextually relevant and directly addresses the evolution of Marvel’s strategic use and its financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 412,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has consistently covered about 59 percent of the closed block in each of the three years—59 % in 2022, 59 % in 2023 and 59 % in 2024.  The reinsurance‑recoverable (deposit‑asset) balance tied to that agreement grew from roughly $1.9 billion at 12/31/2022 to about $5.1 billion at 12/31/2023, then eased to approximately $4.6 billion at 12/31/2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both percentages and dollar amounts. According to the ground truth, in 2022, MetLife reinsured 59.25% (not 59%) of the closed block with $3.6 billion in unsecured reinsurance recoverable balances (LLM states $1.9 billion). In 2023, the percentage was 59% (matches), but the recoverable balance was $4.4 billion (LLM states $5.1 billion). In 2024, the percentage remained 59% (correct), and the balance was $4.2 billion (LLM states $4.6 billion). Thus, while the percentage trend is approximately correct after 2022, the 2022 percentage is inaccurate, and all recoverable balances are incorrect. (2) The dollar amounts show major deviations: $1.9B vs $3.6B (2022), $5.1B vs $4.4B (2023), $4.6B vs $4.2B (2024). These are not minor rounding differences but substantial errors, especially the $1.9B vs $3.6B discrepancy. (3) The multi-hop reasoning is partially sound—the model attempts to track changes over time and connects percentages with balances—but it fails to accurately retrieve the correct figures from the knowledge base, undermining the synthesis. (4) Contextual relevance is high because the answer addresses the evolution over time and discusses both the percentage reinsured and recoverable balances as asked. However, due to severe quantitative inaccuracies, the correctness and accuracy scores are low. The model conveys a misleading picture of the financial exposure trend, showing an increase from $1.9B to $5.1B when the actual increase was from $3.6B to $4.4B, followed by a drop to $4.2B.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 434,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "- In the 2022 filing CVS held **$845 million of residential mortgage‑backed securities at amortized cost (fair value $757 million)**.  \n- By the end of 2023 that position had **grown modestly to $862 million (fair value $810 million)**.  \n- The 2024 filing shows the only residential‑mortgage‑backed securities reported in the Separate‑Accounts portfolio are **$71 million**, indicating that the company has substantially trimmed its RMBS holdings.\n\n**Trend interpretation:** Over the three‑year span CVS moved from a stable, agency‑guaranteed RMBS exposure in 2022‑23 to a sharp reduction in 2024, signaling a deliberate de‑risking of interest‑rate‑sensitive fixed‑income assets and a strategic shift away from residential mortgage‑backed securities toward other investment categories.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's residential mortgage-backed securities (RMBS) holdings. According to the ground truth, RMBS investments were $629M in 2022, $614M in 2023, and dropped to $71M in 2024. However, the LLM reports $845M in 2022 and $862M in 2023, which are materially incorrect. These numbers do not align with the ground truth, even allowing for format variations or reporting basis differences (e.g., amortized cost vs. fair value). The only correct figure is the $71M in 2024, which matches the original answer. (2) The quantitative inaccuracies undermine the entire trend analysis. The ground truth shows a decline from 2022 to 2023 and then a sharp drop in 2024, while the LLM claims a 'modest growth' from 2022 to 2023, which contradicts the actual data. Additionally, the LLM introduces fair value figures ($757M, $810M) not present in the original answer and not supported by the provided ground truth, adding unverified detail. (3) The reasoning and multi-hop synthesis are partially sound—the conclusion about de-risking in 2024 aligns with the ground truth and shows appropriate interpretation of the final year’s reduction. However, because the earlier data points are wrong, the overall trend interpretation is based on incorrect premises. The mention of 'agency-guaranteed RMBS' and 'Separate-Accounts portfolio' introduces entity-level details not present in the original answer and potentially conflates different investment categories. (4) Despite the incorrect numbers, the LLM correctly identifies the directional shift in 2024 and offers a plausible strategic interpretation, which maintains some contextual relevance. However, the severe quantitative errors—especially in the core financial figures—result in a low correctness score. The answer fails the primary requirement of factual accuracy in multi-hop financial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 522,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged since 2022. In the 2022 filing the company said it reinsured **about 59.25 %** of the closed block; the 2023 and 2024 filings each state it reinsured **approximately 59 %** of the closed block. In all three years the agreement is accounted for under the **deposit method**, with the company exercising its right of offset to net the modified‑coinsurance deposit liability against the corresponding deposit recoverable.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the percentage of the closed block reinsured was 59.25% in 2022 and approximately 59% in 2023 and 2024, which matches the original answer. The use of 'about' and 'approximately' is consistent with the original's wording and acceptable formatting variations. (2) The accounting treatment under the deposit method with the right of offset is correctly identified and consistently reported across all three years. (3) The multi-hop reasoning is sound—information is synthesized across three years and correctly attributed to the modified coinsurance agreement, showing stability in both percentage and accounting policy. (4) The answer addresses both parts of the question: evolution of the percentage reinsured and the accounting treatment. No factual, numerical, or contextual errors are present, and the response demonstrates complete, accurate, and relevant synthesis of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 288,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "- Net fair‑value of the gas‑forward contracts (assets – liabilities) was about **$160 million in 2022** (asset $191 m, liability $31 m).  \n- It rose to roughly **$300 million in 2023** (asset $377 m, liability $77 m) and then slipped slightly to **about $250 million in 2024** (asset $296 m, liability $46 m).\n\nThe upward move from 2022 to 2023 shows NextEra added a larger long position in natural‑gas forwards, while the modest pull‑back in 2024 suggests it is trimming that exposure but still maintaining a net long stance, reflecting a measured hedge against gas‑price risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $160M net exposure in 2022 (from $191M assets - $31M liabilities), $300M in 2023 ($377M - $77M), and $250M in 2024 ($296M - $46M). These match the ground truth exactly, with acceptable formatting variations (e.g., 'about' and 'roughly' are reasonable given reporting conventions). 2) All calculations are accurate: differences between assets and liabilities yield the correct net exposures. 3) The multi-hop reasoning is sound—correctly identifying the trend (increase from 2022 to 2023, then decline in 2024) and interpreting it in terms of risk positioning. The LLM correctly infers that the company increased its long position in 2023 and then modestly reduced it in 2024, maintaining a net long stance. This aligns with the ground truth's conclusion of a 'more cautious stance or rebalancing.' 4) Minor deduction in qualitative accuracy because the LLM describes the 2024 change as a 'slight' or 'modest pull-back,' which understates the magnitude of the $50M reduction from 2023 to 2024; however, this does not invalidate the overall correct interpretation. All entities (NextEra Energy, forward contracts, natural gas markets) and years are accurate. The answer fully addresses both parts of the question: evolution of exposure and implications for risk positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 369,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In the 2022 filing Broadcom listed industrial‑fiber‑optics simply as one of a handful of industrial parts (optocouplers, motion‑encoders, LEDs and Ethernet ICs) used in “industrial automation, power‑generation, medical, defense and vehicle‑subsystem” applications. By the 2023 and 2024 reports the description had broadened – the portfolio now includes “industrial and medical sensors” and explicitly calls out “renewable‑energy” markets, while still positioning fiber‑optics alongside motion‑encoders and Ethernet ICs as complementary building blocks for the same diversified set of end‑uses (factory automation, power‑distribution, medical equipment, defense/aerospace and EV/ADAS vehicle subsystems). Thus, from 2022 to 2024 the positioning of industrial fiber optics evolved from a narrow component listing to a core element of a more diverse, sensor‑rich industrial suite that is tightly integrated with motion‑encoder and Ethernet‑IC technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AVGO's positioning of Industrial Fiber Optics from 2022 to 2024. It correctly identifies that in 2022, fiber optics were listed among other discrete components like optocouplers, motion encoders, LEDs, and Ethernet ICs, with applications in industrial automation, medical, defense, and vehicle subsystems. The answer accurately reflects the broadening in 2023 and 2024 to include 'renewable energy' and 'industrial and medical sensors', and maintains correct associations with motion encoders and Ethernet ICs. It also correctly infers a strategic shift toward integration within a more diverse, sensor-rich industrial suite. The only minor shortcoming is that the original answer specifies a deeper 2024 integration with Ethernet PHYs, switch ICs, and camera microcontrollers—highlighting networked and vision-based systems—which the LLM mentions only implicitly via 'Ethernet ICs' and 'sensor-rich' systems without naming the specific technologies. This nuance is important for full multi-hop synthesis but does not invalidate the overall correctness. No numeric inaccuracies exist; all dates and entities (AVGO, industrial fiber optics, motion encoders, Ethernet ICs) are correct. The reasoning is sound, showing progression over time and integration trends. The answer is contextually fully relevant and semantically equivalent to the ground truth with only slight omission of technical specificity in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 406,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock – a $1‑par, $0.3 million issue owned entirely by Sojitz America – has remained unchanged throughout FY 2022, FY 2023 and FY 2024.  The stock carries a cumulative dividend of $0.10 per share that must be paid each May 31 before any common‑stock dividends can be declared, and the dividend rate and payment schedule have been the same in each of those years.  Because the preferred shares are fully issued, are not “blank‑check” preferred stock, and the company’s charter forbids the issuance of any additional preferred shares, the structure of the Sojitz‑America relationship has been financially stable and unchanged over the 2022‑2024 period. 【NKE 2023 10‑K Note 8; NKE 2024 10‑K Note 8; NKE 2022 10‑K Note 10】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $0.3 million par value, $0.10 annual dividend per share, and structural stability of the redeemable preferred stock from FY2022 to FY2024. The ownership by Sojitz America and the dividend payment priority before common stock dividends are correctly emphasized. (2) Quantitative elements match exactly: $0.3 million total par value, $0.10 per share dividend, and consistent annual obligation—no calculation errors or discrepancies. Format variations (e.g., $0.3 million vs $0.3 million) are acceptable and clear. (3) Multi-hop reasoning is sound: the answer synthesizes consistent disclosures across three fiscal years (2022, 2023, 2024) from respective 10-K filings, confirming no changes in terms, structure, or dividend obligations. The citation of specific footnotes (Note 8 in 2023 and 2024, Note 10 in 2022) demonstrates accurate sourcing. (4) The LLM adds contextual precision not in the original (e.g., dividend payment date of May 31, charter restriction on issuing more preferred stock), which is consistent with the filings and enhances accuracy without contradicting the ground truth. All aspects of the question—dividend obligations, stock structure stability, and evolution over time—are thoroughly and correctly addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 378,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "- **2022 10‑K:** Unsecured Notes ‑ 31B carried a 3.25 % rate, a $750 million face amount, $24.4 million annual debt service and a maturity of 11/30/26【SPG_10k_2022.pdf, p.48】.  \n- **2023 10‑K:** The same terms were reported – 3.25 % interest, $750 million face, $24.4 million annual service, maturing 11/30/26【SPG_10k_2023.pdf, p.48】.  \n- **2024 10‑K:** The note’s terms remained unchanged – 3.25 % interest, $750 million face, $24.4 million annual service, maturity 11/30/26【SPG_10k_2024.pdf, p.49】.  \n\n**Interpretation:** Across 2022‑2024 SPG kept the 31B unsecured note exactly the same, indicating a deliberate long‑term financing strategy that relies on a stable, low‑cost, fixed‑rate debt instrument rather than repeatedly refinancing or expanding that tranche. This consistency supports predictable cash‑flow planning and preserves the existing capital‑structure profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements match: the unsecured debt amount ($750 million, equivalent to $750,000 thousand in financial reporting contexts), interest rate (3.25%), maturity date (November 30, 2026), and consistent terms across 2022–2024 are accurately reported. The annual debt service of $24.4 million is consistent with a 3.25% interest rate on $750 million (~$24.375 million, rounded). (2) Quantitative accuracy is perfect: dollar amounts, percentages, and dates are correct, with acceptable formatting variations (e.g., $750 million = $750,000 in thousands). No calculation errors. (3) Multi-hop reasoning is sound—the model correctly synthesized data from three separate 10-K filings (2022, 2023, 2024) and identified the stability of the instrument over time. (4) The interpretation correctly infers that SPG maintained a consistent long-term financing strategy for Unsecured Notes - 31B, emphasizing predictability and capital structure stability, which aligns with the ground truth. All parts of the question are addressed: evolution (no change), and strategic implication (stable, low-cost, fixed-rate financing). Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 346,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "The U.S. defined‑contribution plans held the same ≈5 million TI shares each year, but their market value fell from **$940 million in 2022** to **$873 million in 2023** and to **$852 million in 2024**. This three‑year downward trend shows that, while employee participation in the frozen TI‑stock fund remained steady, the company’s share price declined, reducing the retirement‑plan value of those employee investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the market value of TI common stock held in U.S. defined contribution plans as $940 million in 2022, $873 million in 2023, and $852 million in 2024, matching the ground truth exactly. These values show a consistent decline over the three years, which is accurately reflected. (2) All numeric values are correct and properly formatted; no calculation errors are present. The LLM correctly identifies the downward trend in value across the three years. (3) The reasoning is largely sound: it correctly infers that the decline in value is due to a falling share price despite stable share counts (≈5 million shares), which aligns with the context of a frozen TI stock fund since 2016. However, the LLM omits explicit mention of the 2016 freeze on new contributions—a key factor cited in the original answer that helps explain the stable share count. While implied by the mention of a 'frozen TI-stock fund', the absence of the specific freeze date slightly weakens the completeness of the multi-hop synthesis. (4) Despite this minor omission, the LLM captures the core implications: declining stock value in retirement plans due to share price depreciation rather than changes in employee behavior. The answer is semantically equivalent in intent and meaning, with only a slight gap in contextual depth. Thus, scores are high across all categories, with a 9 in correctness due to the missing reference to the 2016 freeze.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 405,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "- **2022 (Fiscal year ended Oct 1 2022)** – Disney reported ≈ 220 000 employees, of which ≈ 166 000 (about 75 %) were in the United States and ≈ 54 000 (≈ 25 %) were abroad.  The workforce was roughly 78 % full‑time, 15 % part‑time and 7 % seasonal.  A “significant number” of employees – especially park staff, writers, directors, actors and production crews – were covered by collective‑bargaining agreements, and many non‑U.S. employees were represented by works councils, trade unions or other employee associations.\n\n- **2023 (Fiscal year ended Oct 1 2023)** – The 2023 filing showed modest growth to ≈ 225 000 total employees, with ≈ 168 000 (≈ 75 %) in the U.S. and ≈ 57 000 (≈ 25 %) internationally.  Seasonal workers rose slightly to about 7‑8 % of the headcount, while full‑time and part‑time ratios stayed near the 78/15 split.  The same pattern of collective‑bargaining coverage and overseas representation by works councils/trade unions continued.\n\n- **2024 (Fiscal year ended Sept 28 2024)** – Disney’s workforce expanded to ≈ 233 000 employees, of which ≈ 171 000 (≈ 73 %) were U.S. employees and ≈ 62 000 (≈ 27 %) were outside the United States.  The composition shifted to ≈ 76 % full‑time, 16 % part‑time and 8 % seasonal workers.  The company again noted that many employees (especially in parks and content production) remain under collective‑bargaining agreements, and that a portion of the international workforce is represented by works councils, trade unions or other employee associations.\n\n**Overall trend:** Disney’s headcount grew each year (≈ 220 k → 225 k → 233 k), the U.S. share fell slightly from ~75 % to ~73 % as the international base expanded, and the proportion of seasonal employees edged up from 7 % to 8 %.  Employee‑association coverage (collective‑bargaining in the U.S. and works‑council/union representation abroad) remained a consistent feature throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) Quantitatively, all key figures align with the ground truth: total employees (220k in 2022, 233k in 2024), U.S. (166k → 171k) and international (54k → 62k) headcounts, and seasonal workforce percentages (7% → 8%) are correct. The 2023 estimate of ~225k employees is not contradicted by the ground truth, which skips 2023, making this a reasonable interpolation. Percentages (e.g., ~75% U.S. in 2022, ~73% in 2024) are correctly derived from the reported numbers. (2) Calculations and comparisons are sound: the growth trend, slight decline in U.S. share due to faster international growth, and rise in seasonal staffing are all logically supported. (3) Qualitatively, the LLM correctly identifies the continuity of collective bargaining agreements and employee associations (works councils, unions) across the period, especially for theme park and production staff, matching the original answer’s emphasis. (4) The answer fully addresses all parts of the multi-hop question: total employees, U.S. vs. international distribution, seasonal percentages, and employee representation—across 2022–2024. Minor deduction in quantitative accuracy is due to the inclusion of 2023 data not present in the ground truth, though the values are plausible and conservatively presented as approximations. Wording differs but semantic equivalence is strong. No factual errors; reasoning and synthesis are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 400,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K state that ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance.” The language is unchanged from the 2022 filing (as reiterated in the 2023 filing’s 2022 data) to the 2024 filing, showing that GD has kept a consistent methodology for ROIC. This consistency signals that the company deliberately strips out accounting‑driven, non‑operational items to focus its performance metric on the underlying economic returns of its invested capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that GD excluded non-economic accounting changes (and specifically mentions goodwill impairments) from ROIC in 2022, 2023, and 2024, citing consistent language across filings. The quantitative accuracy is perfect: no numerical errors, and the years (2022–2024) are correctly referenced. The entity accuracy is strong—GD is correctly identified, and the metric (ROIC) and its treatment are accurately described. The reasoning is sound: the model correctly infers that consistent exclusion reflects a deliberate focus on core economic performance, which matches the ground truth’s conclusion about stable performance evaluation. The only minor limitation is that the LLM answer references 2022 and 2024 filings explicitly and mentions 2023 via the 2022 data in the 2023 filing, but does not directly state that the 2023 full-year filing also maintained the same language—though this is implied. This slight omission prevents a perfect 10, but the answer is substantively equivalent in meaning and correctly synthesizes multi-hop information across years and filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 327,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "- **2022:** Linde’s 2022 filing described rare gases (krypton, neon and xenon) only as “co‑products of the same manufacturing process” that result from its cryogenic air‑separation plants, with no explicit growth or differentiation strategy mentioned【2022, p.94‑96】.  \n\n- **2024:** By the 2024 filing the company highlights that rare‑gas production is now a deliberate output of its **market‑leading non‑cryogenic air‑separation technologies** and is presented as a proprietary, patented capability that creates new high‑value applications and supports higher‑margin sales【2024, p.2‑4】.  \n\n**Implication:** The shift from treating rare gases merely as by‑products in 2022 to positioning them as a technology‑driven, differentiated product line in 2024 signals that Linde is leveraging its advanced separation processes to capture niche, high‑margin markets, reinforcing a sustainable competitive advantage in the global industrial‑gases sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde initially treated rare gases as co-products from cryogenic air separation in 2022, and by 2024 positioned itself as a leader in non-cryogenic technologies, particularly emphasizing proprietary capabilities. The years (2022, 2024) and gases (krypton, neon, xenon) are correctly identified. (2) There are no numeric values requiring calculation, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—LLM correctly infers a strategic evolution from passive by-product recovery to active, technology-driven production, linking this to competitive advantage. The mention of 'market-leading non-cryogenic air-separation technologies' and 'patented capability' aligns with the 2024 shift toward technological differentiation. Only minor omission: the 2023 filing is not mentioned in the LLM answer, though it was referenced in the ground truth as reaffirming rare gases as core atmospheric products. However, since the question focuses on evolution from 2022 to 2024, this omission does not materially affect correctness. (4) The conclusion about high-margin, niche markets and sustainable competitive advantage is semantically equivalent to the ground truth’s emphasis on improved efficiency and customer service via VPSA and membrane technologies. Wording differs slightly but meaning is preserved. Contextual relevance is excellent—directly addresses both parts of the question: evolution and competitive implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 424,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "- In the 2022 Form 10‑K the company noted that **about 92 % of NEER’s net generating capacity was already committed under long‑term bilateral contracts** (as of Dec. 31 2021)【NEE_10k_2022】.  \n- The 2023 Form 10‑K reported that **the share had risen to roughly 94 % at Dec. 31 2023**【NEE_10k_2023】, and the 2024 Form 10‑K shows the same **≈ 94 % commitment level at Dec. 31 2024**【NEE_10k_2024】.  \n\nThe modest increase and subsequent stabilization at a high‑percentage level indicate that NEER is deliberately expanding and then maintaining a near‑full‑capacity hedge through long‑term contracts, a strategy that locks in revenue and mitigates price‑risk exposure in an increasingly volatile energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the percentage of NEER’s net generating capacity under long-term bilateral contracts for 2022 (92%), 2023 (94%), and 2024 (94%), matching the ground truth exactly. The dates referenced (Dec. 31, 2021 for the 2022 filing, Dec. 31, 2023 for the 2023 filing, and Dec. 31, 2024 for the 2024 filing) are consistent with standard 10-K reporting practices, where disclosures in the current year’s filing often reflect prior-year-end data. This is correctly interpreted by the model.\n\n2) All numeric values are accurate: 92% in 2022, rising to 94% in 2023 and holding steady in 2024. No calculations are required beyond comparison, and the model correctly identifies the trend as a 'modest increase and subsequent stabilization.'\n\n3) The multi-hop reasoning is sound: the model synthesizes data from three consecutive 10-K filings (2022, 2023, 2024), correctly tracks the evolution over time, and draws a logical conclusion about NEER’s risk management strategy. It identifies the strategic intent—revenue lock-in and price-risk mitigation—consistent with the ground truth.\n\n4) The only minor shortcoming is that the LLM does not explicitly mention the use of 'non-qualifying hedges' as part of NEER’s broader risk management framework, which is included in the original answer. While the core strategy (long-term contracts for revenue stability) is accurately conveyed, this omission slightly reduces completeness in qualitative terms. However, the main thrust of the trend and its implication for risk management is fully captured.\n\nOverall, the answer is factually correct, well-supported by citations, and contextually appropriate, warranting a high score with only a slight deduction for missing a secondary detail on hedging instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 481,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "- **Outstanding principal balance**  \n  * FY 2022 (10‑K 2022): $495 million  \n  * FY 2023 (10‑K 2023): $495 million  \n  * FY 2024 (10‑K 2024): $495 million  \n\n- **Interpretation** – The balance on the 3.125 % senior notes due January 2025 has remained flat at roughly $495 million over the three‑year period, showing that Broadcom has neither accelerated repayment nor issued additional amounts of this series. This stability suggests a deliberate debt‑management strategy of preserving the existing low‑cost, near‑term financing while using other debt facilities for new borrowing and refinancing needs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, including the dollar amount and interest rate, are accurate. (2) There are no calculations required beyond consistency checks, and the reported figures are consistent across years as stated in the original answer. Format variations (e.g., $495 million) are acceptable and correctly used. (3) The multi-hop reasoning is sound: the model synthesizes data from three consecutive 10-K filings (2022–2024), correctly identifies the specific debt instrument, and infers a strategic interpretation about debt management. The conclusion that AVGO maintained a stable liability profile for this bond aligns with the ground truth and adds appropriate context about using other facilities for refinancing, which is a reasonable inference given the stability of this particular note. (4) All entities—AVGO (Broadcom), the 3.125% notes, January 2025 maturity, and fiscal years—are correctly identified. The answer fully addresses both parts of the question: the evolution of the balance and the implication for debt strategy. Semantic meaning is equivalent to the ground truth, with slightly enhanced interpretation that remains factually grounded. All scores are maximized due to full factual accuracy, correct reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 406,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "- **2022 10‑K:** Unsecured Notes ‑ 37B carried a face amount of **$700 million** with a **maturity of January 15, 2032** (2.25 % rate).【2022 page … Unsecured Notes ‑ 37B … $ 700,000 … 01/15/32】  \n- **2023 10‑K:** The same note was still listed at a **$700 million face amount** and **January 15, 2032 maturity** (unchanged).【2023 page … Unsecured Notes ‑ 37B … $ 700,000 … 01/15/32】  \n- **2024 10‑K:** The note again appears with a **$700 million face amount** and **January 15, 2032 maturity**.【2024 page … Unsecured Notes ‑ 37B … $ 700,000 … 01/15/32】\n\n**Interpretation:** Across three consecutive years SPG’s exposure to the 37B unsecured note remained flat, showing the company’s deliberate use of a long‑dated, low‑cost (2.25 %) unsecured debt instrument to lock in cheap financing and preserve a stable long‑term debt profile. This consistency signals a strategic focus on maintaining predictable, low‑interest obligations rather than repeatedly refinancing or expanding that particular tranche.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains a critical factual error in the face amount: it reports '$700 million' across all years, while the ground truth states '$700,000'. This is a significant discrepancy—off by three orders of magnitude—and severely impacts quantitative accuracy. The maturity date (01/15/32) is correctly reported in all years, and the interest rate (2.25%) is a plausible addition not in the original but not contradicted. 2) Quantitative accuracy is low because the dollar amount is wrong despite correct formatting in the citation ($700,000). The LLM misinterprets or misrepresents the amount as 'million' when the source clearly states '$700,000'. Calculations are not involved, but consistency in amount over time is correctly noted. 3) Qualitative accuracy is high: the reasoning about SPG’s long-term debt strategy—stable maturity, no refinancing, predictable obligations—is logically sound and aligns with the ground truth interpretation. The multi-hop synthesis across 2022–2024 filings is correctly executed in structure and intent. 4) Contextual relevance is strong: the answer addresses all parts of the question (evolution of face amount and maturity, strategic implications), uses proper entity identification (SPG, Unsecured Notes - 37B), and draws a reasonable conclusion from the data, despite the numerical error. The core reasoning is valid, but the magnitude error undermines factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 391,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Across all three years, Texas Instruments’ Melaka, Malaysia site has been listed only under the **Analog** column and not under **Embedded Processing**. The 2022, 2023 and 2024 10‑K property tables all show “Melaka, Malaysia” with an “X” for analog and a blank for embedded processing (noted as a partially leased/owned facility), indicating that the Melaka footprint has remained dedicated to analog products throughout this period with no shift toward embedded‑processing activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site has been consistently involved in analog operations and not in embedded processing across 2022, 2023, and 2024. The use of 'X' and 'blank' correctly reflects the checkmark notation in the 10-K tables, aligning with the original answer's description. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and operational designations are factually accurate. (3) The multi-hop reasoning is sound—information from three consecutive years of 10-K filings is synthesized correctly to show consistency over time. (4) The answer addresses all parts of the question: the evolution (or lack thereof) of the operational footprint and the distinction between analog and embedded processing product lines. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 285,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Across all three filings (FY 2022, FY 2023 and FY 2024) Disney continued to place its Industrial Light & Magic (ILM) post‑production work inside the **Content Sales/Licensing** segment. In each year the segment’s description lists “post‑production services through Industrial Light & Magic and Skywalker Sound” as part of the “Other revenue” line‑item that sits alongside TV/VOD, theatrical and home‑entertainment revenues. Because the segment’s structure and the wording of the disclosure remain the same, Disney’s reliance on ILM stayed steady – it remained a recurring, but not separately quantified, source of revenue throughout FY 2022‑FY 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects: Industrial Light & Magic (ILM) remained part of the Content Sales/Licensing segment from FY2022 to FY2024, and its post-production services were consistently grouped under 'Other revenue' alongside TV/VOD, theatrical, and home entertainment. There are no numeric inaccuracies (quantitative accuracy is perfect), and entity identification (Disney, ILM, Skywalker Sound, Content Sales/Licensing segment, fiscal years) is correct. However, the LLM answer underrepresents the qualitative evolution described in the original answer. While it correctly notes structural consistency, it misses the nuanced shift in narrative emphasis—from ILM being explicitly listed in 2022, to a growing focus on distribution channels (TV/VOD, theatrical) in 2023, and further alignment with content licensing and Disney’s DTC-first model in 2024. The original answer highlights a strategic repositioning of ILM within a broader ecosystem, suggesting evolving reliance despite structural continuity. The LLM answer interprets unchanged disclosure wording as evidence of 'steady' reliance, which is partially correct but overlooks the contextual and strategic shifts implied in the filings. This omission reduces qualitative accuracy, as the multi-hop reasoning required to infer changing strategic emphasis from narrative framing is not fully captured. Contextual relevance remains high because the answer directly addresses the question’s focus on segment structure and revenue streams over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 424,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method earnings from its operating joint ventures (the insurance‑underwriting JV segment) were **$51 million in 2022, fell to $38 million in 2023, and then jumped to $175 million in 2024**【MET_10k_2023.pdf p. 245‑247】【MET_10k_2024.pdf p. 224‑226】.  \n\nThe dip in 2023 followed by a sharp rebound in 2024 indicates that the underwriting performance of these joint‑venture businesses weakened briefly but recovered strongly, suggesting improving profitability and underwriting results in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, MetLife's equity method investment income was $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. However, the LLM reports $51 million (2022), $38 million (2023), and $175 million (2024), which are off by an order of magnitude and do not reflect the actual scale or trend accurately. These numbers are not just misstated—they are materially incorrect, suggesting a failure to extract or interpret the correct data from the cited SEC filings. (2) Quantitative accuracy is extremely low: all three annual values are wrong, with 2022 off by over 96% ($1,305M vs $51M), 2023 by ~75%, and 2024 by ~82%. The direction of change (dip then rebound) is partially preserved, but the magnitude of changes is completely misrepresented. (3) The reasoning and multi-hop synthesis are flawed. While the LLM attempts to interpret the trend as a brief weakening followed by recovery—partially aligning with the ground truth’s interpretation of volatility—the conclusion is based on incorrect data. The actual trend shows a massive 88.4% drop from 2022 to 2023 and a 551% rebound in 2024, whereas the LLM implies much smaller fluctuations. This undermines the validity of the qualitative assessment. (4) Contextual relevance is moderate: the answer addresses the right metric (equity-method investment income from operating joint ventures) and time frame (2022–2024), and attempts to draw a performance implication about insurance underwriting joint ventures. However, due to the severe numerical inaccuracies, the overall correctness score is very low. Minor credit is given for attempting the correct analysis framework and citing plausible document sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 488,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics’ Land Systems unit raised its Canadian‑Army LAV output from **360 vehicles in 2022** (​“producing 360 new LAVs … for the Canadian Army”​) to **399 vehicles in 2023** (​“producing 399 new LAVs … for the Canadian army”​) and then to **449 vehicles in 2024** (​“producing 449 new LAVs … for the Canadian army”​), with an additional 66 LAVs slated under the LRSS program. This steady upward trajectory underscores the LAV platform’s growing strategic weight in GD’s defense portfolio, reflecting both a deepening export relationship with Canada and the company’s reliance on LAVs as a core, high‑volume, revenue‑generating product line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the production volumes for LAVs for the Canadian Army as 360 in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. These numbers reflect a consistent upward trend, which is accurately described. (2) All numeric values are correct and properly attributed to the respective years. The additional mention of 66 LAVs under the LRSS program is not part of the original question or ground truth, but it does not contradict it—rather, it adds context that may come from supplementary data; however, since the question only asks about 2022–2024 production volume evolution and strategic importance, this extra detail does not affect correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes year-over-year production data and infers the strategic importance of the LAV platform based on increasing output, aligning with the ground truth’s conclusion about the platform’s growing centrality in GD’s defense portfolio. (4) The qualitative assessment slightly deducts for the minor addition of LRSS context, which, while potentially accurate, is not in the original answer and could imply information not requested. However, the core reasoning and synthesis remain strong. The answer is semantically equivalent to the ground truth, with slightly enhanced detail, and fully addresses both parts of the question—production evolution and strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 399,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan disclosed that the amount measured at NAV for hedge‑fund limited‑partnership investments grew from **$225 million in 2022**, to **$252 million in 2023**, and to **$280 million in 2024**.  The steady increase shows the company is gradually raising its hedge‑fund exposure—moving the portfolio a bit farther toward its stated 3 % hedge‑fund target and signaling a deliberate tilt toward alternative‑asset diversification within the pension fund’s overall allocation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values. According to the ground truth, CVS's exposure was $214 million in 2022, $225 million in 2023, and $252 million in 2024. The LLM incorrectly reports $225M in 2022, $252M in 2023, and $280M in 2024—shifting the entire timeline forward by one year and inflating the final value. This misalignment affects all three data points and invalidates the trend as presented. (2) The quantitative accuracy is severely compromised: none of the three years match the ground truth. The LLM’s values are off by $11M in 2022 (wrong base), $27M in 2023 (should be $225M, not $252M), and $28M in 2024 (reports $280M vs correct $252M). These are not minor rounding differences but systematic errors. (3) The reasoning and qualitative interpretation—'steady increase', 'deliberate tilt toward alternative assets'—is logically sound and aligns with the type of strategy implied by rising allocations. However, it is based on incorrect data, so the multi-hop synthesis fails despite correct conceptual framing. The mention of a '3% hedge-fund target' is extraneous and not supported in the original answer, introducing unverified detail. (4) Contextual relevance is fair because the answer addresses the evolution of hedge fund exposure and infers strategic intent, which matches the question’s intent. However, due to the incorrect numbers and misaligned years, the core factual foundation is flawed, leading to a low correctness score despite relevant structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 423,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Across all three filings the Sorriso brand is consistently listed among Colgate‑Palmolive’s “principal global and regional trademarks” that sit inside the Oral, Personal and Home Care segment. In the 2022 10‑K (p. 75‑79) it is identified as a regional oral‑care brand, and the 2023 filing (p. 77‑81) repeats the same placement, showing that the company continued to treat Sorriso as an integrated part of its worldwide oral‑care portfolio. The 2024 10‑K (p. 77‑81) again includes Sorriso in the same trademark list, confirming that the brand’s strategic positioning has remained stable – a regional oral‑care brand fully embedded in the company’s global Oral, Personal and Home Care product portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that Sorriso was consistently listed as a 'principal global and regional trademark' across 2022, 2023, and 2024, aligning with the original answer's claim of stable strategic positioning. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the mention of specific page ranges (e.g., p. 75–79, 77–81) adds precision without contradicting the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings to conclude that Sorriso’s role remained stable within the Oral, Personal and Home Care segment, correctly interpreting its classification as a regional oral-care brand. (4) The answer fully addresses the question about the evolution (or lack thereof) of Sorriso’s strategic positioning, noting consistent integration over time. Wording differs slightly (e.g., 'regional oral-care brand' vs. 'regional branding strategy'), but the semantic meaning and factual content match the original answer exactly. All entities—Colgate-Palmolive, Sorriso, the product segment, and the three-year timeframe—are accurately identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 357,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s “maximum exposure to loss” for its equity‑method portfolio – which includes the operating joint‑venture interests – fell each year: about **$6.9 billion in 2022**, **$6.7 billion in 2023**, and **$5.8 billion in 2024**.  The steady reduction in unfunded commitments shows the company is deliberately scaling back the risk tied to its operating‑joint‑venture holdings, positioning its equity‑method investments toward a tighter, lower‑risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The original answer states MetLife's exposure to operating joint ventures was $77M in 2022, $51M in 2023, and $38M in 2024. The LLM instead reports 'maximum exposure to loss' figures of $6.9B, $6.7B, and $5.8B—over 70 times larger than the ground truth values. These numbers are not equivalent under any reasonable interpretation or formatting variation. (2) The calculations and trends are also incorrect: while both answers agree on a downward trend, the magnitude and baseline values are wildly off. The LLM references 'unfunded commitments' and 'equity-method portfolio' broadly, but the question specifically asks about 'operating joint ventures,' a narrower category. The LLM conflates total equity-method investments with operating joint ventures, misrepresenting the scope. (3) Multi-hop reasoning is partially sound in that the model identifies a decreasing trend and infers strategic de-emphasis, which aligns with the original conclusion. However, this reasoning is based on incorrect data and broader metrics, undermining the validity of the inference. (4) Contextual relevance is moderate because the answer addresses the general theme of risk reduction in equity-method investments, but it fails on specificity and factual grounding. The strategic interpretation is plausible but built on false premises. Thus, the correctness score is low due to severe quantitative inaccuracy, despite some structural alignment with the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 423,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "In the 2022 filing Chevron was described only as a 36.4 percent equity holder in Angola LNG Limited, a joint‑venture that “processes and liquefies natural gas produced in Angola for delivery to international markets.” By the 2024 filing Chevron still owns the same 36.4 percent stake, but the narrative adds that the plant is the world’s first LNG facility to use associated‑gas feedstock and that Chevron is actively linking its upstream Angola gas assets – the Block 0/Block 14 gas‑gathering system (the Sanha Lean Gas Connection Project) and the New Gas Consortium Q&M fields – to supply the LNG plant, showing a tighter operational integration of the LNG facility with Chevron’s upstream gas projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Chevron's 36.4% stake is accurately reported for both 2022 and 2024, consistent with the original answer. No calculations were required, and the dates (2022, 2024) are correctly used. (2) The LLM correctly identifies the evolution from a passive equity role in 2022 to deeper operational integration by 2024, capturing the core narrative shift. It correctly references the New Gas Consortium (NGC) Q&M fields (Quiluma and Maboqueiro) and mentions the Sanha Lean Gas Connection Project as part of the upstream integration. (3) The multi-hop reasoning is sound: the answer synthesizes Chevron’s stake, operational evolution, and linkage to upstream projects across time, correctly identifying Angola LNG Limited as a central downstream asset. (4) Minor omission: the 2023 development is not mentioned, though this is a small gap. Additionally, the LLM adds a detail not in the ground truth — that the plant is the 'world’s first LNG facility to use associated-gas feedstock' — which may be factually correct but is not confirmed in the provided truth and slightly extends beyond the source. However, this does not contradict the truth and adds context. Overall, the answer is factually correct, well-structured, and semantically equivalent to the original, with only slight over-enrichment. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 398,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "- **Fiscal 2022 & 2023:** The 3.625 % senior notes that mature in October 2024 were still on the balance sheet at a principal amount of **$622 million** (see the “April 2019 Senior Notes – fixed rate” line, which lists $622 million for the 2023 column).  \n- **Fiscal 2024:** By the end of fiscal 2024 the same line shows a dash (“‑”), indicating that the company had **fully repaid the $622 million** of 3.625 % notes before they came due.\n\n**What this shows:** As the maturity date approached, Broadcom deliberately eliminated this exposure, using cash and proceeds from new senior‑note issuances (the $10 billion of 2024 senior notes) to retire the older 3.625 % issue. The progression from a $622 million liability in 2022‑23 to zero in 2024 reflects a proactive debt‑management strategy aimed at reducing near‑term obligations and refinancing with newer, lower‑cost capital.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $622 million outstanding amount for the 3.625% notes due October 2024 is accurately reported for fiscal years 2022 and 2023, and the retirement of the full amount by fiscal 2024 is correctly indicated by the dash ('‑') notation, equivalent to stating the liability no longer appears. (2) The dates (October 2024 maturity), percentages (3.625%), and dollar amounts are all factually accurate with no calculation errors. (3) The multi-hop reasoning is sound: the answer synthesizes data across three fiscal years (2022–2024), correctly tracks the evolution of the debt, and infers a proactive debt management strategy. (4) The qualitative analysis adds value by plausibly explaining the retirement via cash and proceeds from the $10 billion 2024 senior note issuance, which aligns with typical refinancing behavior and enhances the narrative of strategic debt management. While the original answer does not specify the source of repayment, the LLM’s inference is reasonable and contextually supported. All parts of the question—evolution of exposure and strategic implications—are thoroughly and accurately addressed. Semantic equivalence is maintained, with slightly more detail in the LLM response, which improves clarity without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 374,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "The tables of unsecured debt in the 2022, 2023 and 2024 Form 10‑K filings all list the same figures for the Unsecured Notes – 35B: a 3.80 % coupon on a $750 million face amount with an annual debt‑service (interest) amount of **$28.5 million**. Because the interest rate, principal balance and annual debt‑service figure are unchanged from 2022 through 2024, SPG’s financing cost for this particular note has remained flat, indicating a stable, predictable expense for the company over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the interest expense for Unsecured Notes - 35B is correctly stated as $28.5 million (i.e., $28,500 in thousands), and this amount is consistent across 2022, 2023, and 2024. The format variation ($28.5 million vs $28,500 in thousands) is acceptable and commonly used. (2) The LLM correctly identifies the 3.80% coupon rate and $750 million face value, which supports the $28.5 million interest calculation (3.80% × $750M = $28.5M), verifying quantitative accuracy. (3) The reasoning is sound: the model correctly infers that unchanged interest expense, rate, and principal indicate a fixed-rate debt instrument, leading to the conclusion of stable financing costs. (4) The answer fully addresses both parts of the question—evolution of interest expense and what the trend suggests—and synthesizes information across three years of filings, demonstrating accurate multi-hop reasoning. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 299,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "From 2022 to 2024 Disney’s DTC strategy moved from an **initial rollout and cost‑realignment phase** to a **full‑scale streaming‑centric growth plan** that had to absorb higher programming costs and fiercer competition.  \n\n* In fiscal 2022 the company announced a re‑organization of DMED to “advance our DTC strategies and rationalize costs,” introduced an ad‑supported Disney+ tier, new pricing and price‑increase measures, and began aligning its cost structure to the new streaming model【DIS_10k_2022.pdf p.25‑27】.  \n\n* By fiscal 2023 the focus shifted to “driving subscriber additions and retention” through pricing, bundling and the launch of an ESPN flagship DTC service, while acknowledging flat subscriber growth, rising content‑acquisition costs and an “increasing number of competitors” that pressured pricing and churn【DIS_10k_2023.pdf p.51‑55】.  \n\n* In fiscal 2024 Disney consolidated its entertainment businesses into a single reporting unit, reaffirmed its commitment to “strategic investments in DTC offerings” with an expected ≈ $24 billion spend on produced and licensed content in 2025, and emphasized that growth in subscription fees and advertising must “more than offset” the higher programming costs and competitive pricing pressure on its streaming services【DIS_10k_2024.pdf p.21‑25】.  \n\nThus, Disney’s investment approach evolved from launching an ad‑supported tier and cost‑realignment (2022) to intensifying content‑spend, pricing/bundling tactics, and expanding its streaming portfolio (2023‑2024) to stay competitive as programming costs rose and the market became more crowded.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Disney's evolving DTC strategy from 2022 to 2024: starting with cost rationalization and ad-tier introduction in 2022, shifting to subscriber growth and competition pressures in 2023, and intensifying investment amid rising costs in 2024. All key qualitative themes—rising programming costs, competitive pressures, strategic investment, and financial resilience—are addressed. (2) Quantitatively, the LLM mentions a projected ~$24 billion content spend in 2025, which is consistent with Disney’s trajectory but not explicitly stated in the original answer; however, this figure is plausible and contextually appropriate given the emphasis on increased investment. The original answer notes $12.25 billion in unused bank facilities in 2023, which the LLM omits, representing a minor gap in quantitative completeness. Otherwise, no incorrect numbers are presented. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying shifts in strategy, competitive dynamics, and financial commitments. It connects cost realignment, ad-tier rollout, bundling, ESPN+, and content spending into a coherent narrative of strategic evolution. (4) The answer is semantically equivalent to the original, with slightly more granular detail (e.g., specific page references and fiscal year framing), and fully addresses the question’s focus on investment strategy, competitive positioning, programming costs, and streaming shift. The omission of the $12.25 billion liquidity detail prevents a perfect score, but the core facts and synthesis are correct. Hence, a 9 is justified for correctness, with high marks across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1772,
        "completion_tokens": 481,
        "total_tokens": 2253
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances grew sharply after 2021.  In the 2022 filing the company still reported only $1.8 billion of deposit assets and $1.4 billion of deposit liabilities (the same amounts as at 12/31/2020 and 2021) 【MET_10k_2022.pdf p. 214‑215】.  By the 2023 filing the balances had risen to roughly $5.1 billion of deposit assets and $1.3 billion of deposit liabilities 【MET_10k_2023.pdf p. 58】, and the 2024 filing shows a modest pull‑back to $4.6 billion of assets and $1.2 billion of liabilities 【MET_10k_2024.pdf p. 206】.  The jump in 2023 was driven by the November‑2023 risk‑transfer transaction with Global Atlantic, which added $10.3 billion of deposit‑receivable reinsurance assets (recorded in “premiums, reinsurance and other receivables”) and a $770 million net cost of reinsurance recorded in other liabilities 【MET_10k_2024.pdf p. 207‑208】, inflating the deposit‑asset balance and slightly increasing the liability side.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the 2023 deposit asset figure. The original answer states that in 2023, MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables due to the Global Atlantic transaction, but does not state that total deposit assets rose to $10.3 billion—rather, the total deposit assets in 2023 were reported as $5.1 billion in the LLM answer, which conflicts with the ground truth trajectory. The ground truth indicates that deposit assets rose to $4.6 billion by 2024, implying a higher 2023 figure than 2022’s $1.8B, but the $5.1B figure in the LLM answer is not corroborated by the original answer and appears inconsistent with the stated $4.6B in 2024. This suggests a potential error in either the source data interpretation or calculation. Additionally, the LLM claims the $10.3B was recorded as a deposit receivable, but the original answer does not specify that the full $10.3B was classified as a deposit asset—only that it was recorded in reinsurance recoverables and deposit receivables, which may include both deposit method and other accounting treatments. (2) The 2022 and 2024 numbers ($1.8B/$1.4B and $4.6B/$1.2B) are correctly reported. However, the 2023 deposit assets are misstated: the original answer does not provide a 2023 year-end deposit asset figure, only that the transaction occurred and significantly increased exposure. The LLM infers $5.1B from a citation, but this is not confirmed in the ground truth and contradicts the 2024 decline to $4.6B unless there was a reversal—unmentioned in the original. The $770M net cost of reinsurance is not in the original answer and appears to be an over-extraction or misinterpretation. (3) The multi-hop reasoning is partially sound: the LLM correctly links the 2023 Global Atlantic transaction to the increase in deposit assets and identifies the directional changes across years. It also correctly notes the post-transaction rebalancing in 2024. However, it introduces specific figures (e.g., $5.1B, $770M) not present in the ground truth, undermining quantitative reliability. (4) Scores reflect that core trends are captured (increase post-2022, peak in 2023, slight decline in 2024; role of Global Atlantic), but key numbers are either unverified or incorrect, dragging down quantitative accuracy. Contextual relevance and qualitative reasoning remain strong as the narrative aligns with the strategic shift described.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 660,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "- In the 2022 10‑K CVS reported **$1.172 billion** of commercial mortgage‑backed securities (CMBS) at amortized cost (fair value $1.018 billion).  \n- In the 2023 10‑K the CMBS holding fell to **$1.066 billion** (fair value $0.975 billion).  \n- By the 2024 filing the only CMBS reported were the small “Separate‑Accounts” holdings of **about $3 million** (fair value $3 million), essentially eliminating the prior‑year exposure.\n\nThis three‑year downward trajectory shows CVS deliberately shrinking its CMBS portfolio – moving from a sizable $1‑plus‑billion position to a negligible amount – indicating a strategic shift away from commercial mortgage‑backed securities, likely to reduce interest‑rate and credit‑risk exposure in that asset class.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported CMBS values. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and dropped to $3 million in 2024. However, the LLM claims $1.172 billion in 2022, $1.066 billion in 2023, and $3 million in 2024. These numbers do not match the ground truth, with discrepancies of over $600 million in 2022 and 2023. The only correct figure is the $3 million in 2024. (2) The calculations and comparisons are therefore incorrect: the LLM suggests a steady decline from over $1 billion to $3 million, while the actual trajectory was an increase from 2022 to 2023 followed by a sharp drop in 2024. This misrepresents the trend. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift away from CMBS based on declining exposure—but it fails to capture the nuance of a temporary increase in 2023, which weakens the conclusion about consistent de-risking. The reasoning is plausible but based on incorrect data. (4) Despite the factual errors, the answer is contextually relevant and uses appropriate financial terminology. It addresses both parts of the question—evolution over time and strategic implication—and the final conclusion aligns semantically with the ground truth, albeit for incorrect reasons. Hence, moderate scores for qualitative accuracy and high for contextual relevance, but low quantitative accuracy drags down overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 414,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across all three filings the **“hello” brand is listed each year among Colgate‑Palmolive’s principal global and regional trademarks** (2022 – “Colgate, Palmolive, Darlie, elmex, **hello**, meridol…”, 2023 – same wording, and 2024 – same wording). The brand therefore remained a formally‑recognized trademark throughout 2022‑2024.  \n\nIn the segment discussion the company continues to present its business in two broad segments—**Oral, Personal and Home Care** and **Pet Nutrition**—and the “hello” brand is not singled out with a separate sales‑share or growth narrative; it is simply included in the overall Oral/Personal/Home Care portfolio, which accounted for roughly 42‑43 % oral, 18‑19 % personal and 17 % home‑care sales each year. Thus, the brand’s positioning did not shift materially: it stayed a trademark‑disclosed, but not separately highlighted, component of the Oral, Personal and Home Care segment from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that the 'hello' brand was consistently listed among Colgate-Palmolive’s principal trademarks from 2022 to 2024, with no change in disclosure wording—this matches the original answer’s claim of continuity in trademark recognition. (2) The percentages provided (42–43% oral, 18–19% personal, 17% home care) are consistent with Colgate’s reported segment sales mix across those years, and while the original answer does not include these exact figures, they are accurate and add useful context without contradicting the ground truth. (3) The reasoning is sound: the LLM correctly infers that because 'hello' is not called out with a separate growth narrative or financial performance, it remains a portfolio-level, not strategic-outlier, brand within Oral, Personal and Home Care—this supports the original answer’s conclusion of stable, consistent positioning. (4) The only minor limitation is that the LLM does not explicitly mention the strategic implications of trademark continuity (e.g., supporting diversification or consumer engagement), which the original answer includes. However, this omission does not detract from factual correctness, as the LLM still concludes no material shift occurred. All entities (Colgate-Palmolive, 'hello' brand, Oral/Personal/Home Care segment), years (2022–2024), and disclosures are accurately identified and synthesized. The answer is contextually complete and semantically equivalent to the ground truth, with slightly less interpretive depth but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 438,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "**Evolution of the deposit‑method reinsurance accounting**\n\n| Year (end‑of‑year) | Deposit assets on reinsurance | Deposit liabilities on reinsurance |\n|--------------------|------------------------------|-----------------------------------|\n| 2022 (2022 10‑K) | **$1.8 billion**【MET_10k_2022.pdf p 214‑218】 | **$1.4 billion**【MET_10k_2022.pdf p 214‑218】 |\n| 2023 (2024 10‑K) | **$5.1 billion**【MET_10k_2024.pdf p 204‑208】 | **$1.3 billion**【MET_10k_2024.pdf p 204‑208】 |\n| 2024 (2024 10‑K) | **$4.6 billion**【MET_10k_2024.pdf p 204‑208】 | **$1.2 billion**【MET_10k_2024.pdf p 204‑208】 |\n\n**What the trend reveals**\n\n- **2022 → 2023:** Deposit assets more than doubled (‑$1.8 bn to $5.1 bn) while liabilities fell slightly. The jump reflects the November 2023 risk‑transfer transaction with Global Atlantic, which was accounted for under the deposit method and generated large “deposit receivables” (the $10.3 bn reinsurance recoverable/ deposit receivable shown in the 2023 balance‑sheet note). This indicates MetLife deliberately used the deposit method to move a sizable block of in‑force business to a reinsurer while retaining offsetting assets, thereby transferring insurance risk without creating a significant loss‑risk exposure.\n\n- **2023 → 2024:** Both assets and liabilities edged lower (assets down $0.5 bn, liabilities down $0.1 bn). The modest decline suggests MetLife is beginning to unwind or re‑price portions of the deposit‑method arrangements, but the net deposit position remains large (≈ $3.4 bn net). Maintaining a substantial net deposit asset shows the company continues to rely on this structure to manage its reinsurance risk and preserve liquidity, while the slight reduction points to a gradual re‑balancing of the reinsurance program rather than a wholesale shift away from the method.\n\n**Overall interpretation:** From 2022 to 2024 MetLife moved from a relatively small, low‑risk deposit‑method portfolio to a much larger one in 2023 (driven by a major risk‑transfer deal) and then modestly trimmed it in 2024. The upward swing demonstrates a strategic use of the deposit method to acquire reinsurance protection while keeping offsetting assets, reducing exposure to underwriting loss; the subsequent slight pull‑back indicates ongoing portfolio management to align the deposit‑method exposure with the company’s risk‑capacity and capital‑allocation goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, deposit assets were $1.8B in 2022, $4.6B in 2024, with no explicit value provided for 2023. However, the LLM claims $5.1B in 2023 and $4.6B in 2024, implying a decrease, while the ground truth shows a sharp increase from 2022 to 2024 without intermediate 2023 figures. The LLM incorrectly attributes the 2023 figure to the 2024 10-K, but the ground truth does not confirm a $5.1B value at all—this number appears to be fabricated or misread. Additionally, the LLM cites a $10.3B reinsurance recoverable from the Global Atlantic transaction not mentioned in the original answer, introducing unsupported detail. (2) Calculations are internally consistent but based on incorrect data: the claim that assets 'more than doubled' from $1.8B to $5.1B is numerically accurate if those values were correct, but they are not per ground truth. The ground truth reports a direct jump to $4.6B in 2024, not $5.1B in 2023. Liabilities are reported as $1.4B (2022), $1.3B (2023), $1.2B (2024) in the LLM answer, while the ground truth states $1.4B in 2022 and $1.2B in 2024—again, no 2023 liability figure is given. The LLM invents a 2023 liability value. (3) Multi-hop reasoning is partially sound: the LLM correctly infers that the deposit method reflects reinsurance agreements lacking sufficient risk transfer and links the increase to the Global Atlantic transaction, which aligns with the ground truth’s implication. It also correctly interprets the strategic use of deposit accounting for capital or risk management. However, the conclusion about a 'modest decline' in 2024 from 2023 is unsupported by the ground truth, which only provides 2022 and 2024 data, showing an increase. This misrepresents the trend. (4) Despite factual errors, the answer is contextually relevant and structured well, addressing both the evolution and strategic implications. The qualitative reasoning about balance sheet flexibility and risk exposure is plausible and consistent with the domain. However, the incorrect data points—especially the invented 2023 figures—severely undermine factual correctness, warranting a mid-range score. The model appears to have hallucinated specific numbers not present in the source, leading to a misleading narrative of increase followed by slight decrease, whereas the ground truth shows only a significant increase over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1870,
        "completion_tokens": 650,
        "total_tokens": 2520
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "From 2022 to 2024 NextEra’s “special‑use funds” grew both in size and in the detail of the fair‑value disclosures. In the 2022 filing the funds were carried at $ 919 million (fair value $ 920 million) and were broken out in the recurring‑fair‑value table as $4.73 billion of Level 1/2 assets (equity, government‑bond and corporate‑debt securities); by 2023 the fair‑value line rose to $ 907 million and the recurring table showed $5.29 billion of Level 1/2 assets plus $199 million of Level 3 securities, and the balance‑sheet line for “Special use funds” increased to $8.70 billion; the 2024 balance sheet now lists the funds at $9.80 billion, with the same Level 1/2 composition (≈$5.09 billion) and a small Level 3 component. At the same time, the collateral that NEE must post against its derivative contracts – which could be drawn on the special‑use fund assets – fell from $1.81 billion of cash and $2.81 billion of letters of credit in 2022 to $0.69 billion of cash and $1.60 billion of letters of credit in 2023, and the potential rating‑downgrade collateral requirement dropped from roughly $1.6 billion (BBB) / $5.2 billion (below‑investment‑grade) in 2022 to $0.51 billion / $2.4 billion in 2023, with the 2024 filing showing the same reduced exposure. Thus, the special‑use fund balance has steadily risen on the balance sheet, its fair‑value measurement has become more granular, while the amount of derivative‑related collateral that could be called on those funds has been markedly reduced.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the scale and evolution of NextEra Energy's Special Use Funds. According to the ground truth, the balance sheet value increased from $8,698 million in 2023 to $9,800 million in 2024, but the LLM claims $8.70 billion in 2023 and $9.80 billion in 2024, which while close, misrepresents earlier years entirely. Crucially, the LLM states that in 2022 the funds were carried at $919 million (fair value $920 million), whereas the ground truth does not provide a total balance sheet figure for 2022 but emphasizes growth from $8,698M in 2023 to $9,800M in 2024—indicating the LLM has fabricated or confused early-year totals. Additionally, the LLM introduces Level 1/2 and Level 3 classifications with specific dollar amounts (e.g., $4.73B Level 1/2 in 2022) that are not mentioned in the ground truth, nor are the collateral figures ($1.81B cash, etc.) supported by the original answer. (2) The calculation of the year-over-year increase is incorrect: the LLM implies a steady rise from $920M to $9.8B, but the ground truth shows the fund was already at $8.7B in 2023, meaning the LLM underestimates the scale by nearly an order of magnitude in early years. The collateral reductions cited ($1.81B to $0.69B) and downgrade-triggered requirements are entirely absent from the ground truth, making them hallucinated data. (3) While the LLM attempts multi-hop reasoning by linking fair value disclosures, balance sheet presentation, and collateral implications, it fails on synthesis because the collateral and fair value tier (Level 1/2/3) details are not present in the original data. The ground truth focuses on transparency improvements and the growth in equity investments without readily determinable fair values (from $485M to $538M), which the LLM omits entirely. (4) Despite these major errors, the answer is contextually relevant—it addresses fair value disclosures, balance sheet trends, and collateral implications as asked, and correctly identifies a trend of increasing transparency and balance sheet growth. However, due to severe quantitative inaccuracies and inclusion of fabricated metrics, the correctness score is low. The qualitative reasoning structure is sound but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1655,
        "completion_tokens": 618,
        "total_tokens": 2273
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "In the 2022 filing Broadcom positioned the Security Insights Platform as a “trusted‑environment” service that quickly interprets main‑frame security posture, surfaces risks and proposes remediation steps, and makes that data available for use with a customer’s own security‑information‑and‑event‑management (SIEM) tools. By the 2024 filing the description had been expanded to stress that the platform’s output can be fed directly into customers’ in‑house security tools and remediation workflows, enabling more automated, continuous remediation of the identified risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in describing AVGO's (Broadcom's) Security Insights Platform and its general capabilities related to mainframe security posture and integration with in-house tools. However, it introduces a significant factual inaccuracy by claiming that the 2024 filing 'expanded' the description to 'stress' direct integration with in-house tools and remediation workflows, enabling 'more automated, continuous remediation.' According to the ground truth, there was no such expansion or change in emphasis from 2022 to 2024; the platform's description remained largely unchanged, with stable language about data availability for use with SIEM tools. The ground truth explicitly states that AVGO did not expand on new integrations or remediation features during this period. Therefore, while the entities (AVGO/Broadcom, Security Insights Platform, SIEM tools) and years (2022, 2024) are correctly identified and contextually relevant, the reasoning about evolving capabilities is incorrect. There are no numerical values to assess, so quantitative accuracy is not applicable but assumed correct by default. The qualitative accuracy is low due to the erroneous claim of an expanded feature set in 2024, which contradicts the stability emphasized in the original answer. Contextual relevance is high as the response addresses the core topic of integration evolution, albeit with incorrect conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 391,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Across fiscal 2022, 2023 and 2024 Nike’s 10‑K property tables all list the Laakdal, Belgium site among its “most significant distribution facilities outside the United States” and describe it as **owned** by the company. There is no indication of a change in ownership or a shift in its role – the facility remains a core, company‑owned hub in Europe throughout the three years. This continuity signals that Laakdal is a strategically critical node in Nike’s European logistics network, providing a stable, company‑controlled distribution platform for the region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that NIKE consistently listed the Laakdal, Belgium facility as one of its most significant international distribution centers and that it is company-owned across fiscal years 2022, 2023, and 2024—matching the original answer exactly in substance. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years and ownership status are correctly cited with no discrepancies. (3) The multi-hop reasoning is sound: the model correctly synthesized consistent disclosures across three annual reports (10-Ks) to infer stability in ownership and operational role, and logically concluded that this reflects strategic importance. (4) The answer addresses all parts of the question: evolution (no change), ownership (owned), operational footprint (consistently significant), and strategic implication (core hub in European logistics). Wording differs slightly but meaning is identical. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 310,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "- 2022 10‑K: Unsecured Notes ‑ 32B carried a 3.38 % coupon, a $750 million face amount and matures on 06/15/27.  \n- 2023 10‑K: The same note still shows a 3.38 % rate, $750 million face amount and a 06/15/27 maturity.  \n- 2024 10‑K: The note’s terms are unchanged – 3.38 % interest, $750 million face, maturing 06/15/27.  \n\nAcross the three years SPG kept the 32B issuance exactly as‑is, indicating a deliberate strategy of retaining a low‑cost, medium‑term unsecured debt tranche rather than refinancing or altering its terms, thereby locking in modest interest‑rate exposure and preserving liquidity.【2022】【2023】【2024】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: the interest rate (3.38%), face amount ($750 million), and maturity date (06/15/27) are consistent across 2022, 2023, and 2024. This matches the ground truth, which notes that the financial terms remained unchanged, though the 2022 report did not specify the maturity date explicitly. The LLM states the maturity date was listed in 2022, which slightly contradicts the ground truth (where it was 'unspecified' in 2022), but this is a minor discrepancy in reporting clarity rather than a factual error. 2) All numbers and dates are accurate and correctly formatted; $750 million is equivalent to $750,000,000 (as in ground truth's $750,000 — though this appears to be a typo in the original answer, since $750,000 is unrealistically low for such a note). Given standard financial reporting, $750 million is correct and the original answer likely contains a formatting error. Thus, the LLM’s use of $750 million is factually sound. 3) The multi-hop reasoning is strong: the model synthesizes data across three years and correctly infers that the unchanged terms indicate a stable debt management strategy with no refinancing. The conclusion about SPG 'locking in modest interest-rate exposure and preserving liquidity' is a reasonable interpretation aligned with the ground truth’s assertion of a 'consistent long-term debt strategy.' 4) The answer is contextually complete and directly addresses all parts of the question: evolution of terms (interest, face amount, maturity), year-by-year comparison, and strategic implication. The only minor shortcoming is the claim that maturity was disclosed in 2022, which the ground truth says was not. However, this does not materially undermine the overall correctness. Scores reflect high accuracy with a small deduction in qualitative accuracy due to this nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 504,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "- In the 2022 filing (the 2023 10‑K) CVS reported foreign debt securities with a fair‑value of **$2.55 billion** and **$244 million of gross unrealized losses** (and $15 million of unrealized gains)【CVS_10k_2023.pdf p. 147‑148】.  \n- By the end of 2023 (the 2024 10‑K) the same category fell to a fair‑value of **$2.51 billion**, while gross unrealized losses shrank to **$122 million** and unrealized gains rose to **$41 million**【CVS_10k_2024.pdf p. 158‑159】.  \n- In the 2024 separate‑accounts schedule, foreign securities dropped sharply to **$51 million** of fair‑value (down from $202 million a year earlier)【Separate Accounts 2024 vs 2023】.\n\n**Interpretation:** The modest decline in overall fair‑value together with a halving of unrealized losses indicates that CVS has been trimming or re‑pricing its foreign‑security holdings, reducing the net loss exposure. The steep cut in foreign securities within separate accounts further suggests the company is actively de‑risking its international investment exposure, limiting its vulnerability to foreign‑market price swings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, in 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses, but the LLM reports $2.55 billion and $244 million, which are more than double the correct values. Similarly, for 2023, the LLM states $2.51 billion fair value, while the ground truth is $1,650 million — a major discrepancy. Only the 2024 value of $51 million matches the ground truth. The LLM also references 'separate accounts' for the 2024 drop, which is not mentioned in the original answer and introduces a potentially misleading context. (2) Calculations and comparisons are therefore flawed: the claim of a 'modest decline' from $2.55B to $2.51B contradicts the ground truth trend of a sharp rise then collapse ($838M → $1,650M → $51M). The LLM incorrectly implies stability, while the truth shows volatility followed by de-risking. (3) Multi-hop reasoning is partially sound — the LLM identifies a reduction in unrealized losses and interprets de-risking, which aligns with the conclusion in the original answer. However, this reasoning is based on incorrect data, undermining validity. It fails to capture the actual trajectory: significant increase in exposure in 2023 followed by near-total divestment in 2024. (4) Contextual relevance is high — the answer addresses fair value, unrealized losses, and international risk exposure as required. The interpretation of de-risking is consistent with the original, even if based on faulty inputs. Overall, partial credit is given for correct 2024 value and reasonable interpretation, but major factual errors in 2022 and 2023 data severely limit correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 472,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s 2022‑2024 10‑K disclosures all state that whenever the insurer purchases a non‑agency RMBS or CMBS that has not yet been evaluated by the NAIC, it assigns an **internally‑developed designation** on a temporary basis and replaces it with the NAIC‑issued designation as soon as the NAIC’s annual modeling review is completed. Because the footnotes repeat the same process each year and the portfolio tables show the securities reported only under the six NAIC designations (1‑6), the company’s practice demonstrates that it **relies almost entirely on the NAIC’s loss‑modeling methodology for credit‑quality assessment**, using internal designations merely as a short‑term stop‑gap.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core concept that MetLife uses internally developed designations temporarily until NAIC designations become available, and that the company ultimately relies on NAIC methodology for credit quality assessment. This aligns with the ground truth's description of a transitional process. However, the LLM answer fails to incorporate key quantitative evidence from the original answer that demonstrates the evolving reliance on NAIC designations over time: specifically, the $4.2 billion (14.5%) increase in Level 3 AFS securities in 2023 and the reduced growth of $1.6 billion (4.9%) in 2024. These figures are critical to showing the multi-year trend of decreasing reliance on internal designations as more securities receive formal NAIC ratings. The absence of these numbers significantly undermines the quantitative accuracy. Additionally, the LLM implies a static process by stating the 'same process each year,' which contradicts the ground truth's indication of a maturing application of NAIC frameworks and slowing growth in Level 3 securities—evidence of systemic change. While the qualitative reasoning about temporary internal use and ultimate reliance on NAIC is sound and contextually relevant, the lack of multi-year comparative data and failure to reflect the evolving pattern weakens the multi-hop synthesis. Thus, while semantically aligned in part, the answer misses the trend analysis central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 398,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "- 2022: Chevron still owned a non‑operated working interest in the Congo‑side of the Lianzi deep‑water field and was expanding its deep‑water licences there (the extension of deep‑water licences in Nigeria and the Republic of Congo added 36 million barrels to African reserves)【CVX_10k_2022.pdf p. 31‑35】.  \n\n- 2023: The company’s Africa capital budget rose to roughly **$0.7 billion**, of which a share was spent on offshore development and natural‑gas projects in the Republic of Congo【CVX_10k_2023.pdf p. 107‑111】.  \n\n- 2024: Chevron announced that it would **sell its 15.75 % non‑operated working interest in the Congo portion of Lianzi (and its 31.5 % interest in the offshore Haute Mer permit)**, effectively exiting the asset in January 2025【CVX_10k_2024.pdf p. 41‑45】.  \n\nThus, from 2022 to 2023 Chevron increased capital spending on Congo‑related offshore work, but by 2024 it was reducing its operational footprint by divesting its remaining Congo interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron operated in the Republic of Congo in 2022 with non-operated interests in Lianzi and deep-water licenses; in 2023, it allocated $0.7 billion to African offshore and natural gas projects, including in Congo; in 2024, it announced the sale of its 15.75% interest in Lianzi and 31.5% in Haute Mer, marking an exit. (2) Quantitative accuracy is perfect: $0.7 billion, 15.75%, and 31.5% are all correctly reported, with no calculation errors. Format variations (e.g., $0.7 billion vs $700 million) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model synthesizes data across three years and multiple filings, correctly inferring a strategic shift from investment to divestment. The only minor discrepancy is the mention of 'January 2025' as the exit date, which is not in the ground truth—though this may reflect a detail from the source document (CVX_10k_2024.pdf p.41-45), it slightly extends beyond the 2024 timeframe in the question. (4) The answer fully addresses capital allocation and asset ownership changes, with excellent contextual relevance and entity accuracy (correct company, country, projects, and metrics). The reasoning and completeness are strong, warranting a 9/10 overall for minor temporal precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 378,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "From the 2022, 2023 and 2024 Form 10‑K filings, Texas Instruments consistently says that its business model is “focused on analog and **embedded‑processing products**” and that the **breadth of the analog‑and‑embedded‑processing portfolio** is one of its four sustainable competitive advantages. In each year the company places embedded‑processing within the “broad portfolio of analog and embedded‑processing products” advantage, emphasizing that it creates additional opportunity per customer and adds value to its investments—showing that the strategic emphasis on embedded‑processing has remained a core, unchanged pillar of TI’s competitive strategy despite the segment’s fluctuating revenue performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on Embedded Processing Products from 2022 to 2024, accurately reflecting the evolution (or stability) of the strategy across the three years. (2) There are no numeric values requiring calculation (e.g., revenue figures or percentages), so quantitative accuracy is not compromised; all references to years (2022, 2023, 2024) are correct and properly contextualized. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings and correctly ties embedded processing to TI’s four sustainable competitive advantages, specifically the 'broad portfolio of analog and embedded-processing products' as a stable strategic pillar. (4) The answer addresses all parts of the question: the role of embedded processing within TI’s competitive advantages over time, with accurate entity names (Texas Instruments, embedded-processing products), correct time frame, and proper context about strategic consistency despite revenue fluctuations (a nuance not in the original but factually plausible and non-contradictory). Wording differs slightly from the original answer but conveys the same core information with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 370,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50 % senior note carried an effective interest‑rate cost of **≈ 3.2 %** in FY 2022 (July 30 2022). By FY 2023 the effective rate had risen to **≈ 6.4 %** (July 29 2023) and in FY 2024 it was **≈ 6.7 %** (July 27 2024). This upward swing shows that, although the coupon remained 3.50 %, the market‑driven discount/premium and hedge adjustments pushed the note’s borrowing cost to more than double its 2022 level, indicating a materially higher cost of debt for Cisco over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Cisco's effective interest rate on the 3.50% Senior Note from FY2022 to FY2024 with accurate figures: ≈3.2% (vs. 3.20%), ≈6.4% (vs. 6.38%), and ≈6.7% (vs. 6.66%). These minor rounding differences (e.g., 6.38% → 6.4%, 6.66% → 6.7%) are acceptable under semantic equivalence and do not affect factual accuracy. The fiscal years are correctly aligned with their respective end dates (July 2022, 2023, 2024), which matches Cisco’s fiscal year-end (typically July). (2) All key financial metrics—effective interest rates, coupon rate (3.50%), and trend—are quantitatively accurate. The dollar amount ($500 million) is missing in the LLM answer, which is a minor omission but does not detract from the core analysis of rate progression. (3) The reasoning is sound: the LLM correctly infers that despite a fixed coupon, the effective borrowing cost rose significantly due to market-driven valuation adjustments (e.g., discounting, hedging), indicating higher financing costs over time. This aligns with the ground truth’s conclusion about increasing borrowing costs reflecting market rate hikes or risk perception shifts. (4) The answer is contextually complete and relevant, addressing both parts of the question: the rate evolution and its implication for borrowing costs. The synthesis across three fiscal years is accurate and well-articulated. Only a perfect 10 would require inclusion of the $500M principal and exact percentages; the current answer is very close but slightly less precise in numerical reporting, warranting a 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 437,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "Across all three filings the company repeatedly warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 10‑K, Risk Factors; same language appears in the 2023 10‑K and again in the 2024 10‑K). The wording is essentially unchanged from 2022 through 2024, showing that BNY Mellon’s exposure to these banking‑law constraints has remained constant rather than easing. This steady‑state exposure signals that, while the board retains discretion over dividends and repurchases, the firm’s strategic flexibility in allocating capital to shareholders is persistently capped by regulatory capital‑planning rules.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its core claim that BNY Mellon consistently cited U.S. banking laws as a constraint on capital returns from 2022 to 2024, and correctly notes the repetition of key language across the 10-K filings. The quantitative accuracy is perfect: no numerical errors, and the years (2022–2024) and references to regulatory constraints are correctly cited. However, the LLM incorrectly asserts that the wording is 'essentially unchanged,' which contradicts the ground truth. The original answer identifies meaningful evolution: in 2023, BNY Mellon added specific references to Delaware law and preferred stock dividends as limiting factors, and in 2024, introduced a stronger emphasis on liquidity management and the consequences of failing to maintain 'well capitalized' and 'well managed' status. By missing these incremental but important additions, the LLM fails to capture the multi-hop progression in regulatory emphasis, leading to a flawed conclusion that exposure 'has remained constant.' This misrepresents the nuanced evolution in risk disclosure and underestimates the increasing regulatory complexity. While the answer is contextually relevant and correctly identifies the overarching regulatory constraint, it lacks completeness in tracing the multi-year progression, particularly the expanding scope of legal and liquidity considerations. Thus, while factually sound on repeated language, it misses key qualitative developments, resulting in a partially correct synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 415,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics’ “Repair and other services” line‑item fell from $1,169 million in 2022 to $1,132 million in 2023 – a $37 million (≈3 %) decline – and then held steady at $1,132 million in 2024 [2022 table shows $1,169 M; 2023 table shows $1,132 M; 2024 table shows $1,132 M]. The flat 2024 result reflects the segment’s reliance on recurring post‑delivery maintenance, modernization and lifecycle‑support contracts for Navy ships, which generate relatively predictable, contract‑driven revenue rather than rapid growth. This pattern suggests the business is a stable, cash‑generating pillar of GD’s Marine Systems segment, emphasizing sustained service commitments over aggressive expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all financial figures: $1,169M in 2022, $1,132M in 2023, and $1,132M in 2024. The $37M decline and ≈3% decrease are accurate calculations. These match the ground truth exactly, earning full marks for quantitative accuracy. (2) The answer addresses the revenue change and flat performance in 2024, satisfying the multi-part structure of the question. However, the explanation for flat 2024 revenue diverges from the ground truth. While the original answer cites possible causes like market saturation, resource reallocation, or operational constraints—implying limited strategic prioritization—the LLM attributes stability to the nature of recurring maintenance contracts and positions the segment as a 'stable, cash-generating pillar' focused on sustained commitments. This reframes stagnation as intentional stability, which is a plausible interpretation but contradicts the ground truth's implication of limited growth due to lower strategic emphasis or external constraints. (3) The multi-hop reasoning is sound in tracking the revenue trend across years and linking it to business implications, but the synthesis of 'why' it remained flat relies on an alternative rationale not supported by the original data. The LLM introduces the idea of 'recurring post-delivery maintenance' and 'predictable, contract-driven revenue' without citing specific evidence from the knowledge graph, making it an inference beyond the provided truth. (4) Despite this, the answer remains contextually relevant and factually precise on numbers and trends. The correctness score is 7 because core facts and calculations are correct, but the qualitative interpretation of the 'why' and strategic implication differs meaningfully from the ground truth, missing the nuance of potential underperformance or strategic deprioritization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 502,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑security (venture) portfolio grew from **$3.7 billion at the end of 2022 to $4.9 billion at the end of 2024** – a roughly 30 % increase, while the unrealized gains recorded on that portfolio rose from **$211 million in 2022 to $710 million in 2024**, showing that the firm is both expanding and benefitting from its health‑tech and other early‑stage investments. At the same time, its **equity‑method stakes in operating health‑care businesses more than doubled, from about $1.5 billion in 2022 to $3.8 billion in 2024**, indicating a strategic shift toward deeper ownership and integration of core health‑care providers alongside the broader venture‑investment focus. These trends signal UnitedHealth’s dual emphasis on building a larger, high‑growth venture portfolio while increasingly committing capital to substantive, revenue‑generating health‑care operating businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UnitedHealth's equity securities (venture investments) were $3.7B in 2022, $4.9B in 2023, and remained at $4.9B in 2024 — not a direct increase from 2022 to 2024 as implied. The LLM incorrectly states growth 'to $4.9B at the end of 2024' without acknowledging the 2023 figure, which misrepresents the timeline. More critically, the LLM claims equity-method investments rose from '$1.5B in 2022' to $3.8B in 2024, but the ground truth states they were $1.4B in both 2022 and 2023, then jumped to $3.8B in 2024. This is a major factual error — the starting point is wrong. Additionally, the LLM introduces 'unrealized gains' ($211M in 2022 to $710M in 2024), which are not mentioned in the original answer and cannot be verified from the provided ground truth, making this information hallucinated. (2) Calculations: The 30% increase from $3.7B to $4.9B is approximately correct, but the 'more than doubled' claim for equity-method investments is misleading — from $1.4B to $3.8B is a ~171% increase, but the LLM uses an incorrect base ($1.5B in 2022). (3) Multi-hop reasoning: The LLM correctly infers a strategic shift toward deeper integration in healthcare operating businesses, which aligns with the ground truth's conclusion. It also correctly identifies the dual focus on venture and operating businesses, showing sound qualitative synthesis. (4) Despite correct strategic interpretation and relevance to the question, the quantitative inaccuracies — especially the misstated equity-method investment values in 2022 — significantly reduce factual reliability. The hallucinated unrealized gains further undermine correctness. Hence, the correctness score is 6 (partially correct with major errors), quantitative accuracy is low (4), qualitative reasoning is reasonable (7), and relevance is high (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 517,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Across the three most recent Form 10‑K filings, Colgate‑Palmolive Co. has been listed every year as a member of PMI’s “Peer Group.” The 2022 filing (pages 19‑23) names Colgate‑Palmolive among the 20 peer companies, the 2023 filing (pages 24‑28) repeats the same list, and the 2024 filing (pages 24‑28) again includes Colgate‑Palmolive in the identical set of peers【2022 10‑K p.19‑23】【2023 10‑K p.24‑28】【2024 10‑K p.24‑28】.  \n\nThis unchanged classification shows that PMI’s benchmarking framework is deliberately stable: it applies a consistent set of criteria (global presence, consumer‑product focus, comparable revenues and market‑cap) and retains the same peers over multiple years to enable longitudinal performance comparison and strategic continuity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's Peer Group across 2022, 2023, and 2024, with no changes in classification—matching the original answer's claim of year-over-year consistency. (2) There are no numerical values requiring calculation (e.g., revenues, market cap figures), but the LLM correctly references the relevant 10-K filing years and page ranges, which align with typical disclosure locations and support verifiability. No quantitative inaccuracies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings to infer stability in PMI’s peer selection, correctly identifying the underlying criteria (global presence, consumer-product focus, comparable revenues and market cap) and linking them to strategic benchmarking objectives. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in peer classification and the implication for PMI’s strategic framework. The conclusion about longitudinal comparison and strategic continuity mirrors the original answer’s interpretation. All entities—Colgate-Palmolive Co., PMI, and the peer group framework—are correctly identified and contextualized. Wording differs slightly but conveys identical meaning. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 384,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "Across the three filings PayPal’s risk‑factor language shows a steady widening of its fraud‑exposure picture. In the 2022 10‑K the company already warned that “failure to deal effectively with fraud, abusive behaviors… may increase our loss rate” and that “our credit products expose us to additional risks” (Risk Factors, 2022 pp. 24‑27). By 2023 the filing added that the growth of consumer‑credit, merchant‑financing and BNPL products – which are funded through “unaffiliated third‑party lenders” and other external funding structures – “creates additional exposure to abusive schemes” and that “measures to detect and reduce the risk of fraud… may not be effective… in connection with new or expanded product offerings” (Risk Factors, 2023 pp. 23‑26). The 2024 filing repeats the same warning and explicitly ties the rising abuse risk to “expanding credit products” and “our reliance on third‑party sources of funding” (Risk Factors, 2024 pp. 21‑24). The progression from a general fraud‑risk statement in 2022 to a more detailed linkage with credit‑product growth and third‑party dependence in 2023‑2024 suggests that PayPal’s exposure to abusive behavior has been increasing faster than its mitigation controls, indicating that its fraud‑prevention effectiveness has not kept pace with the expansion of its credit‑related services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PayPal's increasing exposure to abusive behaviors from 2022 to 2024, the expansion of credit products (especially BNPL), and growing reliance on third-party funding sources are all accurately described. The progression in risk-factor language across the years is correctly interpreted. (2) Quantitative accuracy is perfect: while no specific dollar amounts or percentages (e.g., €40 billion) are mentioned in the LLM answer, it does not misstate any numbers and avoids making false quantitative claims. The omission of the €40 billion figure from the 2023 agreement is a minor gap but does not detract from the overall correctness, as the focus is on the qualitative evolution of risk. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, identifying the evolution from general fraud concerns in 2022 to specific linkage with credit expansion and third-party dependencies in 2023–2024. The conclusion that mitigation efforts have not kept pace with risk growth is logically supported and matches the ground truth’s implication. (4) Semantic equivalence is strong: though the LLM does not quote the regulatory uncertainty about loan receivables post-sale in 2024, it captures the core trend—increasing exposure due to credit product growth and third-party reliance—accurately. The answer is fully contextually relevant, directly addressing all parts of the question. One point is deducted from qualitative accuracy for the slight omission of the regulatory uncertainty nuance in 2024, but the central thesis remains robust and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1659,
        "completion_tokens": 462,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "- In 2022 Southern Company held ≈ 214 million mmBtu of natural‑gas **options** (with 217 mmBtu of swaps, total hedge = 431 mmBtu)【SO_10k_2023.pdf p.115‑119】.  \n- In 2023 the option position rose sharply to ≈ 339 million mmBtu (swaps fell to 109 mmBtu, total hedge = 448 mmBtu)【SO_10k_2024.pdf p.112‑116】.  \n- By 2024 the company reversed that move, cutting options to ≈ 176 million mmBtu while expanding swaps to 255 million mmBtu (total hedge = 431 mmBtu)【SO_10k_2024.pdf p.112‑116】.  \n\n**Interpretation:** The three‑year pattern shows Southern Company scaling up option‑based hedges when natural‑gas price volatility peaked in 2023, then shifting back toward larger swap contracts and reducing option exposure in 2024 as market conditions steadied. This suggests a flexible risk‑management approach that leans on options to protect margins during periods of heightened price uncertainty, but pivots to more fixed‑price swaps when the outlook becomes clearer.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is highly accurate overall, with only a minor discrepancy in the 2022 natural gas options volume. The ground truth states 253 million mmBtu for 2022, while the LLM reports ≈214 million mmBtu, which is incorrect. However, the 2023 (339 million mmBtu) and 2024 (176 million mmBtu) values are correct, matching the ground truth exactly. The inclusion of swap volumes and total hedge amounts adds valuable context not in the original answer but is factually consistent with the cited sources. (2) Quantitative accuracy is high for 2023 and 2024, but the 2022 options figure is off by ~39 million mmBtu, which is significant but does not appear to stem from a calculation error—rather, a misreading or sourcing issue. All other numbers (swaps, totals) are correctly reported and internally consistent. (3) The multi-hop reasoning is excellent: the LLM correctly synthesizes data across years and documents, identifies the shift from options to swaps and back, and interprets the strategic implications accurately. The conclusion about a flexible risk management strategy responding to volatility aligns perfectly with the ground truth’s interpretation. (4) Despite the 2022 number error, the overall trend (increase in 2023, sharp drop in 2024) is correctly identified and interpreted. The added context of swap usage strengthens the analysis. Hence, correctness is docked slightly for the factual inaccuracy in 2022, but qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 422,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022** to **$75 million in 2023** and to **$76 million in 2024**【TXN_10k_2024.pdf p. 41‑42】. Because the company’s non‑qualified defined‑benefit pension plan is **unfunded and closed to new participants**, the steady increase in contribution‑plan expense signals a deliberate shift toward a fully funded, employee‑driven defined‑contribution model as the long‑term cornerstone of its employee‑benefit strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$70 million in 2022, $75 million in 2023, and $76 million in 2024—matching the ground truth exactly. These numbers are cited with correct formatting and year alignment. (2) Quantitative accuracy is perfect: the incremental increases (from $70M to $75M to $76M) are accurately represented, and no calculations are required beyond reporting the values, which are correct. (3) The reasoning is largely sound: the LLM correctly identifies that the non-qualified defined benefit plan is closed to new participants and unfunded, and infers a strategic shift toward defined contribution plans as the primary retirement vehicle. This aligns with the ground truth’s interpretation of a long-term strategic emphasis. However, the LLM slightly overreaches by calling this a 'deliberate shift toward a fully funded, employee-driven... cornerstone' without explicitly acknowledging the historical context since 1997 mentioned in the original answer (i.e., that this structure has been long-standing). While the conclusion is reasonable, it omits the nuance that the strategy reflects continuity rather than a recent shift. (4) Despite this minor omission, the answer is factually correct, contextually relevant, and synthesizes information appropriately across time and plan types. The citation to TXN_10k_2024.pdf p. 41-42 supports the data. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to excellent performance with only a slight gap in contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 425,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "- 2022 10‑K: GM’s U.S. pension‑plan assumption for the long‑term rate of return was **≈ 5.4 %** (the “expected rate of return on plan assets” shown as 5.38 %).  \n- 2023 10‑K: The company raised that assumption to **≈ 6.3 %** (the long‑term ROA was unchanged at 6.3 % after the 2023 investment‑policy study).  \n- 2024 10‑K: A new study increased the assumption again to **≈ 6.5 %** (the weighted‑average long‑term ROA rose from 6.3 % in 2023 to 6.5 % in 2024).  \n\n**Trend interpretation:** The upward shift—from about 5.4 % to 6.5 % over three years—signals that GM is becoming more optimistic about future asset performance and is willing to tolerate a modestly higher level of investment risk (e.g., a larger equity/alternative‑asset allocation) to improve the funded status of its U.S. pension plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the long-term rate of return assumptions for General Motors' U.S. pension plans across 2022–2024 with high precision. The 2022 value is reported as ≈5.4% (ground truth: 5.4%, actual disclosed 5.38%), which is accurate within acceptable rounding. The 2023 value is correctly stated as 6.3%, matching the ground truth that it remained unchanged at that level. The 2024 value is accurately given as 6.5%, consistent with the ground truth. (2) All numeric values align with the original answer, with only minor formatting differences (e.g., ≈5.4% vs. 5.4%) that do not affect factual accuracy. The progression from 5.4% to 6.5% is correctly interpreted as an upward trend. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three annual reports (2022–2024), correctly tracks the evolution of the assumption, and infers the implied shift in risk tolerance and asset performance expectations. The mention of investment-policy studies and asset allocation (equity/alternatives) adds context supported by typical pension plan disclosures. (4) The qualitative interpretation aligns with the ground truth—increased return assumptions suggest greater optimism and risk tolerance, tied to funded status objectives. The only minor shortcoming is that the LLM slightly mischaracterizes the 2023 figure as a 'raise' from 5.4% to 6.3%, whereas the ground truth implies the 6.3% was already in place prior to 2023 (i.e., the change occurred before 2023, and 2023 was unchanged). This could imply a small timing misattribution, but the overall trend and values are correct. Hence, a score of 9 is justified—excellent accuracy with a minor nuance in the narrative flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 469,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s exposure to total‑return swaps used to hedge its deferred‑compensation obligations grew each year – the notional amount rose from $651 million in FY 2022, to $792 million in FY 2023, and $985 million in FY 2024【2022 page “Total return swaps‑deferred compensation … 651”】【2023 page “Total return swaps‑deferred compensation … 792”】【2024 page “Total return swaps‑deferred compensation … 985”】.  The accounting impact also shifted dramatically: the swaps produced a $92 million loss in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024【2022 page “Total return swaps‑deferred compensation … (92)”】【2023 page “Total return swaps‑deferred compensation … 58”】【2024 page “Total return swaps‑deferred compensation … 91”】.  This progression shows Cisco expanding its hedge program while moving from a net expense drag to a net benefit, indicating that its use of total‑return swaps is effectively managing the volatility of compensation charges and aligning those costs with market performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for realized gains/losses: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024, matching the ground truth exactly. It also accurately introduces additional data—the notional amounts of the swaps ($651M, $792M, $985M)—which, while not in the original answer, are factually correct and provide useful context without contradicting the ground truth. (2) All numbers are quantitatively accurate, including directional changes and year-over-year progression. The gains and losses align precisely with the ground truth, and no calculation errors are present. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three fiscal years and correctly infers a strategic trend—Cisco’s shift from a loss to increasing gains, indicating effective risk management. The conclusion about alignment with market performance and volatility management is a reasonable extension of the data. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer did not include notional amounts, so while the added detail is accurate, it slightly exceeds the scope of the ground truth without changing the core correctness. However, this does not detract from factual accuracy. The answer remains semantically equivalent and contextually superior, fully addressing all parts of the question with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 406,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "Across all three years PayPal’s filings say that its exposure to margin risk has **remained essentially unchanged**. In the 2022, 2023 and 2024 10‑K notes the company explains that it **recognizes transaction fees on a gross basis as the principal**; it **sets the fee‑level itself**, controls the product specifications and pricing, and therefore **bears full margin risk on every payment it processes**. When PayPal uses third‑party processors or other financial institutions, the fees it pays them are recorded separately as **transaction expense**, but this does not affect the margin risk it assumes because the fee charged to the customer is determined independently of those costs. Thus, from 2022 through 2024 PayPal’s margin‑risk exposure has stayed consistent – full‑margin risk retained despite the continued use of external processors and the same gross‑basis revenue‑recognition approach.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All key facts are accurately conveyed: PayPal maintained full margin risk across 2022–2024, recognized transaction fees on a gross basis as principal, controlled pricing independently, and recorded fees paid to third-party processors as transaction expense. The answer correctly notes consistency over the three years with no structural changes. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) and financial terms (gross basis, transaction expense, principal role) are used accurately. (3) The multi-hop reasoning is sound—information is correctly synthesized across the three years and across concepts (pricing control, third-party processor use, expense recognition). The LLM correctly infers that because PayPal sets fees independently and bears the economic risk, it retains full margin risk regardless of external costs. (4) The answer is highly relevant, directly addressing all parts of the question: evolution of margin risk, pricing control, use of third parties, and expense recognition. Minor wording differences (e.g., 'remained essentially unchanged' vs 'consistent exposure') do not affect factual accuracy. No omissions or errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 370,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "- **Production trend:** Chevron’s share of natural‑gas output from the Angola LNG project fell from **≈ 49 MMCFD in 2022** to **≈ 48 MMCFD in 2023**, and then held steady at **≈ 48 MMCFD in 2024** (2022 / 2023 figures shown in the 2023 Form 10‑K table and the 2024 figure in the 2024 Form 10‑K table)【CVX_10k_2023.pdf p.9】【CVX_10k_2024.pdf p.9】.  \n\n- **Strategic implication:** The near‑flat output—only a modest dip followed by stability—indicates Chevron is maintaining a consistent supply to the Angola LNG facility, reinforcing its role as a reliable LNG producer and supporting its broader strategy to stay well‑positioned in the growing global liquefied natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that Chevron's natural gas *consumed in operations* related to Angola LNG increased from 592 MMCFD in 2022 to 596 MMCFD in 2023 and 609 MMCFD in 2024. In contrast, the LLM claims Chevron’s 'share of natural-gas output' decreased from ≈49 MMCFD to ≈48 MMCFD and remained flat—values that are an order of magnitude lower and misrepresent both the trend and scale. These numbers likely reflect a misinterpretation of 'Chevron’s share' rather than total gas consumed at the facility, which is the metric reported in the context of Angola LNG operations. (2) The calculation and comparison of values are therefore fundamentally flawed. The LLM reports a decline and stabilization at ~48 MMCFD, whereas the correct data shows a consistent increase from 592 to 609 MMCFD—over a 10-fold difference in volume. This invalidates any numerical or trend-based conclusions. (3) The multi-hop reasoning fails because the model did not correctly identify or synthesize the relevant metric across the 2023 and 2024 10-K filings. Instead of pulling the 'natural gas consumed in operations' for Angola LNG (the correct proxy for production input into LNG), it used a different, unverified metric—possibly conflating equity share with total operational consumption. The strategic implication drawn (stable supply supporting LNG positioning) is partially reasonable but based on incorrect data, weakening the logical foundation. (4) While the answer attempts to address both parts of the question (trend and strategy), the severe numerical inaccuracies and misidentification of the key metric result in a low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but factual grounding is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 498,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In the 2022 filing Southern Power only presented the scheduled cash‑flows for its outdoor‑lighting‑type leases as part of a single “undiscounted cash‑flows under operating leases” table (total ≈ $652 million of future payments, with a $240 million “thereafter” component). By the 2023 10‑K the company added a separate maturity‑analysis schedule that broke out the future payments year‑by‑year (total ≈ $1.15 billion of undiscounted cash‑flows, $607 million of present‑value discount, and a $546 million operating‑lease obligation), and in the 2024 filing the same schedule was refined again to show only the remaining post‑2024 payments (total ≈ $245 million undiscounted, net investment $158 million, difference $87 million). The progression from a lump‑sum disclosure to a detailed, year‑by‑year maturity analysis and the explicit net‑investment accounting signals that the outdoor‑lighting contracts have become increasingly material and are now treated as a distinct, structurally important lease asset class in Southern Power’s financial reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Southern Power (via Mississippi Power) considered outdoor lighting contract cash flows immaterial, but the LLM claims a $652 million disclosure was made, which contradicts the 'immaterial' designation. The LLM invents precise dollar figures (e.g., $1.15 billion, $607 million discount, $546 million obligation, $245 million in 2024) that are not present in the original answer and are unsupported by the ground truth. These numbers appear fabricated and fail the quantitative accuracy test. (2) There is no mention in the original answer of Mississippi Power being the entity reporting in 2022, nor of net investment accounting or present-value discounts—these are hallucinations. The original answer emphasizes qualitative changes in disclosure treatment (e.g., inclusion in maturity analyses with PPAs), not quantitative breakdowns. (3) The multi-hop reasoning is flawed: the LLM misidentifies the nature of the evolution—shifting from immaterial lump-sum disclosure to structural integration—not from lump sum to year-by-year with fabricated metrics. The conclusion about 'distinct, structurally important lease asset class' aligns loosely with the original's 'growing materiality,' but is based on incorrect premises. (4) While the LLM attempts to address the evolution over time and the increasing importance, its reliance on invented financial data severely undermines correctness. The contextual relevance is moderate because it discusses the right topic and timeframe, but the qualitative and quantitative inaccuracies drag down accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 454,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across all three filings, Texas Instruments listed its Melaka, Malaysia site only under the **Analog** segment. In the 2022, 2023 and 2024 10‑K property tables, Melaka shows an “X” for Analog and no mark for Embedded Processing, indicating that the facility’s role did not expand to the Embedded Processing segment during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved only in the Analog segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the use of 'X' in property tables aligns with typical 10-K formatting, indicating accurate interpretation of source documents. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual filings (2022–2024) and consistently linked the Melaka facility to only the Analog segment each year, concluding no expansion into Embedded Processing—this reflects proper cross-year and cross-segment analysis. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of the operational footprint as requested. Wording differs slightly from the original (e.g., referencing 'property tables' and checkmarks), but this enhances clarity without altering meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 343,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From the 2022 filing the 1.600 % senior notes were issued for a **$700 million** aggregate principal, with **semi‑annual interest due on April 15 and October 15** and a **par‑call date of March 15 2026**. The 2023 filing repeats the same terms, and the 2024 filing shows that the company has been **reducing the outstanding balance modestly** (‑$2.6 million in 2023 and an additional ‑$1.5 million in 2024) while leaving the interest‑payment schedule and the March 15 2026 call unchanged. This steady, incremental pay‑down of a low‑cost, long‑dated issue demonstrates AMT’s strategy of locking in cheap financing and gradually retiring it before the call date to manage leverage without disrupting its cash‑flow profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the aggregate principal amount ($700 million), interest payment schedule (April 15 and October 15), and par call date (March 15, 2026) across all years, which matches the ground truth. However, it misrepresents the 'adjustments to principal amount' as actual reductions in outstanding balance (i.e., repayments) of $2.6 million in 2023 and $1.5 million in 2024. The ground truth specifies these as 'adjustments'—likely accounting or administrative adjustments (e.g., amortization of discount, hedging adjustments)—not principal repayments. The aggregate principal remained constant at $700 million throughout. (2) The numbers cited—$2.6 million and $1.5 million—are directionally correct in magnitude and sign (negative adjustments) but are misinterpreted in meaning. The LLM incorrectly infers a 'pay-down' of debt, which is not supported by the data. This leads to a flawed conclusion about debt retirement strategy. (3) The multi-hop reasoning is partially sound: the model synthesizes data across 2022–2024 filings and correctly notes stability in key terms. However, the interpretation of adjustments as principal reduction reflects a failure in accurate financial concept application, undermining the strategic conclusion. (4) The contextual relevance is high—answer addresses all question components. Qualitative accuracy is moderate due to correct entity and date identification but flawed reasoning. Quantitative accuracy is low because the model misrepresents the nature of the numerical changes, even if the raw figures are close. Correctness score is 6 due to core factual accuracy on main terms but significant error in interpreting financial adjustments, leading to an incorrect strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 478,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco’s $2 billion 5.90 % senior note has remained unchanged in absolute size from FY 2022 through FY 2024 (‑ $2 bn in each filing) and its contractual effective rate has stayed at 6.11 % in all three years【2022‑Long‑Term Debt table】, 【2023‑Long‑Term Debt table】, 【2024‑Long‑Term Debt table】.  However, the note’s share of total debt has fallen sharply as Cisco added new, lower‑cost issuances: it represented about 22 % of the $9 bn long‑term debt portfolio in FY 2022, roughly 17 % of the $11.5 bn portfolio in FY 2023, and only about 10 % of the $20.3 bn portfolio in FY 2024.  The constant presence of the 5.90 % tranche together with a rapidly expanding pool of lower‑rate notes signals that Cisco is using the existing high‑rate bond as a stable long‑term anchor while aggressively refinancing and augmenting its capital structure with cheaper debt to support growth and improve overall financing costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 5.90% Note remained at $2,000 million and the effective interest rate at 6.11% across all three fiscal years, which matches the ground truth. However, it introduces significant inaccuracies in the total debt figures: it reports long-term debt as $9 billion in 2022, $11.5 billion in 2023, and $20.3 billion in 2024, whereas the ground truth states long-term debt was $8,416 million in 2022 and $19,621 million in 2024 (no 2023 figure provided in ground truth, but LLM's $11.5B is inconsistent with the trend). These numbers are materially off, especially the 2022 and 2024 figures, leading to incorrect percentage calculations (22%, 17%, 10%) that are not supported by the ground truth. (2) The ground truth emphasizes that total long-term debt increased from $8,416M to $19,621M while short-term debt slightly decreased, but the LLM omits any mention of short-term debt changes, missing a key component of the debt composition shift. (3) The reasoning about Cisco using the 5.90% note as a 'stable anchor' while issuing cheaper debt is plausible and aligns thematically with the ground truth’s conclusion about using fixed-rate instruments to stabilize costs. However, the LLM infers a refinancing strategy based on 'lower-cost issuances,' which is not explicitly supported by the provided ground truth data—this is an interpretive leap. (4) Despite correct identification of the note's value and rate, the quantitative inaccuracies in total debt figures and derived percentages significantly reduce factual correctness. The qualitative reasoning is sound but based on incorrect inputs. The answer is contextually relevant and addresses the evolution of the note and financing strategy, but with flawed data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 483,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics’ Land Systems unit was building roughly **360 new LAVs for the Canadian Army in 2022**, increased to **about 399 LAVs in 2023**, and rose again to **approximately 449 new LAVs in 2024** (plus an additional 66 LAVs under the LRSS‑surveillance variant, for a total of roughly 515 vehicles). This year‑over‑year growth shows a clear strategic emphasis on expanding its LAV production capacity and deepening its partnership with Canada, underscoring LAV manufacturing as a priority export‑growth segment for the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the production volumes of 360 units in 2022, 399 in 2023, and 449 in 2024 for General Dynamics' LAVs for the Canadian Army, matching the ground truth exactly. It also correctly identifies the additional 66 LRSS-specialized LAVs in 2024. However, it adds these 66 units to the 449 to reach a total of ~515 vehicles, which is factually accurate but slightly misrepresents the original answer’s intent—where the 449 already includes the 66 LRSS units (as implied by 'added 66 specialized LAVs' in context of 2024 increase). The original answer treats the 66 as part of the 449, not in addition to it. This leads to a minor overcounting interpretation, though the LLM may be reading 'further to 449 units in 2024' and then 'added 66' as additive, which introduces ambiguity. (2) All numbers are correctly cited, but the summation to 515 suggests a structural misunderstanding of whether the 66 are included in the 449 or not. The ground truth implies inclusion; the LLM interprets as exclusion. This affects quantitative accuracy slightly. (3) The multi-hop reasoning is strong—correctly linking year-over-year increases, identifying the LRSS program, and inferring strategic focus on LAV manufacturing and export growth. The conclusion about strategic emphasis aligns well with the original. (4) Contextual relevance is excellent—the answer addresses both parts of the question: evolution over time and strategic implications. The only issue is the potential double-counting of the 66 LRSS units, which prevents a perfect score. Overall, the answer is highly accurate with only a minor discrepancy in interpretation of unit inclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 458,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth’s 10‑K filings show that its Medicare Advantage (MA) risk‑adjustment exposure grew steadily from 2022 through 2024 as CMS repeatedly altered the methodology used to calculate MA risk‑adjustment payments and froze or cut benchmark rates. In each year the company said it was “adjusting members’ benefits and premiums on a selective basis, ceasing to offer benefit plans in certain counties and intensifying both medical‑and‑operating cost management” to offset the funding pressure, and by 2024 it added that it was also tightening its risk‑adjustment data‑validation (RADV) processes and audit readiness to mitigate any retrospective payment adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth faced ongoing exposure to CMS changes in Medicare Advantage risk adjustment methodologies from 2022 to 2024, with funding pressures due to benchmark freezes/cuts and evolving payment rules. The company responded consistently with selective benefit and premium adjustments, county exits, and cost management—accurately reflected in the LLM response. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent strategic responses across three years and correctly identifies the evolving nature of CMS policy impact. The addition of tightened RADV processes and audit readiness by 2024 is a valid elaboration consistent with the original’s emphasis on ongoing data submission challenges and operational agility, even if not explicitly stated in the ground truth—it represents a plausible and contextually appropriate strategic extension. (4) Semantic equivalence is strong; the LLM captures the core evolution and response strategy without distortion. The only minor gap is that the original emphasizes 'recalibrating bids' in 2023, which the LLM omits, but this is a secondary detail. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 405,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s outstanding balance of the September 2019 fixed‑rate 2.850 % notes (maturing 10 Oct 2029) stayed at **$1.5 billion** in each of the three years: it was $1.5 bn at year‑end 2022 (PYPL 2022 10‑K, p. 106‑108), unchanged at $1.5 bn at year‑end 2023 (PYPL 2023 10‑K, p. 106‑107), and again $1.5 bn at year‑end 2024 (PYPL 2024 10‑K, p. 103‑104).  \n\nThe flat exposure signals that PayPal is keeping this low‑cost, long‑dated tranche as a stable pillar of its capital structure, rather than retiring or refinancing it, which reflects a long‑term debt strategy that relies on a steady, predictable funding base while using newer issuances for liquidity or other financing needs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.5 billion carrying value of the 2.850% notes is accurately reported for all three years (2022–2024), with correct citation of the maturity date (October 10, 2029) and consistent formatting ($1.5 billion = $1.5 bn). (2) The answer is complete, addressing both parts of the question: the evolution (no change) and the strategic implication (stable funding base). (3) Entity accuracy is perfect: correct company (PYPL), correct instrument (2.850% fixed-rate notes issued in September 2019, maturing 2029), and correct time frame (2022–2024). (4) The reasoning is sound and reflects multi-hop synthesis across three annual 10-K filings, correctly inferring that the unchanged exposure indicates a deliberate long-term debt strategy. The conclusion about preserving a low-cost, long-dated liability aligns semantically with the ground truth’s 'strategic intent to preserve this liability structure.' Minor wording differences (e.g., 'stable pillar' vs. 'consistent strategy') do not affect factual equivalence. All scores are 10 due to full factual accuracy, correct synthesis, and contextual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 338,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "- In the 2022 filing Chevron reported a $1.96 billion equity‑method investment in Angola LNG Limited and earned $1.86 billion of its share of the affiliate’s net income.  \n- By the 2023 filing the investment had been trimmed to $1.76 billion and the equity earnings fell to $0.51 billion, and the 2024 filing shows the same $1.76 billion carrying amount and $0.51 billion earnings.  \n\nThis three‑year trend shows Chevron keeping a sizable 36‑plus‑percent stake in the on‑shore Angolan LNG plant while gradually reducing new capital outlays and accepting lower profit participation. The pattern signals a long‑term strategy that leans on the existing LNG facility to monetize the country’s associated gas, rather than expanding its investment, positioning Angola LNG as a stable, low‑cap‑ex conduit for Chevron’s natural‑gas monetization in Angola.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Chevron maintained a consistent 36.4% ownership stake in Angola LNG Limited from 2022 to 2024, but the LLM implies a strategic reduction in investment based on declining equity carrying amounts and earnings—data not present in the original answer and unsupported by the knowledge graph. There is no mention in the ground truth of $1.96B or $1.76B carrying amounts or earnings figures; these numbers are entirely fabricated or misattributed. (2) The quantitative inaccuracies are severe: none of the dollar amounts ($1.96B investment, $1.86B income, $0.51B earnings) appear in the original answer, and no financial metrics were cited in the ground truth. The LLM invents financial data that contradicts the focus on ownership percentage and strategic evolution. (3) The multi-hop reasoning is flawed. While the question requires synthesis of Chevron’s evolving strategic role in Angola LNG over three years, the LLM incorrectly infers a capital drawdown and reduced ambition based on phantom financials. In contrast, the ground truth shows an expansion of upstream assets (Blocks 49/50, Q&M fields) and integration with the LNG plant—indicating increased, not decreased, strategic integration. The LLM misses entirely the key developments in 2024: new exploration acreage and the Q&M project’s connectivity to the LNG facility. (4) The contextual relevance is moderate because the answer addresses Chevron and Angola LNG over the correct time frame and touches on monetization strategy, but the conclusion—that Chevron is minimizing investment—is directly contradicted by the ground truth’s evidence of upstream expansion and infrastructure integration. The reasoning and facts are therefore largely incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 500,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company’s trust holdings grew steadily over the three‑year span.  At year‑end 2022 the company reported $829 million in domestic‑equity trust assets (Level 1 $651 m + Level 2 $178 m) and $161 million in private‑equity (NAV); by year‑end 2023 those balances rose to roughly $859 million of domestic equity (Level 1 $651 m + Level 2 $208 m) and $169 million of private equity, and at year‑end 2024 they reached $1,099 million of domestic equity (Level 1 $849 m + Level 2 $250 m) and $181 million of private equity.  The upward trend—especially the sharp jump in domestic‑equity exposure—signals that Southern Company is progressively directing more long‑term capital into equity‑based trust investments while maintaining a modest, growing foothold in private‑equity, reflecting a strategy that emphasizes diversified, growth‑oriented asset allocation for future earnings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Southern Company's domestic equity investments were $1,016 million, not $829 million as stated in the LLM response. The LLM incorrectly assigns the 2023 domestic equity value ($829 million) to 2022. Additionally, the LLM reports private equity at $161 million in 2022, but the correct figure is $150 million. While the 2024 figures for both domestic equity ($1,099 million) and private equity ($181 million) are correct, the 2023 domestic equity value is inaccurately reported as $859 million (calculated from Level 1 + Level 2), whereas the ground truth is $829 million. (2) The LLM introduces Level 1/Level 2 breakdowns and NAV valuation methods not present in the original answer, which may reflect real data but are extraneous and used to justify incorrect totals. The core dollar amounts for 2022 and 2023 are factually wrong, undermining quantitative accuracy. (3) The reasoning about a long-term shift toward equity investments and diversification is partially sound and aligns with the original conclusion, showing adequate qualitative understanding of strategic intent. However, the multi-hop synthesis is flawed because it misrepresents the starting point (2022) and trend trajectory—claiming a 'steady growth' when domestic equity actually decreased in 2023 before rebounding. (4) Contextual relevance is high as the answer addresses both parts of the question—evolution over time and strategic implications—and maintains focus on trust investments and capital allocation. Despite incorrect numbers, the overall narrative direction is plausible. However, due to major factual errors in key financial figures, especially the reversal of 2022 and 2023 domestic equity values, the correctness score is limited to 5—partially correct but significantly flawed in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 513,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "- In 2022 the “Eliminations / Reclassifications” line reduced total net sales and revenue by **$107 million** (total revenue $156,735 million)【GM_10k_2022.pdf p.65‑66】.  \n- In 2023 the same adjustment grew to **$151 million** (total revenue $171,842 million)【GM_10k_2023.pdf p.68‑70】.  \n- In 2024 it expanded further to **$296 million** (total revenue $187,442 million)【GM_10k_2024.pdf p.66‑69】.  \n\nThe increasingly larger negative impact shows that GM’s internal reporting – the consolidation of inter‑segment sales and reallocation of revenue among GMNA, GMI, Corporate, Cruise and GM Financial – has become more substantial over time, reflecting greater complexity and more extensive intercompany adjustments across its business segments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105 million in 2022 and $107 million in 2023, but the LLM reports $107 million in 2022 and $151 million in 2023. Only the 2024 figure ($296 million) matches the ground truth. These discrepancies affect the accuracy of the trend description. (2) The cited numbers do not align with the original answer: 2022 is off by $2 million, and 2023 is off by $44 million, which is a substantial error in financial reporting context. While the upward trend is real, the magnitude of change is misrepresented—LLM implies a steady rise from $107M to $151M to $296M, whereas the actual progression is $105M → $107M → $296M, meaning the sharp increase occurs only in 2024. (3) The qualitative reasoning about increasing complexity and greater intercompany adjustments is sound and logically follows from the rising elimination amount, especially the jump in 2024. The identification of business segments (GMNA, GMI, Cruise, GM Financial) and the explanation of eliminations as inter-segment consolidation adjustments are accurate and reflect proper multi-hop synthesis across the filings. (4) Contextual relevance is high—the answer directly addresses the evolution of eliminations and interprets the trend in terms of internal reporting changes. However, due to the incorrect intermediate values, the correctness score is limited to 6, as the core trend is partially correct but with significant factual errors in two of the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 430,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "- **2022 10‑K** – Netflix disclosed an **Amended and Restated Performance Bonus Plan** as a stand‑alone exhibit (Exhibit 10.5, filed on December 9 2022) 【NFLX_10k_2022.pdf p. 63】. The plan was presented as a separate, newly‑amended document rather than being folded into any other compensation filing.  \n\n- **2023 10‑K** – The same Performance Bonus Plan continued to appear in the exhibit list (Exhibit 10.5) with no additional amendment, indicating that the plan remained a distinct, stand‑alone document throughout 2023 【NFLX_10k_2023.pdf p. 66】.  \n\n- **2024 10‑K** – The exhibit list still includes the Performance Bonus Plan, but the filing notes that it is now **incorporated by reference** to Netflix’s broader executive‑compensation framework (e.g., the 2020 Stock Plan and other equity‑award plans) 【NFLX_10k_2024.pdf p. 67】. This shows the plan has been integrated into the company’s overall compensation structure rather than being treated as an isolated document.  \n\n**Overall evolution:** From a newly‑amended, stand‑alone plan in 2022, the Performance Bonus Plan remained unchanged in 2023, and by 2024 it was formally incorporated by reference into Netflix’s larger compensation framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a critical factual error in the timeline and documentation status of Netflix's Performance Bonus Plan, which significantly impacts correctness. According to the ground truth, in 2022 the plan was still listed as a historical exhibit (Exhibit 10.6†) from 2014 with no update, but the LLM incorrectly states that an 'Amended and Restated Performance Bonus Plan' was filed as Exhibit 10.5 on December 9, 2022, within the 2022 10-K. This is inaccurate because the 2022 10-K would include filings made during 2022, but the amendment itself (filed December 9, 2022) pertains to the 2023 10-K, not the 2022 filing. The LLM reverses the correct sequence: the amendment occurred in late 2022 but appears in the 2023 10-K, not the 2022. The ground truth confirms the amendment was reflected in 2023 (Exhibit 10.5†), carried forward in 2024. The LLM correctly notes that in 2024 the plan was incorporated by reference into broader compensation frameworks, aligning with integration into performance-based RSU agreements as per the original answer. However, the misattribution of when the amended plan first appeared undermines the quantitative and qualitative accuracy. The reasoning is partially sound—integration in 2024 is correctly identified—but the multi-hop synthesis fails on timing and exhibit evolution. While the overall narrative of stabilization and integration is plausible, the foundational facts about when the amendment took effect are reversed. This results in a partial match: core idea of evolution and integration is present, but key dates and exhibit statuses are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 438,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon consistently states that the “Business Relationships and Related Party Transactions Policy” is disclosed in the proxy statement together with its “Director Independence” discussion and the related committee‑charter information (Audit, Corporate Governance/Nominating/Social Responsibility and Human Resources & Compensation). The language of the reference is essentially unchanged from 2022 through 2024, showing that the company has kept a stable, repeatable approach to reporting this policy and has tied it consistently to its director‑independence assessments and the same set of board committees. This continuity signals a high degree of consistency in its corporate‑governance disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: BK (BNY Mellon) consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in the proxy statement across 2022, 2023, and 2024; the policy was linked to 'Director Independence' and the same three committees—Audit, Corporate Governance/Nominating/Social Responsibility, and Human Resources & Compensation—in each year. (2) There are no numeric values requiring calculation, but the years (2022–2024) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the consistent placement and unchanged language across three years indicate stability in corporate governance disclosures, particularly regarding director independence and committee structures. (4) The only minor deviation is that the LLM refers to the proxy statement rather than explicitly citing 'Item 13' of the 10-K as in the original answer; however, it is common for such disclosures to be incorporated by reference from the proxy, so this does not constitute a factual error. The LLM captures the essence of consistency in disclosure practices and links it appropriately to governance frameworks. Thus, the answer is semantically equivalent and well-reasoned, warranting a high score with only a slight deduction in qualitative accuracy for not specifying the exact 10-K item.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 394,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity (HTM) portfolio fell each year: the fair‑value of HTM debt securities was $679 million in 2022, $596 million in 2023 and $508 million in 2024, while the amortized‑cost (carrying) balances fell from $696 million to $603 million to $512 million over the same period.  The fair value has consistently been a few million dollars below carrying value, with the gap narrowing (‑$17 m → ‑$7 m → ‑$4 m), indicating that rising interest rates have depressed market values but the company still expects to collect principal and interest, treating the losses as temporary and gradually winding down the HTM portfolio as securities mature.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value in 2022 was $643 million, but the LLM states $679 million—a material overstatement of $36 million. Similarly, the carrying value in 2022 is reported as $696 million by the LLM versus the correct $641 million, a $55 million overstatement. The 2023 and 2024 values for both fair value and carrying value match the ground truth ($596M/$508M fair value; $603M/$512M carrying). (2) Calculations: The LLM correctly computes the fair value vs. carrying value gaps as -$17M (2022), -$7M (2023), and -$4M (2024), but these are based on incorrect 2022 inputs. With correct data, the 2022 gap should be -$2M ($643M vs $641M), not -$17M. This undermines the claim that the gap is 'narrowing' from a large negative value, when in reality it was already minimal in 2022. (3) Multi-hop reasoning: The LLM correctly identifies the downward trend in both fair value and carrying value over three years and infers a strategic wind-down of the HTM portfolio, which aligns with the ground truth. It also appropriately links the narrowing gap to interest rate effects and temporary impairments, adding relevant context about expected cash flows. However, it omits the key qualitative insight from the ground truth about the shift away from Level 3 unobservable inputs, which is a critical indicator of changing valuation assumptions and increased reliance on market-observable data. (4) Despite strong contextual relevance and reasonable interpretation of trends, the significant errors in baseline 2022 figures reduce confidence in the quantitative accuracy. The reasoning is sound but built on flawed data, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 476,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In 2022 PayPal still carried the full U.K.‑and‑Europe “buy‑now‑pay‑later” (BNPL) loan portfolio on its balance sheet, so any “bad‑transaction” losses from those loans were absorbed directly in its credit‑risk allowance.  In June 2023 the company entered a multi‑year agreement to sell up to €40 billion of those BNPL receivables (a “substantial majority” of the existing portfolio plus a forward‑flow of future originations), and began transferring the assets in October 2023; the 2024 filing notes that the forward‑flow arrangement is now in place and that the sale of future eligible receivables is expected to further reduce the balance‑sheet exposure.  This progression shows PayPal moving from full exposure in 2022 to a systematic off‑loading of the BNPL loan book in 2023‑24, reflecting a deliberate risk‑mitigation strategy that shifts the credit‑loss risk to third‑party buyers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's full exposure in 2022, the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, the start of asset transfers in October 2023, and the ongoing forward-flow arrangement in 2024. The €40 billion figure is correctly cited, and the timeline (June 2023 agreement, October 2023 transfers, 2024 continuation) matches the original. (2) Quantitative accuracy is perfect: the €40 billion amount is correctly reported, and no calculations are required beyond accurate date references. (3) The multi-hop reasoning is sound—LLM correctly synthesizes PayPal’s evolving risk strategy from 2022 (full exposure) to 2023–2024 (offloading via sale and forward-flow), demonstrating a clear risk-mitigation trajectory. (4) The only minor shortcoming is that the LLM omits PayPal’s caveat in 2024 about the sale being subject to conditions that could delay benefits, which slightly reduces completeness. However, it captures the core strategic shift and risk transfer mechanism accurately. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 348,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "- **Production trend:** Chevron’s share of Myanmar output fell sharply. In 2022 the company produced about **17 thousand barrels of oil‑equivalent per day (≈ 87 MMCFD of gas)**; in 2023 it slipped to **15 thousand barrels (≈ 87 MMCFD)**, and by 2024 it was down to only **4 thousand barrels (≈ 22 MMCFD)**.  \n\n- **Strategic shift:** The collapse in volumes reflects Chevron’s **orderly exit from Myanmar** – the company announced it was withdrawing from the country in April 2024 and is moving its upstream focus away from that region toward other assets and lower‑carbon initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. While it correctly states 17 MBD in 2022 and 15 MBD in 2023, it incorrectly claims production was 4 thousand barrels per day in 2024. The ground truth states Chevron completely withdrew from Myanmar in April 2024, meaning production dropped to zero, not 4 MBD. The associated gas volumes (≈87 MMCFD in 2022–2023, then ≈22 MMCFD in 2024) are not supported by the ground truth, which does not provide gas-equivalent conversions or suggest partial ongoing operations. 2) The dates are partially correct—Chevron did announce its withdrawal in April 2024, which the LLM correctly notes—but the implication of continued 4 MBD production in 2024 contradicts the full exit. 3) The qualitative reasoning about a strategic shift toward portfolio optimization, risk management, and lower-carbon initiatives is plausible and aligns with the general direction of the original answer, though the original emphasizes 'full exit' and 'strategic shift in portfolio optimization and risk management' without mentioning lower-carbon initiatives. The LLM infers 'orderly exit' and strategic reprioritization, which is reasonable but not fully aligned due to the incorrect production level in 2024. 4) Contextually, the answer addresses both parts of the question—production evolution and strategic shift—and attempts multi-hop synthesis (linking declining volumes to strategic exit). However, the incorrect 2024 production figure undermines factual correctness. The answer would score higher if the final year reflected a complete cessation of operations as required by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 444,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "The filings show that the Personal‑electronics market – which includes the PC‑and‑notebooks sub‑segment – has been shrinking as a share of TI’s total revenue: it fell from roughly 24 % of overall sales in the 2021‑2022 period to 15 % in 2023 and then to 20 % in 2024. Because the PC‑and‑notebooks line is only one of many sectors within Personal electronics, its share of that market has been sliding along with the market’s overall decline. This downward trend signals that Texas Instruments is de‑emphasizing the consumer‑computing arena and is focusing its growth strategy on higher‑growth industrial and automotive applications rather than on PCs and notebooks.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its interpretation of the trend and strategic implications, but contains a key quantitative inaccuracy: it states that the 24% figure applies to the '2021-2022 period', while the ground truth specifies 2022 only. There is no mention of 2021 in the original answer, so this introduces an unsupported time frame. The 15% figure for 2023 is correct, but the 2024 figure is stated as 20%, which contradicts the prior sentence claiming a continued decline — a 20% rebound from 15% is an increase, not a continued slide. This creates internal inconsistency. (2) The percentages are mostly accurate except for the misattribution of the 24% to a two-year period and the illogical progression from 15% in 2023 to 20% in 2024 while describing a 'downward trend'. The calculation of directionality (decline vs. increase) is flawed. (3) The reasoning correctly identifies that PC & Notebooks is a subcategory of Personal Electronics and infers reduced emphasis based on segment-level revenue decline. It appropriately synthesizes the strategic shift toward Automotive and Industrial markets, aligning with the ground truth. However, the claim that PC & Notebooks' share is 'sliding along with the market’s overall decline' is speculative, as no data on sub-segment revenue splits is provided in either the original or LLM answer. (4) Despite these issues, the answer captures the core narrative — declining importance of consumer computing and strategic repositioning — making it contextually relevant and qualitatively strong. The correctness score is reduced due to significant quantitative inaccuracies affecting the trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 458,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "Across the three filings GM repeatedly disclosed that, under the 2017 Opel/Vauxhall sale agreement, it indemnifies Stellantis for any breaches of the representations‑warranties, emissions, product‑liability and recall obligations tied to the legacy business. In 2022, 2023 and 2024 the company said the indemnification liability was “immaterial” (no material accrual was recorded) and that it could not estimate any reasonably possible loss; the only amount noted was an immaterial sum for Takata‑related recalls. The filings also warned that additional future indemnifications could arise (e.g., further Takata‑recall costs) but that such exposure was considered remote and is limited by time‑limits, thresholds and caps.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: GM's indemnification obligations to Stellantis stem from the 2017 Opel/Vauxhall sale and cover representations and warranties, emissions, product liability, and recalls. It correctly states that the liabilities were deemed immaterial across 2022–2024, no material accruals were recorded, and that future losses could not be reasonably estimated. It also accurately notes the remote possibility of additional Takata-related indemnifications. However, the LLM answer misses key evolving details highlighted in the ground truth, particularly the 2024 disclosure of an accrual related to the European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era. This omission reduces completeness and weakens the qualitative accuracy, as the trend of increasing specificity and emerging regulatory exposure over time—central to the question—is not reflected. While the LLM generalizes consistently across years, the ground truth shows progression: no specific accruals in 2022, an immaterial payment disclosed in 2023, and a new accrual tied to a specific regulatory investigation in 2024. The LLM incorrectly implies consistency across all three years without acknowledging this evolution. Quantitatively, all references to 'immaterial' amounts and inability to estimate losses align with the truth, and no numerical errors are present. Contextually, the answer remains highly relevant and synthesizes the correct entities (GM, Stellantis, Opel/Vauxhall, Takata) and time frame. The reasoning is sound but lacks the nuanced, year-by-year progression required for full multi-hop accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 452,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "- **2022 10‑K** – The filing lists the 1.450 % senior notes that were issued on September 27 2021 (Exhibit 4.22) as an outstanding unsecured debt instrument maturing in 2026 (see 2022 10‑K, p. 71). No new issuances of this series are reported for 2022.  \n\n- **2023 10‑K** – The same 1.450 % notes due 2026 appear again in the debt schedule, still outstanding and unchanged in amount (2023 10‑K, p. 70). The company did not add to or retire this series during 2023.  \n\n- **2024 10‑K** – The 1.450 % senior notes continue to be shown as part of the company’s long‑term debt portfolio, with the original principal balance still carried (2024 10‑K, p. 73). No additional issuances or repayments of this series are disclosed for 2024.  \n\n**What the pattern shows:** American Tower issued the 1.450 % senior notes in 2021 and has kept them on its balance sheet for three consecutive years without further issuance or early redemption. This reflects a deliberate debt‑management approach that locks in a low‑coupon, long‑dated financing (2026 maturity) to provide stable, inexpensive funding for growth while preserving flexibility for future capital‑structure decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.450% Senior Notes were issued on September 27, 2021, mature in 2026, and remained outstanding without modification or additional issuance in 2022, 2023, and 2024. The years and exhibit references are mostly accurate, though the LLM cites Exhibit 4.22 for 2022 instead of Exhibit 4.25 as in the original (a minor discrepancy in exhibit numbering, but the note's presence is correctly confirmed). (2) Quantitative accuracy is perfect: dates, percentages, and maturity year match exactly. There are no calculations, but the consistency of the principal amount being carried forward is correctly noted. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years of 10-Ks to infer stability in debt structure. It correctly infers that no changes to the notes imply a deliberate, stable debt management strategy focused on low-cost, long-term financing. (4) The answer is contextually excellent, directly addressing both the evolution over time and the strategic implication. The only minor shortcoming is the slight variance in exhibit numbers (4.22 vs 4.25 in 2022), which does not affect the factual core. Overall, the answer captures the semantic meaning and strategic insight of the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 374,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "- **2022 filing** – The 2019 Long‑Term Incentive Plan (Exhibit 10.14) was still the governing plan, but BNY Mellon added a new **2022 Form of Performance Share Unit Agreement** (Exhibit 10.21) and a new **2022 Form of Restricted Stock Unit Agreement** (Exhibit 10.22) to issue awards under that plan.  \n\n- **2023 filing** – The same 2019 Long‑Term Incentive Plan continued to be used, and the company introduced a **2023 Form of Performance Share Unit Agreement** (Exhibit 10.23) together with a **2023 Form of Restricted Stock Unit Agreement** (Exhibit 10.24) for the year’s awards.  \n\n- **2024 filing** – The 2019 Long‑Term Incentive Plan remained in effect, and BNY Mellon filed the latest **2024 Form of Performance Share Unit Agreement** (Exhibit 10.28) and **2024 Form of Restricted Stock Unit Agreement** (Exhibit 10.29), reflecting the most recent set of deferred‑stock‑unit contracts used to grant incentives under the 2019 plan.  \n\nThus, from 2022 through 2024 the 2019 Long‑Term Incentive Plan was consistently the framework for equity awards, while each year saw the issuance of a fresh set of deferred‑stock‑unit (RSU) and performance‑share‑unit (PSU) agreements to implement those awards.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness despite being structurally well-organized and contextually relevant. (1) The key error lies in the misrepresentation of the evolution of agreement forms: the LLM claims that in 2022, BNY Mellon introduced a '2022 Form of Performance Share Unit Agreement' and a '2022 Form of Restricted Stock Unit Agreement', but the ground truth states that in 2022, the company referenced the 2019 forms, not 2022 versions. Similarly, the LLM incorrectly asserts that 2023 and 2024 saw new annual forms (2023 and 2024 versions), whereas the ground truth specifies that in 2023, the company introduced a director-specific Deferred Stock Unit Agreement, and in 2024, it adopted the 2022 Form of PSU Agreement — not newer 2023 or 2024 forms. (2) Quantitatively, the years and exhibit numbers are presented confidently but do not align with the ground truth; for example, there is no mention of the 2022 Form being used in 2024, which contradicts the LLM’s claim of annual updates. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that the 2019 plan was extended to directors in 2023 via a new agreement type, not through annual refreshes of RSU/PSU forms. It also misses the strategic progression — the introduction of director-level DSUs and the reuse of older form versions (like the 2022 PSU form in 2024) — indicating a misunderstanding of the plan's evolution. (4) While the LLM correctly identifies the 2019 plan as the ongoing framework and mentions RSUs and PSUs, it fabricates a pattern of annual form updates that contradicts the original answer. Thus, although the response is relevant and attempts to synthesize information, its core factual claims are incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 485,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "From 2022 through 2024 General Dynamics’ Combat‑Systems segment consistently highlighted its Ordnance & Tactical Systems (OTS) business as a “leading provider of missile subsystems … with critical **aerostructures** for both legacy and next‑generation missiles” (2022 10‑K p. 13; 2023 10‑K p. 13‑14; 2024 10‑K p. 13‑14). Over the three‑year period the language remained unchanged and was reinforced by references to “cutting‑edge hypersonic rocket cases,” indicating that the company has deepened its commitment to supplying the structural core of advanced missile and hypersonic weapons. This steady, and slightly amplified, focus signals that General Dynamics is positioning itself as a strategic supplier of the essential aerostructure component for the next generation of U.S. missile subsystems.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core strategic focus on aerostructures within General Dynamics' Combat Systems segment from 2022 to 2024. It correctly identifies the sustained emphasis on missile subsystems with critical aerostructures, particularly for next-generation and hypersonic weapons, and references the Ordnance & Tactical Systems (OTS) business unit as the source—aligning with the original answer's substance. The qualitative reasoning is strong, noting consistent language across 10-K filings and interpreting this as a sign of deepened strategic commitment. However, the LLM omits the specific revenue percentages (20% in 2023, 19% in 2024) that were present in the ground truth, which are key quantitative markers of the segment’s relative size and slight decline. While the LLM does not fabricate numbers, this omission reduces completeness in the multi-hop synthesis expected—especially since the original answer explicitly tied strategic focus to revenue trends. The mention of 'hypersonic rocket cases' adds contextual detail not contradicted by the ground truth but not emphasized in the original either, slightly extending beyond the provided evidence. All entities (General Dynamics, Combat Systems, aerostructures, next-gen missiles) and years are correct. The reasoning is logically sound and the answer remains highly relevant to the question. Quantitative accuracy is perfect where numbers are mentioned (none are incorrect), but the lack of revenue share data limits full quantitative alignment. Thus, the answer is mostly correct with minor but notable omissions affecting completeness and qualitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 457,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Across the three filings, PMI repeatedly lists Jackpot together with Fortune as “important local cigarette brands” in the Philippines — first in the 2022 10‑K, again in the 2023 10‑K, and once more in the 2024 10‑K where it is highlighted alongside a portfolio now led by Marlboro (≈ 40 % of cigarette volume). This continuity shows that PMI has kept Jackpot as a core, market‑share‑protecting brand in the Philippines, using it to sustain its low‑price/mid‑price foothold in the South‑and‑Southeast‑Asia region while the broader strategy pivots toward premium international brands and the rollout of smoke‑free products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Jackpot as a key local brand in the Philippines across 2022, 2023, and 2024, consistently mentioned alongside Fortune, which matches the original answer. (2) The quantitative claim that Marlboro accounts for approximately 40% of cigarette volume is factually consistent with PMI disclosures in the 2024 10-K and does not contradict the ground truth; this detail adds context not in the original but is accurate and relevant. (3) The multi-hop reasoning is sound: the LLM synthesizes Jackpot’s sustained role over three years while correctly situating it within PMI’s broader strategic pivot to smoke-free products (IQOS, ZYN) and premium brands. (4) The answer captures the core implication — that traditional cigarette brands like Jackpot remain strategically important in key markets despite the long-term smoke-free transition — which is the central point of the ground truth. The only minor limitation is that the LLM does not explicitly reference the integration of Swedish Match in 2023 or the expansion to 95 smoke-free markets in 2024, though it alludes to the broader strategic shift. This omission slightly affects completeness but does not detract from the overall correctness. All entities (Jackpot, Fortune, Marlboro, PMI), years (2022–2024), and strategic themes are accurately represented. Wording differs but semantic meaning is equivalent or enhanced with accurate supplementary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 413,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "- In 2022 Chevron’s activity in the Republic of Congo was still expansion‑oriented – the company bought additional deep‑water licences that added about 36 million barrels of proved reserves to its African portfolio.  \n- In 2023 that expansion turned into execution: roughly $0.7 billion of capital was spent on offshore development and natural‑gas projects in the Republic of Congo (and neighboring Nigeria and Angola).  \n- By 2024 the strategy had shifted to divestiture – Chevron sold its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % stake in the Lianzi area, moving out of the asset while still counting Congo production in its 2024 output mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. The $0.7 billion investment in 2023 for offshore development and natural gas projects in Africa is factually correct and aligns with the ground truth, though the LLM incorrectly specifies that this spending was in the Republic of Congo, Nigeria, and Angola—while the original answer only confirms activity in Africa broadly, including Congo, but does not specify Nigeria or Angola. The 31.5% and 15.75% interests sold are correctly stated, but the LLM claims the sale occurred in 2024, while the ground truth states it occurred in January 2025—this is a critical date error. Additionally, the LLM introduces new information not present in the ground truth: that Chevron bought deep-water licenses in 2022 adding 36 million barrels of proved reserves, which is unsupported by the original answer and likely fabricated. (2) Quantitative accuracy is partially correct: $0.7 billion, 31.5%, and 15.75% are accurate figures, but the 36 million barrel reserve addition and the misattribution of the $0.7B spend to specific countries (Nigeria, Angola) are unsupported. The timing of the divestiture (2024 vs. January 2025) is a factual error. (3) The multi-hop reasoning is partially sound—there is an attempt to show evolution from expansion to execution to divestiture—but it is based on incorrect or unverified data. The synthesis of capital deployment and asset disposition is relevant, but the narrative is built on speculative or inaccurate inputs. (4) Correctness is scored 5 due to a mix of accurate and inaccurate facts—core elements like the divestiture and investment amount are present but miscontextualized. Quantitative accuracy is 5 due to correct numbers but incorrect attributions and dates. Qualitative accuracy is 5 due to flawed reasoning based on unsupported claims. Contextual relevance is 8 because the answer addresses the evolution of investment and operational focus as asked, even if factually flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 539,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Southern Company continued to classify its outdoor‑lighting contracts as operating leases in every filing, but the disclosed “initial‑term” length shifted – the 2022 filing said the contracts run “up to 7 years,” the 2023 filing expanded that to “up to 10 years,” and the 2024 filing returned to “up to 7 years” before converting to a month‑to‑month renewal at the customer’s option. In all three years the contracts were deemed immaterial, so the lease income is recorded as operating‑lease income (not blended into wholesale‑revenue allocations) and the scheduled lease payments are shown only in the maturity tables as immaterial amounts that cease after the initial term and continue on a month‑to‑month basis across all subsidiaries.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, outdoor lighting contracts at Mississippi Power were considered immaterial with no significant value disclosed, but the LLM incorrectly claims details about 'up to 7 years' or '10 years' terms were disclosed in each year — this information is not present in the original answer and contradicts the immateriality assertion. The original answer emphasizes evolving disclosure practices (e.g., inclusion in maturity analyses in 2023, clarification of PPA lease income in 2024), but the LLM fabricates specific contract term lengths across years without support. (2) There are no verifiable numbers (e.g., dollar amounts, percentages) in either answer, but the LLM invents precise 'initial-term' durations (7 or 10 years) and renewal structures not found in the ground truth, which only notes increased disclosure of lease payment schedules and initial terms in 2024 — not specific term lengths. This undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the original answer traces a progression in accounting transparency — from immateriality in 2022, to inclusion in maturity analyses in 2023, to expanded disclosure and integration with wholesale revenues in 2024 across subsidiaries. The LLM fails to capture this evolution correctly, instead focusing on unsubstantiated changes in contract length and incorrectly stating that lease income remains separate from wholesale revenue in all years, while the ground truth explicitly states that by 2024, lease income from PPAs *is* included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power — a key point missed. (4) Contextual relevance is moderate because the LLM addresses the general topic (classification as operating leases, immateriality, subsidiaries), but introduces fabricated details and misses the core narrative of increasing standardization and disclosure. The answer distracts with false precision on contract terms rather than reflecting the actual shift in accounting treatment and reporting emphasis. Thus, despite some topical alignment, the factual and reasoning errors severely reduce correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 593,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Cisco’s 3.50 % senior note (maturing June 15, 2025) has kept the same principal balance of **$500 million** in each of the three most recent filings, but its reported **effective interest rate has risen sharply** – from **3.20 % in FY 2022**【CSCO_10k_2022.pdf p.89】, to **6.38 % in FY 2023**【CSCO_10k_2023.pdf p.89】, and to **6.66 % in FY 2024**【CSCO_10k_2024.pdf p.89】.  \n\nThe stable carrying amount reflects that the note’s principal has not been amortized, while the climbing effective rate signals that market yields (and the discount‑accretion, issuance‑cost and hedge adjustments embedded in the effective rate) have risen, indicating a higher cost of debt and a shift in market conditions that reduced the note’s fair value relative to its book value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying amount of $500 million is correctly reported for all three fiscal years (2022, 2023, 2024), and the effective interest rates—3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024—are exactly as stated in the original answer. Minor formatting differences (e.g., spacing in '3.50 %' vs '3.50%') do not affect meaning. (2) The answer is complete, addressing both the evolution of the carrying amount and effective interest rate across all three years, as well as interpreting the implications for debt valuation and market conditions. (3) Entity accuracy is perfect: Cisco (CSCO) is correctly identified, the note is accurately referenced with its maturity date (June 15, 2025), and all fiscal years align with the source documents. (4) The reasoning is sound and demonstrates multi-hop synthesis: the model correctly infers that the stable carrying amount indicates no principal amortization, while the rising effective rate reflects changes in market yields, discount-accretion adjustments, and overall market conditions that impact debt valuation. The conclusion about increasing cost of debt and reduced fair value relative to book value provides a deeper, accurate interpretation beyond the raw data. (5) Semantically, the LLM answer conveys the same core information as the ground truth and adds valuable context (e.g., mention of hedge adjustments and fair value implications) that enhances understanding without introducing error. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 440,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group’s “Unsecured Notes ‑ 35A” remained unchanged over the three years: each filing lists a $750 million face amount (‑ $750,000 in thousands) with a 2.65 % coupon and a July 15, 2030 maturity 【SPG_10k_2022.pdf p.48‑52】, 【SPG_10k_2023.pdf p.48‑52】, and 【SPG_10k_2024.pdf p.49‑53】. The steady‑size, low‑to‑moderate‑rate issuance shows Simon’s strategy of locking in long‑dated, relatively inexpensive debt and then simply maintaining that tranche rather than expanding or retiring it, thereby preserving funding stability and limiting refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent $750 million face value, 2.65% interest rate, and July 15, 2030 maturity date for Unsecured Notes - 35A across 2022, 2023, and 2024, matching the ground truth exactly. All numeric values are accurate, with acceptable formatting variations (e.g., $750 million vs. -$750,000 in thousands). (2) Quantitative accuracy is perfect: dollar amounts, percentages, and dates are all correct and consistently reported across years. (3) The reasoning is sound and captures the core strategic implication—Simon Property Group is maintaining a stable, long-term tranche of debt to ensure funding stability and reduce refinancing risk. However, the LLM answer omits mention of broader portfolio changes such as the 2024 $1 billion Unsecured Notes - 41A issuance and refinancing of credit facilities, which are part of the multi-hop context that explains the contrast in strategy. This minor omission slightly weakens the qualitative depth compared to the original answer but does not invalidate the conclusion. (4) The answer is highly contextually relevant, directly addressing both the evolution (or lack thereof) and the strategic implication. The absence of explicit comparison to other debt instruments slightly reduces qualitative accuracy, but the core insight remains correct and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 377,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "From 2022 through 2024 Texas Instruments has kept Embedded‑Processing products at the heart of its strategy. In each year’s 10‑K the company states that its business model is “focused on analog and embedded‑processing products” and that a “broad portfolio of analog and embedded‑processing products” constitutes the second of its four sustainable competitive advantages – the advantage that gives customers more opportunity per design and creates greater value for TI’s investments. Thus, while the segment’s revenue and profit margins have varied (growing in 2022, modestly improving in 2023 and declining in 2024), the strategic role of Embedded‑Processing has remained unchanged: it is a core pillar of TI’s portfolio‑strength advantage and a constant focus of the company’s long‑term free‑cash‑flow strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Texas Instruments maintained Embedded Processing Products as the second of its four sustainable competitive advantages from 2022 to 2024, and accurately reflects the consistent strategic language used across the years—specifically, that the broad portfolio provides 'more opportunity per customer' and 'greater value for TI’s investments,' which matches the original answer’s phrasing. (2) There are no numeric values (e.g., revenue figures, margins) in the original answer, so the LLM’s mention of 'revenue and profit margins... growing in 2022, modestly improving in 2023 and declining in 2024' is an addition not present in the ground truth. However, since the original answer does not provide or require such financial performance data, this addition does not contradict known facts and is plausible context; thus, it does not significantly detract from correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent strategic framing across three years and links Embedded Processing to TI’s portfolio-strength advantage and long-term cash flow strategy, which is consistent with the original answer’s emphasis on sustained importance and value creation. (4) The answer is contextually relevant, complete, and semantically equivalent to the ground truth, with only minor elaboration beyond the source. The qualitative accuracy is slightly reduced due to the unverified financial performance commentary, but core facts, entities, years, and strategic reasoning are correct. Overall, this is a strong, factually sound response with high fidelity to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 460,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "- In the 2022 filing, Comcast’s Xfinity Wireless was offered only to U.S. residential customers and could be purchased as an unlimited‑data plan, a shared‑data pool, or a pay‑per‑gigabyte option.  \n- The 2023 filing added an international component – customers in the United Kingdom (via a Virgin Media O2 arrangement) and other overseas markets could now buy wireless service on various gigabyte‑based plans, extending the shared‑data model beyond the United States.  \n- By 2024 the plan menu became even more flexible: a prepaid unlimited‑data option was launched under the NOW brand for domestic users, and the company began offering an unlimited‑data plan (in addition to gigabyte plans) for its international customers, further broadening both plan choice and global reach.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of CMCSA's wireless shared data plans with some correct elements, but contains significant factual inaccuracies that affect correctness. (1) On quantitative and factual accuracy: The 2022 description incorrectly states that shared data plans were available as standalone options; the ground truth specifies they were only offered as part of bundled broadband services to residential customers. The LLM also misrepresents the 2023 developments—there is no evidence in the ground truth that CMCSA extended shared data plans internationally via Virgin Media O2 or in the UK in 2023; international expansion occurred in 2024 under the NOW brand. Additionally, the claim that international customers received unlimited data plans in 2024 is not supported—the ground truth notes prepaid unlimited plans under NOW were for domestic users, while international offerings were not specified in detail. (2) The timeline is partially correct: 2024 did see increased flexibility with the NOW prepaid unlimited plan, which the LLM correctly notes, but attributes incorrectly to domestic users only, whereas the ground truth emphasizes both domestic and international diversification. (3) Multi-hop reasoning is partially sound—the model attempts to synthesize changes over time and across geographies—but fails to accurately link the international expansion to the correct year and entity (NOW brand in 2024). (4) Despite these errors, the answer is contextually relevant and reflects an understanding of the question’s focus on flexibility and international reach. Wording differences are acceptable, but the misattribution of international offerings and bundling conditions reduces factual reliability. Minor formatting variations in data presentation are acceptable, but the core facts—especially timing and scope of international expansion—are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 508,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "In the 2022 filing PayPal warned that its credit‑product line (consumer‑branded loans, PayPal Working Capital and merchant financing) already exposed it to default risk, reliance on third‑party chartered banks, and “generic” fraud‑abuse such as fictitious accounts and stolen‑card transactions. By 2023 the company stressed that fraudsters were increasingly using synthetic‑identity and “third‑party” schemes that exploit new or expanded credit offerings, making the loss‑rate rise and the detection of abusive behavior “often difficult to detect” and “requiring continuous improvement.” The 2024 filing further highlighted that the growth of BNPL, additional credit products and deeper integration with partner lenders has amplified exposure to sophisticated, large‑scale fraud attacks, and that existing risk‑models and controls may no longer be sufficient. Together, these disclosures show a clear trajectory—from baseline credit‑risk concerns to a landscape where increasingly complex, technology‑driven fraud schemes intersect with an expanding credit portfolio—underscoring that PayPal’s risk‑management framework must continually evolve to address multidimensional, digital‑payments threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: PayPal's increasing exposure to abusive behaviors from 2022 to 2024, the evolution of fraud types (fictitious accounts, stolen instruments, synthetic identity, third-party schemes), and the connection to credit products and risk management challenges are accurately represented. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., €40 billion) are mentioned in the LLM answer, it does not misstate any figures, and the omission of the exact receivables amount is not a factual error—just a slight lack of specificity. The ground truth includes the €40 billion figure for BNPL receivables sold, which the LLM omits, but still correctly identifies the expansion of BNPL and credit partnerships as risk amplifiers. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly tracing the progression from baseline fraud risks in 2022 to more sophisticated, large-scale attacks by 2024, and links this to evolving credit products and third-party integrations. (4) Semantic equivalence is strong: though wording differs, the core message—that PayPal faces increasingly complex fraud threats requiring continuous risk-model updates—is fully consistent with the original. The only minor shortcoming is the lack of explicit mention of the legal uncertainty around loan receivables from FDIC-insured banks in 2024, which slightly reduces completeness. However, the overall trajectory and implications for risk management are accurately captured, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 451,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 31‑35) Gilead listed El Segundo, California only as one of its “principal manufacturing facilities,” without describing a specific product focus.  \n- By the 2023 filing (pages 9‑13) the company clarified that the El Segundo site is now being used for **both clinical and commercial manufacturing and processing of its cell‑therapy products**, showing that the plant has been repurposed or expanded to support the growing cell‑therapy portfolio.  \n- The 2024 filing (pages 8‑12) repeats that description and adds that Gilead “continues to develop additional manufacturing capabilities” and has “sufficient capital resources to purchase, lease or construct any additional facilities required to meet our expected long‑term growth needs,” indicating that the El Segundo facility is a strategic anchor for its cell‑therapy manufacturing and that the company is investing in expanding that capability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of GILD's El Segundo facility use from 2022 to 2024. In 2022, the facility was listed as a principal manufacturing site without specific product focus—consistent with the original answer noting its general role. By 2023, the LLM correctly notes the clarification that El Segundo supports both clinical and commercial manufacturing of cell therapy products, matching the ground truth. In 2024, it accurately reflects the continuation of this role and adds context about strategic investment and future capacity planning. (2) There are no numeric values (e.g., dollar amounts, percentages, headcounts) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates and years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly inferring increasing strategic emphasis rather than a static role. The only minor gap is that the LLM does not explicitly mention third-party manufacturers or supply chain risk management in 2024, which the original answer includes as part of GILD’s broader context. However, the LLM does capture the strategic anchor point and investment intent, which are the core implications. (4) The LLM uses slightly stronger language (e.g., 'repurposed or expanded') not present in the original, which cautiously states 'no indication of reduced emphasis.' While this is a reasonable inference, it introduces a small interpretive leap. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for the minor interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 483,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the three annual reports the 2.750 % senior notes are shown as a single tranche that matures on May 18 2024. In the 2022 and 2023 10‑Ks the notes still appear on the balance sheet under long‑term debt, indicating that Costco kept the full principal outstanding and was planning to refinance or repay them when they came due. By the 2024 filing the tranche is no longer listed, confirming that the notes were retired (or refinanced) at maturity, which demonstrates Costco’s strategy of issuing medium‑term, fixed‑rate debt and then rolling it off as each maturity arrives to keep its debt profile well‑staggered and avoid large concentrations of outstanding obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.750% Senior Notes mature on May 18, 2024, and are consistently reported across 2022 and 2023 filings, then absent in the 2024 filing. These dates and percentages match the ground truth exactly. (2) The answer correctly infers from the disappearance of the notes in the 2024 10-K that they were retired or refinanced at maturity, which is a reasonable conclusion given the data. (3) The multi-hop reasoning is sound: it synthesizes information across three years of filings, tracks the presence and then absence of the debt, and draws a logical conclusion about Costco’s debt management strategy—specifically, the use of medium-term fixed-rate debt and a staggered maturity profile. (4) The only minor deviation from the ground truth is that the original answer emphasizes the 'static approach' and lack of refinancing during the reporting period, while the LLM suggests a rolling strategy. However, both interpretations are compatible: maintaining the same maturity without early action and then retiring it supports a predictable, disciplined strategy. The LLM adds value by interpreting this as part of a broader staggered maturity policy. No factual errors; excellent contextual and semantic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 370,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of natural‑gas output from the Angola LNG project fell slightly from 49 million cubic feet per day (MMCFD) in 2022 to 48 MMCFD in 2023 and held steady at 48 MMCFD in 2024 【CVX_10k_2023.pdf p.9‑10】【CVX_10k_2024.pdf p.9‑10】. The flat‑to‑slightly‑downward trend over the three‑year period shows that Chevron is keeping Angola LNG’s gas production essentially constant, signaling a strategy of maintaining a reliable African gas supply rather than pursuing aggressive growth in that basin.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states Chevron's natural gas production volumes associated with Angola LNG increased from 7,107 million cubic feet per day in 2022 to 7,148 in 2023 and 7,569 in 2024 — a clear upward trend. In contrast, the LLM claims Chevron’s 'share' fell from 49 to 48 million cubic feet per day (MMCFD) and remained flat, which contradicts the actual data. The units are off by two orders of magnitude (tens vs. thousands), and the trend is reversed. (2) The numbers cited (49, 48 MMCFD) are not only incorrect but implausibly low for a major LNG project; Angola LNG’s total capacity alone is over 500 million cubic feet per day. The LLM likely misinterpreted 'Chevron’s share' or extracted data from an unrelated context, despite citing 10-K pages. There is no indication in the ground truth that Chevron’s share declined. (3) The multi-hop reasoning fails completely: instead of identifying a rising production trend indicating strategic focus on African gas, the LLM infers a flat-to-declining output implying maintenance rather than growth — the opposite of the correct conclusion. The synthesis across years is flawed due to incorrect data. (4) While the answer attempts to address both parts of the question (volume evolution and strategic implication), the factual foundation is so inaccurate that the reasoning and conclusion are invalid. The contextual relevance is low due to fundamental data errors, though the structure follows the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 426,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s total‑return‑swap exposure tied to deferred‑compensation grew each year – the notional amount rose from $651 million in FY 2022 to $792 million in FY 2023 and to $985 million in FY 2024.  Correspondingly, the accounting impact shifted from a $92 million gain (recorded as a negative expense) in 2022 to a $58 million expense in 2023 and a $91 million expense in 2024.  This upward trend shows Cisco is increasingly using total‑return swaps to hedge its deferred‑compensation obligations, but the growing notional and the move to positive expense reflect rising market‑linked volatility that now adds to, rather than offsets, compensation costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of financial impacts. According to the ground truth, Cisco recorded a $92 million *loss* in 2022, a $58 million *gain* in 2023, and a $91 million *gain* in 2024. However, the LLM incorrectly states a $92 million *gain* in 2022, a $58 million *expense* (implying a loss) in 2023, and a $91 million *expense* in 2024—reversing the sign of the 2022 and 2023 figures and misrepresenting gains as expenses. This fundamentally distorts the financial progression. Additionally, the LLM introduces notional amounts ($651M, $792M, $985M) that are not present in the original answer and unsupported by the provided ground truth, making them unverifiable and likely hallucinated. (2) The quantitative inaccuracies are severe: the direction of P&L (gain vs loss) is wrong for two out of three years, and the introduction of notional values adds false precision. While $91 million in 2024 matches in magnitude, its characterization as an 'expense' contradicts the ground truth 'gain'. (3) The multi-hop reasoning is flawed: the LLM infers increasing use of swaps due to rising notional, but this data isn't in the source. It then draws the opposite conclusion—increasing costs—versus the ground truth’s indication of reduced liability (loss to gain). The logic chain is internally consistent but built on incorrect data. (4) Contextual relevance is moderate: it addresses Cisco, deferred compensation, total return swaps, and the 2022–2024 timeframe, and attempts to interpret strategic implications. However, due to factual inaccuracies and hallucinated data, the conclusion about 'rising market-linked volatility that adds to compensation costs' contradicts the ground truth’s narrative of improving conditions and reduced liability. The answer is structurally relevant but factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 509,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "From the 2022 filing Lowe’s already required all vendors to meet a human‑rights policy (updated in fiscal 2021), a conflict‑minerals policy and a Vendor Code of Conduct that included “enhanced environmental standards,” and it was beginning to grow its portfolio of independently‑certified, eco‑labelled products. In the 2023 report the company refreshed its wood‑sourcing policy – adding country‑specific risk levels, stronger monitoring procedures and a new forestry‑grievance process – and reiterated that it was expanding the share of independently‑certified items. By the 2024 filing the wood‑sourcing policy had been made “more robust and risk‑based” with further monitoring upgrades and the grievance mechanism, and Lowe’s highlighted a continued push to increase third‑party‑certified products across its range, showing a clear progression toward stricter supplier standards, deeper oversight and greater reliance on external certifications.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key elements from the original answer are correctly reflected: the 2022 baseline with the Vendor Code of Conduct, human rights policy, and environmental standards; the 2023 updates to the wood-sourcing policy including country-specific risk levels, enhanced monitoring, and a new grievance process; and the 2024 enhancements making the policy more robust and risk-based, with continued expansion of third-party certified products. (2) There are no numeric values requiring calculation, but all years (2022, 2023, 2024) and policy timelines are correctly referenced. The mention of the human rights policy being updated in fiscal 2021 is additional context not contradicted by the ground truth. (3) The multi-hop reasoning across years and policy domains (environmental standards, human rights, monitoring, certifications) is sound and correctly synthesized across the three-year evolution. (4) The LLM uses slightly different phrasing (e.g., 'refreshed', 'more robust and risk-based', 'grievance mechanism') but these are semantically equivalent to the original. The answer fully addresses policy updates, monitoring enhancements, and third-party certifications as required by the question. All scores are maximized due to full factual alignment, precise temporal tracking, and correct synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 387,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "- In the 2022 filing Comcast first identified wireless‑telecom operators as a growing rival for its broadband and wireless offerings, noting that carriers were beginning to use 4G‑LTE and early‑stage 5G to sell “wireless broadband” and that they were starting to bundle those data plans with voice and video services.   \n- The 2023 10‑K made the threat more concrete, naming the three U.S. majors—AT&T, T‑Mobile and Verizon (and, abroad, BT and Virgin Media)—and describing how they were now deploying full‑scale 5G fixed‑wireless networks as well as 4G/5G mobile broadband, increasingly packaging those services in bundled, price‑competitive bundles.   \n- By 2024 the competition discussion stresses that wireless carriers “offering internet services (using a variety of technologies, including 5G fixed‑wireless networks and 4G and 5G wireless broadband services)” are “offering bundled products and services with favorable pricing,” indicating that the bundling strategy has become a central, intensified lever and that the same carriers (AT&T, T‑Mobile, Verizon, plus European peers) remain the primary challengers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the evolution of competitive threat from wireless telecoms to CMCSA is accurately described across 2022–2024. In 2022, the emergence of 4G/5G wireless broadband as a competitive threat is correctly noted, along with early bundling. In 2023, the specific competitors—AT&T, T-Mobile, Verizon—are correctly named, and the deployment of 5G fixed wireless is accurately described. In 2024, the intensification of bundling with favorable pricing and continued use of 5G fixed-wireless and mobile broadband is correctly reported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) and technological terms (4G, 5G, fixed wireless) are used correctly—hence a score of 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the progression in both technological capabilities and bundling strategies, and maintains consistency in naming key competitors. The mention of BT and Virgin Media as European peers adds a detail not in the original answer but does not contradict it and may reflect additional context from the filings; this does not detract from accuracy. (4) The LLM answer is semantically equivalent to the original, with slightly more granular phrasing (e.g., 'price-competitive bundles', 'favorable pricing') but conveys the same core evolution of threat. The only minor shortcoming is that the original emphasizes DTC streaming bundling in 2024, which the LLM implies via 'bundled products and services' but does not explicitly name as DTC streaming—this slight omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 515,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings PayPal repeatedly states that it **acts as the principal on every payment**, sets the transaction fee **at its own discretion**, and that the fee is **independent of the costs it incurs from third‑party payment processors or other financial institutions**. Consequently, the company **bears full margin risk** on each payment, while any merchant or consumer incentives are recorded as a direct reduction of revenue. The unchanged language over the three years shows that, even as total payment volume grew, PayPal’s exposure to margin risk has remained constant and its **pricing power and ability to manage costs through discretionary fee setting and tiered‑volume pricing have stayed firmly under its control**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies that PayPal acts as principal, sets fees at its discretion, and bears full margin risk across 2022–2024—this aligns with the original answer’s assertion of consistent margin risk exposure. It accurately notes that third-party processor costs are treated as expenses and that incentives reduce revenue, which matches the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense; however, the temporal scope (2022–2024) is correctly referenced, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes PayPal’s pricing autonomy, cost structure, and revenue treatment of incentives across three years, correctly inferring that unchanged language reflects stable control over pricing and cost management. The only minor omission is that the 2024 addition of contractual compensation from sellers (e.g., for fraud) as a revenue stream is not mentioned, which adds nuance to margin dynamics. This detail is present in the original answer but absent in the LLM response, slightly reducing completeness. (4) Despite this omission, the LLM conveys the essential conclusion—consistent margin risk exposure and strong pricing control—making the answer semantically equivalent in intent and substance. Contextual relevance is perfect, as all parts of the question (evolution of margin risk, pricing strategy, processor use, incentives, and implications for control) are addressed directly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 460,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s lease accounting has been unchanged over the three most recent filings. In the 2022, 2023 and 2024 10‑Ks the company states that any free‑rent periods (and step‑rent provisions) are **expensed on a straight‑line basis** over **the original lease term plus any renewal options that management is “reasonably certain” to exercise**. The lease term is defined as the non‑cancelable period plus those certain extension options, and the discounted minimum lease payments over that term are used to measure the right‑of‑use (ROU) asset. Thus, from FY 2022 through FY 2024 Costco made no change in its assumptions about lease term or in the way free‑rent periods affect the valuation of ROU assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Costco applied a consistent accounting policy from FY 2022 to FY 2024, recognizing free-rent periods on a straight-line basis over the lease term, including renewal options that are reasonably certain to be exercised. This matches the original answer’s description of policy continuity. (2) There are no numeric values (e.g., dollar amounts, percentages) in either response, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three fiscal years and correctly infers no material changes in policy, which aligns with the ground truth’s conclusion of a stable approach. (4) The only minor shortcoming is that the LLM omits the additional nuance in the 2023 and 2024 disclosures about variable lease payments tied to price indices or sales volume and the absence of material residual value guarantees. While not critical to the core question about lease term assumptions and ROU asset valuation, this contextual detail is present in the original answer and slightly enhances completeness. However, since the main focus—evolution of accounting treatment around free-rent periods and lease term assumptions—is accurately captured with no factual errors, the answer merits a high score. Wording differs but semantic equivalence is maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 399,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings PayPal repeatedly states that it **recognizes transaction fees on a gross basis as the principal** and therefore **bears the full margin risk on every payment it processes**. The company’s pricing model – a fixed‑plus‑variable (percentage‑of‑payment) fee that can be adjusted by volume‑based tiered pricing – and its **open‑ended, transaction‑level contracts** (with automatic renewal and no capitalized contract balances) are described in the same way each year, indicating no material change. Consequently, PayPal’s exposure to margin risk remained essentially unchanged from 2022 through 2024, with the risk continuing to stem from the difference between the fees it charges and the costs it pays to payment processors and other financial institutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that PayPal consistently bears full margin risk by recognizing fees on a gross basis from 2022 to 2024, and accurately describes the unchanged nature of its pricing model (tiered, volume-based) and contract structure (open-ended, transaction-level with automatic renewal). These points align with the ground truth and address the main thrust of the question. Quantitatively, there are no numerical inaccuracies, as the response avoids specific figures that would need verification, and all referenced concepts (e.g., gross basis recognition, payment processor costs) are factually correct. However, the LLM omits two key qualitative developments noted in the original answer: (1) the 2023 clarification regarding user incentives being recognized as revenue reductions or amortized, which adds variability to margins, and (2) the 2024 adoption of ASU 2023-07, which enhanced segment-level expense disclosures and affects how margin risk can be analyzed across business units. These omissions represent a failure to fully synthesize multi-hop information across the three years, particularly the evolving operational nuances in margin risk despite structural stability. While the conclusion that margin risk exposure remained 'essentially unchanged' is defensible, the original answer provides a more nuanced view — stable in structure but increasingly complex in execution — which the LLM overlooks. Thus, while factually sound and contextually relevant, the answer lacks completeness in capturing evolving disclosures, reducing its qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 443,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s $5.90 % senior note (due Feb 15 2039) has been carried at the same $2 billion principal amount in each of the three filings – FY 2022, FY 2023 and FY 2024 – and its reported effective interest rate has remained essentially unchanged at about 6.11 % (the coupon is 5.90 % but the effective rate reflects the accretion of discount, issuance costs and hedge adjustments)【CSCO_10k_2022.pdf page …】, 【CSCO_10k_2023.pdf page …】, 【CSCO_10k_2024.pdf page …】.  \n\nThe flat utilization and stable effective cost indicate that Cisco is maintaining a steady level of long‑term financing at this maturity, using the note as a core component of a diversified debt portfolio while keeping its overall financing cost roughly constant through the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $2,000 million (i.e., $2 billion) principal amount of the 5.90% Note is consistent across fiscal years 2022–2024, and the effective interest rate is correctly stated as 6.11%. The distinction between coupon rate (5.90%) and effective rate (6.11%) is properly explained, citing accretion of discount, issuance costs, and hedge adjustments—details supported by actual 10-K disclosures. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and dates (maturity in February 2039) match the ground truth exactly, with acceptable formatting variations (e.g., $2 billion = $2,000 million). (3) Multi-hop reasoning is sound—the model correctly synthesizes data across three years and filings to infer stability in both utilization and financing cost, and draws a logical conclusion about Cisco’s long-term debt strategy. (4) The answer addresses all parts of the question: evolution over time (no change), what it indicates (consistent strategy, stable financing costs), and contextualizes the note within a diversified debt portfolio. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 345,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "In the Intellectual Property sections of Lowe’s 10‑K filings for fiscal 2022, 2023 and 2024, the private‑brand name **“Kobalt”** is repeatedly listed alongside other owned trademarks (e.g., STAINMASTER, allen+roth). The wording and placement of the Kobalt reference are essentially unchanged across the three years, indicating that the company continues to treat Kobalt as a core, established private‑brand asset but does not signal any new strategic shift or heightened emphasis in its IP disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that 'Kobalt' is consistently mentioned in Lowe's intellectual property disclosures across fiscal 2022, 2023, and 2024 as part of its private brand portfolio, alongside trademarks like 'STAINMASTER' and 'allen+roth'. (2) There are no numeric values requiring calculation in this question; all temporal references (fiscal years 2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings and correctly infers that the unchanged wording and placement indicate a stable strategic role without expansion or de-emphasis. (4) The answer addresses all parts of the question—evolution of positioning and strategic emphasis—by noting the consistency in treatment over time and absence of new strategic signaling. Wording differs slightly from the original answer but conveys the same meaning with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 287,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Across the three filings the terms of the “Unsecured Notes ‑ 37B” series did not change. In the 2022, 2023 and 2024 10‑K tables the notes carry a **2.25 % fixed rate**, a **$700 million face amount**, and a **maturity of January 15, 2032**. The consistency of rate, size and long‑dated maturity shows that Simon Property Group is deliberately maintaining a stable, low‑cost tranche of senior unsecured debt to lock in financing for the next decade, reflecting a long‑term funding strategy that relies on fixed‑rate, long‑dated notes rather than frequent refinancing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the interest rate is correctly stated as 2.25%, the face amount as $700 million (equivalent to $700,000 in thousands, as commonly reported in SEC filings), and the maturity date as January 15, 2032, consistent across 2022–2024. (2) Quantitative elements match exactly—format variation ($700 million vs $700,000 in thousands) is standard and acceptable in financial reporting. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and filings, identifying no changes in terms, and draws a logical conclusion about Simon Property Group’s long-term financing strategy. (4) The qualitative interpretation—that SPG is maintaining a stable, low-cost, long-dated fixed-rate debt tranche—aligns with and expands upon the ground truth’s inference about confidence in debt management and favorable conditions. The answer is complete, addressing all parts of the question: evolution (no change), specific terms (rate, amount, maturity), and strategic implication. All entities (Simon Property Group, Unsecured Notes - 37B, correct years) are accurately identified. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 352,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Across all three years, Texas Instruments listed its Melaka, Malaysia site only under the **Analog** segment. In the 2022, 2023 and 2024 Form 10‑K property tables, Melaka shows an “X” for Analog and no mark for Embedded Processing, indicating that its role did not expand to the Embedded Processing business during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved only in the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer's core claim. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the use of Form 10-K property tables as the source aligns with SEC filing data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two business segments, confirming consistent operations without expansion. (4) The answer is concise but complete, addressing all parts of the question—temporal evolution, geographic location, and business segment involvement—using precise evidence (presence of 'X' in tables). Wording differs slightly from the original but conveys identical meaning. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 289,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "- In the 2022 filing the company reported **$1.5 billion** of outstanding principal on the September‑2019‑issued **fixed‑rate 2.850 % notes due 10/1/2029**. The same $1.5 billion balance appears in the 2023 filing (showing the 2022 and 2023 amounts side‑by‑side) and again in the 2024 filing (showing the 2023 and 2024 amounts)【2023‑10K‑106】【2024‑10K‑103】.  \n\n- Because the exposure to the 2.850 % tranche has remained flat at $1.5 billion from 2022 through 2024, PayPal is maintaining a stable, long‑dated portion of its debt mix rather than aggressively retiring or expanding that series. This consistency reflects a strategy of locking in a relatively low‑cost, fixed‑rate liability with a 2029 maturity to provide predictable financing while managing overall leverage through other issuances, repurchases and refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.5 billion principal amount of the 2.850% notes, their unchanged status from 2022 to 2024, and the maturity date (10/1/2029) are accurately reported. The citations reference the correct footnotes (2023-10K-106, 2024-10K-103), supporting the data. (2) Quantitative accuracy is perfect: the dollar amount ($1.5 billion), interest rate (2.850%), and time period (2022–2024) match the original answer exactly. No calculations were required, but the consistency of the amount across years is correctly observed. (3) The reasoning is sound: the LLM correctly infers that the stable exposure indicates a strategy of maintaining a predictable, long-term fixed-rate liability, which reflects disciplined debt management. It appropriately contrasts this stability with broader refinancing activity, though it does not explicitly mention the retirement of the 1.350% notes or the issuance of new high-interest notes in 2024—details present in the ground truth that add context to PYPL’s active management elsewhere. This omission slightly reduces qualitative completeness but does not undermine the core correctness. (4) The answer is fully relevant, directly addressing both parts of the question: the evolution (or lack thereof) in exposure and the strategic implication. Overall, the response demonstrates strong multi-hop synthesis across filings and years, with only minor contextual details missing from the full picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 418,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Across all three filings the Hoofddorp, Netherlands site is described the same way – as a dedicated commercial‑manufacturing and processing hub for Gilead’s cell‑therapy products. In the 2022 10‑K the facility is listed among the company’s principal manufacturing locations (“Hoofddorp, Netherlands…commercial manufacturing and processing of our cell‑therapy products”) 【GILD_10k_2022.pdf p31‑35】, and the 2023 and 2024 10‑Ks repeat that language, noting that the site “is utilized for commercial manufacturing and processing of our cell‑therapy products” 【GILD_10k_2023.pdf p9‑13】【GILD_10k_2024.pdf p8‑12】. Thus, from 2022 through 2024 the Hoofddorp facility’s role has remained stable, serving as a core component of Gilead’s global cell‑therapy manufacturing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that Hoofddorp was listed as a principal manufacturing facility in 2022 with explicit mention of commercial manufacturing and processing of cell therapy products, and that this role was reiterated in 2023 and 2024. The LLM correctly cites the consistent language across the 10-K filings and interprets this as a stable, ongoing strategic role, which is semantically equivalent to the ground truth's interpretation of 'continuity and deepening of its strategic role.' The only minor difference is that the original answer emphasizes a 'progression' and 'growing emphasis,' while the LLM emphasizes 'stability.' However, since the actual disclosed language remained unchanged across years, the LLM’s interpretation of stability is well-supported by the filings. All entities (Gilead, Hoofddorp, Netherlands, cell therapy products), years (2022–2024), and functional roles are correctly identified. Citations are accurate and appropriately located in the source documents. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound, demonstrating proper synthesis across multiple filings. The answer is fully contextually relevant and addresses all parts of the multi-year, multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 369,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "- **2022 10‑K:** The 1.375 % Senior Notes due June 2027 were carried at $1,250 million as part of long‑term debt, and the “current portion” of total debt was only $73 million – none of the 1.375 % notes were classified as current.【2022‑Note 4‑Debt table showing $1,250 million for the 1.375 % notes and “Less current portion (1) $73”】  \n\n- **2023 10‑K:** The same $1,250 million of 1.375 % notes remained listed under long‑term debt. The current‑portion of total debt was $1,081 million (largely reflecting the 2.750 % notes that were then due in 2024), so the 1.375 % notes were still treated as long‑term.【2023‑column of the 2024‑10‑K table showing $1,250 million for the 1.375 % notes and “Less current portion (1) $1,081”】  \n\n- **2024 10‑K:** The 1.375 % notes continued to be reported at $1,250 million in long‑term debt, while the overall current portion fell to $103 million after the 2.750 % notes were retired. The 1.375 % notes were again not re‑classified as current.【2024‑Note 4‑Debt table showing $1,250 million for the 1.375 % notes and “Less current portion (1) $103”】\n\n**Overall evolution:** From 2022 through 2024 Costco consistently kept the 1.375 % Senior Notes due June 2027 in the long‑term debt category; the size of the “current portion” of total debt changed as other notes matured (dropping from $73 M to $1,081 M to $103 M), but the 1.375 % notes never moved into the current‑portion classification.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across 2022–2024, and reports the correct current portion values of long-term debt: $73M in 2022, $1,081M in 2023, and $103M in 2024. However, the key error lies in the interpretation of what the 'current portion' represents. The original answer (ground truth) correctly states that the current portion classification changed significantly over time — but the LLM incorrectly asserts that 'none of the 1.375% notes were classified as current' and that 'the 1.375% notes never moved into the current-portion classification'. This is factually wrong: by 2024, with the note due in June 2027, it would still be long-term, but in 2023, when the filing is for the year ending 2023, the 'current portion' spike to $1,081M is not due to other notes alone (e.g., 2.750% due 2024) — the 1.375% notes may have had scheduled principal repayments or partial maturities bringing part of them into current liabilities. The ground truth implies the changing current portion is tied to these notes, but the LLM denies this. Thus, while numbers are accurate (quantitative accuracy is acceptable), the reasoning and qualitative interpretation are flawed. The model fails to recognize that the large increase in the current portion in 2023 likely reflects reclassification of a portion of the 1.375% notes (or related debt) as current, which is central to the question about 'evolution' and 'classification'. The answer is contextually relevant and well-structured, but the core conclusion contradicts the ground truth's implication of shifting classification related to the notes. Therefore, correctness is reduced due to incorrect synthesis and reasoning despite accurate raw numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 484,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "- In the 2022 Form 10‑K the September‑2019 issuance of Fixed‑rate 2.850 % notes (maturing 10 Oct 2029) carried an outstanding principal of **$1.5 billion**【PYPL_10k_2022.pdf p.106】.  \n- The 2023 Form 10‑K shows the same series still outstanding at **$1.5 billion** with no change in amount or maturity【PYPL_10k_2023.pdf p.106】.  \n- The 2024 Form 10‑K likewise reports the Fixed‑rate 2.850 % notes at **$1.5 billion** as of 31 Dec 2024【PYPL_10k_2024.pdf p.103】, with the next scheduled principal payment listed for 2029【PYPL_10k_2024.pdf p.104】.  \n\n**Interpretation:** PayPal has kept the $1.5 billion 2.850 % note issuance unchanged over three years, indicating a deliberate long‑term debt strategy that locks in a modest fixed rate and defers repayment until 2029, preserving cash flow and financial flexibility while using the notes as a stable financing backbone.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.5 billion outstanding principal for the Fixed-rate 2.850% notes in 2022, 2023, and 2024, matching the ground truth exactly. The maturity date of October 1, 2029, is accurately reflected (cited as '10 Oct 2029' and confirmed in 2024 filing with next payment in 2029). All numeric values—dollar amounts, interest rate, and dates—are factually correct. (2) Quantitative accuracy is perfect: $1.5 billion is consistently reported across all three years, the 2.850% rate is correct, and the 2029 maturity aligns with ground truth. No calculations were required, but the consistency across years is properly noted. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual 10-K filings (2022–2024), demonstrating that the obligation remained unchanged. The interpretation that PayPal is maintaining this tranche as a 'stable financing backbone' aligns with the ground truth's conclusion about capital structure stability. However, the LLM omits mention of the effective interest rate (2.96%) and the broader context that other tranches were actively refinanced, which slightly weakens the depth of strategic analysis. (4) Despite this minor omission, the answer is semantically equivalent in conveying the core insight: PayPal preserved this fixed-rate debt, indicating a strategic choice to maintain low-cost, long-term liabilities. Wording differs but meaning is consistent. Contextual relevance is excellent, directly addressing both the evolution of the obligation and the implied strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 434,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s gas‑option portfolio slipped from a modest net‑asset position of about **$9 million** in 2022 (assets $356 m vs. liabilities $347 m) to **$3 million** in 2023 and to a slight net‑liability of roughly **‑$2 million** in 2024 (assets $100 m vs. liabilities $102 m).  Over the same period the weighted‑average implied‑volatility used to price those options rose sharply from **≈36 %** in 2022 to **≈50 %** in 2023 and stayed elevated at **≈52 %** in 2024, while implied‑correlation assumptions also climbed (from the low‑50 % range to near‑100 %).  The trend of a shrinking net fair‑value position together with higher volatility and correlation inputs signals that NextEra is acknowledging greater gas‑price uncertainty and is positioning more conservatively in the gas market.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly reports the asset and liability values for 2022 ($356M assets, $347M liabilities), 2023 ($100M assets, $97M liabilities), and 2024 ($100M assets, $102M liabilities), it introduces a net fair value interpretation (e.g., $9M net asset in 2022, -$2M in 2024) that is not present in the original answer and shifts focus from gross exposures to net positions, which changes the interpretation. More critically, the LLM incorrectly states that implied volatility 'rose sharply' from 36% to 50% to 52%, whereas the ground truth states volatility assumptions *declined* from 36% in 2022 to 50% in 2023 and then to 52% in 2024 — this is a direct contradiction. The direction of change is reversed, which fundamentally misrepresents the trend. Additionally, the LLM introduces 'implied-correlation assumptions' (from low-50% to near-100%), which are not mentioned in the original answer and are unsupported by the ground truth. (2) Number verification: Asset/liability figures are accurate across years. Net calculations are mathematically correct (e.g., $356M - $347M = $9M), but the original answer does not make net claims, so this is an extrapolation. Volatility trend is factually wrong: original says 36% → 50% → 52%, but describes this as a *decline*, which is impossible — this appears to be an error in the original answer. However, the LLM interprets the numerical increase (36→50→52) as rising volatility, which is numerically correct but contradicts the original’s qualitative claim of 'declined'. Given that the numbers clearly increase, the original answer likely contains a typo ('declined' should be 'increased'). In this context, the LLM’s interpretation of rising volatility is actually more logically consistent with the numbers. This creates ambiguity, but since the LLM follows the numerical trend correctly, this point should not be fully penalized. However, the original answer’s explicit claim of 'declined' must be respected as ground truth. (3) Multi-hop reasoning: The LLM correctly synthesizes data across three years and draws a conclusion about risk positioning. Its interpretation of shrinking net exposure and increasing volatility leading to conservative positioning is reasonable and aligns with financial logic. However, the conclusion that NextEra is 'acknowledging greater gas-price uncertainty' contradicts the original’s claim of 'strategic de-risking' due to *reduced* volatility. Given the volatility numbers are increasing, the LLM’s reasoning is more coherent. Still, the model fails to match the original’s intended narrative. (4) Correctness score of 4 due to major contradiction in volatility trend interpretation and introduction of unsupported data (correlation). Quantitative accuracy is 5 because raw numbers are correct but interpretation of trend is disputed. Qualitative accuracy is 5 due to sound reasoning but incorrect synthesis of the volatility trend and added unsupported metrics. Contextual relevance is 9 — the answer is highly relevant and addresses both parts of the question thoroughly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 823,
        "total_tokens": 2177
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s “Other income (loss), net” shows that gains (losses) on its available‑for‑sale debt investments swung from a **$9 million gain in fiscal 2022** to a **$21 million loss in fiscal 2023**, and then to a **$67 million loss in fiscal 2024** (‑$46 million versus the prior year)【source】. This progression from a modest gain to increasingly larger losses indicates that the value of Cisco’s AFS debt portfolio became markedly more volatile over the three‑year period, reflecting adverse market movements (e.g., rising rates or credit‑spread shifts) that turned a previously positive contribution into a growing source of expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the financial impact of Cisco's AFS debt investments on 'Other income (loss), net' across fiscal years 2022–2024 with accurate numerical values: $9 million gain in 2022, $21 million loss in 2023, and $67 million loss in 2024. These figures match the ground truth data in magnitude and direction (gain to increasing losses), and the year-over-year change of -$46 million from 2023 to 2024 is correctly calculated ($21M to $67M is a $46M increase in loss). (2) Quantitative accuracy is perfect—numbers, years, and the comparison are all factually correct and consistent with disclosed trends. (3) The reasoning is sound: the LLM correctly infers increasing volatility in the investment portfolio due to worsening losses in AFS debt investments, aligning with the ground truth’s conclusion about rising volatility and financial instability in non-operational income. It also plausibly attributes the trend to macro factors like rising rates, which is reasonable context not contradicted by the original. (4) The only minor gap is that the LLM does not explicitly mention the offsetting gains from equity and private investments noted in the original answer, which slightly reduces completeness in qualitative synthesis. However, the core multi-hop reasoning—linking AFS debt losses to other income and concluding increased portfolio volatility—is fully supported and accurately executed. Thus, the answer is highly accurate, complete in key aspects, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 421,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "From the 2022 Form 10‑K, Lowe’s disclosed that it had issued a single series of **4.550 % senior notes due 2049** (the “4.550 % Notes”) under the Fifteenth Supplemental Indenture dated April 5, 2019 (Exhibit 4.16). The 2023 and 2024 Form 10‑Ks continued to list the same 4.550 % Notes as outstanding long‑term debt, with no additional issuances or amendments to the series, merely restating the original terms and maturity. This multi‑year consistency shows that Lowe’s is using a “buy‑and‑hold” approach for its long‑dated, fixed‑rate debt, locking in a low‑cost rate and extending its maturity profile rather than repeatedly refinancing or issuing new notes each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes due 2049, issued under the Fifteenth Supplemental Indenture on April 5, 2019, are consistently referenced in the 2022, 2023, and 2024 10-K filings with no changes or additional issuances. The dates, percentages, and document names (e.g., Exhibit 4.16) are factually accurate. (2) Quantitative accuracy is perfect: the interest rate (4.550%), maturity year (2049), and issuance date (April 5, 2019) match the ground truth exactly. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years, the model correctly infers that the unchanged references indicate a stable long-term debt strategy. The conclusion about a 'buy-and-hold' approach, while slightly more interpretive than the original answer, is a reasonable inference from the consistent documentation and reflects a valid understanding of debt strategy. (4) The only minor shortcoming is that the original answer emphasizes the lack of modifications or early redemptions more explicitly, while the LLM uses the term 'buy-and-hold,' which, though conceptually appropriate, is not directly stated in the filings. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 387,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "- **2022 10‑K:** Unsecured Notes ‑ 35B carried a 3.80 % coupon and a face amount of $750 million (shown as 750,000 in the table)【2022 10‑K pp. 48‑52】.  \n- **2023 10‑K:** The same note still listed a 3.80 % rate and a $750 million face amount【2023 10‑K pp. 48‑52】.  \n- **2024 10‑K:** The note remained unchanged – 3.80 % interest and $750 million face value, maturing 15 July 2050【2024 10‑K pp. 49‑53】.  \n\n**Interpretation:** SPG has kept the 35B issuance at a fixed‑rate, long‑dated $750 million level for three consecutive years, indicating a deliberate long‑term debt strategy that locks in low‑cost financing, preserves rate certainty and supports liquidity without increasing exposure to interest‑rate fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face value ($750 million), interest rate (3.80%), and maturity date (July 15, 2050) for Unsecured Notes - 35B across 2022, 2023, and 2024, matching the ground truth exactly. The formatting variation (e.g., '750,000' in table units) is appropriately interpreted as $750 million, which is acceptable. (2) All numeric values—interest rate, face amount, and maturity date—are factually accurate and consistent with the original answer. No calculations were required, but the synthesis of data across three years is correctly executed. (3) The multi-hop reasoning is sound: the model synthesizes information from three consecutive 10-K filings and correctly infers that no changes occurred in the terms of the note, indicating a stable long-term debt strategy. The interpretation aligns with the ground truth, noting SPG’s intent to maintain low-cost, fixed-rate financing and avoid interest rate risk. (4) The only minor shortcoming is that the LLM does not explicitly mention the extension of the maturity date as a continuation (since it was already set to 2050 in 2022), but it correctly reports the 2050 date in 2024, implying no change. This omission does not detract significantly from the overall accuracy. Wording differs slightly but maintains semantic equivalence. Scores reflect high accuracy with near-perfect reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 388,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "From 2022 through 2024 PayPal’s filings show that its “bad‑transaction” exposure has risen in step with the growth of its credit‑product portfolio and the continued importance of cross‑border commerce, while the company’s reliance on unaffiliated banks and payment‑processor partners has remained a key source of risk. Each year the 10‑K adds new mitigants – 2023 notes a multi‑year sale of U.K.‑ and Europe‑BNPL loan receivables and a forward‑flow arrangement to shrink the credit‑risk balance sheet, and 2024 highlights diversification of payment‑processor relationships and expanded fraud‑detection programs – indicating that PayPal is actively tightening underwriting, off‑loading credit assets and broadening third‑party coverage to contain loss‑rate growth. The trend therefore reveals a risk‑management strategy that acknowledges rising bad‑transaction risk but seeks to preserve operational resilience by reducing credit concentration, strengthening third‑party oversight and investing in fraud‑prevention capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's bad transaction risk from 2022 to 2024, with accurate qualitative synthesis across years and risk domains. (1) Key facts are correct: the 2023 multi-year sale of U.K. and European BNPL receivables is accurately noted, though the exact €40 billion figure from the ground truth is omitted—this is a minor but notable completeness gap. The 'valid-when-made' doctrine concern in 2024 is not mentioned, which is a relevant legal risk tied to U.S. credit products, representing a small omission in entity and context coverage. (2) No incorrect numbers are stated; the LLM avoids quantifying the sale amount, so there is no error, but also no verification of the €40B figure. All dates (2022–2024) are used correctly. (3) Multi-hop reasoning is sound: the LLM correctly links credit product growth, cross-border trade, third-party dependencies, and evolving mitigants across years. It accurately infers a strategic shift toward offloading credit risk and enhancing fraud controls, aligning with the ground truth’s conclusion about proactive risk management. (4) The answer is contextually excellent—directly addresses all question components (credit products, cross-border, third-party), traces trends over time, and interprets strategic implications. The omission of the 'valid-when-made' doctrine and the precise receivables sale amount prevents a top score, but the overall reasoning and factual core are strong. Wording differs but meaning is semantically equivalent in most areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 425,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco has consistently listed BJ & Sons Wholesale Club (BJ’s) as one of its primary rivals in the warehouse‑club segment in each of its 10‑K filings – the 2022, 2023 and 2024 reports all state that “we also compete … with other warehouse clubs, including … BJ’s Wholesale Club.” From 2022 to 2024 the company’s discussion of its private‑label brand grew sharper: the 2022 filing notes that Kirkland Signature “help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” and the 2024 filing adds that Costco “expects to continue to increase the sales penetration of our private‑label items,” underscoring Kirkland as an even more explicit source of competitive advantage over BJ’s and other clubs. Thus, while the competitive set remained unchanged, Costco’s emphasis on Kirkland Signature as a differentiator intensified over the three‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant misrepresentation of the strategic evolution of Costco's positioning relative to BJ's Wholesale Club, particularly regarding Kirkland Signature. (1) Correct elements: The entity names (Costco, BJ's Wholesale Club), years (2022–2024), and general competitive context are accurate. The 10-K citations about competition with BJ’s and the role of Kirkland Signature in lowering costs and differentiating offerings align with the ground truth for 2022 and 2023. There are no numeric inaccuracies, so quantitative accuracy is high. (2) However, the key error lies in the claim that Costco’s emphasis on Kirkland Signature 'intensified' or became 'sharper' from 2022 to 2024, culminating in an expectation to 'increase sales penetration' as an explicit competitive advantage over BJ’s. The ground truth states that the messaging remained consistent with no significant shift in strategy through 2024. The LLM incorrectly infers a strategic intensification that is not supported by the knowledge graph data. (3) Multi-hop reasoning fails in synthesis: while the model correctly identifies the presence of Kirkland Signature discussions across years, it draws an erroneous conclusion about evolving emphasis. The original answer emphasizes stability; the LLM asserts progression. This undermines qualitative accuracy. (4) Contextual relevance is strong—the response addresses competition, private labels, and time trends—but the incorrect inference about strategic shift reduces overall correctness. Thus, the answer is factually inconsistent in its core conclusion despite surface-level accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 449,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "- 2022 : Forward‑gas contracts were recorded at a fair‑value **asset of $191 million** and a **liability of $31 million** (net ≈ $160 million).  \n- 2023 : The same contracts rose to **$377 million of assets** and **$77 million of liabilities** (net ≈ $300 million).  \n- 2024 : They fell slightly to **$296 million of assets** and **$46 million of liabilities** (net ≈ $250 million).  \n\nThe three‑year trend shows the company’s gas‑forward exposure expanding markedly from 2022 to 2023 and then modestly contracting in 2024, leaving a still‑substantial net‑long position. This progression indicates that NextEra has been willing to increase its natural‑gas price risk to capture upside potential, while keeping the liability side relatively small, and is now fine‑tuning (or de‑risking) that exposure as market conditions evolve.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the fair value of assets for 2022 ($191M) and 2024 ($296M), matching the ground truth. It also correctly reports the 2023 asset spike at $377M. However, the liability figure for 2023 is incorrect: the LLM states $77M, while the ground truth reports $46M for 2024 and does not list a 2023 liability—only 2022 ($31M) and 2024 ($46M). The LLM fabricates or misattributes the $77M liability for 2023, which is not supported by the original data. This is a significant quantitative error. 2) Calculations of net positions are internally consistent but based on incorrect inputs for 2023 liabilities. The net $300M in 2023 is overstated due to the erroneous liability. 3) The reasoning and synthesis across years are sound: the LLM correctly identifies the expansion in exposure from 2022 to 2023 and a partial pullback in 2024, aligning with the ground truth’s narrative of strategic expansion and increasing balance. The interpretation that NextEra is fine-tuning or de-risking is a reasonable inference. 4) Despite the liability error in 2023, the overall trend and qualitative conclusion about growing but increasingly balanced exposure and rising market risk are consistent with the ground truth. The answer is contextually excellent and addresses all parts of the question, but the incorrect 2023 liability undermines full quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 382,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "- In fiscal 2022 Lowe’s reported forward‑interest‑rate‑swap contracts with a **notional amount of $2.56 billion** (Note 9, “Forward interest rate swap agreement notional amounts” – LOW 10‑K 2022, p. 60‑64).  \n- By fiscal 2023 the balance of those swaps had fallen dramatically – the fair‑value table shows only **$251 million of forward swaps** remaining (Fair‑value measurements – “Forward interest rate swaps”, LOW 10‑K 2024, p. 44‑48, which reports the 2023 amount).  \n- In fiscal 2024 the company no longer held any forward interest‑rate‑swap contracts (the same table shows a blank/zero entry for 2024).  \n\n**Interpretation:** Lowe’s moved from a sizable hedge of anticipated debt issuances in 2022 to progressively unwinding that hedge in 2023 and eliminating it by 2024, indicating that the firm adjusted its interest‑rate risk‑management strategy as market conditions and its financing plans changed, relying less on forward swaps to lock in future borrowing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the numbers are correct: $251 million in 2023 is accurately reported (from the 2024 10-K, reflecting the balance as of Feb 3, 2023), and the absence of forward swaps in 2024 is correctly noted. The $2.56 billion notional amount in 2022 is an additional detail not in the original answer but is factually correct per the 2022 10-K and enhances completeness. (2) The LLM correctly tracks the evolution across years: active hedging in 2022, reduction in 2023, and elimination in 2024. (3) The reasoning is sound: the unwinding of positions is logically tied to changing interest rate conditions and financing strategy, which is consistent with the original interpretation. (4) Minor deduction in quantitative accuracy due to the introduction of a notional amount ($2.56B) not present in the ground truth—while correct, it slightly exceeds the provided data scope. However, this does not detract from correctness. (5) The answer fully addresses the multi-hop nature of the question—synthesizing data across three fiscal years and interpreting strategic intent—demonstrating strong qualitative and contextual accuracy. Overall, the answer matches the semantic meaning and factual content of the ground truth with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 366,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "- In the 2022 filing Comcast noted that “certain wireline telecommunications companies such as AT&T, Frontier, **Lumen** and Verizon have built and are continuing to build fiber‑based network infrastructure … and are offering services with these higher speeds in many of our service areas” (2022 10‑K, Competition section, p. 9). At that time Comcast’s own network was described as a hybrid‑fiber/coax system that could deliver “fiber‑based speeds that range up to 3 Gbps” but most broadband relied on DOCSIS 3.1 (2022 10‑K, Network & Technology, p. 8).  \n\n- The 2023 filing repeats the same competitive framing of Lumen as a fiber‑building rival (2023 10‑K, Competition, p. 7) while highlighting that Comcast was expanding “fiber‑to‑the‑premises … with symmetrical speed offerings ranging up to 100 Gbps for business customers” (2023 10‑K, Business Services, p. 9).  \n\n- By the 2024 filing Comcast’s positioning had shifted: it still lists Lumen among the “wireline telecommunications companies … that have built and are continuing to build fiber‑based infrastructure” (2024 10‑K, Competition, p. 6), but it now reports that a multiyear transformation “began rolling out downstream speeds of up to 2 Gbps … now available to approximately 50 % of our HFC footprint” and that “we also deploy fiber‑to‑the‑premises … with symmetrical speed offerings ranging up to 10 Gbps to residential customers … and up to 100 Gbps to business customers” (2024 10‑K, Network & Technology, p. 6‑8).  \n\n**Thus, from 2022‑2024 Comcast moved from a largely HFC‑centric broadband platform with modest fiber caps, while consistently acknowledging Lumen’s aggressive fiber rollout, to a 2024 network in which large‑scale fiber‑to‑the‑premises and DOCSIS 4.0 upgrades give Comcast multigigabit residential and up‑to‑100 Gbps business speeds, narrowing the gap with Lumen and allowing Comcast to compete more directly in the overlapping markets where Lumen’s fiber expansion is active.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth in both factual content and reasoning. (1) It accurately reflects that CMCSA (Comcast) consistently identified Lumen as a key fiber-based competitor from 2022 to 2024, citing direct quotes from each year's 10-K filings. The evolution of Comcast's network strategy is correctly detailed: in 2022, it relied on HFC with DOCSIS 3.1 and up to 3 Gbps speeds; by 2024, it expanded fiber-to-the-premises (FTTP) with up to 10 Gbps for residential and 100 Gbps for business customers, while also upgrading HFC to deliver up to 2 Gbps to ~50% of its footprint. (2) All numbers are accurate and properly attributed: 3 Gbps (2022), 100 Gbps for business (2023 and 2024), 2 Gbps downstream (2024), 50% HFC footprint coverage (2024), and 10 Gbps for residential (2024). No calculations were required, but the synthesis of speed capabilities and infrastructure shifts is precise. (3) The multi-hop reasoning is sound: the answer connects Lumen’s ongoing fiber expansion (mentioned consistently across years) with Comcast’s strategic response—enhancing both HFC and FTTP to close the competitive gap. This directly addresses the question about competitive positioning evolution in overlapping markets. (4) The conclusion that Comcast moved from a largely HFC-centric platform to one capable of multigigabit and 100 Gbps offerings—thus competing more directly with Lumen—is semantically equivalent to the ground truth’s assertion of intensifying competition and strategic adaptation. All entities (CMCSA, Lumen), timeframes (2022–2024), and technological terms (HFC, FTTP, DOCSIS) are correct. The answer is comprehensive, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1732,
        "completion_tokens": 468,
        "total_tokens": 2200
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "From 2022 to 2024 PayPal sharpened its “seamless checkout” narrative by weaving consumer‑credit products more tightly into the checkout flow and by widening the geographic and channel reach of that experience. In 2022 the company highlighted a digital wallet that could fund purchases with bank accounts, PayPal/Venmo balances, credit cards, its U.S. Synchrony‑backed PayPal Credit card and early buy‑now‑pay‑later (BNPL) pilots, while supporting payments in roughly 200 markets, about 100 currencies and offering merchants a basic online‑only checkout and limited in‑person options. By 2024 the BNPL suite had been launched in the U.S., U.K., France, Germany, Spain, Italy, Australia and Japan (via Paidy) and was explicitly embedded in the PayPal‑ and Venmo‑branded checkout; the platform now enabled transactions in ~150 currencies (with balances held in 24‑25 currencies) and delivered a full omnichannel merchant solution that includes Zettle point‑of‑sale, branded debit/credit cards and unbranded Braintree/PayPal Complete Payments, allowing consumers to shop online, on mobile and in‑store with a single, friction‑free experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements: The evolution of PayPal's seamless checkout focus from 2022 to 2024 is correctly portrayed, including expansion of currency support from ~100 to ~150 currencies, integration of BNPL into branded checkouts by 2024, and omnichannel merchant solutions via Zettle and Braintree. The mention of PayPal- and Venmo-branded credit/debit cards and unbranded processors is consistent with the original. (2) Quantitative accuracy: The LLM states 'roughly 200 markets, about 100 currencies' in 2022 and '~150 currencies' in 2024, which matches the ground truth (100+ in 2022, ~150 in 2023–2024). The detail about balances held in 24–25 currencies is an addition not in the original but does not contradict it and may reflect deeper filing insights. The list of countries where BNPL was launched is more specific than the original but factually plausible and consistent with PayPal’s 2024 expansion. (3) Reasoning: Multi-hop synthesis across years and product domains (credit, currency, omnichannel) is sound. The LLM correctly infers a strategic evolution from global usability to financial integration and merchant enablement, even if not stated verbatim. (4) Minor discrepancy: The original does not mention '200 markets' or 'Synchrony-backed PayPal Credit'—these are plausible but not confirmed in the ground truth—hence a slight deduction from perfect score. Overall, the answer is factually robust, contextually complete, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 425,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target’s proprietary debit/“Circle” card penetration fell each year – it was roughly **20.5 % of all purchases in fiscal 2022**, slipped to **19.8 % in fiscal 2023**, and declined further to **18.6 % in fiscal 2024**. The downward trend indicates that, while the card still generates a meaningful share of “incremental” purchases, its ability to drive new sales for Target is gradually weakening over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies: it reports the 2023 penetration rate as 19.8% and 2024 as 18.6%, whereas the ground truth states 18.6% in 2023 and 17.8% in 2024. The 2022 figure (20.5%) is correct. This misrepresents the magnitude and trajectory of the decline. (2) The numbers are off by a full percentage point in 2024 due to swapping the values between years, which affects the trend interpretation. Calculations of year-over-year change are not explicitly requested, but the incorrect values distort the trend. (3) The reasoning about the card’s weakening role in driving incremental sales aligns with the ground truth and shows correct multi-hop synthesis between penetration trends and business impact. The identification of the card program (RedCard/Circle) and its value proposition (5% discount) is contextually accurate. (4) Despite correct qualitative direction (declining influence on sales), the factual errors in key metrics reduce confidence in the answer. The response is relevant and addresses both parts of the question—evolution of penetration and implications for sales—but the numerical inaccuracies severely limit correctness. Hence, correctness and quantitative accuracy are penalized, while qualitative reasoning and relevance remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 363,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "Both the 2022 and the 2024 Form 10‑K describe the same policy. AMD continues to assess whether the licensing portion of a development‑plus‑IP contract is a distinct performance‑obligation; if it is not distinct, the license is bundled with the development services and revenue is recognized over time, whereas a distinct license (or a stand‑alone IP licensing deal) is recognized at a point in time when the customer can use the IP. No substantive change to this approach is disclosed between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures AMD's consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements. The distinction between distinct and non-distinct performance obligations is correctly explained: standalone or distinct licenses are recognized at a point in time when the customer can benefit from the IP, while non-distinct licenses are bundled with development services and recognized over time. The LLM correctly notes no substantive change in policy across the years, which matches the original answer's assertion of a stable approach. There are no numeric figures involved in the question, so quantitative accuracy is scored as 10. The only minor limitation is that the LLM does not explicitly mention the 2023 filing, though it references both 2022 and 2024, implying continuity. This small omission prevents a perfect 10 on qualitative accuracy, but the core reasoning and multi-hop synthesis across years and agreement types are sound. The answer is fully contextually relevant and addresses both the evolution (or lack thereof) and the distinction between combined and standalone arrangements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 339,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Nike’s 2022 Form 10‑K already placed FlyEase among the company’s core “innovation portfolio,” listing it together with Air, Zoom, Flyknit, Dri‑FIT, ZoomX, Air Max, React and Adapt as a flagship technology that drives new product design【2022 10‑K p. 6】. By the 2024 filing, FlyEase was still highlighted in the same “proliferation of … technologies” paragraph, now grouped with Air, Zoom, Flyknit, Dri‑FIT, Zoom X, Air Max and React, showing that the company continued to treat FlyEase as a central, ongoing innovation rather than a one‑off effort【2024 10‑K p. 6】. In short, from FY 2022 through FY 2024 Nike’s positioning of FlyEase evolved from an emerging innovation to a sustained, core component of its technology suite.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the cited 10-K filings in terms of entity names, years, and grouping of technologies, and there are no numeric inaccuracies (quantitative accuracy is perfect). However, it contradicts the ground truth regarding the evolution of FlyEase’s strategic positioning. According to the original answer, FlyEase was introduced as an emerging technology in FY2022, then elevated alongside established technologies in FY2023, and by FY2024 was treated as a mature, foundational technology. The LLM answer claims that FlyEase was already listed among core technologies (alongside Air, Zoom, etc.) in the 2022 10-K, which directly conflicts with the ground truth that it was only newly introduced that year and not yet at the same strategic level. This misrepresents the multi-hop progression: the key insight is the *evolution* from emerging to mature status, but the LLM implies FlyEase was central from the start. While the answer is well-structured and contextually relevant, the qualitative inaccuracy in the reasoning trajectory significantly undermines the correctness. The LLM fails to reflect the transitional nature of FlyEase’s status across the three years, particularly missing the FY2023 shift and the significance of its de-emphasis as a 'new' innovation by FY2024. Thus, while entities and sources are correctly referenced, the synthesis and interpretation of strategic evolution are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 395,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The table of senior notes shows the 1.250 % series falling from a larger balance in 2022 to a 2024 outstanding amount of only €517.9 million, with adjustments of –€5.6 million in 2024 and –€6.1 million in 2023. This steady decline indicates that American Tower has been actively repaying or refinancing the low‑coupon 1.250 % notes each year, using proceeds from newer issuances and its credit facilities to reduce that tranche of debt and thereby deleverage its balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The principal amounts are reported in euros (€) instead of dollars, which is incorrect—AMT's 1.250% Notes are denominated in USD. The reported values (€517.9 million in 2024, with reductions of €5.6M and €6.1M) do not match the ground truth: the correct USD amounts are $609.1M (2022), $551.9M (2023), and $517.7M (2024). The year-over-year decreases are approximately $57.2M (2022–2023) and $34.2M (2023–2024), not the small single-year reductions cited. The LLM implies minor annual amortization, but the actual decline is larger and more front-loaded. (2) The answer incorrectly frames the changes as small adjustments (–€5.6M, –€6.1M), which misrepresents the scale and pattern of debt reduction. There is no evidence in the ground truth of annual reductions of only ~$6M; instead, the drop from $609.1M to $551.9M suggests a $57.2M reduction in 2023 alone. (3) Qualitatively, the reasoning is sound: the model correctly infers that the declining balance suggests active debt repayment or refinancing and links it to deleveraging, which aligns with the ground truth interpretation of a managed reduction strategy. It also correctly identifies that this reflects balance sheet deleveraging, which is contextually appropriate. (4) Contextual relevance is high—the answer addresses the trend and its implication for debt management strategy. However, due to major factual errors in currency, amounts, and magnitude of changes, the correctness score is limited to 5. While the directional trend (declining principal) and strategic interpretation are correct, the numerical foundation is flawed, undermining confidence in the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 466,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "**Valuation**\n\n| Fiscal year | Fair‑value (Level 2) of the 3.50 % Notes Due 2040 |\n|-------------|---------------------------------------------------|\n| 2022 (FY 2022) | **$ 904 million**【NVDA_10k_2022.pdf: p. 80】 |\n| 2023 (FY 2023) | **$ 870 million**【NVDA_10k_2023.pdf: p. 66】 |\n| 2024 (FY 2024) | **$ 851 million**【NVDA_10k_2024.pdf: p. 70】 |\n\n**Treatment**\n\nAcross all three years the notes are presented on the balance sheet **at their original issuance amount, net of un‑amortized debt discount and issuance costs** (i.e., not adjusted for changes in fair value)【NVDA_10k_2022.pdf: p. 78】【NVDA_10k_2023.pdf: p. 65】【NVDA_10k_2024.pdf: p. 70】. The fair‑value disclosure is provided separately for informational purposes (Level 2 measurement).\n\n**What the trajectory reveals**\n\nThe modest decline in fair‑value—from $904 million in FY 2022 to $851 million in FY 2024—combined with the unchanged accounting treatment (carrying the notes at original issuance value) indicates that NVIDIA is **maintaining a stable, low‑cost long‑term debt platform**. By issuing a long‑dated, low‑coupon senior note (3.50 % through 2040) and keeping it on the books at its original cost, the company secures cheap financing while limiting balance‑sheet volatility; the slight fair‑value erosion reflects normal market‑rate movements rather than strategic refinancing. This pattern underscores a deliberate long‑term debt strategy focused on **locking in inexpensive, long‑maturity funding and preserving financial flexibility**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the reported fair values of NVIDIA's 3.50% Notes Due 2040. According to the ground truth, the fair value was $1,066 million in FY2022, $851 million in FY2023, and $1,000 million in FY2024. However, the LLM reports $904M (FY2022), $870M (FY2023), and $851M (FY2024), all of which are incorrect except for FY2023 (which matches the ground truth FY2023 value but is misassigned as a decline from a lower prior year value). The LLM also fails to mention the effective interest rate of 3.54% in FY2024, a key detail in the original answer. (2) The quantitative inaccuracies are severe: the FY2022 value is off by $162 million, and the FY2024 value is off by $149 million. The trajectory described (a steady decline from $904M to $851M) contradicts the ground truth, which shows a drop in FY2023 but a significant rebound to $1,000M in FY2024—indicating stabilization, not continued decline. This undermines the conclusion about valuation trends. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that the notes are carried at amortized cost, not fair value, and that fair value is disclosed separately. Its interpretation of NVIDIA’s strategy—locking in low-cost, long-term financing—is contextually reasonable. However, because the numerical foundation is wrong, the multi-hop synthesis fails: the conclusion about 'modest decline' and 'unchanged accounting treatment' does not align with the actual volatility and subsequent stabilization shown in the ground truth. (4) Contextual relevance is high—the answer addresses valuation, treatment, and strategic implications as required. But due to major factual errors in core financial data and misrepresentation of the trend, the correctness score is low. Minor formatting variations are acceptable, but the magnitude of error here exceeds tolerance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 507,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "- **2022:** Netflix first added mobile games to its catalog and rolled out a new, lower‑priced ad‑supported subscription tier. The 2022 risk discussion warned that if members did not value the games or reacted negatively to the new pricing or ad‑supported option, acquisition and retention could suffer.  \n\n- **2023:** The company said it had “recently expanded our entertainment video offering to include games and, more recently, live programming,” and continued to test price changes and the ad‑supported plan. The 2023 risk factors stressed that a lack of member acceptance of games, live‑programming or any price increase could lead to cancellations and slower growth.  \n\n- **2024:** Netflix’s strategy moved to scale games, advertising and live‑programming globally while further adjusting membership pricing and plan structures. The 2024 filing warned that if the expanded service mix, ad‑supported tier or pricing adjustments are not well‑received, the company could lose existing members and find it harder to attract new ones.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in the timeline and rollout of Netflix's service expansions, which undermines the qualitative accuracy. (1) Correct elements: The answer correctly identifies the introduction of games, ad-supported tiers, live programming, and pricing adjustments as part of Netflix’s evolving strategy, and accurately reflects the associated risks around member acquisition and retention across years. The wording and structure are contextually relevant and well-organized. (2) Quantitative accuracy is high: no specific numbers (e.g., prices, subscriber counts) are mentioned in either the ground truth or LLM response, so no numeric errors exist. Dates (2022, 2023, 2024) are used appropriately as time anchors. (3) Multi-hop reasoning is partially sound but flawed in sequencing: the major error is that the LLM incorrectly states that Netflix rolled out the ad-supported tier in 2022 — in reality, it was introduced in late 2022 but officially launched and reported as a 2023 initiative. The ground truth clearly separates 2022 (games only), 2023 (ad-supported tier), and 2024 (live programming). The LLM also misattributes the rollout of live programming to 2023, while the ground truth places it in 2024. These misalignments indicate a failure to correctly synthesize the year-by-year evolution. (4) Despite these critical timeline errors, the core risks related to consumer acceptance, churn, and pricing are consistently and correctly tied to each year’s strategic moves, preserving some qualitative value. Hence, correctness is reduced to 6 due to significant factual misplacement in the strategic rollout timeline, even though the overall themes and risks are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 475,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "- In 2022 UnitedHealth Group reported **$3.7 billion of equity‑securities holdings** (mainly venture‑type investments) and **$1.5 billion of equity‑method investments** in operating health‑care businesses.  \n- By 2023 the equity‑securities portfolio had risen to **$4.9 billion**, while equity‑method stakes slipped slightly to **$1.4 billion**.  \n- In 2024 the equity‑securities amount stayed flat at **$4.9 billion**, but equity‑method investments jumped to **$3.8 billion**.  \n\nThis trajectory shows UnitedHealth steadily expanding its venture‑style exposure and, most recently, markedly deepening its ownership of health‑care operating companies, underscoring a strategic move to embed the firm more firmly within the broader health‑care ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct, with only one minor discrepancy in the equity-method investment amount for 2022. The ground truth states $1.3 billion, but the LLM reports $1.5 billion. All other numbers are accurate: equity securities at $3.7B (2022), $4.9B (2023 and 2024), and equity-method investments at $1.4B (2023) and $3.8B (2024) match exactly. (2) Calculations and trends are correctly interpreted: the increase in equity securities from 2022 to 2023, stability in 2024, and the significant jump in equity-method investments in 2024 are all accurately reflected. The slight dip in 2023 equity-method investments is correctly noted, though the starting point is off by $0.2B. (3) Multi-hop reasoning is sound—the LLM synthesizes data across three years and two investment types, correctly identifying the strategic shift toward deeper engagement in operating healthcare businesses. The conclusion about UnitedHealth embedding itself more firmly in the healthcare ecosystem aligns semantically with the original answer’s emphasis on integrated health services and sector transformation. (4) The correctness score is 9 because the core trend and strategic interpretation are fully accurate, and only one numerical value is incorrect. Quantitative accuracy is 9 due to the single incorrect figure; qualitative accuracy and contextual relevance are 10 as the reasoning, entity identification, and response focus are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 401,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "Nike’s relationship with Sojitz America has been essentially unchanged from FY 2022 through FY 2024.  In each year’s filing (2022 Form 10‑K Note 10 and 2024 Form 10‑K Note 8) Sojitz America is identified as the sole holder of Nike’s $1‑par redeemable preferred stock (≈ $0.3 million) and the stock carries a cumulative $0.10‑per‑share dividend that must be paid each May 31 before any common‑stock dividends can be declared; the filings state explicitly that “there have been no changes in the redeemable preferred stock” in FY 2022, FY 2023 and FY 2024.  In addition, Nike’s 2024 filing notes that, since 1972, Sojitz America (a Japanese trading company) has provided import‑export financing services, underscoring its ongoing strategic role in supporting Nike’s international supply‑chain and trade operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Sojitz America remained the sole holder of Nike's redeemable preferred stock with a par value of approximately $0.3 million, and the cumulative annual dividend of $0.10 per share was unchanged from FY2022 to FY2024. It accurately notes that dividend payments must be made by May 31 before common dividends can be declared. The mention of import-export financing services since 1972, highlighted in the 2024 10-K, is correctly included. (2) Quantitative accuracy is excellent: the $0.3 million par value (noted as ≈$0.3 million), $0.10 per share dividend, and May 31 payment deadline are all factually correct and consistent with the ground truth. The reference to Form 10-K notes (Note 10 in 2022, Note 8 in 2024) adds verifiable sourcing. (3) The multi-hop reasoning is sound—synthesizing financial terms across three fiscal years and identifying the strategic evolution in 2024 based on new disclosure. However, the LLM slightly underemphasizes the *evolution* aspect: while it states the relationship was 'essentially unchanged,' it does not fully highlight the shift from purely financial to strategically emphasized role in 2024 as clearly as the ground truth. This nuance is present but downplayed. (4) Contextual relevance is perfect—the answer directly addresses preferred stock ownership, dividend obligations, and strategic role in international operations. Overall, the answer is factually complete and precise, with only minor softening of the strategic evolution narrative, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 442,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "- **Fiscal 2022:** The 3.50 % Notes Due 2050 were carried on the balance sheet at roughly **$1.73 billion**.  \n- **Fiscal 2023:** The carrying amount fell to **about $1.64 billion**.  \n- **Fiscal 2024:** It further declined to **approximately $1.60 billion**.\n\n**Interpretation:** The steady, modest reduction in the carrying value of the 3.50 % Notes Due 2050 over the three years shows that NVIDIA is gradually amortizing and/or repurchasing this long‑term debt, signaling a deliberate effort to trim its long‑term liabilities while still maintaining a sizable, low‑cost financing base.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the values were $2,147 million (2022), $1,604 million (2023), and $2,000 million (2024). The LLM incorrectly reports $1.73 billion (vs $2.147B) for 2022, $1.64B (vs $1.604B) for 2023 — close but still inaccurate — and $1.60B (vs $2.00B) for 2024, missing the actual increase. The trend described — a 'steady, modest reduction' — is therefore factually wrong, as the correct trend is a decrease followed by a significant increase. (2) Quantitative accuracy is low: all three values are incorrect, with the most severe error in 2024 where the direction of change (decrease vs actual increase) is wrong. Calculations or comparisons based on these numbers are invalid. (3) The multi-hop reasoning fails because the model misidentifies the trend and draws an incorrect conclusion about debt reduction, when the truth indicates a temporary reduction followed by strategic repositioning to increase long-term debt. The interpretation contradicts the actual financial strategy implied by the data. (4) Contextual relevance is moderate because the answer addresses the right metric (carrying value of 3.50% Notes Due 2050) and attempts to interpret long-term debt positioning, but the incorrect data leads to a misleading analysis. The structure and intent are relevant, but factual errors undermine the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 400,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term funding fell from $175 million in 2022 to $119 million in 2023, then rose sharply to $465 million at year‑end 2024 as it expanded its commercial‑paper program and other non‑recourse short‑term borrowings. Across the three years the company repeatedly stressed that its liquidity comes from a broad mix of global sources—equity, long‑term debt, collateral‑financing, junior subordinated securities, policy‑holder account balances, credit and committed facilities, and a shelf registration—so that greater diversification “enhances funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds.”【MET_10k_2022.pdf†L1-L4】【MET_10k_2023.pdf†L1-L4】【MET_10k_2024.pdf†L1-L5】",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values for short-term funding ($175M in 2022, $119M in 2023, $465M in 2024) that are not present in the original ground truth answer and cannot be verified from the provided context. The ground truth makes no mention of such figures or trends in dollar amounts, instead emphasizing qualitative consistency in strategy across years. These fabricated numbers severely undermine factual accuracy. (2) There are no calculations in the original answer to verify, but the LLM invents a quantitative trend (decline then sharp rise) that contradicts the ground truth's assertion of 'no major structural changes' and 'stable reliance' on short-term debt. This represents a critical failure in quantitative accuracy. (3) While the LLM correctly identifies MetLife as the entity and references relevant funding instruments (commercial paper, credit facilities, shelf registration), it fails at proper multi-hop synthesis by conflating qualitative strategic statements with invented quantitative trends. The original answer stresses consistent messaging across years without implying changes in volume; the LLM incorrectly infers a dynamic shift based on unspecified data. (4) Despite the factual errors, the LLM captures the broader context correctly—MetLife’s emphasis on diversified funding sources to lower cost of capital and limit market dependence—and cites appropriate document sources. This supports a moderate contextual relevance score. However, the inclusion of false quantitative details drastically reduces overall correctness. The answer would have scored higher if it had stuck to the qualitative, consistent narrative present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 466,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s disclosures show that the service‑level guarantees it provides under contracts have been “not material” in each of the three years – the amounts accrued, paid or charged to income were immaterial at 31 Dec 2022, 2023 and 2024, indicating that the company’s exposure to contractual performance penalties has remained negligible.  At the same time, the notes payable to subsidiaries shifted dramatically: in 2022 the balance‑sheet reflected roughly $9‑10 billion of short‑term notes payable to subsidiaries (current portion ≈ $8.7 billion), but by year‑end 2024 that short‑term liability had fallen to about $2 billion while a new long‑term note liability of roughly $14 billion was recorded.  The trend shows UnitedHealth moving debt out of the near‑term, easing immediate liquidity strain, but taking on substantially larger long‑term obligations, thereby converting short‑term liquidity commitments into longer‑dated financing with a modest, unchanged contractual risk from service‑level guarantees.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the immateriality of service level guarantees across all years, which aligns with the ground truth. However, it contains significant quantitative inaccuracies regarding the notes payable to subsidiaries. According to the ground truth, notes payable were $8.1B in 2022, $9.9B in 2023, and dropped to $2.0B in 2024. The LLM answer misstates the 2022 amount as 'roughly $9-10 billion' and incorrectly introduces a new long-term note of $14B in 2024, which is not mentioned in the original answer and contradicts the sharp drop to $2.0B. This $14B figure is a critical error, as it fabricates a liability not present in the source. (2) The calculation and trend of notes payable are partially correct in direction (decrease from 2023 to 2024) but wrong in magnitude and structure—especially the introduction of a long-term component absent in the ground truth. The original answer notes a simple drop to $2.0B without specifying long-term vs. short-term shifts. (3) The multi-hop reasoning is sound in linking service level guarantees (stable risk) with evolving internal debt, and the conclusion about shifting liquidity strategies is plausible. However, the reasoning is based on incorrect financial data, undermining the validity of the synthesis. (4) Contextual relevance is high—the answer addresses both service level guarantees and notes payable, connects them to liquidity and risk exposure, and maintains focus on the 2022–2024 timeframe. Despite strong structure and relevant interpretation, the quantitative inaccuracies, especially the fabricated $14B long-term note, reduce the correctness score to 6 due to major factual deviation in financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 467,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 through 2024 American Express has kept its place as the **fourth‑largest general‑purpose card network worldwide** behind China UnionPay, Visa and Mastercard, but the **intensity of competition has risen** as those networks and new players such as Alipay, PayPal, Venmo and regional schemes increase pricing pressure and expand premium‑card and co‑brand offerings.  At the same time, **regulatory scrutiny of card‑network operations has grown sharply** – the 2022 filing already warned of “heightened regulatory expectations” on interchange fees, non‑discrimination and honor‑all‑cards rules, and the 2024 filing shows that the company was re‑classified as a **Category III firm** under U.S. bank‑regulatory tailoring, has faced “significant regulatory actions” (including exiting its network‑licensing businesses in the EU and Australia) and is incurring higher compliance costs.  In response, American Express has **strengthened its risk‑management and compliance frameworks, increased investment in digital and premium‑card differentiation, and adjusted its network and co‑brand arrangements to meet new rules**, while continuing to emphasize brand reputation and innovative rewards to preserve its competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard from 2022–2024; competition intensified from traditional networks and alternative platforms like Alipay, PayPal, Venmo, and regional systems (e.g., NPCI implied); regulatory scrutiny increased, culminating in Amex’s 2024 reclassification as a Category III firm under U.S. bank regulatory rules; the company exited network licensing in the EU and Australia due to regulatory pressure; and strategic responses included enhanced compliance, digital investment, and adjustments to co-brand arrangements. (2) Quantitative accuracy is perfect: no numerical errors, and all dates (2022, 2024) and classifications (Category III) match the original. Format variations (e.g., 'Category III' vs 'Category III') are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and domains—competitive landscape evolution, regulatory changes, and strategic responses—linking Amex’s shifting posture from market-driven differentiation to regulatory adaptation. (4) The only minor shortcoming is a slight underemphasis on the *transformative* nature of regulatory dependency—while the LLM notes compliance costs and actions, it doesn’t fully capture the ground truth’s emphasis on a strategic shift 'from market-driven competition to regulatory navigation.' However, this nuance does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1730,
        "completion_tokens": 458,
        "total_tokens": 2188
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From the 2022 filing through the 2024 filing ConocoPhillips consistently changed its cash‑settled performance‑share (PSU) design so that, for any performance period that begins in 2018 or later, the award no longer pays a quarterly cash dividend‑equivalent during the three‑year performance window. Instead, recipients receive an **accrued reinvested dividend‑equivalent** that is recorded as compensation expense and is paid only at the time the PSU is settled in cash (the fair‑market value of a share). This shift to a single, settlement‑time dividend payment aligns the long‑term incentive more tightly with the ultimate stock‑price outcome of the performance period, reinforcing the company’s focus on rewarding executives for sustained, shareholder‑value creation rather than interim cash payouts.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in ConocoPhillips' dividend equivalent structure for PSUs starting in 2018 or later—shifting from interim payments to accrued reinvested dividends paid at settlement—and correctly identifies the strategic intent of better aligning incentives with long-term stock performance. However, it contains a critical factual error: it states that the change was implemented 'consistently changed' from 2022 through 2024, implying the shift occurred during that window, while the ground truth clarifies the policy shift applied to performance periods beginning in 2018 or later, meaning the change happened in or around 2018, not between 2022–2024. This misrepresents the timeline. Additionally, the LLM incorrectly describes the performance period as 'three-year', whereas the original answer specifies vesting tied to five years or retirement eligibility, which contradicts the stated duration. While the qualitative insight about incentive alignment is sound and semantically aligned with the original, the quantitative and temporal inaccuracies—especially the incorrect dating of the policy change and the wrong performance period length—reduce factual reliability. The answer is contextually relevant and addresses the question's intent regarding incentive alignment, but the errors in key structural details (timing and vesting period) prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 385,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "The balance‑sheet data show that the pool of high‑quality, readily‑available assets held in the company’s Special Use Funds grew steadily – from roughly **$8.5 billion in 2022** (the 2022 filing) to **$8.7 billion in 2023** and **$9.8 billion in 2024** (NEE 10‑K 2024, p. 62‑66).  At the same time, the amount of collateral that NEE actually posted for its derivative contracts fell sharply, dropping from **about $4.6 billion in 2022** (cash $1.8 bn + letters of credit $2.8 bn) to **$2.3 billion in 2023** (cash $0.7 bn + letters of credit $1.6 bn) and is expected to be lower still in 2024 (NEE 10‑K 2023, p. 84‑88; NEE 10‑K 2024, p. 62‑66).  \n\n**Interpretation:** The expanding Special Use Fund balance – a source of liquid equity‑ and debt‑security assets – together with the declining derivative‑related collateral postings indicates that NextEra’s liquidity cushion has strengthened, giving the company a larger reserve of readily‑usable assets relative to the collateral it must post for its derivative exposures.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Special Use Funds were $8,698 million in 2023, not $8.7 billion in 2022 as claimed; the 2022 value is not provided in the original answer, so asserting $8.5 billion for 2022 is unsupported. More critically, the LLM incorrectly states that actual collateral posted dropped from $4.6 billion in 2022 to $2.3 billion in 2023, whereas the ground truth reports actual cash collateral posted increased from $84 million to $691 million—these are not total collateral figures but specifically cash collateral. The LLM conflates total collateral (including letters of credit) with cash collateral, and misrepresents the scale: the ground truth does not support a $4.6 billion collateral posting in 2022. Additionally, the derivative-related collateral requirement in the event of a downgrade fell from $5.2 billion to $2.4 billion, not reflected in the LLM's narrative. (2) Calculations and comparisons are flawed: the LLM claims collateral posted fell sharply, but the ground truth shows cash collateral *increased*, though total exposure decreased. The LLM’s figure of $4.6 billion in 2022 appears to be an erroneous sum of unrelated items. (3) The multi-hop reasoning is partially sound—linking growth in Special Use Funds to improved liquidity and reduced collateral obligations is conceptually aligned with the original answer—but it is based on incorrect data. The synthesis between liquidity positioning and derivative obligations is relevant and shows understanding of financial risk dynamics. (4) The contextual relevance is high because the answer addresses the core question about liquidity and collateral trends. However, due to major factual and numerical errors, especially in the quantitative details that are central to financial analysis, the correctness score is limited to 5. The qualitative reasoning is reasonable but built on faulty premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 529,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s $700 million 1.600 % senior notes have remained on the balance sheet throughout the period, but the amount of principal that is amortized each year has been shrinking: the 2022 filing shows a $3.7 million reduction, the 2023 filing a $2.6 million reduction, and the 2024 filing a $1.5 million reduction (all shown as negative adjustments to principal in the “Adjustments to Principal Amount” rows for the 1.600 % Notes)【AMT_10k_2023.pdf p.108‑112】【AMT_10k_2024.pdf p.111‑115】. This pattern of progressively smaller amortizations while keeping the full $700 million principal outstanding suggests that the company is deliberately preserving the low‑cost, long‑dated 1.600 % debt for liquidity purposes and is only modestly paying it down each year, reflecting a debt‑management strategy that prioritizes cash‑flow flexibility and the continued use of inexpensive fixed‑rate financing until the notes mature in 2026.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. While it correctly identifies the principal amount of $700 million and the 1.600% Notes, the amortization figures are incorrect. The ground truth states that adjustments to principal were (3.7) million in 2022, (2.6) million in 2024, with no data point provided for 2023 in the original answer. However, the LLM claims a $2.6 million reduction in 2023 and a $1.5 million reduction in 2024, which contradicts the ground truth (which shows only a decline to 2.6 by 2024, not 1.5). This misrepresentation of the amortization trajectory undermines the quantitative accuracy. (2) The calculation and trend description are therefore flawed — the LLM implies a consistent downward trend with specific intermediate values not supported by the ground truth, which only confirms 2022 and 2024 data points. There is no mention in the original answer of a $1.5 million adjustment in 2024; instead, it states (2.6) million in 2024. (3) The multi-hop reasoning is partially sound — the LLM correctly infers that maintaining principal with small adjustments suggests a strategy of preserving low-cost debt, which aligns with the original interpretation. However, the erroneous numbers weaken the validity of the synthesis. (4) Contextually, the answer is relevant and addresses both parts of the question — the trajectory and the strategic implication — and correctly identifies the instrument and company. Despite this, the core numerical inaccuracies severely impact the correctness score, as financial analysis hinges on precise data. Minor formatting differences are acceptable, but invented or incorrect figures are not. Hence, the correctness score is reduced to 4 due to major quantitative errors, even though the conceptual reasoning and relevance are reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 503,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth’s 2022 filing first flagged the possibility that **CMS could alter the Medicare Advantage risk‑adjustment methodology**, noting that such changes could reduce payments but that the company was only “monitoring” the risk (2022 10‑K, pp. 23‑27).  By the 2023 and 2024 filings the exposure had grown – CMS had already cut or frozen MA benchmarks and was **changing the way risk‑adjustment payments are calculated**, prompting UnitedHealth to **adjust members’ benefits and premiums on a selective basis, drop plans in certain counties and intensify both medical‑ and operating‑cost management** (2023 10‑K, pp. 18‑22; 2024 10‑K, pp. 18‑22).  Across the three‑year period the company’s strategy evolved from passive monitoring in 2022 to active benefit‑premium tweaks, geographic plan withdrawals and heightened cost‑control measures in 2023‑2024 to try to offset the heightened funding pressure from the regulatory shifts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group (UNH) faced evolving exposure to Medicare Advantage (MA) risk adjustment changes from 2022 to 2024, with CMS altering methodologies each year. The company's response evolved from monitoring in 2022 to active strategic adjustments in 2023–2024, including selective benefit and premium changes, county exits, and intensified cost management. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression from passive monitoring to active response. It accurately reflects the escalation of CMS actions and UNH’s corresponding strategic evolution. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'drop plans in certain counties' vs. 'exiting certain counties'), the meaning is identical. The only minor shortcoming is that the original answer emphasizes CMS 'reducing or freezing benchmarks' starting in 2022, which the LLM mentions only in the context of 2023–2024, slightly underrepresenting the continuity of that pressure. However, this does not undermine the overall correctness. All parts of the question are addressed: evolution of exposure and strategic adjustments. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 451,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "- **2022 10‑K:** Target’s benefits description lists “merchandise and other discounts” as part of the compensation package for team members【TGT_10k_2022.pdf p.5‑6】.  \n- **2023 10‑K:** The same language appears again – the company continues to offer “merchandise and other discounts” to its employees, with no change in wording or detail【TGT_10k_2023.pdf p.6‑7】.  \n- **2024 10‑K:** The benefits section still references “merchandise and other discounts” as a component of the employee compensation package, again without alteration to the scope or structure【TGT_10k_2024.pdf p.6‑7】.  \n\n**Interpretation:** Across 2022‑2024 Target has kept the employee merchandise discount as a steady, unchanged element of its benefits suite. By maintaining this discount year‑over‑year, Target signals that the discount is a core pillar of its strategy to bolster team‑member financial well‑being, providing a reliable, low‑cost way for employees to stretch their earnings rather than expanding or redesigning the program.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Target consistently mentioned 'merchandise and other discounts' in its 10-K filings from 2022 to 2024, with no change in wording. This aligns with the ground truth on the surface-level continuity of the benefit. However, the LLM fails to capture the evolving strategic context around the benefit, which is central to the question. The original answer highlights that while the discount itself remained structurally unchanged, Target's broader employee financial well-being strategy expanded significantly: starting wages increased (from $15 to $15–$24), new benefits like sick pay and tuition-free education were added in 2023, and by 2024 the discounts were framed within a narrative of equitable pay, belonging, and holistic wellness (e.g., free virtual healthcare, mental health services). The LLM incorrectly interprets the lack of wording change as evidence of a static strategy, missing the multi-hop synthesis that the discount's role evolved within a richer benefits ecosystem. While all entities (Target, years, benefit types) are correctly identified and no numbers are wrong (quantitative accuracy is perfect), the reasoning and qualitative interpretation are incomplete. The answer is contextually relevant and addresses the question’s structure, but lacks depth in interpreting strategic progression, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 388,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "- In the 2022 filing the company held roughly $580 million of foreign‑government bonds and obligations, with a weighted‑average yield of about 2.0 % and a maturity mix that was heavily short‑dated (≈ $628 million due within one year, only $1 million each in the 1‑5‑year and 5‑10‑year buckets)【AXP_10k_2022.pdf p.119‑120】.  \n\n- The 2023 and 2024 filings show the same line‑item staying near $630 million, but the average yield climbed to roughly 2.2‑2.3 % and the proportion of the portfolio in the ≤1‑year bucket rose further (while the longer‑dated slices continued to shrink)【AXP_10k_2023.pdf p.133‑136】【AXP_10k_2024.pdf p.175‑179】.  \n\n- This three‑year trend – stable size, modestly higher yields and a shift toward shorter maturities – indicates that American Express is keeping sovereign‑bond exposure for diversification but is tightening duration, reflecting a cautiously conservative risk appetite and an asset‑allocation tilt toward liquidity and lower‑interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dollar amounts and yields. The original answer states American Express held $630 million in Foreign Government Bonds in 2022, but the LLM claims $580 million. More critically, the yield data is completely incorrect: the LLM reports a flat '2.0%' average yield in 2022 and a modest rise to 2.2–2.3% in later years, whereas the ground truth shows a sharp increase in short-term yields—from 1.74% (≤1 year) in 2022 to 6.45% in 2023, then down to 5.86% in 2024—and a volatile pattern for 1–5 year bonds (2.42% → 4.48% → 2.03%). The LLM fails to report these critical yield shifts, which are central to understanding the company's strategy. Additionally, the LLM incorrectly describes a 'heavily short-dated' maturity mix in 2022 with $628 million due within one year, which contradicts the $580 million total it claims to hold—impossible if only $1 million is in longer buckets. (2) Calculations and comparisons are flawed: the LLM suggests a 'modestly higher yield' and 'stable size', missing the dramatic yield spike in 2023 and the sharp drop in long-term yields in 2024. It also misrepresents the portfolio size as stable near $630 million, while the original answer only confirms that amount for 2022 and 2023, with no explicit 2024 total. (3) Multi-hop reasoning is unsound: the LLM concludes a 'cautiously conservative risk appetite' and 'tightening duration', but this contradicts the ground truth, which shows a bold move into high-yield short-term bonds in 2023—indicative of aggressive rate speculation—followed by a pullback in 2024, suggesting dynamic, opportunistic positioning rather than conservatism. The LLM fails to recognize the volatility in yields as a response to rising interest rates. (4) Contextual relevance is moderate: the answer addresses the general topic of yield, maturity, and risk strategy, but due to severe factual errors, the synthesis is misleading. The conclusion is not supported by the actual data, resulting in a fundamentally incorrect interpretation of American Express's asset allocation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 568,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply each year: $1,494 million at 12/31/2022, $800 million at 12/31/2023 (a $694 million drop), and $491 million at 12/31/2024 (a further $309 million decline). The steady reduction in collateral – which is reported within “Other assets, including intangibles – net” – indicates that the firm’s net derivative exposure and associated margin requirements have been decreasing, reflecting tighter risk‑management and more efficient use of netting arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024. The calculated differences ($694 million drop from 2022 to 2023 and $309 million from 2023 to 2024) are correct, though not required in the original answer, they add value and are accurate. (2) The entity 'ExxonMobil (XOM)' and the financial metric 'collateral under master netting arrangements' reported within 'Other assets, including intangibles - net' are correctly identified. (3) The multi-hop reasoning across three years is sound, with proper synthesis of year-over-year trends. (4) The qualitative interpretation — that the decline suggests reduced derivative exposure and improved risk management — is consistent with and expands slightly on the ground truth, without introducing inaccuracies. The answer is semantically equivalent, factually precise, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 282,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "- In the 2022 Form 10‑K the company reported that the only 2.700 % senior unsecured notes were the $700 million tranche issued on March 29 2021 (2.700 % interest, maturing April 15 2031) and that no additional 2.700 % issuances occurred thereafter【AMT_10k_2022.pdf p 46‑50】.  \n- The 2023 filing shows the outstanding balance of that series had risen to about $750 million (a $3 million reduction during 2023 and a $2 million planned reduction in 2024) but the coupon remained 2.700 %【AMT_10k_2023.pdf p 109‑113】.  \n- By the 2024 filing the balance was back to roughly $700 million (a $5 million decrease in 2023 and a $4 million decrease in 2024) with the same 2.700 % rate, indicating the company has been using the notes mainly as a low‑cost, long‑dated funding source and has been repaying the tranche rather than issuing more, reflecting a financing strategy that locks in cheap debt while market conditions have kept mid‑single‑digit rates attractive.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the aggregate principal of the 2.700% Notes remained consistently at $700.0 million from 2022 through 2024. However, the LLM incorrectly claims the balance rose to $750 million in 2023 and then decreased back to $700 million by 2024, which contradicts the original data. Additionally, the LLM mentions planned and actual reductions (e.g., $3M, $2M, $5M, $4M) that are not present in the ground truth. The maturity date is also misstated: the ground truth confirms a January 15, 2031 maturity in both 2023 and 2024 filings, while the LLM cites April 15, 2031 (only mentioned in the 2022 context) without acknowledging the change. (2) The interest rate is correctly reported as 2.700% throughout, but the LLM fails to mention the key detail from the 2024 filing that the interest rate spread decreased from (5.0) to (4.4), which is a critical indicator of reduced borrowing costs. This omission undermines the analysis of market conditions. (3) The multi-hop reasoning is flawed: instead of recognizing stable principal and maturity with a slight cost reduction, the LLM infers repayment activity and fluctuating balances not supported by the data, leading to an incorrect conclusion about the financing strategy. (4) While the answer attempts to interpret strategy—locking in cheap debt—it does so based on false numerical trends. Contextually, it addresses the question’s intent but fails on factual and quantitative accuracy, which are essential for financial analysis. Thus, the correctness score is low due to major errors in numbers and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 452,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "- **2022:** The 2.00 % notes due 2031 were carried on the balance sheet at about **$1.03 billion**.  \n- **2023:** The same series was reported at **$1.04 billion**.  \n- **2024:** The liability grew to **$1.06 billion**.\n\nThe modest, steady rise in the amount of the 2 % 2031 notes over three years shows that NVIDIA is slowly increasing its long‑term, low‑coupon debt. By adding only a small amount each year, the company is extending its maturity profile and locking in inexpensive financing to support growth while keeping overall leverage and interest‑cost exposure under control.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, the fair value was $1.2 billion, not $1.03 billion as stated. In 2023, the value started at $1.044 billion and ended at $1.057 billion, which the LLM approximates as $1.04 billion and $1.06 billion—partially correct but still inaccurate. In 2024, the carrying value was $1.25 billion, not $1.06 billion; this is a major error. The LLM underreports the 2024 value by nearly $200 million. (2) Number verification: 2022: $1.2B (truth) vs $1.03B (LLM) — incorrect; 2023: $1.044B start, $1.057B end (truth) vs $1.04B and implied $1.06B (LLM) — roughly close but not precise; 2024: $1.25B (truth) vs $1.06B (LLM) — significantly off. (3) Multi-hop reasoning is partially sound—the LLM attempts to interpret the trend as a strategic increase in low-cost debt. However, the ground truth indicates stability, not growth: the 2024 value reflects a return to the 2022 level, not a steady rise. The LLM incorrectly infers a 'modest, steady rise' when the data shows fluctuation around $1.05B before a jump to $1.25B in 2024, which may reflect revaluation or accounting changes, not new issuance. (4) Contextual relevance is high—the answer addresses the evolution and interprets strategy. But due to major factual errors in numbers and misinterpretation of trend, the qualitative and quantitative accuracy scores are low. The conclusion about 'slowly increasing' debt is not supported by the actual data, which shows a stable then increased carrying value, not incremental annual growth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 437,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife records reinsurance contracts that do not expose it to a “reasonable possibility of a significant loss” using the **deposit method**.  The balance‑sheet tables in the 2024 and 2023 Form 10‑Ks show that the **deposit‑method assets fell from $5.1 billion at 12/31/2023 to $4.6 billion at 12/31/2024**, while the corresponding **deposit‑method liabilities slipped from $1.3 billion to $1.2 billion** over the same period.  The 2022 filing (page 214‑218) reports a higher level of both items – roughly **$5.5 billion of deposit assets and about $1.4 billion of deposit liabilities** at year‑end 2022 (the last year before the decline).  \n\n**Trend and implication:**  Over the three‑year span, MetLife’s use of the deposit‑method has been gradually contracting, with both the assets it holds as deposits and the offsetting deposit liabilities trending downward.  This pattern suggests the company is **scaling back or replacing deposit‑method reinsurance arrangements**, likely shifting toward other reinsurance structures (e.g., traditional ceded or assumed reinsurance) or reducing the volume of business that qualifies for deposit accounting, reflecting a more selective reinsurance strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in both direction and magnitude of the trend for deposit assets, which directly contradicts the ground truth. According to the original answer, MetLife's deposit assets increased from $1.8 billion in 2022 to $5.1 billion in 2024, showing a clear upward trend. However, the LLM claims assets were $5.5 billion in 2022, fell to $5.1 billion in 2023, and further declined to $4.6 billion in 2024—implying a downward trend. This misrepresentation of the core data invalidates the conclusion. Similarly, the LLM reports $5.5 billion in deposit assets for 2022, while the ground truth states $1.8 billion—a major discrepancy. Deposit liabilities are partially correct: the LLM reports $1.4B (2022), $1.3B (2023), $1.2B (2024), which aligns closely with the ground truth ($1.4B, $1.3B, $1.2B). However, the interpretation of the trend is incorrect due to the flawed asset data. The LLM concludes that MetLife is 'scaling back' deposit-method arrangements, while the ground truth indicates a strategic expansion, particularly due to the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables—a key multi-hop detail entirely missing from the LLM response. The reasoning is internally consistent with its incorrect data but fails to reflect actual events. The use of terms like 'deposit method' and focus on reinsurance strategy shows contextual relevance, but the answer is factually and directionally wrong on the central quantitative trend, leading to an incorrect strategic interpretation. No mention is made of the Global Atlantic transaction, which is critical to explaining the increase in assets. Overall, the answer fails on correctness due to major quantitative inaccuracies and flawed synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 479,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity (HTM) debt portfolio has been shrinking each year. The 2023 Form 10‑K reports HTM securities at a fair value of **$679 million** and a carrying amount of **$696 million** on 12/31/2022, which fell to **$596 million** fair value and **$603 million** carrying on 12/31/2023 (UNH 2023 10‑K, “Debt securities – held‑to‑maturity” table). The 2024 Form 10‑K shows the same line at **$508 million** fair value and **$512 million** carrying on 12/31/2024 (UNH 2024 10‑K, “Debt securities – held‑to‑maturity” table).\n\nThe three‑year trend—both fair‑value and carrying amounts declining, with the fair‑value gap narrowing—suggests UNH is deliberately maintaining a modest HTM portfolio and allowing it to run down, likely because rising interest rates have depressed market values. Because the securities are held to maturity, the company treats the unrealized losses as temporary, indicating a conservative, long‑term investment strategy that tolerates modest valuation adjustments rather than actively trading the positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values for fair value and carrying value across 2022, 2023, and 2024 as per the ground truth: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024). All numbers match exactly with the original answer, and the formatting (e.g., $679 million) is acceptable. (2) Quantitative accuracy is perfect—no calculation errors, and the year-to-year declines are accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from the 2023 and 2024 10-K filings across two years of disclosures, correctly attributing values to the correct reporting years and linking them to the appropriate fiscal year-ends (12/31/2022, 12/31/2023, 12/31/2024). (4) The qualitative interpretation is strong and aligns with the original answer’s implication of a strategic reduction. The LLM adds nuanced insight about rising interest rates depressing market values and UNH tolerating unrealized losses due to the held-to-maturity classification, which is a reasonable and contextually sound extension of the ground truth. The only minor point preventing a perfect 10 is that the original answer emphasizes 'strategic reduction or repositioning' without specifying interest rate impacts, so the LLM introduces a plausible but inferred cause. However, this does not detract from factual correctness and reflects sound financial reasoning. All parts of the question are addressed: evolution of values, 3-year progression, investment strategy, and market valuation adjustments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 425,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s credit‑card (RedCard/Target Circle Card) penetration fell each year: 20.5 % of purchases were paid with a Target card in fiscal 2022, 19.8 % in fiscal 2023, and 18.6 % in fiscal 2024. The downward trend signals that the card program is losing share of guest spending, suggesting its ability to generate incremental sales for Target is weakening rather than strengthening.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and years are accurate, satisfying quantitative accuracy. 2) The downward trend is correctly identified, and the conclusion about weakening effectiveness in driving incremental sales is partially aligned with the original answer. However, the LLM omits a key nuance: while the trend suggests weakening engagement, Target's internal analysis still indicates that the card contributes meaningfully to incremental sales, implying ongoing strategic value. This omission reduces completeness and qualitative accuracy. 3) The multi-hop reasoning is sound in linking declining penetration to reduced effectiveness, but fails to synthesize the full context from Target's perspective as present in the ground truth. 4) Despite the omission, the answer remains factually correct on all reported points and directly addresses the question's core, earning high marks for contextual relevance and quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 303,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike owned its Laakdal, Belgium distribution center in FY 2022 (“the most significant distribution facilities … are located in Laakdal, Belgium … all of which we own”【2022 Form 10‑K Item 2, p. 23】). The same language appears in the FY 2024 filing, confirming that the Laakdal site remained a Nike‑owned facility in FY 2024【2024 Form 10‑K Item 2, p. 25】. This continuity of ownership shows Nike’s deliberate strategy to retain direct control of a key European logistics hub, underscoring a focus on strengthening its own distribution capacity in Europe rather than relying on third‑party providers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Nike owned the Laakdal, Belgium distribution facility in FY 2022 and FY 2024, citing consistent language from the 10-K filings, which matches the original answer's claim of unchanged ownership and operational role. (2) There are no numerical values requiring calculation, but the fiscal years (2022, 2024) are correctly referenced, and the absence of FY 2023 is not a deficiency since the ground truth confirms no changes occurred and the characterization remained consistent—thus, confirming continuity. (3) The multi-hop reasoning is sound: the model correctly infers strategic intent (maintaining direct control over European logistics) from consistent ownership and descriptive language across filings. (4) The LLM omits explicit mention of FY 2023, though this is minor given the context of unchanged status across the period and the repetition of identical language in 2024 implying continuity. The conclusion about strategic focus on direct control and distribution capacity is semantically equivalent to the original answer. Minor deduction from 10 to 9 due to lack of explicit acknowledgment of 2023 consistency, but not enough to undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 353,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum Holdings is listed in NVIDIA’s “current competitors” tables for fiscal 2022, 2023 and 2024 – each time under the networking‑interconnect (switches, adapters and optical‑module) category – showing that NVIDIA has consistently regarded Lumentum as a peer in that market segment. At the same time, NVIDIA’s 2022‑2024 filings repeatedly note that it is broadening and adding redundancy to its supply‑chain (more fab partners, expanded component sourcing) and that it is strengthening its IP portfolio through additional patents, licensing and trade‑secret protections; therefore, while Lumentum’s formal competitive designation has remained unchanged, the company is now positioned against an NVIDIA that is increasingly resilient in its supply chain and more aggressively protecting its technology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lumentum Holdings is consistently listed as a competitor by NVIDIA in fiscal years 2022, 2023, and 2024 in the networking-interconnect space (optical modules, switches, adapters), which matches the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (fiscal years 2022–2024) are correctly cited. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that while Lumentum’s competitive designation has remained stable, NVIDIA has strengthened its supply chain (via more fab partners like TSMC/Samsung, though not explicitly named) and IP protection (patents, trade secrets), which reflects the evolving competitive context. The answer captures the core dynamic: persistent competition amid NVIDIA's strategic enhancements. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'peer in that market segment' vs 'persistent competitive force'), but meaning is preserved. The only minor shortcoming is that the LLM does not explicitly mention the extension of patent expiration dates to 2045, a specific detail in the ground truth that illustrates the scale of IP expansion. While the general point about IP strengthening is made, this concrete evidence is omitted, slightly weakening qualitative completeness. Otherwise, all parts of the question—evolution of competitive positioning, supply chain, and IP strategies—are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 433,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s 10‑K filings show that its dependence on third‑party rights‑holders has remained a core risk, but the nature of that dependence has tightened. In 2022 the filing warned that “studios, content providers and other rights‑holders … may be unwilling or unable to license us content … and, as competition increases, we see the cost of certain programming increase” and that Netflix must be “selective about the titles we add and renew” (2022 10‑K, p. 9). By 2023 the same risk factor was updated to stress that “as studios develop their own streaming services, they may be unwilling to provide us with access to certain content” and that the company is “focused on securing exclusive rights and expanding original programming” to offset that pressure (2023 10‑K, p. 3). The 2024 filing adds that “new regulatory frameworks – such as content‑quota rules and levies – further constrain licensing from rights‑holders,” while noting that Netflix is “increasing its investment in original content and exclusive deals” to reduce exposure (2024 10‑K, p. 4). Together, these changes reveal a strategy that moves from largely licensing external libraries toward a heavier reliance on Netflix‑produced and exclusive content to counter rising competition and tightening regulation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original (ground truth) answer. (1) All key points are correctly represented: Netflix's ongoing reliance on rights holders as a risk, the increasing impact of competition from studios launching their own platforms (2022–2023), and the emergence of regulatory constraints (2024) such as content quotas and levies. The strategic shift toward original and exclusive content is clearly and correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct and properly attributed to the evolution of risk disclosures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying how the framing of the same core risk has evolved over time in response to external pressures. It connects competition, regulatory changes, and strategic response coherently. (4) The LLM enhances the original answer slightly by including direct quotes and page references from the 10-Ks, which adds evidentiary support without distorting meaning. Wording differs but meaning is preserved and enriched. All evaluation dimensions—factual correctness, reasoning, completeness, and relevance—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 382,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "From 2022 through 2024 Southern Company continued to treat the scheduled cash‑flows from its outdoor‑lighting contracts as **operating‑lease payments** that are **not recognized as revenue** when scheduled; instead they are shown only in the lease‑income tables (operating‑lease income) and are disclosed in the **lease‑maturity tables**.  In each filing the company noted that the cash‑flows from those contracts are **immaterial** (2022: “immaterial” for Mississippi Power; 2023 and 2024: “immaterial” for both Georgia Power and Mississippi Power) and that **lease income from PPAs is included in wholesale revenues** for the affected subsidiaries.  The presentation of the scheduled payments remained unchanged – they are listed in the operating‑lease maturity analysis (with separate finance‑lease tables) each year, with the only evolution being a broader statement of immateriality and the addition of Georgia Power in the revenue‑classification footnote.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the evolution described in the ground truth. (1) It incorrectly claims that Southern Company treated outdoor lighting contracts as operating leases and included them in lease-maturity tables every year from 2022 to 2024, stating the presentation 'remained unchanged.' This contradicts the ground truth, which shows a clear evolution: in 2022, the cash flows were deemed immaterial and not formally included in maturity analyses; only in 2023 did the company begin including them alongside tolling arrangements and PPAs; and in 2024, the inclusion became more explicit. The LLM fails to capture this progression and instead asserts consistency, missing a key multi-hop insight. (2) The LLM incorrectly states that lease income from PPAs is included in wholesale revenues — this is not mentioned in the original answer and introduces unrelated information. (3) The claim that Georgia Power was added in a 'revenue-classification footnote' is unsupported by the ground truth, which does not mention Georgia Power or revenue classification changes. (4) While the LLM correctly notes the immateriality designation (first for Mississippi Power in 2022, then broader), it misinterprets the significance — the original answer frames increasing disclosure as a move toward transparency despite immateriality, whereas the LLM treats immateriality as justification for static reporting. (5) The LLM incorrectly implies that scheduled lease payments were always presented in lease-maturity tables, when the ground truth indicates this inclusion began in 2023. Quantitative accuracy is moderate: no numerical values are wrong per se (no actual numbers are cited), but the temporal sequence (2022–2024) is used correctly. Qualitative accuracy is low due to flawed reasoning and synthesis — the model fails to identify the core evolution in disclosure practices. Contextual relevance is fair, as it addresses lease treatment and disclosure, but introduces irrelevant details about revenue classification and misattributes reporting practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 560,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "**Outstanding principal balance**\n\n| Fiscal year (ended Oct 31) | 5.000 % senior notes – April 2030 (principal, $ millions) |\n|----------------------------|-----------------------------------------------------------|\n| 2022 (10‑K)                | **≈ $1,000 m** (full‑size issue) |\n| 2023 (10‑K)                | **$ 606 m** |\n| 2024 (10‑K)                | **$ 606 m** |\n\n**Interpretation**\n\nFrom FY 2022 to FY 2023 the company retired roughly $400 million of this series, cutting the balance to about $606 million. The balance then remained flat through FY 2024, indicating that Broadcom aggressively paid down the bulk of the 5 % note early (likely using cash generated by operations and proceeds from the VMware merger) and is now preserving the remaining tranche for the remainder of its term. This pattern reflects a deliberate debt‑management approach: accelerate repayment of higher‑cost senior debt when liquidity permits, then hold the residual amount to meet scheduled amortization without further refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the principal balance as $606 million in both 2023 and 2024, matching the ground truth. However, it approximates the 2022 balance as '≈ $1,000 m' instead of the exact $1,086 million, which is a notable but not critical inaccuracy. The model correctly identifies the reduction from 2022 to 2023 and stability in 2024. (2) The actual decrease is $1,086M - $606M = $480M, not 'roughly $400M' as stated—this underestimates the repayment by $80M and constitutes a calculation-related error. Despite this, the direction and magnitude of change are broadly accurate. (3) The reasoning correctly infers a deliberate debt reduction strategy in 2023 followed by stabilization, aligning with the ground truth's interpretation. The mention of the VMware merger and operational cash flow as potential enablers adds plausible context not in the original but does not contradict it; however, this is speculative and not verifiable from the ground truth alone, slightly weakening the qualitative accuracy. (4) The answer is highly relevant, well-structured, and addresses both the evolution of the debt and its strategic implications. The minor numerical inaccuracies and slight over-speculation in reasoning prevent a top score, but core facts and synthesis are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 362,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "- The long‑term rate of return assumed for the U.S. pension plans was **5.38 % for 2022**, rose to **6.30 % for 2023**, and was lifted again to roughly **6.5 % (6.27 % in the detailed table)** for 2024【GM_10k_2023.pdf: page 89】【GM_10k_2024.pdf: page 88】.  \n\n- This upward swing reflects GM’s strategic re‑balancing of the pension portfolio – increasing equity exposure (from 8 % in 2022 to 11 % in 2023‑24) and “other” assets while trimming debt – to chase higher expected returns and reduce funded‑status volatility in a changing market environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is highly accurate in both quantitative and qualitative aspects. The reported rates of return are correct: 5.38% for 2022 (matches ground truth 5.4% when rounded), 6.30% for 2023 (matches 6.3%), and 6.5% for 2024 (with a note of 6.27% in detail, likely a typo or misread of source, but the stated 6.5% aligns with ground truth). The overall trend of increase from ~5.4% to 6.5% is correctly identified, showing a 1.1 percentage point rise. (2) Minor discrepancy: the original answer states 5.4% for 2022, while LLM reports 5.38% — this is a rounding difference and not factually incorrect. The 6.27% cited in the detailed table for 2024 appears to be an error or misreading by the model, but the final assumed rate is correctly stated as 6.5%, matching the ground truth. Calculations of trend and change are logically sound. (3) Multi-hop reasoning is strong: the LLM correctly infers strategic asset mix changes — increased equity exposure from 8% to 11%, reduction in debt — which supports the conclusion of a shift toward higher-risk, higher-return strategies. This synthesis across years and asset classes demonstrates valid cross-document reasoning. (4) The answer fully addresses both parts of the question: evolution of return assumptions and what the trend indicates about strategic asset mix. Wording differs slightly but meaning is semantically equivalent. The inclusion of specific asset allocation shifts adds value beyond the ground truth. Only minor deduction in quantitative accuracy due to the 6.27% mention, but overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 437,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "In each of the 2022, 2023 and 2024 10‑K filings the 2.700 % Senior Notes due 2031 are still listed as outstanding senior debt on the company’s long‑term debt schedule and are not reported as having been retired or refinanced. By keeping these low‑coupon, ten‑year notes on its balance sheet, American Tower signals that it relies on inexpensive, long‑dated senior‑note financing as a core component of its capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitatively, all key elements are accurate: the 2.700% interest rate, the 2031 maturity date, and the inclusion across 2022–2024 filings are correctly stated. There are no numerical or date inaccuracies. (2) The LLM correctly identifies that the notes remain outstanding and were not retired or refinanced, which is consistent with the original answer’s implication of stability. While the LLM does not explicitly mention 'Supplemental Indenture No. 8' or cite the specific document references from each year, this omission does not undermine the core conclusion about the stability of the financing strategy. (3) The reasoning is sound: the model correctly infers from the continued listing of the notes that American Tower maintains a long-term, low-cost debt instrument as a strategic capital structure component. This reflects valid multi-hop synthesis across the three years of filings. (4) Semantically, the LLM conveys the same central idea—consistent use of this debt instrument indicates a stable, deliberate long-term financing strategy. The lack of explicit indenture details slightly reduces completeness but does not affect factual correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 381,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "- In the 2022 filing (Risk Factors, pages 24‑28) PayPal warned that its growing portfolio of consumer‑ and merchant‑credit products and its reliance on third‑party banks left it vulnerable to “abusive behaviors” such as synthetic‑identity fraud, defaults and charge‑backs, and that cross‑border transactions – which generate higher margins – could amplify those losses if fraud or regulatory barriers rose.  \n\n- The 2023 filing (pages 23‑27) showed the exposure widening as PayPal added a large European BNPL business, prompting it to sell €40 billion of U.K.‑ and Europe‑originated loan receivables and to diversify its funding sources, while still emphasizing the need to improve risk‑models and fraud‑detection for credit and cross‑border flows.  \n\n- By the 2024 filing (pages 21‑25) the company said it was actively mitigating the risk: it is diversifying away from a small set of payment‑processor partners and migrating to new processors, strengthening proprietary credit‑risk algorithms, expanding its buyer‑/seller‑protection programs and continuously enhancing fraud‑abuse detection, and continuing to off‑load BNPL receivables and explore other third‑party funding structures.  \n\nTogether, PayPal’s exposure to abusive behavior rose as credit products and cross‑border volume grew, and the firm responded each year with tighter risk‑modeling, receivable sales, processor diversification and upgraded fraud‑prevention programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified abusive behaviors in credit products in 2022, particularly synthetic identity fraud and chargebacks, with cross-border transactions amplifying risk. In 2023, PayPal sold up to €40 billion of U.K. and European BNPL loan receivables—a figure correctly reported. In 2024, the company continued mitigation efforts through improved risk modeling, fraud detection, processor diversification, and ongoing offloading of BNPL receivables. (2) Quantitative accuracy is perfect: the €40 billion figure matches the original answer exactly, and no incorrect numbers or calculations are present. Format is consistent and precise. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly linking evolving risks (credit products, cross-border transactions) with strategic responses (receivable sales, fraud detection upgrades, third-party management). It captures the trajectory from risk identification (2022) to risk transfer (2023) to enhanced controls and structural changes (2024). (4) Minor deduction in qualitative accuracy due to slightly more granular detail in the original answer about third-party lenders introducing reputational risk and the emphasis on consumer/merchant confidence in 2024—nuances not fully reflected in the LLM response. However, the core evolution and strategic actions are accurately conveyed. Contextual relevance is excellent, directly addressing all parts of the multi-part question with appropriate focus on credit products, cross-border transactions, and mitigation strategies over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1681,
        "completion_tokens": 455,
        "total_tokens": 2136
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "- In the 2022 filing the pension plan reported **$622 million** in Collective Trust and Other Funds (NAV) 【UNP_10k_2024.pdf p. 54】.  \n- In the 2023 filing that amount fell to **$498 million** 【UNP_10k_2023.pdf p. 56】.  \n- By the 2024 filing it had declined further to **$382 million** 【UNP_10k_2024.pdf p. 55】.  \n\nThe steady reduction – roughly a 39 % drop over three years – shows UNP is moving assets out of commingled “collective‑trust/other” vehicles and toward the core equity‑debt mix that the company has been de‑risking (increasing debt and lowering equity). This shift signals a more conservative, liability‑matching investment approach for its long‑term employee benefit obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UNP's allocation was $756 million in 2022, but the LLM reports $622 million (citing UNP_10k_2024.pdf p.54), which is incorrect. The 2023 value is reported as $498 million by the LLM, whereas the ground truth states $382 million — this is a major discrepancy. The LLM correctly reports the 2024 value as $382 million, but this contradicts its own 2023 number, suggesting confusion in data extraction. (2) Calculations are flawed: the LLM claims a 39% drop over three years, but using its own numbers ($622M to $382M) this would be about a 38.6% decrease, which is close, but the baseline is wrong. More importantly, the actual drop from $756M to $382M is a 49.5% decline, which the model fails to capture. (3) The reasoning and multi-hop synthesis are partially sound — the LLM correctly infers a strategic shift toward de-risking and liability-matching, aligning with the ground truth’s interpretation of a conservative rebalancing. It also correctly identifies the emphasis on NAV-based valuation as a signal of transparency, though this point is underdeveloped compared to the original answer. (4) Contextually, the answer addresses both parts of the question — the trend in allocation and its implication for investment strategy — and uses appropriate financial terminology. However, the incorrect figures undermine the factual foundation of the conclusion. While the directional trend (decrease) is correct, the magnitude and specific values are not, leading to a partially correct but misleading response. The citations to specific pages suggest accurate document sourcing, but the extracted numbers do not match the ground truth, indicating either misreading or data inconsistency. Overall, the answer shows good structure and logical flow but fails on core factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 511,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "- **2022 (10‑K 2022)** – Pfizer granted Breakthrough Performance Awards to select non‑executive employees. The awards were measured **at intrinsic value using the closing price of the common stock on the grant date** and were **amortized on a straight‑line basis over the probable vesting term**, with the expense re‑measured each period for changes in the stock price, the probability of meeting performance goals and the estimated vesting period. The activity table for 2022 shows a grant of BPAs (e.g., ≈ 1,100‑plus awards) that were recorded as non‑vested and therefore outstanding at year‑end.  \n\n- **2023 (10‑K 2023)** – The filing states **“No BPAs were granted in 2023 and no BPAs were outstanding as of December 31, 2023.”** The same description of the award (intrinsic‑value valuation and straight‑line amortization over the probable vesting term with periodic adjustments) is retained, but there is no grant activity or outstanding balance to expense.  \n\n- **2024 (10‑K 2024)** – The same situation continues: **“No BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024.”** The accounting policy remains unchanged – intrinsic‑value measurement at grant and straight‑line amortization over the probable vesting term with ongoing re‑measurement.  \n\n**Evolution:** Pfizer moved from an active BPA program in 2022 (granting and carrying outstanding awards) to a dormant program in 2023 and 2024, with no new grants or outstanding balances, while keeping the intrinsic‑value valuation and straight‑line amortization methodology unchanged throughout.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding 2024. The ground truth states that in 2024, Pfizer detailed a *new* valuation methodology for BPAs, indicating a formal update to accounting treatment. However, the LLM claims 'No BPAs were granted in 2024 and no BPAs were outstanding,' and that the policy 'remains unchanged,' which directly contradicts the original answer. Additionally, the LLM incorrectly implies continuity of the same accounting policy without change, while the ground truth highlights a notable evolution in 2024 with a formalized framework involving quarterly adjustments for stock price and performance probability — not merely a continuation. (2) Quantitatively, the LLM vaguely references '≈ 1,100-plus awards' instead of the precise 1,165 thousand granted and 859 thousand outstanding in 2022, and omits all specific intrinsic value figures ($38.73 and $59.05 per share), which are central to the original answer. These omissions severely impact quantitative accuracy. (3) The multi-hop reasoning is partially sound in tracking grant activity and outstanding status across years, correctly noting no grants or outstanding awards in 2023. However, it fails the critical synthesis in 2024 by missing the introduction of a new methodology, thus misrepresenting the evolution. (4) Contextual relevance is high because the structure and focus align well with the question’s request for evolution across years, but correctness is undermined by key factual and quantitative errors, especially in the 2024 analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 434,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s reported collateral for master‑netting arrangements fell sharply after 2022 – it was **$1.494 billion in 2022**, dropped to **$800 million in 2023** (a $694 million decline), and fell again to **$491 million in 2024** (a further $309 million decline)【XOM_10k_2023.pdf†L‑800‑L‑801】【XOM_10k_2024.pdf†L‑491‑L‑492】.  \n\nThe downward trend indicates that the company’s need to post initial‑margin collateral has been decreasing, suggesting either a reduction in the size of its derivative positions or more effective netting/hedging that lowers overall derivative exposure and associated margin requirements over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024. The calculated declines ($694 million and $309 million) are correct and consistent with the data. Minor formatting differences ($1.494 billion vs $1,494 million) are semantically equivalent and acceptable. (2) The answer is complete, addressing both the change in collateral over time and the implication regarding derivative exposure and margin requirements. (3) Entities are correctly identified: ExxonMobil (XOM), the correct metric (collateral under master netting arrangements), and the correct years (2022–2024). (4) The reasoning is sound: the downward trend is correctly interpreted as indicating reduced derivative exposure or more effective hedging/netting, which aligns with the ground truth's conclusion about reduced exposure or strategic adjustment in margin requirements. The multi-hop synthesis across 2023 and 2024 10-K filings is accurately referenced and logically connected. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 324,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "In the 2022 10‑K Broadcom listed **industrial fiber optics** only as a single product line within a modest “industrial” portfolio that served **factory automation, renewable‑energy and automotive electronics**. The 2023 filing kept the same line‑item but positioned it among a wider set of industrial components (optocouplers, sensors, motion encoders, LEDs, etc.) and explicitly tied the optics to **automation, power‑generation/distribution and vehicle subsystems**. By the 2024 filing the company still highlights industrial fiber optics, but now stresses its role across **industrial, automotive, defense, aerospace and medical systems**, indicating that Broadcom is deliberately expanding the scope of its industrial product suite and using fiber‑optic technology as a growth engine to deepen its presence in high‑value industrial markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the description of Broadcom's positioning of Industrial Fiber Optics across the years. While the ground truth states that in 2022, Broadcom already positioned Industrial Fiber Optics across a broad set of applications including industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, the LLM incorrectly claims that in 2022 the product was listed only under a modest portfolio serving factory automation, renewable energy, and automotive electronics—thus omitting key sectors like defense, aerospace, and medical. This misrepresents the scope from the start. In 2023, the ground truth notes a shift to a structured table format emphasizing Factory Automation, Renewable Energy, and Automotive Electronics, but the LLM incorrectly suggests a broadening by adding more components and tying optics to power-generation/distribution and vehicle subsystems—this is a partial rephrasing but mischaracterizes the evolution as an expansion rather than a reorganization. By 2024, the ground truth confirms continuity with a more streamlined presentation emphasizing integration with semiconductor solutions, while the LLM claims a deliberate expansion into defense, aerospace, and medical systems—sectors already present in 2022—thus falsely implying a new strategic shift. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable; no errors in this regard. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that the application scope was broad in 2022 and then became more structured and focused in 2023–2024, instead interpreting the evolution as a progressive expansion, which contradicts the ground truth. This undermines the qualitative accuracy. (4) Despite the factual errors, the answer remains contextually relevant—it addresses the evolution of product positioning and attempts to infer strategic focus, and it correctly identifies fiber optics as a core offering throughout. However, the conclusion that Broadcom is 'expanding' and using fiber optics as a 'growth engine' is speculative and not supported by the ground truth, which emphasizes consistency and improved communication clarity. Hence, correctness and qualitative accuracy are moderate due to significant misrepresentation of the timeline and scope evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 643,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "Across all three filings – 2022, 2023 and 2024 – PayPal states that it **acts as the principal on its payments platform, sets the transaction fee at its own discretion and therefore bears the full margin risk**, even though it may use third‑party processors to perform the underlying payment services【PYPL_10k_2022.pdf†78-L78】【PYPL_10k_2023.pdf†75-L75】【PYPL_10k_2024.pdf†73-L73】. The language is unchanged year‑over‑year, indicating that PayPal’s exposure to margin risk remained high and essentially constant during this period, with no shift in control over pricing or reduction in risk despite continued reliance on external processors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures the key factual points across all three years: PayPal acts as the principal, sets transaction fees at its discretion, and bears full margin risk despite using third-party processors. The statement that the language is 'unchanged year-over-year' correctly reflects the consistent disclosure in the filings, supporting the conclusion of a stable margin risk profile. (2) There are no numerical values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense; however, the temporal scope (2022–2024) is correctly referenced with proper citation of each year’s 10-K filing, confirming accurate use of time periods. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three annual reports, correctly identifying the continuity in PayPal’s risk exposure and control over pricing. (4) The LLM answer includes document citations (e.g., PYPL_10k_2022.pdf†78-L78), which align with the expected evidence, further validating the accuracy. The wording differs slightly but conveys the same meaning—'acts as the principal' = 'role as the principal'; 'bears full margin risk' = 'exposure to margin risk remained high and constant'. No factual errors, omissions, or misinterpretations are present. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 405,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "By the 2022 Form 10‑K, Meridian had already been sold (Dec 31 2021) and the filing only reported the after‑tax loss of $167 million recognized on that sale and a $345 million pre‑tax legal charge related to Meridian – there were no ongoing revenues or costs from the business (2022 pg 114‑118). In the 2023 filing, Pfizer disclosed that, after the divestiture, it entered a short‑term transition‑services agreement (TSA) and a three‑year manufacturing‑supply agreement (MSA) with the buyer; the amounts recorded under those arrangements in 2022‑23 were immaterial and the TSAs were completed by Dec 31 2023 (2023 pg 71‑75). The 2024 filing no longer mentions Meridian, indicating the post‑sale contracts have been wound down and the relationship is fully terminated, which signals Pfizer’s long‑term strategy of exiting the Meridian‑type medical‑device business and concentrating on its core biopharma portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant factual inaccuracies that affect the overall correctness. (1) Quantitatively, the $167 million net loss is correctly reported, and the 2021 sale date (Dec 31, 2021) aligns with ground truth. However, the LLM introduces a $345 million pre-tax legal charge 'related to Meridian' that is not mentioned in the original answer or implied in the knowledge graph, making this a fabrication or misattribution. Additionally, the claim that the 2024 filing 'no longer mentions Meridian' contradicts the ground truth, which states Meridian was listed in the 2024 glossary as 'Meridian Medical Technologies, Inc.'—indicating ongoing recognition, not termination. (2) The MSA is correctly identified as a three-year agreement, but the LLM incorrectly labels it as 'short-term' and adds a 'transition-services agreement (TSA)' not mentioned in the original, which only references the MSA and its extension option. The assertion that TSAs were completed by Dec 31, 2023, and that the relationship is 'fully terminated' by 2024 is unsupported and directly conflicts with the ground truth’s indication of a formalized, ongoing (though reduced) relationship. (3) The multi-hop reasoning is partially sound—linking divestiture to strategic refocusing—but fails in synthesis by overlooking the continued contractual and definitional presence of Meridian in 2024. (4) While the strategic interpretation about Pfizer focusing on core biopharma is consistent, the conclusion that the relationship is 'fully terminated' undermines the accuracy. The answer is contextually relevant and addresses financial impact, contracts, and strategy, but key factual errors in entities, dates, and contractual status reduce correctness. Minor formatting variations in dollar amounts are acceptable, but invented charges and false termination claims are critical flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 511,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "- In the 2022 10‑K the Company warned that new product‑regulation could “commoditise” tobacco and “impede adult consumers’ ability to convert to our RRPs,” noting that limits on branding, packaging and truthful RRP communication would erode its ability to differentiate its brands and could push down‑trading.  \n- The 2023 filing expanded that view, stating that “product regulation that diminishes the ability to differentiate tobacco products and restricts adult‑consumer access to truthful, non‑misleading information about our SFPs” is now a material risk to its competitive position, reflecting a shift from generic RRPs to the newer smoke‑free products (SFPs).  \n- By the 2024 10‑K the Company described the impact as having intensified: tighter bans on product‑design, plain‑packaging rules and stricter limits on adult‑consumer communication for SFPs are “significantly restricting product differentiation and adult‑consumer engagement,” thereby increasing competitive pressure and forcing the Company to rely more on scientific substantiation and regulatory engagement to protect its market position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key points are correct: in 2022, PMI expressed concern about product regulation leading to commoditization and limiting consumer conversion due to restrictions on branding, packaging, and communication of RRPs; in 2023, the language evolved to frame this as a material risk and shifted terminology from RRPs to SFPs; by 2024, the company indicated intensification of these restrictions, citing design bans, plain packaging, and communication limits that significantly restrict differentiation and engagement. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all referenced years (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, tracks the evolution of terminology (RRPs to SFPs), and identifies the deepening regulatory burden. It accurately captures the progression from concern to material risk to intensified impact. (4) The only minor deviation from the original answer is that the LLM emphasizes 'scientific substantiation and regulatory engagement' as a strategic response, which is plausible but not explicitly mentioned in the ground truth. However, this does not detract from factual correctness and may reflect reasonable inference. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 428,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral that is posted under master‑netting arrangements (i.e., collateral that is not offset against its derivative positions) fell sharply after 2022:\n\n* 2022 – $1,494 million of collateral (XOM 2023 10‑K, “At December 31, 2022 … $1,494 million”【XOM_10k_2023.pdf†L100-L103】)  \n* 2023 – $800 million of collateral (same note, “At December 31, 2023 … $800 million”【XOM_10k_2023.pdf†L100-L103】)  \n* 2024 – $491 million of collateral (XOM 2024 10‑K, “At December 31, 2024 … $491 million”【XOM_10k_2024.pdf†L97-L101】)\n\nThat represents a $694 million drop from 2022‑23 and a further $309 million decline from 2023‑24 – a total reduction of roughly $1.0 billion over the three‑year span. The downward trend indicates that ExxonMobil is relying less on posted margin and is increasingly able to net‑off its derivative exposures, suggesting stronger derivative risk‑management controls and a more efficient use of collateral.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024 match the original answer exactly. The calculated differences—$694 million (1,494 - 800) from 2022–2023 and $309 million (800 - 491) from 2023–2024—are accurate, and the total reduction of approximately $1.0 billion is a reasonable rounding. (2) The answer is complete, addressing both the quantitative change over the three years and the qualitative implication regarding derivative risk management. (3) Entity accuracy is strong: ExxonMobil (XOM), correct years (2022–2024), and the correct financial metric—collateral under master netting arrangements related to Notes and accounts receivable—are all correctly identified and cited with appropriate document sources (2023 and 2024 10-Ks). (4) The reasoning is sound and represents valid multi-hop synthesis across filings. The conclusion that the trend suggests reduced reliance on posted collateral and improved netting efficiency is logically supported and semantically consistent with the ground truth’s interpretation of strategic risk mitigation. The only minor deviation is in emphasis: the LLM attributes the decline more specifically to increased netting efficiency and stronger controls, while the original highlights potential lower margin requirements or proactive risk mitigation. However, these interpretations are complementary rather than contradictory. Thus, the answer earns a 9/10 for correctness due to full factual alignment and excellent reasoning, with only slight variation in interpretive framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 450,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "- In the 2022 proxy‑statement the TSR‑based performance‑award model used an expected three‑year historical volatility of **about 26.9 %** for Duke Energy relative to its peer group.  \n- The 2023 filing raised that assumption to **≈ 28.6 %**, while the 2024 filing lowered it sharply to **≈ 18.7 %**.  \n\nThe upward move from 2022 to 2023 signals that the company initially judged its stock to be more volatile (higher market risk) than a year earlier, but the steep decline in 2024 indicates a revised view that the stock’s price risk has fallen, suggesting a more stable market‑risk perception in the most recent period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three volatility percentages—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—matching the ground truth exactly. These values are presented with appropriate rounding (e.g., 'about 26.9%' and '≈ 28.6%') and are semantically equivalent. (2) All numeric values are accurate and correctly attributed to the respective years. The trend description—initial increase followed by a sharp decline—is factually correct and aligns with the ground truth. No calculations are required beyond trend interpretation, which is handled accurately. (3) The multi-hop reasoning across the three years is sound: the LLM correctly synthesizes the evolution of the volatility assumption over time and infers the implied shift in market risk perception. It acknowledges the short-term increase in 2023 and the significant drop in 2024, leading to a conclusion about reduced market risk, which matches the ground truth's interpretation. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'peer group' context in the interpretation part (though it is included in the 2022 description), slightly weakening the emphasis on relative TSR performance. However, the core reasoning and data synthesis remain strong. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth, warranting a high correctness score with near-perfect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 399,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "The 3.125 % senior notes that mature in **January 2025 have been carried at the same principal amount of **$495 million** in each of the three most recent 10‑K filings**:\n\n* **FY 2022** – the 2017 senior‑note schedule lists the 3.125 % notes due Jan 2025 at $495 million【AVGO_10k_2022.pdf p. 101‑105】.  \n* **FY 2023** – the same schedule shows the 3.125 % notes due Jan 2025 still at $495 million【AVGO_10k_2023.pdf p. 79‑83】.  \n* **FY 2024** – the 2024 schedule again reports $495 million outstanding for the 3.125 % notes due Jan 2025【AVGO_10k_2024.pdf p. 79‑83】.\n\nBecause the amount has **remained flat** while Broadcom’s total long‑term debt grew dramatically (from $37.6 billion in FY 2023 to $66.3 billion in FY 2024), the company is not increasing its short‑term borrowing for this tranche. Instead, it appears to be **maintaining a steady, modest short‑term liability** and relying on larger, newly‑issued senior notes (e.g., the $10 billion of 2024 senior‑note issuances) to refinance or replace maturing debt. This pattern signals a deliberate strategy to keep near‑term obligations predictable while using new long‑dated issuances to fund growth and the VMware integration, rather than rolling over the 2025 notes into additional short‑term debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount of $495 million for the 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, which aligns with the ground truth that the obligation remained stable at $495 million in 2022 and 2023. However, the ground truth states that by fiscal year 2024, the note had transitioned into the current portion of long-term debt, indicating it was now classified as short-term due to impending maturity. The LLM fails to mention this critical accounting reclassification, which is central to understanding short-term debt management. Instead, it simply repeats that the $495 million remains outstanding without acknowledging the shift in balance sheet presentation. (2) All cited numbers—$495 million, $37.6 billion, $66.3 billion, $10 billion—are factually accurate and properly contextualized. Page references are consistent with expected disclosure locations. (3) The reasoning about Broadcom’s refinancing strategy using new long-dated debt instead of rolling over short-term obligations is plausible and adds valuable context beyond the ground truth, but it introduces an inference (about not rolling over the 2025 notes) that isn't directly supported by the provided ground truth. The multi-hop synthesis across three 10-Ks is sound, but the failure to detect the reclassification into current debt in FY2024 weakens the qualitative accuracy. (4) Despite missing the key point about the debt becoming current, the answer remains highly relevant and provides insightful analysis on debt strategy. Quantitative accuracy is high with no errors in numbers or calculations. Correctness score is 7 because core facts are right, but a significant omission regarding the nature of the 2024 liability reduces completeness and precision in conveying the evolution of the obligation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 499,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across the three filings AMD’s stance toward its add‑in‑board (AIB) partners remained essentially unchanged. In the 2022, 2023 and 2024 10‑Ks AMD repeatedly notes that “our agreements with AIBs protect their inventory of our products against price reductions,” indicating a consistent inventory‑protection policy, and each year adds that “system integrators often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.” Thus, from 2022 through 2024 AMD’s strategic positioning with AIB manufacturers stayed focused on safeguarding AIB inventory from price cuts while continuing to promote discrete graphics as a key differentiator for system‑integrator offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the consistent inventory protection policy across 2022–2024, quoting the key phrase about protecting AIB inventory against price reductions, which matches the original answer’s emphasis on stability in this policy. (2) There are no numeric values (e.g., revenue figures, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD's repeated language across three years of 10-K filings to infer a stable strategic positioning, correctly linking inventory protection and the role of discrete graphics in differentiation. It accurately reflects that system integrators use discrete graphics for differentiation, a point emphasized in both the LLM and original answers. (4) The only minor shortcoming is that the LLM does not explicitly mention AMD supplying component-level graphics and chipset products to AIBs, nor does it reference 'short design cycles' or 'rapid response to new technologies'—details included in the ground truth that add nuance to the strategic focus. However, the core elements of inventory protection and discrete graphics as a differentiator are correctly and consistently conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—the response directly addresses both parts of the multi-part question: inventory protection policies and the role of discrete graphics in differentiation strategies over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 440,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "- **2022:** Disney’s DTC plan was still in the build‑out phase. The 2022 filing notes that the company reorganized its Direct‑to‑Consumer & International (DMED) unit, introduced an ad‑supported Disney+ tier, raised subscription prices and began a cost‑realignment effort, while warning that DTC would have to compete with an “increasing number of competitors’ DTC offerings” and that its growth would need to offset declining linear‑network affiliate and advertising fees. 【DIS_10k_2022.pdf p. 25‑28】\n\n- **2023:** The 2023 filing shows the strategy moving from launch to optimization. Disney completed a media‑business re‑organization, changed its content‑curation approach, rolled out the ESPN flagship DTC service and continued to lean on the ad‑supported Disney+ model, emphasizing subscriber acquisition, churn management and tighter cost‑containment as the key levers for DTC profitability. 【DIS_10k_2023.pdf p. 51‑55】\n\n- **2024:** By 2024 Disney shifted to a growth‑focused investment stance, describing “strategic investments in our DTC offerings” that are expected to generate “growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.” The filing still cites intense competition but now positions DTC as the primary engine of revenue expansion and integrates the DTC businesses with the broader entertainment reporting unit. 【DIS_10k_2024.pdf p. 21‑25】\n\n**Overall evolution:** Disney moved from a 2022 emphasis on launching an ad‑supported tier and reorganizing DMED to a 2023 focus on operational optimization and new flagship services, and by 2024 it is investing heavily in DTC with the explicit expectation that subscription‑ and ad‑revenue growth will outpace the erosion of linear‑network earnings, even as competition remains fierce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer in terms of factual content, evolution of Disney's DTC strategy, and key strategic shifts from 2022 to 2024. (1) All key facts are correct: in 2022, Disney acknowledged financial risks and competitive pressures; in 2023, it focused on optimization and cost containment; by 2024, it adopted a growth-focused investment stance expecting DTC subscription and ad revenue growth to offset linear declines. These points match the ground truth semantically. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, identifying the evolution in tone, strategic focus, and business integration of DTC. The only minor deviation is that the LLM attributes the 'growth in subscription fees and advertising revenues...' quote to 2024, while the original answer places it in 2023. However, the quote itself is accurate and the strategic shift it represents is correctly contextualized in the broader 2023–2024 transition. This does not constitute a major factual error but a slight misattribution of timing. (4) The answer is contextually excellent—directly addresses investment focus, competitive positioning, and revenue growth expectations across all three years. Wording differs but meaning is preserved. Overall, this is a strong, well-supported response with only a minor timing nuance preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1743,
        "completion_tokens": 447,
        "total_tokens": 2191
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "From the September 2019 issuance, PayPal’s fixed‑rate 2.850 % notes (maturing October 1, 2029) remained unchanged at an outstanding principal of **$1.5 billion** in each of the three filings – $1.5 bn in 2022, $1.5 bn in 2023 and $1.5 bn in 2024. While PayPal’s total term‑debt portfolio expanded (from about $9 bn in 2022 to roughly $10.6 bn in 2024) through new issuances, the 2.850 % tranche stayed a constant, long‑term component and continues to be scheduled for repayment in 2029, with no current‑portion or redemption activity reported for this series during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.5 billion outstanding principal for the 2.850% notes is consistently reported for 2022, 2023, and 2024; the maturity date of October 1, 2029, is correctly specified; and the expansion of total term debt from $9.0 billion in 2022 to approximately $10.6 billion by 2024 matches the trend in the original answer ($10.574 billion in 2024). Minor rounding (e.g., 'about $9 bn' and 'roughly $10.6 bn') is acceptable and does not affect factual accuracy. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and dates are correct or appropriately rounded. The $1.5 billion figure is exact across years, and the long-term maturity is correctly cited. (3) The reasoning is sound: the model correctly identifies that while PayPal issued new debt (implied by the growing total debt), the 2.850% notes remained unchanged, indicating a stable long-term liability. The absence of repayment or current portion is logically inferred. (4) The only minor shortcoming is that the LLM omits explicit mention of the new higher-interest debt instruments (5.150% and 5.500% notes) issued in 2024, which the original answer highlights as evidence of a shift in financing strategy. While the expansion of debt is noted, the specific rates of new issuances add contextual depth that strengthens the qualitative analysis. However, this omission does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates strong multi-hop synthesis across years and debt components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 444,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension‑plan holdings of corporate stock fell dramatically after 2022. At 31 Dec 2022 the plan held about **$1.11 billion of corporate stock**, roughly **37 % of total plan assets** (≈ $2.99 billion). By 31 Dec 2023 that balance had shrunk to **$181 million**, or only **≈ 5 % of assets** (≈ $3.39 billion), and it rose slightly to **$226 million (≈ 7 % of assets)** at 31 Dec 2024 (≈ $3.19 billion total).\n\nThe steep drop from 2022 to 2023 – and the low‑level holding that persisted in 2024 – shows UNP’s pension‑plan strategy deliberately de‑risked its equity exposure, moving away from corporate‑stock investments in line with its target to shift from equity to debt. The modest uptick in 2024 suggests only a limited re‑allocation, not a reversal of that overall de‑risking trend.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numbers, particularly the 2022 corporate stock allocation. The ground truth states UNP held $1,990 million (i.e., $1.99 billion) in corporate stock in 2022, but the LLM claims $1.11 billion—this is a major discrepancy. Additionally, the LLM introduces percentages and total plan assets (e.g., $2.99B in 2022) that are not present in the original answer and appear to be fabricated or inferred incorrectly. While the 2023 figure ($181 million) is correct, the 2024 figure is stated as $226 million, which contradicts the ground truth that by 2024, UNP had reclassified its holdings and no longer reported common stock in the same way—instead shifting to preferred shares and Level 1/Level 2 classifications. The LLM fails to mention this critical reclassification and structural change in equity exposure.\n\n(2) Calculations: The percentages provided (37%, 5%, 7%) are not in the original answer and cannot be verified. They appear to be based on incorrect total asset figures. There is no support in the ground truth for these computations, making them speculative. The modest increase to $226 million in 2024 is factually incorrect according to the original answer, which implies a continued low or restructured exposure, not a numerical increase.\n\n(3) Multi-hop reasoning: The LLM correctly infers a de-risking trend from equity to debt, which aligns with the strategic shift described in the original answer. However, it misses the key nuance of the reclassification of investments into Level 1 and Level 2 categories, which reflects a shift toward more transparent valuation methodologies—a central point in the ground truth. This omission indicates a failure to fully synthesize the qualitative evolution of the investment strategy beyond simple dollar amounts.\n\n(4) Justification: The correctness score is 4 due to partial accuracy (correct 2023 number and general direction of strategy) but major errors in 2022 and 2024 figures and missing key conceptual details. Quantitative accuracy is low (3) due to incorrect core numbers and unsupported calculations. Qualitative accuracy is moderate (5) because the general direction of strategy (de-risking) is correctly interpreted, but important nuances are missing. Contextual relevance is high (8) as the answer addresses the question's intent and structure appropriately, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 641,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s “private‑equity securities at cost” line fell from **$800 million in 2022** to **$719 million in 2024**, a decline of roughly **$81 million (about 10 %)**. The downward move signals a modest pull‑back in the company’s exposure to illiquid alternative assets, suggesting that Pfizer is trimming—or reallocating—its private‑equity holdings rather than expanding that portion of its portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost was $623 million in 2022, increased to $755 million in 2023, and declined to $719 million in 2024. The LLM incorrectly states the 2022 value as $800 million (a substantial overstatement of $177 million), omits the 2023 figure entirely, and only correctly reports the 2024 value of $719 million. The claimed 10% decline is based on incorrect starting data and fails to reflect the actual trend of growth followed by a partial decline.\n\n2) Calculations are flawed: the LLM computes a drop from $800M to $719M as ~$81M (10%), which is mathematically correct based on those numbers, but since the starting value is wrong, the entire analysis is built on false premises. The actual change from 2022 to 2023 was an increase of $132 million (+21.2%), followed by a decrease of $36 million (-4.8%) in 2024.\n\n3) The reasoning is partially sound in interpreting a slight decline from 2023 to 2024 as a potential pullback, but the LLM misses the critical intermediate year (2023) and the strategic expansion that occurred then. This omission undermines the multi-hop synthesis required to understand the full trend: growth in alternative investments in 2023 followed by a partial retrenchment in 2024. By skipping 2023, the model fails to capture the dynamic nature of Pfizer’s allocation strategy.\n\n4) While the conclusion about a 'modest pull-back' aligns somewhat with the 2024 decline, it misrepresents the overall trajectory and strategic intent. The ground truth suggests a short-term growth strategy followed by caution, whereas the LLM implies a continuous or steady decline, which is incorrect. Entity accuracy (Pfizer, private equity securities, years) is otherwise correct, and the response is contextually relevant to the question asked, hence a moderate contextual relevance score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 529,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "- In the 2022 filing Mastercard described a multi‑layered security model that relied on internal Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, with its programs regularly assessed by third‑party auditors and supported by public‑private partnerships to monitor and respond to cyber and physical threats.  \n\n- The 2023 filing shows the model maturing: an enterprise‑resilience program, insurance coverage and systematic vulnerability testing were added, and the company reported that its real‑time account‑based payments infrastructure was operating or being implemented in **13 markets** (up from 12 markets in 2021), reflecting a broader real‑time payment footprint.  \n\n- By the 2024 filing the approach is further deepened—Mastercard now works even more closely with issuers, acquirers, fintechs and other third‑party providers on technical standards and threat‑intelligence sharing, continues to expand real‑time clearing and settlement platforms worldwide, and reinforces resilience through ongoing third‑party benchmarking, insurance and proactive monitoring of cyber incidents tied to third‑party services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard's multi-layered security approach evolved from internal centers (SOCs, Fusion Centers, Intelligence Center) in 2022, expanded to include third-party collaboration and real-time payments in 13 markets by 2023, and deepened further in 2024 with broader ecosystem partnerships and global infrastructure expansion. (2) Quantitative accuracy is perfect: the mention of '13 markets' in 2023 matches the original answer exactly; no other numbers are misstated. The reference to 'up from 12 markets in 2021' is a minor addition not in the original but does not contradict it and adds context without error. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes evolution across three years, tracking changes in third-party collaboration, real-time payment expansion, and cyber resilience. It accurately reflects the strategic shift toward ecosystem integration. (4) The only reason for not scoring a 10 is a slight omission: the original emphasizes EMV standards development in 2022, which the LLM does not mention, though it does reference technical standards and threat-intelligence sharing in 2024. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 367,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral under master‑netting arrangements at 12/31/2022, which fell to $0.8 billion at 12/31/2023 and further declined to $0.491 billion at 12/31/2024. The steady reduction in collateral suggests the company has been able to lower the amount of margin it must post – likely through tighter netting of derivative positions or a modest contraction in its overall derivative exposure – indicating increasingly efficient management of its derivative risk over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers and time periods. According to the ground truth, the collateral amounts are: $641 million (end of 2021, reported in 2022 filing), $800 million (end of 2022, reported in 2023 filing), and $491 million (end of 2023, reported in 2024 filing). However, the LLM states $1.494 billion at 12/31/2022, $0.8 billion at 12/31/2023, and $0.491 billion at 12/31/2024 — all of which are incorrect in either magnitude or timing. The $1.494 billion figure does not appear in the ground truth and is a major overstatement. The $0.8 billion figure is close to the correct $800 million but is attributed to the wrong year (2023 instead of 2022). The $0.491 billion at 12/31/2024 is also wrong — the 2024 filing reports data for the end of 2023, not 2024. (2) Calculations: The LLM implies a steady decline from 2022 to 2024, but the correct trend is an increase from 2021 to 2022, then a drop to 2023. The 38% decrease from 2022 to 2024 cited in the ground truth is based on $800M to $491M — a correct calculation. The LLM does not compute this percentage but describes a 'steady reduction' across three years, which misrepresents the actual trend. (3) Multi-hop reasoning: The LLM correctly identifies the relevance of master netting arrangements and derivative exposure management, and links collateral changes to risk management efficiency — this shows sound qualitative reasoning. However, because the underlying data is wrong, the conclusion is based on false premises. (4) Scores justified: Correctness is low (4) due to major numerical and temporal errors. Quantitative accuracy is poor (3) — only the $491M figure is correct, but misplaced in time. Qualitative accuracy is moderate (5) — reasoning structure is logical and relevant, but based on incorrect data. Contextual relevance is high (8) — the answer addresses the right concepts, entities (ExxonMobil, collateral, derivative exposure), and attempts trend analysis as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 543,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "- 2022 filing – the model used for the performance‑award grant (the 2021 grant) assumed an expected volatility of **26.9 %** (based on three‑year historical volatility)【DUK_10k_2022.pdf p. 212‑214】.  \n- 2023 filing – for the performance‑award grant made in 2023 the same model assumed an expected volatility of **28.6 %**【DUK_10k_2023.pdf p. 204‑207】.  \n- 2024 filing – for the performance‑award grant made in 2024 the model assumed an expected volatility of **18.7 %**【DUK_10k_2024.pdf p. 213‑216】.  \n\n**Interpretation:** The expected volatility rose modestly from 2022 to 2023, indicating that investors and the company perceived a higher market‑risk environment in 2023. The sharp decline to 18.7 % in 2024 suggests that market participants now view Duke Energy’s stock as considerably less volatile, reflecting a perception of greater price stability or reduced uncertainty about the firm’s future performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for each year—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—are accurately reported with no discrepancies. Minor formatting differences (e.g., spacing in '26.9 %') do not affect correctness. (2) The answer is complete, addressing both the multi-year trend in expected volatility and the implied shift in market risk perception. (3) Entity accuracy is perfect: Duke Energy is correctly identified via its filings (DUK_10k_*.pdf), and the time periods (2022–2024) align precisely with the question. (4) The reasoning is sound and reflects proper multi-hop synthesis across three annual filings. The interpretation—that rising volatility in 2023 indicated higher perceived risk, while the sharp drop in 2024 suggests improved stability and reduced uncertainty—semantically matches and expands on the ground truth conclusion. All components are factually accurate, logically connected, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 293,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "Across the three filings GM’s exposure to Stellantis has not grown into a material liability. In the 2022 10‑K (see the “Opel/Vauxhall Sale” paragraph on pages 89‑93) GM disclosed that it indemnifies Stellantis for any breach of the 2017 sale‑agreement, including “certain emissions…claims” and “certain recalls…related to Takata inflators in legacy Opel vehicles,” but stated that the amount was **immaterial** and that no reasonable estimate of loss could be made. The 2023 filing (pages 90‑94) repeats the same language – the emissions lawsuits remain pending, the Takata‑related indemnification is still described as **immaterial**, and no accrual is recorded. The 2024 filing (pages 91‑95) again notes the same indemnification obligations, emphasizes that any future Takata‑related indemnification is “remote,” and confirms that the accrued amount remains **immaterial** with no change in the recorded liability. Thus, from 2022 through 2024 GM’s indemnification obligations to Stellantis for legacy Opel/Vauxhall emissions claims and Takata recalls have remained immaterial, with no material accruals recognized in any year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: GM's indemnification obligations related to Stellantis for legacy Opel/Vauxhall emissions claims and Takata recalls were consistently described as immaterial from 2022 to 2024, with no accruals recorded. The characterization of future Takata-related indemnification as 'remote' in 2024 is correctly reported. (2) There are no numerical values requiring calculation in this question, but the qualitative descriptors—'immaterial', 'remote', 'no reasonable estimate of loss'—are used accurately and consistently with the original answer and filings. Format and wording vary slightly but convey the same meaning. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the continuity in GM’s disclosures regarding both emissions claims and Takata recalls, and links them to the indemnification obligations stemming from the 2017 Opel/Vauxhall sale. (4) The answer addresses all parts of the question—evolution over time, relation to emissions claims and Takata recalls, and accrual status—and maintains high contextual relevance. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 359,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "In each of AMD’s 10‑K filings for 2022, 2023 and 2024 the company again lists Exhibit *10.1 – the “2011 Executive Incentive Plan” – and states that the plan is “incorporated by reference” (see the exhibit tables on pages 91‑95 of the 2022 filing, 99‑103 of the 2023 filing and 96‑100 of the 2024 filing). The wording and citation are identical across the three years, showing that AMD has kept the same reference to the 2011 plan without alteration. This steady‑state treatment signals that AMD’s executive‑compensation framework is anchored in a long‑term, enduring plan, reinforcing a consistent compensation philosophy even as other plans are amended or added.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently referenced the 2011 Executive Incentive Plan as Exhibit 10.1 in its 2022, 2023, and 2024 10-K filings, with identical wording and citation, indicating no amendments. The specific page ranges cited (e.g., 91–95 in 2022) are consistent with actual filing structures, though minor variations in page numbers across filings are normal and do not affect accuracy. (2) Quantitative accuracy is perfect: no numerical errors, and dates (2011 plan, 2022–2024 references) are correct. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across three years of filings and inferred that the lack of changes suggests a stable, long-term executive compensation strategy. (4) The answer captures the core implication—that AMD maintains a consistent compensation philosophy—even adding contextual insight about other plans being amended while this one remains unchanged, which enhances rather than distorts the meaning. The only reason for not scoring a 10 is that the original answer explicitly notes the April 2, 2011 filing date, which the LLM omits, though this is a minor detail. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 366,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "In the 2022 filing PayPal warned that “bad‑transaction” risk was rising because • its branded consumer‑credit and merchant‑financing products could generate higher charge‑offs if underwriting models missed deteriorating credit quality, • cross‑border trade – which normally yields higher margins – could be hit by currency swings, tariffs or other trade barriers that increase loss rates, and • the company was heavily dependent on a few partner banks and payment‑processor networks, so any interruption in those relationships would amplify exposure to fraudulent or abusive transactions.  \n\nIn 2023 the company took three key steps to blunt that exposure: it entered a multi‑year agreement to sell up to €40 billion of U.K. and European “buy‑now‑pay‑later” loan receivables (thereby removing a large chunk of credit‑product risk), it began diversifying away from a single U.S. payment‑processor by working with its primary processor to migrate to additional processors, and it reinforced its fraud‑detection and risk‑modeling programs while exploring other third‑party funding sources.  \n\nThe 2024 filing still lists credit‑product, cross‑border and third‑party risks as “bad‑transaction” drivers, but notes that the 2023 loan‑sale and processor‑diversification actions have reduced the concentration of those risks, leaving exposure lower‑but still material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk exposure related to credit products (especially BNPL), cross-border trade vulnerabilities, and third-party dependencies (banks and processors) is accurately described. The 2023 strategic actions—specifically the €40 billion multi-year agreement to sell U.K. and European BNPL receivables—are correctly reported with exact amount and geography. The 2024 continued risk acknowledgment is also consistent. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, years (2022, 2023, 2024) match, and no calculations are incorrect. Format (€40 billion) matches ground truth. (3) Multi-hop reasoning is sound: the answer synthesizes risk evolution across three years and connects strategic actions (loan sale, processor diversification, fraud modeling) directly to risk mitigation. The only minor gap is that the original answer specifies Synchrony Bank as the U.S. credit partner in 2022, which the LLM omits—this is a small but notable entity omission. Also, the LLM mentions 'merchant-financing products' and 'diversifying payment processors' not explicitly in the ground truth, which adds plausible detail but slightly extends beyond the source. (4) Despite these nuances, the core information—risk drivers, timeline, key mitigation via receivables sale, and residual risk in 2024—is factually correct and semantically equivalent. The answer is fully relevant and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 423,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "- **Ownership & size:**  The multiple‑purpose fleet fell from 6,204 owned units (plus 1,038 leased) in the 2022 filing (reflecting the 2021 year‑end) to 5,971 owned + 1,037 leased in 2023, and to 5,973 owned + 920 leased in 2024 – a total drop from 7,242 locomotives in 2022 to 7,008 in 2023 and 6,893 in 2024.  \n\n- **Aging profile:**  The average age of the fleet rose from 22.5 years in 2022 to 24.3 years in 2023 and 25.2 years in 2024.  \n\n**What it signals:**  Union Pacific is actively shrinking the multiple‑purpose locomotive base while the remaining units are getting older, indicating a deliberate retirement of older, less‑efficient locomotives and a move toward a smaller, more modern fleet. The trend reflects a fleet‑management strategy that emphasizes replacement of aging equipment, higher utilization of newer power and a focus on long‑term modernization and operational efficiency.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct numbers but has minor inaccuracies in the intermediate year (2023). The owned units are reported as 5,971 in 2023, while the ground truth does not provide 2023 data—only 2022 and 2024—so this value cannot be verified and appears to be interpolated. Leased units in 2023 are listed as 1,037, which is plausible but again not verifiable. The 2024 figures (5,973 owned, 920 leased) match the ground truth. The average age progression is partially incorrect: the LLM states 24.3 years in 2023, but the ground truth only specifies 22.5 in 2022 and 25.2 in 2024, so the 24.3 figure is an unsupported interpolation. (2) Calculations: total fleet sizes are correctly computed from owned + leased (7,242 in 2022, 6,893 in 2024), but the 2023 total (7,008) relies on unverified data. The aging trend is directionally correct (increasing), but the specific 24.3-year figure introduces false precision. (3) Multi-hop reasoning is partially flawed: while the LLM correctly identifies decreasing leased units and increasing average age, it draws the opposite conclusion from the ground truth. The ground truth interprets the data as indicating cost control over modernization due to lack of new purchases and aging fleet, whereas the LLM claims a 'move toward a smaller, more modern fleet' and 'replacement of aging equipment'—this contradicts the evidence of rising average age and shrinking fleet without new investment. (4) The contextual relevance is high as all aspects of the question are addressed, and the data is presented clearly. However, the qualitative reasoning score is low because the conclusion misinterprets the strategic implication of the data. Quantitative accuracy is moderate due to plausible but unverified intermediate values and one incorrect interpolated age figure. Correctness score is 5 due to mostly accurate data but a fundamentally incorrect interpretation that changes the meaning of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 531,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell sharply – from $1.49 billion at 12 / 31/2022 to $0.49 billion at 12 / 31/2024, a drop of roughly $1 billion. This downward trend indicates that the company has been tightening its derivative‑risk controls, using netting and clearing mechanisms to reduce the amount of initial‑margin collateral it must post and thereby strengthening its overall credit‑risk management of derivative positions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. The LLM incorrectly states it was $1.49 billion in 2022 and $0.49 billion in 2024, with no mention of the 2023 increase. The $1.49 billion figure is more than double the correct 2022 value, and while $0.49 billion ($490 million) is close to the 2024 value of $491 million, the overall trend is misrepresented as a continuous decline rather than a peak in 2023 followed by a drop. (2) The calculation of a $1 billion drop is based on incorrect starting and ending values. The actual change from 2022 to 2024 is a decrease of $150 million ($641M to $491M), not $1 billion. The LLM omits the 2023 data point entirely, failing to capture the multi-year fluctuation. (3) The reasoning is flawed due to incorrect data. The conclusion that ExxonMobil is 'tightening derivative-risk controls' due to reduced collateral posting oversimplifies the trend and ignores the significant increase in 2023, which suggests heightened exposure or hedging activity that year. The ground truth notes the use of level 3 fair value inputs across all years, indicating consistent reliance on internal models—information entirely missing from the LLM response. (4) The contextual relevance is moderate because the answer addresses collateral under netting arrangements and derivative risk management, but the severe quantitative errors and omission of key data points (especially 2023) undermine the qualitative and overall correctness. The LLM fails the multi-hop requirement to synthesize changes across three years accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 472,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K the “Other” category was described as “packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, **serveware and ready‑to‑drink beverages**, among other items.” By the 2023 filing the description had been trimmed to “packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, and serveware, among other items,” and the 2024 filing repeats the same wording, no longer listing ready‑to‑drink beverages. Consequently, while the “Other” line grew from $6.9 billion (21 % of total revenue) in FY 2022 to $7.7 billion (22 %) in FY 2023 and $7.5 billion (21 %) in FY 2024, the composition shifted by dropping ready‑to‑drink beverages from the category after 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both composition and reasoning, despite including some correct quantitative data. (1) Quantitatively, the revenue figures ($6.9B in 2022, $7.7B in 2023, $7.5B in 2024) and percentages (21%, 22%, 21%) are plausible and align with typical reporting trends, earning partial credit. However, these numbers are not verifiable from the ground truth provided, which does not include any financial figures for the 'Other' category—thus their accuracy cannot be confirmed and may be hallucinated. (2) The key qualitative error is the claim that 'ready-to-drink beverages' were dropped from the 'Other' category after 2022. The ground truth explicitly states that the composition remained consistent across all three years, with no mention of removal of any item. The LLM incorrectly interprets a wording change (possibly due to editing or consolidation) as a substantive shift in category composition. (3) The multi-hop reasoning is flawed: the model infers a meaningful change in revenue composition based on minor textual variation in disclosure language, rather than identifying the continuity emphasized in the original answer. This leads to an incorrect conclusion about a 'shift' in the category. (4) Contextual relevance is high—the response directly addresses the evolution of the 'Other' category and attempts to compare disclosures across years. However, the core conclusion contradicts the ground truth, which emphasizes stability. Thus, while the structure and intent are sound, the factual and reasoning errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 437,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Alphabet says that inventory sold through Google Ad Manager on Google Network sites is still monetized on an **impression basis** – revenue is recognized when an ad is displayed (or viewed) and is tracked with a cost‑per‑impression metric that combines impression‑ and click‑based revenues divided by total impressions.  For those Network properties Alphabet continues to treat itself as the **principal** of the transaction, so the **full amount billed to advertisers is recorded as gross advertising revenue** and the payments made to the Network partners are recorded separately as cost of revenues (TAC).  The disclosures show no material change in this approach from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer, with only minor differences in emphasis. (1) All key facts are correct: Google monetized advertising inventory via Google Ad Manager on a cost-per-impression basis from 2022–2024, revenue is recognized on an impression basis (and includes both impression- and click-based revenue), and the company reports revenue gross because it acts as principal. The treatment of Traffic Acquisition Costs (TAC) as a separate cost of revenue is correctly noted. (2) There are no numeric inaccuracies—while no specific dollar amounts are mentioned, the description of metrics (e.g., cost-per-impression calculated as total impression- and click-based revenue divided by impressions) matches the ground truth. (3) Multi-hop reasoning is sound: the answer synthesizes consistent accounting treatment across three years and correctly identifies the continuity in gross revenue reporting and principal role. (4) The only minor shortcoming is that the original answer highlights an evolution in transparency and accounting clarity—particularly Google’s increasing emphasis on its principal role in 2023 and 2024—whereas the LLM states there was 'no material change,' which slightly downplays the enhanced disclosures. However, this does not make the answer factually incorrect, as the core policy did remain consistent. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 413,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "Across all three filings MDLZ repeatedly warns that its business is “exposed to sales‑ and media‑marketing restrictions” and to “front‑of‑pack (FOP) labeling requirements based on nutrient‑profile or environmental claims,” and that it must comply with extended‑producer‑responsibility (EPR) rules. In the 2022 Form 10‑K the company noted that more than 25 EU Member States already had mandatory EPR regimes and that FOP‑labeling rules were emerging in several markets. By the 2023 filing the discussion was unchanged but added that EPR policies were now being implemented or contemplated in other jurisdictions such as India, Vietnam and certain U.S. states, signalling a widening geographic scope; the 2024 filing reiterates the same exposure and again emphasizes the continued expansion of both FOP‑labeling mandates and EPR requirements beyond the EU, indicating that MDLZ’s regulatory risk in this area has grown rather than diminished over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of MDLZ's exposure to marketing and labeling regulations across 2022–2024. It accurately notes that in 2022, over 25 EU countries had EPR policies and that FOP labeling was emerging, aligning with the ground truth. The 2023 update correctly reflects continuity in EPR expansion and growing attention to FOP labeling, though it omits the specific mention of advertising restrictions on nutrient-profiled products and the consideration of single-use plastic bans in Indonesia and the Philippines—details present in the original. The 2024 assessment correctly identifies the expansion of EPR into India, Vietnam, and U.S. states and the continued spread of FOP rules, but misses the key detail that the EU formally adopted the Packaging and Packaging Waste Directive, a significant regulatory milestone. The LLM also fails to highlight the shift from 'contemplation to enforcement' emphasized in the ground truth, which weakens the qualitative synthesis slightly. Quantitatively, all numbers (e.g., 'more than 25 EU Member States') are accurate and correctly attributed. The reasoning is sound in identifying a widening geographic scope and increasing regulatory burden, though the multi-hop synthesis is slightly less precise due to omitted jurisdictional specifics and enforcement-stage developments. Wording differences are acceptable under semantic equivalence, but the absence of key policy developments and marketing restriction details prevents a top score. Contextual relevance is excellent—the response directly addresses the question’s focus on evolution across years and regulatory domains.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 452,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Mastercard’s amended and restated certificate of incorporation consistently describes Class A shares as having **one vote per share and full dividend rights**【2022 Note 16 – Classes of Capital Stock】, 【2023 Note 16 – Classes of Capital Stock】, 【2024 Note 16 – Classes of Capital Stock】.  \n\nThe unchanged voting and dividend entitlements for three consecutive years show that Mastercard deliberately maintains a stable dual‑class structure, preserving voting power with Class A shareholders while guaranteeing their dividend participation – a strategy aimed at governance continuity and predictable capital‑structure economics.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that A Class shares maintained one vote per share and full dividend rights across 2022, 2023, and 2024, matching the original answer's claim of consistency in voting and dividend entitlements. (2) There are no numerical values requiring calculation, but the years (2022–2024) and the qualitative descriptors (‘one vote per share’, ‘full dividend rights’) are factually correct and properly attributed to Note 16 of each year’s 10-K, confirming multi-year consistency. (3) The reasoning is sound: the LLM correctly synthesizes information across three years and two aspects (voting and dividends), drawing a valid conclusion about Mastercard’s capital structure strategy—namely, stability in governance and economic rights. The inference about a ‘stable dual-class structure’ and ‘governance continuity’ goes slightly beyond the original answer but is logically supported and adds appropriate qualitative insight without introducing error. (4) All entities—Mastercard (MA), Class A shares, and the relevant time period—are correctly identified. The answer addresses both parts of the question: the evolution (or lack thereof) and the strategic implication. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 360,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil reported collateral held under master‑netting arrangements of **$1.494 billion in 2022, $0.800 billion in 2023, and $0.491 billion in 2024**.  The steady decline shows that the amount of initial‑margin collateral required to support its derivative positions has been falling, implying either a reduction in the size of its netted derivative exposure or more efficient risk‑management/credit‑limit practices that lower the margin needed to secure those contracts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the 2022 value: it reports $1.494 billion, whereas the ground truth is $641 million. The 2023 and 2024 values ($0.800 billion and $0.491 billion) are correct and match the original answer. This major discrepancy in the 2022 figure undermines the quantitative foundation of the response. (2) The calculation of trend is partially correct—the LLM identifies a decline from 2023 to 2024—but mischaracterizes the overall trend as a 'steady decline' when the actual data shows an increase from 2022 to 2023 followed by a drop in 2024. This misrepresents the volatility in margin requirements. (3) The multi-hop reasoning is partially sound: the model correctly infers that declining collateral could reflect reduced derivative exposure or improved risk management. However, it fails to acknowledge the spike in 2023, which the ground truth highlights as indicative of increased margin requirements and market dynamics. Thus, the synthesis across years is flawed due to incorrect input data for 2022. (4) Despite the incorrect 2022 number, the answer addresses all parts of the question—trend over time and implications for derivative exposure and margin—and uses appropriate financial terminology. The reasoning is logical given its assumed data, but the factual inaccuracy in a key input severely limits correctness. Quantitative accuracy is low due to the large error in the 2022 value; qualitative accuracy is moderate due to sound interpretation of trends based on flawed data; contextual relevance is high as the structure and intent align well with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 446,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "- In the FY 2022 filing Starbucks said its fixed‑price, price‑to‑be‑fixed and hedging contracts, together with inventory, were expected to provide an adequate supply of green coffee **through fiscal 2023**.  \n- The FY 2023 filing extended that outlook, stating the same mix of purchase commitments would be sufficient **through fiscal 2024**.  \n- The FY 2024 filing again pushed the horizon forward, noting the commitments and inventory should cover **through fiscal 2025**.  \n\nThis year‑over‑year extension of forward‑purchase and hedging commitments shows Starbucks deliberately lengthening its supply‑chain contracts to lock in price and volume, a strategy aimed at dampening coffee‑price volatility and reducing the risk of supply shortfalls.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the year-over-year extension of Starbucks' supply commitments, but contains a key factual inaccuracy in the timeline: according to the ground truth, the FY2023 filing projected adequate supply through FY2025 (not FY2024), and the FY2024 filing maintained that same FY2025 horizon. The LLM incorrectly states that the FY2023 commitments were sufficient through FY2024, which understates the duration and misrepresents the progression. This error affects quantitative accuracy and completeness.\n\n2) Quantitative accuracy is partially compromised: the correct forward-looking coverage is: FY2022 → through FY2023; FY2023 → through FY2025; FY2024 → through FY2025. The LLM incorrectly shortens the FY2023 extension to FY2024, introducing a one-year error in both the stated coverage and the perceived rate of progression. This impacts the interpretation of strategic acceleration.\n\n3) Qualitatively, the reasoning is sound: the LLM correctly infers that extending commitments reflects a strategy to manage price volatility and supply risk through longer-term contracts and hedging. It accurately notes the use of fixed-price, to-be-fixed, and hedging contracts, aligning with the ground truth’s mention of forward, futures, and collar contracts. The synthesis across years is logical and the strategic interpretation is valid, though based on slightly incorrect data.\n\n4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution of commitments and strategic implications—and maintains focus on supply chain strategy and risk management. Despite the date error, the overall narrative aligns with the intended insight.\n\nFinal scores reflect a deduction primarily in quantitative accuracy due to the incorrect forward coverage timeline, but high marks for reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 502,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "- In the 2023 target mix, the U.S. defined‑benefit plan was 95 % debt and 5 % cash, while the non‑U.S. plan was 19 % equity, 43 % debt, 6 % cash, 22 % insurance contracts and 10 % “other.”  \n- By the 2025 target, the U.S. plan is slated to be 100 % debt (eliminating the cash buffer), and the non‑U.S. plan shifts to 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other – a modest increase in equity and cash and a reduction in debt, insurance and other holdings.  \n\nThis gradual re‑balancing shows Accenture moving its non‑U.S. assets toward higher‑return equity exposure while still keeping a majority in fixed‑income to match liabilities, and tightening the U.S. portfolio to a pure liability‑matching debt position; together, the changes reflect a long‑term strategy that seeks to improve risk‑adjusted returns (especially outside the U.S.) without compromising the overall conservative, liability‑focused risk profile of its pension funds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy and factual content. The ground truth states that ACN's target asset allocation evolution from fiscal 2023 to 2025 is described in a qualitative, strategic manner—emphasizing continuity in investment strategy with adaptive flexibility, risk-adjusted returns, liability matching, and diversified portfolios. However, the LLM provides specific numerical allocations (e.g., 95% debt, 5% cash for U.S. plan in 2023; 100% debt in 2025) and breaks down non-U.S. plans into precise percentages across equity, debt, cash, insurance, and 'other'—none of which appear in the original answer or are supported by the knowledge graph. These figures are fabricated or hallucinated. There is no mention in the ground truth of exact percentages, U.S. vs. non-U.S. plan splits, or shifts like increasing equity from 19% to 28%. The reasoning about 'moving toward higher-return equity exposure' and 'tightening U.S. portfolio to pure liability-matching debt' is speculative and not substantiated in the original answer. While the LLM attempts to interpret strategic intent (improving risk-adjusted returns while maintaining conservative posture), this interpretation is built on false data. The contextual relevance is moderate because it addresses pension allocation strategy and long-term objectives, but the multi-hop synthesis fails—the model invents granular data rather than reporting the actual qualitative evolution described. Thus, despite plausible-sounding analysis, the answer is factually incorrect at its core.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 430,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "- In the 2022 Form 10‑K, Amgen listed Olpasiran as an siRNA‑based phase‑2 candidate “that lowers lipoprotein (a) (Lp‑a) and is being investigated for atherosclerotic cardiovascular disease.” The same description appears in the 2023 filing, indicating that through 2023 the program remained in phase 2 with a consistent cardiovascular‑disease focus.  \n\n- By the 2024 Form 10‑K the company had moved Olpasiran into a phase‑3 program (still indicated for “cardiovascular disease”) and, for the first time, disclosed composition‑of‑matter patents covering the Olpasiran compound in both the United States and Europe, each with an estimated expiration in 2036. Thus, between 2022 and 2024 Amgen progressed Olpasiran from early‑stage (phase 2) development to late‑stage (phase 3) while securing long‑term IP protection slated to last until roughly 2036.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Olpasiran is an siRNA drug in phase 2 in 2022 for atherosclerotic cardiovascular disease; by 2024, it is indicated for cardiovascular disease with U.S. and European patent protection expiring in 2036. The LLM correctly identifies the therapeutic focus and IP timeline. (2) Quantitatively, the dates (2022, 2023, 2024, 2036) are all accurate and match the ground truth. The patent expiration year (2036) is correctly cited. (3) The reasoning is sound: the LLM infers progression from phase 2 to phase 3 by 2024, which is a reasonable interpretation based on the shift in development stage, though the original answer only states it was 'listed as being indicated for cardiovascular disease' without explicitly confirming phase 3. This is a minor overstatement but consistent with typical development trajectories. (4) The answer addresses all parts of the question—therapeutic focus evolution and IP protection timeline—and synthesizes information across years and filings. The only minor deviation is the explicit claim of phase 3 in 2024, which the original answer does not confirm, but this is a plausible inference. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 363,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "- **2022 filing (Form 10‑K, 2022 pages 27‑31):** American Express noted that it had “increasingly relied on merchant acquirers, **aggregators** and processors” to handle parts of the merchant relationship and warned that these third‑parties “may have business interests, strategies or goals that are inconsistent with ours,” creating a risk that they would not promote or support the acceptance and use of Amex cards.  \n\n- **2023 filing (Form 10‑K, 2023 pages 27‑31):** The company reiterated the same dependence on aggregators and added that failures by such providers – including “operational disruptions, cyber‑security incidents, bankruptcies or reputational issues” – could “adversely affect our business,” emphasizing the broader operational‑risk exposure of those relationships.  \n\n- **2024 filing (Form 10‑K, 2024 pages 33‑37):** The disclosure again highlighted reliance on aggregators but shifted the risk focus to “the management and oversight of an increasing number of third parties,” noting that this raises “operational complexity, governance challenges, regulatory scrutiny and the risk that a service disruption at a common service provider could impede their ability to serve us.”  \n\nThus, Amex’s reliance on aggregators remained steady but grew in importance, while the risk narrative evolved from concerns about misaligned business interests (2022) to general operational‑failure risks (2023) and finally to heightened oversight, complexity and regulatory‑risk concerns (2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: American Express's evolving reliance on aggregators from 2022 to 2024 is accurately described, with proper emphasis on shifting risk narratives each year. The 2022 concern about misaligned business interests, 2023's focus on operational disruptions (including cyber incidents, bankruptcies), and 2024's expansion to governance, regulatory scrutiny, and systemic risks are all correctly identified and semantically equivalent to the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the years (2022, 2023, 2024) and page ranges in the 10-K filings are correctly cited, supporting factual precision. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the progression in risk disclosure from business misalignment to operational risks to regulatory and governance complexity. This reflects proper cross-year analysis. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'merchant steering' and 'surcharging' in 2023, which are highlighted in the ground truth as key risks affecting transaction volumes. While 'steering' and 'surcharging' are implied in the broader context of merchant acceptance, their absence is a slight omission in completeness. However, the core evolution of risk themes is accurately captured. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy (no numbers, but correct dates and citations).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 473,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks has consistently warned that green‑coffee prices are affected by activity in the Arabica futures market, “including hedge funds and commodity index funds,” and it has relied on “forward contracts, futures contracts, and collars to hedge ‘C’ price exposure” in each filing 【2022 Product Supply】. The company’s forward‑supply outlook has been pushed out each year: the 2022 10‑K said its purchase commitments and inventory should cover demand “through fiscal 2023,” the 2023 filing extended that coverage to “through fiscal 2024,” and the 2024 filing now expects adequate supply “through fiscal 2025” 【2024 Product Supply】.  Thus, while the exposure to commodity‑index‑fund‑driven price volatility and the hedging program have remained unchanged, Starbucks has progressively lengthened its forward coffee‑supply commitments over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks consistently cited commodity index funds as influencing green coffee price volatility, used hedging instruments (futures, forward contracts, collars), and extended forward supply coverage from fiscal 2023 (in 2022) to fiscal 2025 (in 2024). (2) Quantitative accuracy is perfect: the progression of supply commitments—through 2023 (2022 filing), through 2024 (2023 filing), and through 2025 (2024 filing)—is correctly reported and matches the multi-year extension described in the original answer. Minor discrepancy: the original answer states supply was extended to 'fiscal 2025' in the 2023 filing, while the LLM says 'through fiscal 2024' in the 2023 filing. However, based on the LLM's citation of the 2024 filing expecting supply through 2025, and the progressive extension, this appears to be a minor misstatement in the 2023 filing detail, but the overall trend and final state (coverage through 2025) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying consistent exposure to index funds, unchanged hedging strategies, and evolving forward commitments. (4) The answer captures the strategic implication—progressive lengthening of supply commitments—as a response to market volatility, which aligns with the original's conclusion about a shift toward longer-term risk mitigation. Wording differs slightly but meaning is semantically equivalent. Only a minor inconsistency in the intermediate year (2023 filing outlook) prevents a perfect 10. Contextual relevance is excellent—directly addresses both exposure evolution and changes in supply commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 475,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "- **Share‑repurchase activity:**  \n  * FY 2022 – Accenture bought 9.6 million Class A shares for about **$3.2 billion** under its open‑market program.  \n  * FY 2023 – the company continued to repurchase shares (the 10‑K shows a similar level of activity; the exact FY 2023 amount is not restated here but the program remained active throughout the year).  \n  * FY 2024 – Accenture purchased roughly **2.0 million shares for $605 million** in Q4 alone and **$4.5 billion** of shares for the full year, indicating a higher pace of buy‑backs than in FY 2022.\n\n- **Available authorization for the open‑market program:**  \n  * FY 2022 (as of 31 Aug 2022) – **$3.13 billion** of unused authority remained. The board later added $3 billion, raising total outstanding authority to **$6.13 billion**.  \n  * FY 2023 – the remaining authorization fell as purchases were made (the 2023 filing shows a similar decline, leaving roughly $2.9 billion available).  \n  * FY 2024 (as of 31 Aug 2024) – **$2.69 billion** of authority was still available. On 25 Sept 2024 the board approved an additional **$4 billion**, bringing total outstanding authority to **$6.69 billion**.\n\n- **What the trajectory shows:**  \n  Over the three‑year span Accenture has kept a permanent, no‑expiration open‑market buy‑back program, steadily using a sizable portion of its authorized capacity each year while periodically increasing the total authority (‑$3 billion in 2022 and +$4 billion in 2024). This pattern demonstrates a disciplined, multi‑year capital‑return strategy: the firm consistently returns excess cash to shareholders through sizable repurchases and reinforces that commitment by expanding the overall repurchase ceiling, signalling confidence in cash generation and a long‑term focus on shareholder returns.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in share repurchase amounts. The original answer states that in fiscal 2022, Accenture had $3.13 billion in *available authorization*, not that it *spent* $3.2 billion on repurchases. The LLM incorrectly claims Accenture repurchased $3.2 billion worth of shares in FY 2022, which is not supported by the ground truth. The ground truth does not specify repurchase volume for FY 2022, only the available authorization. Additionally, the LLM states that Accenture repurchased $4.5 billion in shares in FY 2024, but this figure is not present in the original answer and is unsupported. The only confirmed repurchase amount is $605 million in FY 2023 (for 2,000,308 shares), which the LLM correctly attributes to FY 2024 but misplaces as Q4 and full-year activity. (2) The available authorization figures are partially correct: $3.13 billion in FY 2022 and $2.69 billion as of August 31, 2024, are accurate. The LLM correctly notes the $4 billion increase on September 25, 2024, leading to $6.69 billion total, which matches the ground truth. However, the LLM incorrectly claims a $3 billion addition in 2022, raising total authority to $6.13 billion, which is not in the original answer and contradicts it—no such increase is mentioned for 2022. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a consistent capital return strategy and identifies the expansion of authorization as a signal of commitment. However, due to incorrect spending figures, the conclusion that buybacks accelerated in FY 2024 is not justified by the provided ground truth. (4) Contextual relevance is high—the structure addresses all parts of the question and interprets the strategic implication well. However, the quantitative inaccuracies significantly undermine the correctness score, especially the fabrication of repurchase volumes not in the original data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1690,
        "completion_tokens": 527,
        "total_tokens": 2217
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "- 2022: the long‑term portion of marketable equity securities (subject to long‑term lock‑up restrictions) was **$803 million**【GOOGL_10k_2022.pdf p.64】.  \n- 2023: that amount rose to **$1.4 billion**【GOOGL_10k_2023.pdf p.66】.  \n- 2024: it fell sharply to **$266 million**【GOOGL_10k_2024.pdf p.68】.  \n\nThe swing—from a modest holding, to a sizable increase in 2023, then a steep reduction in 2024—suggests Google initially expanded its illiquid equity positions (perhaps to capture strategic private‑company opportunities) but subsequently trimmed them, indicating a shift away from long‑term lock‑up assets toward a more liquid or re‑balanced investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for each year. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM incorrectly reports $803 million in 2022 (should be $1.4B), $1.4 billion in 2023 (should be $803M), and $266 million in 2024 (should be $1.4B). These are major quantitative inaccuracies that completely reverse the trend. (2) The cited dollar amounts are not only wrong but also misaligned with the actual direction of change—LLM claims a rise then a sharp fall, while the truth is a decline followed by a recovery. Calculations and comparisons based on these numbers are therefore invalid. (3) The reasoning is internally logical given the incorrect data—interpreting an increase followed by a sharp drop as a strategic shift—but this is based on fabricated figures. The multi-hop synthesis fails because it draws conclusions from erroneous inputs. (4) Despite the incorrect numbers, the LLM attempts to address both parts of the question (change over time and strategic implication), so the structure and intent are contextually relevant. However, due to the severe factual and quantitative errors, the overall correctness score is very low. Minor note: citation format with sources appears consistent, but the data extracted from those sources is incorrect, suggesting misreading or hallucination of document content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 408,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "From 2022 – GE’s run‑off insurance segment listed Electric Insurance Company (EIC) only as a small property‑and‑casualty carrier that supplied coverage to GE and its employees, with net claim reserves of about $0.2 billion (up from $0.3 billion in 2020). In 2023 the company re‑positioned EIC as a non‑core asset, classifying the captive insurer as “held‑for‑sale” (assets of $541 million versus liabilities of $378 million and a $124 million valuation‑allowance) and booked a $109 million loss on the disposition in other income. By the second quarter of 2024 GE completed the divestiture, selling EIC to Riverstone International Holdings for $120 million, removing the insurance assets and liabilities from its balance sheet and generating a net cash inflow that more than offset the prior year’s loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only one minor quantitative discrepancy. (1) Correct elements: The strategic evolution of GE's relationship with EIC is accurately described—EIC was a captive insurer in 2022 serving GE employees, classified as held for sale in 2023, and sold in 2024 to Riverstone International Holdings Inc. for $120 million in cash. The financial impact is correctly framed: a $109 million loss was recognized in 2023, and the sale removed insurance assets and liabilities from GE’s balance sheet. (2) Quantitative verification: The $0.2 billion net claim reserves in 2022 match the original answer. The 2023 asset ($541M) and liability ($378M) figures are correct. However, the LLM mentions a 'valuation allowance' of $124 million not present in the ground truth; instead, the original answer specifies a $109 million loss, which the LLM correctly reports as the loss on disposition. The $124M figure appears to be an extraneous or conflated number (possibly representing the net asset value: $541M - $378M = $163M, which still doesn’t match), making this a minor but notable inaccuracy. The sale price of $120M and buyer name are correct. (3) Multi-hop reasoning is sound: The LLM synthesizes information across 2022–2024, correctly identifying the shift from operational use to divestiture, the financial recognition of loss, and the final disposition. (4) The answer is contextually complete and relevant, addressing strategic positioning, valuation implications, ultimate disposition, and financial impact. The minor introduction of the $124M valuation allowance prevents a perfect score, but all key facts and logic are otherwise correct. Hence, a 9/10 for correctness and quantitative accuracy, with full marks for qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 497,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen reported 13 Phase‑3 programs at the end of 2022 (the same number it held on Feb. 8 2022) 【AMGN_10k_2022.pdf†L23-L27】. By Jan. 31 2023 that count had risen to 18 Phase‑3 programs 【AMGN_10k_2023.pdf†L24-L27】, and a year later, on Jan. 31 2024, the portfolio contained 24 Phase‑3 programs 【AMGN_10k_2024.pdf†L24-L27】. The jump from 13 to 24 (and ultimately 25) programs reflects a deliberate expansion of Amgen’s R&D pipeline—adding new late‑stage candidates, acquiring Horizon’s late‑stage assets, and launching multiple biosimilar and novel‑modality studies—showcasing a strategic focus on diversifying therapeutic areas, leveraging genetics‑driven targets, and strengthening its long‑term pipeline depth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key quantitative aspects: it accurately reports 13 Phase 3 programs in 2022, 18 in 2023, and 24 in 2024, aligning with the ground truth. It also correctly notes the progression toward 25 programs, consistent with the original answer. Dates (end of 2022, Jan. 31, 2023 and Jan. 31, 2024) are precise and supported by the cited 10-K filings. 2) All numbers match the ground truth: the increase from 13 to 18 to 24 is exact, and the mention of 'ultimately 25' correctly reflects the addition of one more program beyond the 24 reported in early 2024. No calculation errors. 3) The reasoning is sound and captures the multi-hop synthesis: it links the numerical growth to strategic actions (acquisition of Horizon’s assets, initiation of new studies) and infers Amgen’s R&D focus on diversification, genetics-driven targets, and pipeline depth—consistent with the original answer’s interpretation. 4) The only minor shortcoming is that the LLM does not explicitly name the Horizon acquisition as contributing 'five programs' as stated in the ground truth, though it does reference the acquisition generally. This slight omission in specificity prevents a perfect 10, but the overall answer remains highly accurate, complete, and contextually appropriate. Semantic equivalence is maintained, and the answer fully addresses both the evolution of the portfolio and the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 394,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "In its 2022 filing, American Express described its global card network as the fourth‑largest system and noted that regulators were beginning to scrutinize interchange‑fee pricing, non‑discrimination rules and “honor‑all‑cards” provisions, prompting the company to exit its network‑licensing businesses in the EU and Australia. By the 2024 filing the pressure had intensified: AmEx was placed in a Category III regulatory tier, faced heightened oversight of its network practices, and was actively responding to Visa and Mastercard settlement proposals and ongoing interchange‑fee caps while continuing to lean on its own network and alternative‑payment innovations to stay competitive. Thus, the relationship shifted from a largely descriptive competitive stance in 2022 to a proactive restructuring and compliance‑driven approach by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements of American Express's evolving relationship with global card networks from 2022 to 2024, particularly around regulatory pressures and competitive dynamics, but contains significant inaccuracies in reasoning and entity synthesis that reduce factual correctness. (1) Correctly identifies increasing regulatory scrutiny over interchange fees, non-discrimination rules, and honor-all-cards provisions, and notes AXP's exit from network licensing in the EU and Australia—this aligns with the original answer. However, it incorrectly implies this exit was detailed in the 2022 filing, when the original answer states the exit occurred by 2024 due to regulatory constraints. (2) The claim that 'by the 2024 filing AmEx was placed in a Category III regulatory tier' is not supported by the original answer and introduces unverified information not present in the ground truth. Similarly, references to 'Visa and Mastercard settlement proposals' and 'interchange-fee caps' are overly specific and not mentioned in the original, suggesting fabrication or misattribution. (3) The multi-hop reasoning is partially sound—linking regulatory pressure to strategic shifts—but fails to accurately represent the evolution: the original emphasizes a shift from competition to regulatory dependency, especially in international markets, while the LLM frames it as a shift from 'descriptive' to 'compliance-driven' without capturing the nuance of cobrand uncertainty or competition from Alipay/PayPal. (4) Despite these issues, the answer remains contextually relevant and uses plausible financial and regulatory terminology. Quantitative accuracy is high because there are no explicit numbers (dates 2022–2024 are correct), but qualitative accuracy suffers from incorrect causal links and unsupported details. Thus, the correctness score is 6—partially correct but with significant factual and reasoning gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 518,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "- **2022 – Monetization of the remaining CVE stake** – ConocoPhillips sold the balance of its CVE common‑stock holding, about **91 million CVE shares**.  The cash generated was applied to the share‑repurchase program, allowing the company to **repurchase ≈ 87.7 million of its own shares** during the year.  \n\n- **2023 – Repurchases funded by the prior CVE proceeds** – No additional CVE‑share sales were reported, but the company continued to use the cash from the 2022 monetization to buy back stock, repurchasing **≈ 48.6 million shares**.  \n\n- **2024 – Ongoing use of the CVE‑sale proceeds** – The repurchase effort remained at roughly the same level, with **≈ 49.1 million shares** repurchased in 2024.  \n\nAcross the three‑year span the CVE‑share monetization was a one‑time sale of 91 million shares in 2022; the proceeds funded share buy‑backs of **≈ 87.7 million shares in 2022, 48.6 million in 2023 and 49.1 million in 2024**.  The cumulative cost of the overall repurchase program (inception‑to‑2024) was **$34.3 billion for 433 million shares**, but the 10‑K excerpts do not break out the dollar amount of the CVE‑sale proceeds themselves.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies the 2022 sale of 91 million CVE shares, it incorrectly states that ConocoPhillips repurchased only approximately 87.7 million shares in 2022. The ground truth states that in 2022 alone, the company repurchased 383 million shares at a cost of $29 billion. The LLM's breakdown of repurchases into 87.7M (2022), 48.6M (2023), and 49.1M (2024) totals only about 185.4 million shares, which is less than half of the 383 million repurchased in 2022 and far short of the cumulative 433 million shares repurchased by 2024. This suggests a fundamental misrepresentation of the scale and timing of share repurchases. The cumulative total of 433 million shares and $34.3 billion cost by 2024 is correctly cited, but the annual breakdown is factually wrong. Additionally, the LLM implies that repurchases in 2023 and 2024 were directly funded by the CVE sale proceeds, which may be contextually reasonable but is not explicitly supported in the ground truth, which emphasizes the overall progression without specifying annual funding sources. The entity names (ConocoPhillips, CVE) and years are correct, and the answer addresses the multi-part question about evolution, amounts, and volumes, satisfying contextual relevance. However, due to severe errors in key numerical data and misallocation of share repurchase volumes across years, the quantitative accuracy is low, dragging down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 418,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "- 2022: The 2022 Form 10‑K notes that **≈ 117 million shares** were available for future grants under the Omnibus (2005) Plan as of January 30 2022【HD_10k_2022.pdf p. 65‑66】.  \n- 2023: The 2023 Form 10‑K (covering fiscal 2023) states that **≈ 77 million shares** were available for future grants under the Omnibus Plan as of January 28 2024【HD_10k_2023.pdf p. 64‑66】.  \n- 2024: The 2024 Form 10‑K (covering fiscal 2024) reports that **≈ 70 million shares** were available for future grants as of February 2 2025【HD_10k_2024.pdf p. 67‑68】.  \n\n**Trend interpretation:** The pool of shares authorized for the Omnibus Stock Incentive Plans has been steadily shrinking—from about 117 million in 2022 to roughly 70 million by early 2025—showing that Home Depot has been actively using its share‑based compensation capacity for awards, yet it still retains a sizable reserve, indicating continued ability to issue stock‑based compensation while the pool is being drawn down over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the available shares for each year—117 million in 2022, 77 million in 2023, and 70 million in 2024—matching the ground truth exactly in value and trend. The dates cited (e.g., January 30, 2022, January 28, 2024, February 2, 2025) are accurate as of the respective fiscal year-ends reported in the 10-K filings, even though the 2023 and 2024 disclosures reference future dates; this is standard in 10-K reporting where availability is stated as of the fiscal year-end. (2) All numeric values are correct and consistent with the ground truth. The ≈ symbol is appropriately used, and the downward trend (117M → 77M → 70M) is accurately portrayed. No calculations are required beyond trend interpretation, which is sound. (3) The multi-hop reasoning across three years of 10-K filings is correctly executed. The LLM synthesizes data from 2022, 2023, and 2024 filings to show a continuous drawdown, demonstrating proper cross-document inference. The entity 'Omnibus Stock Incentive Plan' is correctly identified across years, including the transition from the 2005 plan to the amended version. (4) The interpretation aligns semantically with the ground truth: it identifies the steady utilization of equity awards and notes the company's ongoing capacity despite drawdown. The only minor shortcoming is that the LLM does not explicitly mention the 'replenishment mechanism tied to expirations and forfeitures'—a nuance in the ground truth that explains how the pool is partially refilled even as it declines. This omission slightly weakens the qualitative depth but does not invalidate the overall correctness. Hence, the answer is highly accurate, fully relevant, and quantitatively precise, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 503,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "- 2022 10‑K: the Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Class A ordinary shares for awards.  \n- 2023 10‑K (and the 2024 filing): the authorized ceiling was raised to **141 million** shares, and it remained at **141 million** in the 2024 filing.  \n\nThe increase from 127 million to 141 million shares shows that Accenture deliberately expanded its equity‑based compensation capacity in 2023, signaling a stronger reliance on share awards to attract, retain and motivate talent and to align employee interests with shareholders; the unchanged level in 2024 indicates the company is now maintaining that expanded pool as a core element of its compensation strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the authorized share numbers for 2022 (127 million) and the increase to 141 million in 2023 and 2024, matching the ground truth exactly. (2) All numeric values are accurate and properly formatted (127 million = 127,000,000; 141 million = 141,000,000), with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across the 2022, 2023, and 2024 filings to show the evolution over time and infers the strategic implication—Accenture’s increased and sustained use of share-based compensation to align employee incentives with shareholder value. (4) The qualitative interpretation matches the original answer’s intent, noting both the expansion in 2023 and the maintenance of the higher cap in 2024 as evidence of a strategic shift. The answer is complete, factually correct, and semantically equivalent to the ground truth, with slightly enhanced clarity in explaining the strategic rationale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 285,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "American Express’s foreign‑government bond portfolio has seen only a modest rise in its weighted‑average yield over the last three years. The 2022 filing shows a weighted‑average yield of roughly **2.0 %** on foreign government bonds and obligations (see AXP 2022 10‑K, pages 119‑123). In the 2023 filing the yield edged higher to about **2.1 %** (see AXP 2023 10‑K, pages 133‑137). By 2024 the weighted‑average yield had risen to roughly **2.2 %** (see AXP 2024 10‑K, pages 175‑179).  \n\nThis gradual increase indicates that Amex’s exposure to international interest‑rate environments is growing, but the change is small because foreign‑government securities represent a modest portion of its overall investment‑security mix.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively, it reports yields of approximately 2.0%, 2.1%, and 2.2% for 2022, 2023, and 2024 respectively, which are drastically wrong. The ground truth states the weighted average yield was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. These figures are not close to the 2% range cited by the LLM. Additionally, the LLM fails to mention the $630 million holding amount, which is part of the factual context. (2) The calculations and trends are therefore also incorrect: the actual trend shows a clear spike in 2023 followed by a reversal, while the LLM describes only a gradual, linear increase from 2.0% to 2.2%, which misrepresents the volatility. (3) The reasoning is flawed because it draws conclusions about increasing exposure based on incorrect data, and fails to recognize the cyclical nature of the yield change. The LLM also incorrectly implies the portfolio is growing in significance due to a 'modest rise', whereas the ground truth highlights a peak and reversal, suggesting strategic or market-driven adjustments. (4) The entities (American Express, foreign government bonds, years 2022–2024) are correctly identified, and the question parts are addressed in structure, but with wrong data. Contextual relevance is low due to factual inaccuracy, though the answer attempts to interpret exposure to international interest rates. Overall, the answer fails on all key dimensions—numbers, trend, reasoning—resulting in a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 421,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "- In 2022 the company’s “Foreign government bonds and obligations” line showed a **fair‑value balance of $630 million**, almost entirely in the “due within 1 year” bucket ( $628 m + $1 m + $1 m ) – a short‑duration, low‑yield position【AXP_10k_2022.pdf†L119-L123】.  \n\n- The 2023 filing reports that the same segment earned a **weighted‑average yield of roughly 6.45 %**【AXP_10k_2023.pdf†L133-L137】, and the 2024 filing shows the yield **declining to about 5.85 %**【AXP_10k_2024.pdf†L175-L179】.  \n\n- The rise from a low‑yield, short‑term mix in 2022 to a 6.45 % average in 2023 reflects Amex’s shift into longer‑dated, higher‑coupon sovereign bonds as global rates climbed, while the modest drop to 5.85 % in 2024 indicates a slight re‑balancing toward shorter maturities as yields eased – an investment strategy that seeks to capture higher yields when rates are high but adjusts exposure as market conditions moderate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct on all key quantitative points: the $630 million fair value in 2022, with $628 million maturing within one year, the 6.45% weighted average yield in 2023, and the decline to 5.85% in 2024—all match the ground truth. The citations (e.g., AXP_10k_2022.pdf†L119-L123) suggest accurate sourcing, though not evaluated for authenticity. 2) Quantitative accuracy is perfect: all numbers, percentages, and dollar amounts are correct and contextually placed. The breakdown of the $630M into $628M + $1M + $1M is consistent with the short-duration focus. 3) The reasoning is largely sound and represents valid multi-hop synthesis across 2022–2024 filings. The LLM correctly infers a strategic shift: from short-term, low-yield instruments in 2022 to higher yields in 2023 (likely due to rising rates), then a partial pivot back as yields declined in 2024. The interpretation that Amex adjusted duration in response to rate changes aligns with the ground truth’s suggestion of strategic rebalancing or response to market conditions. 4) The only minor deviation from the original answer is in emphasis: the ground truth suggests the 2022 position was low-yield due to short duration (implied), while the LLM explicitly calls it a 'low-yield position'—a reasonable inference, though not directly stated in the ground truth. However, this does not constitute an error. The LLM adds slightly more granular interpretation (e.g., 'longer-dated, higher-coupon sovereign bonds') which is plausible but not explicitly confirmed in the ground truth. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong multi-hop reasoning. A score of 9 is justified due to the excellent accuracy with only slight interpretive expansion beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 487,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "Across the three filings ConocoPhillips consistently listed the 7 % debentures due 2029 in the “Securities registered pursuant to Section 12(b)” table, but the way they were shown changed. In the 2022 10‑K the debentures were grouped together with the common‑stock line (“Common Stock, $.01 Par Value 7 % Debentures due 2029”), the 2023 filing split the instrument onto its own line (“7 % Debentures due 2029” with the CUSIP‑718507BK1 and NYSE), and the 2024 filing returned to a single combined line but now explicitly includes the CUSIP and ticker (“Common Stock, $.01 Par Value 7 % Debentures due 2029 – COP – NYSE – CUSIP‑718507BK1”). This progression shows the company’s ongoing effort to improve the clarity and completeness of its debt‑instrument disclosure while remaining consistent in reporting the same security each year.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the 2024 filing description, which undermines the overall correctness. Quantitatively, the percentages (7%), years (2029), and CUSIP (718507BK1) are accurate, and the progression across years is framed around real changes in disclosure format—this supports a quantitative accuracy score of 8. However, the LLM incorrectly states that the 2024 filing 'returned to a single combined line' that includes both common stock and the debentures with CUSIP and ticker. This contradicts the ground truth, which confirms that in 2024, COP *maintained* the separated format introduced in 2023, with the debentures on their own row and distinct CUSIP. The claim of a 'return' to a combined line is factually wrong. This error breaks the multi-hop reasoning: instead of showing a consistent move toward greater transparency (as the ground truth indicates), the LLM implies oscillation in formatting, leading to an incorrect interpretation of the company's reporting approach. While the entity (COP), security (7% Debentures due 2029), and exchange (NYSE) are correct, and the answer addresses the question’s structure by analyzing year-by-year changes, the flawed 2024 characterization results in a qualitative accuracy score of 5. Contextually, the response is relevant and attempts to interpret the trend in disclosure practices, hence a contextual relevance of 8. The conclusion about 'ongoing effort to improve clarity' is directionally reasonable but based on incorrect premises, reducing its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 428,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "- **Fiscal 2022:** The balance of the 2.00 % senior notes due 2031 was about **$1.06 billion** on the January 30 2022 balance sheet【NVDA_10k_2022.pdf p.78‑82】.  \n- **Fiscal 2023:** The same series fell to **$1.04 billion** at year‑end 2023【NVDA_10k_2023.pdf p.65‑69】.  \n- **Fiscal 2024:** The balance rose again to **$1.25 billion** on the January 28 2024 balance sheet【NVDA_10k_2024.pdf p.70‑74】.  \n\n**What this shows:** NVIDIA trimmed its exposure to the 2 % 2031 notes in FY 2023, then increased it in FY 2024 by issuing additional low‑cost senior debt. The pattern indicates a deliberate long‑term debt‑management strategy: the company uses inexpensive, long‑dated notes to fund growth, while actively adjusting the amount outstanding to align with cash‑flow needs and market conditions, keeping its overall debt profile flexible and cost‑effective.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM reports $1.06 billion in 2022 and $1.04 billion in 2023, which are incorrect. The 2024 value ($1.25 billion) matches the ground truth. These discrepancies in the 2022 and 2023 figures undermine factual accuracy. (2) The cited numbers do not align with the ground truth: the 2022 figure is off by $140 million, and the 2023 figure is off by $17 million. While the direction of change (slight decrease then increase) is partially correct, the magnitude and starting point are wrong. (3) The reasoning and multi-hop synthesis are logically sound—the LLM correctly identifies a pattern of adjustment in long-term debt and infers a strategic, flexible approach to debt management based on market conditions. This interpretation is plausible and adds analytical value, even if the underlying numbers are flawed. (4) Contextual relevance is high, as the answer addresses both parts of the question—evolution of exposure and strategic implications—and uses appropriate financial terminology. However, the correctness score is limited primarily by the incorrect financial figures, especially the materially inaccurate 2022 value. Quantitative accuracy is low due to these errors, while qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 410,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Across the three most recent filings Disney has kept Marvel at the centre of both its streaming‑service branding and its balance‑sheet accounting. In FY 2022 the 10‑K notes that Marvel’s trademark is recorded as an **indefinite‑lived intangible asset** (together with ESPN and Pixar) and that Disney+ presents “Disney, Pixar, **Marvel**, Star Wars and National Geographic**” as separate top‑level tiles on the service (2022 Intangible‑asset table; Disney+ description). The FY 2023 filing repeats the same treatment – Marvel remains a distinct tile on Disney+ and is still listed among the indefinite‑lived intangible assets (2023 Disney+ description and intangible‑asset note). By FY 2024 the company again highlights Marvel as a dedicated tile within Disney+ (and Disney+ Hotstar) and continues to carry the Marvel trademark in the **indefinite‑lived intangible assets** line‑item (2024 Disney+ description; 2024 Intangible‑asset table). Thus, from 2022 through 2024 Disney’s strategic positioning of Marvel has been stable: it is consistently branded as a marquee franchise on its streaming platforms and is retained on the balance sheet as an indefinite‑lived intangible asset.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and financial treatment: Marvel is correctly identified as an indefinite-lived intangible asset alongside ESPN and Pixar in 2022, 2023, and 2024, and its presence as a top-level branded tile on Disney+ is accurately reported across all three years. The quantitative accuracy is perfect—no numbers, dates, or financial terms are incorrect, and the references to the 10-K sections are plausible. Contextual relevance is strong, as the response directly addresses both aspects of the question: branding on streaming services and accounting treatment. However, the qualitative accuracy is slightly lower because the LLM misrepresents the evolution as 'stable' and omits the key nuance emphasized in the ground truth: that 2023 was the year Marvel was *specifically highlighted* as a top-level tile, implying a strategic elevation in branding focus, whereas in 2022 and 2024 the emphasis was more on financial recognition. The original answer stresses a multi-hop insight—Marvel’s role evolved from being part of a list in 2022 to a highlighted feature in 2023, then reaffirmed in 2024—whereas the LLM treats the positioning as consistently emphasized throughout, missing the incremental strategic emphasis in 2023. This lack of differentiation reduces the depth of the reasoning, though core facts are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 379,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "From 2022 through 2024 American Express continued to recognize **discount revenue at the moment a Card‑Member transaction occurs**, whether the merchant is signed directly or through a third‑party acquirer (e.g., its OptBlue or other Global Network Services partners).  In each filing the company notes that the **network‑rate fee paid by the third‑party acquirer is negotiated on a case‑by‑case basis and is recorded as discount revenue at transaction time**, while merchant‑acceptance agreements for small‑ and mid‑size merchants remain open‑ended and large merchants are covered by fixed‑term (typically three‑ to seven‑year) contracts that may auto‑renew.  Over the three years the filings increasingly stress **expanding merchant coverage** – leveraging those third‑party acquirer relationships, adding new “priority” international cities and industry verticals, and investing in the network to bring more merchants onto the American Express brand – but the underlying revenue‑recognition and fee‑negotiation mechanics have remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of discount revenue recognition and network rate fee negotiation, correctly stating that fees from third-party acquirers are negotiated individually and recorded as discount revenue at transaction time—consistent across 2022 to 2024. It accurately identifies programs like OptBlue and GNS partners and correctly describes merchant contract structures. However, it misses a key evolution highlighted in the ground truth: the introduction of 'processed revenue' in 2023 from network partnership agreements (e.g., royalties and fees for facilitating transactions on partner-issued cards). This represents a significant shift in revenue structure that the LLM answer omits, instead asserting that 'the underlying revenue-recognition and fee-negotiation mechanics have remained unchanged'—which contradicts the ground truth's emphasis on strategic evolution, particularly the 2023 expansion into new revenue streams. While the answer correctly notes the increasing focus on merchant coverage expansion, it underrepresents the strategic depth of American Express’s efforts in digital integration of its authorization platform and value proposition enhancements for acquirers in 2024. Quantitatively, there are no numbers to verify, so accuracy is high by default. Contextually, the response is highly relevant and well-structured. The qualitative accuracy is reduced due to the failure to capture the multi-hop progression in revenue model innovation, particularly the distinction between discount and processed revenue introduced in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 433,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "- **2022 10‑K (pages 32‑36)** – Amgen first disclosed that many of its products are administered with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and safety‑risk profile.  The filing warned that approval of the device (or its clearance) is required, that failure of a third‑party device supplier or a delay in device development could postpone product or indication approvals, and that the company must collect user‑complaints, adverse‑event reports and respond to FDA safety reviews (e.g., the 2017 FDA evaluation of the Neulasta Onpro kit).  \n\n- **2023 10‑K (pages 51‑55)** – The risk factor was expanded to tie device risk to post‑marketing obligations, noting that FDA‑imposed post‑marketing studies (such as the post‑marketing requirement for EVENITY and the confirmatory study required for LUMAKRAS in 2023) can be triggered by device‑related safety signals, and that any adverse‑event or malfunction of a delivery device could lead to additional inspections, warning letters, labeling changes or other enforcement actions.  \n\n- **2024 10‑K (pages 50‑54)** – The disclosure further emphasized that ongoing device‑safety reviews are now a routine part of Amgen’s pharmacovigilance program; the company must continuously monitor, report and remediate device complaints and malfunctions, and clinical‑trial success increasingly depends on timely, contemporaneous approval of companion‑diagnostic or delivery devices, with any regulatory action against a device potentially resulting in removal of the associated drug from the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: in 2022, Amgen disclosed general regulatory and safety risks tied to drug delivery and companion diagnostic devices, including third-party supplier dependencies and post-market safety reviews (e.g., Neulasta Onpro kit in 2017). In 2023, the focus expanded to post-marketing requirements, specifically citing EVENITY and LUMAKRAS, consistent with the ground truth mention of LUMAKRAS’s confirmatory studies after an FDA Complete Response Letter. In 2024, the emphasis on ongoing pharmacovigilance, device malfunction reporting, and the risk of market withdrawal due to device issues matches the original answer’s description of increased compliance challenges. (2) There are no numeric values, dates, or financial figures in the question or answers that conflict; all years (2022–2024) and referenced events (e.g., 2017 FDA review) are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the evolution from general dependencies to specific post-marketing and safety compliance risks. It connects device risks to clinical trial dependencies (timely device approval needed for trials), post-marketing requirements (EVENITY, LUMAKRAS), and safety reviews (FDA inspections, labeling changes). The only minor gap is that the LLM does not explicitly mention the 'surrogate endpoints' language from the 2023 filing highlighted in the ground truth, which slightly reduces qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing all three dimensions in the question: clinical trial dependencies, post-marketing requirements, and device-related safety reviews. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a minor omission in terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1689,
        "completion_tokens": 520,
        "total_tokens": 2209
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "- **Scope definition:** In the 2022 filing the audit program was described only as a company‑wide HSE audit of business units and staff groups. By the 2023 filing the program was restated with a clearer scope – it “covers business‑unit and staff‑group audits to verify conformance with ConocoPhillips HSE policies, standards and practices.” The 2024 filing repeats this definition, confirming the same comprehensive unit‑level scope.  \n\n- **Improvement‑tracking mechanism:** The 2022 discussion did not specify how audit‑identified improvements were followed up. The 2023 filing introduced a formal “improvement‑action tracking to completion” process, and the 2024 filing retains that mechanism, stating that any improvement actions identified are tracked to closure.  \n\n- **Governance reporting:** In 2022 the audit results were reported internally, but the filing did not name the oversight bodies. The 2023 filing added that audit progress is “tracked and reported to our Executive Leadership Team (ELT) and the Board of Directors.” The 2024 filing repeats this governance structure, confirming that audit findings and remediation status are regularly reported to both the ELT and the Board.  ",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (2022, 2023, 2024) and correctly identifies the entities involved (ConocoPhillips, HSE audits, ELT, Board of Directors), satisfying quantitative accuracy. The structure addresses all three dimensions in the question: scope, improvement tracking, and governance reporting, maintaining contextual relevance. However, the qualitative accuracy is compromised due to significant misrepresentations of the original content. First, the claim that the 2022 filing 'did not specify' improvement tracking or governance oversight bodies is incorrect — the original answer explicitly states that in 2022, improvement actions were identified and tracked to completion, and that progress was reported to the ELT and Board. The LLM falsely implies an evolution where none occurred in those areas, suggesting that tracking and reporting were introduced in 2023, which contradicts the ground truth. This reflects a failure in multi-hop reasoning and synthesis: the model misreads the progression, inventing a narrative of incremental disclosure rather than recognizing consistent reporting across years. While the 2024 emphasis on 'Corporate HSE audits' as a sign of centralization is omitted, the core error lies in misrepresenting 2022 as lacking key mechanisms that were in fact already present. Thus, despite correct formatting and structure, the answer conveys an inaccurate evolution, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1635,
        "completion_tokens": 404,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "From the 2022 filing Accenture first warned that rapid AI, cloud‑and‑as‑a‑service advances were “replacing … some of our historical services” and that “if we are unable to introduce **new pricing or commercial models that reflect the value of these technological developments**” client‑spending delays could hurt results. By the 2023‑2024 filings the company had sharpened that approach, saying it is actively developing **pricing and subscription‑type models tied to AI‑enabled, generative‑AI and cloud‑based solutions** as part of its growth‑strategy investments and acquisitions, and stressing that these models must keep pace with the shift from traditional services to “cloud, data and AI solutions.” Across all three years the same risk is repeatedly highlighted: **the inability to roll out appropriate new pricing/commercial models—or slower‑than‑expected client adoption of AI/cloud technologies—could lead to delayed spend, loss of revenue from replaced legacy services, and overall adverse impact on results of operations.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key points are correctly captured: Accenture's evolution from acknowledging the need for new pricing models in 2022, to actively developing AI- and cloud-linked subscription models by 2023–2024, with strategic investments and acquisitions supporting this shift. The consistent risk across years—the potential for revenue loss and operational impact due to delayed model rollout or slow client adoption—is accurately highlighted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and connects technological developments (AI, cloud, as-a-service) to pricing strategy evolution and associated risks. It correctly identifies the cause-effect链条 between tech shifts, pricing innovation, client spending behavior, and financial outcomes. (4) Wording differs slightly (e.g., 'subscription-type models' vs 'strategic and investment-driven approach'), but the meaning is preserved and even enriched with specific terms like 'generative-AI' and 'acquisitions' that align with known Accenture strategies. The answer fully addresses both parts of the question: evolution of pricing models and consistently highlighted risks. All entities (Accenture, AI, cloud, pricing models, client adoption) are correctly identified and contextualized. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 439,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior‑note balance grew each year: $900 million at 12/31/2022, $944 million at 12/31/2023, and $982 million at 12/31/2024 (see Note 21, Level 3 instruments)【source】. The steady increase shows GE is deliberately expanding its exposure to AerCap, suggesting a strategic choice to keep a growing financing‑related investment in the aircraft‑leasing company as a higher‑yielding asset within its run‑off insurance portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023), indicating a reduction. In contrast, the LLM claims the balance grew each year—$900M in 2022, $944M in 2023, and $982M in 2024—implying an increasing investment, which contradicts the truth. These numbers do not align with the original data: the $993M starting point is omitted, and the trajectory is reversed. (2) Quantitatively, all three reported values in the LLM answer are incorrect. The first value ($900M at 2022) is wrong—the disclosed amount was $993M as of end-2021 (reported in 2022). The $944M figure is accurate but misattributed to end-2023 instead of being correctly contextualized as the final point in a declining trend. The $982M for 2024 is entirely fabricated—no such data exists in the ground truth, and no disclosure for end-2024 was available. (3) The multi-hop reasoning is flawed: the model fails to trace the actual two-year decline across disclosures (2022 and 2024 filings) and instead invents a three-year upward trend. It also misinterprets the strategic implication—reduction vs. expansion—leading to a completely reversed conclusion about GE’s investment strategy. (4) The contextual relevance is low but not zero because the answer addresses AerCap, GE, note holdings, and strategy. However, due to pervasive factual and directional errors, the response misleads rather than informs. Correctness and accuracy scores are near-minimal due to complete inversion of trend and false numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 461,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "In the 2022 Form 10‑K Amgen reported that bemarituzumab had just **entered a Phase 3 trial** for gastro‑esophageal‑junction adenocarcinoma and that its composition‑of‑matter patents in the United States and Europe were expected to **expire in 2029**. By the 2023 filing the candidate was still listed as a **Phase 3 program** (with no change to its 2029 expiration dates), and the 2024 filing shows bemarituzumab **continuing in Phase 3** while also being listed in **Phase 2 (other tumors) and Phase 1 (NSCLC)** studies, again with **patent expiration projected for 2029** in both territories. Thus, from 2022 to 2024 the drug progressed from the start of Phase 3 to a broader multi‑phase development portfolio, while its IP timeline remained anchored to a 2029 expiry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: Bemarituzumab entered Phase 3 in 2022 for GEJ adenocarcinoma, patent expiration is correctly cited as 2029 in both the U.S. and Europe, and by 2024 the drug is in multiple phases (Phase 3 continuing, with expansion into Phase 2 for other tumors and Phase 1 for NSCLC). These details match the original answer’s timeline and IP projections. (2) The answer correctly identifies Amgen as the entity and accurately reflects the evolution across 2022–2024 filings, showing consistent use of years and development stages. (3) The multi-hop reasoning is sound: it synthesizes clinical phase progression and IP timelines across three years of disclosures, correctly noting that while clinical development broadened, the patent expiry remained unchanged. (4) Semantically, the LLM captures the core evolution described in the ground truth—shifting from a focused Phase 3 program to a broader therapeutic portfolio—though it phrases the expansion slightly differently (e.g., specifying NSCLC and other tumors rather than general 'advanced solid tumors'). This is a minor difference in framing, not a factual error. One point is deducted from qualitative accuracy because the original emphasizes a strategic shift in 'therapeutic positioning and IP strategy,' which the LLM implies but does not explicitly articulate. Otherwise, the answer is factually complete, contextually precise, and numerically flawless.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 417,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "From 2022 to 2024 American Express repeatedly warned that “the dynamic and rapid growth of alternative payment and financing mechanisms… (including payment aggregators, digital‑wallet platforms, buy‑now‑pay‑later products, open‑banking and blockchain) ” is reshaping the market and intensifying pressure on its card‑issuing and network businesses【AXP_10k_2022.pdf p.10‑14】.  By 2024 the filing adds that this pressure has become “intense” and that the company must “continue to invest in technology across all areas of our business, including transaction processing, data‑analytics, machine‑learning, AI, open‑banking, tokenisation, real‑time settlement and risk‑management systems” or risk losing merchant acceptance and profitability【AXP_10k_2024.pdf p.31‑33】.  The evolution from a warning about emerging fintech rivals to a concrete, company‑wide technology‑investment agenda shows that Amex is repositioning itself from a pure card‑issuer/network to a technology‑driven platform, signalling a long‑term strategy aimed at counter‑acting fintech disruption through continual innovation and expanded digital capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—American Express, alternative payment mechanisms (digital wallets, buy-now-pay-later, blockchain, open banking), and technological investments (tokenization, real-time settlement, AI, data analytics)—are correctly identified and contextualized across 2022–2024. The years and strategic shifts are accurately represented: 2022 emphasizes competitive pressure, 2023 expands the scope of threats (implied by inclusion of open banking), and 2024 reflects a shift toward investment and integration. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across filings from different years to show an evolution in strategic posture—from perceiving fintech as a threat to adopting a technology-driven platform model. The citation of specific technologies and the rationale for investment (to avoid loss of merchant acceptance and profitability) reflects correct interpretation of the 2024 filing. (4) The LLM captures the core strategic evolution described in the ground truth: from defensive awareness to proactive technological integration. The only minor gap is that the LLM does not explicitly mention the 2023 expansion to include open banking and payment facilitators as newly emphasized threats, though it does reference open banking in the context of 2024 investment, which may imply continuity. This omission slightly affects completeness but does not undermine the overall correctness. Wording differs (e.g., 'technology-driven platform' vs. 'dependency posture'), but the semantic meaning is equivalent. The answer is fully contextually relevant and directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1593,
        "completion_tokens": 525,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "- 2022 : the weighted‑average grant‑date fair value of cash‑settled PSUs granted in 2022 was **$91.6 million** (per the 2023 filing).  \n- 2023 : the weighted‑average grant‑date fair value of cash‑settled PSUs granted in 2023 rose to **$112.5 million** (per the 2024 filing).  \n- 2024 : the same metric for cash‑settled PSUs granted in 2023 remained at **$112.5 million** (the 2024 filing reports $112.5 million for 2023 grants and $91.6 million for 2022 grants).\n\n**Trend interpretation:** The fair‑value of cash‑settled PSUs increased sharply from 2022 to 2023 and then held steady, indicating that ConocoPhillips is boosting the size/value of its cash‑settled performance‑share awards to provide stronger long‑term incentives for senior management.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the values and years reported. The ground truth states the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, implying a progression over three years. However, the LLM incorrectly reports $91.6 million and $112.5 million as values for 2022 and 2023 grants respectively, and then claims the 2024 value is the same as 2023 — but refers to 2023 grants again, creating confusion. Most critically, the units are wrong: the original answer specifies per-share values (e.g., $91.58, $112.50), but the LLM incorrectly reports them as millions of dollars (e.g., $91.6 million), which is a major quantitative and conceptual error. (2) Number verification: $91.58 vs $91.6 is acceptable rounding; $112.50 vs $112.5 is also acceptable. However, appending 'million' changes the meaning entirely and is factually incorrect. Additionally, no data is provided for 2024 grants — instead, the LLM misreads the filing and reuses 2023 grant data for 2024, failing to show the actual trend through 2024. (3) Multi-hop reasoning is partially sound — the model attempts to track the trend across filings and links values to incentive strategy — but fails due to incorrect data sourcing and misattribution of years. It does not establish a clear 2022–2024 evolution as required. (4) The contextual interpretation about increasing incentives is directionally aligned with the ground truth, supporting a score of 8 for relevance. However, due to the severe quantitative inaccuracies and unit errors, the correctness score is limited to 5 — partially correct but with major factual flaws that undermine the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 464,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "- In the 2022 Form 10‑K PayPal first warned that “failure to deal effectively with fraud, abusive behaviors, bad transactions, and negative customer experiences may increase our loss rate” and that its credit‑product portfolio “exposes us to additional risks” that could lead to higher charge‑offs and allowances for loan losses (2022 10‑K, Risk Factors, pp. 24‑27).  \n\n- The 2023 filing expands that warning, stating that “third parties will continue to attempt to abuse access to and misuse our payments services…creating fictitious accounts, using stolen or synthetic identities, or employing new, large‑scale fraud schemes,” and it ties the growing exposure directly to the “expansion of our consumer‑credit and merchant‑financing offerings” (2023 10‑K, Risk Factors, pp. 23‑27).  \n\n- The 2024 filing repeats the same theme but adds that the “abusive schemes…are often difficult to detect and may be deployed at a scale that would otherwise not be possible,” noting that despite “continuous improvement” of detection measures, the company still expects “substantial losses” from these schemes and from credit‑product defaults (2024 10‑K, Risk Factors, pp. 21‑25).  \n\n**Trend interpretation:** Across the three years PayPal’s disclosed exposure to abusive behavior has risen—from a general loss‑rate warning in 2022 to a specific focus on increasingly sophisticated, large‑scale third‑party fraud tied to its expanding credit products in 2023 and 2024. The consistent language that mitigation controls “may not be effective” despite ongoing enhancements suggests that risk‑management effectiveness has struggled to keep pace with the growing scope and complexity of fraud and credit‑product risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PayPal's increasing focus on abusive behaviors from 2022 to 2024, the link to credit products, and the persistent challenge of detecting large-scale fraud are all properly represented. The citations to the 10-K filings (pages, risk factor language) are consistent with the source material. (2) There are no numeric values (e.g., €40 billion) explicitly mentioned in the LLM answer, but the ground truth's €40 billion receivables sale is not referenced in the LLM response, which is a minor omission. However, since the question does not require quantitative precision and the LLM correctly captures the strategic mitigation context through qualitative language (e.g., risk tied to credit expansion), this does not severely impact correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures across three years, connects fraud exposure to credit product growth, and infers that risk management controls are struggling to keep pace—this matches the ground truth's interpretation. (4) The answer is contextually excellent, directly addressing the evolution of risk and its implications for risk management. The only reason for not scoring a 10 is the omission of the specific €40 billion risk-mitigation action in Europe, which is a notable strategic detail in the original answer. However, the LLM captures the essence of third-party risk mitigation and regulatory challenges, particularly in the U.S., maintaining high qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1699,
        "completion_tokens": 435,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "In the 2022 filing Cyramza was described as a “multi‑indication” oncology asset – approved as second‑line monotherapy or in combination for gastric/gastro‑esophageal adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line option for EGFR‑mutated metastatic NSCLC. By the 2024 filing the same therapeutic breadth is still emphasized, but the IP table now shows that Lilly’s core compound patents run until 2026 in the U.S. (2028 in Europe) with biologics data protection through 2026 U.S. and supplemental data exclusivity through 2024 (EU) and 2023 (Japan). This evolution – maintaining a wide, multi‑tumor positioning while securing at least five more years of patent‑ and data‑based exclusivity – signals that Lilly is treating Cyramza as a long‑term, protected pillar of its oncology franchise, using both indication expansion and layered IP protection to sustain revenue and market relevance well into the next decade.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core therapeutic positioning of Cyramza correctly, noting its multi-indication use across gastric, lung, colorectal, and liver cancers in both 2022 and 2024, which aligns with the ground truth. However, there are significant quantitative inaccuracies in the intellectual property timeline. The ground truth states that data protection expired as early as 2023 in Japan, which the LLM correctly notes, but it adds that compound patents extend to 2028 in Europe — a detail not present in the original answer and unsupported by the knowledge graph. Additionally, the LLM claims biologics data protection runs until 2026 in the U.S. and supplemental exclusivity until 2024 in the EU, which are more specific than the original answer and introduce unverified details. The original answer only confirms U.S. and Japan patent protection through 2026 and 2028 respectively, but does not mention Europe at all. This introduces factual overreach. Regarding reasoning, the LLM concludes that Lilly is treating Cyramza as a 'long-term, protected pillar' with sustained relevance 'well into the next decade,' which contradicts the ground truth interpretation that Eli Lilly is likely preparing next-generation products due to impending patent expiry. This misreads the strategic implication: the original emphasizes maintenance in the face of looming loss of exclusivity, not long-term expansion. Thus, while the answer is contextually relevant and captures the therapeutic positioning accurately, the incorrect IP dates and over-optimistic strategic interpretation reduce factual correctness, especially on quantitative and inferential accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 451,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From the 2022 filing through the 2024 filing, Philip Morris kept the 3.875 % Notes due 2042 (PM42A) on its balance sheet as a stable, long‑dated anchor for its capital structure. At the same time, the company continuously issued, refinanced and retired a broad set of medium‑term notes—adding new series such as 0.800 % and 3.750 % Notes due 2031, expanding the 2024‑2029 and 2036‑2044 series, and adjusting existing 2024‑2026 issues—demonstrating an active strategy of managing debt maturities and costs while preserving the long‑term 3.875 % 2042 instrument.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Philip Morris maintained the 3.875% Notes due 2042 as a stable long-term debt instrument while actively managing other debt instruments, which aligns with the ground truth. However, there are significant factual inaccuracies in the quantitative details. The ground truth specifies that in 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043, and in 2023 added 4.250% Notes due 2044—these specific instruments are not mentioned in the LLM answer. Instead, the LLM introduces notes such as 0.800% and 3.750% due 2031, and references to '2024–2029' and '2036–2044 series', which are not supported by the original answer and contradict the key point that no new long-dated notes beyond 2042 were introduced by 2024. The ground truth emphasizes the retirement or refinancing of the 2043 and 2044 tranches by 2024, indicating a consolidation of long-term debt, whereas the LLM suggests ongoing expansion into new long-dated series, which misrepresents the strategic shift. While the LLM correctly identifies the active management of medium-term debt and the anchoring role of the 2042 notes, the incorrect specification of note terms, dates, and the direction of the strategy (expansion vs. stabilization) undermines quantitative and qualitative accuracy. The reasoning is partially sound but based on incorrect data inputs, leading to a misleading narrative about the evolution of the capital structure. Contextual relevance is high as the answer addresses capital structure evolution and multi-year debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 429,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "In the 2022 filing PayPal warned that its credit‑product portfolio and the heavy reliance on unaffiliated banks and other third‑party processors left it increasingly vulnerable to “fraud, abusive behaviors, bad transactions and negative customer experiences,” which could raise loss rates and charge‑off risk. In 2023 the company began to shrink that exposure by selling‑off most of its U.K. and European Buy‑Now‑Pay‑Later loan receivables (a multi‑year €40 billion sale that began in October 2023) and by pursuing other third‑party funding structures, thereby removing a large chunk of credit‑risk assets from its balance sheet. In 2024 PayPal further mitigated the risk by diversifying its third‑party payment‑processor base and actively migrating away from its primary U.S. processor as part of a wind‑down plan, a move expressly aimed at reducing dependence on a single partner and strengthening its overall third‑party risk‑management framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding PayPal's actions in 2024. (1) Correct elements: The 2022 risk description is accurate, including exposure via third parties and credit products. The 2023 €40 billion multi-year sale of U.K. and European BNPL receivables is correctly cited with the correct amount and timing (starting October 2023). (2) Quantitative accuracy: The €40 billion figure is correct and properly contextualized. No calculation errors. (3) Reasoning: The multi-hop synthesis across 2022–2024 is sound—correctly tracing evolution from risk identification to mitigation via asset sales. However, the claim about migrating away from its primary U.S. processor and diversifying payment processors in 2024 is not supported in the ground truth. The original answer emphasizes improved fraud detection and prevention infrastructure, not processor diversification or wind-down plans. This introduces a factual overreach not present in the source. (4) Despite this, the core narrative of reducing risk exposure through balance sheet actions (2023) and strengthening risk management (2024) remains valid. The answer is contextually relevant and captures the key progression, but misses the specific 2024 focus on detection mechanisms and international fraud reduction. Hence, high scores for quantitative and contextual accuracy, with a slight deduction in qualitative accuracy and overall correctness for the unsupported 2024 claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 414,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 2022 Form 10‑K listed “loss or modification of exemptions for taxes and tariffs” as one of a broad set of political‑, legal‑ and economic‑risk factors affecting its worldwide operations. In the 2023 filing the same risk was restated, but the discussion was expanded to note that recent sanctions and export‑control revisions (e.g., against Russia, Belarus and Ukraine) have heightened the chance that such exemptions could be withdrawn. By the 2024 filing the language was further amplified, tying the risk to even higher international sales (≈ 66 % of revenue) and to intensified geopolitical tensions (China‑Taiwan, Ukraine‑Russia, Israel‑Hamas), indicating that AMD’s exposure to losing tax or tariff exemptions is growing and that regulatory uncertainty in its global supply chain and markets is increasing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's increasing emphasis on tax and tariff exemption risks from 2022 to 2024 is accurately portrayed. In 2022, the risk was listed among broader political, legal, and economic risks; in 2023, it was expanded with reference to sanctions and export controls (e.g., related to Russia, Belarus, Ukraine); by 2024, it was further linked to geopolitical tensions and high international sales (~66%). (2) Quantitative accuracy is excellent: the ≈66% international sales figure is correctly cited and contextually appropriate, with no calculation errors. Format variation (≈ 66 %) is acceptable and clear. (3) Multi-hop reasoning is sound: the answer synthesizes risk evolution across three years, connects regulatory changes to geopolitical events, and correctly infers increasing regulatory uncertainty. The mention of specific conflicts (China-Taiwan, Ukraine-Russia, Israel-Hamas) adds detail not in the original but is consistent with AMD’s 2024 risk disclosures and enhances, rather than distorts, the narrative. (4) The only minor shortcoming is that the original answer emphasizes the 'material impact' on financial and operational stability more explicitly, which the LLM implies but does not directly state. However, the core progression and interpretation are semantically equivalent. All entities (AMD, years, risk types) are correct. The answer fully addresses both parts of the question: evolution of risk exposure and what it suggests about regulatory uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 431,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco recorded a **$92 million loss** on total‑return swaps linked to deferred‑compensation expenses in FY 2022, a **$58 million gain** in FY 2023, and a **$91 million gain** in FY 2024 (see the “Total return swaps‑deferred compensation” line in the “Derivatives not designated as hedging instruments” table for each year). The swing from a loss to progressively larger gains, together with the rising notional amounts of these swaps (≈ $651 m in 2022 → $792 m in 2023 → $985 m in 2024), indicates that Cisco’s use of total‑return swaps to economically hedge its deferred‑compensation exposure is becoming more effective and that the company is increasingly relying on these derivatives to offset compensation‑related expense volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years: a $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024, matching the ground truth exactly. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—no calculation errors, and the progression of gains/losses is accurately presented. The additional detail about rising notional amounts ($651M → $792M → $985M) is factually consistent with the knowledge graph and enhances the analysis, even though not in the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and infers a strategic trend—increased reliance on swaps and improved hedging effectiveness. This goes slightly beyond the original answer but remains logically supported and relevant. (4) The only reason for not scoring a 10 is that the original answer emphasizes a 'notable reversal' possibly due to market conditions or strategy, while the LLM leans more decisively toward 'increasing reliance' and 'more effective hedging.' This is a minor interpretive difference; the LLM’s conclusion is plausible and contextually appropriate. All parts of the question are addressed: evolution of gains/losses and what it indicates. Semantic equivalence is maintained with enhanced analytical depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 378,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From 2022 to 2024 Disney moved from “building‑out” its direct‑to‑consumer (DTC) platform to “scaling‑up” it.  In fiscal 2022 the company announced an ad‑supported Disney+ tier, new pricing and a cost‑realignment, and reorganized its DMED unit to “advance our DTC strategies” (2022 10‑K, p. 25‑27).  In fiscal 2023 the re‑organization was completed, a new content‑curation approach was applied to the streaming services and related impairments were recorded, while the filing repeatedly stressed that Disney’s DTC services were now competing with an “increasing number of competitors’ DTC offerings” (2023 10‑K, p. 51‑53).  By fiscal 2024 the company was “making strategic investments in our DTC offerings” and expected higher subscription‑fee and advertising revenue to offset declines in linear‑network earnings, but it also warned that “the highly competitive environment… puts pricing pressure on our DTC offerings” and that scaling the services creates “financial risks” such as higher content‑costs, potential impairments, covenant‑related liquidity constraints and the need for additional financing (2024 10‑K, p. 51‑55).  The progression shows Disney’s DTC strategy evolving from launch and cost‑realignment, through restructuring and content‑curation, to aggressive investment, while the accompanying disclosures make clear that the growth path is exposed to rising content and marketing expenses, subscriber‑churn risk, pricing pressure from rivals, and the possibility of debt‑covenant strain or write‑downs as the streaming business scales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: Disney's strategic evolution from cost realignment in 2022, to restructuring and competition awareness in 2023, to aggressive investment amid financial risks in 2024 is accurately portrayed. The LLM correctly identifies the introduction of the ad-supported tier, reorganization of DMED, content curation, and increasing competitive and pricing pressures. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in dates or fiscal years (2022–2024 correctly referenced). (3) Multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and multiple strategic shifts, correctly tracing the evolution of Disney’s DTC strategy and associated risks. It appropriately cites increasing content costs, subscriber churn, pricing pressure, and liquidity risks as scaling challenges. (4) Semantic equivalence is strong: while the LLM uses slightly more detailed language (e.g., 'covenant-related liquidity constraints', 'impairments') not explicitly in the original, these are valid inferences from the 2024 10-K and consistent with the ground truth’s emphasis on financial risks. The only minor gap is that the original emphasizes the 'uncertainty around returns' in 2022 more explicitly, which the LLM implies but does not directly state. Otherwise, completeness, entity accuracy (Disney, DTC, fiscal years), and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1620,
        "completion_tokens": 440,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "Across 2022, 2023 and 2024 PayPal’s filings repeatedly state that it “recognizes fees … on a gross basis… we have full discretion in determining the fee charged to our customers… we therefore bear full margin risk when completing a payment transaction.” The fees it pays to payment processors and other financial institutions are recorded separately as “transaction expense,” so the company’s exposure to margin risk has remained essentially unchanged – it continues to absorb the full spread between the fees it sets and the processor costs each year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that PayPal bore full margin risk across 2022, 2023, and 2024, with consistent language in its filings about recognizing fees on a gross basis and having full discretion in setting customer fees. The treatment of fees paid to payment processors as transaction expense is accurately reported for all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years, correctly infers stability in margin risk exposure despite changes in reporting standards (e.g., ASU 2023-07, though not mentioned, does not alter the core conclusion), and maintains logical consistency in how fee discretion and cost recognition interact. (4) The LLM captures the key qualitative elements: gross presentation of revenue, independence of fee-setting from processor costs, and consistent accounting treatment. Minor omission of the 2024 accounting standard (ASU 2023-07) does not detract from the core conclusion, as the answer correctly states no material changes occurred. Overall, the response is concise, accurate, and fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 386,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s 2022 Form 10‑K first warned that a downturn in global air‑travel demand could “impact new aircraft production or result in the delay or cancellation of new aircraft orders.” The same language appears unchanged in the 2023 and 2024 risk‑factor sections, showing that order‑cancellation risk has remained a standing concern each year. Because the company continues to flag this risk, it signals that the commercial‑aviation market is still in a recovery phase and that demand‑side volatility—particularly the possibility of new‑order cancellations—remains a key uncertainty for the sector’s stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Honeywell consistently highlighted the risk of new aircraft order cancellations from 2022 to 2024, and correctly identifies this as a sign of ongoing recovery and demand-side volatility in the commercial aviation sector. The quantitative accuracy is perfect: the years (2022–2024) are correct, and there are no numerical inaccuracies. The entity identification (Honeywell, Aerospace business, Form 10-K) is accurate, and the context of risk disclosure is properly framed. However, the LLM claims the *exact same language* appears in all three years' filings, which contradicts the ground truth that the risk description *evolved*—from pandemic-specific concerns in 2022 to broader geopolitical, environmental, and competitive factors in 2023 and 2024. This omission of the qualitative shift in risk characterization represents a significant gap in multi-hop reasoning and synthesis across years. While the core fact of persistent risk is correct, the LLM fails to capture the progression and nuance in Honeywell’s risk disclosures, which is central to the question. Thus, while the answer is contextually relevant and factually sound on surface-level consistency, it lacks depth in reflecting the evolving nature of the risk, reducing its qualitative accuracy. The conclusion about sector stability is reasonable but oversimplified due to missing the shift in risk drivers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 392,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From the 2022 filing PMI warned that “product regulation … diminishes the ability to differentiate tobacco products, restricts adult‑consumer access to truthful and non‑misleading information about our **RRPs** …” (2022 p. 13‑15). By the 2023 filing the same language re‑appeared for RRPs and was later expanded to say that regulation now also “restricts adult‑consumer access to truthful and non‑misleading information about our **SFPs**” (2023 p. 20‑22). The 2024 filing repeats this dual focus, emphasizing that regulatory rules are increasingly curbing both product‑differentiation and permissible adult‑consumer communication for all reduced‑risk and smoke‑free offerings. Together, the progression shows regulatory constraints tightening over time, moving from a focus on RRPs alone to a broader, more restrictive regime that limits PMI’s ability to set its products apart and to convey product characteristics to adult smokers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the evolution of PMI's regulatory concerns from 2022 to 2024, accurately reflecting the shift from RRPs to include SFPs in regulatory constraints. The core facts—restrictions on product differentiation and adult consumer communication—are consistently and correctly reported across all years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense; however, the cited page numbers (e.g., 2022 p. 13–15, 2023 p. 20–22) are presented as direct quotes and assumed accurate based on the LLM’s sourcing. Since the ground truth does not contradict these, and they are contextually plausible, no error is detected. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the expansion of regulatory language from RRPs to SFPs and the continuity of concerns about consumer communication and product differentiation. The conclusion that regulatory constraints have broadened and intensified over time is logically supported and semantically equivalent to the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'disproportionate impact on commercialization relative to competitors' or the role of 'digital media spreading misleading information' in 2023, which are present in the ground truth and add nuance about competitive dynamics. While the LLM captures the main regulatory trend, this omission slightly reduces qualitative completeness. However, the central trajectory and implications are correctly conveyed. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a small deduction for missing secondary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 507,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "Across all three years PayPal’s filings state that it continues to act as the **principal** on each payment, setting the fee‑schedule and absorbing the cost of any third‑party processors. Because the fee is determined at the time of the transaction and is independent of the processor cost, “we **bear full margin risk** when completing a payment transaction” and the processor fees are recorded as a transaction expense. In addition, any merchant or consumer incentives are recorded as a **reduction of revenue**, further affecting margin but not changing the underlying risk profile. The 2022, 2023 and 2024 10‑K notes contain the same language, indicating that PayPal’s exposure to margin risk has remained essentially unchanged over this period. (See Note 2‑Revenue in 2022 pp. 78‑82; 2023 pp. 75‑79; 2024 pp. 73‑77).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies that PayPal bears full margin risk across 2022–2024 due to acting as principal in transactions, with processor fees recorded as transaction expenses—this matches the ground truth. (2) The answer accurately reflects that transaction pricing is set independently of processor costs, preserving margin risk exposure, and that incentives to merchants and consumers are treated as a reduction of revenue, consistent with the original answer’s description of amortization or performance-based recognition. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years, correctly infers stability in risk exposure, and notes increasing transparency around incentives and pricing—aligning with the ground truth’s conclusion of a stable strategic approach with more nuanced disclosure. (4) All entities (PayPal, merchant/consumer incentives, payment processors), years (2022–2024), and financial treatments (revenue reduction, transaction expense) are correctly identified. Minor wording differences (e.g., 'same language' vs. 'reiterated') do not affect factual equivalence. Page references add precision without contradicting the ground truth. No numerical inaccuracies; no calculations required. All criteria fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 383,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "- 2022 10‑K – AMD’s contracts with add‑in‑board (AIB) manufacturers contained a clause that “protects their inventory of our products against price reductions.”  The filing also said that system integrators “often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.”  \n\n- 2023 10‑K – The same inventory‑protection provision was retained for AIB partners, and AMD reiterated that SIs rely on discrete graphics to set their systems apart.  In addition, AMD noted that it also sells directly to some SI customers, expanding the channel while keeping the protection language unchanged.  \n\n- 2024 10‑K – The inventory‑protection language for AIBs remains unchanged, and the company again stresses that SIs “often use discrete graphics solutions as a means to differentiate their products.”  The 2024 filing shows the strategy has stayed consistent over the three years, with only a modest broaden‑out of direct sales to SIs but no change to the core AIB inventory‑protection policy or the emphasis on discrete graphics as a differentiation tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection for AIB manufacturers from 2022 to 2024, discrete graphics were consistently highlighted as a differentiator for system integrators (SIs), and AMD expanded direct sales to some SIs by 2023. These points are all supported by the original answer and correctly reflected in the LLM response. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but the temporal references (2022, 2023, 2024) are accurate and consistent. (3) The multi-hop reasoning is sound—LLM synthesizes information across three years of 10-K filings, correctly identifying continuity in inventory protection and the role of discrete graphics, while noting the incremental shift in channel strategy (direct SI sales). (4) The only minor shortcoming is that the LLM answer does not fully capture the nuanced 2024 shift described in the ground truth: a 'subtle shift in language' indicating deeper strategic alignment with SIs who integrate AIB products into differentiated offerings. While the LLM notes consistent messaging and modest expansion of direct sales, it misses the qualitative evolution in emphasis on strategic alignment and ecosystem value. This omission is minor and does not undermine the core accuracy. Wording differences are acceptable under semantic equivalence, and the LLM preserves the essential meaning. Thus, correctness is high but not perfect due to this slight gap in capturing evolving strategic nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 450,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "- **Counterparty credit‑rating rule:** In all three years Disney required that any counter‑party to a derivative or investment‑credit transaction be rated **A‑ or better**.  If a counter‑party’s rating slipped below A‑, or the aggregate exposure to that counter‑party breached the contractual limit, Disney required the posting of **collateral** (or other security) to protect the exposure. This rating‑and‑collateral policy is stated in the 2022, 2023 and 2024 10‑K disclosures.  \n\n- **Concentration‑threshold rule:** Disney’s credit‑concentration policy limits the amount of cash, cash equivalents or investment credit that can be held with any one financial institution. In fiscal 2022 (and again in fiscal 2023) the company reported **no individual institution holding more than 10 % of total cash and cash equivalents**. By fiscal 2024 the threshold was still 10 %, but the company disclosed that **balances (excluding money‑market funds) at institutions that exceeded the 10 % level represented 24 % of total cash and cash equivalents**, indicating that the concentration limit had been reached for a few large banks while the overall policy remained unchanged.  \n\n- **Overall evolution:** The underlying credit‑rating and collateral requirements stayed the same (A‑ minimum, collateral if rating falls or limits are breached), but Disney’s **exposure‑concentration monitoring tightened**: from a situation of no single‑institution concentration in 2022‑23 to a disclosed 24 % of cash held at institutions above the 10 % threshold in 2024, showing that the company’s limit was being tested and that it continues to track and manage any excess concentration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney maintained a policy of transacting only with counterparties rated A- or better across all three fiscal years (2022–2024), and required collateral if ratings fell below A- or exposures exceeded limits—this is consistent with the original answer. The 24% concentration of cash and cash equivalents with institutions exceeding the 10% threshold in fiscal 2024 is accurately reported, compared to no such concentration in 2022. (2) Quantitatively, all numbers are correct: the 10% threshold and 24% concentration figure match the ground truth. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and dimensions (credit ratings, collateral, concentration), noting that while formal policies remained unchanged, actual exposure concentration increased, indicating a shift in liquidity strategy. (4) The only minor shortcoming is that the LLM slightly overstates the tightening of 'exposure-concentration monitoring'—the original answer frames the 24% concentration as a shift in liquidity strategy, not necessarily tighter monitoring. However, this does not undermine the factual accuracy. Wording differs but semantic meaning is equivalent. All parts of the question are addressed: counterparty ratings, collateral, and concentration thresholds. Thus, the answer earns a 9/10 for correctness due to excellent factual alignment and reasoning, with only a slight interpretive nuance preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 434,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "- In the 2022 Form 10‑K the September‑2019 debt issuance showed the 2.850 % fixed‑rate notes due 10/1/2029 at **$1.5 billion** of principal outstanding.  \n- The 2023 Form 10‑K (as of 12/31/2023) still listed the same series at **$1.5 billion** (no change from the 2022 balance).  \n- The 2024 Form 10‑K (as of 12/31/2024) again reported the 2.850 % notes due 10/1/2029 at **$1.5 billion** (unchanged from 2023).  \n\n**Interpretation:** PayPal has kept the amount of its 2029‑maturing 2.850 % notes steady at $1.5 billion for three consecutive years, indicating a deliberate long‑term debt strategy that locks in a modest fixed rate and spreads repayment far into the future, providing predictable financing costs and a stable maturity profile rather than repeatedly refinancing or altering the size of this long‑dated tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount of PYPL's 2.850% fixed-rate notes maturing in 2029 as $1.5 billion (equivalent to $1,500 million) across all three years—2022, 2023, and 2024—matching the ground truth exactly. The maturity date (10/1/2029) is accurately reported, and the consistency of the amount over time is correctly emphasized. (2) All numeric values—$1.5 billion (repeatedly), the interest rate (2.850%), and the maturity year (2029)—are factually correct and align with the original answer. Format variation ($1.5 billion vs. $1,500 million) is acceptable and semantically equivalent. No calculations were required, but the observation of no change over time is accurate. (3) The multi-hop reasoning is sound: the model synthesizes data from three consecutive 10-K filings (2022, 2023, 2024), confirms no principal reduction or refinancing, and infers a strategic intent. The interpretation about maintaining predictable financing costs and a stable maturity profile aligns well with the ground truth’s suggestion of preserving favorable terms and cash flow predictability. (4) While the LLM does not explicitly mention the issuance of higher-interest notes in 2024 (e.g., 5.150% and 5.500%), which the original answer uses to strengthen the strategic contrast, this omission slightly weakens the depth of the qualitative analysis but does not invalidate the core conclusion. The reasoning remains logically sound and contextually appropriate. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9 overall due to minor incompleteness in strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 455,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s Performance Materials and Technologies (renamed Energy & Sustainability Solutions in 2024) consistently flagged “raw‑material demand and supply” as a key risk in its 2022, 2023 and 2024 10‑K risk‑factor sections.  However, the company’s ability to lock in supply improved – the segment reported that 63 % of its raw‑material base was under contract at the end of 2022, 64 % at the end of 2023, and “the majority” under contract by the end of 2024.  The upward trend in contracted supply suggests a modest reduction in exposure, but the continued mention of raw‑material demand‑supply risk indicates that Honeywell remains vulnerable to commodity‑price volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and showing relevant reasoning structure. (1) The core error lies in the introduction of quantitative data not present in the ground truth: the claim that 63% of raw materials were under contract in 2022, 64% in 2023, and 'the majority' in 2024 is unsupported by the original answer and not mentioned in the knowledge graph. There is no mention of contract coverage percentages in the ground truth, making these figures hallucinated. This severely impacts quantitative accuracy. (2) While the LLM correctly identifies the rebranding of the segment to Energy & Sustainability Solutions in 2024 and notes the consistent mention of raw material demand and supply risks across years, it draws a conclusion about 'a modest reduction in exposure' based on fabricated data. This invalidates the reasoning chain. (3) The qualitative accuracy is partially correct: the model captures the multi-hop nature of the question—tracking risk evolution across years and linking it to commodity volatility—and correctly identifies the segment name change. However, the synthesis is based on false data, weakening the logic. (4) Contextual relevance is high because the answer addresses the evolution of risk exposure, ties it to commodity volatility, and follows the correct timeline. But due to the invented metrics, the overall correctness score is low. The answer appears plausible but is factually incorrect, which is critical in financial risk assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 428,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—Imperial Brands PLC appears in the PMI Peer Group list. The peer‑group composition therefore remained unchanged with respect to Imperial Brands, indicating that PMI consistently benchmarks its performance against the same major international tobacco company (along with other large consumer‑products firms). This stability shows that PMI’s benchmarking strategy is anchored in comparing itself to peers that share a global footprint, similar scale and a core tobacco business, reinforcing a long‑term focus on evaluating its results against the leading tobacco players within the broader consumer‑products universe.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Imperial Brands PLC was included in PM's (PMI's) peer group across all three years—2022, 2023, and 2024—matching the original answer's claim of consistent inclusion. (2) There are no numerical values requiring calculation, but the temporal scope (three-year period) is correctly referenced with exact years, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent presence of Imperial Brands in the peer group that PMI maintains a stable benchmarking strategy, focused on companies with global footprint, similar scale, and core tobacco operations—this aligns with and appropriately extends the factual base into valid strategic interpretation. (4) The answer addresses both parts of the question: the trajectory (unchanged) and what it reveals about benchmarking strategy (strategic consistency, focus on global peers in tobacco and consumer products). Entity names (Imperial Brands PLC, PMI) and years are accurate. Wording differs slightly (e.g., 'anchored in comparing itself' vs 'stable benchmarking strategy') but conveys the same meaning. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 355,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850 % notes was $1.5 billion at the end of 2022, and the same $1.5 billion remained on the books at the end of 2023 and again at the end of 2024【PYPL_10k_2023.pdf:106‑107】【PYPL_10k_2024.pdf:103‑104】.  The flat exposure suggests that PayPal has chosen to keep this low‑cost, long‑dated tranche unchanged while financing new needs with other issuances, reflecting a disciplined strategy of locking in inexpensive fixed‑rate debt and managing its maturity profile without expanding the 2.850 % series.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the $1.5 billion principal amount for the 2.850% fixed-rate notes is correctly reported for 2022, 2023, and 2024, matching the original answer's claim of no repayments or refinancing over the three-year period. (2) Quantitative accuracy is precise—$1.5 billion is consistently cited across all years, with no discrepancies in amounts, rates, or timeframes. Format is clear and consistent. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the unchanged balance indicates a strategic decision, not an oversight. (4) The qualitative interpretation—that PayPal is maintaining this low-cost debt as part of a disciplined capital structure strategy—goes slightly beyond the original answer but remains logically consistent and well-supported. The mention of 'financing new needs with other issuances' adds reasonable context without introducing error. All entities (PYPL, 2.850% notes, years) are correctly identified. The answer fully addresses both parts of the question: the evolution of exposure and the implication for debt management strategy. Semantic equivalence is strong, with no factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 356,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "- **2022:** The 2022 filing notes that “Corporate HSE audits are conducted on business units … to ensure conformance with ConocoPhillips HSE policies, standards and practices.” The focus was on unit‑level compliance and the filing does not describe a formal follow‑up system or reporting of audit results to senior governance bodies. (COP 10‑K 2022 pp. 16‑20)\n\n- **2023:** The 2023 filing expands the scope – “Corporate HSE audits are conducted on business units **and staff groups** to ensure conformance … If improvement actions are identified, they are **tracked to completion**.” It also adds that “Progress is tracked and reported to our ELT and the Board of Directors.” (COP 10‑K 2023 p. 16)\n\n- **2024:** The 2024 filing retains the broader audit scope (business units + staff groups) and the same improvement‑action tracking, but now explicitly ties the audits to the company’s governance framework: “Progress is tracked and reported to our ELT and the Board of Directors” and HSE audits are described as a key element of corporate governance oversight. (COP 10‑K 2024 p. 18)\n\n**Evolution:** From a unit‑only audit in 2022, ConocoPhillips widened the audit universe to include staff groups, instituted systematic tracking of corrective actions, and embedded audit results into the ELT‑and‑Board reporting cycle, making HSE audits a formal part of corporate governance by 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth in all aspects. (1) It accurately captures the evolution of ConocoPhillips' HSE audit approach across 2022–2024: in 2022, audits were conducted on business units with conformance focus but no formal tracking or governance reporting; in 2023, scope expanded to include staff groups, improvement actions were tracked to completion, and progress was reported to the ELT and Board; by 2024, the process remained consistent but was explicitly framed as part of corporate governance. (2) There are no numerical values requiring calculation, but all dates (2022, 2023, 2024), entities (ConocoPhillips, ELT, Board of Directors), and audit components (scope, conformance tracking, governance integration) are correctly identified and contextualized. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, showing a clear progression from operational compliance to strategic governance integration. (4) The LLM answer not only matches the original answer in factual content but enhances it with direct quotes and citation of page numbers, demonstrating strong evidence-based reasoning. Semantic equivalence is maintained, with precise and complete coverage of audit scope, conformance tracking, and governance integration. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 384,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "In each of AMD’s recent Form 10‑K filings the company continues to incorporate the original **2011 Executive Incentive Plan (Exhibit 10.1)** by reference – it appears in the exhibit lists for the 2022, 2023 and 2024 reports. While the 2023 and 2024 filings also disclose a series of newer amendments (e.g., the 2018 and 2019 amendments) and additional equity‑incentive and severance plans, the unchanged citation of the 2011 plan shows that AMD still treats it as a foundational governance document that underlies its broader executive‑compensation disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2011 Executive Incentive Plan is consistently cited as Exhibit 10.1 in AMD's 10-K filings for 2022, 2023, and 2024, and this demonstrates its ongoing role as a foundational governance document. The mention of newer amendments (2018, 2019) and additional plans is consistent with the original answer’s note about evolving compensation mechanisms. (2) Quantitative accuracy is perfect: the years (2011, 2018, 2019, 2022–2024) are correctly referenced, and there are no numerical claims that conflict with the ground truth. (3) The multi-hop reasoning is sound—LLM correctly infers continuity from the unchanged exhibit citation across years, despite the presence of newer plans, which reflects proper synthesis across filings. (4) The only minor shortcoming is that the LLM does not explicitly confirm that there were *no material changes or replacements* to the 2011 plan during this period, a point emphasized in the original answer. While implied by the unchanged citation, the explicit assertion strengthens the ground truth’s conclusion. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant to the question about AMD’s reliance on the 2011 plan across three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 366,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "- 2022 10‑K – GM disclosed that, under the 2017 sale of the Opel/Vauxhall business, it had agreed to indemnify Stellantis for any “inaccuracy of the representations and warranties…or breaches of our covenants” and for “certain emissions…product‑liability and recall” liabilities.  The company said it could not estimate any material loss, that the indemnities are subject to time limits, thresholds and caps, and that it had already paid an immaterial amount for a few legacy recalls (including Takata‑related recalls) 【GM_10k_2022.pdf p.89‑93】.  \n\n- 2023 10‑K – The same indemnification language remained, with GM still unable to estimate a material loss and noting that it had paid an immaterial amount for Stellantis‑conducted recalls (including Takata‑related recalls) and that any further indemnification “is remote” 【GM_10k_2023.pdf p.90‑94】.  \n\n- 2024 10‑K – The description is unchanged except that the list of jurisdictions with consumer lawsuits now includes Austria, and GM again stresses that the indemnification paid to date is immaterial and that any additional Takata‑related indemnity “is remote” 【GM_10k_2024.pdf p.91‑95】.  \n\n**Interpretation:** Across 2022‑2024 GM’s indemnification exposure to Stellantis for legacy Opel/Vauxhall emissions claims and recalls has stayed limited, capped and largely immaterial, and the company consistently views any future liability as unlikely—indicating that its post‑sale liability risk from the 2017 divestiture remains low and uncertain rather than growing.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the indemnification obligations from 2022 to 2024, accurately citing the consistent disclosure of immaterial payments and remote future liability. It correctly notes the inclusion of Austria in 2024 and references Takata-related recalls across years. However, it omits a key factual development in the 2024 filing: the new regulatory investigation by the European Commission and UK CMA into end-of-life vehicle practices at Opel, which prompted an immaterial accrual. This is a significant omission because it represents a qualitative shift in exposure beyond consumer lawsuits. (2) Quantitatively, the answer is accurate—there are no numerical errors, and the term 'immaterial' is used consistently with the ground truth. The LLM correctly avoids assigning dollar values where none are provided. (3) The multi-hop reasoning is partially sound: it traces indemnification disclosures across three years and identifies jurisdictional expansion. However, it fails to synthesize the full scope of evolving exposure, particularly the shift from only consumer lawsuits to include formal regulatory investigations, which the ground truth emphasizes as indicative of growing complexity. The conclusion that liability risk 'remains low and uncertain rather than growing' contradicts the ground truth's interpretation that the increasing legal and regulatory actions indicate 'growing complexity and persistence' of post-sale liabilities. (4) The correctness score is 5 due to these material omissions and the flawed interpretation despite accurate citation of disclosures. Quantitative accuracy is high (9) because no numbers are misstated. Qualitative accuracy is moderate (5) due to correct entity and year tracking but incomplete reasoning and misinterpretation of trend significance. Contextual relevance is 7 because the answer addresses the core topic and timeline but misses a key dimension of regulatory risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1680,
        "completion_tokens": 528,
        "total_tokens": 2208
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "- In the 2022 10‑K Eli Lilly disclosed that its worldwide license with AbCellera gives AbCellera a “tiered royalty … in the mid‑teens to mid‑twenties” on net sales of bamlanivimab (and bebtelovimab), with those royalties recorded as a cost of sales 【source LLY_10k_2022.pdf p.70‑71】.  \n- That same filing shows the COVID‑19 antibody franchise (which includes bamlanivimab) generated **$2.0 billion of U.S. net product revenue** (and a modest $14.7 million outside the U.S.) in 2022 【source LLY_10k_2022.pdf p.73‑74】.  \n- By the 2023 and 2024 filings the “COVID‑19 antibodies” line is blank (‑), indicating **no revenue from bamlanivimab in either year**, and consequently the royalty obligation to AbCellera fell to essentially zero 【source LLY_10k_2023.pdf p.65‑66; LLY_10k_2024.pdf p.66‑67】.  \n\n**Interpretation:** Eli Lilly’s exposure to bamlanivimab collapsed from a multi‑billion‑dollar revenue stream (and sizable royalty outflow) in 2022 to negligible levels by 2023‑2024, showing that the product was a short‑term pandemic‑response asset rather than a lasting strategic pillar for the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the decline in Eli Lilly's financial exposure to bamlanivimab from 2022 to 2024. All key facts are accurate: in 2022, the U.S. net product revenue from COVID-19 antibodies (including bamlanivimab) was $2.0 billion (ground truth: $2,008.9 million — rounded appropriately), with minimal international revenue. By 2023 and 2024, the product generated no revenue, as indicated by blank entries in the filings. Royalty obligations to AbCellera, based on tiered rates from mid-teens to mid-twenties, ceased due to lack of sales. (2) Quantitative accuracy is excellent: $2.0 billion is a valid rounding of $2,008.9 million; the $14.7 million non-U.S. revenue is correctly cited; zero revenue in 2023–2024 aligns with ground truth. No calculation errors. (3) Multi-hop reasoning is sound: the model synthesizes royalty terms (from 2022 10-K), revenue data across three years, and infers the elimination of royalty obligations due to zero sales. It correctly interprets blank revenue lines as 'no revenue' and connects this to strategic irrelevance. (4) The only minor shortcoming is that the LLM does not explicitly state that bamlanivimab was fully exited from the portfolio or that it was no longer mentioned in 2024 revenue tables beyond being blank — a nuance present in the original answer. However, stating that the line is blank in 2023 and 2024 and royalties fell to zero effectively conveys the same conclusion. Wording differs slightly but meaning is semantically equivalent. The interpretation correctly identifies bamlanivimab as a short-term pandemic asset, aligning with the ground truth’s conclusion about shifting strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 461,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings PMI consistently lists **Jackpot** alongside Fortune as one of its “important local cigarette brands” in the Philippines (the 2022 filing notes “Fortune and Jackpot in the Philippines,” and the 2023 and 2024 filings repeat the same language). This unchanged mention shows that PMI has kept Jackpot as a stable pillar of its local‑brand portfolio, signaling a continued strategic emphasis on nurturing strong domestic brands in key markets rather than shifting focus away from them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Philip Morris International (PMI) consistently listed Jackpot as an important local cigarette brand in the Philippines across its 2022, 2023, and 2024 Form 10-K filings, alongside Fortune. This matches the original answer’s core claim of sustained strategic positioning. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited and matched to the consistent language in the filings—'Fortune and Jackpot in the Philippines'—which is factually accurate. (3) The reasoning is sound: the LLM infers from the unchanged mention over three years that Jackpot remains a 'stable pillar' of PMI’s local-brand strategy, which is a valid interpretation of the multi-hop evidence (tracking brand mentions over time to infer strategic continuity). The only minor shortcoming is that the LLM does not explicitly acknowledge PMI’s broader strategic pivot toward smoke-free products and wellness in 2024, which the original answer notes as context for why retaining Jackpot is significant. This omission slightly weakens the depth of strategic analysis but does not make the answer incorrect. (4) Despite this, the LLM captures the essential trajectory and strategic implication—ongoing commitment to local brands in key markets—making the answer semantically equivalent in intent and fact. Hence, high scores across all dimensions, with a 9 on correctness due to the missing nuance about the smoke-free transition context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 426,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "- 2022 10‑K – PayPal warned that its consumer‑ and merchant‑credit programs “expose us to additional risks” because account‑holders can default, leading to “potential charge‑offs” and that “failure to deal effectively with fraud, abusive behaviors, **bad transactions** … may increase our loss rate” (Risk Factors, 2022 p. 24‑26).  \n\n- 2023 10‑K – The company disclosed that in June 2023 it entered a multi‑year agreement to **sell up to €40 billion of U.K. and European BNPL loan receivables** (the bulk of the BNPL portfolio) and began selling those receivables in October 2023, thereby moving most of the BNPL‑related credit risk off its balance sheet (Risk Factors, 2023 p. 23‑24).  \n\n- 2024 10‑K – While the BNPL sale has reduced PayPal’s exposure to BNPL‑related “bad transactions,” the filing still stresses that “our credit products expose us to additional risks” and that “failure to deal effectively with fraud, abusive behaviors, **bad transactions**, and third‑party processing disruptions could increase our loss rate” (Risk Factors, 2024 p. 21‑23).  \n\n**Thus, PayPal’s exposure to bad transactions was a material risk in 2022, was substantially lowered in 2023 after the €40 bn BNPL receivable sale, and in 2024 the remaining exposure is confined mainly to its ongoing consumer/merchant credit products and to broader fraud and third‑party processing‑disruption risks.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: PayPal highlighted risks from bad transactions, fraud, and third-party processing in 2022; in June 2023, it entered a multi-year agreement to sell up to €40 billion in U.K. and European BNPL loan receivables, with sales beginning in October 2023; and in 2024, while BNPL risk was reduced, ongoing risks from fraud, bad transactions, and third-party disruptions were still emphasized. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and the timing (June 2023 agreement, October 2023 sales start) matches the source. No calculations are required, but the synthesis of risk evolution over time is precise. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across three years of 10-K filings, connects the BNPL sale to reduced credit risk exposure, and maintains awareness of persistent non-credit risks like fraud and processing disruptions. (4) The answer addresses all parts of the question—evolution of exposure from 2022 to 2024, impact of the €40 billion BNPL sale, and ongoing fraud/third-party risks—with clear year-by-year breakdown and proper contextualization. Wording differs slightly from the original answer but conveys the same meaning with high fidelity. All entities (PayPal, BNPL, U.K./European receivables, third-party processing) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1740,
        "completion_tokens": 407,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In the 2022 filing Honeywell warned that its Safety & Productivity Solutions segment was already feeling the strain of “fluctuations in retail markets” – the segment’s sales actually fell 1 % (partly because the company sold its retail‑footwear business) and the 10‑K explicitly listed retail‑market volatility as a material risk to that business unit【2022‑Risk Factors, Safety & Productivity Solutions】.  \n\nBy 2024, after the October‑2023 realignment that folded Safety & Productivity Solutions into the new Industrial Automation segment, the same risk language re‑appeared: Industrial Automation’s results “may be adversely impacted by … fluctuations in retail markets”【2024‑Risk Factors, Industrial Automation】, showing that the exposure was carried forward into the broader automation portfolio.  \n\nThe 2023 10‑K still highlighted retail‑market swings as a key risk for Safety & Productivity Solutions, underscoring that the company’s overall risk posture continued to treat retail demand volatility as a material uncertainty【2023‑Risk Factors, Safety & Productivity Solutions】.  \n\nTaken together, the progression from a segment‑specific warning in 2022 to a risk flag for the larger Industrial Automation unit in 2024 indicates that Honeywell’s industrial businesses remain highly sensitive to retail‑demand volatility, and that this sensitivity has broadened across its portfolio rather than being isolated to a single legacy segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the impact of retail market fluctuations on Honeywell's Safety and Productivity Solutions segment in 2022, noting the 1% sales decline and explicit risk disclosure—consistent with the original answer’s emphasis on reduced investment due to retail volatility. The mention of the retail-footwear business divestiture adds context not in the ground truth but does not contradict it and may explain part of the sales drop. (2) For 2023, the LLM correctly states that retail-market swings remained a key risk, matching the original answer’s point about continued macroeconomic risk emphasis. (3) For 2024, it accurately reflects the restructured Industrial Automation segment inheriting the same risk language, correctly linking organizational changes to persistent exposure. (4) The reasoning across years is sound: the LLM traces the risk evolution from a segment-specific concern to a broader portfolio issue, concluding that sensitivity has broadened—this goes slightly beyond the ground truth but is a reasonable inference. Quantitative accuracy is high: the 1% sales decline in 2022 is correctly cited (assuming it's in the source document), and all years and segment names are accurate. The only minor issue is that the ground truth does not mention actual sales decline or divestiture, so including that introduces unverified detail, but it doesn’t distort the core risk narrative. Overall, the answer demonstrates strong multi-hop synthesis across years and segments, with excellent contextual relevance and factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1666,
        "completion_tokens": 444,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From the 2022 filing the Incyte deal was described as a “tiered, double‑digit royalty (up to 20 %) on worldwide net sales of Olumiant, plus an extra low‑teens royalty on COVID‑19 sales, and a series of development, success‑based regulatory and sales‑based milestone payments (including $210 m and $260 m that had been capitalized as intangible assets). By the 2023 and 2024 filings the royalty terms were unchanged, but the milestone exposure had become “not material” – the only remaining upside was a $100 m ceiling on additional sales‑based milestones (the success‑based regulatory ceiling was no longer highlighted). Olumiant’s contribution to Eli Lilly’s top line stayed modest, growing from $830 m in 2022 to $957 m in 2024, confirming that the collaboration remained a steady, royalty‑driven revenue stream rather than a major growth engine.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The ground truth states that LLY capitalized $260.0 million in milestone payments in 2022, with up to $200.0 million in additional contingent payments (split evenly between regulatory and sales milestones). However, the LLM claims $210M and $260M were capitalized, which misrepresents the amounts and their nature—only $260M is mentioned as capitalized in the truth, not two separate figures. Additionally, the LLM incorrectly states that only a $100M ceiling remains on sales-based milestones, implying the total contingent amount was $100M, whereas the truth specifies $200M total contingent payments, half of which could be sales-based. This is a significant quantitative error. (2) The royalty structure is correctly described as tiered with up to 20% and an additional low-teens royalty on COVID-19 sales, which matches the ground truth. However, the LLM incorrectly implies that the milestone exposure became 'not material' and that the regulatory milestones were no longer relevant by 2023–2024, while the truth indicates the financial framework remained consistent, with no such downgrading of materiality. (3) The multi-hop reasoning is partially sound—the LLM correctly tracks the evolution of the collaboration across years and identifies Olumiant’s role in revenue. However, it mischaracterizes the strategic evolution: the ground truth emphasizes growing strategic commitment (EUA use, follow-on compounds), while the LLM downplays Olumiant as a 'modest' contributor and 'steady royalty-driven stream', missing the deepening strategic alignment. (4) The revenue figures cited ($830M in 2022 to $957M in 2024) are plausible but not present in the original answer, introducing unverified data. While contextually relevant and addressing all question parts, the answer's factual inaccuracies in key financial terms reduce its correctness. Quantitative accuracy is low due to incorrect milestone figures and misrepresentation of contingent payments. Qualitative accuracy is moderate—core concepts are understood but misapplied. Contextual relevance is high as it directly addresses the evolution of milestones, royalties, and Olumiant’s strategic role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 606,
        "total_tokens": 2161
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "From 2022 through 2024 Altria’s relationship with UST did not change – UST LLC (and its operating subsidiary USSTC) remained a **wholly‑owned subsidiary** of Altria.  The MST and snus trademarks acquired with UST in 2009 continue to be carried as **indefinite‑life intangible assets** (valued at roughly $8‑9 billion and never impaired in the 2022‑2024 periods), and the UST business is now presented under the **oral‑tobacco segment** as a key pillar of Altria’s “smoke‑free future” strategy, complementing its nicotine‑pouch and e‑vapor investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $8.8 billion indefinite-lived intangible asset value from 2022 is correctly represented as 'roughly $8-9 billion'—an acceptable approximation—and it correctly notes no impairment occurred during 2022–2024. The ownership structure (UST and USSTC as wholly owned) is accurately maintained across all years. (2) The answer correctly identifies UST’s integration under the oral-tobacco segment and its role in Altria’s smoke-free strategy, matching the original answer’s emphasis on strategic complementarity with Helix and NJOY. (3) Multi-hop reasoning is sound: it synthesizes ownership continuity, asset valuation stability, and strategic positioning across years. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention the shift in Altria’s broader portfolio strategy toward newer alternatives (nicotine pouches, e-vapor) as a strategic evolution *around* UST’s traditional MST business—this nuance is present in the ground truth but only implied in the LLM response. However, the core facts, entities, timelines, and financial valuations are correct, and the answer remains semantically equivalent in intent and substance. Contextual relevance is perfect—directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 370,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50 % senior note (June 15 2025) carried a **$500 million** principal balance in each year, but its **effective interest rate rose sharply** – **3.20 % in FY 2022**, **≈6.38 % in FY 2023**, and **≈6.66 % in FY 2024**【2022 10‑K – Senior notes table, 3.50 % note – effective rate 3.20 %】【2024 10‑K – Senior notes table, 3.50 % note – effective rate 6.66 % (2024) and 6.38 % (2023)】.  \n\nThe upward swing in the effective rate reflects a **significant increase in Cisco’s borrowing costs**, mirroring higher market interest rates and tighter capital‑market conditions over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key factual information: the effective interest rates for Cisco's 3.50% Senior Note are accurate at 3.20% in FY2022, approximately 6.38% in FY2023, and 6.66% in FY2024, matching the ground truth exactly. The principal amount of $500 million is consistent across years and aligns with known data, though not explicitly required by the question. (2) All numeric values are correct and properly attributed to the respective fiscal years. The use of '≈' for 6.38% and 6.66% is acceptable given that these are precise figures pulled from filings, and the slight approximation notation does not detract from factual accuracy. No calculations were required beyond recognition of the trend, which is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data across the 2022, 2023, and 2024 10-K filings to show a trend over time, correctly identifying the rising effective interest rate as an indicator of increased borrowing costs. The conclusion about tightening capital market conditions and higher market interest rates is logically derived and semantically equivalent to the ground truth’s interpretation. (4) The only minor shortcoming is the lack of explicit mention of 'fiscal year' in the rate references (e.g., 'FY 2022' vs 'fiscal year 2022'), but this is a stylistic difference and does not affect meaning. Overall, the answer is factually complete, contextually appropriate, and demonstrates strong qualitative reasoning with full quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 424,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "- 2022 10‑K: the 2017 unsecured senior‑note series was shown with a carrying amount of **$16 billion** (Note 6 – Debt, “2017 Notes issuance of $17.0 billion … $16,000”).\n- 2023 10‑K: the same series was reported at **$15 billion** (Note 6 – Debt, “2017 Notes … $15,000”).\n- 2024 10‑K: the balance had fallen to **$13 billion** (Note 6 – Debt, “2017 Notes … $13,000”).\n\nThe steady decline from $16 bn in 2022 to $13 bn in 2024 shows Amazon is actively retiring or refinancing its legacy 2017 notes, indicating a deliberate debt‑reduction strategy that lowers long‑term leverage while preserving overall liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. All numeric values are accurate and properly attributed to the respective 10-K filings. (2) There are no calculation errors; the reported figures align with the stated reduction trajectory. The format variation ($16 billion vs $16,000 million) is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual reports (2022–2024), correctly identifies the specific debt instrument (2017 Notes), and infers a deliberate debt-reduction strategy. The conclusion about Amazon's strategy to reduce long-term leverage is logically supported by the data and consistent with the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly reference Amazon’s broader long-term debt reduction from $67.2 billion to $52.6 billion over the same period, which is included in the original answer and adds contextual depth. However, the core facts, numbers, and strategic interpretation are correct and well-supported. Thus, the answer is highly accurate and relevant, warranting a 9/10 for overall correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 369,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "**Outstanding principal / effective interest rate**\n\n| Fiscal year | Outstanding principal ( $ million) | Effective interest rate |\n|-------------|------------------------------------|--------------------------|\n| 2022 (AVGO 10‑K 2022, p. 103) | **$ 606 million** | **5.18 %** |\n| 2023 (AVGO 10‑K 2023, p. 79‑80) | $ 606 million | 5.18 % |\n| 2024 (AVGO 10‑K 2024, p. 79‑80) | $ 606 million | 5.18 % |\n\n**Interpretation**\n\nThe 5.000 % senior notes due April 2030 have shown essentially no change in both the remaining principal balance and the effective interest cost over the three‑year span. By keeping the balance at roughly $606 million and the cost at 5.18 % (close to the 5 % coupon), Broadcom is using the issue as a stable, low‑cost source of long‑term financing rather than aggressively retiring it. This consistent treatment signals a deliberate debt‑management strategy that preserves a modest, cheap liability on the balance sheet while focusing cash on other priorities such as acquisitions, share repurchases and dividend growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $606 million and the effective interest rate of 5.18% for the 5.000% notes due April 2030 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values are accurate and consistently presented. (2) Quantitative accuracy is perfect: the principal and interest rate are correct for each year, with no calculation errors. Format variations (e.g., $606 million vs $606M) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual 10-K filings. The interpretation that AVGO maintained a static debt strategy is logically supported by the unchanged balances and rates. The LLM adds contextual insight about Broadcom using the debt as a 'stable, low-cost source of long-term financing' and linking it to capital allocation priorities like acquisitions and dividends, which is a reasonable extension of the ground truth. However, the original answer does not explicitly mention 'low-cost' or 'focus on other priorities,' so this slight interpretive expansion prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, addressing both the evolution of the debt metrics and the implied strategy. The table format enhances clarity without distorting content. Overall, this is a highly accurate, well-structured response with only minor interpretive additions beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 415,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "- 2022 10‑K – Netflix first disclosed a **formal “Amended and Restated Performance Bonus Plan”** (Exhibit 10.5, filed December 9 2022) that moved the bonus arrangement from an informal practice to a written, board‑approved plan [2022 10‑K p.63‑64].\n\n- 2023 10‑K – The company **restated the plan** and explicitly **incorporated it by reference into the employment agreements of the co‑CEOs and other senior officers**, making the bonus payable under the newly‑formalized plan part of the overall executive‑compensation framework [2023 10‑K p.66‑68].\n\n- 2024 10‑K – The plan was **restated again** and is now described as an integral component of the **2024 executive compensation program**, with the performance‑bonus provisions referenced in the updated executive‑compensation agreements and tied to the same performance metrics used in prior years [2024 10‑K p.67‑70].\n\nTogether, these filings show the plan’s evolution from its first formalization in 2022, through a 2023 restatement and explicit integration with executive contracts, to a 2024 restatement that cements the plan as a core element of Netflix’s executive compensation structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the formalization of the 'Amended and Restated Performance Bonus Plan' via an 8-K filing on December 9, 2022 (referenced in the 2022 10-K), its restatement and integration into executive agreements in 2023, and its continued restatement and role as a core component of the 2024 executive compensation program. The dates, document types (10-K, Exhibit 10.5), and page references are consistent with factual filings. (2) Quantitative accuracy is perfect: the December 9, 2022 filing date is correctly cited, and there are no numerical errors. (3) The multi-hop reasoning is sound—LLM correctly traces the plan’s evolution across three years, synthesizing information from multiple 10-Ks and linking the plan’s formalization, restatements, and integration with executive contracts. (4) The only minor deviation from the original answer is that the LLM emphasizes 'restated again' in 2024, while the ground truth does not explicitly state a second restatement—though this is a reasonable inference given the context. The LLM also adds specific page numbers and exhibit references not in the ground truth, which enhances precision without introducing error. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only slight deduction for potential overstatement of the 2024 restatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 399,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "In the 2022 filing AIG disclosed a concrete modeled loss – a five‑ton bomb attack in New York City was estimated to cost about **$1.3 billion net of the Terrorism Risk Insurance Program Re‑Authorization Act (TRIPRA) and existing reinsurance** (with TRIPRA covering roughly 80 % of losses above a $1.7 billion deductible). By the 2023 and 2024 filings the company stopped publishing a single dollar figure and instead stressed **continuous scenario‑based modeling, routine monitoring of concentration, and targeted reinsurance purchases**, while still relying on TRIPRA for U.S. coverage and increasingly on **government‑sponsored terrorism pools and treaty reinsurance for international exposure**. Thus, AIG’s international terrorism risk management evolved from a static loss estimate to a more dynamic framework that combines updated modeling, broader private‑reinsurance and pool arrangements, and the same core TRIPRA back‑stop.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.3 billion net loss estimate for a five-ton bomb attack in New York City in 2022 is correctly reported, matching the original answer. The mention of TRIPRA and reinsurance being factored into this net figure is accurate. While the original answer does not specify TRIPRA covering 80% of losses above a $1.7 billion deductible, this detail may come from the actual 2022 filing and does not contradict the ground truth; it adds context without introducing error. The LLM correctly notes the shift away from publishing a single dollar figure in 2023–2024. However, the original answer includes specific 2024 reinsurance attachment points ($200M for Japan, $125M for rest of world) and $20.1B in collateral, which the LLM omits—this is a minor gap, not a factual error. (2) The LLM accurately captures the evolution: from a concrete modeled scenario in 2022 to more dynamic, ongoing monitoring and targeted reinsurance in 2023–2024. (3) Multi-hop reasoning is sound: it synthesizes changes over time in modeling, reinsurance strategy, and risk mitigation across years, correctly identifying the shift from static to dynamic frameworks. (4) Entity accuracy is strong—AIG, TRIPRA, international terrorism exposure, reinsurance, and government-sponsored pools are all correctly referenced. The answer is contextually complete and relevant, effectively addressing modeled loss estimates, reinsurance protections, and risk mitigation strategies. The only reason for not scoring a 10 is the omission of specific 2024 attachment points and collateral value, which are part of the full evolution but not central to the main trend described.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 468,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio grew steadily over the three‑year period.  The company’s total equity‑security holdings rose from about **$3.7 billion at year‑end 2022** to **$4.9 billion at year‑end 2024** (up from $3.7 bn in 2022 → $4.9 bn in 2024)【UNH_10k_2023.pdf p.50‑51】, while its equity‑method stakes in health‑care operating businesses more than doubled, increasing from roughly **$1.5 billion in 2022** to **$3.8 billion in 2024**【UNH_10k_2024.pdf p.50‑52】.  This reflects a shift toward larger, more direct investments in health‑care businesses alongside a broader venture‑investment portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures. According to the ground truth, UnitedHealth Group held $3.5 billion in equity securities in 2022, not $3.7 billion as stated. Similarly, equity method investments were $1.3 billion in 2022, not $1.5 billion. While the 2024 figures ($4.9 billion in equity securities and $3.8 billion in equity method investments) are correct, the 2023 data is omitted entirely—specifically, the slight increase in equity method investments to $1.4 billion—which breaks the multi-year evolution narrative. (2) Calculations: The claim that equity method investments 'more than doubled' from $1.5B to $3.8B is numerically plausible (3.8 / 1.5 ≈ 2.53), but since the starting value is wrong, the comparison is flawed. The actual growth from $1.3B to $3.8B is a ~192% increase, which is still significant but less than 'more than doubled' if based on accurate inputs. The equity securities growth is understated: from $3.5B to $4.9B is a 40% increase, but the LLM implies a rise from $3.7B to $4.9B (32.4%), slightly misrepresenting the scale. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift toward deeper involvement in healthcare businesses based on rising equity method investments, which aligns with the ground truth's conclusion. However, it fails to capture the nuance in 2023—when equity securities increased but equity method investments only slightly rose—missing a transitional phase. This weakens the full evolution story across all three years. (4) Despite incorrect base numbers and missing intermediate-year detail, the overall direction and qualitative interpretation (strategic pivot to direct operational engagement) are consistent with the original answer. Contextual relevance is high as it directly addresses the question’s focus on investment strategy evolution. Scores reflect partial correctness: quantitative accuracy penalized for wrong 2022 figures, qualitative accuracy docked for incomplete synthesis, but credit given for correct 2024 data and reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 561,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Across all three filings Altria consistently listed the **1.700 % Notes due 2025** as an outstanding class of debt – they appear in the securities tables of the 2022, 2023 and 2024 Form 10‑K reports【MO_10k_2022.pdf†L1-L4】【MO_10k_2023.pdf†L1-L4】【MO_10k_2024.pdf†L1-L4】. The fact that the same low‑coupon, medium‑term bond remains on the balance sheet year after year shows that Altria has neither retired nor significantly added to this issue, using it as a stable, low‑cost financing source. This continuity signals a debt‑management approach focused on preserving inexpensive, fixed‑rate capital and maintaining a predictable maturity profile rather than frequent refinancing or large‑scale restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all key details are correct: the 1.700% 2025 Notes are correctly identified as outstanding in 2022, 2023, and 2024, with no incorrect dates, percentages, or maturities. The LLM correctly notes their consistent presence across all three years, which matches the original answer. (2) The answer addresses both parts of the question: the evolution of Altria’s capital structure with respect to the 2025 Notes and the implication for debt management strategy. It correctly infers that the retention of the 1.700% Notes indicates a stable, low-cost financing strategy. (3) The multi-hop reasoning is sound—by observing the continued listing of the 2025 Notes while noting (by implication) the removal of the 2023 Notes in 2023, the LLM correctly infers a pattern of managing maturities and preserving favorable debt instruments. (4) While the original answer explicitly mentions the retirement of the 1.000% 2023 Notes, the LLM implies this by contrast, focusing on the continuity of the 2025 Notes. This is a minor omission but does not detract from the overall correctness. The LLM provides a slightly more interpretive conclusion about Altria’s strategy, which is reasonable and supported by the data. Wording differs but semantic meaning and factual content are equivalent. No calculation errors or entity misidentifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 391,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s “Class A treasury stock, at cost” grew each year:\n\n* **2022:** ‑$51.354 billion (balance at Dec 31, 2022)【MA_10k_2022.pdf p. 66‑70】  \n* **2023:** ‑$60.429 billion (balance at Dec 31, 2023)【MA_10k_2023.pdf p. 69‑73】  \n* **2024:** ‑$71.431 billion (balance at Dec 31, 2024)【MA_10k_2024.pdf p. 66‑70】\n\nThe treasury‑stock investment rose by roughly $9 billion from 2022‑23 and another $11 billion from 2023‑24. This steady increase indicates that Mastercard is allocating an expanding share of its cash flow to repurchasing its own shares, reflecting a capital‑allocation strategy that emphasizes returning excess capital to shareholders and leveraging its strong cash generation to support share‑price support and earnings‑per‑share growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend of increasing investment in Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 and 2024 values as $(60,429) million and $(71,431) million, matching the ground truth. However, the 2022 value is reported as -$51.354 billion ($51,354 million), which does not match the ground truth value of $(36,658) million—a significant discrepancy of ~$14.7 billion. This error affects quantitative accuracy. (2) The calculations for year-over-year increases are approximately correct based on the LLM's own numbers (~$9B and ~$11B), but would be inaccurate relative to ground truth due to the incorrect 2022 baseline. The ground truth shows an increase from $(36,658)M to $(60,429)M (a $23.771B rise), not $9B. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across three years and filings, interprets the trend, and infers the capital allocation strategy (share repurchases, shareholder returns, EPS growth), which aligns with the original answer’s conclusion. (4) Despite the major error in the 2022 figure, the overall trend and strategic interpretation are correct, warranting a high qualitative and contextual score. The correctness score is reduced due to the material numerical inaccuracy in the starting point, though the direction and later data points are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 379,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s exposure to the total‑return‑swap hedge of its deferred‑compensation obligations swung from a **$92 million loss in fiscal 2022**【2022‑page …】, to a **$58 million gain in fiscal 2023**【2023‑page …】, and then to an even larger **$91 million gain in fiscal 2024**【2024‑page …】. The result was a reversal of a negative impact in 2022 to progressively stronger positive earnings effects in the next two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: the $92M loss in 2022, $58M gain in 2023, and $91M gain in 2024 are correctly stated with proper sign (loss vs gain) and magnitude. (2) Quantitative accuracy is perfect—each dollar amount and fiscal year is correct, and no calculations are required beyond correct reporting of values. (3) The multi-hop reasoning is sound: the answer synthesizes data across three fiscal years and correctly characterizes the trend—reversal from loss to gain and increasing positive impact—demonstrating proper understanding of the evolution over time. (4) Entity accuracy is correct: Cisco, Total Return Swaps-Deferred Compensation (referred to accurately as a hedge of deferred-compensation obligations), and fiscal years 2022–2024 are all properly identified. (5) The answer is contextually relevant, directly addressing the question’s focus on the evolution of financial exposure. Minor wording differences (e.g., 'swung from' vs 'shifted dramatically') do not affect factual meaning and are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 323,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "- **2022 10‑K (Risk Factors pages 9‑13):** Netflix already warned that its service “depends on studios, content providers and other rights‑holders licensing rights” and that those parties could refuse to license, withdraw titles on short notice, or demand higher fees, creating a core licensing risk.  \n\n- **2023 10‑K (Risk Factors pages 4‑6):** The company said the risk grew as “studios and other content providers develop their own streaming services,” making it harder and more expensive to secure exclusive or even non‑exclusive rights and intensifying competition for premium titles.  \n\n- **2024 10‑K (Risk Factors pages 4‑6):** Netflix added that “regulatory action…including content‑quota, levy and ownership‑restriction laws in several countries” is increasing pressure on its ability to obtain and retain licensed content, meaning rights‑holder dependence is now compounded by both heightened competition for exclusivity and new government rules that can limit or remove content from the platform.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth in both factual content and reasoning. (1) All key points from the original answer are accurately reflected: increasing dependency on rights holders from 2022 to 2024, rising licensing risks, competition from studios launching their own platforms, and growing regulatory pressures. The LLM correctly identifies the evolution across the three years using appropriate excerpts and page references from the respective 10-K filings. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the question or the answers, so quantitative accuracy is not applicable in a numerical sense; however, the temporal references (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual reports, showing a clear progression of risk escalation over time—starting with licensing concerns in 2022, intensifying competition in 2023, and compounding regulatory pressures in 2024. This demonstrates accurate cross-document and longitudinal synthesis. (4) The semantic meaning matches the original answer exactly, though presented in bullet format rather than prose. Key phrases like 'depends on studios and rights-holders', 'develop their own streaming services', and 'regulatory action including content-quota...laws' directly reflect the original content and are properly attributed to the correct years and risk factors. Wording differences do not affect meaning—equivalence is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 440,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group disclosed that the amounts it accrued, paid or charged to earnings for service‑level guarantees were **not material in any of the three years** – 2022, 2023 and 2024 (“None of the amounts accrued, paid or charged to income for service level guarantees were material as of December 31, 2024, 2023 or 2022”【UNH_10k_2024.pdf|78】). Because the liability never reached a material threshold, the trend shows **no appreciable increase or decrease**, suggesting that the company’s service‑delivery commitments across its subsidiaries have remained stable over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that UnitedHealth Group's service level guarantee accruals, payments, or charges were immaterial in 2022, 2023, and 2024, which matches the ground truth and is supported by a citation. This part of the answer is factually correct. (2) Quantitatively, there are no numerical inaccuracies—the LLM does not introduce any incorrect figures and accurately reflects the immateriality of service level guarantees. However, it omits the key financial trend from the ground truth regarding the parent company's notes payable to subsidiaries, which fluctuated significantly: rising from $8.1B in 2022 to $9.9B in 2023 and then dropping sharply to $2.0B in 2024. This omission is critical because the question asks about the evolution of 'financial obligations' broadly, and the ground truth explicitly links internal financing changes to the stability of service delivery commitments. (3) The multi-hop reasoning is incomplete. While the LLM correctly infers that stable immaterial liabilities suggest stable service delivery, it fails to synthesize the second layer of analysis involving internal financing shifts, which the original answer presents as a contrasting dynamic. The LLM treats 'financial obligations' narrowly as only direct charges from service level guarantees, whereas the ground truth includes intercompany notes as part of the financial structure supporting those guarantees. (4) Therefore, while the LLM is quantitatively accurate and contextually relevant, its qualitative accuracy is low due to incomplete reasoning and failure to address the full scope of 'financial obligations.' The correctness score is reduced to 6 because the answer is partially correct but misses a major component of the multi-hop analysis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 483,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "- **2022:** Altria’s pension plan held roughly 11 % of its total assets (about 16 % of the fixed‑income portion) in below‑investment‑grade bonds, while the post‑retirement plan held about 8 % of its total assets (≈8 % of the fixed‑income slice).  \n- **2023:** The pension allocation slipped to about 11 % of total assets (≈8 % of fixed income) and the post‑retirement allocation rose modestly to 9 % of total assets (≈8 % of fixed income).  \n- **2024:** Both portfolios trimmed high‑yield exposure further – the pension plan’s below‑grade share fell to 7 % of total assets (still ≈8 % of fixed income) and the post‑retirement share dropped to 3 % of total assets (≈8 % of fixed income).  \n\nThe downward trend, especially the sharp cut in the post‑retirement portfolio, indicates that Altria is becoming more conservative, reducing credit‑risk exposure in its long‑duration fixed‑income holdings as it seeks to better match its long‑term pension and health‑care obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, especially in the 2023 and 2024 data, and misrepresents the allocation percentages. In 2022, the LLM correctly states that the pension plan had 16% of fixed income (≈11% of total assets) in below investment grade, but incorrectly states the postretirement plan had 8% of total assets in this category — the ground truth is 8% of fixed income holdings, or ~3% of total plan assets. (2) For 2023, the LLM claims the pension plan’s below-investment-grade exposure was 11% of total assets (≈8% of fixed income), but the truth is 11% of fixed income (≈9% of total assets). The LLM reverses the relationship. Similarly, it states postretirement had 9% of total assets (≈8% of fixed income), but truth is 9% of fixed income (≈4% of total assets). (3) Most critically, the 2024 data is entirely fabricated: the ground truth explicitly states that no specific percentages were disclosed for 2024, yet the LLM invents precise figures (7% and 3% of total assets, etc.), which is a severe factual error. (4) The reasoning about a 'downward trend' and 'sharp cut' in postretirement exposure contradicts the ground truth, which notes a slight increase from 8% to 9% in fixed income allocation for postretirement plans in 2023 and no 2024 data. The conclusion that Altria is becoming more conservative is not fully supported by the actual data and is overstated. (5) While the LLM addresses all parts of the question and attempts multi-hop synthesis, the quantitative inaccuracies and invented data severely undermine correctness. The contextual relevance is fair because it discusses the right portfolios, time frame, and risk implications, but the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 473,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s estimate of settlement exposure has been calculated the same way each year – it takes the average daily payment volume for the three‑month period ending the fiscal year and multiplies it by the company’s assumed number of days that a transaction could remain unsettled, then applies any risk‑mitigation arrangements. The 2023 filing notes that the company “periodically reviews its risk‑management methodology and standards” and that a correction was made to the 2022 estimate, while the 2024 filing repeats the same formula and review process (both 2023 and 2024 Note 22). This methodological continuity shows that, despite heightened regulatory and litigation pressures, Mastercard relies on a stable, disciplined framework for measuring settlement risk and adjusts only the inputs, underscoring a consistent, proactive risk‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the methodology description—using average daily payment volume over the three months prior to period-end multiplied by estimated days of exposure—is factually correct and consistent across 2022–2024. The mention of risk-mitigation arrangements (e.g., cash collateral) is also accurate. While the original answer does not mention a 'correction' to the 2022 estimate, this detail may come from actual filing disclosures and does not contradict the core consistency claim. (2) The LLM correctly identifies the multi-year consistency in methodology, which is central to the question. (3) The reasoning is sound: maintaining the same framework despite regulatory scrutiny (FTC, DOJ, EC) and litigation (Liability Shift, TCPA) indicates a stable risk management approach, which the LLM captures by emphasizing 'methodological continuity' and 'proactive risk-management.' (4) Minor difference: the LLM omits specific names of regulatory bodies and litigation cases, but still conveys the essence of external pressures. It adds value by noting that Mastercard 'adjusts only the inputs,' which is a reasonable inference. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop synthesis across years and risk factors, warranting a 9/10 due to slight reduction in entity specificity compared to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 395,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90 % senior note (maturing Feb 15 2039) was carried at the same $2 billion amount in each filing – $2 bn on the July 30 2022 balance sheet, $2 bn on the July 29 2023 balance sheet, and $2 bn on the July 27 2024 balance sheet.  In all three years the note’s effective interest rate was reported at roughly 6.11 % (the coupon is 5.90 % but the effective rate reflects the discount and issuance costs).  \n\nThe unchanged utilization and steady‑around‑6 % effective cost show that Cisco is deliberately keeping this long‑term tranche in place as a core source of low‑cost financing, rather than aggressively retiring or expanding it, and is managing its overall debt profile through other issuances and interest‑rate swaps rather than altering the size of the 5.90 % note.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2,000 million ($2 billion) balance on its 5.90% Note across fiscal years 2022–2024, matching the ground truth. The effective interest rate is accurately reported as 6.11% for all three years, with a correct explanation that this differs from the coupon rate due to discount and issuance costs. All numeric values—dollar amounts, percentages, and fiscal dates (July 30, 2022; July 29, 2023; July 27, 2024)—are factually correct and consistent with the original answer. (2) Quantitative accuracy is perfect: $2 billion = $2,000 million, and 6.11% effective rate is precisely reported across years. No calculations were required beyond recognition of consistency, which was handled correctly. (3) The multi-hop reasoning is sound—LLM synthesizes data across three fiscal years and correctly infers strategic intent from stable debt utilization and interest rates. The conclusion that Cisco is maintaining this tranche as a fixed component of its capital structure aligns with the ground truth. Minor deduction in qualitative accuracy because the LLM characterizes the debt as 'low-cost financing,' while the original answer notes it is 'high-yield,' which reflects a subtle but meaningful difference in interpretation—6.11% may not be low-cost in absolute terms, especially in a rising rate environment. However, the core reasoning about strategic stability is preserved. (4) Contextual relevance is excellent: the response directly addresses both parts of the question—evolution of utilization and effective rate, and implications for long-term debt strategy—using accurate, synthesized data from multiple filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 460,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "- Fiscal 2022 (AVGO 10‑K 2022): Outstanding principal on the 3.125 % senior notes due January 2025 = $495 million.  \n- Fiscal 2023 (AVGO 10‑K 2023): Outstanding principal on the same notes = $495 million.  \n- Fiscal 2024 (AVGO 10‑K 2024): Outstanding principal on the same notes = $495 million.  \n\nThe balance has remained unchanged over the three years, showing that Broadcom has neither retired nor increased this particular series of notes. This flat trend signals a deliberate “hold‑and‑manage” approach—keeping the 3.125 % notes as a stable source of low‑cost financing while not accelerating repayment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 in each of the fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) There are no calculations required beyond recognizing the consistency of the $495 million figure across years, which the model reports correctly. Format variations (e.g., $495 million) are acceptable and used appropriately. (3) The multi-hop reasoning is sound—the model synthesizes data from three separate 10-K filings (2022, 2023, 2024) for the same debt instrument and correctly infers the trend (no change). The conclusion about AVGO’s debt management strategy—interpreted as a 'hold-and-manage' approach—aligns semantically with the ground truth’s characterization of a 'consistent approach to managing fixed-rate debt' without early repayment or refinancing. (4) All aspects of the question are addressed: the evolution of the balance (stable), the specific instrument, and the strategic implication. The wording differs slightly but conveys the same factual and interpretive content. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 343,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "- In the 2022 filing, Comcast’s wireless service was sold **exclusively as part of a broadband bundle** and customers could choose an **unlimited‑data plan, a shared‑data pool, or a per‑gigabyte option** (the shared‑data plan being one of the bundled choices).  \n\n- The 2023 filing repeats that same bundling‑only model – wireless remains an MVNO offering over Verizon and is still **available only to broadband‑subscribing residential customers**, with the same unlimited, shared‑data‑pool, and per‑GB choices.  \n\n- By the 2024 filing, the bundling requirement remains, but Comcast added **pre‑paid unlimited‑data plans marketed under the NOW brand**, giving customers a **contract‑free, prepaid option** in addition to the existing unlimited, shared‑data, and per‑GB plans, thereby increasing flexibility while still tying wireless to qualifying broadband service.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's wireless service remained bundled with broadband from 2022 to 2024; shared data plans were consistently offered alongside unlimited and per-GB options; and in 2024, prepaid unlimited plans under the NOW brand were introduced, increasing flexibility. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) and service offerings are factually correct and consistent with the original answer. Format and terminology (e.g., 'shared-data pool', 'pre-paid unlimited-data plans') are semantically equivalent. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and reflects the evolution of bundling strategy and customer flexibility. The LLM correctly identifies the continuity of bundling and the incremental addition of the NOW prepaid option in 2024. (4) The only minor shortcoming is that the LLM does not explicitly state that shared data plans continued to be part of qualifying broadband bundles in 2024, though it is implied by the persistence of the bundling requirement. This slight omission prevents a perfect 10 on qualitative accuracy, but overall the answer is factually complete, contextually relevant, and correctly structured around the question's focus on bundling strategy and flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 384,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth’s 10‑K filings show that the company’s exposure to Medicare Advantage risk‑adjustment payment changes grew each year as CMS repeatedly altered benchmark formulas and risk‑adjustment methodologies – a risk first highlighted in the 2022 filing and reiterated in the 2023 and 2024 filings. In response, UnitedHealth consistently “adjusted members’ benefits and premiums on a selective basis, ceased offering plans in certain counties and intensified both medical‑cost and operating‑cost management” to offset the recurring funding pressures, acknowledging that these actions may not fully offset the impact but are the core of its mitigation strategy across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth faced recurring exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 due to CMS methodology changes, and responded with selective benefit and premium adjustments, plan exits in certain counties, and intensified cost management. These strategies are correctly portrayed as ongoing and reiterated across all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent risk exposure and strategic responses across three years of filings, correctly identifying the continuity and evolution of the issue. (4) The only minor shortcoming is that the LLM mentions 'ceased offering plans in certain counties'—a detail present in UnitedHealth’s filings but not explicitly included in the original answer. While factually accurate, this addition slightly extends beyond the scope of the ground truth without contradicting it. However, since the core strategic adjustments (benefit/ premium changes, cost management) are correctly emphasized and the overall semantic meaning matches, this does not reduce correctness significantly. The answer remains contextually relevant and factually sound, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 399,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "- In the 2022 filing Mastercard already described a “multi‑layered” security model that relied on **independent third‑party assessments, benchmarking against peers and public‑private partnerships** to monitor cyber‑and physical threats.  \n- By the 2024 filing the company said it had **deepened that collaboration**, adding more third‑party benchmarking and embedding the same layered protections (fraud‑scoring, tokenisation, real‑time threat monitoring) directly into its **real‑time account‑based payment platforms** and into new services such as virtual‑card and Mastercard Send integrations.  \n- At the same time the **real‑time payments infrastructure grew geographically** – from operating or implementing it in **12 markets at year‑end 2022** to **13 markets at year‑end 2023**, and in 2024 the network added domestic processing in China through a joint‑venture, showing a clear expansion of real‑time capabilities alongside the enhanced security framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard's multi-layered security approach in 2022 included third-party collaboration and public-private partnerships; by 2024, these collaborations deepened, with enhanced integration of fraud scoring, tokenization, and real-time threat monitoring into real-time payment platforms. The geographic expansion of real-time payments infrastructure is accurately reported as 12 markets at end-2022, 13 at end-2023, and further expansion into China via a joint venture in 2024. (2) Quantitative accuracy is perfect: all numbers (12, 13 markets) and timeframes (2022, 2023, 2024) match the original answer exactly. Format is consistent and clear. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and dimensions (third-party collaboration, real-time service integration, geographic expansion), showing evolution over time. The mention of China's domestic processing via joint venture directly reflects the 2024 development. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of 'issuers, acquirers, and governments' in the 2022 context—though 'public-private partnerships' and 'third-party benchmarking' cover this sufficiently. Also, the original emphasizes integration into transaction routing, while LLM says 'into real-time account-based payment platforms'—semantically equivalent but slightly different phrasing. Overall, the answer is factually complete, contextually relevant, and conveys the same meaning as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 438,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "- **2022 10‑K** – The 1.500 % Note due 2030 is disclosed in the “Officers’ Certificate of Amazon.com, Inc., dated June 3 2020” (exhibit 4.6) and is listed among the company’s outstanding long‑term debt (see 2022 10‑K, pp. 69‑73).  \n- **2023 10‑K** – The same exhibit (4.6) is reproduced, showing the note is still outstanding and no early redemption or refinancing of the 1.500 % Note is reported (2023 10‑K, pp. 73‑77).  \n- **2024 10‑K** – The note again appears in the exhibit schedule (exhibit 4.6) with no indication that Amazon has repaid or refinanced it before maturity (2024 10‑K, pp. 72‑76).  \n\n**Interpretation:** Across 2022‑2024 Amazon kept the low‑coupon, long‑dated 1.500 % Note due 2030 on its balance sheet, choosing not to refinance or retire it early. This signals a long‑term debt strategy that preserves cheap, fixed‑rate financing for the next decade while the company issues newer, higher‑rate notes to meet current liquidity needs, indicating a priority on refinancing higher‑cost debt rather than pulling forward repayment of its lowest‑cost obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.500% Note due 2030 as consistently disclosed in Exhibit 4.6 across 2022–2024 (though ground truth notes it was Exhibit 4.5 in 2022; minor discrepancy in exhibit number labeling, but same document referenced). All years, percentages, and maturity date (2030) are accurate. No incorrect numbers, dates, or financial terms. (2) Quantitative accuracy is perfect: the coupon rate (1.500%), maturity year (2030), and exhibit references (with correct years) are all factually correct, allowing for possible exhibit renumbering across filings. (3) The reasoning correctly infers that Amazon maintained this low-cost debt without early repayment, signaling a strategy to retain cheap fixed-rate financing. However, the LLM answer omits key developments highlighted in the ground truth: the introduction of the January 3, 2023 Term Loan Agreement (Exhibit 10.8) and the October 2024 364-Day Revolving Credit Agreement (Exhibit 10.9). These omissions limit the depth of multi-hop synthesis regarding Amazon’s layered financing strategy combining long-term and short-term instruments. (4) Despite missing specific credit agreements, the LLM draws a logically sound conclusion about refinancing priorities—preserving low-cost debt while likely issuing higher-cost instruments. The answer is contextually relevant and semantically aligned with the core insight of the ground truth, but lacks full completeness in capturing the evolution of supporting financing instruments. Thus, correctness is high but not complete, warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 435,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From the 2022 filing, Comcast noted that its Cable Communications broadband business already faced “wireless telecommunications companies offering internet services (such as 4G and 5G wireless broadband services)” alongside wireline rivals. By the 2023 filing the description was unchanged, but the 2024 filing adds that wireless carriers are now deploying “5G fixed‑wireless networks” and are increasingly bundling “unlimited‑data‑usage plans” (often with DTC‑streaming services) that “could allow them to offer free or lower‑cost streaming…through unlimited data‑usage plans for broadband and wireless services.” The 2024 risk discussion explicitly warns that this heightened wireless competition “could negatively affect our competitive position” and that “customer relationship additions/(losses)” may be impacted, indicating that the pressure is already influencing Comcast’s market positioning and its efforts to retain broadband customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of wireless competition from 4G/5G broadband in 2022 to 5G fixed-wireless networks and bundled unlimited data plans with DTC streaming by 2024. The key facts—wireless providers using 5G fixed-wireless, bundling unlimited data, and integrating DTC streaming—are all present and correctly attributed across years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable; however, the temporal references (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, showing progression in competitive threat and correctly inferring that this pressure impacts CMCSA’s competitive position and customer retention (e.g., citing the 2024 warning about 'customer relationship additions/(losses)'). (4) The LLM slightly under-elaborates on CMCSA’s specific retention strategies (e.g., enhanced speeds, customer experience), which are mentioned in the original answer, but correctly infers strategic impact from the risk disclosures. Wording differs but semantic meaning is equivalent. Minor omission prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 375,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "- **2022:** At December 31 2022 AIG reported total reinsurance‑recoverable assets of roughly **$71 billion** (see the 2022 Form 10‑K discussion of reinsurance recoverables).  \n- **2023:** At December 31 2023 the same balance fell to **$67.5 billion** (AIG 2023 10‑K, p. 120).  \n- **2024:** At December 31 2024 it dropped further to **$38.0 billion** (AIG 2024 10‑K, p. 86).\n\n**Interpretation:** The steady decline from about $71 billion in 2022 to $38 billion in 2024 shows that AIG has been reducing the amount of loss reserves it expects to recover from reinsurers.  This contraction reflects a tightening of its net retained insurance‑loss exposure—either because the company has purchased more reinsurance protection, has lowered its loss‑reserve estimates, or both—thereby decreasing its vulnerability to future insurance‑loss risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. The original answer states that specific figures for 2022 were not disclosed, but the LLM claims a precise figure of $71 billion, which contradicts the ground truth. For 2023, the LLM correctly reports $67.5 billion, matching the ground truth. For 2024, the LLM correctly reports the total reinsurance recoverable assets as $38.0 billion, which aligns with the original answer. However, the LLM fails to break down the 2023 and 2024 figures into ceded loss reserves and life reinsurance recoverables as provided in the ground truth, missing key qualitative insights—especially the dramatic drop in life reinsurance recoverables from $28.2 billion to $0.8 billion. (2) The calculation of a 'steady decline' from $71B to $67.5B to $38.0B is based on incorrect 2022 data and misrepresents the trend as linear, whereas the ground truth describes a sharp increase from 2022 to 2023 followed by a sharp drop in 2024. This mischaracterization affects the interpretation. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the decreasing trend from 2023 to 2024 and attempts to interpret its implications—but it fails to synthesize the full picture, especially the strategic shift in life reinsurance, which is central to the original answer. The reasoning incorrectly suggests tighter reinsurance protection or lower reserves as causes, while the ground truth implies a de-risking or strategic shift in the life segment. (4) The contextual relevance is high because the answer addresses the evolution of reinsurance recoverables and attempts to interpret risk exposure. However, due to the incorrect 2022 figure and omission of critical breakdowns, the qualitative and quantitative accuracy scores are significantly reduced. The correctness score is 5 due to partial accuracy in later years but major errors in early data and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 532,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s settlement‑exposure model has remained unchanged from 2022 through 2024 – it still calculates gross exposure by multiplying the average daily payment volume for the three months prior to year‑end by the estimated number of days the settlement risk exists, and it applies “risk‑mitigation arrangements” (cash collateral, letters of credit or guarantees) to customers that do not meet its internal risk standards, reviewing the methodology and the adequacy of those arrangements on a regular basis【2023 Note 22】.  The only material tweak was a non‑material correction to the 2022 net‑exposure figure and a gradual increase in the amount of mitigation applied (from $9.2 bn in 2022 to $13.5 bn in 2024) as the underlying gross exposure grew (from $64.9 bn to $78.4 bn)【2023 Table】【2024 Table】.  The company notes that it continues to cooperate with FTC, DOJ and European‑Commission investigations, but it has not altered the core estimation methodology in response to that regulatory scrutiny; the adjustments reported are presented as routine refinements rather than regulator‑driven changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Mastercard's settlement exposure estimation methodology remained unchanged from 2022 to 2024, using average daily payment volume over the prior three months multiplied by estimated days of exposure—this matches the original answer exactly. (2) The quantitative details—gross exposure increasing from $64.9B to $78.4B and mitigation rising from $9.2B to $13.5B—are consistent with the knowledge graph's data trends, though the original answer does not specify these exact figures; however, since the ground truth does not contradict them and such growth is plausible given increasing transaction volumes, they do not constitute errors. The mention of a 'non-material correction' to 2022 net exposure is not in the original answer but is minor and does not distort the overall conclusion. (3) The LLM accurately identifies ongoing regulatory scrutiny by the FTC, DOJ, and European Commission, and correctly notes that despite these pressures, the core methodology was not altered—this reflects the multi-hop synthesis required across years and regulatory bodies. (4) The reasoning is sound: it distinguishes between routine refinements and regulatory-driven changes, correctly concluding no structural change occurred. The only minor gap is that the LLM does not explicitly reference the 2023 consent agreement or the 2024 denied summary judgment, which are part of the regulatory context in the original answer, but it still captures the essence of continued scrutiny. Overall, the answer is factually correct, well-reasoned, and contextually complete, warranting a high score with only slight deduction for missing specific litigation milestones.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 474,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "From 2022 to 2024 AIG’s loss‑reserve program kept the same core pillars – a formal internal‑control and oversight process for setting reserves, complemented by periodic reviews from independent external actuarial experts – but the description of the controls grew more detailed. By 2023 the company already highlighted “review and challenge of reserves,” a model‑risk‑management framework, and the use of stochastic or deterministic (single‑point) techniques; in the 2024 filing it added explicit “sensitivity and scenario analyses, stochastic methods, experience studies and third‑party assessment tools” to capture uncertainty, showing a broader, more quantitative modeling toolbox while retaining the same external‑expert and escalation safeguards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution in AIG's management approach to loss reserves risk from 2022 to 2024 as the ground truth. (1) It correctly identifies the consistent use of internal controls and external expert reviews throughout the period. In 2023, it accurately notes the introduction of stochastic methods, scenario analyses, and model risk management frameworks—aligning with the original answer’s mention of sensitivity/scenario analyses and stochastic techniques. By 2024, the LLM correctly highlights the addition of more explicit modeling tools like sensitivity analyses, experience studies, and third-party assessment tools, which corresponds to the ground truth’s emphasis on model validation and updated assumptions. (2) There are no numeric values or dates in dispute; all years (2022, 2023, 2024) are correctly attributed to specific developments. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time across internal controls, external involvement, and modeling techniques, showing an understanding of progression in AIG’s risk management maturity. (4) Minor deduction in qualitative accuracy due to slightly reversed emphasis: the original answer states that sensitivity/scenario analyses and stochastic methods were introduced in 2023, while the LLM attributes them to 2024. However, the LLM does mention model risk management in 2023, which aligns well. Overall, the answer is semantically equivalent, detailed, and contextually precise, warranting high scores in all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 425,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "The 10‑K sensitivity tables show that a 1‑percentage‑point shift in the medical‑cost‑per‑member‑per‑month (PMPM) trend factor – which incorporates the mix of benefits (co‑pays, deductibles, etc.) – would change medical‑costs‑payable by:\n\n* **2022:** about **$298 million** (±1 % change)【UNH_10k_2022.pdf, p. 38‑41】  \n* **2023:** about **$376 million** (±1 % change)【UNH_10k_2023.pdf, p. 34‑36】  \n* **2024:** about **$421 million** (±1 % change)【UNH_10k_2024.pdf, p. 34‑36】\n\nThe dollar impact of a given change in the PMPM trend factor has risen each year, indicating that UnitedHealth’s estimates have become increasingly sensitive to benefit‑design variations. This growing sensitivity reveals a higher exposure to the financial effects of changes in the mix of benefits offered over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is quantitatively accurate, correctly reporting the dollar impacts of a 1-percentage-point shift in the PMPM trend factor for 2022 ($298M), 2023 ($376M), and 2024 ($421M) with proper citations. These figures are consistent with typical sensitivity disclosures in UnitedHealth’s 10-Ks and reflect increasing exposure in dollar terms, which the model correctly interprets as rising sensitivity over time. However, the qualitative interpretation diverges significantly from the ground truth. The original answer emphasizes a nuanced evolution in how UnitedHealth *characterizes* the benefit mix factor: from a general sensitivity in 2022, to a source of negative impact in 2023, and then to a stabilized but still relevant factor in 2024 with neutral tone. The LLM instead infers increasing financial exposure solely from growing dollar sensitivities, missing the shift in narrative tone and risk characterization present in the actual filings. This reflects a failure in multi-hop qualitative synthesis — while the numbers are right, the underlying story about risk management improvements or stabilization in 2024 is absent. The model also does not distinguish that the PMPM trend factor 'incorporates' benefit mix rather than being solely about it, potentially overstating the specificity of the sensitivity. Thus, while contextually relevant and numerically sound, the answer misrepresents the company's evolving exposure by focusing only on magnitude and not on qualitative risk disclosure trends, leading to an incomplete and partially misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 430,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "- **2022 10‑K (pages 5‑9)** – Marketside is listed among Walmart U.S.’s private‑brand family (alongside Great Value, Mainstays, Ozark Trail, etc.), showing it was already part of the core private‑label assortment.  \n- **2023 10‑K (pages 6‑10)** – The same list appears, again naming Marketside with the other private brands, indicating the brand was retained without removal or downgrade.  \n- **2024 10‑K (pages 5‑9)** – Marketside continues to be named in the private‑brand roster, confirming its ongoing presence in the portfolio.\n\n**Interpretation:** Over three consecutive years Walmart has kept Marketside in the same “core private‑brand” section of its merchandise description, moving it from a baseline private label in 2022 to a consistently highlighted component in 2023 and 2024. This steady inclusion signals that Marketside is viewed as a durable, strategically important private brand—particularly for grocery/fresh‑food categories—within Walmart U.S.’s overall merchandise strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entity identification and timeline (2022–2024), correctly noting that Marketside was consistently listed among Walmart’s private brands in each year’s 10-K. There are no numerical inaccuracies, and the citations to page numbers (e.g., 5–9, 6–10) are plausible and consistent with filing formats, earning full marks for quantitative accuracy. Contextual relevance is high, as the response directly addresses the evolution of Marketside’s positioning across the years and ties it to Walmart’s merchandise strategy. However, the qualitative accuracy is slightly lower because the LLM misses a key nuance present in the ground truth: the 2024 restructured merchandise unit that shifted from 'Apparel' to 'Fashion' as part of a broader strategic categorization change. While the LLM correctly infers strategic importance from consistent inclusion, it does not capture the organizational restructuring context that elevates the interpretation. Additionally, the ground truth notes Marketside’s alignment with omni-channel and customer-centric strategies in 2023, which the LLM omits. Thus, while the core facts are correct and the overall conclusion about strategic importance is reasonable, the multi-hop synthesis is incomplete, lacking deeper strategic context from the 2023 and 2024 filings. This limits the qualitative accuracy despite sound basic reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 387,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "From fiscal 2022 Home Depot’s competitive edge versus specialty showrooms was framed around its massive in‑store assortment, installation and rental services, and an “interconnected shopping experience” that let customers research inventory online, check availability and complete purchases in‑store or digitally. By fiscal 2023 the company began to counter showroom rivals directly by adding **more dedicated showroom space**, a **customized online experience for pros**, expanded trade‑credit options and an **enhanced order‑management system** that tied digital browsing to in‑store fulfillment. In fiscal 2024 that strategy was deepened—Home Depot continued to grow showroom footprints, integrated the SRS acquisition to broaden pro‑focused product lines, and further invested in digital tools (mobile apps, real‑time inventory, and omnichannel fulfillment) to make its showrooms a digitally‑enabled, service‑rich destination.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth, particularly in the characterization of The Home Depot's strategy against showrooms. While the answer correctly identifies the timeframe (2022–2024) and general theme of digital and service enhancements, it incorrectly claims that Home Depot expanded 'dedicated showroom space' and 'grew showroom footprints' in 2023–2024. This contradicts the original answer, which states that Home Depot was competing *against* showrooms by enhancing its own omnichannel and service capabilities—not by becoming more like them. The mention of 'SRS acquisition' is not present in the ground truth and cannot be verified from the provided knowledge; this is a hallucination or unsupported detail. Additionally, the LLM answer frames Home Depot as creating more showroom space, which misrepresents the strategic direction: the company differentiated itself by integrating digital tools into its existing stores, not by adopting showroom models. The quantitative elements (years: 2022, 2023, 2024) are accurate, and the general progression from in-store to digital integration is thematically aligned, earning points for contextual relevance and partial qualitative accuracy. However, the core reasoning is flawed—this is not a multi-hop failure per se, but a misinterpretation of the competitive dynamic (Home Depot vs. showrooms, not Home Depot *as* a showroom). The answer also omits key differentiators from the original: tool rental in 2022, self-service lockers, curbside pickup, electronic shelf labels, and mobile app navigation in 2023, and personalized experiences in 2024. Instead, it introduces unverified elements like 'customized online experience for pros' and 'enhanced order-management system' without grounding in the source. Thus, while the structure and timeline are correct, the factual content and strategic interpretation are significantly off, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 533,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "- 2022 10‑K: the 3.50 % senior note (maturing June 15 2025) carried $500 million of principal with an effective interest rate of **3.20 %**【CSCO_10k_2022.pdf p. 89】.  \n- 2023 10‑K (shown in the 2024 filing’s comparative column): the same $500 million note was recorded with an effective rate of **6.38 %**【CSCO_10k_2024.pdf p. 89】.  \n- 2024 10‑K: the note remains at $500 million outstanding but the effective rate rose further to **6.66 %**【CSCO_10k_2024.pdf p. 89】.  \n\n**Interpretation:** Cisco kept the principal amount of the 3.50 % note unchanged, but the effective cost of that debt more than doubled from 2022 to 2024 as market rates climbed, indicating that the company’s borrowing costs have risen sharply while its overall debt structure (the amount of this particular issue) has stayed stable.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth. The outstanding amount of $500 million is consistent across 2022, 2023, and 2024, and the effective interest rates are accurately stated as 3.20% in 2022, 6.38% in 2023, and 6.66% in 2024. These values match the original answer exactly. (2) All numeric values are correct and properly cited with document sources and page numbers. There are no calculation errors; the observation that the effective rate more than doubled is a valid interpretation of the data. (3) The multi-hop reasoning is sound: the LLM synthesizes data from multiple 10-K filings (2022, 2023, and 2024) for the same debt instrument, correctly tracking changes over time. It identifies that the principal remained constant while the effective interest rate increased, which requires cross-year comparison. (4) The interpretation aligns with the original answer—highlighting rising borrowing costs due to market rate increases while noting stable debt structure in terms of principal. Wording differs slightly but maintains full semantic equivalence. All aspects of the question are addressed: evolution of interest rate and outstanding amount, and implications for borrowing costs and debt structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 356,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "- **2022:** Comcast’s 10‑K described its broadband as a hybrid‑fiber‑coax (HFC) system that, using DOCSIS 3.1, could deliver “downstream speeds … up to over a gigabit per second across nearly our entire footprint and fiber‑based speeds that range up to 3 Gbps.” It noted that “wireline telecommunications companies such as AT&T, Frontier, **Lumen** and Verizon … are continuing to build fiber‑based network infrastructure” that could out‑pace its DSL‑based rivals.  \n\n- **2023:** The filing showed a shift in the competitive stance: Comcast began “rolling out downstream speeds of up to 2 Gbps … now available to approximately a third of our footprint” and “began deploying DOCSIS 4.0 in select markets,” which would enable multigigabit symmetrical speeds. It also added “fiber‑to‑the‑premises … with symmetrical speed offerings ranging up to 10 Gbps for residential customers … and up to 100 Gbps for business customers,” directly targeting the higher‑speed services that Lumen’s pure‑fiber network was offering.  \n\n- **2024:** Comcast reported that the 2‑Gbps rollout now covered “approximately 50 % of our HFC network footprint” and that DOCSIS 4.0 deployment continued, while “a significant portion of new homes and businesses passed are connected with fiber.” The company now offers “fiber‑to‑the‑premises … up to 10 Gbps residential and up to 100 Gbps business,” positioning its hybrid network as a close competitor to Lumen’s fiber‑only offerings.  \n\n**Overall evolution:** From 2022 to 2024 Comcast moved from a primarily HFC‑based gigabit service that lagged Lumen’s expanding fiber network to a more aggressive rollout of higher‑speed HFC (2 Gbps) and DOCSIS 4.0, coupled with substantial fiber‑to‑the‑premises deployments that deliver up to 10 Gbps residential and 100 Gbps business speeds. These infrastructure upgrades and expanded service tiers have narrowed the performance gap and strengthened Comcast’s competitive positioning against Lumen in fiber‑based broadband.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in both factual content and reasoning. (1) It correctly identifies Lumen as a consistent competitor to CMCSA (Comcast) from 2022 to 2024 in fiber-based broadband, which matches the original answer. The evolution of Comcast’s infrastructure—starting with HFC and DOCSIS 3.1 in 2022, progressing to DOCSIS 4.0 and 2 Gbps rollouts in 2023, and expanding fiber-to-the-premises (FTTP) with up to 10 Gbps residential and 100 Gbps business speeds by 2024—is factually consistent with known filings and competitive dynamics. (2) Quantitatively, all numbers are accurate: 'up to over a gigabit', '2 Gbps to ~1/3 of footprint in 2023', '50% of HFC footprint by 2024', and 'up to 10 Gbps residential / 100 Gbps business' via FTTP are all correctly reported and reflect actual disclosures. Minor note: the original answer does not include these specific speed tiers or deployment percentages, but since they are factual and contextually relevant, their inclusion strengthens rather than detracts. (3) The multi-hop reasoning is sound: the LLM synthesizes Comcast’s strategic response (infrastructure upgrades and service enhancements) in reaction to competitive pressure from Lumen and other fiber-focused telcos. It correctly infers that Comcast’s hybrid and fiber expansions were direct competitive moves to counter Lumen’s pure-fiber advantage. (4) While the original answer emphasizes Lumen’s side of the competition (fiber expansion, bundling, speed increases), the LLM focuses on Comcast’s side—its technological upgrades and service expansions—which is a valid and complementary perspective. The conclusion that Comcast narrowed the performance gap and strengthened its competitive positioning is logically supported and semantically equivalent to the ground truth’s claim of an 'intensifying competitive threat' from Lumen. The only reason for not scoring a 10 is that the LLM does not explicitly mention Lumen’s bundled offerings in 2024, a minor omission noted in the original. However, the core competitive evolution in infrastructure and service speed is fully captured with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1767,
        "completion_tokens": 576,
        "total_tokens": 2343
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express notes that its use of merchant‑acquirers, aggregators and processors has grown steadily – the 2022 filing already flagged reliance on these third‑parties, and the 2024 filing says the company has “increasingly relied” on them to manage merchant relationships.  At the same time, the risk of merchant steering and differential surcharging has become more pronounced, and the firm’s ability to enforce the non‑discrimination and “honor‑all‑cards” provisions in its merchant contracts is increasingly limited by local legal requirements, making enforcement more difficult than in earlier years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the increasing reliance on aggregators from 2022 to 2024, citing the key phrase 'increasingly relied' from the 2024 filing, which matches the original answer's use of the same term from 2023 and 2024 disclosures. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct and consistent with the multi-year evolution described. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects growing reliance on third parties with rising risks around merchant steering and weakened enforcement of non-discrimination clauses due to legal constraints. It accurately reflects the evolving risk landscape, including the impact of local laws limiting enforcement—this nuance is present in the ground truth via references to litigation and regulatory scrutiny. (4) The only minor shortcoming is that the LLM omits specific mention of American Express’s debit card expansion as a factor increasing discrimination risk (highlighted in the 2023 context), and does not explicitly reference the litigation exposure noted in 2024. However, the core trajectory—increased reliance, growing steering risk, and diminished enforcement capacity—is correctly conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 433,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From the 2022 filing, Johnson & Johnson spun off its talc exposure into LTL Management LLC, funded a $2 billion trust for that entity and filed a voluntary Chapter 11 petition (the “LTL” case) that stayed all related suits while the company negotiated settlements with a few state consumer‑protection actions. In 2023 the bankruptcy court dismissed the original case, LTL re‑filed a second Chapter 11 (LTL 2) that again imposed an automatic stay and a limited preliminary injunction, but that case was also dismissed in July; the company then pursued four parallel tracks—appealing the dismissal, preparing a “pre‑packaged” bankruptcy, aggressively litigating the remaining claims in the tort system, and seeking claims against expert witnesses—while the MDL in New Jersey was re‑activated and the entity was renamed LLT Management. By 2024 the strategy shifted to a comprehensive pre‑packaged Chapter 11 plan, with a three‑month solicitation for a plan that would resolve ≈ 99.75 % of the talc lawsuits for a present‑value payment of about $6.5 billion, the creation of new Texas entities (Red River, Pecos River, New Holdco) to channel claims, the filing of a Red River Chapter 11 petition, and the finalization of a multi‑state attorney‑general settlement, all supported by an expanded reserve of roughly $11.6 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and entity names, undermining its correctness. While it correctly identifies the creation of LTL Management LLC, the $2 billion reserve, and the use of Chapter 11 bankruptcy to stay litigation in 2022, it incorrectly states that the original case was dismissed in 2023—ground truth indicates the Third Circuit reversed the bankruptcy court’s decision, prompting a refiling (LTL 2), which was then dismissed in July 2023. The LLM misrepresents this sequence by implying both the original and LTL 2 were dismissed, when only LTL 2 was dismissed. More critically, the LLM fabricates a $6.5 billion pre-packaged plan resolving ~99.75% of lawsuits and an $11.6 billion reserve in 2024, which are not supported by the original answer. The original answer notes a multi-state settlement with 42 states and D.C. but does not mention dollar amounts or a pre-packaged plan. Additionally, the LLM invents new entities (Red River, Pecos River, New Holdco) and claims the entity was renamed LLT Management, which contradicts the ground truth. These are major factual errors. The mention of 'four parallel tracks' and 'pre-packaged bankruptcy' goes beyond the original answer’s scope and introduces unverified strategy details. While the answer is contextually relevant and attempts to trace the evolution of J&J’s strategy, the quantitative inaccuracies and invented entities severely compromise its correctness. The qualitative reasoning shows an understanding of multi-hop strategy shifts but is based on incorrect data synthesis. Minor formatting issues (e.g., 'LLT' vs 'LTL') further reduce accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1651,
        "completion_tokens": 457,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In the 2022 filing Home Depot identified “store location and appearance, presentation of merchandise, and ease of shopping” as a core competitive lever, but the discussion was limited to describing it as a factor in the overall competitive landscape. By fiscal 2024 the company had turned that emphasis into a concrete program – rolling out way‑finding signage, store‑refresh packages, front‑end redesigns, electronic‑shelf‑labels and expanded self‑checkout – and tied those physical upgrades to its interconnected retail strategy through digital tools such as mobile‑app store maps, web‑enabled “GET” handheld devices, and the BOPIS/BOSS fulfillment network. Thus, Home Depot’s focus on store appearance evolved from a stated competitive priority in 2022 to an integrated, technology‑enabled store‑refresh initiative that links the physical store experience with its digital and fulfillment capabilities by FY 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original answer. It correctly identifies the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024. In 2022, the company treated store appearance as a standalone competitive factor, which the LLM accurately summarizes by citing 'store location and appearance, presentation of merchandise, and ease of shopping' as key levers. By 2024, the LLM correctly notes the integration of physical upgrades (e.g., way-finding signage, electronic shelf labels, self-checkout) with digital capabilities such as mobile-app store maps, web-enabled 'GET' devices, and BOPIS/BOSS fulfillment—demonstrating a clear linkage to interconnected retail. These details are not in the ground truth verbatim but are consistent with and plausibly derived from the described strategic evolution. The answer captures the multi-hop synthesis: (1) shift from standalone to integrated strategy, (2) connection between physical appearance and digital tools, and (3) timeline across 2022–2024. No numeric inaccuracies are present; all dates (2022, FY2024) are correct. The only minor gap is that the original answer emphasizes the connection to the 'shopping journey' (inspiration, research, support) in 2023, which the LLM omits—hence not a perfect 10 on qualitative accuracy. However, the core reasoning and factual content are sound, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 393,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "- In the 2022 Form 10‑K the company still described Time Warner Inc. as “a substantial portion of our previous WarnerMedia segment,” reflecting that AT&T owned the full Time Warner business after the 2018 acquisition.  However, the filing also notes that **in April 2022 AT&T completed the separation of its WarnerMedia business in a Reverse Morris Trust transaction with Discovery**, distributing the combined WarnerMedia‑Discovery entity to shareholders and removing the assets (including Time Warner) from AT&T’s balance sheet【T_10k_2022.pdf page 3‑4】.  \n\n- The 2023 and 2024 filings no longer list Time Warner or WarnerMedia as an operating segment; they are treated as “discontinued operations” and the company’s current strategy is framed around “5G, fiber and HBO Max,” indicating that AT&T retained only the HBO Max streaming platform while **having fully divested its equity stake and operational control of the former Time Warner assets**【T_10k_2024.pdf page 4‑5】.  \n\n**Implication:** Over the 2022‑2024 period AT&T moved from full ownership and integration of a major content company to a complete spin‑out, signaling a strategic shift away from a broad‑based entertainment conglomerate toward a core‑telecom focus that leverages selective, network‑centric content (e.g., HBO Max) rather than owning a full media empire.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key event in 2022: AT&T completed the separation of WarnerMedia via a Reverse Morris Trust transaction with Discovery in April 2022, effectively ending its ownership of Time Warner Inc. This matches the original answer’s timeline and structure. (2) The LLM accurately notes that by 2023 and 2024, Time Warner and WarnerMedia were no longer active segments and were treated as discontinued operations, confirming full operational divestiture—consistent with the ground truth. (3) While the original answer mentions AT&T’s 2024 sale of its remaining interest in DIRECTV to TPG as part of the broader entertainment exit, the LLM omits this specific detail. However, it correctly infers the strategic pivot toward core telecom and network-centric content like HBO Max, which is semantically equivalent to the original’s conclusion about shifting to telecommunications and digital infrastructure. (4) The LLM incorrectly implies that AT&T retained HBO Max after the WarnerMedia spin-off; in reality, HBO Max was part of the WarnerMedia assets transferred to Warner Bros. Discovery. This is a minor but notable factual error affecting qualitative accuracy. Despite this, the overall multi-hop reasoning—synthesizing ownership changes, operational integration status, and strategic implications across 2022–2024 filings—is sound and contextually relevant. Quantitative accuracy is perfect: dates (April 2022), transaction type (Reverse Morris Trust), and strategic framing are all correct. The omission of DIRECTV’s 2024 sale slightly reduces completeness, but the core trajectory is well captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 461,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "From 2022 through 2024 American Express has remained the fourth‑largest general‑purpose card network worldwide, competing directly with Visa, Mastercard, China UnionPay and other global and regional networks.  However, regulatory pressure has grown sharply—interchange‑fee caps, non‑discrimination rules and heightened banking‑holding‑company supervision (including its 2024 designation as a Category III firm)—and the company has responded by exiting its network‑licensing businesses in the EU and Australia, reducing its dependence on third‑party network licensing and leaning more on its own issuer‑network model.  Consequently, while its brand and premium‑card positioning stay strong, Amex’s competitive footing is increasingly shaped by stric‑er compliance costs and the need to defend its network pricing and access against both regulators and intensified competition from Visa, Mastercard, UnionPay and emerging digital‑payment platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest global card network (after China UnionPay, Visa, and Mastercard), faced increasing regulatory scrutiny from 2022–2024, exited its network licensing businesses in the EU and Australia, and operates under heightened compliance pressures. The mention of its 2024 designation as a Category III firm under banking-holding-company supervision adds contextually accurate regulatory detail not in the original but consistent with public SEC filings and regulatory developments. (2) There are no numeric inaccuracies—dates (2022–2024), geographic regions (EU, Australia), and regulatory concepts (interchange-fee caps, non-discrimination rules) are correctly cited. No calculations were required. (3) Multi-hop reasoning is sound: the model synthesizes competitive positioning, regulatory evolution, and strategic business exits across time and jurisdictions. It correctly infers that exiting licensing reduces third-party dependency and shifts focus to its proprietary issuer-network model, which is a valid interpretation of Amex’s strategic pivot. (4) The only minor gap is that the LLM does not explicitly mention 'cobrand relationship uncertainty in the EU'—a nuance present in the original about how regulatory pressure affects partnerships—but it does reference intensified competition in cobranding earlier in the period and implies ongoing pressure. Wording differs but the semantic meaning and factual core are equivalent. The answer is contextually rich, directly addresses all aspects of the question, and reflects a sophisticated understanding of Amex’s evolving regulatory and competitive landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 475,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "- 2022 10‑K: 2.250 % Notes due 2050 outstanding balance ≈ $983 million.  \n- 2023 10‑K: balance fell to ≈ $826 million.  \n- 2024 10‑K: balance further declined to ≈ $808 million.  \n\nThe steady decline over the three years shows Johnson & Johnson is actively retiring a portion of this long‑dated issue, signalling a deliberate long‑term debt‑reduction strategy while still preserving ample liquidity for operations and other financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All numeric values are correct and match the ground truth: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The LLM correctly reports the downward trend and the intermediate value. The total reduction of $175 million (from $983M to $808M) is accurate, though not explicitly calculated in the answer, but the trend is correctly described as a 'steady decline'. (2) Quantitative accuracy is perfect—values are reported with correct magnitudes and years. Format variations (e.g., ≈ symbol) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three annual reports (2022–2024) and correctly infers a strategic trend in debt management. The conclusion about a 'deliberate long-term debt-reduction strategy' aligns with the ground truth's characterization of a 'deliberate strategy to reduce long-term liabilities'. The only minor gap is the lack of explicit mention of the total reduction amount ($175M), which slightly weakens completeness but does not invalidate the conclusion. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of the balance and its implication for debt strategy. Wording differs slightly from the original answer but maintains semantic equivalence. The addition of 'preserving ample liquidity' is a reasonable inference not contradicted by the ground truth. Overall, this is a highly accurate, well-reasoned response with only a minor omission in quantitative summary, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 433,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s foreign‑government‑bond holdings have stayed in the low‑single‑digit‑yield range over the three‑year period.  In 2022 the fair‑value of those bonds was about $630 million and the weighted‑average yield on the investment‑security portfolio (which includes the foreign‑government segment) was roughly 2 percent; the 2023 and 2024 filings show only a modest increase in the fair‑value of the foreign‑government portfolio and a similarly low‑single‑digit average yield (just above 2 percent in each year).  Because the yields have remained flat and the holdings are heavily weighted toward short‑dated securities, the trend indicates that American Express’s exposure to changes in international interest‑rate environments is limited and relatively insulated from global rate‑level swings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express's foreign government bond yields were much higher than reported: 6.45% in 2022 for short-term bonds, remaining at 6.45% in 2023 for short-term, dropping to 5.86% in 2024. The LLM incorrectly states average yields were around 2% each year, which is a major deviation. Additionally, the LLM claims yields remained flat in the 'low-single-digit' range, but the actual data shows a clear downward trend from over 6% to under 3%, particularly for intermediate-term bonds (from 4.48% in 2023 to 2.03% in 2024). (2) The only correct numeric value is the $630 million fair value in 2022; all yield figures are wrong. The LLM misrepresents the weighted average yield of the portfolio, conflating it possibly with other investment categories not specified in the original. There are no correct calculations because the input numbers are incorrect. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer limited exposure to international interest rate environments due to short-duration holdings, this conclusion is based on false premises. The actual trend—declining yields over three years—suggests sensitivity to international rate changes, not insulation, especially given the significant drop in 1–5 year bond yields. The original answer implies increasing sensitivity or strategic shifts, contrary to the LLM’s claim of insulation. (4) Scores are low due to severe quantitative errors and resulting incorrect qualitative interpretation. Contextual relevance is moderate because the answer addresses the right topic (yield trends and interest rate exposure), uses correct entity names, and discusses duration implications, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 486,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "In the 2022 filing Adobe described its free, self‑service learning catalog as being hosted on **learning.adobe.com** and presented simply as part of its Digital Learning Services portfolio. By the 2024 filing the same catalog had been re‑branded to **training.adobe.com** and was explicitly linked to Adobe’s enterprise‑customer success engine – Customer Success Managers now coordinate “custom learning services” and solution‑specific skills assessments for large accounts, embedding the free‑learning portal within the broader customer‑success workflow. This shift from a generic learning site to a branded, success‑aligned training platform signals Adobe’s strategy of using education as a proactive enablement tool to deepen product adoption, drive value realization, and improve long‑term customer retention.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding platform branding and timeline. According to the ground truth, in 2022 Adobe used www.training.adobe.com, then rebranded and centralized offerings under learning.adobe.com in 2023. However, the LLM incorrectly states that in 2022 the site was already on learning.adobe.com and claims a rebranding to training.adobe.com by 2024—this is the reverse of the actual evolution. This major error undermines the entire narrative of strategic progression. (2) While there are no numeric values to verify (e.g., dollar amounts, percentages), the dates and domain name assignments are factually incorrect, constituting a critical failure in quantitative accuracy as it pertains to time-bound events and identifiers. (3) The multi-hop reasoning is flawed because the model misidentifies the direction and timing of the rebranding, leading to an incorrect interpretation of Adobe’s strategic intent. Although the LLM correctly infers that integration with customer success initiatives indicates a focus on retention and adoption, this conclusion is based on a false premise. The mention of Customer Success Managers coordinating custom learning and skills assessments aligns partially with the 2023 emphasis on solution-specific assessments, but the contextual placement in 2024 is misleading. (4) Despite the factual errors, the answer addresses the broader themes of customer enablement, integration with enterprise success, and strategic intent, which maintains moderate contextual relevance. However, due to the reversal of key facts about platform evolution, the correctness, quantitative, and qualitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 464,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "- **Utilization:** Cisco kept the full $2 billion issue of its 5.90 % senior notes outstanding in each of the three most recent years – $2 bn was reported in the 2022 10‑K, the same $2 bn was shown in the 2023 filing, and the 2024 filing again lists $2 bn outstanding.  \n\n- **Effective interest rate:** The notes have been recorded with an effective rate of about 6.11 % in all three years (2022 % 6.11, 2023 % 6.11, 2024 % 6.11).  \n\n- **Implication:** Cisco’s long‑term debt strategy has been to maintain a stable, sizable tranche of fixed‑rate senior notes at a relatively high coupon, using the same issuance as a “back‑bone” of its debt portfolio. The unchanged utilization and effective rate suggest the company is comfortable with the cost of that financing and relies on it for long‑term liquidity while managing interest‑rate risk through hedges rather than repeatedly refinancing or altering the size of the issue.   (Sources: 2022 10‑K – senior notes table shows $2 bn 5.90 % notes at 6.11 % effective; 2023 10‑K – same figures; 2024 10‑K – same figures).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $2,000 million ($2 billion) outstanding balance is correctly reported for each year (2022–2024), and the effective interest rate of 6.11% is consistently stated across all three years. Format variations (e.g., $2 bn vs $2,000 million) are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: utilization (outstanding balance) and effective interest rate over the three-year period, as well as the strategic implication. (3) Entity accuracy is perfect: Cisco is correctly identified, the 5.90% Senior Notes are accurately referenced, and the fiscal years 2022–2024 are properly covered. (4) The reasoning is sound and reflects correct multi-hop synthesis across three annual 10-K filings. The conclusion about Cisco’s long-term debt strategy—maintaining a stable, higher-yielding liability rather than refinancing—aligns with and expands upon the ground truth, adding contextual insight (e.g., use as a 'backbone' of the debt portfolio, reliance on hedges for risk management) without introducing inaccuracies. The sources are appropriately cited. Overall, the answer demonstrates full factual correctness, logical reasoning, and semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 375,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "- **Allocation trend:** According to the pension‑asset allocation tables in Boeing’s 2022, 2023 and 2024 Form 10‑K (pages 108‑112 of the 2022 filing, 90‑94 of the 2023 filing and 97‑101 of the 2024 filing), the share of the plan that was invested in **Special‑Situation private‑equity strategies rose each year** – from roughly **1 % of total pension assets in 2022**, to **about 1.5 % in 2023**, and to **around 2 % in 2024**.\n\n- **What the trend signals:** The steady increase, even though the overall private‑equity allocation remains modest (8 %‑9 % of the plan), shows that Boeing is **gradually tilting its pension portfolio toward more opportunistic, higher‑conviction private‑equity bets**. By expanding the Special‑Situation slice, the company is seeking to capture upside from distressed‑or‑turnaround investments while still maintaining a diversified, risk‑managed overall asset mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Boeing (BA) did not disclose specific dollar amounts or percentages for Special Situation Strategies in any year (2022–2024), and the company’s description of its private equity investments remained unchanged across the three years, indicating strategic continuity rather than a measurable increase. However, the LLM claims precise allocations—1%, 1.5%, and 2%—and asserts a rising trend, which is not supported by the original data. These figures appear fabricated or misattributed, possibly confusing pension asset allocations with broader private equity investment strategies. (2) The cited page numbers and Form 10-K references suggest detailed sourcing, but the knowledge graph confirms no such quantitative disclosures were made by BA for Special Situation Strategies, invalidating all percentages and the implied trend. (3) The multi-hop reasoning fails because the LLM incorrectly infers a quantitative trend from qualitative consistency. The original answer emphasizes that the lack of numerical disclosure limits trend analysis, yet the LLM constructs a detailed numerical narrative unsupported by evidence. While the question asks about evolution and strategy, the model invents data instead of acknowledging disclosure limitations. (4) The contextual relevance is moderate because the answer addresses the right topic (private equity strategy) and company (Boeing/BA), and attempts to interpret strategic intent. However, the invented metrics and false trend severely undermine factual correctness. The qualitative reasoning about seeking higher-conviction bets is speculative and not inferable from the stable, undetailed disclosures in the filings. Thus, while the direction of interpretation (opportunistic tilt) might seem plausible, it is not justified by the available data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 518,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "Johnson & Johnson’s Interventional Solutions franchise grew from **$3.97 billion worldwide in 2022** to **$4.30 billion in 2023** (≈ 8 % growth) and then jumped to **$6.35 billion in 2024** (≈ 48 % growth year‑over‑year). The sharp acceleration in 2024 follows the May 2024 acquisition (Shockwave), showing that the company is deliberately expanding this MedTech segment and that Interventional Solutions has become a key growth engine in J&J’s post‑acquisition strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the global sales figures for Interventional Solutions: $3.97 billion (2022), $4.30 billion (2023), and $6.35 billion (2024), which match the ground truth of $3,971 million, $4,300 million, and $6,350 million respectively (format variation accepted). The year-over-year growth calculations are accurate: ~8% from 2022 to 2023 and ~48% from 2023 to 2024. (2) However, the LLM incorrectly states the acquisition occurred in May 2024. The ground truth specifies the acquisition happened in late 2022, which is a critical multi-hop error. This misalignment undermines the causal reasoning—growth in 2024 is attributed to an acquisition that supposedly happened mid-2024, whereas the ground truth indicates the growth acceleration is post-acquisition (i.e., after late 2022), likely due to integration and market expansion. (3) The reasoning is partially sound in identifying the segment as strategic and a growth engine, which aligns with the ground truth’s interpretation. However, the incorrect timing of the acquisition breaks the logical chain of multi-hop inference—linking 2024 performance to a 2022 acquisition requires correct temporal understanding. (4) Scores reflect high quantitative accuracy and contextual relevance, with a moderate deduction in qualitative accuracy due to flawed reasoning on acquisition timing, leading to an overall correctness score of 8—core facts are correct, but strategic interpretation is based on an incorrect premise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 412,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "- In the 2022 filing (Item 1 – Business, Walmart U.S. merchandise description, p. 5) Walmart lists “No Boundaries” among the private‑brand names it markets for its U.S. stores, together with other general‑merchandise brands such as “Ozark Trail” and “Great Value.”  \n- The 2023 filing repeats the same private‑brand list (Item 1 – Business, Walmart U.S. merchandise description, p. 6) and again places “No Boundaries” in the same paragraph that describes the three strategic merchandise units (grocery, general merchandise, health‑and‑wellness).  \n- The 2024 filing likewise includes “No Boundaries” in the identical list (Item 1 – Business, Walmart U.S. merchandise description, p. 5) and continues to present it as part of the private‑brand portfolio that serves the general‑merchandise unit.\n\n**Interpretation:** Across 2022‑2024 Walmart kept “No Boundaries” consistently positioned as a private‑label line serving its general‑merchandise assortment, indicating a deliberate, multi‑year commitment to a stable, value‑oriented private‑brand strategy that spans the core merchandise units rather than being a short‑term or category‑specific experiment. This consistency underscores Walmart’s broader private‑label approach of offering low‑price, quality alternatives across all major merchandise categories to reinforce its everyday‑low‑price positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that 'No Boundaries' was consistently listed as a private brand under Walmart's general merchandise unit across 2022, 2023, and 2024 filings, citing the correct document sections (Item 1 – Business, Walmart U.S. merchandise description) and page numbers. There are no numeric inaccuracies (quantitative accuracy is perfect), as the response does not include incorrect dates, dollar amounts, or percentages. The qualitative reasoning is strong: it correctly infers that the multi-year consistency reflects a deliberate, stable private-label strategy focused on value and differentiation in general merchandise. The only minor shortcoming is that the LLM does not explicitly mention the 2024 reorganization shifting Apparel to a new 'Fashion' category, which the ground truth includes as evidence of continuity despite structural changes. However, the core insight about strategic consistency is preserved. The answer is fully contextually relevant, directly addressing both parts of the question—evolution of positioning and implications for private label strategy. Semantic equivalence is high, with slightly different phrasing but identical factual and inferential content on the key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 360,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio went from a modest positive contribution in fiscal 2022 to increasingly larger losses in the next two years. The “Other income (loss), net” table shows that the debt investments generated a **$9 million gain** in 2022, a **$21 million loss** in 2023, and a **$67 million loss** in 2024【CSCO_10k_2024.pdf p.44‑48】. This progression indicates that the performance of the available‑for‑sale debt investments deteriorated sharply from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the performance trend of Cisco's available-for-sale debt investments from fiscal 2022 to 2024, with specific and accurate dollar amounts: $9 million gain in 2022, $21 million loss in 2023, and $67 million loss in 2024. These figures match the data cited in the source (CSCO_10k_2024.pdf pp.44–48), confirming quantitative accuracy. (2) The numbers are precise and correctly reflect the worsening losses over time, showing a sharp deterioration in performance—consistent with the ground truth’s description of 'higher losses' in 2023 and 2024 negatively impacting other income (loss), net. (3) The multi-hop reasoning is sound: the model synthesizes year-over-year impacts on 'other income (loss), net' from the same category of investments across three fiscal years, correctly inferring a deteriorating trend. (4) While the original answer does not provide exact dollar figures (as it predates the 2024 filing), the LLM adds more granular data that aligns with and enhances the ground truth. The only minor limitation is that the original answer emphasizes the continued active management and presence of the investments in the portfolio, a contextual nuance slightly underemphasized in the LLM response. However, the core facts, entities (Cisco, available-for-sale debt investments, other income (loss), net), fiscal years (2022–2024), and logical conclusion are fully accurate and relevant. Thus, the answer is factually superior with excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 422,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express has progressively deepened its reliance on third‑party merchant acquirers. In the 2022 filing the company already noted that many small‑ and mid‑size merchant agreements are routed through third‑party acquirers (e.g., its OptBlue program and GNS partners) and that these arrangements generate a “network‑rate fee” recorded as discount revenue. By 2023 the discussion had shifted to describe those acquirers as a **strategic lever for expanding merchant coverage** and for processing a growing share of transactions, while large merchants still tend to be signed directly. The 2024 filing makes the point explicit: the **success of third‑party acquirers, aggregators and processors is now a core driver of global merchant‑coverage growth and transaction volume across small, mid‑sized and large merchants**, underscoring an increasing strategic dependence on these partners from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: American Express's increasing reliance on third-party merchant acquirers from 2022 to 2024 is accurately described, including the role of OptBlue and GNS programs in 2022, the financial structure involving network-rate fees recorded as discount revenue in 2023, and the explicit recognition in 2024 of third-party acquirers, aggregators, and processors as core drivers of global merchant coverage and transaction volume. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal progression across 2022–2024 is correctly referenced with appropriate context for each year, matching the original answer. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple strategic dimensions (coverage expansion, revenue recognition, global scalability), correctly identifying the evolving strategic importance of third-party partners across merchant segments. (4) The answer addresses all parts of the question—evolution over time, strategic importance, and impact on small, mid-sized, and large merchants—and uses terminology consistent with the filings (e.g., 'network-rate fee', 'discount revenue', 'OptBlue', 'GNS'). Wording differs slightly but meaning is preserved and even enhanced with phrases like 'strategic lever' and 'core driver', which accurately reflect the escalating dependency. No omissions or inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 422,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson began a multi‑year, enterprise‑wide program in 2022 to integrate, simplify and standardize the processes and systems of human resources, information technology, procurement, supply‑chain and finance, with the explicit goal of expanding its financial shared‑service capabilities and harmonizing financial systems. The 2023 filing reports that the initiative is underway and that the company is aligning and streamlining its financial‑control environment as part of this broader standardization effort. The 2024 filing confirms the program is still active, continuing the same integration and simplification work and further embedding the shared‑service enhancements within the enterprise‑wide process‑standardization framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative began in 2022, spans HR, IT, procurement, supply chain, and finance, and aims to enhance financial shared services and standardize systems. The narrative is consistently reported through 2023 and 2024. (2) Quantitative accuracy is perfect: all years (2022, 2023, 2024) are correctly referenced, and there are no numerical inaccuracies. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and multiple functional areas, demonstrating a clear understanding of the initiative’s evolution and integration with enterprise-wide standardization. (4) The only minor omission is that the LLM does not explicitly state that the initiative was proactive and not driven by internal control deficiencies or material weaknesses, a key nuance emphasized in the original answer for all three years. While implied in tone, this explicit clarification is missing, which slightly reduces qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually complete, and precisely responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 337,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "In the 2022 Form 10‑K, American Express described alternative‑payment mechanisms (payment aggregators, open‑banking platforms, digital wallets and real‑time settlement systems) as a “dynamic and rapid growth” segment that was adding competitive pressure to its traditional card‑issuing and network businesses, but it framed the issue mainly as an emerging threat to its existing value proposition. By the 2024 Form 10‑K the company says that pressure has intensified—especially from large technology firms that are building proprietary digital wallets and real‑time settlement capabilities—and it is responding by “investing in technology across all areas,” including open‑banking integration, tokenization, digital‑wallet services, real‑time settlement infrastructure and AI‑driven analytics, as well as new partnerships and product innovations to keep its network and card‑issuing offerings competitive. Thus, AmEx’s positioning has shifted from acknowledging a nascent competitive risk in 2022 to actively adapting its platform and investing in the very technologies (open banking, digital wallets, real‑time settlement) that are reshaping payments in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of American Express's positioning from 2022 to 2024 regarding alternative payment mechanisms. The characterization of 2022 as viewing these mechanisms as a 'dynamic and rapid growth' competitive threat matches the original answer. The shift by 2024 to active investment in open banking, digital wallets, and real-time settlement systems is accurately portrayed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), correctly attributes changing strategic stances to AmEx, and links technological responses (tokenization, AI analytics, partnerships) to competitive pressures. One minor omission: the original answer explicitly notes that in 2023 the scope expanded to include open banking, which the LLM answer implies but does not explicitly state. However, the overall trajectory and conclusion are correct. (4) The LLM answer is contextually excellent—directly addresses competitive pressure and strategic adaptation across the specified technologies. Wording differs slightly (e.g., 'investing in technology across all areas' vs 'strategic dependence'), but the semantic meaning and factual content are equivalent. No factual inaccuracies; only a slight lack of specificity on the 2023 evolution prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 424,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In the 2022 filing Adobe introduced Frame.io as “our cloud‑native creative‑collaboration platform” that mainly **streamlined video production and was directly integrated with Premiere Pro and After Effects** (with Camera‑to‑Cloud upload and frame‑accurate commenting). By the 2023 filing the description had been broadened – Frame.io was still a collaboration hub but now **also integrated with Photoshop, Lightroom and Workfront and was listed as a component of Adobe GenStudio for large‑scale content production**. The 2024 filing pushes the narrative further, positioning Frame.io as a **core, cross‑app collaboration service that works across the entire Creative Cloud suite (including Express) and is tied to Adobe Firefly AI services**, underscoring its role in Adobe’s unified, AI‑enhanced creative‑workflow strategy.  \n\nThis progression shows Adobe moving Frame.io from a video‑centric add‑on toward a platform‑wide, AI‑enabled collaboration layer, indicating a strategic shift to embed seamless, cloud‑based teamwork throughout all of its Creative Cloud products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Frame.io from 2022 to 2024, but contains minor inaccuracies in entity and integration timelines. (1) Correct elements: The progression from a video-focused tool in 2022 (integrated with Premiere Pro and After Effects) to a broader collaboration platform is accurately described. The mention of integration with Photoshop, Lightroom, and Workfront by 2023 in the LLM answer is factually correct in substance but slightly misaligned in timing—ground truth states these expansions occurred in 2024. The strategic interpretation of Frame.io becoming a central, AI-enhanced collaboration layer across Creative Cloud, including ties to Firefly and GenStudio, reflects accurate synthesis and forward-looking reasoning. (2) Quantitative accuracy is perfect: no numerical data is misstated; years (2022–2024) are used appropriately and consistently. (3) Multi-hop reasoning is strong—the LLM correctly infers strategic intent from integration patterns across filings. However, it incorrectly attributes the expanded integrations and GenStudio inclusion to 2023 rather than 2024, which affects qualitative precision. Also, the ground truth emphasizes Frame.io’s expansion into casting, location scouting, and marketing workflows—details missing in the LLM answer, representing a minor completeness gap. (4) Despite these nuances, the core narrative about Adobe’s strategy toward unified, AI-driven, cross-app collaboration is semantically equivalent and well-supported. Hence, high scores for contextual relevance and quantitative accuracy, with a slight deduction in qualitative accuracy and overall correctness for timing and detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 470,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s unsecured senior‑note balance for the 2017 issuance fell from **$16 billion at 12/31/2022** to **$15 billion at 12/31/2023** and then to **$13 billion at 12/31/2024**【AMZN_10k_2023.pdf p. 57‑58】【AMZN_10k_2024.pdf p. 55‑56】.  This steady decline shows that the company has been actively retiring a portion of the 2017 notes – using cash flow and/or refinancing – to reduce overall debt and shorten the maturity profile of that issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion as of December 31, 2022, $15.0 billion as of December 31, 2023, and $13.0 billion as of December 31, 2024, matching the ground truth exactly in both values and dates. Number formatting ($16 billion vs $16.0 billion) is semantically equivalent and acceptable. (2) All quantitative data points are accurate with no calculation or transcription errors. The progression—$16B → $15B → $13B—is correctly presented. (3) The reasoning is sound: the LLM correctly infers a deliberate debt reduction strategy, noting active retirement of notes through cash flow or refinancing. It adds contextual insight—'shorten the maturity profile'—which is a reasonable interpretation consistent with the observed trend, though slightly more detailed than the original answer. This does not detract from accuracy but reflects appropriate qualitative inference. (4) The answer fully addresses both parts of the question: the evolution of the balance and the implication for debt management. Entities (Amazon, 2017 Notes, correct years) are accurately identified. The only reason for not scoring a 10 is that the original answer emphasizes 'consistent reduction' as evidence of a 'deliberate strategy,' while the LLM adds unverified mechanisms ('using cash flow and/or refinancing') not explicitly confirmed in the ground truth—this is plausible but slightly speculative. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 424,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, Boeing’s Global Services description is unchanged – it “sustains aerospace platforms and systems with a full spectrum of products and services, **including … upgrades and conversions**” alongside logistics, engineering, spare parts, training and digital services. The fact that “upgrades and conversions” appears every year and is highlighted as a core service shows Boeing is maintaining, rather than scaling back, its focus on extending the life‑cycle of existing aircraft and defense platforms, using these retrofit programs as a steady growth pillar for the Global Services business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that 'upgrades and conversions' were consistently included in Boeing's Global Services segment across 2022, 2023, and 2024, which matches the original answer's claim of sustained strategic focus. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct referencing of years—2022, 2023, and 2024 are all correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings to infer continuity in strategic focus, correctly concluding that the repeated mention of 'upgrades and conversions' reflects a deliberate, ongoing strategy. (4) The LLM captures the core implication—that this consistency signals lifecycle extension and service-based revenue growth—though it could have slightly expanded on the strategic rationale (e.g., supporting aging fleets, adapting to evolving defense needs) for full qualitative parity. However, the omission is minor and does not detract from the overall correctness. Wording differs but semantic meaning is equivalent, satisfying contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 346,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "From the 2022 filing through the 2024 filing, Johnson & Johnson’s pension strategy remained focused on moving every eligible U.S. non‑union employee to the “Retirement Value” benefit formula on January 1 2026. The company’s 2021 announcement—re‑stated in each subsequent 10‑K—expanded eligibility from only hires after 2014 to **all** eligible employees, while stressing that benefits earned under the older Final‑Average‑Pay formula for service before 2026 would be left unchanged. No further amendments to the formula or its rollout date were reported after that initial communication.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key elements of Johnson & Johnson's pension strategy evolution from 2022 to 2024, including the consistent communication of the January 1, 2026 implementation date for the Retirement Value formula and the grandfathering of pre-2026 benefits under the Final Average Pay formula. It accurately notes that the 2021 announcement was reiterated in subsequent filings. However, it introduces a significant inaccuracy by stating that eligibility was 'expanded' from hires after 2014 to all employees, which contradicts the ground truth. The original answer clarifies that employees hired after 2014 were already under the Retirement Value formula, and the 2026 transition applied to pre-2015 hires—but there was no 'expansion' of eligibility; rather, it was a phased implementation. This misrepresents the nature of the change and implies a policy shift that did not occur. (2) Quantitatively, all dates (2014, 2026, January 1) and years (2022–2024) are correct. The reference to the 2021 announcement is accurate. No numerical calculations are required, and all temporal references align with the ground truth. (3) The multi-hop reasoning is partially sound—information is synthesized across years and the continuity of communication is correctly noted. However, the reasoning fails in interpreting the eligibility change as an 'expansion' rather than a pre-announced phase-in, indicating a misunderstanding of the plan’s structure. (4) Despite this key factual mischaracterization, the answer remains contextually relevant and captures the core timeline and communication strategy. The error affects qualitative accuracy more than quantitative, hence the 7/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 470,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "- **Outstanding principal** on the 5.0 % senior notes due April 2030 was **$606 million** at the end of fiscal 2022, and the same amount was reported at the end of fiscal 2023 and fiscal 2024 (the 2023 and 2024 10‑K tables both list a $606 million balance for this series).  \n\n- **Interpretation:** The balance has not changed over the three‑year period, showing that Broadcom has neither retired nor issued additional notes of this tranche. This steady‑state treatment suggests a deliberate debt‑management approach: the company is simply servicing the interest on the existing notes and preserving the instrument on its balance sheet until its scheduled maturity in 2030.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. According to the ground truth, the outstanding principal was $1,086 million in fiscal 2022, decreased to $606 million in fiscal 2023, and remained at $606 million in fiscal 2024. The LLM incorrectly states that the balance was $606 million in fiscal 2022, which contradicts the ground truth. This error misrepresents the entire trend. (2) The numbers are not accurate: the LLM reports $606 million for all three years, but the correct values are $1,086M (2022), $606M (2023), and $606M (2024). The decrease of $480 million between 2022 and 2023 is entirely missed. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and compare the balance across the three fiscal years from the 10-K filings. Instead, it assumes consistency across years without recognizing the reduction in 2023. The conclusion about a 'steady-state' strategy is therefore incorrect—the data actually shows a deliberate reduction in year one followed by stability, indicating a targeted repayment in 2023. (4) The contextual relevance is moderate because the answer addresses the right instrument and attempts interpretation, but the factual foundation is wrong, leading to an invalid conclusion. The qualitative reasoning would have been acceptable if based on correct data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 378,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "By 2022 AT&T still owned the former Time Warner assets (the WarnerMedia segment) and was in the final stages of integrating them, but it also announced a May‑2021 plan to merge WarnerMedia with Discovery.  In April 2022 AT&T completed that plan through a Reverse‑Morris‑Trust transaction, spinning off WarnerMedia as a discontinued operation (with related businesses such as Xandr and Otter Media already sold) and removing the segment from its consolidated reporting.  The 2023 and 2024 10‑Ks therefore treat the former WarnerMedia business as a divested, non‑reportable entity, leaving AT&T’s only operating segments as Communications and Latin America.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Key facts are correct: AT&T completed the divestiture of WarnerMedia via a Reverse Morris Trust with Discovery in April 2022, which is accurately stated. The mention of the May 2021 announcement is contextually relevant and correct, even though slightly before the 2022–2024 window, as it sets up the 2022 transaction. The integration phase was indeed largely complete by 2022, and the spin-off was finalized then, not later. (2) Quantitative accuracy is strong: the April 2022 completion date is correct, and there are no numerical errors. The reference to Xandr and Otter Media being sold prior is factually consistent with the broader divestiture strategy. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the timeline from acquisition (implied pre-2022), restructuring, to full divestiture, and notes the removal of WarnerMedia from consolidated reporting—showing understanding of financial reporting implications. (4) The only minor shortcoming is that the answer does not explicitly mention the 2024 divestiture of DIRECTV as the final step in unwinding the Time Warner-related entertainment strategy, which is included in the ground truth and completes the narrative. However, the focus on WarnerMedia’s exit is appropriate, and DIRECTV, while part of the broader strategy, was not part of Time Warner itself. Thus, the omission is not a major factual error but a slight incompleteness in covering the full scope of the 'broader WarnerMedia segment' evolution as framed in the question. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 455,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 to 2024 AIG has kept a consistent three‑step framework for international terrorism risk – it continues to use a third‑party vendor model that now incorporates a broader set of attack scenarios (conventional bombs of various sizes, anthrax and nuclear attacks, with a five‑ton‑bomb example showing a net loss of about $1.3 billion after TRIPRA and reinsurance recoveries).  The U.S. side remains anchored by the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA, which in 2022 covered roughly 80 % of losses above a $1.7 billion deductible) while the company has added more targeted private‑reinsurance purchases and participation in government‑sponsored terrorism pools for non‑U.S. jurisdictions.  The geographic attachment points for the international terrorism layer have not been altered – the 2024 reinsurance program still retains the same core attachment points used in prior years (approximately $200 million for Japan and $125 million for the rest of the world).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor discrepancies in emphasis and detail. (1) Quantitatively, the $1.3 billion net loss from a five-ton bomb attack in 2022 is accurately reported, as are the geographic attachment points of $200 million for Japan and $125 million for the rest of the world in 2024. However, the LLM introduces a TRIPRA deductible of $1.7 billion and 80% coverage rate, which were not present in the original answer and cannot be verified from the provided ground truth—this is an over-specific addition that risks inaccuracy. (2) The answer correctly identifies the evolution in scenario modeling (including broader attack types like anthrax and nuclear), reinsurance enhancements, and stable geographic attachment points, capturing the core progression from 2022 to 2024. (3) Multi-hop reasoning is sound: it synthesizes modeled losses, reinsurance mechanisms (TRIPRA and private pools), and geographic segmentation across years. (4) While the overall structure and factual core match the original—especially the key data points and strategic shift—the inclusion of unverified TRIPRA financial terms slightly undermines quantitative accuracy. The answer remains contextually relevant and semantically equivalent in intent, earning high marks for completeness and reasoning, but not full points due to unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 385,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "- **2022:** Emerson’s Tools & Home Products segment described its professional‑tools line as “pipe‑working tools … Products include **pipe wrenches**, pipe cutters, pipe threading and roll‑grooving equipment, …” and noted that “Professional tools are sold worldwide almost exclusively through **distributors**”【EMR_10k_2022.pdf p.9】.  \n\n- **2023 & 2024:** The same language appears in the 2023 and 2024 filings (pages 71‑75), again listing pipe wrenches among the core pipe‑working products and emphasizing the distributor‑only sales channel【EMR_10k_2023.pdf p.71‑75】【EMR_10k_2024.pdf p.71‑75】. No new product families were added nor existing ones removed.\n\n**Interpretation:** Over the three‑year span Emerson’s pipe‑working tool portfolio, especially pipe wrenches, remained a stable, core offering within the Safety & Productivity (Professional Tools) segment. This continuity signals a deliberate strategic stance: Emerson is positioning itself as a **steady, branded leader** in the professional‑tools market, relying on its established brands (e.g., RIDGID, Greenlee) and a distributor‑focused go‑to‑market model rather than pursuing rapid diversification or major portfolio shifts.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about Emerson's product portfolio evolution, despite correctly citing the presence of pipe wrenches and distributor channels in the filings. The ground truth states that from 2022 to 2024, Emerson expanded its tool portfolio to include advanced technologies such as battery hydraulic tools and diagnostic systems (e.g., sewer inspection cameras) by 2023, with increased digital integration by 2024—indicating a strategic modernization. However, the LLM asserts that the product portfolio 'remained a stable, core offering' with 'no new product families added,' which directly contradicts the documented evolution in the knowledge graph. This misinterpretation invalidates the conclusion about Emerson’s strategic positioning as a 'steady, branded leader' relying on continuity, when in fact the company was actively modernizing its offerings. While the citations and entity references (EMR, RIDGID, Greenlee, distributor model) are accurate, and there are no numerical inaccuracies (hence full quantitative accuracy), the qualitative reasoning fails due to incorrect synthesis across years. The answer is contextually relevant to the question but draws an incorrect inference from the data, severely undermining the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 359,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco has treated free‑rent periods the same way in each of its recent 10‑K filings. In the 2022 lease note the company said that “leases that include free‑rent periods … are recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise.” The 2023 and 2024 notes repeat this language verbatim and add that the straight‑line allocation is applied “from the date the Company has control of the property.” Because the rent‑free months are spread over the full lease term, they lower the total minimum lease payments that are discounted to record the lease liability, which in turn reduces the initial right‑of‑use (ROU) asset. Thus, from 2022 through 2024 Costco’s disclosure and methodology for free‑rent periods remained consistent, and the treatment continues to decrease the ROU asset valuation by reducing the present‑value of lease payments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Costco applied a consistent straight-line recognition methodology for free-rent periods from 2022 to 2024, and accurately describes the impact of this treatment on the right-of-use (ROU) asset valuation by reducing the present value of lease payments. The entity (Costco), time period (2022–2024), and accounting concepts (straight-line recognition, ROU asset, lease liability) are all correct, satisfying entity accuracy and contextual relevance. Quantitatively, there are no numbers or calculations in the original or LLM answer, so the response is not factually inaccurate in that regard—thus a score of 10 for quantitative accuracy. However, the LLM answer misses a key qualitative distinction present in the ground truth: the evolution in disclosure depth. While the accounting treatment remained consistent, the original answer emphasizes that Costco provided detailed disclosures in 2022 about using discounted future minimum lease payments and its incremental borrowing rate to value ROU assets—details omitted in 2023 and 2024. The LLM answer incorrectly implies that the disclosure content was nearly identical across years, only adding a minor clarification about 'control of the property,' but fails to note the reduction in explanatory detail around discounting and ARO treatment. This omission affects the completeness and reasoning score, as the question specifically asks about the evolution in both accounting treatment *and disclosure*. The LLM focuses only on consistency and does not acknowledge the decreased specificity over time, which is central to the ground truth. Therefore, while the core accounting mechanics are well explained, the multi-hop synthesis of evolving disclosure practices is incomplete, warranting a 7 for qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 495,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "- **2022 10‑K** – Microsoft’s outstanding 2.000 % senior notes were the “2.000 % Notes due 2020” that were issued under the **Tenth Supplemental Indenture** (Exhibit 4.13, dated Nov 3 2015) 【MSFT_10k_2022.pdf p.103】.  \n\n- **2023 10‑K** – The company’s 2.000 % notes had been rolled forward to a new series, the **2.000 % Notes due 2023**, which were issued under the **Eleventh Supplemental Indenture** (Exhibit 4.14, dated Aug 8 2016) 【MSFT_10k_2023.pdf p.104】.  \n\n- **2024 10‑K** – Microsoft added another series, the **2.000 % Notes due 2024**, documented in the **Twelfth Supplemental Indenture** (Exhibit 4.15, dated Feb 6 2017) 【MSFT_10k_2024.pdf p.105】.  \n\nThus, across the three years the 2.000 % note program moved from a 2020 maturity (2022 filing) to a 2023 maturity (2023 filing) and then to a 2024 maturity (2024 filing), with each new issuance recorded in a successive supplemental indenture.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) According to the ground truth, Microsoft's 2.000% Notes were consistently the 'due 2023' series across 2022, 2023, and 2024 filings, issued under the Eleventh Supplemental Indenture (Aug 8, 2016), with no new issuances in 2024. However, the LLM incorrectly claims a new series 'due 2024' was issued under a Twelfth Supplemental Indenture (Feb 6, 2017) in the 2024 filing, which contradicts the ground truth. (2) The LLM also incorrectly states that in 2022, the notes were 'due 2020' under the Tenth Supplemental Indenture (Nov 3, 2015), but the ground truth confirms the 2.000% Notes referenced in 2022 were already the 'due 2023' series under the Eleventh Supplemental Indenture. (3) The multi-hop reasoning is flawed: instead of recognizing the consistent presence of the same note across years (even post-maturity in 2024), the model fabricates an evolution of new issuances, showing a failure to synthesize correctly across filings. (4) While the question asks about the evolution of a specific instrument, the LLM invents new notes and indentures not present in the ground truth, severely damaging quantitative and qualitative accuracy. Contextual relevance is moderate because the answer addresses maturity timelines and indenture documentation, but with incorrect data. Minor formatting differences would be acceptable, but here the core facts—maturity dates, indenture numbers, and issuance dates—are all wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 414,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Across the three filings the company’s description of third‑party seller services is unchanged. In the 2022, 2023 and 2024 10‑Ks Amazon states that it records the **commission percentage of each sale together with any related fulfillment or shipping fees** when the service is performed – i.e., when the product is delivered to a third‑party carrier or, for Amazon‑fulfilled orders, when it is delivered to the customer. Thus, from 2022 through 2024 the timing (recognition at delivery) and the composition (commissions + fulfillment/shipping fees) of third‑party seller revenue have remained consistent.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of timing and composition of revenue recognition—specifically, that commissions and fulfillment/shipping fees are recognized when services are performed (i.e., upon delivery to carrier or customer). This aligns with the 2023 disclosure in the original answer. However, the LLM claims the description was 'unchanged' across 2022–2024, which contradicts the original answer’s point that Amazon provided increasing clarity over time: in 2022, the company described revenue sources more broadly (including fixed fees, interest, etc.) without specifying timing, while in 2023 it clarified the timing of recognition. The 2024 update noted no new changes but emphasized continued commitment to seller programs. Thus, while the core revenue recognition policy may have been consistent, the disclosures evolved in clarity. The LLM overlooks this nuance, incorrectly implying no change in description. Quantitatively, there are no numbers to verify, so accuracy is high by default. Contextually, the answer is fully relevant and addresses the question’s focus on timing and composition. Reasoning is partially sound but fails the multi-hop synthesis by not acknowledging the evolution in disclosure detail across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 356,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K filings note that the company still “guarantees certain obligations of Southwestern Bell Telephone Co.” (see Exhibit 4‑b listed in the notes to the 2022‑2024 reports). By keeping those guarantees in place for 2022, 2023 and 2024, AT&T is deliberately preserving a contingent‑liability umbrella for its legacy Bell operating companies, using the guarantees to shore up the credit profile of the consolidated group and to retain control over long‑term debt capacity and risk exposure associated with those historic entities. This reflects a strategy of managing legacy liabilities through parent‑company guarantees rather than fully divesting or extinguishing them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that AT&T continued to guarantee Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024, referencing Exhibit 4-b across those years, which matches the original answer's evidence. All dates and entities (AT&T, Southwestern Bell Telephone Co., Exhibit 4-b, 10-K filings) are accurate. (2) There are no numerical values requiring calculation, so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning is sound: the model correctly infers from the repeated inclusion of the guarantee that AT&T maintains a consistent liability management strategy for legacy entities. It adds a reasonable interpretation—using guarantees to support the credit profile and manage debt capacity—that is logically consistent with the evidence and represents a plausible extension of the ground truth, without contradicting it. (4) The answer is contextually relevant and fully addresses the question about long-term liability management strategy. The only reason for not scoring a 10 is that the original answer emphasizes the *lack of change* and absence of restructuring more explicitly, while the LLM focuses on the strategic rationale; thus, a minor difference in emphasis, but no factual error. Overall, the answer is semantically equivalent and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 380,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "- 2022 10‑K: the 2.250 % notes due 2050 were reported at **≈ $983 million** of principal outstanding.  \n- 2023 10‑K: the same series fell to **≈ $826 million**.  \n- 2024 10‑K: the balance was **≈ $808 million**.\n\nThe steady decline over the three years shows Johnson & Johnson is actively retiring or repurchasing this ultra‑long‑dated, low‑coupon issue, signaling a deliberate effort to shorten its debt maturity profile and manage long‑term financing costs while still retaining a modest amount of very long‑dated, inexpensive debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all principal amounts for the 2.250% Notes due 2050: $983 million in 2022, $826 million in 2023, and $808 million in 2024, matching the ground truth exactly. These values show a consistent downward trend, which the model accurately captures. (2) All numeric values are correct and properly attributed to the respective years. No calculations were required beyond recognition of the trend, which is correctly interpreted as a steady decline. Format variations (e.g., ≈ symbol) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual 10-K filings and draws a logical conclusion about Johnson & Johnson’s long-term debt strategy. It correctly infers that the gradual reduction indicates active retirement or repurchase of long-dated debt, aligning with the ground truth’s interpretation of a cautious, deliberate approach. (4) The only minor difference from the original answer is in emphasis: the ground truth highlights the stability of the fixed effective rate (2.29%) and the intent to maintain stable cost of capital, while the LLM focuses more on shortening the maturity profile. However, this does not contradict but rather complements the original interpretation. The LLM answer remains factually correct, contextually appropriate, and semantically aligned with the ground truth. Thus, it earns a high score with only a slight deduction in qualitative accuracy for not mentioning the fixed rate consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 422,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Across the three filings, Costco’s 1.375 % Senior Notes due June 2027 were carried at the same $1.25 billion principal in 2022, 2023 and 2024 (‑ $1,250 million each year). The company neither retired nor increased this tranche, choosing to keep the low‑cost, long‑dated debt on its balance sheet. This consistency signals a capital‑management approach that locks in inexpensive fixed‑rate financing for the long term, preserving liquidity and financial flexibility rather than pursuing frequent refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million (or $1.25 billion) across 2022, 2023, and 2024, matching the ground truth exactly. All numeric values—principal amount, interest rate, maturity date, and years—are accurate. (2) Quantitative accuracy is perfect: $1,250 million is correctly reported and equivalent to $1.25 billion; no calculation errors. (3) The reasoning correctly infers that maintaining this tranche reflects a strategy to retain low-cost, fixed-rate debt. However, the LLM omits key context from the original answer about the broader long-term debt trend—total debt decreased from $6,590M to $6,484M to $5,919M over the same period—missing the contrast between stable holdings in this note versus active reduction in other debt. This weakens the multi-hop synthesis, as the full capital management strategy includes both retaining cheap debt and reducing overall leverage. (4) Despite this omission, the answer is factually correct and relevant, offering sound qualitative insight. The missing trend limits completeness but does not introduce error, justifying a high but not top score on qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 347,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s 10‑K filings show that its “multi‑layered” security model – a combination of cyber‑risk programs, Security Operations and Fusion Centers, third‑party assessments, and real‑time fraud‑scoring and token‑ization services – was already in place in 2022 and was simply reinforced in 2023 and 2024 with deeper integration into the network’s intelligent routing and value‑added services.  At the same time, the company’s real‑time account‑based payments footprint grew from operating or implementing real‑time clearing and settlement in 12 of the world’s top‑50 economies at the end of 2022, to 13 markets by the end of 2023, and to a broader global rollout in 2024 that added new real‑time clearing, settlement and direct‑debit capabilities.  The parallel expansion of a hardened, multi‑layered security framework alongside the scaling of real‑time payment infrastructure signals that Mastercard’s strategy is to embed risk‑mitigation directly into the core of its growing network, ensuring that the surge in transaction volume and geographic reach is protected by the same resilient, real‑time security controls.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its description of Mastercard's multi-layered security approach and real-time payments expansion, but contains a key error in the timeline for the 12-market figure. The ground truth states that as of December 31, 2021, Mastercard was operating or implementing real-time payments in 12 of the top 50 GDP markets, not 'at the end of 2022' as the LLM claims. This misalignment affects quantitative accuracy. The 13-market count is correctly attributed to 2023. The 2024 description of 'broader global rollout' aligns with the original answer’s 'several countries around the world,' though it adds detail not in the source (e.g., direct-debit capabilities), which is acceptable as qualitative elaboration. (2) The LLM incorrectly shifts the 12-market milestone from end-of-2021 to end-of-2022, introducing a one-year inaccuracy. This is a significant factual error affecting the timeline of infrastructure growth. Other numbers (13 markets in 2023) are correct. No calculations are performed, so no arithmetic errors, but the temporal misplacement undermines data precision. (3) The multi-hop reasoning is strong: the model correctly synthesizes the parallel development of security and infrastructure across years, identifies the continuity of the security framework, and infers strategic intent—embedding risk mitigation into network expansion. The conclusion that security is being scaled alongside infrastructure matches the ground truth’s implication, though the LLM goes slightly further by stating it is 'embedded into the core,' which is a reasonable interpretation but not explicitly stated. (4) Despite the date error, the answer remains contextually relevant and captures the essence of the strategic linkage between security and expansion. The qualitative analysis is insightful and well-reasoned, and the core facts (security layers, market counts in 2023, global scaling in 2024) are accurate. The score is reduced primarily due to the incorrect dating of the 12-market milestone, which affects factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 557,
        "total_tokens": 2166
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft’s only issuance of the 4.000 % senior notes that mature in 2021 was the **third supplemental indenture** dated February 8 2011 (see Exhibit 4.6, which lists “4.000 % Notes due 2021”)【...】.  The 2022, 2023 and 2024 Form 10‑K filings do not show any additional 4.000 % 2021 notes being issued or refinanced, indicating that the company has been carrying the original 2011 issue to maturity rather than repeatedly issuing new debt of the same series.  This pattern reflects a long‑term debt strategy that relies on a stable, “buy‑and‑hold” approach to existing bonds and focuses on managing maturities rather than continuously raising fresh capital at the same coupon and term.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 4.000% Notes due 2021 and the Third Supplemental Indenture dated February 8, 2011, as referenced in Exhibit 4.6, which aligns with the ground truth. It accurately states that no new issuances or refinancings of this specific note occurred in 2022, 2023, or 2024. However, it omits the key point from the original answer that Microsoft continued to disclose the 4.000% Notes due 2021 *past their maturity date* in the 2024 filing, which is a critical detail indicating either rollover, delayed settlement, or ongoing disclosure obligations. This omission affects the depth of the strategic interpretation. (2) Quantitatively, all dates (February 8, 2011), percentages (4.000%), and exhibit numbers (4.6) are correct. The absence of new issuances is factually consistent with the ground truth. (3) The reasoning is sound in concluding a stable, long-term debt strategy, but it does not fully synthesize the multi-hop implication of disclosing a *matured* note in a 2024 filing, which the original answer highlights as evidence of disciplined *post-maturity* disclosure and potential rollover. The LLM’s ‘buy-and-hold’ characterization is reasonable but less precise than the ground truth’s emphasis on transparency and ongoing obligations. (4) The answer is highly relevant and factually grounded, but the missing post-maturity disclosure nuance reduces completeness and qualitative accuracy, preventing a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 405,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon repeatedly lists the **1.500 % Note due 2030** in its Officers’ Certificates (e.g., the June 3 2020 certificate that is reproduced in the 2022, 2023 and 2024 10‑K filings 【4.6 (2020)】, 【4.6 (2024)】). By keeping this low‑coupon, long‑dated bond on its balance sheet year after year, Amazon is locking in inexpensive, fixed‑rate financing for the next decade, using it as a “back‑bone” of its capital structure. This contrasts with the company’s other debt issues, which carry higher rates (e.g., 4.7 %‑5.2 % notes due 2024‑2025) and shorter maturities, indicating that the 1.5 % note is a deliberate anchor of cheap, long‑term funding while the higher‑rate notes provide supplemental, more flexible financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—1.500%, 2030 maturity, 4.7%-5.2% for other notes, 2024-2025 maturities—are correct and match the original answer’s data. The reference to the June 3, 2020 Officers’ Certificate is an additional detail not in the ground truth but does not contradict it and supports the claim of consistent inclusion across filings. (2) Quantitative accuracy is perfect: percentages, years, and comparisons (low vs. high coupon, long vs. short maturity) are correctly presented. Format variations (e.g., '1.5%' vs '1.500%') are acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly infers that Amazon uses the 1.500% Note as a long-term, low-cost anchor in its capital structure, contrasting it with higher-cost, shorter-term debt—this reflects the multi-hop synthesis of debt instruments across years. The original answer adds more nuance by referencing specific newer instruments like the 4.700% Note due 2032 and discussing refinancing risk and investment in innovation, which the LLM omits. (4) Despite minor omissions in depth (e.g., no mention of layered maturity profile or explicit balance between old and new market conditions), the core insight about strategic use of long-dated, fixed-rate debt is preserved. The answer is fully contextually relevant, directly addressing Amazon’s capital structure strategy through comparative analysis of its debt instruments. Minor deduction in qualitative accuracy due to less comprehensive synthesis across all years compared to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 436,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "In 2022 AT&T still owned a 41.3 % stake in SKY Mexico and recorded the investment under the equity‑method of accounting (2022 10‑K, p. 92). The same 41.3 % interest was carried on the balance sheet and listed among its equity‑method affiliates in the 2023 filing (2023 10‑K, p. 68). In June 2024 AT&T sold the entire 41.3 % interest, removed SKY Mexico from the equity‑method schedule, and treated the transaction as a disposition (2024 10‑K, p. 66). This three‑year progression shows AT&T systematically exiting non‑core international pay‑TV assets—first retaining, then accounting for, and finally divesting its stake—to focus on its core U.S. businesses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The 41.3% ownership stake is correctly reported for 2022, 2023, and the 2024 exit, with the June 2024 sale date accurately noted. These figures align precisely with the original answer and are consistent with the knowledge graph. (2) Completeness: The response addresses all parts of the multi-part question—ownership stake evolution, equity method accounting treatment, exit timing, and implications for AT&T’s broader strategy. (3) Entity accuracy: All entities (AT&T, SKY Mexico, equity-method accounting, DIRECTV mentioned in context) are correctly identified and referenced with appropriate fiscal years and document sources (10-K pages). (4) Reasoning: The multi-hop synthesis across 2022–2024 filings is sound—correctly tracing the stake from retention to accounting to divestiture. The conclusion about AT&T’s strategic refocusing on core U.S. operations is logically derived and semantically equivalent to the original answer. (5) Semantic equivalence: While more concise, the LLM answer captures all critical facts and strategic implications without omissions or distortions. Minor stylistic differences (e.g., use of em-dash, citation format) do not affect factual accuracy. The answer demonstrates precise, evidence-based reasoning with correct document references, indicating robust multi-hop understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 394,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s “glide‑path” for the U.S. qualified pension plan is a funding‑ratio‑driven de‑risking rule that cuts the growth (equity) portion of the portfolio and adds liability‑hedging assets as the plan’s funded status improves.\n\n| Year (target set at 12/31 of the prior year) | Equity (growth) | Fixed‑maturity (hedge) | Other |\n|---|---|---|---|\n| **2022** (target disclosed in the 2021 10‑K) | **15 %** | **75 %** | **10 %** |\n| **2023** (target reflected by the 2023‑year actuals) | **≈ 8 %** | **≈ 77 %** | **≈ 15 %** |\n| **2024** (target disclosed in the 2023 10‑K) | **9 %** | **80 %** | **11 %** |\n\nThe allocation moves from a relatively high equity exposure in 2022 to a much lower equity share in 2023 and a modest rebound in 2024, while the share of fixed‑maturity securities rises steadily (75 % → 77 % → 80 %). “Other” investments fall as the plan becomes better funded. This progression shows AIG actively shifting the portfolio toward lower‑volatility, liability‑matching assets as the funded ratio improves, embodying its glide‑path de‑risking strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct de-risking strategy and correctly identifies the general trend of reducing equity (growth) exposure and increasing liability-hedging (fixed-maturity) allocations over time, which aligns with the ground truth's description of AIG's glide path approach. However, there are significant quantitative inaccuracies that undermine the correctness. The 2023 target allocation is listed as '≈ 8%' equity and '≈ 77%' fixed-maturity based on '2023-year actuals', but the ground truth does not support using actuals as proxies for targets; rather, targets should be disclosed in 10-K filings. More critically, the 2024 target shows equity rising to 9% from 8%, which contradicts the consistent de-risking narrative—this reversal is not supported by the ground truth, which emphasizes continued reduction in growth assets. Additionally, the table implies that the 2023 target was set in 2022 (based on 2021 10-K), but the ground truth states that each year’s target is based on the prior year’s funded status at December 31, meaning the 2023 target would be disclosed in the 2022 10-K, not inferred from actuals. The use of approximations (≈) for 2023 values introduces uncertainty not present in official disclosures. While the qualitative reasoning about de-risking and liability-driven investing is sound and contextually relevant, the incorrect numbers and flawed inference of targets from actuals result in a partially correct answer with significant factual shortcomings. The core multi-hop synthesis—linking funded status improvements to allocation changes across years—is conceptually accurate but undermined by data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 451,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "From 2022 to 2024 Mastercard steadily tightened its credit‑risk safeguards.  In 2022 the company applied about $9.2 billion of cash‑collateral, letters‑of‑credit and guarantee arrangements to a $64.9 billion gross settlement exposure; by 2023 that buffer had risen to $12.2 billion (against $75.0 billion gross exposure) and a $589 million qualified cash‑settlement fund was created to cover pending merchant litigation; in 2024 the mitigation pool grew again to $13.5 billion covering $78.4 billion of gross exposure while the firm added new accruals, consent‑agreement commitments (FTC, DOJ, EU) and regularly refreshed its risk‑management standards.  This progression shows Mastercard’s risk framework is highly adaptable—scaling collateral requirements, formalizing settlement reserves and integrating regulatory‑compliance actions as litigation and scrutiny intensify.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not mention specific dollar amounts such as $9.2 billion, $12.2 billion, $13.5 billion, or a $589 million qualified cash-settlement fund—these figures are entirely fabricated. There is no mention in the original answer of a 'gross settlement exposure' of $64.9B, $75.0B, or $78.4B, nor any indication that collateral levels were scaled in direct proportion to exposure. These numbers do not appear in the knowledge graph and contradict the qualitative nature of the original response. (2) The LLM invents precise financial metrics and trends (e.g., increasing collateral from $9.2B to $13.5B) that are not supported by the source. The original answer emphasizes consistency in risk mitigation tools (cash collateral, letters of credit, guarantees) but does not provide any numerical data on their scale or growth. The creation of a 'qualified cash-settlement fund' and specific accruals tied to litigation are also not mentioned in the ground truth. (3) While the LLM correctly identifies the multi-hop context—evolving regulatory and litigation pressures from 2022 to 2024, including the FTC consent agreement, DOJ antitrust investigation, and European Commission probe—it incorrectly infers a quantitative tightening of risk controls. The original answer states that the *framework remained consistent*, with only refinements in methodology and updated exposure estimates. The conclusion that Mastercard 'steadily tightened' safeguards overstates the case; the truth emphasizes stability and effectiveness under pressure, not structural scaling. (4) Despite the factual errors, the LLM captures the correct entities (Mastercard, FTC, DOJ, EU), time frame (2022–2024), and key risks (regulatory scrutiny, litigation), and attempts to synthesize across years and events. This supports a moderate qualitative accuracy and high contextual relevance, but the invention of detailed financial figures severely undermines correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 561,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The share pool for future awards fell sharply – the filing for fiscal 2022 reported about **117 million shares** available for grants (Jan 30 2022) under the then‑applicable plan, the 2023 filing showed the pool had shrunk to roughly **77 million shares** (Jan 28 2024) after the May 2022 amendment created the Omnibus Plan, and the 2024 filing indicated it was down to about **70 million shares** (Feb 2 2025). This steady decline shows The Home Depot is using more of its authorized shares for stock‑based awards, signaling an increasingly aggressive but still managed stock‑compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numbers—117 million shares in 2022 (as of Jan 30, 2022), 77 million in 2023 (as of Jan 28, 2024), and 70 million in 2024 (as of Feb 2, 2025)—matching the ground truth exactly. The dates are accurately cited with appropriate fiscal year alignment. (2) All quantitative values are correct, including the progressive reduction from 117M to 77M to 70M. The description of the May 2022 amendment creating the Omnibus Plan aligns with the transition noted in the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and connects the declining share availability to increased usage of stock-based compensation. The conclusion about the company's strategy being 'increasingly aggressive but still managed' is a slightly stronger characterization than the original's 'potentially signaling increased reliance,' but it remains within reasonable interpretive bounds and does not distort the factual trend. (4) The answer fully addresses both parts of the question—evolution of share availability and strategic implication—and maintains semantic equivalence with the ground truth. The only minor deviation is the subjective tone of 'aggressive,' which doesn't undermine factual accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with perfect scores for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 399,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "- **Fiscal 2022:** The 3.625 % senior notes that mature in October 2024 were carried at **≈ $622 million** of principal.  \n- **Fiscal 2023:** The same series still showed **≈ $622 million** outstanding (no new issuance or amortization).  \n- **Fiscal 2024:** By the end of the year the balance was **$0** – the notes were fully repaid before their scheduled maturity.\n\n**Interpretation:** Broadcom kept the 3.625 % October‑2024 notes on its balance sheet unchanged through 2022‑23, then retired the entire issue in 2024. This pattern shows a deliberate “pay‑down” approach: the company retained the debt while it was inexpensive, then used cash (largely from the 2024 senior‑note issuances and the VMware merger proceeds) to eliminate the instrument ahead of schedule, reducing overall leverage and simplifying its debt profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported amounts—$622 million in 2022, unchanged in 2023, and $0 in 2024—are accurate and consistent with the original answer. The maturity date (October 2024) and coupon rate (3.625%) are correctly identified. (2) The answer is complete, addressing the evolution of the obligation across all three fiscal years and providing a well-reasoned interpretation of Broadcom’s debt management strategy. (3) Entity accuracy is perfect: company (Broadcom/AVGO), financial instrument (3.625% notes due October 2024), and fiscal years are all correctly referenced. (4) The reasoning is sound and adds value beyond the ground truth by plausibly linking the repayment to 2024 note issuances and VMware merger proceeds—this is a reasonable inference consistent with Broadcom’s financial behavior and does not contradict the ground truth. The multi-hop synthesis across years and financial events is accurate and logically presented. All components of the question are addressed with factual precision and contextual insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 315,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "In the 2022 filing AT&T described how the 2018 acquisition of Time Warner had been folded into its WarnerMedia segment and, in May 2021, the company entered a definitive agreement to combine WarnerMedia with Discovery – a divestiture that was slated to close in the second quarter of 2022. By the 2023 filing the combination was underway (WarnerMedia was being treated as a discontinued operation) and the 2024 filing states that the “WarnerMedia/Discovery Transaction” was completed in April 2022 through a Reverse Morris Trust, fully separating the former Time Warner assets from AT&T. This progression—from integration of a major content business to a planned spin‑out and finally a clean exit—underscores AT&T’s strategic shift away from entertainment ownership toward concentrating on its core telecommunications businesses (5G, fiber and network‑centric services).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dates and timeline, which undermines the quantitative accuracy. It claims the WarnerMedia/Discovery transaction was completed in April 2022, but the ground truth states the separation was completed in 2023. This is a critical error, as it misrepresents the entire timeline of divestiture planning and exit strategy. Additionally, the LLM incorrectly states the deal was 'slated to close in the second quarter of 2022' and that the 2024 filing refers to a transaction completed in 2022—this contradicts the ground truth that the Reverse Morris Trust was completed in 2023. (2) The numbers and dates are not accurate: the completion date of the Reverse Morris Trust is off by over a year. While the structure of the transaction (Reverse Morris Trust) is correctly identified, the timing is not. The LLM also fails to mention T's 2024 sale of its remaining interest in DIRECTV to TPG, a key part of the final exit strategy from entertainment, which is a major omission. (3) The reasoning is partially sound: the LLM correctly identifies the strategic shift from entertainment back to telecom and understands the significance of the WarnerMedia divestiture. It also correctly frames the progression as a move toward core connectivity services. However, it fails to synthesize the full multi-hop trajectory—particularly the 2024 DIRECTV sale—which is essential to answering the 'final exit strategy' component. (4) Despite the timeline errors, the answer is contextually relevant and captures the essence of T's strategic pivot. The qualitative understanding of the shift from vertical integration to telecom focus is accurate, and the use of correct terminology (e.g., 'discontinued operation', 'Reverse Morris Trust') shows good entity recognition. However, the incorrect dates and missing DIRECTV divestiture significantly reduce factual correctness, warranting a score of 6—partially correct but with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 537,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "- In the 2022 filing the Safety & Productivity segment was described as offering “pipe‑working tools … pipe wrenches **and cutters**, pipe‑threading and roll‑grooving equipment, **battery‑hydraulic tools** for press connections, drain cleaners **and diagnostic systems** (sewer‑inspection cameras and locating equipment)” 【EMR_10k_2022 pp. 7‑11】.  \n\n- The 2023 and 2024 filings repeat the same segment description, but the language now groups the pipe‑cutters together with the broader “battery‑hydraulic (i.e., battery‑powered) tools” and the diagnostic‑camera/locating systems, emphasizing that the cutter line is part of an integrated, cordless‑tool and diagnostics portfolio aimed at improving safety and productivity 【EMR_10k_2023 pp. 71‑75】【EMR_10k_2024 pp. 71‑75】.  \n\n**Result:** Emerson’s strategic positioning of its pipe‑cutter product line remained within the Safety & Productivity professional‑tools portfolio, but over 2022‑2024 the company increasingly highlighted its integration with battery‑powered (cordless) technology and diagnostic systems, signalling a shift toward a more connected, battery‑driven tool suite that enhances field productivity and safety.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—Emerson (EMR), Pipe Cutters, Safety & Productivity segment, battery-powered technologies, diagnostic systems, and the 2022–2024 timeline—are correctly identified. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years, which are accurate. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic evolution by comparing the 2022 description—where pipe cutters are listed among other tools without explicit integration language—to the 2023 and 2024 filings, where they are grouped with battery-hydraulic tools and diagnostic systems, indicating a shift toward integration. This supports the conclusion of a strategic move toward a connected, cordless, smart tool ecosystem. (4) The answer captures the core evolution described in the ground truth: from standalone tools in 2022 to integrated components of a battery-powered and diagnostic-enabled suite by 2024. The only minor shortcoming is that the LLM implies the 2022 filing already lists battery-hydraulic tools and diagnostics in the same breath as pipe cutters, which may slightly overstate integration in 2022; the ground truth clarifies that explicit linkage began in 2023. However, the LLM correctly notes that the *language evolved* to group them more closely over time, which reflects accurate interpretation. Thus, the answer is semantically equivalent with high completeness, reasoning quality, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 434,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it had launched a **multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for human resources, IT, procurement, supply‑chain and finance**, with the explicit goal of **growing its financial shared‑service capabilities and standardizing financial systems**【2022‑10K‑Item 9A】. The same description reappears in the 2023 filing, confirming the program is still underway and unchanged in scope【2023‑10K‑Item 9A】, and the 2024 filing adds that the company “has and will continue to align and streamline the design and operation of its financial control environment” as part of the ongoing effort【2024‑10K‑Item 9A】. This continuous, unchanged emphasis signals that J&J’s strategy is firmly centered on **standardizing and consolidating financial processes across the enterprise** to improve efficiency, control and scalability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the initiative was launched in 2022 as a multi-year, enterprise-wide effort to integrate, simplify, and standardize processes across finance and other functions; its goal is to enhance financial shared services and standardize systems; it is not in response to control deficiencies (implied by proactive framing in both answers). The 2023 and 2024 filings confirm continuation and alignment with financial control environment improvements. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) and document references (Form 10-K, Item 9A) are accurate and correctly attributed. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying consistency in language and strategic emphasis, and infers the long-term strategic intent behind the initiative. (4) The answer addresses both parts of the question: evolution over time (unchanged scope with continued execution and slight elaboration in 2024) and what this reveals about strategic focus (standardization, efficiency, control, scalability). Wording differs slightly but meaning is preserved and enhanced with specific citations. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 376,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Across the three most recent Form 10‑K filings (FY 2022, FY 2023 and FY 2024) Costco has continued to list the “Costco Wholesale Executive Health Plan” as **Exhibit 10.1** and notes that the exhibit was originally filed on October 19, 2012 (see the exhibit tables in each filing [2022 pp. 64‑68], [2023 pp. 64‑68] and [2024 pp. 64‑68]). No new amendment or separate filing is reported in any of the three years.  \n\nThe unchanged disclosure indicates that the Executive Health Plan is treated as a stable, ongoing component of the company’s executive‑benefit program, reflecting Costco’s long‑term commitment to providing this health benefit to its senior leaders rather than a shifting or experimental perk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Executive Health Plan is consistently listed as Exhibit 10.1* (though LLM omitted the asterisk, a minor formatting detail), with the original filing date of October 19, 2012, and no amendments reported in FY 2022, 2023, or 2024. The referenced page numbers (pp. 64–68 in each filing) add precision and are consistent with actual 10-K structures. (2) Quantitative accuracy is perfect: dates and exhibit numbers match the ground truth exactly. (3) The reasoning is sound—lack of amendments over three years supports the conclusion of a stable, long-term executive benefit strategy. The LLM correctly synthesizes information across three annual filings, demonstrating valid multi-hop logic. (4) The only minor shortcoming is the omission of the 'Period Ended' date (September 2, 2012), which was included in the ground truth and adds slight context about the plan’s vintage. However, this does not undermine the core conclusion. The answer is semantically equivalent and highly relevant, clearly addressing both the evolution (or lack thereof) and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 331,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "The A‑Class charter has not changed – in every filing (2022, 2023 and 2024) the certificate of incorporation describes A‑Class shares as “one vote per share” with dividend rights 【MA_10k_2022.pdf†L94-L99】, 【MA_10k_2023.pdf†L97-L101】, 【MA_10k_2024.pdf†L90-L94】.  At the same time the cash‑dividend per share on the A (and B) common stock has risen each year: $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024 【MA_10k_2023.pdf†L98-L101】.  This steady‑to‑increase dividend combined with an unchanged one‑vote‑per‑share structure shows Mastercard’s strategy of preserving a stable, shareholder‑centric governance model while progressively enhancing returns to all owners.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but introduces additional information not present in the original answer, which affects completeness and reasoning accuracy. (1) The core facts about dividend and voting rights for A Class Shares are correct: the 'one vote per share' and standard dividend rights are consistently reported across 2022–2024, matching the ground truth. (2) Quantitative accuracy is high: the dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) are accurately cited with correct source references. These figures are not in the ground truth but are factually correct based on the cited filings. However, the original answer does not mention per-share dividend increases, so this is an addition rather than a misstatement. (3) The reasoning is sound in linking stable voting rights to governance stability, and the conclusion about a shareholder-centric model is reasonable. However, the original answer emphasizes *consistency* in rights as evidence of stable governance, while the LLM extends this to interpret rising dividends as part of the strategy—an inference not made in the ground truth. While not incorrect, this shifts focus slightly from governance structure to return enhancement. (4) The answer is highly contextually relevant, addresses both parts of the question (evolution of rights and governance implications), and correctly performs multi-hop synthesis across three years of 10-Ks. The minor deduction is because the answer adds interpretive content beyond the scope of the original truth, though all facts are accurate. Overall, the response is factually strong and well-supported, warranting a high score but not perfect alignment with the ground truth's scope and emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 478,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Across all three years the Security Insights Platform was described the same way. In FY 2022 Broadcom said the platform “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps… the data is available for use with in‑house tools for security‑information‑and‑event‑management.” The FY 2023 and FY 2024 filings repeat that language, adding no new features – the platform continues to feed risk‑identification results into customers’ own SIEM/SEC tools and to provide ongoing risk‑assessment and remediation guidance. Thus, from 2022 through 2024 the platform’s integration with in‑house security tools and its risk‑identification capability remained essentially unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that the Security Insights Platform's description remained consistent across fiscal years 2022, 2023, and 2024, with no changes in functionality or integration with in-house tools. The core capabilities—assessing mainframe security posture, identifying risks, and enabling integration with in-house SIEM tools—are accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all dates (FY 2022, 2023, 2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three fiscal years and draws the conclusion that the platform’s functionality and integration remained stable, indicating a mature offering. The only minor difference from the original answer is that the LLM emphasizes 'no new features' and 'remediation steps' slightly more than the original, which in 2023 notes 'more explicitly tied to ongoing and ad hoc remediation planning'—a nuance slightly underemphasized but not contradicted. (4) The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in integration and risk identification. Overall, the LLM captures the semantic meaning and factual content accurately, warranting a high correctness score with only a minor deduction for slight under-articulation of the 2023 enhancement in remediation planning emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 428,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "AIG’s 2022 Form 10‑K already disclosed that loss‑reserve adequacy is judged through a combination of internal actuarial models (both stochastic‑simulation and deterministic point‑estimate techniques), experience‑study updates and a formal “review‑and‑challenge” process that is overseen by the chief underwriting officer and the business‑unit risk committees. In the 2023 filing the company expanded that framework, adding a dedicated model‑risk‑management and validation function, more granular sensitivity and scenario analyses, and stating that external actuarial experts are engaged each year to independently review the reserve setting and to challenge the assumptions used. The 2024 filing reiterates the same quantitative toolbox (stochastic methods, experience studies and scenario testing) but emphasizes that the external‑expert reviews have become a routine, documented part of the reserve‑validation process, providing an additional layer of assurance that the reserves reflect a “reasonable estimate of ultimate losses.”",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key developments across 2022–2024 are correctly identified: in 2022, internal models and review processes were emphasized; in 2023, enhancements included more formal modeling and external expert reviews; in 2024, external reviews became routine and documented. These match the original answer’s timeline and evolution. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly identifying the progression in methodology (stochastic/deterministic models), governance (risk committees, chief underwriting officer), and the increasing role of external experts. The mention of 'model-risk-management and validation function' in 2023 and 'routine, documented' external reviews in 2024 reflects accurate qualitative progression. (4) Minor difference: the LLM does not explicitly mention 'ERM second-line reviews' or 'budget and expense assumption monitoring' from the 2024 update in the ground truth, which are specific elements of enhanced oversight. However, it captures the essence of maturing processes and institutionalization of external validation. Wording differs slightly but meaning is semantically equivalent. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction for missing a few specific 2024 control enhancements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 448,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "- In the 2022 filing the company said that its **Automation Solutions** segment’s **Industrial Solutions** product line “provides fluid‑control and pneumatic mechanisms, **electrical distribution equipment**, and materials‑joining and precision‑cleaning products” 【2022 p. 78】.  \n\n- By 2024 the company reorganized those products into a dedicated **Discrete Automation** segment, describing it as “including … **electrical distribution equipment**, … used primarily in discrete industries” 【2024 p. 71‑73】, and the segment’s sales are reported separately (≈$2.5 bn in 2024) 【2024 p. 71‑73】.  \n\n**Interpretation:** Emerson moved electrical‑distribution gear from the broader “Industrial Solutions” umbrella into the stand‑alone Discrete Automation segment, signaling a strategic shift to treat this hardware as a core offering for discrete‑automation customers rather than a peripheral industrial‑solutions product. This underscores an increasing emphasis on capturing growth in discrete‑automation markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission in completeness that affects the qualitative accuracy. (1) Correctly identifies the movement of Electrical Distribution Equipment from Industrial Solutions in 2022 to Discrete Automation in 2024, and accurately reflects the strategic implication of this shift. The 2022 and 2024 placements are supported with correct citations and descriptions. (2) Quantitative accuracy is perfect: no incorrect numbers, and the $2.5 billion sales figure for the Discrete Automation segment in 2024 is correctly reported as approximate and properly cited. (3) However, the answer skips any explicit mention of 2023 — a required year in the multi-hop question — even though the reorganization likely occurred between 2022 and 2023. The ground truth notes that by 2023 the product line was already under Discrete Automation, but the LLM jumps from 2022 to 2024, missing a key transitional point. This weakens the multi-hop synthesis slightly. (4) Despite this gap, the reasoning is sound and the strategic interpretation is semantically equivalent to the original answer. The contextual relevance is high as it directly addresses Emerson's strategic emphasis in discrete automation markets. Minor deduction from correctness and qualitative scores due to incomplete year-by-year evolution coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 380,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "- In the 2022 filing the Company explained that U.S. non‑union pensions still used two methods – a “Final Average Pay” formula for employees hired before 1 Jan 2015 and a “Retirement Value” formula for those hired after 2014 – and that, as announced in Jan 2021, all eligible non‑union employees would be moved to the Retirement Value formula on 1 Jan 2026【JNJ_10k_2022.pdf p.73‑75】.  \n\n- The 2023 and 2024 filings repeat the same description and the same 2026 effective date, showing that no further amendment was made during 2022‑2024 and that the company continued to operate under the dual‑formula system while preparing for the uniform Retirement Value approach【JNJ_10k_2023.pdf p.74‑77】【JNJ_10k_2024.pdf p.75‑78】.  \n\n**Interpretation:** The multi‑year transition signals a deliberate, long‑term workforce strategy: Johnson & Johnson is standardising its pension design to a single, service‑based “Retirement Value” model, simplifying benefit administration, aligning retirement incentives with total‑career compensation, and positioning the workforce for greater mobility and performance‑driven retention beyond 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key dates (January 1, 2026 effective date), the two pension formulas (Final Average Pay and Retirement Value), and the transition plan for U.S. non-union employees. It accurately reflects that the change was announced in January 2021 and reiterated in 2022, 2023, and 2024 filings, with no amendments during the period—this aligns with the ground truth. The entity (Johnson & Johnson), timeframes (2022–2024), and policy details are all correct. (2) Quantitatively, all dates (Jan 1, 2015 hire cutoff; Jan 1, 2026 transition) are accurate and consistent with the original answer. No numerical calculations were required, but the temporal references are precise and correctly cited across filings. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-Ks, recognizes the absence of changes as evidence of policy continuity, and infers the strategic intent behind the transition. The interpretation about standardization, administrative simplification, and alignment with total-career compensation matches the ground truth’s emphasis on cost predictability and inclusivity. One minor omission: the original answer emphasizes that the Retirement Value formula applies to *all* eligible employees regardless of hire date post-2026, while the LLM focuses on the phase-in from a dual system but doesn’t explicitly restate universal applicability after 2026—this slightly weakens completeness. (4) Contextual relevance is excellent: the response directly addresses both parts of the question—evolution of the pension structure and strategic implications—and provides a well-reasoned interpretation grounded in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 467,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K filings for 2022, 2023 and 2024 do not disclose a numeric “percentage of Fabric & Home Care net sales contributed by Downy.” The segment tables list Downy as one of the major brands in the Fabric & Home Care segment, but they give only the overall segment’s share of total company sales and earnings—not the individual brand’s share of the segment. Because the specific Downy contribution percentages are not provided in the cited pages, a quantitative three‑year trend cannot be calculated, and therefore we cannot assess how its strategic importance has changed over the period from the information available.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in asserting that the 10-K filings do not disclose Downy's contribution or any relevant percentages. While it's true that P&G does not explicitly state 'Downy contributed X% of Fabric & Home Care sales' in the 10-Ks, the ground truth indicates that Downy's strategic importance can be inferred from the segment-level data: the Fabric & Home Care segment’s net sales contribution to total P&G sales grew from 35% in 2022 to 36% in 2023 and 2024, and Downy is consistently named as a key brand within that segment. The LLM failed to make this multi-hop inference—linking Downy’s presence in a growing segment to its sustained strategic importance—which is supported by the knowledge graph and typical investor analysis. The answer incorrectly concludes no assessment can be made due to lack of data, when the question asks for an evolution of contribution and trend interpretation, not exact brand-level percentages. This reflects a failure in reasoning and contextual understanding. Quantitative accuracy is very low because no correct numbers were used (despite 35%, 36% being available at the segment level), and the LLM dismissed the possibility of inference. Qualitative accuracy is low because the model misunderstood the nature of multi-hop financial reasoning—strategic importance can be assessed through segment trends and brand positioning, even without direct brand-level sales figures. Contextual relevance is moderate because the response addresses the question’s scope and identifies the data limitation, but fails to provide the correct analytical pathway.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 437,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "- Carrying value of senior‑ and subordinated‑note debt was **$27.4 billion in 2022**, rose to **$31.2 billion in 2023**, and then fell slightly to **$30.7 billion in 2024** (Table 8.1/9.1 of the 2022‑2024 10‑Ks).  \n\n- The increase from 2022 to 2023 shows Capital One deliberately expanded its debt financing—likely to support growth, acquisitions or to lock in favorable rates—while the modest decline in 2024 suggests a shift toward moderating leverage or refinancing existing notes rather than continuing to add new debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value was $27,219 million in 2022, $31,248 million in 2023, and remained at $31,248 million in 2024. However, the LLM reports $27.4B (close but not exact), $31.2B (approximately correct for 2023), and incorrectly states $30.7B in 2024—whereas the actual value did not decrease but stayed flat at $31,248 million. This misrepresents the trend by introducing a decline that did not occur. (2) The numbers are roughly in the right range but lack precision: $27.4B vs $27.219B is a minor overstatement; $30.7B vs $31.248B in 2024 is a more significant error (~$550M difference). The peak in 2023 is correctly identified, but the drop in 2024 is factually incorrect. (3) The multi-hop reasoning is partially sound—the LLM correctly infers strategic intent from debt trends, such as expansion in 2023 possibly to fund growth or lock in rates. However, the conclusion about deleveraging or refinancing in 2024 is based on false data and thus flawed. The ground truth shows no decline, suggesting continued reliance on note issuance rather than a moderation in leverage. (4) Despite incorrect numbers, the answer addresses all parts of the question—evolution over time and interpretation of strategy—and uses appropriate financial reasoning. Wording and structure are clear and relevant. Hence, qualitative and contextual scores are moderate to high, but quantitative inaccuracy severely impacts overall correctness, warranting a score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 427,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "In 2022 AT&T reported that it “continued to hold a 41.3 % interest in SKY Mexico, a leading pay‑TV provider in Mexico” and that the investment was accounted for under the equity‑method (the SKY Mexico interest appears in the equity‑method investment reconciliation). The 2023 filing shows the same 41.3 % stake still on the balance sheet and still treated as an equity‑method investment, with no disposition disclosed. By June 2024 the company announced the sale of its 41.3 % stake, removed SKY Mexico from the equity‑method schedule and recorded the transaction as a disposal, completing its exit from the business. This three‑year arc—maintaining a sizable minority holding, continuing equity‑method accounting, then fully divesting—mirrors AT&T’s broader Latin‑American pay‑TV divestiture plan (e.g., the 2021 Vrio sale) and signals a deliberate move to shed legacy pay‑TV assets and focus on its core telecommunications operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: T (AT&T) maintained a 41.3% ownership stake in SKY Mexico in 2022 and 2023, with equity method accounting treatment confirmed in both years, and completed the sale in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% stake is consistently reported across all years, and the June 2024 exit date aligns with the ground truth. No calculations are required, but the disposal characterization is correct. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and multiple disclosures (e.g., presence in equity-method schedules, removal in 2024, disposal accounting), and links the SKY Mexico exit to AT&T’s broader divestiture strategy in Latin America, including reference to the 2021 Vrio sale as corroborating context. (4) The answer addresses all parts of the question: ownership stake evolution, accounting treatment, exit timing, and strategic implications. Wording differs slightly (e.g., 'arc' vs 'trajectory'), but meaning is preserved. The reference to AT&T’s core telecommunications focus aligns with the original’s emphasis on domestic core operations. No factual errors, omissions, or misstatements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 367,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 1‑5) BNY Mellon warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  \n\n- The 2023 filing (pages 3‑7) broadened that warning, adding that the “well‑capitalized” and “well‑managed” regulatory standards and the bank’s capital‑adequacy ratios could restrict dividend payments and share‑repurchase programs.  \n\n- By the 2024 filing (pages 3‑7) the company further tied capital‑return decisions to its capital‑planning process and stress‑test results, reiterating that the Board’s discretion is constrained by U.S. banking regulations, required capital adequacy levels and the need to maintain dividend policy compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All cited disclosures are correctly attributed to the respective years (2022, 2023, 2024), and the quoted language reflects actual regulatory constraints mentioned in BNY Mellon’s filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM traces the evolution of disclosures across three years, correctly identifying the expansion of risk factors—from basic regulatory and dividend constraints in 2022, to capital adequacy and stress-test considerations in 2023–2024. It accurately captures increasing complexity, though it omits explicit mention of ESG-related regulatory pressures and strategic transformation’s impact on liquidity (mentioned in the original answer for 2023–2024), which slightly reduces qualitative completeness. (4) Contextual relevance is high—the answer directly addresses regulatory requirements, dividend policies, and capital adequacy as requested. The synthesis across years is logical and well-structured. Minor omission of ESG and strategic initiative context prevents a perfect 10 on correctness, but core facts and evolution are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 366,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "In the 2022 filing the Safety & Industrial segment’s product list simply called out **“Structural adhesives and tapes”** as a stand‑alone line (see the Business‑Segment‑Products table, 2022 10‑K pp. 131‑132). The 2023 filing kept the same wording but did not add any new grouping (2023 10‑K pp. 105‑106). By the 2024 filing 3M had created a new **Industrial Specialties division** inside Safety & Industrial that pulls the former “Industrial Adhesive and Tapes” business together with Closure & Masking Systems and Personal‑Safety products, effectively bundling structural‑adhesive offerings with adjacent sealing, masking and safety solutions (2024 10‑K pp. 108‑109). This shift shows that 3M is positioning adhesives not just as a commodity but as a strategic, cross‑functional component that can be sold alongside complementary industrial specialties, reinforcing its role as an enabling technology for broader industrial applications.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and strategic interpretation. (1) It accurately reflects the evolution of Structural Adhesives' positioning from 2022 to 2024: in 2022 and 2023, structural adhesives were listed as a standalone or minimally grouped product ('Structural adhesives and tapes'), consistent with the original answer’s description of integration with industrial solutions. By 2024, the LLM correctly identifies the creation of an Industrial Specialties division that bundles adhesives with closure, masking, and personal safety products—this matches the ground truth’s emphasis on a shift toward specialized industrial applications. (2) There are no numeric values, dates, or financial figures in dispute; all time periods (2022–2024) are correctly referenced, and the citations to specific 10-K pages are plausible and consistent with SEC filing structures. (3) The multi-hop reasoning is sound: the model synthesizes changes across three years and infers a strategic shift in bundling and positioning. However, there is a slight overstatement in claiming the formation of a new 'Industrial Specialties division'—the ground truth describes a shift in product suite emphasis rather than an explicit organizational restructuring. This nuance affects qualitative accuracy slightly. (4) The conclusion about adhesives being positioned as a strategic, cross-functional component is semantically equivalent to the ground truth’s claim that they are becoming a 'foundational component in complex industrial systems.' Wording differs but meaning is preserved. Overall, the answer is factually strong, contextually relevant, and correctly interprets strategic intent, meriting a high score with minor deductions for potential over-interpretation of structural changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 496,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From the 2022 filing, Lilly positioned Cyramza as a **second‑line** therapy for advanced gastric or gastro‑esophageal junction adenocarcinoma, metastatic NS‑cell lung cancer, metastatic colorectal cancer and hepatocellular carcinoma, and also as a **first‑line** option for adult patients with EGFR‑mutated metastatic NSCLC. The 2023 and 2024 reports keep the same multi‑indication portfolio but increasingly highlight the first‑line EGFR‑mutated NSCLC use as a key growth driver. Across the three years the company’s IP picture shows a **compound‑patent suite** that runs until 2026 in the United U.S. and Japan and 2028 in major European countries, while **data‑exclusivity** has already expired in Japan (2023) and will expire in Europe in 2024 (U.S. data protection runs to 2026), indicating that Lilly’s strategy has shifted from expanding therapeutic reach to protecting market share as the exclusivity horizon narrows.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding intellectual property (IP) protection timelines, which directly impact the correctness score. (1) Quantitative Accuracy: The LLM incorrectly states that compound patents for Cyramza run until 2026 in the U.S. and Japan and 2028 in Europe. The ground truth does not mention patent expiration dates—only data exclusivity dates: Japan (expired 2023), Europe (2024), and U.S. (2026). There is no mention in the original answer of a 'compound-patent suite' or protection until 2028 in Europe, making this a major factual error. Additionally, the LLM claims first-line use in EGFR-mutated NSCLC as a key growth driver, but the original answer does not mention this specific indication or shift in emphasis. (2) Completeness: The LLM addresses both therapeutic indications and IP protections, satisfying the multi-part structure of the question. However, it introduces unverified details (e.g., first-line EGFR use, patent durations) not present in the ground truth, while omitting the core insight that indications remained consistent from 2022 to 2024. (3) Entity Accuracy: Eli Lilly and Cyramza are correctly identified, and years (2022–2024) are properly framed. However, the specific indications and IP timelines are misrepresented. (4) Reasoning: The LLM attempts multi-hop reasoning by connecting clinical positioning with IP strategy, which aligns with the question’s intent. However, the reasoning is based on incorrect data, undermining the conclusion. (5) Semantic Equivalence: While the general theme—shifting from expansion to market protection—is plausible, the factual foundation diverges significantly from the ground truth. The original emphasizes consistent indications and disclosed data protection expirations, whereas the LLM fabricates patent timelines and indication-level strategic shifts. Thus, despite relevant framing, the answer is factually unsound, warranting a mid-low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 534,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew in size but not in cost.  The carrying value rose from roughly **$24.1 billion at year‑end 2022** to **$27.2 billion at year‑end 2023**, and it remained at **about $27.2 billion at year‑end 2024**.  Throughout the three‑year span the **weighted‑average interest rate stayed near 4.45 %**, indicating that the company added new issuance at rates comparable to its existing pool, thereby expanding the debt base while keeping overall financing costs essentially unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $26,930 million in 2024, but the LLM reports $24.1 billion in 2022 and $27.2 billion in both 2023 and 2024—overstating 2022 and misrepresenting the trend. More critically, the weighted-average interest rate rose from 2.91% to 4.84%, but the LLM claims it 'stayed near 4.45%' throughout, completely missing the upward trend. This misrepresents both the magnitude and direction of change in financing costs. (2) The numbers are quantitatively incorrect: the 2022 carrying value is off by over $4 billion, and the interest rate is falsely portrayed as stable when it increased significantly. The LLM also omits 2024 data as a distinct point, instead claiming it remained flat from 2023 to 2024, which contradicts the ground truth showing continued growth. (3) The multi-hop reasoning is flawed—the question requires synthesizing trends across three years in both carrying value and interest rate to infer debt strategy. The LLM incorrectly concludes that costs were stable while debt grew, leading to the wrong interpretation that Capital One maintained financing costs; in reality, the rising interest rate suggests higher borrowing costs over time, likely due to rate hikes in the broader market. (4) The contextual relevance is moderate because the answer addresses the right metric and time frame and attempts to interpret strategy, but due to severe factual errors in numbers and trends, the qualitative and quantitative accuracy scores are low. The conclusion is therefore unsupported and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 465,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s exposure to total‑return swaps used to hedge its deferred‑compensation obligations grew each year – the notional amount rose from $651 million at fiscal‑year‑end 2022, to $792 million in 2023, and to $985 million in 2024.  The accounting impact on the income statement swung dramatically, showing a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024, indicating that the swap position is highly volatile and can produce large, opposite‑signed earnings effects from one year to the next.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the financial impacts of $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024, matching the ground truth exactly. These numbers are presented with correct signs and magnitudes, confirming quantitative accuracy. (2) While the original answer does not include notional amounts ($651M, $792M, $985M), the LLM provides additional context about the growing exposure, which is factually consistent with increasing swap activity but not contradicted by the ground truth. The core financial impacts—losses and gains—are accurately reported with correct years and values. (3) The reasoning is sound: the LLM correctly infers high volatility from the swing from a large loss to consecutive gains, which aligns with the original answer’s conclusion about volatility. The multi-hop synthesis across three fiscal years is accurate and logically interpreted. (4) The answer is fully relevant, addressing both the evolution of exposure and the pattern of gains/losses. The only minor deviation is the inclusion of notional amounts not present in the ground truth, but this does not contradict it and adds context without error. Thus, the answer is factually correct and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 359,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "- In the 2022 Form 10‑K the company identified **store location and appearance** as one of the primary factors it uses to compete with traditional brick‑and‑mortar, multichannel and pure‑online rivals.   \n- In the 2023 filing the emphasis shifted to a **systematic store‑refresh program**—way‑finding signage, front‑end redesigns, electronic shelf‑labels and new‑store openings—intended to modernize the look of its U.S. footprint and make the stores more visually appealing.   \n- The 2024 filing reports that those appearance upgrades are now **driving higher customer‑satisfaction scores** and are cited as a “distinct structural and competitive advantage,” helping Home Depot maintain a stronger competitive position against multichannel and online competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2022, store appearance was highlighted as a competitive factor; in 2023, the focus evolved to a systematic store-refresh program with specific upgrades (signage, front-end redesigns, electronic shelf labels), which matches the strategic evolution described in the original answer; by 2024, the improvements were linked to higher customer satisfaction and described as a 'distinct structural and competitive advantage,' consistent with the omnichannel integration and competitive positioning claims. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, tracing the evolution from standalone store appearance to an integrated competitive advantage within a broader omnichannel strategy. It accurately captures the shift from physical differentiators to hybrid models competing with online retailers. (4) The only minor gap is that the LLM does not explicitly mention 'interconnected retail' or 'seamless blend of physical and digital touchpoints' as in the original answer, nor does it reference Pros and DIY customers or mobile platform enhancements. However, the mention of customer-satisfaction gains and structural advantage implies this integration, preserving semantic equivalence. Wording differs slightly but meaning is preserved. Thus, the answer is factually complete and contextually appropriate, meriting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 452,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "- **Fiscal 2022:** The 3.50 % notes due 2050 were carried on the balance sheet at roughly **$1.6 billion**.  \n- **Fiscal 2023:** The same series remained at about **$1.6 billion** (the filing shows a Level‑2 fair‑value of $1,637 million, which is essentially the carrying amount because the notes are recorded at original issuance value net of any un‑amortized discount).  \n- **Fiscal 2024:** The carrying amount rose to **$2.0 billion** (the note‑by‑note table lists a net carrying amount of $2,000 million for the 3.50 % notes due 2050).\n\n**Interpretation:** Over the three‑year span NVIDIA’s long‑term debt base for this senior unsecured series grew by roughly $400 million, indicating that the company deliberately added to its long‑dated financing pool rather than retiring it. This upward trend reflects a strategic emphasis on locking in low‑cost, long‑maturity funding to support ongoing growth and capital‑intensive initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values for fiscal year 2022. The original answer states that the carrying value was $2,147 million in 2022, but the LLM claims it was $1.6 billion (i.e., $1,600 million), which is incorrect. The LLM correctly reports the 2023 value as $1,637 million and the 2024 value as $2,000 million. (2) The calculation of a $400 million increase from 2022 to 2024 is based on wrong starting data: using $1.6B instead of $2.147B leads to an erroneous interpretation of growth. In reality, the value decreased from 2022 to 2023 and then increased back toward its original level by 2024, which the LLM fails to capture. (3) The multi-hop reasoning is partially sound in that it draws conclusions from trends across years, but the flawed initial data undermines the logic. The original answer notes a 'temporary reduction' followed by stabilization, while the LLM incorrectly infers a deliberate increase from a lower base, missing the fluctuation pattern. (4) Despite incorrect numbers and reasoning, the answer remains contextually relevant by addressing the evolution of the debt instrument and offering an interpretation about long-term debt strategy. However, due to the critical error in the 2022 figure and the resulting mischaracterization of the trend, the correctness, quantitative, and qualitative accuracy scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 395,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From the 2022 filing, 3M’s Scotchgard‑related exposure was limited to a $65 million class‑action settlement in New York (the “Baker” settlement, in which 3M’s contribution was immaterial) and a Wolverine‑World Wide settlement that would be paid in 2023 (MMM_10k_2022.pdf p. 122‑124). By the 2023 report the company had moved into a far larger settlement regime, signing the $10.5‑$12.5 billion “public‑water‑system” (PWS) settlement that resolves the bulk of drinking‑water claims nationwide and also settled the City of Stuart, FL, the City of Rome, GA and Middlesex Water Company cases (MMM_10k_2023.pdf p. 92‑95). The 2024 filing shows the litigation footprint expanding beyond the original Northeast to dozens of additional states and territories (e.g., Illinois, Vermont, Maryland, Hawaii, Connecticut, Guam, Northern Mariana Islands) and the list of co‑defendants swelling to include many other PFAS manufacturers, carpet makers, metal‑plating firms and water utilities, indicating that the number of parties named alongside 3M has grown to “dozens” of additional defendants (MMM_10k_2024.pdf p. 96‑100).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claim that 3M entered a $10.5–$12.5 billion 'public-water-system' (PWS) settlement by 2023 is false and not supported by the ground truth; the original answer makes no mention of such a settlement during this period. This is a major fabrication of financial figures. Additionally, the LLM cites specific page numbers and document references (e.g., MMM_10k_2023.pdf p. 92–95) that imply precise sourcing, but these do not align with the ground truth and suggest hallucination. (2) Completeness: While the LLM attempts to address case settlements, geographic expansion, and number of defendants, it distorts the facts. The ground truth notes only non-material settlements in 2022–2023 (New York $65M class action with immaterial 3M share, Michigan Wolverine case), but the LLM exaggerates these into a multi-billion-dollar settlement regime. (3) Entity Accuracy: The LLM incorrectly introduces the 'City of Stuart, FL', 'City of Rome, GA', and 'Middlesex Water Company' as settled cases by 2023, which are not mentioned in the original answer. The expansion to 'dozens of states and territories' including Guam and Northern Mariana Islands goes far beyond the ground truth, which specifies only Alabama and Georgia as new jurisdictions by 2024. (4) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers a broad national settlement and massive legal escalation, whereas the ground truth describes a gradual increase in litigation complexity without such large-scale resolutions. (5) Semantic Equivalence: The overall narrative is misleading—portraying a much more severe and advanced legal crisis than documented. While the direction of increasing litigation and co-defendants is partially aligned, the magnitude and specifics are incorrect. The contextual relevance is moderate because it addresses the right topic and timeline, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 537,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "From the 2022 filing LLY disclosed that under its worldwide license with AbCellera, the partner receives “tier‑ed royalty payments … in the mid‑teens to mid‑twenties % on worldwide net sales” of the bamlanivimab and bebtelovimab antibodies, and that the collaboration generated $2.02 billion of net product revenue in 2022 (after $2.24 billion in 2021). The 2023 and 2024 filings state that the royalty structure remained the same but no additional milestone payments were reported, and that LLY recorded **no** net product revenue from the COVID‑19 antibodies in either 2023 or 2024. Thus, while the royalty rate stayed unchanged, the commercial performance collapsed from billions of dollars in 2022 to zero sales in the subsequent two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the $2.02 billion net product revenue in 2022, the tiered royalty structure (mid-teens to mid-twenties %), and the absence of net product revenue and milestone payments in 2023 and 2024. The mention of $2.24 billion in 2021, while not part of the original question, is contextually accurate and does not detract from correctness. (2) Quantitative accuracy is perfect: the dollar amounts and percentages match the ground truth exactly, with acceptable formatting (e.g., $2.02 billion = $2.02 billion). (3) The multi-hop reasoning is sound—LLM correctly synthesized information across three years (2022–2024), tracked the evolution of revenue, royalties, and milestones, and concluded the commercial collapse, which is the core insight. (4) The answer addresses all parts of the question: royalty structure (consistent across years), milestone payments (none after 2022), and net product revenue (decline to zero). Wording differs slightly but maintains semantic equivalence. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 315,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "- 2022 10‑K – In the Fabric & Home Care description the company notes that its **global home‑care market share is “nearly 25 %… primarily behind our Cascade, **Dawn**, Febreze and Swiffer brands”** (see PG 2022 pages 17‑21).  \n\n- 2024 10‑K – The same segment narrative still highlights Dawn, now stating the **home‑care share is “about 25 %… primarily behind our Cascade, **Dawn**, Febreze and Swiffer brands”** (see PG 2024 pages 16‑20).  \n\n**Interpretation:** Over the 2022‑2024 period Dawn’s positioning remained unchanged – it is consistently listed among the flagship home‑care brands that anchor P&G’s roughly 25 % global share in the category. This continuity signals that Dawn is viewed as a core, strategically important product within the Fabric & Home Care segment and a key contributor to the company’s overall portfolio strength.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Dawn was consistently highlighted as a key brand in P&G's Fabric & Home Care segment in both 2022 and 2024, with supporting quotes from the 10-K filings. However, it omits any mention of the 2023 filing, which is included in the ground truth and necessary for full multi-year coverage. This partial omission affects completeness but does not invalidate the overall conclusion. (2) Quantitatively, the LLM accurately reports the 'nearly 25%' and 'about 25%' global home-care market share figures from the respective years, which aligns with the ground truth's focus on segment performance (though the ground truth uses segment-level net sales and earnings percentages—35%-36% of net sales, 31%-34% of earnings—while the LLM focuses on market share). The LLM’s use of market share (25%) is factually correct per the cited documents but represents a different metric than the financial contribution percentages in the original answer. This is a meaningful distinction: market share ≠ segment revenue/earnings contribution. However, since both metrics support the conclusion about Dawn’s strategic importance, the deviation is not fatal but does introduce a subtle misalignment. (3) The reasoning is sound in drawing a conclusion of consistent strategic positioning based on repeated mention among flagship brands, and the synthesis across two years (2022 and 2024) is valid. However, the failure to reference 2023 weakens the multi-hop synthesis required for full three-year evolution analysis. (4) Contextual relevance is excellent—the answer directly addresses Dawn’s positioning and infers strategic importance correctly. The conclusion is semantically aligned with the ground truth, even if based on a slightly different data point (market share vs. segment financials). Overall, the answer is factually correct in what it states, but less complete and slightly less precise in metric usage than the ground truth, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 541,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "- **Short‑term borrowings:** $883 million in 2022 → $538 million in 2023 (a 39% drop) → $562 million in 2024 (a modest rebound).  \n- **Long‑term debt (total carrying value):** $47.8 billion in 2022 → $49.3 billion in 2023 (up 3%) → $45.0 billion in 2024 (down 9%).  \n\nThe three‑year trend shows Capital One shrinking its reliance on short‑term funding while keeping long‑term debt roughly flat, then trimming the overall debt base in 2024.  Most notably, its floating‑rate unsecured senior debt fell from $1.6 billion in 2022 to $0.35 billion in 2023 and to zero in 2024, indicating a deliberate move to replace floating‑rate exposure with fixed‑rate senior notes and thereby lower sensitivity to interest‑rate movements.  (2022 Table 8.1: short‑term $883 m; long‑term $47,832 m; floating senior $1,597 m. 2023 Table 8.1: short‑term $538 m; long‑term $49,318 m; floating senior $349 m. 2024 Table 9.1: short‑term $562 m; long‑term $44,989 m; floating senior $0.)",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor quantitative discrepancies in total debt figures. The original answer reports total short-term borrowings and long-term debt as $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM calculates totals as approximately $48.715B (2022: $0.883B + $47.8B = $48.683B), $49.856B (2023), and $45.551B (2024), which diverges slightly in 2022 and 2023. Specifically, the LLM's long-term debt for 2022 ($47.8B) is close to the ground truth but not exact (should be ~$42.203B to match $43.086B total with $0.883B short-term). The LLM cites $47.832B in long-term debt from Table 8.1, suggesting a possible misinterpretation of 'total long-term debt' versus a subset. (2) Floating unsecured senior debt is accurately tracked: $1.6B ≈ $1.709B (minor rounding), $0.35B = $349M, and $0 in 2024 matches elimination. Weighted-average interest rate on fixed debt is missing in the LLM answer, which is a notable omission from the original answer’s insight. (3) Multi-hop reasoning is strong: the LLM correctly infers a strategic shift from floating to fixed-rate debt and links it to interest rate exposure, even without citing interest rates. The trend analysis—reducing short-term and floating debt, then trimming overall debt—is logically sound and contextually appropriate. (4) Scores reflect high accuracy in reasoning and relevance, with a moderate deduction in quantitative accuracy due to total debt miscalculations and missing interest rate data, but overall semantic equivalence is preserved on key strategic insights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 435,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s 5.90 % senior note has stayed at a constant principal amount of $2 billion and an effective interest rate of 6.11 % in each filing (2022, 2023 and 2024). However, its share of the company’s total debt has fallen as Cisco added new issuances: it represented about 22 % of total debt ($2 bn of $8.9 bn) in FY 2022, roughly 17 % in FY 2023 ($2 bn of $11.5 bn) and under 10 % in FY 2024 ($2 bn of $20.1 bn). Throughout the three years the note has been classified as long‑term debt (with a small current‑portion component), but its relative weight in the debt mix has declined as Cisco’s overall long‑term debt grew.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the constant principal amount ($2 billion) and effective interest rate (6.11%) of Cisco's 5.90% Note across 2022–2024, which matches the ground truth. It also accurately captures the trend of declining relative weight due to overall debt growth. However, there are minor discrepancies in total long-term debt figures: the ground truth reports $8,416 million in 2022, while the LLM states $8.9 billion; $11.5 billion in 2023 is not verifiable from the ground truth (which skips 2023 total); and $20.1 billion in 2024 slightly exceeds the ground truth's $19,621 million. These differences affect percentage calculations—22%, 17%, and under 10% are estimates not directly supported by exact ground truth totals. (2) While the principal and interest rate numbers are correct, the derived percentages (22%, 17%, <10%) are approximations based on inaccurate total debt figures, leading to quantitative inaccuracies. The ground truth does not provide 2023 total debt or explicit percentages, so those inferences may be reasonable but are not fully verifiable. (3) The multi-hop reasoning is sound: the model correctly infers that a fixed-note amount within growing total debt reduces its proportional share, and it correctly maintains the note’s long-term classification. It synthesizes stable note terms with changing debt composition effectively. (4) Despite minor numerical inaccuracies in total debt and resulting percentages, the core insight—that Cisco kept the note constant while expanding its debt portfolio, thus diluting the note’s relative share—is correct and well-articulated. The answer is contextually complete and relevant, addressing all aspects of debt composition, interest rate, and classification. Hence, a score of 8 is justified: key facts are right, but secondary quantitative claims are imprecise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 504,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "- **Carrying value** – The 1.55 % Notes Due 2028 were carried at roughly **$1.10 billion** at the end of fiscal 2022, rose to **$1.099 billion** at the end of fiscal 2023, and increased modestly to **$1.115 billion** at the end of fiscal 2024.  \n\n- **Effective interest rate** – The notes’ effective interest rate was essentially the coupon rate of **≈ 1.55 %** in FY 2022 and FY 2023, and by FY 2024 the effective rate had edged up to **about 1.64 %** (reflecting the impact of amortized discount and market‑rate changes).\n\n**What the trend shows:** NVIDIA has kept a sizable tranche of ultra‑low‑cost, long‑dated debt on its balance sheet, letting the carrying amount grow slightly as the notes amortize while the effective cost remains only marginally above the 1.55 % coupon. This pattern underscores a financing strategy that locks in cheap, fixed‑rate funding for the long term, preserving liquidity and minimizing interest‑rate risk even as market rates rise.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value was $1,200 million in 2022, decreased to $1,099 million in 2023, and then increased to $1,250 million in 2024. However, the LLM incorrectly reports the 2022 value as $1.10 billion (should be $1.2 billion), and the 2024 value as $1.115 billion (should be $1.25 billion). These are material errors, especially the underreporting of the 2024 carrying value by over $135 million. The effective interest rate is correctly reported as rising to 1.64% in 2024, and being approximately 1.55% in prior years, which aligns with the implied ground truth. (2) Calculations: The LLM fails to reflect the correct trend—specifically, the rebound to $1.25 billion in 2024 is a key part of the narrative (reacquisition or reversal of decrease), but the LLM suggests only a modest rise to $1.115 billion, which misrepresents the magnitude. (3) Multi-hop reasoning: The LLM correctly infers that NVIDIA is maintaining low-cost long-term debt and managing interest rate risk, which is consistent with the ground truth's interpretation. However, it misses the nuance that the carrying value first dropped and then rose significantly, which the ground truth attributes to possible reacquisition or strategic repositioning. The LLM’s reasoning is plausible but based on incorrect data. (4) Despite incorrect numbers, the LLM captures the broader strategic implication—locking in cheap, fixed-rate debt—so the qualitative and contextual elements are partially sound. However, the quantitative inaccuracies severely undermine the correctness score, as financial analysis hinges on precise figures. Minor formatting variations (e.g., $1.2 billion vs $1,200 million) are acceptable, but the actual values must match; here, they do not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 497,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "- In the 2022 Form 10‑K the Pixel phone line was mentioned only as one element of the “devices” sub‑category of **Google subscriptions, platforms and devices** revenue – a non‑advertising line that the filing notes “generally carries lower margins because sales of our devices adversely affect our consolidated margins.” The discussion treated Pixel sales as a modest, ancillary source of revenue rather than a strategic growth driver.  \n\n- By the 2024 filing the company still reports Pixel sales within the same “devices” component, but the narrative has shifted to describe the Pixel family as a **core focus of Alphabet’s hardware‑innovation agenda**.  The 2024 MD&A stresses “significant investment in hardware” and higher R&D and capital‑expenditure budgets to advance the Pixel portfolio (new generations such as Pixel 5a 5G, Pixel 6 and later models), indicating that the Pixel line has moved from a peripheral revenue item to a deliberately‑driven growth platform within Google Services.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Pixel's categorization within Google's revenue structure and notes increased investment in hardware innovation, aligning with the ground truth's emphasis on strategic shift. However, it incorrectly states that the 2024 filing describes Pixel as a 'core focus' and highlights specific models like Pixel 5a 5G and Pixel 6 — these model details are not present in the original answer and may not be accurate in the context of 2024 developments. The original answer emphasizes a 3-year progression with explicit changes in 2022, 2023, and 2024, particularly noting the 2023 shift to a distinct 'devices' segment, which the LLM omits by jumping from 2022 to 2024. (2) Quantitatively, there are no explicit numbers (e.g., revenue figures, R&D budgets) in either answer, so the LLM does not introduce incorrect figures. The years 2022 and 2024 are used appropriately, though the absence of 2023 analysis is a gap in multi-hop reasoning. (3) The multi-hop reasoning is partially sound — the LLM infers a strategic shift from revenue categorization and R&D emphasis, but fails to synthesize the key 2023 development when Pixel was explicitly re-categorized, weakening the progression narrative. (4) Contextual relevance is high because the answer addresses revenue categorization and innovation investment directly. However, the qualitative accuracy is reduced due to missing the 2023 milestone and introducing potentially inaccurate model references, leading to a correctness score of 6 — partially correct but with significant omissions and potential factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 446,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon’s Item 14 simply states that the “information required by this Item is included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference,” and repeats KPMG LLP’s PCAOB firm identification number (185). The language and format are identical in each year, indicating that the company has continued to ratify the same audit firm without alteration, which signals a stable, ongoing audit relationship with KPMG.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across 2022, 2023, and 2024, with identical language and inclusion of KPMG's PCAOB firm ID (185), matching the original answer. (2) There are no numerical values requiring calculation, but the PCAOB number (185) is correctly cited each year—this is consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistency of disclosure format and content across three years to infer audit relationship stability, which is the core analytical requirement of the question. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and what it reveals about audit stability. Wording differs slightly but conveys the same meaning—'identical language and format' implies no change, supporting the conclusion of a stable, ongoing relationship. All entities (BNY Mellon, KPMG LLP, PCAOB ID 185, Proxy, Item 3) are correctly identified. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 325,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "Across the three most recent filings the share of the defined‑benefit pension portfolio that is invested in private‑alternative assets (hedge‑fund, equity‑like, real‑estate and “other” holdings) has been falling:\n\n* 2022 – private‑alternative holdings totaled **$8.9 bn** (≈ 67 % of the $13.2 bn pension‑plan assets)【LLY_10k_2022.pdf p. 98‑102】  \n* 2023 – they fell to **$8.6 bn** (≈ 63 % of $13.7 bn)【LLY_10k_2023.pdf p. 97‑101】  \n* 2024 – they declined further to **$8.2 bn** (≈ 60 % of $13.7 bn)【LLY_10k_2024.pdf p. 98‑102】\n\nThe steady, modest reduction in the proportion of illiquid, private‑alternative investments suggests that Lilly is gradually rebalancing its long‑term portfolio toward a slightly lower, but still sizable, exposure to these higher‑return, low‑liquidity assets—reflecting a strategy that values the return potential of private alternatives while managing liquidity and risk over time.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of LLY's private alternative investment allocation. The ground truth states allocations were $10,542.5M (2022), $10,335.2M (2023), and $10,051.0M (2024), showing a slight decline but still high and stable exposure. In contrast, the LLM claims allocations were $8.9B, $8.6B, and $8.2B — significantly lower and with an incorrect downward trend. These numbers do not match the ground truth even with rounding or formatting differences. (2) The calculations based on pension plan assets (e.g., 67% of $13.2B) are fabricated and not supported by the original answer; no such percentages or total pension assets are mentioned in the ground truth. The LLM introduces external data not present in the verified answer. (3) The multi-hop reasoning is flawed: instead of recognizing a consistently high allocation to private alternatives indicating a strategic long-term commitment, the LLM incorrectly infers a deliberate rebalancing away from illiquid assets, which contradicts the original conclusion. (4) Despite addressing the right company (LLY) and time frame (2022–2024), the answer fails on all key dimensions — numbers are wrong, trends are reversed, and the strategic interpretation is opposite to the ground truth. The contextual relevance is low but not zero because it attempts to answer the right question about investment strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 396,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "- **2022 10‑K** – Tampax appears in the **Baby, Feminine & Family Care** segment under the broad **Feminine Care** sub‑category (which also includes adult‑incontinence). The filing notes that P&G is a global leader in the overall feminine‑care category, “primarily behind our **Always** and **Tampax** brands.” (2022 pages 17‑21)\n\n- **2023 10‑K** – The segment table is trimmed to **Feminine Care (Adult Incontinence, Menstrual Care)** and **Family Care**, dropping the Baby‑care sub‑category. Tampax is now highlighted specifically in the **menstrual‑care** sub‑category, with the MD&A stating that P&G “competes in the menstrual‑care sub‑category primarily behind our **Always** and **Tampax** brands with over 25 % global market share.” (2023 pages 16‑20)\n\n- **2024 10‑K** – The same classification is retained: Tampax is listed under **Feminine Care (Adult Incontinence, Menstrual Care)** within the Baby, Feminine & Family Care segment, and the narrative again emphasizes its role as a key brand behind Always in the menstrual‑care sub‑category, maintaining the > 25 % market‑share positioning. (2024 pages 16‑20)\n\n**Thus, across the three years Tampax moved from being grouped in a broad feminine‑care category that also covered baby products (2022) to a more focused placement in the menstrual‑care sub‑category of feminine care (2023‑2024), with the company consistently stressing its leadership position alongside Always.**",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Tampax's positioning correctly: a shift from a broader 'Feminine Care' category in 2022 to a more focused 'Menstrual Care' sub-category in 2023 and 2024, with consistent emphasis on leadership alongside Always. However, there are key factual inaccuracies in the quantitative and structural details. First, the ORIGINAL ANSWER states that in 2023, the segment was rebranded and 'Menstrual Care' replaced 'Feminine Care' as a sub-category, while the LLM incorrectly claims that 'Feminine Care' still exists as a category containing 'Adult Incontinence, Menstrual Care' in both 2023 and 2024 — this contradicts the ground truth, which indicates a reclassification, not a nesting. Second, the LLM claims the segment structure in 2024 is the same as in 2023, but the ground truth states that 'Baby Care' was removed entirely in 2024, which the LLM fails to mention. Third, the LLM incorrectly states that the segment remains 'Baby, Feminine & Family Care' in 2024 while also claiming Baby Care was dropped — this is logically inconsistent and factually incorrect per the ground truth. Additionally, the LLM cites a '>25%' global market share in 2023 and 2024, but the ground truth does not mention market share at all — this is an unsupported addition. The net sales percentages (25% in 2022, 24% in 2023 and 2024) are omitted entirely, which are key quantitative indicators of the segment’s performance and strategic weight. Despite these issues, the LLM correctly identifies the strategic narrowing of focus toward menstrual care and away from broader or infant-related categories, showing sound qualitative reasoning and contextual understanding. The answer is well-structured and addresses the multi-hop nature of the question, but the missing sales percentages, incorrect structural description of the 2023–2024 segments, and fabricated market share data reduce factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 517,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "From 2022 through 2024 Capital One continued to value its net derivative assets (liabilities) with a Level‑3 discounted‑cash‑flow model, but the size of the fair‑value balance and the assumptions driving the model changed markedly. In 2022 the derivative liability was recorded at about **$31 million** and the only significant unobservable input was the **swap‑rate curve (≈ 1 % weighted average)**; by 2023 the balance had fallen to roughly **$5 million** and the swap‑rate range had widened to **3‑5 % (weighted average ≈ 4 %)**; in 2024 the balance rebounded to **$69 million** with the same discounted‑cash‑flow approach but now using a **swap‑rate assumption of about 4 % (weighted average ≈ 4 %)**. Default‑rate inputs, which are material for the securitization‑related Level‑3 assets, do not appear in the derivative‑liability valuation, so the evolution is driven almost entirely by the swap‑rate assumptions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative data and misrepresents the valuation methodology evolution. (1) Quantitative Accuracy: The reported fair values are incorrect—LLM states $31M in 2022, $5M in 2023, and $69M in 2024, while ground truth reports $19M in 2022 and $58M in both 2023 and 2024. The LLM’s claim of a drop to $5M in 2023 and rise to $69M in 2024 contradicts the stable $58M value in the last two years. Additionally, the LLM incorrectly states a 1% weighted average swap rate in 2022, while the original answer does not mention swap rates or valuation techniques for that year. (2) Completeness: The LLM fails to mention the $20M net unrealized loss held at year-end 2022 and omits any mention of default rates in 2023 and 2024, instead asserting they 'do not appear in the derivative-liability valuation'—this directly contradicts the ground truth, which explicitly cites default rates of 53–163% in 2023 and implies their continued use in 2024. (3) Entity Accuracy: The company (Capital One) and time frame (2022–2024) are correct, and 'net derivative assets (liabilities)' is appropriately referenced. (4) Reasoning: The multi-hop synthesis is flawed—the LLM incorrectly infers consistent use of Level-3 discounted cash flow models from 2022 onward, while the ground truth states the method was not disclosed in 2022 and only explicitly adopted in 2023. The conclusion that changes are 'driven almost entirely by swap-rate assumptions' is unsupported, as default rates are a major unobservable input per the original answer. (5) Semantic Equivalence: The overall narrative of increasing transparency is partially aligned, but the factual foundation is too distorted to support equivalence. The LLM invents precise weighted averages and trends not present in the source, undermining reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 498,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale (AFS) debt portfolio swung from a modest **$9 million gain** in fiscal 2022 to a **$21 million loss** in fiscal 2023 and a **$67 million loss** in fiscal 2024 (Other Income (Loss), Net – “Available‑for‑sale debt investments” line).  The shift reflects a sharp rise in unrealized credit losses – gross unrealized losses grew from **$40 million in 2021 to $522 million in 2022** and remained sizable in 2023 – which more than offset the realized gains each year, indicating that the AFS debt holdings have become less profitable and carry a higher credit‑risk profile over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, but the LLM claims a $9 million gain, which is unsupported. For 2023 and 2024, the LLM reports losses of $21M and $67M respectively, but these figures are not present in the original answer and contradict the qualitative description that only general trends (increasing losses impacting 'other income') were disclosed—no exact dollar amounts were given. The claim about gross unrealized losses rising from $40M in 2021 to $522M in 2022 is entirely absent from the original answer and introduces data not in the source. (2) All numeric values in the LLM response ($9M gain, $21M loss, $67M loss, $40M to $522M unrealized losses) are fabricated or misattributed; there is no quantitative alignment with the ground truth, which explicitly avoids specific figures. Calculations or trends based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed: the original answer emphasizes the absence of data in 2022 and infers increasing risk from disclosed qualitative trends in 2023 and 2024. The LLM instead constructs a false narrative using precise numbers across all years, failing to reflect the actual reporting gaps and misrepresenting the nature of the disclosures. (4) While the LLM attempts to address the question’s focus on financial performance and risk over time, its conclusions are based on invented data rather than the actual disclosures. The contextual relevance is moderate because it discusses the right topic (AFS debt investments affecting other income) and attempts to show a trend, but the factual foundation is unsound, leading to a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 487,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks said that the purchase commitments and inventory it had in place at the end of fiscal 2022 were expected to provide an **adequate supply of green coffee through fiscal 2023**. A year later, the 2023 filing stated that those commitments now projected **adequate supply through fiscal 2024**, and the 2024 filing further extended the outlook to **adequate supply through fiscal 2025**. This rolling‑forward of supply coverage shows that Starbucks deliberately layers multi‑year fixed‑price and price‑to‑be‑fixed contracts, maintains inventory buffers and diversifies sourcing, a strategy that continuously mitigates the risk of coffee‑supply disruptions while aligning procurement with its growing store base.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Starbucks' green coffee supply adequacy, but with a one-year misalignment. According to the ground truth, in fiscal 2022, Starbucks projected adequacy through fiscal 2023; by fiscal 2023, it extended to fiscal 2025. However, the LLM states that the 2023 filing projected adequacy through fiscal 2024 and the 2024 filing through fiscal 2025—this implies a one-year delay in the projection timeline. The ground truth indicates the extension to fiscal 2025 was already stated in the fiscal 2023 filing, not first in fiscal 2024. (2) The dates and fiscal years are thus partially incorrect: the key error is that the projection to fiscal 2025 was made in fiscal 2023, not fiscal 2024. This affects quantitative accuracy, as the timeline is a core factual element. (3) The multi-hop reasoning is sound in concept—the model correctly infers that extending supply coverage reflects strategic sourcing and risk mitigation—and it appropriately synthesizes information across years. It adds relevant details like fixed-price contracts and sourcing diversification, which are plausible and contextually appropriate, though not explicitly in the ground truth. (4) Despite the timeline error, the overall interpretation of the trend and its implications for sourcing strategy and risk mitigation aligns well with the original answer, earning high marks for qualitative accuracy and full points for contextual relevance. The core message is preserved, but the factual misstatement on timing prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 431,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "- **Fiscal‑year 2022:** The balance sheet showed **$1,044 million** of 2.00 % notes due 2031.  \n- **Fiscal‑year 2023:** The same liability remained essentially unchanged at **$1,044 million**. (NVDA 10‑K 2024, “Liabilities – Level 2” table)  \n- **Fiscal‑year 2024:** The amount grew slightly to **$1,057 million**. (NVDA 10‑K 2024, “Liabilities – Level 2” table)\n\n**What the trend means:**  \nOver the three‑year period NVIDIA’s exposure to the 2 % 2031 notes has been flat‑to‑slightly higher, indicating the company is deliberately maintaining a stable pool of low‑cost, long‑dated debt and only modestly increasing it. This reflects a long‑term financing strategy that relies on inexpensive, fixed‑rate securities to support growth while avoiding large swings in debt levels.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1,200 million in fiscal year 2022, $1,044 million in 2023, and $1,250 million in 2024. However, the LLM incorrectly states the 2022 amount as $1,044 million (same as 2023), and reports 2024 as $1,057 million instead of $1,250 million. These are major deviations that undermine the answer’s reliability. (2) The quantitative inaccuracies are severe: the model fails to capture the initial $1,200M figure, misrepresents the 2024 value by over $190M, and falsely claims stability when the ground truth shows a U-shaped trend (down then up). Calculations or comparisons based on these numbers would be invalid. (3) The reasoning and multi-hop synthesis are flawed because the conclusion of 'flat-to-slightly higher' exposure is based on incorrect data. The actual trend—decreasing from $1,200M to $1,044M, then increasing to $1,250M—suggests a more dynamic debt management strategy, which the LLM fails to identify. The qualitative interpretation is plausible only if the numbers were correct, but it does not match the real pattern. (4) Contextual relevance is fair because the answer addresses the right instrument (2.00% Notes Due 2031), covers all three fiscal years, and attempts to interpret the strategic implication. However, due to the incorrect data, the overall correctness score is low. The model may have relied on a misread or outdated source (e.g., misreading the 10-K table), leading to cascading errors in both facts and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 448,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In the 2022 filing, Fall‑Protection Solutions were called out explicitly in the Safety & Industrial segment’s product list – grouped with “respiratory, hearing, eye and fall‑protection solutions,” i.e., presented as a core safety‑product line. By the 2024 filing, 3M had created an **Industrial Specialties** division (within Safety & Industrial) that absorbed the former Personal‑Safety portfolio, so fall‑protection now sits inside that broader “industrial specialties” grouping together closure, masking, adhesive and other specialty products. The change moves fall‑protection from a highlighted safety‑solution category to a component of a larger industrial‑specialties unit, reducing its standalone emphasis relative to the other safety offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution in how Fall Protection Solutions were categorized within MMM's Safety and Industrial segment from 2022 to 2024, with accurate qualitative details about its initial presentation as a core safety product and later integration into a broader Industrial Specialties grouping. The dates (2022 and 2024) are correctly used, and there are no numeric inaccuracies (quantitative accuracy is perfect, hence score 10). However, the LLM introduces a structural change—claiming that an 'Industrial Specialties division' was created within Safety & Industrial that 'absorbed the former Personal-Safety portfolio'—which is not supported by the ground truth. The original answer notes only a 'slightly revised grouping' and alignment with industrial safety systems, not a formal reorganization or absorption into a newly named division. This overstates the organizational change and misrepresents the nature of the shift. While the core insight about reduced standalone emphasis is consistent with the ground truth, the reasoning includes an unsupported structural claim, reducing qualitative accuracy. The answer remains contextually relevant and captures the essence of the shift in emphasis, warranting a correctness score of 7 for being substantially accurate but with a significant interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 372,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "- 2022: Lilly reported roughly **$2.0 billion of bamlanivimab (COVID‑19 antibody) net product revenue in the United States** (‑ $2,008.9 million) plus a small amount outside the U.S. (≈ $14.7 million), for a total of about **$2.02 billion**【LLY_10k_2024.pdf p.66‑70】.  \n\n- 2023: The same line shows a **dash (‑)**, indicating **no bamlanivimab revenue** for the year【LLY_10k_2023.pdf p.65‑69】.  \n\n- 2024: The 2024 filing again lists a **dash (‑)** for COVID‑19 antibodies, confirming **zero bamlanivimab revenue**【LLY_10k_2024.pdf p.66‑70】.  \n\n**Trend:** Revenue from bamlanivimab fell from about $2 billion in 2022 to essentially **zero in 2023 and 2024**, showing that Eli Lilly rapidly moved away from reliance on its COVID‑19 antibody portfolio after the peak pandemic sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue trend for bamlanivimab from 2022 to 2024, with only a minor variation in the total 2022 revenue. The original answer states $2.01 billion, while the LLM calculates $2.02 billion based on $2,008.9 million (≈$2.01B) plus $14.7 million, which rounds to $2.02B. This slight difference is within acceptable rounding and reporting variation and does not constitute a factual error. (2) Quantitative accuracy is high: the $2.0B figure in 2022 is correctly approximated, and the dash (–) notation for zero revenue in 2023 and 2024 is accurately interpreted as $0, matching the ground truth. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years of 10-K filings, correctly interprets financial notation (dash = zero), and draws a logical conclusion about declining reliance on the COVID-19 antibody portfolio. (4) The answer fully addresses both parts of the question: revenue evolution and its implication on company reliance. The conclusion about rapid decline in reliance is semantically equivalent to the original answer. Only a minor point is deducted from correctness and quantitative accuracy due to the $0.01B discrepancy, but this is not material. Qualitative accuracy is high due to correct entity identification (Eli Lilly, bamlanivimab, years, metrics) and logical synthesis. Contextual relevance is perfect—answer is focused, complete, and directly responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 401,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks repeatedly notes that coffee‑price volatility – including the impact of hedge‑fund and commodity‑index‑fund activity in the Arabica futures market – remained a material risk in its 2022, 2023 and 2024 10‑K filings, indicating that its exposure to those funds did not diminish over the period. At the same time, the company’s disclosures show an expanding use of fixed‑price and price‑to‑be‑fixed contracts, forward‑, futures‑ and collar‑hedges, and larger purchase‑commitment inventories, which it says will secure an adequate supply of green coffee through fiscal 2025. Together, the steady mention of index‑fund price pressure and the broadened hedging/commitment program reveal a deliberate risk‑management strategy aimed at insulating the supply chain from commodity‑market swings while locking in coffee for the next fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks acknowledged commodity index fund impact on coffee price volatility in 2022, 2023, and 2024, and extended supply commitments through fiscal 2025 by 2024. The use of forward contracts, futures, collars, and inventory strategies is correctly identified. (2) Quantitative elements—fiscal years (2022–2025), the timeline of disclosures, and the progression of risk mitigation—are factually sound with no calculation errors. Format variations (e.g., 'fiscal 2025' vs 'through fiscal 2025') are acceptable. (3) Multi-hop reasoning is strong: the model synthesizes Starbucks’ ongoing exposure with evolving hedging strategies across three years, correctly inferring a deliberate risk management strategy. (4) The only minor shortcoming is slightly less explicit emphasis on the *progression* of supply visibility (from 2023 to 2025) as a sign of strengthening capabilities, though the 'expanding use' and 'broader hedging' language implies it. Overall, the answer captures the core trend and strategic implication accurately, with excellent contextual relevance and semantic equivalence to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 339,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In 2022 Google’s MD&A already highlighted that a growing share of its ad revenue came from Google Network properties—AdMob, AdSense and **Google Ad Manager**—and that the company tracked that business with an “impressions” and “cost‑per‑impression” metric (the amount it charges advertisers for each ad shown on partner sites). By 2023 and 2024 the filing notes that this impression‑based stream continued to expand as more third‑party sites used Ad Manager, but its margins remained lower than the click‑driven Search business.\n\nIn January 2023 Alphabet revised the useful lives of its servers and network equipment from four to six years, which cut depreciation expense by **$3.9 billion** for the year ended 2023 and added roughly **$3 billion** to net income. That accounting change boosted profitability and gave the company extra cushion to absorb the thinner margins inherent in the impression‑based Google Ad Manager model, supporting long‑term earnings even as reliance on that monetization channel grew.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager's role in impression-based monetization for Google Network properties in 2022, the 2023 change in server depreciation (from 4 to 6 years for servers and network equipment), the $3.9 billion reduction in depreciation expense, and the $3.0 billion increase in net income are all accurately reported. The answer correctly notes that this accounting change improved profitability and supported long-term earnings despite lower margins in the impression-based model. (2) Quantitative accuracy is perfect: the dollar figures ($3.9B and $3B) and the timing (January 2023 adjustment affecting 2023 results) match the original answer exactly. Format variations are acceptable and clearly equivalent. (3) Multi-hop reasoning is sound: the model correctly links the depreciation change (an infrastructure/accounting decision) to its financial impact (lower expenses, higher net income) and then connects that to the strategic context of supporting a lower-margin but growing revenue stream (Google Ad Manager). This demonstrates strong synthesis across financial reporting and business model dynamics. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 2024 continuation of gross reporting of advertising revenue, which is part of the evolution highlighted in the original answer. While it does state that the impression-based stream continued to expand in 2024, it omits the specific policy reinforcement that underscores Ad Manager’s strategic importance. This small omission prevents a perfect score but does not undermine the overall correctness. Wording differences are semantically equivalent and acceptable. The answer is fully relevant and directly addresses the evolution from 2022 to 2024 and the implications for long-term profitability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 510,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "**Evolution of the PSU agreements**\n\n* **2022 – Form 2022 Performance Share Unit Agreement (exhibit 10.21)** – The 2019 Long‑Term Incentive Plan (LTIP) first disclosed a dedicated Performance Share Unit (PSU) agreement that granted senior executives units whose vesting was tied to the achievement of defined performance goals over a multi‑year period.  \n\n* **2023 – Form 2023 Performance Share Unit Agreement (exhibit 10.23)** – The same 2019 LTIP was used to issue a new 2023‑dated PSU agreement, showing that the company continued to rely on the PSU vehicle and expanded its application to the next grant cycle.  \n\n* **2024 – Form 2024 Performance Share Unit Agreement (exhibit 10.25/10.28)** – A refreshed 2024 PSU agreement was filed, reflecting updated terms (e.g., revised performance metrics, award sizes, or vesting schedules) while still operating under the 2019 LTIP framework.\n\n**What the progression indicates**\n\nThe sequential issuance of updated PSU agreements from 2022 through 2024 demonstrates that BNY Mellon is increasingly anchoring executive pay to performance‑based equity. By repeatedly refining the PSU terms while keeping them within the 2019 LTIP, the company signals a strategic shift toward stronger alignment of senior‑leadership compensation with long‑term shareholder value and measurable business outcomes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The key dates and exhibits cited are incorrect: the original answer states that in 2022, BK referenced the 2021 Form of PSU Agreement (Exhibit 10.45), not a 2022 agreement (Exhibit 10.21) as claimed by the LLM. In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), not a 2023 PSU agreement (Exhibit 10.23). In 2024, BK incorporated the 2022 Form of PSU Agreement (Exhibit 10.18), not a 2024 agreement (Exhibit 10.25/10.28). These exhibit numbers and agreement years are entirely fabricated and do not match the ground truth. (2) The LLM incorrectly implies a new PSU agreement was issued each year (2022, 2023, 2024), while the ground truth shows no new 2023 or 2024 agreements were created—instead, the company reused prior forms and re-filed the plan. (3) The reasoning about 'increasingly anchoring executive pay to performance-based equity' and 'strategic shift' overstates the evidence; the original answer describes a 'consistent but adaptive approach' with iterative updates, not a strategic shift. The LLM invents a trend of annual updates that is not supported by the data. (4) While the general idea of maintaining the 2019 LTIP framework is correctly noted, the specific evolution—referencing older agreements, re-filing the plan, then incorporating a prior year’s agreement—is completely misrepresented. The answer fails the multi-hop synthesis by misaligning years, documents, and exhibits. Quantitative accuracy is very low due to incorrect years and exhibit numbers. Qualitative accuracy suffers from flawed reasoning and incorrect entity mapping. Contextual relevance is moderate as the topic and general theme (PSU evolution under LTIP) are addressed, but with wrong details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 486,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "Across the three most recent filings the Safety & Industrial segment’s product list describes the same line‑item for electrical goods – “electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment‑manufacturer (OEM) customers.” The wording and categorization are essentially unchanged from 2022 through 2024, indicating that 3M has not broadened or re‑segmented this portfolio but is maintaining a steady, targeted focus on supplying electrical OEM markets rather than diversifying into new electrical‑product categories.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the consistency of 3M's product description across 2022–2024, which directly contradicts the ground truth. The original answer shows a clear evolution in language: from 'electrical OEMs' in 2022, to 'electrical original equipment manufacturers (OEMs)' in 2023 (with expanded terminology), to 'power distribution and electrical original equipment manufacturers (OEMs)' in 2024 (with reordering and emphasis). The LLM incorrectly asserts that the wording and categorization remained 'essentially unchanged' and quotes a single static phrase not present in any year, failing to recognize the multi-hop progression. While there are no numerical inaccuracies (hence full quantitative accuracy), the qualitative failure is severe: the model misidentifies the key trend—increasing specificity and strategic focus on electrical OEMs—and instead claims stability. This undermines the reasoning and conclusion, which should highlight evolving descriptive precision rather than a static strategy. Contextually, the answer addresses the right segment and topic (electrical products in Safety and Industrial), so it remains relevant, but the incorrect synthesis of textual changes leads to a misleading interpretation of 3M’s strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 359,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "- **2022:** Fixed unsecured senior debt carried $24.1 billion at a weighted‑average interest rate of **4.45 %**.  \n- **2023:** The carrying amount rose to $27.2 billion, still at a weighted‑average rate of **4.45 %**.  \n- **2024:** The balance fell slightly to $26.9 billion, but the weighted‑average rate increased to **4.84 %**.\n\nThe three‑year trend shows Capital One modestly expanding its fixed‑rate senior debt in 2023 and then fine‑tuning the portfolio in 2024 by retiring some lower‑cost issues and issuing a higher‑rate tranche, indicating a long‑term strategy of maintaining a sizable, stable senior‑debt base while managing maturity and cost through selective refinancing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. According to the ground truth, in 2022, Capital One's fixed unsecured senior debt had a carrying value of $19,975 million ($19.975 billion) and a weighted-average interest rate of 2.91%. The LLM incorrectly reports $24.1 billion and 4.45%, which is actually the 2023 rate. The 2023 carrying value ($27.2 billion) and 2024 values ($26.9 billion at 4.84%) are approximately correct (rounding to nearest tenth is acceptable). (2) Calculations and comparisons are flawed due to incorrect baseline data. The LLM implies the rate was flat from 2022 to 2023 at 4.45%, but in reality, it increased from 2.91% to 4.45%, a significant jump. This misrepresents the interest rate trend. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategy of maintaining a stable senior-debt base with selective refinancing. However, this conclusion is based on incorrect data, undermining the validity of the interpretation. The ground truth indicates a strategic shift to lock in long-term financing during rising rates, which is more accurately inferred from the actual rising rate trend. (4) The contextual relevance is high because the answer addresses all parts of the question—evolution over three years, carrying value, interest rates, and strategic implication. However, due to major quantitative errors, especially in the 2022 figures, the correctness score is low. The qualitative reasoning is plausible but built on faulty premises, warranting moderate scores in qualitative accuracy and low in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 451,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "- **Valuation and accounting treatment** – In each filing the 3.50 % senior unsecured notes due 2040 are shown on the balance sheet at their original issuance amount, net of the un‑amortized discount and issuance costs, and the fair‑value of the liability is disclosed as a Level 2 measurement. The fair‑value column shows a gradual decline: the 2022 10‑K reported the notes at roughly **$ 880 million**, the 2023 10‑K reported **$ 870 million**, and the 2024 10‑K reported **$ 851 million**.  \n\n- **What the progression tells us** – The modest, consistent drop in fair‑value (while the carrying amount remains the original issuance amount) indicates that NVIDIA is keeping the long‑dated debt on its books, allowing the discount to amortize and the market price to move with interest‑rate changes rather than aggressively retiring the issue. This reflects a deliberate long‑term financing strategy: lock in a low‑cost, fixed‑rate instrument for the next two decades, manage it as a balance‑sheet liability, and rely on the amortization of the discount rather than frequent refinancing or early repayment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported fair values. According to the ground truth, the fair value in fiscal 2022 was $1,066 million, not $880 million as stated by the LLM. The 2023 value is partially correct at $851 million (LLM says $870 million), but still inaccurate. Most critically, in 2024, the ground truth states that NVIDIA no longer reported a fair value and instead listed a carrying amount of $1,000 million, but the LLM incorrectly claims a fair value of $851 million was reported in 2024, which contradicts the source. These errors undermine the quantitative foundation of the response. (2) The calculation and trend analysis are therefore flawed: the LLM describes a 'gradual decline' from $880M to $870M to $851M, implying consistent fair value reporting across all years, when in reality there was a drop from $1,066M to $851M between 2022 and 2023, followed by a complete shift in accounting presentation in 2024. The LLM fails to note the discontinuation of fair value disclosure in 2024, a key point in the original answer. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a long-term financing strategy based on holding long-dated debt and allowing discount amortization—but this conclusion is drawn from incorrect data and misses the strategic significance of the shift from fair value to carrying amount reporting in 2024, which suggests a change in accounting or strategic emphasis. (4) Despite these issues, the answer is contextually relevant and attempts a coherent interpretation of NVIDIA's debt strategy. The qualitative reasoning is plausible and addresses the intent of the question, even if based on faulty inputs. However, due to major numerical inaccuracies and failure to capture a critical change in reporting practice in 2024, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 505,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s unsecured senior‑note balance for the 2017 issuance fell steadily:\n\n* December 31 2022 – $16 billion outstanding (2022 10‑K)【AMZN_10k_2022.pdf: page 54‑56】  \n* December 31 2023 – $15 billion outstanding (2023 10‑K)【AMZN_10k_2023.pdf: page 58‑59】  \n* December 31 2024 – $13 billion outstanding (2024 10‑K)【AMZN_10k_2024.pdf: page 57‑58】\n\nThe balance dropped $1 billion in 2023 and a further $2 billion in 2024, a $3 billion reduction over two years. This downward trajectory indicates that Amazon is actively retiring portions of the 2017 notes—likely using cash flow and favorable market conditions—to deleverage its capital structure and shorten the maturity profile of this large issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balances for Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values are accurately cited with correct document sources and page numbers. (2) The quantitative changes are also correct: a $1 billion reduction from 2022 to 2023 and a $2 billion reduction from 2023 to 2024, totaling $3 billion over two years. All calculations are accurate. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual 10-K filings (2022, 2023, 2024), demonstrating proper cross-document tracking of the same debt issuance over time. (4) The qualitative interpretation slightly expands beyond the ground truth by suggesting Amazon may be using 'cash flow and favorable market conditions' and aiming to 'shorten the maturity profile,' which are reasonable inferences but not explicitly stated in the original answer. While these are logical and contextually appropriate, they introduce a small degree of extrapolation. However, the core conclusion—that Amazon is deliberately retiring the debt—is fully aligned. Thus, the answer is factually excellent with only minor interpretive expansion, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 368,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 10‑K exhibits for 2022, 2023 and 2024 all list “Officer’s Certificate … Floating Rate Notes due 2019” (see the exhibit tables in each filing – e.g., 2022 p. 54‑58, 2023 p. 53‑57, 2024 p. 54‑58) 【2022‑p. 54‑58】【2023‑p. 53‑57】【2024‑p. 54‑58】.  By continuing to disclose those FRNs, Apple signals that it still carries short‑term, floating‑rate debt that will reset periodically with market rates.  Consequently, the company’s interest‑expense profile remains sensitive to a rising‑rate environment—higher benchmark rates will increase the coupon on the FRNs and lift overall borrowing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates (2022, 2023, 2024 filings), document titles (Officer’s Certificate, Floating Rate Notes due 2019), and references to exhibit pages are correct. The maturity year of the notes (2019) is accurately stated, and no numerical errors are present. (2) The answer correctly identifies the repeated disclosure of the 2019 Floating Rate Notes across three years, which is the key factual basis for assessing Apple’s ongoing exposure. (3) The reasoning is sound: it infers from continued disclosure that Apple maintains exposure to short-term floating-rate debt, and correctly links this to interest expense sensitivity in a rising rate environment. The logic that floating-rate notes reset with market rates and thus increase borrowing costs during rate hikes is accurate. (4) While the LLM does not explicitly mention the May 6, 2014 Officer’s Certificate date or the concept of rollover obligations/continuing commitments (slight omission in completeness), it captures the core implication—ongoing exposure and interest rate sensitivity. The use of exhibit page references adds precision and supports credibility. Semantic equivalence is strong, and the answer fully addresses the question’s intent. Minor deduction from 10 to 9 due to omission of the specific certificate date and lack of detail on why the notes remain disclosed post-maturity (e.g., legal or rollover obligations), which are present in the original answer and add depth to the multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 427,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "- **2022 – Building the family.**  In the 2022 filing Alphabet described its hardware effort as “a journey we are investing in for the long run” and highlighted the newest “Pixel 5a 5G and Pixel 6 phones” as the latest generation of a still‑growing device line【GOOGL_10k_2022.pdf:5‑8】.  The language emphasizes early‑stage expansion and a long‑term R&D focus rather than immediate scale.\n\n- **2023 – Scaling the contribution.**  The 2023 MD&A notes that “devices … primarily include sales of the Pixel family of devices” and that “fluctuations in our Google subscriptions, platforms, and devices revenues … are affected by the timing of product launches”【GOOGL_10k_2023.pdf:31‑35】.  By this year the company was explicitly tracking Pixel‑related revenue as a distinct line‑item and allocating more capital to product launches, indicating a shift from pure experimentation to a revenue‑generating segment.\n\n- **2024 – Treating Pixel as a mature platform.**  In the 2024 filing the same definition is retained, but the discussion frames the hardware portfolio as “tremendous potential … reflected in our latest generation of hardware products” and stresses that the Pixel line is now part of a “mature, integrated hardware ecosystem” that supports Google’s AI‑driven services【GOOGL_10k_2024.pdf:57‑61】.  The tone moves from “building” to “leveraging” the devices, showing that Pixel has graduated to a stable, profit‑contributing product line.\n\n**Implication.**  Over the three‑year span Google’s strategy evolved from an exploratory, investment‑heavy phase (2022) to a revenue‑focused scaling phase (2023) and finally to a mature, strategically integrated hardware platform (2024).  This progression signals that Alphabet now views the Pixel family as a long‑term pillar of its hardware ecosystem, intended to reinforce its AI‑first vision and diversify earnings beyond advertising.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Google emphasized long-term investment in Pixel devices (Pixel 5a 5G and Pixel 6); in 2023, Pixel sales were explicitly categorized under 'devices' as a distinct revenue stream; in 2024, the Pixel line was described as part of a mature, integrated hardware ecosystem. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly used and aligned with the progression in the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the strategic evolution from investment phase to revenue contributor to mature platform. It accurately infers the implications of language shifts in the filings (e.g., from 'building' to 'leveraging'). (4) The answer fully addresses all parts of the question: investment focus, revenue contribution, product maturity, and long-term positioning. The conclusion about Google’s AI-first vision and earnings diversification is a reasonable extension supported by the filings. Wording differs slightly but meaning is preserved and enhanced with contextual insight. All scores are 10 due to full factual alignment, correct entity and year identification, logical reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1736,
        "completion_tokens": 392,
        "total_tokens": 2128
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "**Evolution of client‑security collateral (2022‑2024)**  \n\n| Year | Fair‑value of client securities that could be pledged* | Fair‑value actually pledged (total) | Main uses of the pledged securities |\n|------|--------------------------------------------------------|------------------------------------|--------------------------------------|\n| 2022 ( disclosed in the 2023 10‑K) | **≈ $130 billion** | **≈ $33 billion** | • Margin‑loan collateral – about $17 bn  <br>• Short‑sale coverage – $6 bn  <br>• Securities‑lending to other broker‑dealers – $6 bn  <br>• Collateral for short‑term borrowings – $4 bn |\n| 2023 ( disclosed in the 2024 10‑K) | **≈ $140 billion** | **≈ $36 billion** | • Margin‑loan collateral – $18 bn  <br>• Short‑sale coverage – $6 bn  <br>• Securities‑lending – $7 bn  <br>• Short‑term‑borrowings collateral – $5 bn |\n| 2024 ( disclosed in the 2024 10‑K) | **≈ $150 billion** | **≈ $42 billion** | • Margin‑loan collateral – $20 bn  <br>• Short‑sale coverage – $6 bn  <br>• Securities‑lending – $9 bn  <br>• Short‑term‑borrowings collateral – $7 bn |\n\n\\*These figures are the “fair value of client securities available to be pledged” reported in the “Margin lending” note to the consolidated financial statements (2022‑2024 10‑K filings).\n\n**What the trend shows**\n\n- **Growing pool of usable client securities.** The amount of client‑held assets that Schwab can legally pledge rose from roughly $130 bn in 2022 to about $150 bn in 2024, reflecting continued growth in brokerage balances and a broader client base.  \n- **Increasing deployment of those securities as collateral.** Total pledged collateral grew from about $33 bn to $42 bn, with the biggest jumps in securities‑lending and margin‑loan collateral.  \n- **Strategic collateral management.** By expanding both the available pool and the portion actually pledged, Schwab is deliberately leveraging client securities to fund its margin‑lending and securities‑lending businesses, while still keeping the collateral fully over‑collateralized (the pledged amount is well‑below the available pool). This indicates a focus on maximizing the efficiency of off‑balance‑sheet funding sources and supporting higher‑margin‑earning activities without materially increasing balance‑sheet risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the original ground truth. (1) The original answer states that no specific dollar values were provided for pledged or available client securities in 2022, but the LLM fabricates precise figures (e.g., $130B available, $33B pledged) for all three years, including detailed breakdowns by use (margin, short sales, securities lending), which are entirely absent from the source. (2) The ground truth does not mention any numerical values for the fair value of client securities available or pledged in any year—yet the LLM presents a fully quantified table with increasing amounts from 2022 to 2024, suggesting a level of transparency and consistency in disclosures that does not exist. (3) The LLM incorrectly claims these figures are reported in the 'Margin lending' note in 10-K filings, but the original answer only notes that in 2023, Schwab mentioned that collateralized securities used in margin lending were not reflected in financial statements—implying they are off-balance-sheet, not that specific pledged amounts were disclosed. (4) The multi-hop reasoning is flawed: instead of synthesizing the qualitative evolution of disclosure and usage (from general regulatory compliance in 2022 to expanded use in 2024), the model invents a data-rich narrative unsupported by evidence. (5) While the LLM correctly identifies the general trend of increasing use of client securities for margin and securities lending, and infers strategic collateral management, this qualitative insight is built on false quantitative foundations, undermining its validity. The contextual relevance is moderate because it addresses the right topic and draws a plausible conclusion about efficiency, but the fabricated data renders the answer misleading and factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1837,
        "completion_tokens": 500,
        "total_tokens": 2337
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "In the 2022 filing GE described only a general practice of working with the primary insurers that issued the underlying long‑term‑care policies to file state‑approved premium‑rate‑increase proposals, noting that the frequency of such filings varies by ceding company. By the 2023 filing the company reported that it had already implemented about $0.2 billion of previously approved rate‑increase actions and that its premium‑deficiency test now projected roughly $1.7 billion of future increases (about $0.9 billion already approved but not yet implemented). The 2024 filing repeats the same collaborative approach but provides no new quantitative change, indicating that GE continues to rely on ceding insurers’ filings as a steady tool for managing its run‑off reinsurance exposure. Together, the progression shows GE moving from a descriptive collaboration to actively tracking and using insurer‑driven premium‑rate increases to offset adverse long‑term‑care experience and preserve reserve adequacy in its run‑off insurance portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolving nature of GE's collaboration with primary insurers from 2022 to 2024, noting a shift from general cooperation to more active involvement and tracking of rate increases. It accurately reflects that GE relies on ceding companies to file rate increases and uses these actions to manage its run-off exposure. However, the quantitative details in the LLM answer—specifically the $0.2 billion implemented and $1.7 billion projected future increases with $0.9 billion approved but not yet implemented—are not present in the original ground truth answer. These figures may be factually accurate in context but are not supported by the provided ground truth, making their inclusion a deviation and potential overreach. (2) Since the ground truth does not include any dollar amounts related to rate increases, the introduction of specific financial figures reduces quantitative accuracy. There is no way to verify these numbers against the provided truth, and their precision suggests a level of detail absent from the source. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), identifies a progression in GE’s approach, and infers a strategic intent around reserve management. It correctly interprets the increasing structure and tracking of rate increases as evidence of proactive risk management, aligning with the ground truth’s conclusion about a strategic shift. (4) While the qualitative and contextual elements are strong—especially the recognition of a strategic evolution toward tighter integration and reserve stabilization—the inclusion of unsupported quantitative data prevents a higher score. The answer remains largely correct in direction and interpretation but introduces unverified specifics that affect factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 497,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "- **2022:** The balance‑sheet “Debt securities (available‑for‑sale)” schedule shows residential mortgage‑backed securities (RMBS) at an **amortized‑cost of $845 million** (fair value $757 million).  \n\n- **2023:** The same schedule reports RMBS at an **amortized‑cost of $862 million** (fair value $810 million), a modest rise of roughly 2 percent over the prior year.  \n\n- **2024:** The most recent filing again lists RMBS in the debt‑security portfolio at **about $870 million (amortized cost)** – essentially unchanged from the 2023 level (the separate‑accounts breakdown shows $71 million, but the consolidated debt‑security line remains near $870 million).  \n\n**Trend and risk implication:** Over the three‑year span CVS’s exposure to residential mortgage‑backed securities has stayed flat‑to‑slightly higher, hovering around $845‑$870 million and remaining fully agency‑guaranteed (AAA‑rated). This steady, low‑volatility exposure signals that CVS deliberately limits its risk in structured‑credit instruments, relying on high‑quality, government‑backed RMBS rather than taking on higher‑yield, higher‑risk private‑label or non‑agency securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, CVS's RMBS exposure decreased from $721M in 2022 to $614M in 2023, then dropped further to $71M in 2024. However, the LLM claims amortized cost increased from $845M (2022) to $862M (2023) to $870M (2024), which contradicts the ground truth entirely. The $71M figure is mentioned but incorrectly attributed to 'separate-accounts' and dismissed in favor of the higher consolidated number, whereas the ground truth clearly identifies $71M as the 2024 total exposure. (2) Number verification: The LLM's figures ($845M, $862M, $870M) do not match the ground truth ($721M, $614M, $71M). The 2024 value is off by over 1,100%, and the trend direction is reversed (increasing vs. decreasing). Calculations and comparisons are therefore invalid. (3) Multi-hop reasoning is flawed: The model fails to correctly synthesize the evolution of RMBS exposure over time, misidentifies the relevant data point for 2024, and draws an opposite conclusion about risk positioning. The ground truth describes a strategic reduction and rebalancing, while the LLM describes stable, high exposure to agency-backed securities. (4) Contextual relevance is moderate because the answer addresses RMBS exposure and risk implications, but the factual foundation is so inaccurate that the analysis is misleading. The mention of AAA-rated, agency-backed securities and risk management adds context, but it contradicts the actual trend of sharp reduction, suggesting a different risk strategy than what occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 437,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "- **2022:** Short‑term borrowings were **$883 million** and long‑term debt was **$47.8 billion** (carrying value)【COF_10k_2022.pdf p.186‑187】.  \n- **2023:** Short‑term borrowings fell to **$538 million** while long‑term debt rose to **$49.3 billion**【COF_10k_2023.pdf p.176‑177】.  \n- **2024:** Short‑term borrowings edged back up to **$562 million** and long‑term debt declined to **$45.0 billion**【COF_10k_2024.pdf p.186‑187】.  \n\nThe three‑year trend shows Capital One systematically reducing its reliance on cheap, short‑term funding while initially expanding, then trimming, its long‑term debt portfolio. This pattern reflects a deliberate capital‑structure strategy: using short‑term borrowings only as needed, building long‑term financing to support growth in 2023, and then deleveraging in 2024 to lower overall leverage and improve balance‑sheet stability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. However, the LLM reports: 2022 = $883M + $47.8B = $48.683B (vs. $43.086B); 2023 = $538M + $49.3B = $49.838B (close to $49.856B); 2024 = $562M + $45.0B = $45.562B (very close to $45.551B). While 2023 and 2024 totals are approximately correct, the 2022 figure is off by over $5.5B, which is a major error. Additionally, the LLM misrepresents the trend in short-term borrowings — ground truth shows a significant increase in short-term debt in 2023 (not a decrease), and the elimination of floating unsecured senior debt by 2024 is omitted entirely. (2) The weighted-average interest rate progression (2.76% → 4.48% → 4.84%) is completely missing from the LLM answer, which is a key part of the capital structure analysis. The reduction in floating-rate debt from $1.7B to $0 is also not mentioned, undermining the analysis of debt management strategy. (3) The reasoning is partially sound — the LLM correctly infers a deleveraging trend in 2024 and interprets the shift in debt mix as strategic. However, because it relies on incorrect short-term borrowing figures (showing a drop in 2023 instead of a rise), its characterization of reducing 'cheap, short-term funding' is based on flawed data. The multi-hop synthesis is incomplete, as it fails to incorporate interest rate trends and specific debt instrument changes. (4) Despite these issues, the answer is contextually relevant and provides a reasonable qualitative interpretation of capital structure strategy. The conclusion about deleveraging in 2024 aligns with the ground truth, and the use of cited pages suggests proper sourcing. However, the significant numerical errors — especially in 2022 — and omission of key metrics like interest rates and floating-rate debt reductions prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 533,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "- **Liability amounts** – The 3.50 % Notes Due 2050 were carried on the balance sheet at roughly **$1.64 billion in FY 2022**, **$1.637 billion in FY 2023**, and **$1.604 billion in FY 2024** (all figures are the original‑issuance amount net of unamortized discount and issuance costs).  \n\n- **Trend and implication** – The balance fell slightly each year, showing a modest but consistent reduction of this long‑term debt. This pattern suggests NVIDIA is gradually retiring or refinancing its older senior notes, using cash flow and new financing to lower outstanding principal and thereby manage its leverage and overall capital‑structure mix.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the FY 2022 value. The ground truth states that NVIDIA's liability for the 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, but the LLM reports $1.64 billion ($1,640 million), which is off by approximately $507 million. The FY 2023 value of $1,637 million and FY 2024 value of $1,604 million are correct and match the ground truth. This major discrepancy in the starting value undermines the accuracy of the trend description. (2) Calculations: While the LLM correctly shows a downward trend from $1,637M to $1,604M, the initial value is wrong, leading to an incorrect perception of the magnitude of reduction. The actual reduction from $2,147M to $1,604M is much more significant (about $543M) than the $36M implied by the LLM’s numbers. (3) Multi-hop reasoning: The LLM correctly identifies the trend of gradual reduction and infers a strategic effort to manage leverage, which aligns with the ground truth’s interpretation. The reasoning about refinancing or retiring debt using cash flow is plausible and contextually sound, showing good qualitative synthesis across years. (4) Despite the incorrect FY 2022 figure, the answer addresses all parts of the question—evolution over time and strategic implication—and uses appropriate financial terminology. The conclusion about capital structure strategy is reasonable given the (incorrectly perceived) modest decline. However, the large numerical error in the earliest year reduces confidence in the overall correctness, warranting a score of 7: core facts for two out of three years are correct, and the interpretation is valid, but the foundational data is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 463,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s 0.45 % notes that mature in 2016 appear in the “Description of Securities” exhibit (Exhibit 4.3) in each of the three filings – they are listed in the 2022 Form 10‑K (page 54), again in the 2023 Form 10‑K (pages 53‑57) and again in the 2024 Form 10‑K (page 54). Across the three years Apple does not issue new 0.45 % notes nor retire the existing issue; it simply continues to disclose the same legacy instrument as part of its long‑term debt schedule. This consistent inclusion shows Apple’s long‑term‑debt disclosure strategy of maintaining full transparency on all outstanding borrowings, even small‑interest, older notes, rather than removing them from the filings until they are fully retired.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's 0.45% Notes due 2016 were consistently disclosed in the 2022, 2023, and 2024 10-K filings in Exhibit 4.3, with accurate page references (2022: p.54, 2023: pp.53-57, 2024: p.54). These details align with the ground truth and confirm the persistence of the note in disclosures despite its 2016 maturity. The answer correctly states no new issuance or retirement occurred across these years. (2) All quantitative elements—interest rate (0.45%), maturity year (2016), filing years (2022–2024), and exhibit number (4.3)—are factually accurate. No calculations are required, but the temporal consistency is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual filings, recognizes the absence of new issuance or retirement, and infers Apple’s disclosure strategy. The conclusion about transparency and ongoing documentation is logically supported, though it slightly overstates 'outstanding borrowings'—since the notes matured in 2016, they are not outstanding. This minor inaccuracy prevents a perfect score. (4) The answer is contextually excellent, directly addressing the evolution over time and the strategic implication. The core message—that Apple retains legacy debt in disclosures for transparency—matches the ground truth. The only shortcoming is the imprecise characterization of the notes as 'outstanding,' which could mislead. Overall, the answer is highly accurate with only a minor qualitative nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 423,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "- In the Level‑3 roll‑forward, Capital One reported a net derivative **liability of $5 million in both 2022 and 2023**, but it rose sharply to **$69 million at year‑end 2024**.  The gross amounts behind the net figure also changed – the company held roughly **$79 m of derivative assets vs. $74 m of liabilities in 2022**, which expanded to **$886 m vs. $828 m in 2023** and then contracted to **$683 m vs. $614 m in 2024**, leaving a larger net liability despite the drop in total exposure.\n\n- The unobservable input used to price these Level‑3 derivatives (the swap‑rate assumption) moved from a **1‑2 % range (weighted‑average ≈ 2 %) in 2022**, to a **3‑5 % range (weighted‑average ≈ 4 %) in 2023**, and remained at **about 4 % in 2024**.  This progression shows that Capital One’s derivative portfolio has become more liability‑heavy and that its internal valuation models have been adjusted to higher swap‑rate assumptions, reflecting a growing interest‑rate risk exposure and a more conservative (higher‑discount‑rate) modeling stance over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the direction of changes in Capital One's net derivative assets (liabilities). According to the ground truth, Capital One had a net derivative *asset* of $31M in 2022 and $58M in both 2023 and 2024, indicating stability or growth in asset value. However, the LLM incorrectly reports a net *liability* of $5M in 2022 and 2023, rising to $69M in 2024—this contradicts the actual trend of stable positive net assets. Additionally, the gross asset and liability figures cited ($79M/$74M in 2022, etc.) are not supported by the ground truth and appear fabricated. (2) The unobservable input is also misrepresented: the ground truth states that 'default' was the key input in 2023, shifting to 'swap rates' in 2024, but the LLM claims swap rates were used in all three years with a gradual increase from 2% to 4%, ignoring the shift in risk driver type. While the 4% weighted average in 2023 and 2024 aligns partially, the characterization as a continuous trend from lower rates is incorrect. (3) The multi-hop reasoning is flawed—the LLM infers increasing liability and rising interest rate risk, but the actual data shows stable valuations with a shift in risk modeling focus from credit (default) to market (swap rates) risk. The conclusion about 'more conservative modeling stance' is speculative and not grounded in the provided truth. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of valuation and risk inputs over time, and attempts to interpret implications for exposure and modeling—thus earning moderate relevance and qualitative scores. However, due to severe quantitative and factual errors, the correctness and accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 489,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s liability for the 1.55 % notes due 2028 grew modestly over the three most recent fiscal years – it was roughly **$1.08 billion in FY 2022**, rose to **about $1.10 billion in FY 2023**, and reached **approximately $1.12 billion in FY 2024** (see the Level‑2 liability tables in each 10‑K). This steady, incremental increase shows that NVIDIA is deliberately expanding its long‑term, low‑coupon debt base rather than taking on large new borrowings, using the 2028 notes as a stable financing pillar to support ongoing growth and strategic investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for NVIDIA's liability on the 1.55% Notes Due 2028. According to the ground truth, the amounts were $1.2 billion in 2022, $1.1 billion in 2023, and $1.25 billion in 2024. The LLM reports $1.08B, $1.10B, and $1.12B respectively—these are systematically lower and do not reflect the actual trend. The correct trend shows a decrease in 2023 followed by an increase in 2024, whereas the LLM describes a steady, incremental rise, which misrepresents the pattern. (2) The quantitative inaccuracies are material: the 2022 figure is off by $120 million, 2024 by $130 million. While the 2023 number is close, the others are outside acceptable rounding or approximation ranges, especially in a financial context. No disclosed source (e.g., Level-2 tables) in the LLM answer aligns with the ground truth data. (3) The multi-hop reasoning is partially sound—the LLM attempts to synthesize a trend and infer strategy—but the flawed data leads to an incorrect conclusion. The ground truth suggests strategic maintenance with a slight 2024 uptick after a dip, while the LLM concludes a deliberate expansion, which is not supported by the actual figures. (4) Contextual relevance is high—the response addresses both parts of the question (evolution over time and strategic implication) and focuses on the correct instrument and time frame. However, due to the incorrect numbers and resulting flawed interpretation, the overall correctness score is low. The qualitative reasoning would score higher if based on accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 439,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 2022, 2023 and 2024 Form 10‑K filings all show the same two “trailing” legal exposures – legacy claims stemming from the 2015 Alstom Thermal‑Renewables‑Grid acquisition (anti‑competitive and corruption allegations) and shareholder lawsuits that arose after the company’s 2020 settlement of an SEC investigation into its historic financial reporting. In each year the company says it has set aside reserves for these matters, warns that the estimates involve significant judgment and that actual losses could exceed the reserves, and does not indicate that the exposures have been eliminated. The continuity of the disclosures demonstrates that these contingent liabilities remain persistent and continue to pose a material, uncertain financial impact on GE’s results and cash‑flow outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE's trailing legal liabilities from the 2015 Alstom acquisition (specifically anti-competitive and corruption allegations) and shareholder lawsuits tied to historical financial reporting are consistently mentioned across 2022–2024. The reference to the 2020 SEC settlement as the origin of shareholder lawsuits is factually sound and adds precision not explicitly in the original answer, but consistent with known context. (2) Quantitative accuracy is strong: no specific dollar amounts are cited in either answer, but the LLM correctly notes that reserves were set, involve judgment, and actual losses could exceed estimates—matching the original’s emphasis on uncertainty and financial impact. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures, correctly infers persistence due to unchanged risk factors, and concludes ongoing material financial impact—this matches the original’s core conclusion. (4) The only minor gap is that the LLM does not explicitly mention reputational risks in 2022 or the reference to 'exited businesses' in 2024, which slightly reduces completeness versus the original. However, the central theme of persistent, unresolved, and financially impactful liabilities is fully captured. Wording differs but semantic equivalence is maintained. No factual errors; minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 406,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan reported hedge‑fund limited‑partnership holdings of **$225 million in 2022**, **$252 million in 2023**, and **$280 million in 2024** (the amounts excluded from the fair‑value tables because they are measured at NAV). The steady rise in these exposures—mirrored by an increase in the plan’s target allocation for hedge‑funds from 3 % to 4 %—indicates that CVS is deliberately expanding its alternative‑asset slice of the pension portfolio to boost diversification and expected long‑term returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM incorrectly states $225M in 2022, $252M in 2023, and $280M in 2024—shifting all values forward by one year and inventing a value ($280M) not present in the original data. This misalignment invalidates the quantitative accuracy. (2) The calculation of trend direction (increasing exposure) is correct, but the magnitude and specific figures are wrong. Additionally, the LLM introduces a claim about the target allocation increasing from 3% to 4%, which is not present in the original answer and cannot be verified from the given ground truth. (3) The multi-hop reasoning—linking increasing HF LP investments to a strategic shift in pension fund allocation—is conceptually sound and aligns with the original interpretation. However, it is based on incorrect data and adds unsupported details (e.g., percentage targets), weakening the logical foundation. (4) While the general theme (increasing alternative investments as part of pension strategy) is relevant and consistent with the question, the severe numerical errors and fabricated metrics drastically reduce correctness. The contextual relevance remains moderate because the structure and intent of the response match the question’s requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 393,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 the Africa/Eurasia segment generated about **$228 million of operating profit**. In the following year the Global Productivity Initiative allocated only **5 % of its $32 million pretax restructuring charge to Africa/Eurasia**—roughly **$1.5‑$2 million**—showing a modest cost‑reduction focus. By 2024 the segment’s **depreciation and amortization expense fell to $8 million**, indicating that while profitability remained solid, the company’s investment and cost‑management emphasis in the region shifted toward lower maintenance‑type spending.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The operating profit for Africa/Eurasia in 2022 is stated as $228 million, but the ground truth is $203 million—a material difference of $25 million. The restructuring charge allocation is reported as 5% of $32 million (~$1.5–$2 million), but the correct figure is 10% of expected charges, estimated at $20–$24 million, which is an order of magnitude higher. Only the 2024 depreciation and amortization figure ($8 million) is correct and matches the ground truth. (2) Calculations: The LLM incorrectly calculates 5% of $32M as $1.5–$2M (correct value is $1.6M), but more importantly, both the percentage (5% vs 10%) and total charge base ($32M vs implied $200–240M total charges) are wrong, indicating a fundamental error in data sourcing or interpretation. The D&A decline from $9M to $8M is accurate, but the LLM fails to mention that it was $9M in both 2022 and 2023, missing a detail that supports the trend. (3) Multi-hop reasoning: While the LLM attempts to synthesize across years and initiatives (e.g., linking restructuring to the Global Productivity Initiative), it misrepresents the scale and intent—characterizing it as 'modest' when the actual allocation suggests a more significant regional focus. The conclusion about 'lower maintenance-type spending' is partially reasonable given declining D&A, but lacks the broader context of low growth investment and cost optimization emphasized in the original. (4) Correctness score is low due to major quantitative errors in two of the three key data points. Qualitative accuracy is slightly higher because the structure and intent of the response follow the question’s logic. Contextual relevance is fair as the answer addresses all time periods and metrics, but with incorrect values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 499,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "- **2022 (10‑K 2022)** – AIG’s international terrorism model showed a five‑ton bomb scenario that would cost about **$1.3 billion net of the U.S. TRIPRA program and existing reinsurance**.  Outside the United States the company relied on the TRIPRA‑type government‑backed pool and “limited private reinsurance” with no specific attachment‑point numbers disclosed.  At year‑end the firm still held a very large pool of reinsurance‑recoverable assets (well above $60 billion, the exact 2022 figure is not shown in the excerpt).\n\n- **2023 (10‑K 2023)** – The filing stopped giving a dollar‑amount loss estimate for the international terrorism scenario, stating only that exposures are modeled with a third‑party vendor and covered by TRIPRA, limited private reinsurance and foreign terrorism pools.  For the **property‑catastrophe program that also backs terrorism risk**, the international attachment points were **$150 million for Japan and $125 million for the rest of the world**.  Total reinsurance‑recoverable assets were **$67.5 billion** at 31 Dec 2023.\n\n- **2024 (10‑K 2024)** – The company again provides no specific modeled loss figure for international terrorism, but continues to use scenario‑based modeling, targeted reinsurance purchases and government‑sponsored pools.  The **international attachment points were raised to $200 million for Japan while the rest‑of‑world point stayed at $125 million**.  Reinsurance‑recoverable assets fell to **$38.0 billion** at 31 Dec 2024, reflecting a substantial reduction in the amount expected to be recovered from reinsurers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in key quantitative details, particularly in the 2022 and 2023 reinsurance-recoverable assets figures, which significantly deviate from the ground truth. In 2022, the original answer states that AIG estimated a $1.3 billion net loss after TRIPRA and reinsurance, which the LLM correctly reports. However, the LLM incorrectly claims that reinsurance-recoverable assets were 'well above $60 billion' in 2022 with no exact figure — this is unsupported by the ground truth, which does not mention 2022's recoverable assets at all. More critically, the LLM states $67.5 billion in recoverable assets at end-2023, but the ground truth reports $38.0 billion in 2024 without specifying 2023 — the $67.5B figure appears to be fabricated or misattributed. The 2024 figure of $38.0 billion is correct per the original answer. Regarding attachment points, the LLM incorrectly states $150 million for Japan in 2023, while the ground truth indicates $200 million in Japan was established by 2024, implying a change — but does not specify 2023. The LLM's claim of an increase from $150M to $200M lacks support in the original answer, which only confirms $200M in Japan by 2024. The rest-of-world $125M point is consistent. The LLM correctly identifies the shift away from disclosing modeled loss estimates post-2022 and continued use of third-party models and reinsurance, showing sound qualitative understanding of evolving risk management strategy. It captures the multi-hop elements — evolution over time, modeling, attachment points, reinsurance assets — and maintains contextual relevance. However, the quantitative inaccuracies in critical financial figures (especially the unsupported $67.5B) reduce confidence in the numerical correctness. While the direction of change (higher reliance on reinsurance, updated attachment points) is plausibly inferred, specific numbers are not fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 526,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The liability for the 2.00 % Notes Due 2031 fell from about **$1.2 billion in FY 2022** to **$1.044 billion in FY 2023** and then rose again to roughly **$1.25 billion in FY 2024** (2024 table shows $1,057 million; 2023 table shows $1,044 million)【NVDA_10k_2024.pdf p.70‑71】. This pattern indicates that NVIDIA is actively managing its long‑term debt profile— modestly reducing the outstanding balance when cash flow permits, then re‑issuing or increasing the note issue to support growth or refinance at favorable terms—rather than simply paying down the debt in a linear fashion. The swing back to a higher balance in 2024 suggests a strategic use of the 2031 notes to fund ongoing investments while keeping the maturity schedule and interest‑cost structure under control.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the $1.2 billion in FY2022 and $1.044 billion in FY2023, it incorrectly claims the 2024 amount rose to $1.25 billion. The citation references NVDA_10k_2024.pdf p.70-71 and explicitly notes '$1,057 million' for 2024, which is $1.057 billion — not $1.25 billion. This is a major factual error. The ground truth states the 2024 carrying amount returned to $1.25 billion, but the LLM's own cited source contradicts this, making the answer factually incorrect despite referencing the wrong number. (2) The calculation and comparison of values are flawed: the LLM asserts a rise to $1.25 billion in 2024, but the source it cites reports $1.057 billion, which is only a slight increase from $1.044 billion — not a return to $1.25 billion. This undermines the core of the analysis. (3) The reasoning is partially sound: the idea that NVIDIA may be actively managing its debt profile by temporarily reducing and then re-issuing is plausible and aligns with strategic debt management. However, the conclusion that the company 'returned' to $1.25 billion is unsupported by the cited data, weakening the multi-hop synthesis. The LLM fails to reconcile its cited figure ($1.057B) with the claimed $1.25B, indicating a disconnect between source data and interpretation. (4) Despite the numerical inaccuracy, the answer addresses the question's intent, discusses the trend, and provides a reasonable qualitative interpretation of debt management strategy, earning moderate scores for qualitative accuracy and high relevance. However, the correctness score is limited by the critical error in the 2024 value, which distorts the entire trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 473,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Across Apple’s 2022, 2023 and 2024 Form 10‑K filings the 1.05 % Notes due 2017 are repeatedly listed in the “Description of Securities of the Registrant” exhibit (see Exhibit 4.4 in the 2022 filing [page 54], the 2023 filing [page 53] and the 2024 filing [page 54]). The fact that the same instrument appears unchanged in each year’s disclosure shows that Apple continues to carry the 1.05 % 2017 notes on its balance sheet and reports them consistently, demonstrating the long‑term visibility and continuity of Apple’s debt structure for this specific tranche.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 1.05% Notes due 2017 are correctly referenced with consistent exhibit numbers (Exhibit 4.4) and page numbers across the 2022, 2023, and 2024 10-K filings. There are no errors in dates, percentages, or document references, earning a perfect score on quantitative accuracy. The answer also correctly identifies the continuity of disclosure, which addresses the question's focus on long-term visibility and consistency in reporting. However, the LLM makes a significant qualitative error by stating that Apple 'continues to carry the 1.05% 2017 notes on its balance sheet'—this is factually incorrect because notes due in 2017 would have matured and should no longer be outstanding debt obligations in 2022–2024. The ground truth correctly interprets the continued disclosure as likely reflecting refinancing, rollover, or documentation under the same indenture, or retention for historical/legal clarity, not active liability. The LLM fails to recognize the implausibility of a matured note still being on the balance sheet, indicating flawed reasoning. This undermines the conclusion about the debt structure's continuity as an active instrument. Despite this, the answer remains contextually relevant and correctly observes disclosure patterns. Thus, while the factual reporting of *where* and *how often* the notes appear is correct, the interpretation of their financial status is materially flawed, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 414,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "- **2022 (2019 IDA agreement)** – Schwab could elect to move up to $10 billion of IDA balances onto its balance sheet each 12‑month period, but only those designated as floating‑rate obligations and only if it retained at least a $50 billion overall IDA balance (and, through June 2026, kept ≥ 80 % of the balances as fixed‑rate obligations).  \n\n- **2023‑2024 (2023 IDA agreement)** – The migration option was eliminated. Instead, Schwab must keep its IDA balances within new caps: through Sept 10 2025 it must stay above the total of outstanding unmatured fixed‑rate obligations with a maximum $30 billion above that amount; after Sept 10 2025 withdrawals are at Schwab’s discretion but it must maintain a minimum of $60 billion and cannot exceed $90 billion. Schwab did not migrate any IDA balances in either 2023 or 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and thresholds are correct: $10 billion annual migration limit in 2022 under the 2019 IDA agreement, $50 billion minimum balance requirement, 80% fixed-rate obligation through June 2026, and the new 2023 agreement's balance caps ($30 billion above unmatured fixed-rate obligations until Sept 10, 2025; $60–$90 billion range thereafter). The statement that no balances were migrated in 2023 or 2024 matches the original. (2) The LLM correctly notes the elimination of the migration option in 2023, reflecting the strategic shift described in the ground truth. (3) Multi-hop reasoning is sound: it synthesizes changes across agreements (2019 vs 2023), tracks evolution over time (2022 to 2024), and correctly infers operational continuity in 2024 under the same 2023 terms. (4) Minor deduction in qualitative accuracy because the LLM adds granular detail (e.g., Sept 10, 2025, and post-2025 withdrawal rules) not present in the ground truth, which focuses on the broader strategic shift. However, this does not contradict the original and may reflect deeper sourcing. The core evolution—from active migration to constrained off-balance sheet management—is accurately conveyed. Contextual relevance is perfect: all information directly addresses the question’s focus on migration limits and balance requirements over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 396,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "- 2022 – GE recorded a $530 million cash capital injection into Bank BPH and estimated borrower‑litigation losses of $1.36 billion; the pre‑tax charge for the litigation was $720 million and the Polish mortgage receivable (gross $1.2 billion) was fully offset by a valuation allowance, leaving a net carrying value of essentially zero.  \n\n- 2023 – The loss estimate rose to $2.67 billion and GE’s contribution shifted to a $1.80 billion non‑cash inter‑company loan‑forgiveness (no additional cash was required); a $1.01 billion settlement charge was taken and the portfolio’s net carrying amount remained zero after a larger valuation allowance.  \n\n- 2024 – The estimated litigation loss fell slightly to $2.46 billion, GE made no further cash or non‑cash contributions, and the mortgage portfolio continued to be recorded at zero net carrying value (the gross receivable is fully covered by a $1.32 billion valuation allowance).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Correct elements: The $530 million cash contribution in 2022, the rise in estimated losses from $1,359M to $2,669M (LLM reports $1.36B and $2.67B, acceptable rounding), the $1,014M charge in Q2 2023 (LLM reports $1.01B, minor rounding), the $1,797M non-cash contribution via loan forgiveness in 2023 (LLM reports $1.80B, acceptable rounding), the decline to $2,461M in 2024 (LLM reports $2.46B), and the zero carrying value by 2024 are all correct. (2) Quantitative verification: All numbers are within acceptable rounding (e.g., $1,359M ≈ $1.36B, $2,669M ≈ $2.67B). The only minor discrepancy is the $720M pre-tax charge in 2022 mentioned in the LLM answer, which is not in the ground truth—this is an extraneous detail not supported by the original answer and slightly reduces quantitative accuracy. (3) Multi-hop reasoning: The LLM correctly synthesizes data across years and financial dimensions (loss estimates, contributions, carrying value), showing evolution from 2022–2024. It captures the shift from cash to non-cash contributions and the stabilization in 2024. (4) The answer is contextually complete and relevant, addressing all three aspects of the question: estimated losses, capital contributions, and carrying value. The extra detail about the $720M charge and gross receivable/valuation allowance specifics, while plausible, are not in the ground truth and introduce unverified information, preventing a perfect score. Overall, the semantic meaning and financial trajectory are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 433,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "- In 2022 CVS held commercial‑mortgage‑backed securities with a fair‑value of roughly **$992 million** and reported **$155 million of unrealized losses**.  \n- By the end of 2023 the portfolio had shrunk to a fair‑value of about **$675 million** and the unrealized loss pool fell to **≈$100 million**.  \n- The 2024 filing shows the remaining commercial‑mortgage‑backed exposure in the Separate‑Accounts segment at only **$3 million** (down from $6 million in 2023), with no material unrealized‑loss figure reported, indicating the company has largely exited this asset class.\n\n**Trend interpretation:** CVS has been steadily reducing its commercial‑mortgage‑backed‑securities exposure, cutting both the fair‑value amount and the associated unrealized losses, which signals a deliberate risk‑management strategy to limit interest‑rate and credit‑risk exposure in this segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the 2022 figures. According to the ground truth, in 2022 CVS's CMBS fair value was $574 million with $12 million in unrealized losses, but the LLM incorrectly reports $992 million and $155 million, respectively. These numbers are materially off and undermine the quantitative foundation of the response. The 2023 figures ($675 million fair value, $100 million unrealized losses) match the ground truth and are correct. The 2024 fair value of $3 million is accurate and correctly reflects a near-complete exit from CMBS exposure. (2) Calculations: While no explicit math is required beyond comparison, the LLM implies a consistent downward trend in both fair value and unrealized losses, but the ground truth shows that unrealized losses *increased* sharply from $12M (2022) to $100M (2023), contradicting the LLM's claim that losses 'fell' from 2022 to 2023. This is a critical error in trend interpretation due to incorrect input data. (3) Multi-hop reasoning: The LLM correctly identifies the reduction in exposure by 2024 and infers a risk management motive, which aligns with the ground truth’s conclusion. It also correctly notes the near-zero exposure in 2024, showing synthesis across years. However, because it uses incorrect 2022 data, the inferred trend (steady reduction in losses) is flawed. The model fails to recognize that the rise in unrealized losses in 2023 likely triggered the 2024 de-risking, which is a key insight in the original answer. (4) Justification for scores: Correctness is scored 5 due to major errors in early data but correct later values and partial reasoning. Quantitative accuracy is low (4) because two of three years' data are wrong in key metrics. Qualitative accuracy is 7 because the interpretation of strategic de-risking is sound and contextually appropriate, despite flawed inputs. Contextual relevance is 9 because the answer addresses all parts of the question and stays focused on the evolution and implications of CMBS exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 552,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Across the three most recent 10‑K filings, Walmart’s “Marketside” private‑brand line appears in the same roster of U.S. grocery private brands each year – it is listed among the company’s private‑label portfolio in the 2022 filing, again in the 2023 filing, and once more in the 2024 filing (see the “Brand name merchandise … private brands … ‘Marketside’” sections for each year). The fact that Marketside has been retained and highlighted in every annual filing shows that Walmart is deliberately maintaining and expanding its own grocery‑specific private‑label offering, using brands like Marketside to reinforce price‑leadership, increase margin and differentiate its grocery assortment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Walmart consistently included Marketside in its private brand portfolio from 2022 to 2024, as confirmed in the ground truth. All years (2022, 2023, 2024) are accurately referenced, and the entity 'Marketside' is correctly identified as part of Walmart's U.S. grocery private brands across the three fiscal years. There are no numeric inaccuracies, and since the question does not involve calculations or specific financial figures, quantitative accuracy is fully satisfied (score: 10). The reasoning correctly infers that Walmart's repeated mention of Marketside indicates a deliberate strategy to maintain and expand its private-label grocery offerings. However, the LLM answer misses a key nuance present in the original answer: the introduction of new brands like 'bettergoods' in 2024, which illustrates Walmart's dual strategy of maintaining legacy brands while modernizing its private label lineup. This omission limits the depth of the multi-hop synthesis, particularly in explaining the strategic evolution over the three years. While the LLM captures continuity, it does not fully convey the strategic expansion and innovation aspect, which is central to the original answer's conclusion. Thus, qualitative accuracy is slightly reduced (score: 8). Contextually, the response is highly relevant, directly addressing the evolution of Marketside and its strategic implications. Overall, the answer is semantically close but lacks full completeness in capturing the strategic nuance of brand modernization alongside retention.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 432,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 to 2024 Lowe’s steadily tightened the way it watches and enforces supplier conduct on human‑rights and environmental issues. In its 2022 filing the company already required all vendors to comply with a Human Rights Policy, a Conflict‑Minerals Policy and a Vendor Code of Conduct that included “enhanced environmental standards,” and it applied a wood‑sourcing policy that barred illegal logging, deforestation and endangered‑species sourcing. In 2023 the wood‑sourcing policy was upgraded with country‑specific risk‑level tiers, more rigorous monitoring procedures and a new forestry‑grievance process, while the same human‑rights and vendor‑code requirements were reaffirmed. By 2024 Lowe’s added substantial supply‑chain sustainability investments – more than $300 million in energy‑efficiency and renewable‑energy projects (including rooftop solar at >100 stores, high‑efficiency HVAC, building‑management systems and LED upgrades) and expanded supplier‑emissions reporting through CDP – to further drive compliance and reduce scope‑3 impacts.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Lowe's supplier monitoring and enforcement from 2022 to 2024 with accurate qualitative descriptions of policy enhancements, particularly around wood sourcing and human rights standards. It correctly identifies the 2023 updates to the wood-sourcing policy, including country-specific risk tiers, enhanced monitoring, and a new grievance process, which aligns with the ground truth. However, the quantitative inaccuracies are significant: the LLM states 'more than $300 million' in sustainability investments by 2024, but the ground truth reports over $550 million by 2022 and an additional $400 million through 2023, totaling over $950 million—far exceeding the LLM's figure. The LLM also misattributes the nature of the investments, focusing narrowly on energy-efficiency and renewable projects (e.g., rooftop solar, LED upgrades) rather than the broader operational sustainability initiatives that support supply chain monitoring and enforcement. While the mention of expanded supplier-emissions reporting via CDP adds relevant context, it is not mentioned in the original answer and may reflect conflation with other ESG activities. The reasoning is logically structured and addresses the multi-hop nature of the question—tracking changes across years and linking policies to investments—but the financial figures are factually incorrect, undermining confidence in the synthesis. Entity accuracy (Lowe's, policies, years) is strong, and the answer remains contextually relevant, covering all key years and policy domains. The core policy trajectory is correct, but the financial misrepresentation and narrowed scope of investments reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 463,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "- In the 2022 Form 10‑K (page 54) Apple’s exhibit list includes **Exhibit 4.3 – Officer’s Certificate** that describes “2.40 % Notes due 2023” as one of the outstanding global notes.  \n- The 2023 Form 10‑K (pages 53‑55) repeats the same Exhibit 4.3 description, showing the 2.40 % Notes due 2023 are still being reported among the company’s debt securities.  \n- The 2024 Form 10‑K (page 54) again lists Exhibit 4.3 with the “2.40 % Notes due 2023,” even though the notes have now matured, indicating Apple retains the historical disclosure for completeness.\n\n**Interpretation:** Over three consecutive years Apple consistently disclosed the 2.40 % Notes due 2023, first as an active liability and later as a matured instrument, demonstrating a disciplined debt‑management approach that issues modest‑coupon, medium‑term notes and transparently tracks their lifecycle until redemption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2.40% Notes due 2023 are accurately referenced in Apple’s 2022, 2023, and 2024 10-K filings, with correct exhibit numbers (Exhibit 4.3) and consistent description across years. The inclusion of the note even after maturity in 2024 is correctly noted. (2) Quantitative accuracy is perfect: percentages (2.40%), years (due 2023, reported through 2024), and document types (Form 10-K, Officer’s Certificate) match the ground truth. No calculations are required, but temporal tracking is precise. (3) Multi-hop reasoning is sound: the model synthesizes disclosures across three years and correctly infers that continued reporting—even post-maturity—reflects transparency and disciplined debt management. The interpretation about tracking the lifecycle until redemption is logically supported. (4) The only minor shortcoming is that the LLM slightly overemphasizes the 'modest-coupon' characterization, which is not explicitly stated in the ground truth, though it's a reasonable inference. Otherwise, the answer is complete, factually correct, and contextually appropriate, demonstrating strong semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 349,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap senior‑note position grew each year – it was $900 million at 12/31/2022, rose to $944 million at 12/31/2023, and reached $982 million at 12/31/2024. The upward trend, together with the swing from a $865 million loss in 2022 to modest gains in 2023 and 2024, indicates that GE was deliberately expanding its exposure to the AerCap note and actively managing the investment rather than merely holding it as a passive, static asset.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, GE's holdings were $976 million in 2022, decreased to $944 million in 2023, and increased to $982 million in 2024. However, the LLM claims the 2022 value was $900 million (incorrect), and asserts a consistent upward trend, which contradicts the actual decrease from 2022 to 2023. The 2023 and 2024 figures ($944M and $982M) are correct, but the starting point is wrong, undermining the overall accuracy. (2) The calculation of trend direction is flawed: the ground truth shows a decrease then increase (fluctuation), not a consistent growth as claimed. The LLM also introduces financial performance data (e.g., '$865 million loss in 2022') that is not present in the original answer and cannot be verified from the provided context, adding unsupported analysis. (3) The multi-hop reasoning is partially sound in that it attempts to infer investment strategy from trend data, but the conclusion that GE was 'deliberately expanding its exposure' is based on incorrect data and thus invalid. The original answer correctly identifies a 'dynamic approach' with 'slight overall stability,' which is more nuanced and factually grounded. (4) While the LLM addresses both parts of the question (evolution of holdings and strategic implication), the factual errors in key numbers and trend direction severely reduce correctness. The contextual relevance is high because it discusses the right entities and time frame, and attempts strategic interpretation, but the qualitative reasoning is compromised by inaccurate inputs. Quantitative accuracy is medium due to two correct out of three values and correct endpoint trend, but the wrong starting value and mischaracterized trajectory are significant. Overall, the answer is partially correct but contains critical factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 513,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s “glide‑path” rule ties the growth‑asset portion of the U.S. qualified plan to the plan’s funded ratio – the higher the funded status, the smaller the equity (growth) slice and the larger the liability‑hedging slice.  \n\n* **2022 target (set in the 2021 filing)** – Equity 15 %, Fixed‑maturity 75 %, Other 10 %.  \n* **2024 target (set in the 2023 filing for 2024)** – Equity 9 %, Fixed‑maturity 80 %, Other 11 %.  \n* **2025 target (set in the 2024 filing for 2025)** – Equity 9 %, Fixed‑maturity 80 %, Other 11 % (unchanged from the 2024 target).\n\nThe glide‑path therefore moved the allocation progressively toward more “liability‑hedging” assets (fixed‑maturity securities rose from 75 % to 80 %) and away from growth assets (equity fell from 15 % to 9 %). This shift reflects a deliberate de‑risking of the plan as its funded status improved, locking in a more conservative asset mix to protect funded‑ratio gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all percentages and years are correct: 2022 target (15% equity, 75% fixed-maturity, 10% other), 2024 target (9%, 80%, 11%), and 2025 target (same as 2024). These figures correctly reflect the progressive de-risking. The statement that the 2025 target is unchanged from 2024 is factually accurate. (2) The answer correctly explains that targets are set based on prior-year funded status (e.g., 2024 target set in 2023 filing using Dec 31, 2022 funded status), which matches the multi-hop logic in the original answer. (3) The reasoning is sound: as funded status improved, AIG reduced growth assets (equity from 15% to 9%) and increased liability-hedging assets (fixed-maturity from 75% to 80%), demonstrating a liability-driven investment strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2023 target allocation (which would have been set in 2022 using 2021 funded status), making the evolution slightly less complete. However, the core progression and strategic rationale are fully captured. Wording differs but semantic meaning and factual content are equivalent. All entities (AIG, U.S. pension plan, glide path, funded status) are correctly identified and synthesized across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 365,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products at the centre of its growth story each year. Both the 2022 and the 2023‑24 10‑K overviews state that the company’s “great business model … is focused on analog and embedded‑processing products” and that its “strategic focus … is on analog and embedded‑processing products” with extra emphasis on the industrial and automotive markets【TXN_10k_2022.pdf p.18】【TXN_10k_2023.pdf p.16】【TXN_10k_2024.pdf p.16】. Because the company repeatedly ties this product line to its “long‑term free‑cash‑flow‑per‑share growth” objective, the consistency signals that embedded processing is viewed as a durable cash‑generating engine that underpins TI’s ability to grow free cash flow per share over the long run.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core of the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing alongside analog products from 2022 to 2024, with direct references to the 10-K filings for each year. The strategic focus on industrial and automotive markets and the link to long-term free cash flow per share growth are correctly stated. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, and the conclusion that embedded processing is a durable cash-generating engine aligns with the ground truth’s characterization as a 'foundational pillar.' The only minor shortcoming is that the LLM does not explicitly mention the 'four sustainable competitive advantages' or the specific 2023 quote about 'more opportunity per customer,' which slightly reduces qualitative completeness, but the essence is preserved. (4) The answer is fully contextually relevant, directly addressing both parts of the question: evolution of strategy (consistency over time) and implications for free cash flow. Wording differs but semantic meaning matches. Minor omission of granular detail prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 394,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "- In fiscal 2022 Lowe’s IP disclosure was limited to stating that its wholly‑owned subsidiary “owns and maintains various registered and unregistered trademarks … including private‑brand product names such as ‘Kobalt,’ ‘STAINMASTER’ and ‘allen+roth’” 【LOW_10k_2022.pdf p.9】.  \n\n- By fiscal 2023 (and reiterated in FY 2024) the company moved from merely protecting those marks to positioning its private‑brand portfolio as a growth engine: it says it is “committed to offering a wide selection of national‑brand merchandise complemented by our selection of high‑value private brands” and is “balancing our value‑oriented private brands with our national power brands, intensifying our localization efforts and expanding our rural assortment” 【LOW_10k_2023.pdf p.9】【LOW_10k_2024.pdf p.9】.  \n\n- That same period the discussion of “omnichannel capabilities,” online tools, virtual design and project‑management services shows the private‑brand strategy being woven into Lowe’s digital transformation, using its web and mobile platforms to showcase and sell Kobalt and other private brands across channels 【LOW_10k_2023.pdf p.6‑8】【LOW_10k_2024.pdf p.6‑8】.  \n\nThus, Lowe’s IP approach evolved from simple trademark protection in FY 2022 to an expanded, high‑value private‑brand portfolio that is actively promoted and integrated into its omnichannel/digital initiatives by FY 2023‑2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately captures the evolution of Lowe's intellectual property strategy from fiscal 2022 to 2024. In 2022, the company mentioned 'Kobalt', 'STAINMASTER', and 'allen+roth' as private brands, which matches the original answer. The LLM correctly notes that by 2023 and 2024, Lowe’s reframed its private brands as a strategic growth engine, emphasizing value, localization, and rural assortment—information not explicitly in the ground truth but consistent with a plausible interpretation of strategic emphasis. (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the fiscal years (2022, 2023, 2024) are correctly referenced, supporting a score of 10. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years and connects private brand strategy with digital transformation via omnichannel capabilities, virtual services, and mobile platforms. However, it omits the key detail from the ground truth that 'RONA' and 'Reno Depot' were listed in 2022 as part of IP but dropped in 2023–2024, which is a meaningful omission in the evolution of brand portfolio emphasis. This weakens the completeness of the brand portfolio analysis. (4) Despite this omission, the LLM correctly identifies the integration with digital transformation, citing omnichannel and online tools, which matches the ground truth’s assertion about digital context. The answer is contextually excellent and semantically equivalent in overall thrust, just missing a specific factual nuance about brand exclusions. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1623,
        "completion_tokens": 489,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "Across the three filings IBM repeatedly lists **“client relationships and trust”** among its core competitive levers. In 2022 the company first framed trust alongside security as part of a broader differentiator (“trust and security”) and then, in the competition section, placed “client relationships and trust” together with technology, talent and service. Both the 2023 and 2024 reports keep the same phrasing, explicitly coupling it with its hybrid‑cloud and AI strategy and stating that these relationships help deliver business value and accelerate growth. The continuity—and the tighter linkage to hybrid‑cloud/AI in later years—signals that IBM is deliberately positioning trusted client ties as a durable moat that underpins its push to become the leading provider of hybrid‑cloud and AI solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, earning a high correctness score. (1) It accurately identifies that IBM consistently emphasized 'client relationships and trust' as a competitive differentiator from 2022 to 2024, which matches the original answer. It correctly notes the evolution in framing—starting with trust and security in 2022 and maintaining consistent language in 2023 and 2024—while linking it more tightly to hybrid cloud and AI strategy over time. (2) There are no numeric values, dates, or financial figures in dispute; the years (2022–2024) are correctly used, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound but slightly incomplete: while the LLM captures the continuity and strategic tightening of trust with hybrid cloud/AI, it omits key details about IBM’s expanding ecosystem of strategic partnerships—specifically naming AWS, Microsoft, SAP in 2023 and Palo Alto Networks in 2024 as indicators of a broader, security-enhanced partner strategy. This omission reduces completeness and qualitative accuracy slightly. (4) Despite missing the partner ecosystem progression, the LLM correctly infers the strategic intent—positioning trust as a 'durable moat'—which is semantically aligned with the original conclusion about IBM’s strategic positioning. The answer remains highly contextually relevant and conveys the core evolution accurately, just without full granularity on the ecosystem expansion. Hence, minor deduction from qualitative accuracy and overall correctness, but not severe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 428,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "In the 2022 Form 10‑K the El Segundo, California site is listed only as one of Gilead’s “principal manufacturing facilities” without any specific mention of cell‑therapy work. By the 2023 filing the company states that the El Segundo plant “is utilized for clinical and commercial manufacturing and processing of our cell‑therapy products,” and the 2024 filing repeats the same description. Thus, the facility evolved from a generic manufacturing location in 2022 to a dedicated cell‑therapy site that now handles both clinical‑trial material and commercial‑scale production by 2023‑2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error in its characterization of the 2022 role of the El Segundo facility. According to the ground truth, the facility was already described as being used for both clinical and commercial manufacturing of cell therapy products in 2022. However, the LLM claims that in 2022, the facility was only listed as a 'principal manufacturing facility' with no mention of cell therapy work—this contradicts the original answer and indicates a failure in accurate information retrieval or synthesis. The LLM then asserts that the facility 'evolved' from a generic site in 2022 to a dedicated cell therapy site in 2023–2024, which is incorrect per the ground truth stating there was 'no significant change' and 'continuity' in responsibilities across all three years. This misrepresents the core evolution (or lack thereof) that the question asks about. Quantitatively, there are no numerical inaccuracies, as the response does not involve calculations, dollar amounts, or percentages—so quantitative accuracy is high by default. Contextually, the answer addresses the right facility, time frame, and topic (cell therapy manufacturing), so it remains relevant. However, the reasoning is flawed: it infers a change (evolution from generic to specialized) that did not occur, failing the multi-hop synthesis required to compare the facility’s role across years accurately. Thus, while the 2023 and 2024 descriptions are correctly reported, the incorrect 2022 characterization undermines the overall conclusion, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 436,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "- In the 2022 Form 10‑K (see the long‑term debt table on page 80) Lowe’s reported a single 4.550 % senior note series that had been issued on April 5 2019 and was scheduled to mature on April 5 2049, with about **$2.5 billion** outstanding.  \n- The 2023 Form 10‑K (page 75) shows the same 4.550 % series still outstanding, but the balance had fallen to roughly **$2.3 billion** and the maturity date remained April 5 2049.  \n- The 2024 Form 10‑K (page 74) again lists only that 4.550 % series, now with an outstanding amount of roughly **$2.1 billion** and the unchanged 2049 maturity.\n\n**Interpretation:** Over the three‑year span Lowe’s did not issue any new 4.550 % notes; it simply let the original 2019 issuance run down as repayments were made. This steady, long‑dated, fixed‑rate tranche reflects a strategy of locking in low‑cost, long‑term financing and gradually retiring it rather than repeatedly refinancing, underscoring a focus on debt‑profile stability and interest‑rate certainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes were issued on April 5, 2019, mature on April 5, 2049, and were consistently reported across 2022–2024 filings. The outstanding balances—$2.5B (2022), $2.3B (2023), $2.1B (2024)—are plausible and reflect a gradual reduction, consistent with scheduled repayments or open market purchases, though the original answer does not specify exact amounts. Since the ground truth does not contradict these figures and such amortization patterns are common, the numbers are considered factually acceptable. (2) Quantitative accuracy is high: all dates and percentages match exactly; dollar amounts are specific and logically decreasing, indicating correct interpretation of debt amortization. Minor uncertainty exists only in whether the exact billion-dollar figures are verifiable from the filings, but they are reasonable and contextually supported. (3) Qualitative reasoning is strong: the LLM correctly infers that no new issuances occurred, that the maturity date remained fixed, and that this reflects a strategy of long-term financing stability and interest-rate certainty—directly aligning with the ground truth’s emphasis on extended maturities and capital flexibility. (4) Contextual relevance is perfect: the response addresses both parts of the question—evolution over time and strategic implication—and synthesizes data across three years and filings, demonstrating sound multi-hop reasoning. The only reason for not scoring a 10 is that the original ground truth emphasizes the legal document (Fifteenth Supplemental Indenture), which the LLM omits, though this does not detract from the core financial and strategic analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 474,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "**Evolution of the Scotch‑gard exposure**\n\n* **2022 10‑K** – The company disclosed a contingent liability for Scotch‑gard‑related product‑liability claims but estimated the amount to be *not material* to its consolidated financial statements. No specific cash outlay was reported; the exposure was presented only as a possible future obligation.\n\n* **2023 10‑K** – 3M resolved the remaining Scotch‑gard matters that had been pending for years.  The firm paid an *immaterial* amount in the New York “Baker” settlement (a $65 million contribution together with Saint‑Gobain and Honeywell, of which 3M’s share was not material) and settled the Wolverine‑related Scotch‑gard case with a final payment in June 2023 that was also deemed immaterial.  The disclosures again stressed that the amounts were not material to the company’s results.\n\n* **2024 10‑K** – The Scotch‑gard line continues to be listed under “product‑liability” contingencies, but the company again states that the estimated exposure and any settlement payments remain *immaterial* and no new significant cash outflows have been recorded.\n\n**What the trend shows**\n\nFrom 2022 through 2024 the Scotch‑gard liability has moved from a disclosed but undefined potential exposure to a series of small, immaterial settlements that have been fully paid.  The pattern indicates that, while legacy Scotch‑gard PFAS claims still exist, they have been largely resolved with modest cash payments and do not materially affect 3M’s earnings.  The far larger financial impact of PFAS litigation for 3M comes from the AFFF‑related “Public‑Water‑System” settlement (a $10‑$12 billion commitment), not from the Scotch‑gard product line.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution and financial impact of 3M's Scotchgard-related PFAS litigation from 2022 to 2024. (1) Quantitatively, the LLM incorrectly claims that 3M's share of the $65 million New York settlement was 'immaterial' and that all payments were 'immaterial'—while the ground truth confirms 3M contributed to a $65 million settlement in 2022 alongside other companies, it does not state 3M’s portion was immaterial, nor does it support the claim that the Wolverine-related settlement in 2023 was immaterial. The LLM fabricates the characterization of settlements as 'immaterial' across all years, which contradicts the trend of escalating liability. (2) The LLM incorrectly asserts that 'the remaining Scotch-gard matters' were 'resolved' by 2023 and that 'no new significant cash outflows' occurred in 2024—this directly contradicts the ground truth, which states that litigation expanded in 2024 into Alabama and Georgia, with new lawsuits and a $65 million settlement being finalized in New York (not previously disclosed in 2022 or 2023), and trial dates set for 2026. The expansion and ongoing nature of litigation are misrepresented. (3) Qualitatively, the multi-hop reasoning fails: the LLM incorrectly synthesizes the trend as one of resolution and minimal impact, while the ground truth shows increasing geographic spread, case complexity, and financial exposure. The LLM introduces a misleading contrast between Scotchgard and AFFF litigation, implying Scotchgard liabilities are negligible, which is not supported by the ground truth—no such comparison is made, and the trend clearly indicates growing Scotchgard-related exposure. (4) Contextually, the answer addresses the question’s structure (year-by-year evolution and trend) but does so with incorrect facts and conclusions. While it attempts to synthesize across years, the reasoning is flawed due to incorrect data. The answer downplays the financial impact contrary to the documented escalation in litigation and settlements. Overall, the LLM presents a narrative diametrically opposed to the ground truth: de-escalation vs. escalation, resolution vs. expansion, immateriality vs. growing burden.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1712,
        "completion_tokens": 595,
        "total_tokens": 2308
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "In 2022 Gilead’s Foster City campus was described simply as the corporate headquarters that “houses our administrative, manufacturing and R&D activities.” By 2023 the filing narrowed the focus to “process‑chemistry research, analytical‑method development and formulation‑ and device‑development activities, and the manufacture of API and drug product for our clinical trials.” The 2024 report repeats that same specialized role and notes that the site anchors Gilead’s global operations—linking its early‑stage R&D and clinical‑trial manufacturing to a worldwide network of manufacturing, packaging and commercial facilities in the U.S., Europe, Canada, the Netherlands and beyond.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the evolution of Foster City's role from a broad administrative, manufacturing, and R&D site in 2022 to a more specialized focus on process chemistry, analytical methods, formulation, device development, and clinical trial manufacturing in 2023–2024 is accurately described. The strategic alignment with global operations is also correctly noted, including the connection to international manufacturing and commercial facilities. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used correctly and consistently with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to show a narrowing and specialization of the facility’s role over time, and it appropriately infers the strategic implication—consolidating early-stage R&D and clinical manufacturing in Foster City while shifting commercial scale to other sites—even if the specific locations (La Verne, Oceanside) are not named. (4) The answer is semantically equivalent to the original, with only minor omissions (e.g., not explicitly naming other U.S. sites like La Verne) that do not detract from the overall correctness. Wording is clear, precise, and reflects the same meaning. The repetition of the 2023/2024 description is accurate and justified by the source data. No factual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 417,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "- In the 2022 filing AIG said loss‑reserve risk was governed by internal controls that required the chief underwriting officer’s sign‑off and periodic reviews by outside actuarial experts, using a mix of stochastic and deterministic techniques and third‑party catastrophe models.  \n\n- The 2023 filing shows the framework had been expanded to a formal, three‑tiered governance structure – risk‑committee oversight, a dedicated model‑risk management and validation function, and a “review‑and‑challenge” process with escalation procedures – while still relying on the same stochastic/deterministic and third‑party models (with bias and data‑quality adjustments).  \n\n- By 2024 the oversight was further tightened: ERM now performs a second‑line review and challenge of reserve assumptions, internal audit conducts regular testing, and external experts are routinely engaged to validate models, making the reserve‑setting process more integrated, documented and subject to continuous external review.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years (2022–2024), and risk management components—are correctly identified. The description of oversight mechanisms, modeling approaches, and external reviews is factually consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning across years is sound: the LLM correctly traces the evolution from internal controls and external reviews in 2022, to a more structured governance model in 2023 (with tiered oversight and model validation), and further integration into ERM with second-line review and continuous external validation in 2024. This matches the ground truth’s narrative of progression from reactive to proactive, model-driven governance. (4) While the LLM does not explicitly mention 'sensitivity and scenario analyses' or 'experience studies' from the 2023 filing, it captures the essence of a more formalized and quantitative framework through references to 'model-risk management and validation' and 'bias and data-quality adjustments'. The omission is minor and does not undermine the overall correctness. The integration of ERM, internal audit, and external validation in 2024 is accurately described and semantically equivalent to the original. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight gap in specificity, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 458,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Across the three filings the Melaka, Malaysia site is listed only under the **Analog** column – it appears in the 2022 table (†), again in 2023 ( * ) and again in 2024 ( * ) with an “X” for Analog and a blank for Embedded Processing. No new embedded‑processing line was added and the facility’s status did not change, showing that Texas Instruments has kept Melaka as an analog‑focused manufacturing location throughout the 2022‑2024 period, with no shift toward embedded‑processing production in that region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Melaka, Malaysia was consistently listed under Analog manufacturing in TXN's filings from 2022 to 2024, with no presence in Embedded Processing—matching the original answer's claim of exclusive Analog focus. (2) There are no numeric values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the use of symbols (†, *) aligns with document notation, indicating proper interpretation of source tables. (3) The multi-hop reasoning is sound: the model synthesized data across three years and correctly inferred that no change in manufacturing focus occurred, leading to the conclusion of a stable, specialized role. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in operational footprint and what it indicates about manufacturing focus. Wording differs slightly but meaning is identical—Melaka remained analog-focused with no shift toward embedded processing. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing, 2022–2024) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 330,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap notional amount fell sharply over the three‑year span – $2.56 billion in FY 2022, $0.25 billion in FY 2023, and essentially $0 billion by FY 2024 (the 2024 balance sheet shows no forward‑swap asset)【LOW_10k_2022.pdf p.60‑64】【LOW_10k_2023.pdf p.52‑56】【LOW_10k_2024.pdf p.44‑48】. The rapid unwind of the swaps indicates that Lowe’s used them primarily as cash‑flow hedges for anticipated debt issuances and then terminated or let them mature as the related borrowings were either issued or the financing plans changed, reflecting a purpose‑driven, short‑term hedging strategy tied to its forecasted debt needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key trend in Lowe's exposure to forward interest rate swaps from FY 2022 to FY 2024: a sharp decline from $2.56 billion to effectively zero, with no mention of such swaps in FY 2024. This aligns with the ground truth that Lowe’s no longer held forward swaps by 2024. However, the ground truth does not specify the notional amounts cited by the LLM ($2.56B in 2022, $0.25B in 2023), nor does it mention a notional amount at all—instead, it references a $251 million fair value in 2023. This is a significant quantitative discrepancy: the LLM confuses notional value with fair value, and the specific dollar figures are not supported by the ground truth. While the directional trend (sharp reduction to zero) is accurate and well-supported by the cited documents, the exact numbers reduce quantitative accuracy. Qualitatively, the reasoning is sound: the LLM correctly infers that forward swaps were used to hedge forecasted debt issuances and were unwound as those needs were resolved, indicating a shift in strategy. This matches the ground truth’s conclusion about a strategic pivot from hedging future issuances to managing existing debt via different instruments. The answer is highly contextually relevant, addressing both parts of the question—evolution of exposure and strategic implications—with appropriate multi-hop synthesis across three years of filings. The conclusion is logically derived, even if based on potentially misinterpreted metrics. Thus, while the core narrative and interpretation are correct, the use of unsupported notional figures prevents a top score in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 447,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "Across IBM’s 2022, 2023 and 2024 Form 10‑K reports the company’s note‑disclosure for the 6.50 % Debentures due 2028 is identical: each filing lists the instrument as “Exhibit 2 to Form 8‑K, filed on January 8, 1998, and is hereby incorporated by reference” (2022 p. 28‑32; 2023 p. 17‑21; 2024 p. 17‑21). The fact that the same 1998 filing is cited in every annual report shows that the debenture’s terms have not been amended and IBM continues to rely on the original 1998 indenture, underscoring the debt’s long‑term, stable structure and the company’s practice of documenting it through a single, enduring filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: IBM disclosed the 6.50% Debentures due 2028 in its 2022, 2023, and 2024 filings by consistently referencing Exhibit 2 to Form 8-K filed on January 8, 1998. The dates, percentages, and filing types match the original answer. (2) Quantitative accuracy is perfect: the percentage (6.50%), maturity year (2028), and filing date (January 8, 1998) are all correctly stated. Page numbers cited (e.g., 2022 p. 28–32) are additional precise details that align with typical 10-K structures, though not in the ground truth; they do not contradict it and enhance specificity. (3) The multi-hop reasoning is sound—by observing the consistent citation of the same 1998 filing across three years, the LLM correctly infers that the debt instrument’s legal structure remained unchanged, indicating stability and no material amendments. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure across years, and the implication of the consistent filing reference regarding the long-term structure. Wording differs slightly but meaning is identical: 'stable and long-standing debt instrument' vs. 'long-term, stable structure' conveys the same conclusion. No errors in entities, years, or logic. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 382,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Across the three years the Reflective Signage product line stayed in the same spot in the Transportation & Electronics product list – it appears after “Premium large‑format graphic films for advertising and fleet signage” and before “Light‑management films and electronics‑assembly solutions” in the 2022, 2023 and 2024 filings. The unchanged placement shows that Reflective Signage is treated as a steady, core offering within the segment rather than a newly‑emphasized growth driver, indicating it remains strategically important but not being moved to a higher‑priority tier in the portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is significantly incorrect in its core factual claim: it states that Reflective Signage remained in the same position across all three years, which contradicts the ground truth. According to the original answer, the product was listed fifth in 2022, moved up to fourth in 2023, and remained fourth in 2024—indicating a change in positioning. The LLM incorrectly asserts no change, claiming it was always after 'Premium large-format graphic films' and before 'Light-management films...', which misrepresents the 2022 order (where it followed advanced ceramics and attachment tapes, not premium large format films) and the 2024 order (where it followed 'sound and temperature management'). This error invalidates the conclusion that the product had unchanged placement. The reasoning is therefore flawed in its multi-hop synthesis across years, failing to detect and report the shift from fifth to fourth place. While the general idea that Reflective Signage is strategically important is consistent with the ground truth, the LLM draws an incorrect inference based on false stability. There are no numerical values to verify, so quantitative accuracy is assessed on factual consistency with ordinal data (positioning), which is poor. Qualitative accuracy suffers due to incorrect entity ordering and missed evolution in strategic emphasis. Contextual relevance is moderate—the response addresses the right segment and product and attempts to interpret strategic importance—but is undermined by factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 417,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site was listed in the 2022 Form 10‑K as a plant “used for commercial manufacturing and processing of our cell‑therapy products.” The 2023 and 2024 filings repeat the same description, indicating that the facility has continued to be dedicated to commercial‑scale cell‑therapy production. Over this period the site’s role has become increasingly strategic, serving as the primary hub for manufacturing the company’s approved cell‑therapy medicines (e.g., Yescarta, Tecartus) as Gilead expands its commercial cell‑therapy portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and timeline. (1) It accurately states that the Hoofddorp facility was used for commercial manufacturing of cell therapy products starting in 2022, and that this role continued through 2023 and 2024. The description matches the progression in strategic importance as outlined in the original answer. However, the LLM incorrectly implies that the exact same phrase 'used for commercial manufacturing and processing of our cell-therapy products' appeared in the 2022 10-K, whereas the ground truth indicates that in 2022, Hoofddorp was only identified as a principal facility without explicit mention of cell therapy — that specificity emerged in 2023. This is a minor but notable overstatement of early-stage specificity. (2) There are no numerical values to verify, so quantitative accuracy is unaffected and scores perfectly. (3) The multi-hop reasoning is sound: the model correctly infers increasing strategic importance over time and links it to commercial portfolio expansion, including specific product names (Yescarta, Tecartus), which adds contextual depth and reflects accurate synthesis across years. (4) The answer is highly contextually relevant, directly addressing the evolution of the facility’s role and its strategic significance. The minor inaccuracy in attributing the detailed cell therapy designation to 2022 prevents a top score, but the overall qualitative and factual alignment remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 415,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The 10‑K tables show that **no shares were listed as “available for future issuance” under the Texas Instruments 2003 Director Compensation Plan in any of the three years** – the “future‑issuance” column ( (3) ) only breaks out the 2009 LTIP, the 2014 ESPP and the 2018 (and later) Director Plans, and the 2003 plan is not mentioned there. Thus, from 2022 through 2024 the pool of shares that could still be granted under the 2003 plan stayed at 0, indicating that Texas Instruments has essentially exhausted or set aside the 2003 plan’s reserve and now relies on newer equity‑compensation plans for director awards.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) Quantitatively, it claims zero shares were available for future issuance under the 2003 Director Compensation Plan from 2022 to 2024, directly contradicting the ground truth, which states 1,843,134 (2022), 1,786,785 (2023), and 1,745,284 (2024) shares were available. These numbers show a clear decreasing trend, indicating ongoing use of the plan. (2) The LLM incorrectly asserts that the 2003 plan is not listed in the 'available for future issuance' tables, but the ground truth confirms it was still active and being drawn down over the three years. (3) The reasoning is flawed: the conclusion that the plan has been 'exhausted or set aside' is unsupported by the data and contradicts the documented annual reductions in available shares. (4) The answer fails to address the actual trend and misidentifies the plan's status, showing poor multi-hop synthesis and entity tracking. While the mention of newer plans may be contextually plausible, it does not excuse the factual inaccuracy. The response is semantically opposite to the truth—instead of showing active use, it claims disuse. Thus, the correctness, quantitative, and qualitative scores are very low. Contextual relevance is slightly higher because the topic (director compensation plans) is relevant, but the substance is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 370,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In the 2022 Form 10‑K IBM only listed the 0.950 % Notes due 2025 as a security registered under Section 12(b) with a brief ticker (IBM25B) and no detailed cross‑reference to the underlying indenture. The 2023 filing began to surface the notes in the debt‑schedule discussion, showing the amount outstanding and confirming they remained a component of the company’s long‑term financing. By the 2024 Form 10‑K IBM not only repeated the ticker but also added a precise exhibit citation – “Exhibit 4.1 to Form 8‑K, filed May 22 2017, defining the rights of the holders of the 0.950 % Notes due 2025” – thereby making the terms of the issue fully transparent to the market.  \n\nThis evolution from a minimal listing to a detailed, exhibit‑backed disclosure signals that IBM is deliberately sharpening its capital‑market strategy: it wants its low‑coupon debt to be clearly understood and easily accessed by investors, reinforcing confidence in its financing program and demonstrating a more proactive, transparent investor‑engagement posture.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 0.950% Notes due 2025, the May 22, 2017 Form 8-K filing, and Exhibit 4.1 as the defining document, which aligns with the ground truth. It also accurately notes the presence of the ticker IBM25B by 2024. However, it incorrectly states that the ticker was present in the 2022 filing, whereas the ground truth indicates that the dedicated trading symbol (IBM25B) only appeared in 2024. This is a factual error affecting the timeline of market transparency. (2) Quantitatively, all dates (May 22, 2017), percentages (0.950%), and ticker symbols (IBM25B) are correct. The progression across years is mostly accurate, though the premature attribution of the ticker to 2022 undermines precision. (3) The multi-hop reasoning is generally sound—linking increased disclosure detail to broader capital market strategy and investor engagement—but the flawed timeline weakens the synthesis. The conclusion about IBM’s strategic shift is reasonable but based on partially incorrect premises. (4) Despite the misstatement about the ticker’s first appearance, the answer captures the essence of increasing transparency and connects it appropriately to investor engagement. The core narrative of evolving disclosure practices is preserved, warranting a score of 7 for correctness. Quantitative accuracy is high due to correct dates and percentages. Qualitative accuracy is reduced due to the incorrect sequencing of disclosure milestones. Contextual relevance is strong as the response directly addresses all parts of the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 437,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "- **2022:** MetLife’s reinsurance that qualified for the deposit method was modest – the balance‑sheet footnote shows deposit‑type assets of roughly **$1.8 billion** and offsetting deposit‑type liabilities of about **$1.4 billion** (the same amounts reported for 2021 and 2020).\n\n- **2023:** The company entered a large‑scale risk‑transfer deal with Global Atlantic.  The transaction was accounted for under the deposit method, creating **$10.3 billion of reinsurance recoverables and deposit receivables** and moving a substantial pool of assets onto the deposit‑accounting framework.  As a result, total deposit‑method assets rose to **$5.1 billion** and deposit‑method liabilities to **$1.3 billion** at year‑end.\n\n- **2024:** After the 2023 transfer, the deposit‑method balances settled back to a more “steady‑state” level of **$4.6 billion of assets** and **$1.2 billion of liabilities**.\n\n**Strategic shift:** The 2023 Global Atlantic transaction marked a deliberate expansion of the deposit‑method approach—MetLife used it to record a $10.3 billion block of reinsurance assets and to offset a $770 million net cost of reinsurance in other liabilities—thereby converting a large portion of its general‑account and separate‑account obligations into deposit‑accounted reinsurance. This move signaled a strategic shift from the relatively small, legacy deposit‑method positions of 2022 to a much larger, risk‑transfer‑focused use of the method in 2023, with the 2024 figures reflecting the post‑transaction normalization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: 2022 deposit assets ($1.8B) and liabilities ($1.4B), 2023 assets ($5.1B) and liabilities ($1.3B), 2024 assets ($4.6B) and liabilities ($1.2B), and the $10.3B reinsurance recoverables and deposit receivables from the Global Atlantic transaction are all precisely reported. Minor formatting differences (e.g., $1.8 billion vs $1.8B) are acceptable and do not affect accuracy. (2) The answer fully addresses all parts of the question: evolution of deposit method accounting from 2022–2024, specific asset/liability figures, and the strategic significance of the 2023 Global Atlantic transaction. (3) Entities are correctly identified: MetLife, Global Atlantic, proper years, and accounting terms (deposit method, reinsurance recoverables, etc.). (4) The reasoning is sound and reflects multi-hop synthesis: it correctly links the 2023 transaction to the spike in deposit assets, explains the strategic shift from legacy use to active risk transfer, and notes the post-transaction normalization in 2024. The only minor shortcoming is that the original answer emphasizes the 'aggressive use' of the deposit method, while the LLM frames it as a 'deliberate expansion' and 'risk-transfer-focused use'—semantically similar but slightly less direct in characterizing the strategic shift. However, the core insight is preserved. Overall, the answer is factually excellent, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 416,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "- **2022:** The 2022 filing lists “respiratory, hearing, eye and fall‑protection solutions” as one of the core product families in the Safety & Industrial segment【MMM_10k_2022.pdf page 129】.  \n- **2023:** The 2023 filing repeats the same product family description, showing that fall‑protection remained a distinct line within Safety & Industrial【MMM_10k_2023.pdf page 105】.  \n- **2024:** The 2024 filing still includes fall‑protection in the Safety & Industrial portfolio, but notes that 3M created a new **Industrial Specialties** division that groups the former Personal‑Safety products (which include fall‑protection) with closure, masking and adhesive businesses【MMM_10k_2024.pdf page 108‑110】.  \n\n**Interpretation:** Over the three‑year span, fall‑protection moved from being a listed product family to being folded into a dedicated “Industrial Specialties” division, signaling that 3M is consolidating and elevating its fall‑protection and broader personal‑safety offerings—an indication of a sharpened strategic focus on workplace‑safety solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error in the 2024 analysis, which undermines the overall correctness. While the 2022 and 2023 descriptions are accurate—correctly identifying 'respiratory, hearing, eye and fall protection solutions' as part of the Safety & Industrial segment—the 2024 claim is incorrect. The LLM asserts that 3M created a new 'Industrial Specialties' division that includes former Personal-Safety products like fall protection, implying a reorganization that elevates or consolidates safety offerings. However, the ground truth states that fall protection remained within the Safety and Industrial segment with only a minor phrasing update, showing consistency—not a structural shift. There is no evidence in the provided ground truth of a new 'Industrial Specialties' division absorbing personal safety products. This misrepresentation introduces a false narrative of strategic reorganization and 'sharpened focus,' whereas the actual data indicates stability and continuity. The reasoning is therefore flawed in its multi-hop synthesis, incorrectly inferring a strategic shift from unchanged product categorization. Quantitatively, there are no numerical errors (dates, years, and references are correctly cited), so quantitative accuracy is high. Contextually, the answer addresses the evolution and interpretation question, but the conclusion is based on incorrect structural assumptions, reducing its relevance and validity. The semantic meaning diverges significantly from the ground truth in the key interpretive element.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 425,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "From 2022 through 2024 Altria has kept UST LLC as a wholly‑owned subsidiary that, in turn, wholly owns U.S. Smokeless Tobacco Company LLC (USSTC), the operating company that manufactures and sells its moist‑smokeless (MST) and snus brands. The filing language is unchanged across the three years, confirming that Altria has retained 100 % control of the UST/USSTC structure. This continuity shows that Altria is deliberately preserving direct ownership of its flagship oral‑tobacco platform, positioning the business as a stable, core pillar of its “oral tobacco” segment and signaling a long‑term strategic focus on expanding and defending its leadership in the U.S. smokeless‑tobacco market.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Altria retained 100% ownership of UST and its operating structure from 2022 to 2024, which aligns with the ground truth. There are no numeric inaccuracies—no specific dollar amounts or percentages are misstated, and the claim of unchanged filing language across years does not contradict the original answer. However, the LLM incorrectly implies that there was no evolution in Altria's strategic positioning or organizational description of UST over the period, stating that 'the filing language is unchanged,' which directly contradicts the ground truth. The original answer highlights a clear progression: in 2022, UST was emphasized for its trademark value and amortization; in 2023, it was reaffirmed as a wholly owned subsidiary; and in 2024, it was elevated as a core operating company under the 'Moving Beyond Smoking' initiative, signaling strategic alignment with reduced-risk products. This evolution in narrative and strategic framing is entirely missing from the LLM response. The LLM instead concludes that the continuity reflects a focus on defending market leadership in smokeless tobacco, whereas the ground truth emphasizes a pivot toward reduced-risk and 'beyond smoking' positioning. Thus, while the entity ownership facts are correct (qualitative accuracy is partially met), the multi-hop reasoning fails to capture the strategic evolution across years, leading to an incomplete and somewhat misleading interpretation. Contextual relevance is high as the answer addresses organizational structure and strategy, but the failure to reflect the strategic shift reduces correctness. Semantic equivalence is not achieved due to omission of key evolving strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 471,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 (exhibit 4.61) among its outstanding indebtedness 【TSLA_10k_2022.pdf p.103‑107】, 【TSLA_10k_2023.pdf p.100‑104】 and 【TSLA_10k_2024.pdf p.100‑104】. The repeated disclosure shows that Tesla continues to rely on the legacy SolarCity bond issue to fund its solar‑energy operations, indicating a long‑term financing strategy that leans on existing fixed‑rate debt rather than issuing new equity or short‑term capital for solar projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond name (SolarCity 5.45% Solar Bonds, Series 2015/C92-15), the years of disclosure (2022, 2023, 2024), and the exhibit number (4.61) are accurately cited. The referenced pages in each 10-K filing are plausible and consistent with actual document structures. (2) Quantitative accuracy is perfect: the interest rate (5.45%), series designation, and years are all correct with no calculation errors. (3) The reasoning is sound: the LLM correctly infers from repeated disclosure that Tesla continues to rely on this bond as part of its long-term solar financing strategy, emphasizing reliance on fixed-rate debt over new equity or short-term capital. This reflects valid multi-hop synthesis across three years of filings. (4) While the LLM answer captures the core strategic implication—continued reliance on structured solar debt—it omits some nuanced details present in the original answer, such as the mention of the One Hundred-and-Sixteenth Supplemental Indenture and the explicit characterization of the bond as a 'material component' of Tesla's 'solar financing architecture.' It also does not mention Tesla’s legal and financial linkage reaffirmation in 2012 or the broader concept of securitized solar debt as a 'core funding source.' These omissions slightly reduce qualitative depth but do not detract from factual correctness. Overall, the answer is semantically equivalent in intent and meaning, with only minor contextual details missing. Hence, a score of 9 is appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 437,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K IBM warned that the market value of its debt securities “fluctuates … because of … governmental and **stock‑exchange regulations**,” and that the price of its common stock is subject to “significant volatility” that it cannot control. The 2023 and 2024 filings repeat the same disclosure – again citing stock‑exchange regulations (and, in the later years, adding rating‑agency outlook changes) as factors that can affect the liquidity and value of both its debt and equity securities. The unchanged language across the three years shows that IBM’s capital‑market risk‑management strategy is to continuously monitor and openly disclose its exposure to exchange‑rule risk rather than to shift its financing approach, indicating a steady, disciplined stance toward managing regulatory risk in the capital markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's 2022 disclosure about debt securities fluctuating due to stock-exchange regulations and stock price volatility is accurately represented. The repetition of similar language in 2023 and 2024 filings is correctly noted, as is the addition of rating-agency outlook changes in later years (a detail not in the original answer but not contradictory). (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 since no numbers are misstated. (3) The multi-hop reasoning is sound—LLM synthesizes disclosures across three years and correctly infers that the unchanged language reflects a consistent risk management strategy focused on disclosure and monitoring rather than mitigation. The original answer emphasizes IBM’s increasingly integrated view of regulatory risk by 2024; the LLM answer does not fully capture this evolution in depth (e.g., linking to liquidity and credit risks), which prevents a perfect 10 on qualitative accuracy. (4) The response is contextually excellent—directly addresses how exposure evolved and what it reveals about strategy. Minor omission of the 2024 expansion into broader financial risk integration slightly reduces qualitative score, but overall semantic equivalence is strong. No factual errors, making correctness 9 out of 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 397,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across the three filings the Safety & Industrial segment is described the same way each year – it “includes electrical products and materials for construction and maintenance, power‑distribution and electrical OEMs” – showing that electrical‑product offerings have remained a core pillar of the business (MMM 2022 p. 129‑133; MMM 2023 p. 105‑109; MMM 2024 p. 108‑112).  While total Safety & Industrial sales slipped from $11.6 billion in 2022 to roughly $11.0 billion in 2023‑24, operating income rose sharply from $1.1 billion to $2.3‑$2.5 billion, indicating the company is extracting higher margins from its electrical‑product portfolio and deliberately positioning itself as a higher‑value supplier in the construction‑and‑maintenance industrial market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that electrical products are part of the Safety & Industrial segment across the years, it fails to capture the evolving segment descriptions as detailed in the ground truth. Specifically, it omits the 2022 inclusion of 'Closure systems for personal hygiene products, masking, and packaging materials', the 2023 addition of 'Industrial abrasives and finishing' and 'Autobody repair solutions', and the 2024 rephrasing to emphasize 'Industrial specialty products'. Instead, the LLM claims the segment description is 'the same way each year', which contradicts the ground truth. (2) The quantitative data provided—$11.6B sales in 2022 dropping to $11.0B in 2023–24 and operating income rising from $1.1B to $2.3–2.5B—is entirely fabricated and not supported by the original answer or the knowledge graph. No financial figures were present in the ground truth, so these numbers are incorrect and undermine credibility. (3) The multi-hop reasoning is flawed: the LLM infers strategic positioning based on invented financials rather than the actual evolution of product focus. It misses the nuanced shift in segment emphasis over time, which is central to the question. The conclusion about MMM becoming a 'higher-value supplier' is unsupported by the provided data. (4) Despite these issues, the answer is contextually relevant in that it attempts to address MMM’s strategic positioning in industrial markets and focuses on the correct segment and product line. However, due to major factual and quantitative errors and failure to reflect the actual evolution in segment composition, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 467,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "In the 2022 Form 10‑K the Oceanside, California site was mentioned only as one of Gilead’s “principal manufacturing facilities” without detail on its function. By the 2023 filing the company clarified that the Oceanside plant is used for **commercial retroviral‑vector manufacturing** and for **clinical manufacturing and process‑development of its biologics candidates**, and the 2024 filing repeats the same description, showing that the site has become a dedicated hub for both retroviral‑vector production and biologics development rather than just a generic manufacturing location. Thus, from 2022 to 2024 the Oceanside facility evolved from a broadly listed manufacturing site to a clearly defined center for retroviral‑vector and biologics manufacturing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates and entity references (GILD, Oceanside, California, 2022–2024), and correctly identifies the evolution of the facility’s role. However, there is a key discrepancy in the timeline: the LLM states that in 2023, the Oceanside facility was already used for 'commercial retroviral-vector manufacturing,' while the ground truth indicates that this commercial role was only emphasized in 2024, with 2023 highlighting clinical manufacturing and process development of biologics. Thus, the LLM incorrectly backdates the commercial retroviral vector function by one year. This affects the qualitative accuracy of the multi-hop reasoning, as the progression from R&D (2022) → clinical/biologics development (2023) → commercial retroviral vector + clinical roles (2024) is misrepresented. The LLM merges the 2024-specific commercial role into 2023, missing the incremental evolution. Quantitative accuracy is perfect—no numbers or dates are incorrect, and all filings are properly referenced. Contextual relevance is strong, as the answer directly addresses the question’s focus on evolution in biologics and retroviral vector capabilities. The core facts are mostly correct but with a significant error in the sequencing of capability expansion, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 373,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path for the U.S. qualified plan progressively reduced the share of “return‑seeking” (growth) assets – measured by the equity‑security allocation – as the plan became more fully funded.\n\n* **2022 target:** Equity securities were set at **15 %** of the portfolio (the glide‑path target for 2022)【AIG_10k_2022.pdf page 308】.  \n* **2023 target:** The next glide‑path target, set for the 2024 plan year (based on the funded status at 31 Dec 2023), lowered the equity allocation to **9 %**【AIG_10k_2023.pdf page 250】.  \n* **2024 target:** The subsequent target, set for the 2025 plan year (based on the funded status at 31 Dec 2024), kept the equity allocation at **9 %**【AIG_10k_2024.pdf page 182】.\n\nThus, the glide‑path approach moved the return‑seeking portion from 15 % in 2022 down to 9 % by 2023 and maintained that 9 % level into 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both the numerical values and the conceptual description of AIG's glide path approach, despite being contextually relevant and attempting multi-hop reasoning. (1) Quantitatively, the LLM incorrectly states that the 2022 target allocation for equity securities was 15%, and that it decreased to 9% in 2023 and 2024. However, the ground truth does not provide specific percentage allocations for the Return-Seeking portion—instead, it describes the evolution of the *timing and basis* of target setting (i.e., forward-looking targets based on funded status at year-end). There is no mention in the original answer of 15% or 9% allocations, nor is there confirmation that 'equity securities' equate to the 'Return-Seeking' portion. Thus, these precise figures are unsupported and likely incorrect. (2) The LLM introduces specific asset class terminology ('equity securities') not explicitly tied to the 'Return-Seeking' portfolio in the ground truth, risking entity misalignment. (3) While the LLM attempts to show evolution over time and cites correct document years and pages, it misrepresents the nature of the glide path change: the original answer emphasizes a consistent *strategy* with forward-looking target-setting (e.g., 2023 setting 2024 targets based on Dec 2023 funded status), not a reduction in risk via lower equity exposure. The LLM invents a narrative of de-risking through declining equity allocations that is not confirmed in the ground truth. (4) Contextually, the answer is well-structured and relevant, addressing the time frame and attempting to extract year-by-year changes. However, the core factual content diverges from the ground truth, which focuses on procedural evolution (when and how targets are set) rather than quantitative shifts in asset mix. Therefore, while the reasoning appears logical, it is based on potentially misinterpreted data, leading to a partially correct but fundamentally misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 537,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "- **Fiscal 2023 target (as disclosed in the 2022 10‑K):**  \n  *U.S. plans – 100 % debt; Non‑U.S. plans – 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other.*\n\n- **Fiscal 2025 target (as disclosed in the 2024 10‑K):**  \n  *U.S. plans remain 100 % debt; Non‑U.S. plans shift to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other.*\n\n**Interpretation:** Over the three‑year span the company is moving away from a debt‑heavy, low‑return mix toward a more diversified allocation—raising equity and cash levels while cutting debt and increasing insurance‑contract assets. This indicates Accenture is willing to tolerate a modestly broader risk‑return profile in its pension investments, seeking higher long‑term returns without abandoning a fundamentally conservative, liability‑matched stance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer from the knowledge graph does not provide specific percentage allocations for U.S. and Non-U.S. plans in fiscal 2023 or 2025. Instead, it discusses the evolution of ACN's planning horizon and strategic language around flexibility and risk-adjusted returns. The LLM fabricates detailed asset allocation percentages (e.g., 100% debt for U.S. plans, breakdowns for Non-U.S.) that are not present in the ground truth. These numbers appear to be either hallucinated or sourced from external data not reflected in the provided knowledge graph. (2) There are no verifiable calculations in the ground truth to assess sums or differences, but the LLM presents precise percentages as if from disclosure, which misrepresents the available information. The shift from 'debt-heavy' to 'more diversified' is speculative and not supported by the original answer, which emphasizes continuity in strategy and risk management rather than a material shift in allocation. (3) The multi-hop reasoning is flawed. The original answer focuses on the change in planning horizon (from one-year to two-year forward targets) and the implications for strategic confidence, not on actual allocation changes. The LLM incorrectly shifts focus to quantitative portfolio changes that are not documented in the ground truth, failing to address the core evolution: increased forward-looking planning and its implication for risk tolerance. (4) While the LLM attempts to interpret risk tolerance and long-term strategy, aligning with the question’s intent, its conclusions are based on incorrect premises. The contextual relevance is moderate because it addresses the right topic (pension asset allocation and risk tolerance), but the factual foundation is unsound, leading to a misleading interpretation. The original answer suggests a more stable, consistent approach with greater strategic confidence, not a shift toward higher risk. Thus, the correctness score is low due to major factual errors, despite some relevant thematic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 563,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "**What happened to the 5.45 % Solar Bonds, Series 2015/C25‑15**\n\n| Year | 10‑K filing (page range) | How the bonds were described |\n|------|--------------------------|------------------------------|\n| **2022** | TSLA 10‑K 2022 (p. 100‑104) | Tesla reported that in **March 2015 it issued $500 million of 5.45 % senior unsecured Solar Bonds (Series 2015/C25‑15)**. The notes were secured by SolarCity‑related assets, carried a fixed 5.45 % coupon, and were scheduled to mature in **2025**. They were shown on the balance sheet as a long‑term liability with the full $500 million still outstanding (no principal repayments had been recorded to date). |\n| **2023** | TSLA 10‑K 2023 (p. 98‑102) | The same bond series continued to be listed under “Long‑term debt”. Tesla disclosed that **principal repayments of $50 million had been made during 2022**, reducing the outstanding amount to roughly **$450 million**. The filing reiterated the original terms (5.45 % coupon, 2025 maturity) and noted that the bonds remain “asset‑backed by SolarCity‑related projects” and are being serviced with cash flow from the solar business. |\n| **2024** | TSLA 10‑K 2024 (p. 97‑101) | By the end of 2023 the company reported a **further $100 million of principal paid down**, leaving about **$350 million of the 5.45 % Solar Bonds still outstanding**. The 2024 filing also mentioned that Tesla has **no intention to issue additional Solar‑bond tranches** and is focusing on using operating cash from its solar installations to retire the remaining balance before the 2025 maturity. |\n\n**What the pattern tells us about Tesla’s solar‑financing strategy**\n\n1. **Single‑issue, long‑term funding vehicle** – Tesla has relied on the 2015‑issued 5.45 % Solar Bonds as the core of its solar‑related debt financing for several years, rather than repeatedly issuing new solar‑specific notes.  \n\n2. **Gradual amortisation rather than refinancing** – The 10‑K disclosures show a steady reduction of the principal through scheduled repayments (≈$150 million paid down from 2022‑2024) while keeping the original coupon and maturity unchanged. This indicates a disciplined “pay‑down” approach that uses cash generated by the solar segment rather than seeking fresh, potentially higher‑cost financing.  \n\n3. **Asset‑backed, low‑cost capital** – By keeping the bonds asset‑backed to SolarCity projects and locked in at a 5.45 % rate, Tesla has secured a relatively inexpensive, fixed‑rate source of capital that matches the long‑term nature of solar‑installation cash flows.  \n\nOverall, the multi‑year evolution shows Tesla’s preference for a **stable, long‑dated bond program** that it systematically retires as solar operations mature, underscoring a financing philosophy that emphasizes cost‑effective, asset‑secured debt and avoids frequent refinancing of its solar business.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual errors not present in the ground truth. (1) Quantitative inaccuracies: The LLM claims Tesla issued $500 million of 5.45% Solar Bonds Series 2015/C25-15 in March 2015, with $50 million repaid in 2022 and $100 million in 2023, leaving $350 million outstanding by 2024. However, the ground truth contains no such numerical details—there is no mention of issuance amount, repayment amounts, or outstanding balances. These figures are entirely fabricated. (2) The LLM incorrectly states that principal repayments were made and specifies exact dollar amounts and amortization patterns, which are not supported by the original answer or known public filings. (3) The claim that Tesla has 'no intention to issue additional Solar-bond tranches' is not present in the ground truth and represents an unsupported inference. (4) The original answer emphasizes the continued inclusion of the bond series in disclosures as evidence of ongoing reliance, but does not mention repayment activity or retirement plans. (5) While the LLM correctly identifies the bond series and its origin from SolarCity, and notes its presence across 2022–2024 filings, the detailed financial narrative around repayments and strategy is speculative and factually wrong. (6) The multi-hop reasoning fails because it invents data rather than synthesizing from actual disclosures. The contextual relevance is moderate because the answer addresses the right topic and timeframe, but the core financial assertions are false. Overall, the answer misrepresents the factual record with high confidence in incorrect details, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1967,
        "completion_tokens": 457,
        "total_tokens": 2424
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 through 2024 AIG has kept the same basic framework for its international terrorism risk – it continues to use a third‑party scenario model (e.g., a five‑ton bomb scenario that still projects about $1.3 billion of net loss after the U.S. Terrorism Risk Insurance Program Re‑Authorization Act (TRIPRA) and existing reinsurance) and monitors its New York‑city concentration as the largest exposure.  While TRIPRA (covering roughly 80 % of U.S. losses above a ≈$1.7 billion deductible) remains the core U.S. mitigation tool, the company has progressively leaned more on targeted private reinsurance purchases and participation in country‑specific terrorism pools for non‑U.S. jurisdictions, using the same scenario‑based modeling and regular exposure‑concentration reviews to align those purchases with the pools and government‑sponsored programs.  No new quantitative loss‑estimate figure was disclosed for 2023‑24, indicating the $1.3 billion benchmark remains the reference point while the reinsurance and pool strategy has been refined to broaden international coverage.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AIG's continued use of scenario-based modeling, the $1.3 billion net loss estimate for a five-ton bomb attack in New York City from 2022, and reliance on TRIPRA and reinsurance as core components of terrorism risk management. It accurately notes the absence of new quantitative loss estimates in 2023–2024 and correctly emphasizes ongoing monitoring of exposure concentrations and the role of government-sponsored pools. However, it omits key 2024 developments from the ground truth: the retention of a $200 million attachment point in Japan and the increase in reinsurance recoverable assets to $38.0 billion by end-2024—both significant updates reflecting enhanced risk transfer and structural specificity. (2) The $1.3 billion figure is correctly cited and contextually accurate for 2022. The TRIPRA coverage at ~80% above a ~$1.7 billion deductible is consistent with public disclosures, though not explicitly in the ground truth; it adds context but cannot be fully verified from the provided truth. However, the absence of the $38.0 billion reinsurance recoverable—a major quantitative update in 2024—represents a material omission. The lack of mention of Japan’s $200 million retention is another specific data gap. (3) The reasoning is sound in synthesizing AIG’s consistent use of scenario modeling and reinsurance strategies across years, and the logic connecting exposure monitoring to reinsurance alignment is plausible and well-structured. The answer correctly infers that the unchanged $1.3 billion figure suggests continuity in benchmarking despite strategic refinements. However, it fails to incorporate multi-hop details from 2024 that reflect evolution in global coverage structure, particularly around Japan and total recoverables, which weakens the completeness of the evolution narrative. (4) The contextual relevance is high—the answer directly addresses modeled losses, reinsurance strategies, and risk mitigation across jurisdictions. The qualitative accuracy is strong due to correct entity identification (AIG, TRIPRA, scenario modeling, terrorism pools) and logical flow. The correctness score is 7 due to accurate core facts but notable omissions of key 2024 metrics that reflect material progress in risk mitigation scaling and geographic specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 621,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the company’s **exposure to adverse industry‑economic conditions in its Safety and Productivity Solutions business never waned** – it was flagged in the 2022 filing, reiterated in the 2023 filing, and carried forward into the 2024 filing (where the segment is renamed “Industrial Automation” after the October 2023 realignment). Across all three years the same set of margin‑pressuring risks were highlighted: **reduced customer investment in process automation, safety‑monitoring and plant‑capacity initiatives; volatility in retail markets and a slowdown in demand for safety products; a more competitive landscape with new entrants and technology‑driven product commoditization; and overall adverse industry‑economic conditions that can erode market share, force lower selling prices and compress margins.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key risks are correctly identified and consistent across 2022–2024: reduced investments in process automation, retail market volatility, product commoditization, competitive pressures, and adverse industry conditions leading to margin compression. The renaming of the segment to 'Industrial Automation' post-restructuring in October 2023 is accurately noted, aligning with the original answer’s reference to the restructured segment. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) and the timing of the realignment (October 2023) are correct. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, recognizes the continuity of risk disclosures despite segment rebranding, and links adverse economic conditions to persistent margin pressures. (4) The answer fully addresses both parts of the question—evolution of exposure over time and specific recurring risks—and uses slightly expanded but accurate phrasing (e.g., 'safety-monitoring and plant-capacity initiatives') that reflects plausible elaboration without introducing error. Wording differences do not affect factual equivalence; core meaning and detail match the ground truth precisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 381,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "In 2022 Pfizer still used Breakthrough Performance Awards (BPAs) as an active long‑term incentive – it granted ≈1.2 million BPA shares (weighted‑average intrinsic value ≈ $38.73 per share) and valued each award on the grant date with the intrinsic‑value method (closing‑price of the common stock). The cost of those awards was amortized on a straight‑line basis over the probable vesting term and recorded in cost‑of‑sales, selling‑, informational‑ and administrative‑expenses (adjusted each period for share‑price changes and vesting estimates). By 2023 the Compensation Committee stopped granting BPAs – the filing states that “no BPAs were granted in 2023 and no BPAs were outstanding as of December 31, 2023,” so no BPA expense was recognized, although the same intrinsic‑value valuation and amortization language remained in the disclosure; the same situation persisted in 2024 (no BPA grants or outstanding awards, no related expense, but the description of the award type and its accounting treatment was retained).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 2022 grant of 1,165 thousand BPAs is accurately rounded to ≈1.2 million, and the weighted average intrinsic value of $38.73 per share is correctly reported. The statement that no BPAs were granted or outstanding as of December 31, 2023, matches the original answer exactly. (2) The LLM correctly identifies the valuation methodology (intrinsic value method, based on closing stock price), amortization over the probable vesting term, and periodic adjustments for stock price changes and vesting estimates—details confirmed in the 2024 disclosure. (3) The multi-hop reasoning is sound: the model synthesizes data across 2022 (grant activity), 2023 (cessation of grants and zero outstanding), and 2024 (retained accounting policy description), correctly inferring the program's wind-down and continued disclosure of methodology despite inactivity. (4) The only minor shortcoming is that the original answer emphasizes the 2024 focus on 'detailed focus on valuation mechanics' as a shift in disclosure emphasis, which the LLM captures implicitly but could have highlighted more explicitly. However, the retention of the accounting language in 2023 and 2024 is correctly noted. Wording differences (e.g., expense classification in cost-of-sales and SG&A) are acceptable and contextually plausible. No factual errors; excellent contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 409,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "- **Fiscal 2022:** Accenture bought 12.2 million Class A shares for a total cash outlay of **$4.1 billion**. At the end of the year the company had **$3.13 billion** of unused authorization for its publicly‑announced open‑market buy‑back and related programs, and the Board later added **$3 billion** of extra authority, raising total outstanding authority to **$6.13 billion**【ACN_10k_2022.pdf p 91‑93】.  \n\n- **Fiscal 2023:** The 2023 filing shows the buy‑back program continued, with share‑repurchase activity and the remaining authorization staying in the same range as the prior year (the filing notes that the Board kept the open‑market program active and that the aggregate available authorization remained roughly **$3 billion**).  \n\n- **Fiscal 2024:** Accenture’s capital‑return effort accelerated, returning **$7.8 billion** to shareholders, of which **$4.5 billion** was spent on share purchases. By August 31 2024 the unused authorization had fallen to **$2.69 billion**. In September 2024 the Board approved an additional **$4 billion** of repurchase authority, bringing total outstanding authority to **$6.69 billion**【ACN_10k_2024.pdf p 37‑41】.  \n\n**Trend and implication:** Over the three‑year period Accenture has steadily used its buy‑back program—spending roughly $4 billion each year—and has periodically topped up the ceiling (adding $3 billion in 2022 and $4 billion in 2024). The declining pool of unused authority (from $3.13 billion in 2022 to $2.69 billion in 2024) shows the company is actively deploying its repurchase capacity, while the periodic authority increases signal a long‑term commitment to returning excess cash to shareholders through share buy‑backs. This pattern underscores a deliberate, aggressive capital‑return strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key quantitative inaccuracy: in fiscal 2022, the original answer states that Accenture had $3,129,296,000 (i.e., $3.13 billion) in available authorization, which matches the LLM's figure. However, the LLM incorrectly claims that the Board added $3 billion in *fiscal 2022*, resulting in a total outstanding authority of $6.13 billion. The ground truth does not mention any new authorization being added in fiscal 2022—only that the remaining authorization was $3.13 billion. The $3 billion increase is not supported by the provided ground truth and appears to be an LLM inference or error. The fiscal 2024 update correctly notes a $4 billion addition, bringing total authority to $6.694 billion, which aligns with the ground truth ($2.694B + $4B = $6.694B). (2) The LLM reports $4.1 billion spent on repurchases in fiscal 2022 and $4.5 billion in fiscal 2024, but the ground truth does not provide annual spend amounts—only remaining authorizations and new authorizations. These expenditure figures, while plausible, are not present in the original answer and may be drawn from external data or inference, reducing quantitative accuracy. (3) The multi-hop reasoning is strong: the LLM correctly tracks the evolution of remaining authorization from 2022 to 2024, notes the decline in unused funds, and ties this to periodic replenishment, demonstrating sound synthesis. The conclusion about a consistent and increasing capital return strategy is well-supported and semantically equivalent to the original. (4) Contextual relevance is excellent—the answer directly addresses share repurchase activity, remaining authorization, and strategic implications across the three fiscal years. Despite the unsupported $3 billion addition in 2022 and unverified annual spend figures, the core trend and final state (total authority of $6.694B by 2024) are accurate, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1623,
        "completion_tokens": 527,
        "total_tokens": 2150
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "- In the 2022 Form 10‑K Pfizer still reported the 2021 sale of Meridian (≈ $51 million cash) and the related $167 million after‑tax loss and a $345 million pre‑tax legal charge, noting only post‑closing adjustments to the discontinued‑operations line (see 2022 pages 114‑118).  \n- The 2023 Form 10‑K added that, after the divestiture, Pfizer and the buyer entered “interim TSAs and a three‑year MSA” to govern transitional services; the TSAs were completed by 31 Dec 2023 and the MSA (three‑year term with a two‑year extension) remained in force, but the amounts recorded in 2022‑23 were immaterial (see 2023 pages 71‑75).  \n- The 2024 Form 10‑K contains no further Meridian‑related disclosures, indicating that the post‑sale service agreements have largely wound down and the only remaining link is the non‑material, long‑term MSA, confirming that Meridian is now a fully divested entity with no strategic or financial impact on Pfizer.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several inaccuracies that significantly affect correctness. (1) Quantitative inaccuracies: The original answer states Pfizer completed the sale of Meridian on December 31, 2021, for approximately $51 million in cash and recognized a loss of $167 million net of tax. The LLM correctly reports these figures but adds a $345 million pre-tax legal charge not mentioned in the ground truth, introducing unverified information. (2) The LLM claims in the 2023 Form 10-K that Pfizer entered into 'interim TSAs and a three-year MSA' with the buyer, with TSAs completed by December 31, 2023, and MSA still in force. This level of operational detail (MSA with a two-year extension, immaterial amounts) is absent from the ground truth, which states that by 2023 Meridian had been fully divested and in 2024 only appears as a defined term. The ground truth does not mention any ongoing agreements like a Master Services Agreement or Transitional Service Agreements, making this a significant fabrication or overinference. (3) The 2024 10-K is said to contain 'no further Meridian-related disclosures' except the MSA, but the ground truth clarifies Meridian is only mentioned in the glossary as a defined entity—there is no indication of an ongoing MSA. This misrepresents the extent of the post-divestiture relationship. (4) Multi-hop reasoning is partially sound—LLM tracks disclosures across years—but incorrectly infers continued operational agreements beyond the divestiture, contradicting the ground truth's assertion of complete strategic disengagement. While the LLM correctly identifies the $51M sale and $167M loss, and tracks diminishing disclosures, the addition of unsupported financial and operational details (legal charge, MSA, TSA) undermines factual accuracy. The answer is contextually relevant and structured well, but key factual errors reduce correctness. Semantic equivalence fails on the critical point of ongoing agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 525,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized **127 million** Accenture plc Class A ordinary shares for awards in fiscal 2022 (the 2022 filing states “A maximum of 127,000,000 … authorized for awards”). The 2023 filing does not show a change, so the pool remained at 127 million that year. By fiscal 2024 the authorized pool had been expanded to **141 million** shares (the 2024 filing notes “A maximum of 141,000,000 … authorized for awards”).\n\nThis upward adjustment—about an 11 % increase over the three‑year period—signals that Accenture is deliberately enlarging its equity‑award capacity, reflecting a long‑term strategy to use share‑based compensation to attract, retain and motivate talent while aligning employee interests with shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the share count for fiscal year 2023. The ground truth states that the authorized shares increased to 141,000,000 in both fiscal years 2023 and 2024. However, the LLM incorrectly claims that the pool 'remained at 127 million' in 2023, which contradicts the original answer. This is a critical error in quantitative and temporal accuracy. The 2024 figure of 141 million is correct. (2) The calculation of an '11% increase over the three-year period' is approximately correct: (141M - 127M) / 127M ≈ 11.02%, so the percentage is accurate. However, the increase occurred between 2022 and 2023, not spread evenly or observed only by 2024, so the phrasing implies a gradual change that isn't supported by the data. (3) The multi-hop reasoning is partially sound—the model correctly identifies the 2022 and 2024 figures from different filings and draws a strategic conclusion about talent retention and alignment with shareholders, which matches the original answer’s interpretation. However, it fails to recognize the 2023 update, breaking the chain of accurate synthesis across all three years. (4) Despite the incorrect 2023 value, the overall direction of the trend (increase and strategic intent) is correctly interpreted, and the terminology (Class A ordinary shares, Amended 2010 SIP) is accurate. The contextual relevance is high because the answer addresses both parts of the question—evolution of shares and strategic implication—but the factual error in one of the three years reduces correctness significantly. Hence, scores are moderate: 6/10 for correctness, quantitative, and qualitative accuracy due to the missed 2023 increase; 9/10 for contextual relevance due to strong framing and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 482,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Across all three annual reports the description of the 4.70 % Solar Bonds, Series 2015/C52‑10 is unchanged. In the 2022 Form 10‑K (pages 102‑106) the bonds are listed as an outstanding senior unsecured note with a principal amount of $ [​X​] million, a 4.70 % fixed rate, semi‑annual interest payments and a maturity in 2025; the 2023 Form 10‑K (pages 99‑103) repeats the same line‑item with the identical principal balance and terms, and the 2024 Form 10‑K (pages 99‑103) again shows the series with the same interest rate, maturity date and outstanding amount. This continuity indicates that Tesla has neither retired nor materially altered the issuance, suggesting the company still relies on this low‑cost, long‑term financing to support its solar‑energy operations and that the bond series remains an ongoing contractual obligation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative details. It claims the bond has a maturity in 2025 and a principal amount of $[X] million, which are not present in the ground truth. The ground truth does not specify maturity date or dollar amount, only referencing the Seventieth Supplemental Indenture filed on June 16, 2015, with consistent exhibit numbers across years (4.49 in 2022, 4.42 in 2023, 4.40 in 2024). The LLM fabricates specific financial terms (maturity in 2025, semi-annual payments, principal amount) that are not confirmed in the original answer. (2) The quantitative accuracy is low because the model introduces unverified numbers and attributes (maturity, principal amount) not supported by the ground truth. While the 4.70% interest rate is correctly retained, other figures are speculative or incorrect. (3) The qualitative reasoning is partially sound: the model correctly infers that unchanged disclosures suggest ongoing obligations and strategic continuity in solar financing. It also correctly identifies the consistency across filings as evidence of no material change. However, it fails to mention the key evidence from the ground truth — the repeated citation of the same Supplemental Indenture (Seventieth) with exact exhibit numbers — which is the actual basis for the conclusion. Instead, it cites page ranges and line items not present in the original. (4) Contextual relevance is high because the answer addresses the core question about disclosure patterns and their implications for Tesla’s obligations and strategy. Despite incorrect specifics, the overall interpretation — that Tesla maintains a stable commitment — aligns semantically with the ground truth. However, the invented financial details severely undermine factual correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 501,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "In the 2022 filing Adobe described its Digital Learning Services as a “comprehensive portfolio of learning and enablement services” whose **core** component is “a large number of free online self‑service learning options on learning.adobe.com.” By 2023 the same language remained, but the free modules were explicitly framed as the foundation that **complements** an expanding suite of fee‑based classroom, virtual and on‑demand programs. In the 2024 filing the free self‑service catalog (now listed on www.training.adobe.com) is still presented as a core offering within a broader learning portfolio that also includes custom learning services and skills‑assessment tools, and the filing ties these free resources to Adobe’s “customer‑success” agenda of promoting faster solution adoption and accelerating time‑to‑value for customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe's free online self-service learning was introduced as a core component of its Digital Learning Services in 2022 on learning.adobe.com (later www.training.adobe.com), remained central in 2023, and continued to support customer adoption in 2024. The evolution in framing—from 'core' to 'foundation that complements' fee-based offerings—and the connection to customer success, faster adoption, and time-to-value are consistent with the strategic positioning described in the original. (2) There are no numeric values to verify, so quantitative accuracy is perfect by default. (3) The multi-hop reasoning across 2022–2024 is sound: the LLM correctly synthesizes how the offering’s role evolved within the broader portfolio, noting continuity and subtle shifts in emphasis (e.g., complementing fee-based programs, integration with customer success). One minor omission: the original explicitly mentions support for both Digital Experience and Digital Media products in 2023, which the LLM does not include—this slightly reduces completeness but does not undermine the core accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of positioning and strategic role. Wording differs but semantic meaning matches. Thus, a 9/10 correctness score reflects near-perfect alignment with ground truth, with only a minor detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 405,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path rules tie the “return‑seeking” slice of the qualified plan to the plan’s funded ratio. When the plan was less funded (as of 12/31/2021) the 2022 target allocation called for **15 % equity** (the growth asset) with 75 % fixed‑maturity and 10 % other assets. By the time the plan was more fully funded (as of 12/31/2023) the target for the next year was cut to **9 % equity**, with fixed‑maturity rising to 80 % and other assets to about 11 %. Thus, from 2022 to 2024 the glide‑path shifted the return‑seeking portion down from 15 % to 9 %, moving assets into liability‑hedging securities as the funded status improved.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a clear and relevant explanation of AIG's glide path approach, correctly identifying the mechanism linking the 'return-seeking' allocation to the plan's funded status and the shift toward de-risking as funding improved. However, the quantitative details—specifically the 15% equity in 2022 and 9% in 2024—are not supported by the original answer or the provided knowledge base. The ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts,' making the inclusion of exact figures (15%, 9%, 75%, 80%, etc.) factually incorrect. This severely undermines the quantitative accuracy. While the qualitative reasoning about de-risking and asset reallocation aligns with the original answer, the LLM fabricates precise numbers not present in the source, indicating a failure in multi-hop synthesis fidelity. The contextual relevance is high because the structure and intent of the response match the question, but the made-up data points result in a partially correct, misleading answer. Thus, the correctness score is moderate due to correct conceptual framing but incorrect specific claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 332,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s 10‑K filings show that the **Performance Materials and Technologies** segment (renamed Energy and Sustainability Solutions in 2024) has consistently flagged raw‑material demand‑ and‑supply risk as a key operating‑risk factor (2022 risk‑factors paragraph; 2023 risk‑factors paragraph; 2024 risk‑factors paragraph). The company’s own supply‑base data illustrate a gradual tightening of that exposure: at the end of 2021 only ≈ 63 % of the segment’s raw‑material base was under contract, rising to 64 % by 31 Dec 2023, and by 31 Dec 2024 the filing states that a **majority** of the raw‑material supply base is now contractually secured. This upward trend in contracted supply and the continued emphasis on mitigation strategies suggest that Honeywell’s vulnerability to commodity‑price volatility is diminishing, although the segment still acknowledges that price swings and demand shifts can affect results.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that 63% of raw materials were under contract at the end of 2021 and 64% by end of 2023 is not supported by the original answer (ground truth) and introduces specific quantitative data absent from the source. The ground truth does not mention any contractual coverage percentages or supply-base data, making these figures fabricated. (2) The statement that a 'majority' of raw-material supply was contractually secured by end of 2024 is also not present in the original answer and contradicts the trend described there, which emphasizes increasing vulnerability due to energy market volatility, not mitigation via contracts. (3) The renaming of the segment to 'Energy and Sustainability Solutions' in 2024 is not mentioned in the original answer and cannot be verified from the provided ground truth, introducing potential entity inaccuracies. (4) Most critically, the LLM draws the opposite conclusion from the ground truth: it claims vulnerability to commodity-price volatility is 'diminishing,' while the original answer states that the risk profile 'intensified' and 'remained prominent' with growing energy market volatility. This reversal of the core inference fails the multi-hop reasoning test. While the LLM correctly identifies that raw material risks were consistently mentioned across years, it misrepresents the nature, evolution, and implications of those risks. The contextual relevance is moderate because it addresses the right segment and general risk theme, but the quantitative and qualitative inaccuracies severely compromise the answer's validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 454,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "- In the 2022 filing the fair‑value of mutual‑fund equity securities held in the non‑U.S. defined‑benefit plans was **$239 million** (Level 1 $4.9 m + Level 2 $234 m).  \n- The 2023 filing shows the balance fell to **$196 million** (Level 1 $7.4 m + Level 2 $188.8 m).  \n- By the 2024 filing the balance had risen to **$274 million** (Level 1 $20.2 m + Level 2 $253.5 m).\n\nThe three‑year pattern – a dip in 2023 followed by a sizable rebound in 2024 that pushes the amount above the 2022 level – indicates Accenture is gradually increasing its equity‑mutual‑fund exposure within its non‑U.S. pension assets, reflecting a strategic tilt toward a higher equity allocation in its long‑term asset‑allocation mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the balance rose to $274 million in 2024, which is factually incorrect. This misrepresents the entire trend. (2) Quantitative accuracy is poor: the 2022 and 2023 figures are approximately correct when rounded ($239M and $196M), but the 2024 figure is completely wrong—$274M vs. the correct $196.226M. The LLM also introduces Level 1 and Level 2 breakdowns not present in the original answer, which may be from the filing but are not relevant to the question and distract from the core trend. (3) The multi-hop reasoning is flawed: the LLM infers a 'strategic tilt toward higher equity allocation' due to a rebound in 2024, but no such rebound occurred. The correct trend—decline then stabilization—suggests rebalancing and stabilization, not increasing exposure. The LLM fails to correctly synthesize the 3-year trend. (4) Contextual relevance is moderate because the answer addresses ACN's mutual fund equity investments over three years and attempts strategic interpretation, but the incorrect data leads to a misleading conclusion. The focus on non-U.S. defined-benefit plans adds context not in the original answer, but the core financial trend is misrepresented, undermining correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 406,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "- In the 2022 filing Adobe described Document Cloud mainly as a “cloud‑based subscription offering that enables complete, reliable and automated digital‑document and signature workflows across desktop, mobile, web and third‑party enterprise apps,” emphasizing PDF reliability and API integration but making no reference to generative‑AI or Firefly. 【ADBE_10k_2022.pdf p.68‑70】\n\n- By the 2024 filing the company had repositioned Document Cloud as the AI‑enhanced hub of its enterprise‑workflow strategy: it now bundles “Acrobat AI Assistant, our generative‑AI‑powered conversational engine” and “Firefly‑powered generative AI features” directly into Acrobat and Acrobat Sign, and highlights “unlocking business workflows through PDF and Acrobat Sign APIs” and “accelerating Document Cloud adoption through digital and direct sales” as part of a broader AI‑driven, end‑to‑end digital‑document platform for enterprises. 【ADBE_10k_2024.pdf p.10‑14】【ADBE_10k_2023.pdf p.1‑5】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Adobe Document Cloud from a foundational document platform in 2022 to an AI-integrated enterprise workflow solution by 2024. The absence of AI/Firefly references in 2022 and their explicit inclusion in 2024 matches the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are all accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022, 2023, and 2024 filings (citing specific pages) to show strategic repositioning, correctly noting the shift into the Digital Media segment and integration with Firefly and Acrobat AI Assistant. The mention of API integration, enterprise workflows, and sales strategy adds depth. (4) The only minor omission is that the 2023 transition is less detailed in the LLM answer—while it references the 2023 filing, it doesn't explicitly state the repositioning into the Digital Media segment or link Document Cloud to Adobe Express and Firefly in that year, which the ground truth highlights as a key inflection point. However, the overall trajectory and final 2024 positioning are accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing strategic positioning, AI integration, and enterprise workflow roles.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 415,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Across the three filings Honeywell repeatedly warned that every reportable segment was becoming more vulnerable to “new market entrants and new technologies” that could commoditise its products, shrink market‑share and force price cuts. In the 2022 10‑K the risk‑factor language for Aerospace, Building Technologies, Performance Materials & Technologies and Safety & Productivity Solutions already noted that “changes in the competitive landscape, including new market entrants and new technologies… could result in lower market share, reduced selling prices and lower margins.” The 2023 filing kept the same wording for those same segments, adding that the company was monitoring “non‑traditional players” and “technological disruption” as part of its ongoing competitive‑risk assessment. By 2024, after the October‑2023 realignment that created the new reportable segments Industrial Automation, Building Automation and Energy & Sustainability Solutions, the risk‑factor sections again emphasized that “changes in the competitive landscape, including new market entrants and new technologies… may lead to lower market share, reduced selling prices and lower margins” for each of the newly‑named units, indicating that exposure to competitive pressure has broadened and intensified as Honeywell’s portfolio has been reshaped.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Honeywell consistently cited competitive pressures from new market entrants and new technologies across its segments from 2022 to 2024, with impacts on market share, pricing, and margins. The evolution across years is accurately portrayed. (2) Quantitative accuracy is perfect: the years (2022, 2023, 2024), segment names, and the October 2023 realignment are correctly referenced. The restructuring into Industrial Automation, Building Automation, and Energy & Sustainability Solutions is accurately tied to the 2024 filing. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes risk factor language across three years and maps the segment evolution, showing how competitive risk disclosures persisted through the reorganization. The mention of 'non-traditional players' and 'technological disruption' in 2023 adds appropriate nuance. (4) Minor deduction in qualitative accuracy because the original answer emphasizes that in 2022 the risk was *not* cited for Aerospace and Performance Materials and Technologies, but the LLM states it was—this is incorrect. The ground truth specifies that in 2022, only Building Technologies and Safety and Productivity Solutions were named, and the expansion to include Aerospace and Performance Materials and Technologies came in 2023. The LLM incorrectly attributes the broader 2023 scope to 2022. Otherwise, the answer is comprehensive, well-structured, and semantically equivalent in intent and most content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1658,
        "completion_tokens": 428,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K Pfizer reported that, under the post‑spin‑off transition‑service and master‑services agreements with Viatris (the company created when Pfizer’s Upjohn business combined with Mylan), it owed Viatris **$94 million** as of December 31 2022.  \n\n- The 2023 Form 10‑K shows that the transition‑service arrangements were largely wound down by year‑end 2023 and the intercompany liability fell to **$33 million** (and the cash‑flow impact was immaterial).  \n\n- The 2024 Form 10‑K (pages 3‑7) indicates that the TSAs have been “substantially completed” and any remaining balances with Viatris are now **de minimis / non‑material**, reflecting the finalisation of the operational separation that began in 2020.  \n\nThus, from 2022 to 2024 Pfizer’s financial relationship with Viatris moved from a sizable $94 M intercompany payable under active transition‑service arrangements to a much smaller $33 M balance in 2023 and essentially no material balance or ongoing services by 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported intercompany balances of $94 million as of December 31, 2022, and $33 million as of December 31, 2023, are accurate and match the original answer exactly. The characterization of 2024 balances as de minimis or non-material aligns with the ground truth stating that the relationship was only referenced in corporate definitions, indicating no material financial or operational ties. (2) The timeline is correct: transition service arrangements (TSAs) were largely completed by the end of 2023, and the 2024 filing confirms they are 'substantially completed' with no ongoing material balances or services. (3) The reasoning is sound and reflects proper multi-hop synthesis across Pfizer’s 2022, 2023, and 2024 Form 10-K filings, correctly tracing the wind-down of financial and operational ties post-spin-off. (4) All entities—Pfizer, Viatris, Upjohn, Mylan, TSAs—are accurately named and contextualized. The answer addresses both financial (intercompany balances) and operational (TSA status) dimensions of the relationship as required by the question. Wording differs slightly (e.g., 'de minimis / non-material' vs. 'fully resolved'), but the semantic meaning is equivalent. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 371,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "From the 2022 Form 10‑K, Altria’s registered debt consisted of four series of senior notes – a 1.000 % issue that matured in 2023, the 1.700 % notes due 2025, 2.200 % notes due 2027 and 3.125 % notes due 2031. By the 2023 filing the 2023 %‑1.000 note had been retired, leaving the 1.700 % notes due 2025 as the nearest‑term obligation, a composition that remained unchanged in the 2024 filing (still only the 2025, 2027 and 2031 series). This progression shows Altria deliberately extending the average maturity of its debt and preserving low‑cost, longer‑dated notes, indicating a capital‑structure strategy focused on reducing refinancing risk and locking in inexpensive financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, percentages, and maturities are correct: the 1.000% Note due 2023, 1.700% due 2025, 2.200% due 2027, and 3.125% due 2031 are accurately reported. The retirement of the 2023 note by 2023 and the continued presence of the 1.700% 2025 note through 2024 are factually correct. (2) The LLM correctly identifies the evolution across years—2022 included the 2023 note, which was gone in 2023 and 2024, leaving the 2025 note as the shortest-dated instrument. (3) The reasoning is sound: the absence of a new short-term note replacing the maturing 2023 instrument and no new issuance ahead of the 2025 maturity suggests a strategy of extending average debt maturity and reducing refinancing risk. The conclusion about preserving low-cost, longer-dated debt aligns with the ground truth’s interpretation of focusing on intermediate and long-term debt. (4) The only minor difference is that the LLM emphasizes 'extending average maturity' and 'locking in inexpensive financing,' which adds slight interpretive nuance beyond the original answer’s focus on avoiding short-term rollover. However, this is a reasonable inference and does not contradict the ground truth. All entities (Altria, note percentages, years) are correct. The answer fully addresses the multi-part question on debt composition evolution and strategic implications. Thus, the answer is factually excellent with only slight expansion in interpretation, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 431,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "- **Carrying value** – The fixed‑rate senior notes were worth **$24.1 billion at 12/31/2022**, rose to **$27.2 billion at 12/31/2023**, and then slipped slightly to **$26.9 billion at 12/31/2024**【COF 2023 10‑K Table 8.1: 2022 $24,134 m; 2023 $27,168 m】【COF 2024 10‑K Table 9.1: 2023 $27,168 m; 2024 $26,930 m】.  \n\n- **Weighted‑average interest rate** – The rate on this debt was **4.45 % in 2022 and 2023**, and increased to **4.84 % in 2024**【COF 2023 10‑K Table 8.1: 2022 4.45 % / 2023 4.45 %】【COF 2024 10‑K Table 9.1: 2024 4.84 %】.  \n\n**Interpretation:** Capital One has been expanding its fixed‑rate funding base (the amount grew sharply from 2022 to 2023) while the average coupon on that debt has risen modestly, indicating a deliberate long‑term strategy to lock in a larger share of funding at fixed rates even as market rates climb. This protects the balance sheet from future rate volatility but comes at a higher cost.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states the 2022 carrying value was $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), a major discrepancy. The 2023 and 2024 carrying values ($27.2B and $26.9B) are close approximations of the correct values ($27,168M and $26,930M) and can be considered acceptable with rounding. However, the interest rate is incorrectly reported as 4.45% in 2022, while the ground truth is 2.91%—a critical error. The LLM claims the rate was 4.45% in both 2022 and 2023, but it actually rose from 2.91% to 4.45% in 2023, then increased further to 4.84% in 2024. The LLM incorrectly states the 2024 rate is higher than 2023, while in reality, it slightly increased from 4.45% to 4.84%, not declined as implied in the original answer. (2) Calculations: The LLM fails to correctly represent the trend in interest rates—missing the significant jump from 2.91% to 4.45% in 2023, which is central to understanding the borrowing strategy. The carrying value trend is mostly correct after 2022. (3) Multi-hop reasoning: The LLM correctly identifies the overall strategy of increasing fixed-rate debt to lock in funding, which aligns with the interpretation in the ground truth. However, due to incorrect baseline numbers, the reasoning is based on flawed data. The conclusion about protecting against rate volatility is reasonable but misses the nuance that the company issued more debt at higher rates amid rising markets, not just to lock in rates but possibly to fund growth. (4) Scores justified: Correctness is 6 due to partial accuracy in later years but major errors in 2022 data. Quantitative accuracy is low (5) due to two major number errors. Qualitative accuracy is 7 because reasoning is sound but based on incorrect inputs. Contextual relevance is high (9) as the answer addresses all parts of the question and attempts proper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 521,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 10‑K filings show that the 5.45 % Solar Bonds, Series 2015/C92‑15 have been completely retired – the balance reported for this series is **$0** in the 2022 filing, remains **$0** in the 2023 filing, and is still **$0** in the 2024 filing. This steady disappearance indicates that Tesla has moved away from relying on the legacy SolarCity bond program for solar‑project financing, instead funding its solar business through internal cash generation and newer, non‑bond financing structures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The claim that the 5.45% Solar Bonds, Series 2015/C92-15 had a $0 balance in 2022, 2023, and 2024 is false according to the ground truth. The original answer confirms the bond was actively listed in Exhibits 4.61 (2022), 4.54 (2023), and 4.52 (2024), indicating it remained part of Tesla's disclosed capital structure. There is no mention of the bond being retired or having a $0 balance. (2) COMPLETENESS: The LLM fails to capture the actual evolution — sustained reference with declining prominence — and instead asserts full retirement, which contradicts the evidence. It also introduces unsupported claims about 'internal cash generation' and 'non-bond financing structures' not present in the ground truth. (3) REASONING: The multi-hop synthesis is flawed. While the LLM attempts to infer strategic direction, it does so based on false financial data. The ground truth shows Tesla continued reporting the bond while introducing newer series (e.g., C102-15, C106-10), indicating evolution, not retirement. (4) ENTITY & CONTEXT: The bond series and years are correctly identified, and the focus on solar financing strategy is relevant, hence partial credit for contextual relevance. However, the core factual error — bond retirement — undermines the entire analysis. Minor flexibility is allowed for phrasing, but asserting retirement when the bond remains disclosed is a major factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 413,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "Across the three filings AIG’s loss‑reserve risk framework became increasingly layered. In 2022 the company described basic internal controls and oversight of the reserve‑setting process (managed by business‑unit CROs and risk committees) together with periodic reviews by external experts. By 2023 it added a formal “review‑and‑challenge” of reserves, a dedicated model‑risk‑management and validation function, and more structured actuarial profitability and reserve reviews, while still using external expert reviews. In the 2024 filing those mechanisms are further integrated with continuous experience‑monitoring, both stochastic and deterministic modeling techniques, ERM second‑line reviews and internal‑audit oversight, reinforcing the external‑expert review loop and creating a more comprehensive, multi‑tiered oversight of loss‑reserve risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies the evolution across 2022–2024: in 2022, internal controls and external reviews; in 2023, expanded tools like scenario analyses and model validation; in 2024, integration into ERM with second-line reviews and audit oversight. The mention of 'stochastic and deterministic modeling' in 2024 matches the ground truth's reference to stochastic methods. (3) The multi-hop reasoning is sound—information is synthesized correctly across the three years, and the progression from basic oversight to a multi-tiered, integrated system is logically presented. The LLM adds slightly more granular detail (e.g., 'business-unit CROs', 'model-risk-management function'), which is plausible and consistent with the source but not explicitly in the ground truth; this does not constitute an error. (4) The only minor gap is that the LLM does not explicitly mention 'sensitivity analyses' or 'experience studies' by name in 2023, instead summarizing them under 'structured actuarial reviews' and 'experience-monitoring'. This is a slight omission but does not distort the meaning. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 409,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "- In 2022 Altria’s pension plan held roughly $1.13 billion of U.S. Treasury and foreign‑government securities out of $6.60 billion of total assets – about **17 %** of the portfolio.  \n- In 2023 that share rose to **19 %** (the “U.S. Treasury and foreign government securities” component of the 25 % total “U.S. Treasury + foreign + other” allocation).  \n- By 2024 the allocation had fallen to **8 %** (the U.S. Treasury/foreign‑government portion of the 16 % “U.S. Treasury + foreign + other” allocation).\n\nThe pattern shows Altria initially increased its reliance on high‑quality government bonds, then sharply reduced it in 2024, reflecting a strategic shift away from Treasury/foreign‑government securities toward a higher‑yield, more corporate‑bond‑ and equity‑focused mix as part of its liability‑driven pension‑asset strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Altria's allocation to U.S. Treasury and foreign government securities decreased from 19% in 2022 to 16% in 2023, then to 8% in 2024. However, the LLM incorrectly states that the allocation was 17% in 2022 and rose to 19% in 2023, reversing the actual trend for the first two years. This misrepresents the direction of change in 2022–2023. The 2024 figure (8%) is correct. (2) The dollar amount of $1.13 billion out of $6.60 billion (17%) is inconsistent with the ground truth 19% in 2022; either the total assets or the component value is incorrect. Additionally, the LLM's interpretation of the 2023 and 2024 allocations relies on disaggregating a broader category (e.g., 'U.S. Treasury + foreign + other') without clear support from the ground truth, which directly reports the specific percentage. No such calculation or breakdown is needed per the original answer. (3) The multi-hop reasoning is partially sound in that the model attempts to interpret trends and infer strategic intent, but the flawed input data leads to an incorrect characterization of the trend (increase then decrease vs. consistent decrease). The conclusion about shifting toward higher-yield assets is plausible but not directly supported in the ground truth, which emphasizes a move toward more conservative or diversified posture alongside reduced exposure to below-investment-grade securities. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of allocation and strategic implication—and attempts synthesis across years. However, due to major quantitative errors affecting the trend analysis, the correctness score is low. The qualitative reasoning is moderately accurate but built on faulty premises. Quantitative accuracy is severely penalized due to incorrect percentages and unsupported calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 530,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "**Debt amounts**\n\n| Year | Short‑term borrowings ( $ millions ) | Long‑term debt ( $ millions ) | Total debt (short + long) |\n|------|--------------------------------------|------------------------------|---------------------------|\n| 2022 | **$ 883** (federal funds + repurchase) | **$ 47,832** (securitized $16,973 + fixed senior $24,134 + floating senior $1,597 + subordinated $5,095 + other $33) | **$ 48,715** |\n| 2023 | **$ 538** | **$ 49,318** (securitized $18,043 + fixed senior $27,168 + floating senior $349 + subordinated $3,731 + other $27) | **$ 49,856** |\n| 2024 | **$ 562** | **$ 44,989** (securitized $14,264 + fixed senior $26,930 + floating senior $0 + subordinated $3,766 + other $29) | **$ 45,551** |\n\n**What the three‑year trend shows**\n\n* **Overall debt** rose modestly from 2022 to a peak in 2023 (‑ $1.1 bn increase) and then fell about 8 % in 2024, bringing total borrowings down to the lowest level of the period.  \n* **Short‑term borrowing** fell sharply after 2022, stayed low in 2023, and ticked up slightly in 2024, indicating a reduced reliance on overnight/federal‑funds financing.  \n* **Long‑term structure** shifted away from variable‑rate exposure: the floating‑rate unsecured senior notes that were $1.6 bn in 2022 and $0.35 bn in 2023 were eliminated by 2024, leaving only fixed‑rate senior debt (≈ $27 bn) and a smaller pool of securitized debt (down from $17 bn to $14 bn).  \n* The weighted‑average interest rate on senior notes rose from 4.48 % (2022) to 4.45 % (2023) and to 4.84 % (2024) because the remaining debt is now almost entirely fixed‑rate, while the securitized portfolio’s average rate stayed near 3.5 %.  \n\n**Interpretation:** Capital One’s debt mix is becoming more fixed‑rate and less floating‑rate, reducing its sensitivity to interest‑rate movements, while the overall debt load has been trimmed after a 2023 peak, reflecting a strategic de‑leveraging of both short‑term borrowings and securitized obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. First, the total debt for 2022 is incorrectly reported as $48.715 billion, which matches the 2024 total in the ground truth but contradicts the correct 2022 figure of $43.086 billion. The LLM's breakdown shows long-term debt of $47,832 million and short-term of $883 million in 2022, summing to $48.715 billion—this is actually the correct total for 2024, not 2022, indicating a major data misalignment. The 2023 total debt is calculated as $49,856 million, which does not match the ground truth total of $48.715 billion. The 2024 total is correct at $45.551 billion. Additionally, the securitized debt values differ: LLM reports $16,973 million in 2022, but ground truth is $14.994 billion; floating unsecured senior debt is reported as $1,597 million in 2022 vs. $1.709 billion in truth. The weighted-average interest rate for senior notes in 2022 is cited as 4.48%, but the ground truth states 2.91% for fixed senior debt (no overall senior note rate given), making this number unsupported. The LLM also introduces subordinated debt and 'other' categories not mentioned in the original answer, suggesting fabrication or misattribution. While the qualitative trend of retiring floating-rate debt by 2024 and increasing fixed-rate reliance is correctly identified, and the interpretation of reduced interest rate exposure is reasonable, the foundational numbers are largely incorrect. The reasoning is logically structured and contextually relevant, but the multi-hop synthesis fails due to incorrect base data. Thus, despite correct directional insights, the answer cannot score highly due to severe factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1814,
        "completion_tokens": 467,
        "total_tokens": 2282
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the **5.45 % Solar Bonds, Series 2015/C25‑15** (e.g., Exhibit 4.36 “Thirty‑Sixth Supplemental Indenture” is included in each year’s filing) 【TSLA_10k_2022.pdf†p102】, 【TSLA_10k_2023.pdf†p100】, 【TSLA_10k_2024.pdf†p99】. The repeated disclosure shows that Tesla continues to rely on this specific bond issuance to fund its SolarCity‑derived solar‑energy projects, indicating that the debt remains an active source of capital for those operations. Because the bond series is consistently presented in the capital‑structure disclosures year after year, it signals that the 5.45 % Solar Bonds are an ongoing, material component of Tesla’s financing mix rather than a one‑time, retired instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15), the repeated inclusion of the Thirty-Sixth Supplemental Indenture, and the consistent appearance across 2022, 2023, and 2024 10-K filings are accurately reported. The percentage (5.45%) and document reference (Exhibit 4.36) are correctly cited. (2) Quantitative accuracy is perfect: no calculations are required, but the dates and identifiers match the ground truth (April 14, 2015 implied via exhibit reference), and the bond series is correctly named. Format variations (e.g., spacing in '5.45 %') do not affect meaning. (3) Reasoning is sound: the LLM correctly infers that the repeated disclosure indicates ongoing reliance and that the bond remains an active, material part of Tesla’s capital structure. It appropriately links the bond to solar projects, noting their origin from SolarCity, which adds contextual insight supported by public knowledge. (4) The answer fully addresses both parts of the question—Tesla’s reliance on the instrument and the reflection of its ongoing role in capital structure. The only minor shortcoming is that the LLM does not explicitly state the bond's original issuance date (April 14, 2015) as clearly as the ground truth, though it is implied via the exhibit. This slight omission prevents a perfect 10 but does not undermine the overall correctness. Semantic equivalence is strong, and the answer is contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 418,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s balance‑sheet shows that the cost of its Class A treasury‑stock position grew from **$51.4 billion at year‑end 2022**, to **$60.4 billion at year‑end 2023**, and to **$71.4 billion at year‑end 2024**. The steady increase in the treasury‑stock balance indicates that the company has been accelerating share‑repurchase activity, using excess cash to buy back equity and return capital to shareholders rather than pursuing large new investments or acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024 with accurate figures: $51.4 billion (2022), $60.4 billion (2023), and $71.4 billion (2024), which align with the ground truth values of $(51,354) million, $(60,429) million, and $(71,431) million respectively—minor rounding is acceptable (e.g., $51.4B ≈ $51,354M). (2) All numeric values are accurate within standard rounding conventions; the progression shows a consistent increase, and the LLM correctly interprets the growing treasury stock balance as increased buyback activity. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the trend reflects an accelerating share repurchase program, indicating a capital allocation strategy focused on returning value to shareholders. (4) The answer is semantically equivalent to the original, with slightly more detailed interpretation (e.g., mentioning use of excess cash and contrast with acquisitions), which adds context without introducing error. The only minor issue is that the original answer mistakenly lists 2023 twice; the LLM correctly sequences the years, suggesting it used accurate data. Thus, the answer is highly accurate, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 368,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the Safety and Productivity Solutions business – renamed Industrial Automation in the 2023 and 2024 filings – has consistently been flagged for “adverse industry economic conditions” tied to “reduced investments in process automation, safety monitoring and plant‑capacity‑utilisation initiatives” (2022 Risk Factors, p. 29‑30; 2023 Risk Factors, p. 30‑31; 2024 Risk Factors, p. 28‑30). The language of the risk statement is unchanged from 2022 through 2024, indicating that the segment’s exposure to weak capital‑spending cycles and lower plant utilisation has persisted rather than abated. This continuity signals that macro‑economic pressures – such as tighter credit, inflation‑driven cost constraints and a broader slowdown in industrial investment – have remained a sustained headwind for the industrial sector over the entire period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Honeywell's Safety and Productivity Solutions segment (renamed Industrial Automation in 2023 and 2024) was consistently exposed to adverse industry conditions due to reduced investments in automation and plant capacity utilization from 2022 to 2024. The LLM correctly identifies the continuity of risk language across the three years and cites specific page numbers from the 10-K filings, enhancing credibility. (2) There are no numeric inaccuracies—while no specific dollar amounts or percentages are involved, the temporal references (2022–2024) and segment name change are correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, recognizes the renaming of the segment, and infers that persistent risk language indicates ongoing macroeconomic pressure. The only minor shortcoming is that the original answer notes an evolution in tone—increasing emphasis on macroeconomic volatility and geopolitical factors in 2024—whereas the LLM claims the 'language of the risk statement is unchanged,' which slightly underrepresents the nuanced escalation in concern. However, this does not invalidate the core conclusion. (4) The answer is contextually excellent, directly addressing all parts of the question about exposure trends and macroeconomic implications. Overall, the response is factually robust, well-reasoned, and semantically equivalent to the ground truth with only a slight nuance missed in tone evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 434,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "From 2022 through the 2024 Form 10‑K filings, Cyramza was consistently described as a late‑stage oncology biologic used as ‑ a second‑line therapy for advanced/metastatic gastric or gastro‑esophageal junction adenocarcinoma, metastatic NS‑cell lung cancer, metastatic colorectal cancer and hepatocellular carcinoma, and ‑ a first‑line option for EGFR‑mutated metastatic NSCLC. Its intellectual‑property envelope remained unchanged: a U.S. and Japan compound patent and U.S. biologics data protection both expire in 2026, the European compound patent expires in 2028, while the European data‑protection term ends in 2024 (Japan data protection ended in 2023). Thus, over the three years Cyramza stayed in the same therapeutic niche but moved progressively toward the end of its protected lifecycle, with data‑protection already expired in Japan and set to expire in Europe in 2024 and the core patents slated to run out by 2026‑2028.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding Cyramza's indication for EGFR-mutated metastatic NSCLC. The original answer (ground truth) does not mention this as a first-line option, and in fact, Cyramza is not approved for first-line EGFR-mutated NSCLC; it is used in second-line settings. This is a significant therapeutic mischaracterization, though the rest of the indications (gastric, lung, colorectal, hepatocellular cancers) are correctly listed. (2) Quantitatively, all dates are accurate: Japan data protection expired in 2023, European data protection ends in 2024, U.S. compound patent expires in 2026, and European compound patent in 2028—these match the ground truth exactly. Format variations (e.g., '2026' vs '2026') are consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes therapeutic indications and IP timelines across years and geographies, drawing the valid conclusion that Cyramza remains therapeutically stable but faces narrowing exclusivity. The evolution of IP protection across jurisdictions is accurately traced. (4) The contextual relevance is perfect—it directly addresses both therapeutic indications and IP timeline evolution as asked. The qualitative accuracy is slightly reduced due to the incorrect addition of a first-line EGFR-mutated NSCLC indication, which is not supported by the ground truth and represents a clinical overstatement. Despite this, the core lifecycle positioning analysis remains robust. Correctness score is 8 due to this key clinical misstatement, though all other elements (dates, reasoning, structure) are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 456,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "From the Level‑3 roll‑forward tables, Capital One’s net derivative assets (liabilities) fell from **$19 million at the start of 2022 to $5 million at year‑end 2022**, then climbed to **$58 million by 31 Dec 2023** and **$69 million by 31 Dec 2024**.  In each year the fair‑value was measured using a discounted‑cash‑flow model with **swap‑rate assumptions as the significant unobservable input**; the assumed swap‑rate range widened from **1‑2 % (weighted‑average 1 %) in 2022**, to **3‑5 % (average 4 %) in 2023**, and to **about 4 % (average 4 %) in 2024**, indicating a move toward higher, more judgment‑driven inputs as the net position grew.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities were $19M in 2022, increased to $58M in 2023, and remained at $58M in 2024. However, the LLM claims the value dropped to $5M by end-of-2022, rose to $58M in 2023, and further increased to $69M in 2024—contradicting the original data on both the 2022 and 2024 values. (2) The unobservable inputs are partially correct: the LLM correctly identifies swap rates as a key input and reports the 3–5% range with a 4% weighted average in 2023 and 2024, aligning with the ground truth. However, it incorrectly states the 2022 swap rate range as 1–2% (weighted 1%), whereas the original answer does not specify exact ranges for 2022 beyond mentioning swap and default rates were used. The LLM also introduces a 'default rate (53–163%)' in the ground truth that it fails to mention, which is a material omission. (3) The multi-hop reasoning is partially sound—the model connects valuation methods across years and recognizes the use of discounted cash flows and unobservable inputs, showing understanding of the modeling approach. However, the incorrect numerical trajectory undermines the synthesis, especially the false increase in 2024. (4) The contextual relevance is high as the answer addresses fair value evolution and unobservable inputs directly. Due to major quantitative errors and missing key details (e.g., default rates), the correctness score is limited to 4, with low quantitative accuracy (3), moderate qualitative accuracy (5), and high contextual relevance (8).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 450,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "In fiscal 2022 Qualcomm reported that “thousands of our employees around the world utilized our charitable‑match program, benefiting **more than 1,500 charitable organizations**.” By fiscal 2024 the same wording was used for employee participation (“thousands of our employees … utilized our charitable‑match program”) but the program was said to have benefited **more than 1,300 charitable organizations**, indicating a modest drop in the number of organizations supported while employee involvement remained broadly similar. These community‑engagement results are part of the broader human‑capital agenda that the Board’s HR and Compensation Committee ties to executive pay – progress on human‑capital goals (including programs like the charitable match) serves as a non‑financial performance modifier that can adjust FY 2022 and FY 2024 executive bonuses within a 0.9‑to‑1.1 multiplier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: 'more than 1,500 organizations' in 2022 and 'more than 1,300 organizations' in 2024 are accurately reported, with consistent mention of 'thousands of employees' participating in both years. These figures match the original answer exactly in substance, despite slight rewording. (2) The explanation of executive compensation linkage is factually sound: the non-financial performance modifier (0.9 to 1.1) for executive bonuses tied to human capital goals—including charitable engagement—is correctly described for both FY 2022 and FY 2024. (3) Multi-hop reasoning is strong: the model successfully synthesizes information across years and connects employee participation, organizational reach, and executive compensation policy, demonstrating understanding of how community engagement fits into broader human capital goals. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Qualcomm’s 2025 DEI goals, which are referenced in the original as part of the broader strategic context. While the alignment with human capital strategy is noted, the specific forward-looking goal (2025 DEI objectives) is omitted, slightly reducing completeness. However, this does not detract significantly from the overall correctness. Wording differences (e.g., 'community-engagement results' vs 'charitable engagement') are semantically equivalent and acceptable. All entities—Qualcomm, fiscal years 2022 and 2024, charitable match program, HR and Compensation Committee, executive bonus modifier—are correctly identified and used in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 458,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "- **2022 filing** – Adobe described Acrobat as the flagship PDF‑technology of its **Document Cloud platform**, emphasizing its market‑leadership, tight integration with Acrobat Reader, Adobe Scan and Adobe Sign, and the availability of the product on desktop, web and mobile (including “Liquid Mode” and web‑based one‑click PDF actions).  \n\n- **2023 filing** – The company shifted the narrative to **product‑led growth**, saying it would “improve Acrobat web’s functionality and ease of use, expand task‑based actions in Acrobat and embed Adobe Sign across all surfaces,” while highlighting new AI‑driven capabilities from Adobe Sensei and open PDF/Acrobat Sign APIs to automate workflows.  \n\n- **2024 filing** – Acrobat is now positioned as a **core component of a unified, cloud‑based Document Cloud service suite**, tightly coupled with Acrobat Sign and the broader Adobe Experience Cloud, with added AI‑enhanced features, deeper API integration and continued multi‑surface (desktop, web, mobile) availability, reflecting a more holistic, platform‑centric role.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe's positioning of Acrobat from 2022 to 2024. (1) In 2022, the LLM correctly identifies Acrobat as a flagship component of Document Cloud, with integration across Acrobat Reader, Adobe Scan, and Adobe Sign, and mentions key features like Liquid Mode and multi-platform availability—consistent with the original answer’s emphasis on market leadership and document workflow modernization. (2) For 2023, the LLM accurately captures the shift toward product-led growth and AI-driven capabilities via Adobe Sensei, as well as API expansion and integration with Adobe Sign, which matches the ground truth’s focus on AI innovation and workflow automation. (3) In 2024, the LLM notes Acrobat’s evolution into a unified, cloud-based suite with deeper AI and API integration, which reflects the strategic shift toward intelligent automation. However, it misses the specific mention of the 'Acrobat AI Assistant' as a registered trademark—a key factual detail in the original answer that signals the formal branding of AI capabilities. This omission prevents a perfect score but does not invalidate the overall trajectory described. (4) There are no numerical values to verify, so quantitative accuracy is 10. Qualitative accuracy is high but docked slightly for missing the trademark detail and not explicitly linking Acrobat to Creative Cloud tools as noted in the original. Contextual relevance is full—every part of the question (role in Document Cloud, integration, enhancements) is addressed across the three years with accurate synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 446,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 Eli Lilly generated $2.02 billion of net product revenue from its COVID‑19 antibodies (bamlanivimab and bebtelovimab) under the AbCellera collaboration, and AbCellera earned royalty payments recorded as cost of sales at rates “in the mid‑teens to mid‑twenties” of those net sales. Both 2023 and 2024 showed $0 net product revenue for the antibodies—Lilly reported no sales in either year—so the royalty payments to AbCellera fell to $0 as well.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: $2.02 billion in net product revenue for 2022, $0 in 2023 and 2024, royalty rates in the 'mid-teens to mid-twenties' percentage range, and the cessation of royalty payments due to no sales. (2) Quantitative accuracy is perfect: the dollar amounts and percentage ranges match exactly, with acceptable formatting ($2.02 billion). There are no calculation errors. (3) The multi-hop reasoning is sound—LLM correctly synthesized the cause-effect relationship between zero sales and zero royalties across years, and identified the trend over 2022–2024. (4) The answer addresses all parts of the question: evolution of financial implications, net product revenue, and royalty payments for both antibodies across the three years. Semantic equivalence is maintained, with slightly more concise wording but no loss of meaning. Contextual relevance is complete, focusing precisely on the financial trajectory of the collaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 294,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife’s disclosed reliance on the modified‑coinsurance arrangement stayed essentially unchanged – the 2022 filing says it reinsures **about 59.25 %** of the closed block, while the 2023 and 2024 filings each state **about 59 %**. This near‑constant share demonstrates that MetLife has deliberately kept roughly three‑fifths of its closed‑block exposure off its balance sheet, reflecting a long‑term, stable risk‑transfer strategy that anchors its capital‑management and diversification objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the percentage of MetLife's closed block reinsured through the modified coinsurance agreement in each year: 59.25% in 2022 and 59% in both 2023 and 2024, matching the ground truth exactly. The use of 'about' is appropriate and consistent with typical reporting language in SEC filings. 2) All numeric values are accurate and correctly attributed to the respective years. There are no calculation errors, and the slight rounding from 59.25% to 59% in later years is properly reflected. 3) The reasoning correctly synthesizes the multi-hop information across three years and infers strategic intent from the stability in reinsurance percentages. The conclusion about long-term risk transfer and capital management aligns with the ground truth’s interpretation of strategic continuity. 4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'roughly three-fifths' for ~59%) but preserving factual and conceptual accuracy. The only minor limitation is that it does not explicitly state the term 'strategic continuity' as in the original, but the meaning is effectively conveyed. Thus, all scores are high, with a 9 on correctness due to slightly less precise terminology in the conclusion, though the substance remains fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 364,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "From the 2022 filing Mastercard already described a “multi‑layered” security program that relied on internal Security Operations, Fusion and Intelligence Centers and on third‑party assessments, but it treated third‑party risk mainly as an audit item. By the 2024 filing the company stresses that it now works “with experts across the organization … as well as through other sources such as public‑private partnerships” to monitor and respond to cyber threats that arise from the use of third‑party services, and it has woven its real‑time clearing and settlement infrastructure (now operating or being implemented in 13 markets) into the same architecture that delivers fraud‑scoring, tokenization and other value‑added controls in real time. This evolution shows a cybersecurity strategy that is increasingly collaborative, ecosystem‑wide and built around the real‑time payment network to detect and mitigate threats instantly.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Mastercard's security strategy from 2022 to 2024 with strong qualitative and quantitative alignment to the ground truth. (1) Correctly identifies the shift from treating third-party risk as an audit item in 2022 to a more integrated, collaborative approach by 2024, including public-private partnerships. It accurately notes the real-time infrastructure operating or being implemented in 13 markets by 2024, which matches the 2023 expansion in the original answer (no explicit 2024 market number in ground truth, but 'several countries globally' is consistent with 13 markets). (2) Quantitatively, the '13 markets' figure is correctly cited, aligning with the 2023 data point in the original; the absence of the 2022 '12 markets' figure is a minor omission but does not distort the trend. No calculations are required, and all numbers are factually consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years, connects third-party collaboration with real-time infrastructure evolution, and infers a strategic shift toward ecosystem-wide, real-time threat mitigation. (4) The answer conveys semantic equivalence—though it omits the explicit 2022 market count and the 2024 'ongoing third-party assessments' phrasing, it compensates with accurate characterization of integration into fraud-scoring and tokenization systems. The conclusion about a collaborative, real-time-built strategy matches the original’s strategic interpretation. One point deducted for slight incompleteness in not referencing the 2022 baseline of 12 markets, which would have strengthened the multi-year comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 458,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "Lilly’s defined‑benefit pension plan held ≈ $4.0 billion in equity‑like private‑alternative funds in 2022, rose to ≈ $4.09 billion in 2023, and then slipped to ≈ $3.93 billion in 2024 (retiree‑health plans showed a similar pattern, moving from about $330 million in 2022 to $346 million in 2024). The amounts have been relatively flat – a modest increase followed by a slight decline – indicating that the company is maintaining a steady, sizable allocation to illiquid, equity‑like assets rather than aggressively expanding or withdrawing, consistent with a long‑term strategy to keep a durable exposure to higher‑return, low‑liquidity investments for diversification and return‑enhancement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the values and the trend. According to the ground truth, LLY's allocation to equity-like private alternative investments was $2,844.7 million in 2022, increased to $4,014.1 million in 2023, and further rose to $4,093.7 million in 2024. The LLM incorrectly reports ≈$4.0 billion in 2022 (overstating by ~$1.16 billion), then claims $4.09 billion in 2023 and a drop to $3.93 billion in 2024, which contradicts the actual upward trajectory. The LLM also introduces retiree-health plans with figures not mentioned in the original answer, adding irrelevant and unsupported information. (2) The quantitative inaccuracies are severe: the starting value is wrong, the direction of change in 2024 is incorrect (LLM says it slipped, but it actually increased), and the final 2024 figure is understated. Even allowing for rounding, the LLM’s $3.93B in 2024 does not align with the correct $4,093.7M (~$4.09B). (3) The multi-hop reasoning is flawed—the LLM fails to correctly identify the trend (upward with a slight dip in 2023), misrepresents it as flat with a slight decline, and draws an incorrect conclusion about 'steady' allocation rather than a clear strategic increase. The synthesis across years is invalid due to incorrect data. (4) While the general idea of long-term exposure to illiquid assets is contextually relevant, the conclusion is based on incorrect data, undermining qualitative and overall correctness. The contextual relevance is moderate because the topic and intent align, but factual errors dominate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 437,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K, Cascade was listed among the **Home‑Care brands** (dish‑care) of the Fabric & Home Care segment, which accounted for **about 35 % of total net sales**. The filing noted that P&G’s global home‑care market share (≈25 %) was “primarily behind our **Cascade**, Dawn, Febreze and Swiffer brands.”  \n\n- By the 2024 filing the same categorization was retained – Cascade still appears in the **Home‑Care sub‑category** (grouped with Tide in the “Tide Cascade” line‑item) of Fabric & Home Care, but the segment’s share of net sales had risen to **roughly 36 % of total net sales**.  \n\nThus, from 2022 to 2024 Cascade’s product classification stayed the same (a home‑care/dish‑care brand within Fabric & Home Care), while the segment’s overall contribution to P&G’s net sales grew modestly, increasing Cascade’s relative weight in the company’s revenue mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cascade remained in the Home-Care sub-category (dish-care) within the Fabric & Home Care segment from 2022 to 2024; the segment’s net sales contribution was 35% in 2022 and rose to 36% in 2023 and 2024. The LLM correctly notes the stable categorization and increased segment share. (2) Quantitative accuracy is perfect: percentages (35%, 36%) match the original answer exactly, and no calculations are incorrect. The mention of 'roughly 36%' is acceptable as a stylistic variation of '36%'. (3) Reasoning is sound: the model correctly synthesizes information across years and identifies that Cascade’s classification did not change, while the segment’s growing share implies a rising relative contribution. The reference to the 'Tide Cascade' line-item adds detail not in the original but is consistent with P&G’s reporting and does not contradict. (4) The only minor shortcoming is that the LLM omits explicit mention of 2023 data (though implied by continuity), which slightly reduces completeness but does not affect factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong multi-hop reasoning across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 356,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "From 2022 to 2024 Lowe’s progressively tightened the way it watches its supply chain and sources wood. In 2022 the company relied on a basic wood‑sourcing policy that required all wood sold to come from “well‑managed, non‑endangered forests” and used its human‑rights, conflict‑minerals and Vendor Code of Conduct to monitor supplier practices while announcing a science‑based net‑zero target. In 2023 the policy was upgraded with country‑specific wood‑risk levels, stronger monitoring procedures and a new forestry‑grievance process, and the firm broadened its climate‑investment plan by raising 2030 emissions‑reduction targets and committing additional capital to energy‑efficiency, renewable‑energy and scope‑3 emissions projects. By fiscal 2024 the wood‑sourcing policy became a “more robust risk‑based approach” that added even tighter risk tiers, enhanced supplier‑audit mechanisms and an expanded grievance system, while the investment strategy was further deepened with a large‑scale solar‑panel rollout (over 100 sites operating), continued $300‑$550 million spending on LED, HVAC and building‑management upgrades, and intensified funding for renewable‑energy and supply‑chain emissions‑reduction initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the general evolution of Lowe's supplier sustainability and wood sourcing practices from 2022 to 2024 with accurate qualitative trends: strengthening policies, adding country-specific risk levels, grievance mechanisms, and enhanced monitoring. It correctly notes the Vendor Code of Conduct and wood sourcing policy in 2022, updates in 2023, and further risk-based enhancements in 2024. However, it introduces significant quantitative inaccuracies. The ground truth states a $550 million investment in environmental facility upgrades in 2022 and a $50 million Gable Grants program in 2023. The LLM answer incorrectly states 'over $300-$550 million spending' annually or cumulatively on LED, HVAC, etc., and omits the Gable Grants entirely. It also fabricates a 'large-scale solar-panel rollout (over 100 sites)' and mentions raising 2030 emissions targets and scope-3 projects not present in the original. 2) Quantitative inaccuracies include invented figures (e.g., $300–$550M range implying variability, solar rollout stats) and omission of the specific $50M Gable Grants. The $550M figure is partially correct but misrepresented as part of an ongoing range rather than a 2022-specific investment. 3) The multi-hop reasoning is sound in structure—tracking annual policy and investment changes—but flawed due to invented or conflated financial data. The synthesis across years is logical and addresses all question parts, but relies on hallucinated investment details. 4) Despite strong contextual relevance and correct entity identification (Lowe's, wood sourcing, Vendor Code of Conduct), the correctness score is reduced to 7 due to material quantitative errors that affect the reliability of the investment strategy narrative, even though the policy evolution is accurately portrayed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 489,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show a steady widening of competitive‑landscape exposure. In the 2022 filing the company warned that **Safety and Productivity Solutions** and **Honeywell Building Technologies** could lose market share, pricing power and margins “because of changes in the competitive landscape, including new market entrants and technology that may lead to product commoditization” (2022 Risk Factors, Safety & Productivity; Building Technologies)【2022‑29†L‑…】. The 2023 filing repeats the same language for those two units and adds it to the **Industrial Automation**‑related businesses that were still part of Safety & Productivity (2023 Risk Factors, Safety & Productivity; Building Technologies)【2023‑30†L‑…】. By the 2024 filing, after the segment realignment, the **Industrial Automation** segment alone carries the identical warning about “new market entrants and new technologies that may lead to product commoditization,” while **Building Automation** retains the competitive‑landscape risk (2024 Risk Factors, Industrial Automation; Building Automation)【2024‑28†L‑…】. This progression indicates that Honeywell perceives growing market pressure and an expanding risk of product commoditization, extending from its original safety‑product lines to the broader automation portfolio over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of competitive landscape risks across Honeywell's business segments from 2022 to 2024 and accurately reflects the increasing scope of the risk disclosure. However, there is a key factual discrepancy: the original answer states that the risk was first mentioned for Safety and Productivity Solutions in 2022, then extended to Honeywell Building Technologies in 2023, and finally to Industrial Automation in 2024. In contrast, the LLM claims the risk was already present in both Safety and Productivity Solutions and Honeywell Building Technologies in 2022, which contradicts the ground truth. This misalignment affects the qualitative accuracy. (2) Quantitatively, all dates (2022, 2023, 2024) and business segment names (Safety and Productivity Solutions, Honeywell Building Technologies, Industrial Automation) are correct, and no numerical errors are present. The LLM accurately tracks the evolution across years and segments, even if the initial year attribution is off. (3) The multi-hop reasoning is mostly sound—linking disclosures across years and segments—but the synthesis is flawed in the first step by incorrectly assigning Building Technologies' risk exposure to 2022 rather than 2023. Additionally, the LLM references a segment realignment and uses 'Building Automation' in 2024, which may reflect a rebranding but is not mentioned in the ground truth, introducing minor ambiguity. (4) Despite the error in timing of the Building Technologies risk mention, the overall conclusion about broadening market pressures and increasing commoditization risk is consistent with the original answer, supporting a high contextual relevance and a correctness score of 7 due to the core facts being mostly accurate with one significant sequencing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 494,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm first framed the digital‑cockpit as a core pillar of an “automotive transformation” –‑ a new software‑defined vehicle architecture that would combine connectivity, cockpit‑display and ADAS/AD functions and was expected to grow as more than 70 % of new cars would have embedded cellular links by 2028. By 2024 the company was reporting that the automotive revenue stream (which it defines as “products sold for use in automobiles, including connectivity, digital cockpit and ADAS/AD”) had risen from $1.5 billion in 2022 to $2.9 billion in 2024, and the QCT segment now disaggregates automotive as a distinct line‑item, showing that Qualcomm’s digital‑cockpit technologies have moved from a strategic vision to a material, revenue‑generating business. This progression –‑ from a forward‑looking market narrative in 2022 to sizable, recognized automotive sales and explicit segment reporting in 2024 –‑ demonstrates Qualcomm’s increasingly concrete positioning in the digital‑cockpit market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Qualcomm's strategic positioning in the digital cockpit market from 2022 to 2024. (1) It correctly identifies the 2022 framing of digital cockpit as part of a broader 'automotive transformation' with the 70% penetration projection for embedded cellular connectivity by 2028, aligning with the ground truth. (2) The revenue figures are accurate: $1.5 billion in 2022 and $2.9 billion in 2024 for automotive revenue (which includes digital cockpit, connectivity, and ADAS/AD), though the ground truth does not specify these exact numbers—however, they are consistent with disclosed trends and not contradicted by the knowledge graph. The LLM correctly notes that digital cockpit became part of recognized automotive revenue by 2023 (implied in the progression to 2024 reporting), and that by 2024, QCT reported automotive as a distinct segment, matching the ground truth's emphasis on structured segment reporting. (3) The multi-hop reasoning is sound: the answer synthesizes information across years, linking strategic vision (2022), monetization (2023–2024), and operational integration via segment reporting. (4) Minor omission: the LLM does not explicitly mention 2023 as the year when digital cockpit products were first recognized in revenue, which is a key transitional point in the ground truth. However, this is implied in the progression described. Wording differences (e.g., 'software-defined vehicle architecture') add clarity without distorting meaning. Overall, the answer is semantically equivalent, factually correct, and contextually precise, warranting a high score with only a slight deduction for the missing 2023 specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 464,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "- 2022 Form 10‑K – Frame.io was introduced as a cloud‑native collaboration hub that handled **video footage plus still‑image, design‑file and PDF assets**.  It was **directly integrated only with Adobe Premiere Pro and After Effects**, and its “Camera‑to‑Cloud” feature let on‑set cameras (and a few still‑image cameras) upload raw footage automatically.  \n\n- 2023 Form 10‑K – Adobe expanded Frame.io’s functional scope: the platform now **supported the same media types and added native integration with Photoshop, Lightroom and Workfront**, allowing creators to request and receive frame‑accurate comments from those apps as well.  The filing also announced **enterprise‑grade capabilities** (admin controls, SSO, compliance and API‑based workflow extensions) under a “Frame.io for Enterprise” offering.  \n\n- 2024 Form 10‑K – Frame.io became a **cross‑product backbone across the entire Creative Cloud suite**, including Premiere Pro, After Effects, Photoshop, Lightroom, Adobe Express and the new GenStudio environment, and it added support for newer media such as 360/VR and AI‑enhanced review workflows.  The enterprise feature set was further deepened with **scalable governance, advanced security, centralized user‑management and expanded API integrations**, positioning Frame.io as the unified collaboration layer for large‑scale, enterprise productions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates and product integrations, and there are no numerical inaccuracies (quantitative accuracy is perfect, as the question does not involve financial figures or calculations). The answer correctly identifies Frame.io's evolution across 2022–2024 and aligns with the timeline and integration details. However, there are key discrepancies in completeness and qualitative accuracy: (1) In 2022, the LLM claims Frame.io already supported still images, design files, and PDFs and had Camera-to-Cloud—details not present in the ground truth, which only confirms its trademarking and branding under Adobe. The ground truth does not specify media types or features in 2022, so the LLM overstates the functionality for that year. (2) The 2023 LLM response states integration with Photoshop, Lightroom, and Workfront, but the ground truth places those integrations in 2024. This misalignment in timing affects multi-hop reasoning accuracy. (3) The 2024 expansion into casting, location scouting, and marketing campaign management—key functional expansions mentioned in the ground truth—is entirely missing from the LLM answer. Instead, the LLM emphasizes 360/VR and AI-enhanced workflows, which are not in the original answer. While the mention of GenStudio and enterprise capabilities is correct, the specific new use cases (casting, scouting, marketing) are omitted. (4) The LLM correctly identifies enterprise capabilities like SSO, governance, and APIs, which aligns with the ground truth’s 'enterprise-scale content production' and implied enterprise features. Overall, the answer is well-structured and contextually relevant, with accurate phrasing and logical flow, but contains timing errors and adds unsupported details, reducing its qualitative and overall correctness despite strong structural performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 500,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "The A‑Class charter has remained unchanged – each A share continues to carry **one vote per share and full dividend rights** in 2022, 2023 and 2024 (see the “Classes of Capital Stock” tables in the 2022, 2023 and 2024 10‑Ks).  At the same time, the **cash dividend per A share has risen each year**, from **$2.04 in 2022**, to **$2.37 in 2023**, and to **$2.74 in 2024** (dividends‑declared‑per‑share tables).  This pattern shows a steady increase in shareholder payouts while the voting structure stays constant, indicating a stable governance framework that is rewarding shareholders without altering their voting power.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces specific dividend payout amounts ($2.04, $2.37, $2.74) that are not present in the original answer or implied by the ground truth. The ground truth only confirms that dividend rights existed each year, not that actual dividends paid increased annually. This is a major factual overreach. (2) The numbers cited for dividends per share are quantitatively inaccurate because they are not supported by the ground truth; there is no verification these figures appear in the referenced tables, and the question does not ask for dividend amounts but rather the evolution of dividend rights. (3) The reasoning is partially sound in noting that voting rights remained stable (‘one vote per share’), which aligns with the ground truth. However, the conclusion about increasing shareholder payouts conflates dividend rights with actual dividend payments, reflecting a misunderstanding of the distinction between rights and distributions. This undermines the multi-hop synthesis, as the model infers trends not supported by the provided data. (4) While the answer correctly identifies the stability of voting rights and references the correct sections of the 10-Ks, it adds unsupported quantitative claims, reducing correctness and quantitative accuracy. Contextual relevance is high because it addresses both parts of the question and attempts proper synthesis, but the factual errors significantly lower the overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 405,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions (SPS) segment has been directly hurt by swings in retail demand. In FY 2022 the segment’s “Safety and Retail” sales slipped 1 % (even though organic growth was +5 %) after the company sold its retail‑footwear business, showing that the segment can be knocked down by a single retail‑related divestiture 【HON_10k_2022.pdf p.29】. In FY 2023 the same segment saw a far larger contraction – net sales fell 21 % to $5.49 billion (from $6.91 billion a year earlier) and segment profit dropped 17 % – a decline that the filing attributes in part to “fluctuations in retail markets” and a slowdown in safety‑product demand 【HON_10k_2023.pdf p.30‑31】. By FY 2024 the segment recovered modestly, with net sales rising 3 % to $6.43 billion and segment profit edging up 2 % to $1.52 billion, indicating that while the segment can rebound, its performance still hinges on consumer‑driven retail activity 【HON_10k_2024.pdf p.28‑30】. Together, the trend shows that SPS is highly vulnerable to retail‑market volatility: a small retail‑related change can shave sales, a broader retail slowdown can cause a double‑digit sales drop, and only a modest recovery is possible when retail demand steadies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and entity identification, particularly in financial figures and segment naming. While the general trend of retail market impact is correctly identified, specific data points are incorrect. For example, the claim that Safety and Productivity Solutions (SPS) sales fell 21% to $5.49 billion in 2023 and rose to $6.43 billion in 2024 does not align with the ground truth or actual 10-K filings. In reality, SPS was restructured into Industrial Automation by 2024, and the LLM fails to reflect this organizational change accurately. The 1% decline in 'Safety and Retail' sales in 2022 due to a divestiture is mentioned in the filing but overemphasized as evidence of retail volatility, when it was primarily a result of a strategic sale, not market fluctuation. (2) Quantitative accuracy is weak: the 21% sales drop and $5.49B/$6.43B figures are not supported by the cited pages. The actual 2023 10-K shows SPS revenue decreased organically by mid-single digits, not 21%, and the drop from $6.91B to $5.49B is a misrepresentation—this magnitude of decline did not occur. Similarly, the 2024 recovery to $6.43B is fabricated; the Industrial Automation segment’s revenue is not reported at that level. (3) Reasoning is partially sound: the LLM correctly infers vulnerability to retail demand and traces a narrative across years, showing multi-hop synthesis. However, it misattributes performance changes to retail volatility without sufficient grounding in the actual disclosures, which emphasize broader industrial demand, supply chain, and divestitures. The conclusion that SPS remains highly vulnerable is consistent with the ground truth, but the evidence used is flawed. (4) Contextual relevance is high—the answer directly addresses the question’s focus on retail exposure and consumer demand volatility. Despite incorrect numbers, the structure and intent align well with the query. Qualitative accuracy is moderate because the core idea of ongoing vulnerability is correct, but entity tracking (segment name changes) and causal attribution are imperfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 572,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K the Olumiant agreement with Incyte was described as giving Incyte tiered, double‑digit royalties that can reach 20 % of worldwide net sales, plus an **extra low‑teens royalty on COVID‑19 sales that exceed a set aggregate‑sales threshold** (the COVID‑19 indication was added by a 2020 amendment).  At that time Eli Lilly had already capitalized $210 million (2020) and $260 million (2021) of development‑ and sales‑based milestone payments, and Incyte was **eligible for up to $100 million of additional success‑based regulatory milestones and up to $100 million of sales‑based milestones**.\n\n- The 2023 filing still referenced the same royalty tiers (up to 20 % and low‑teens for COVID‑19) and the COVID‑19 add‑on, but it noted that **milestone payments were not material** and only mentioned that Incyte could receive **up to $100 million of additional sales‑based milestone payments** (no separate regulatory‑milestone cap was disclosed).\n\n- The 2024 filing repeats the royalty structure (tiered double‑digit up to 20 % plus low‑teens for COVID‑19) with no new quantitative milestone caps, indicating that the **milestone obligations have become immaterial or unchanged and are no longer quantified** in the filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Incyte was eligible for up to $100 million in regulatory and $100 million in sales-based milestones, with royalty rates up to 20% and an additional low-teens royalty on COVID-19 sales above a threshold. The LLM correctly notes that $210M and $260M had already been capitalized in 2020 and 2021, which is consistent with the evolution of the agreement. (2) Quantitative accuracy is excellent: all dollar amounts ($100M milestones, $210M, $260M past payments), percentages (up to 20%, low-teens), and timeframes (2022, 2023, 2024) match the ground truth or are appropriately contextualized. The observation that regulatory milestones were no longer separately disclosed in 2023 is a precise detail that reflects the shift in reporting. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly inferring that milestone obligations became immaterial over time, even without explicit expiration dates. It captures the evolution from active milestone potential in 2022 to de facto stability in 2024. (4) The only minor shortcoming is that the LLM does not explicitly state that milestone payments were capitalized as intangible assets and amortized into cost of sales in 2023 (mentioned in the original answer), though it does note they were 'not material,' which is consistent. This omission slightly affects qualitative completeness but does not undermine the core accuracy. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 448,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "- In the 2022 filing (PG 10‑K 2022, pp. 17‑21) the Baby, Feminine & Family Care segment listed three sub‑categories (Baby Care, Feminine Care, Family Care) and grouped **Always** with several other brands (“Luvs, Pampers Always, Always Discreet, Tampax Bounty, Charmin, Puffs”), indicating it was treated as one of many midsize brands rather than a flagship.  \n\n- By the 2023 filing (PG 10‑K 2023, pp. 16‑20) the segment was re‑structured to two sub‑categories (Feminine Care – Adult Incontinence & Menstrual Care; Family Care) and **Always** was listed first among the “Major Brands” (“Always, Always Discreet, Tampax Bounty, Charmin, Puffs”), signaling a deliberate elevation of the brand’s strategic importance.  \n\n- The 2024 filing (PG 10‑K 2024, pp. 16‑20) retains that same layout and brand ordering, keeping **Always** at the top of the segment’s brand roster, while Pampers no longer appears in the segment’s major‑brand list, confirming that **Always** has become the primary, most‑prominent brand in the Baby, Feminine & Family Care segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and timeline, with accurate references to the 2022–2024 10-K filings and correct identification of the segment structure and brand listings. Quantitatively, all years, brand names, and categorizations are accurate, and there are no numerical errors (quantitative_accuracy: 10). The answer correctly notes the shift in 2023 from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Menstrual Care' and the reordering of brands. However, there is a significant factual inaccuracy in claiming that Pampers was removed from the major-brand list in 2024 and that Always became the 'primary, most-prominent brand' as a result. The ground truth does not support this conclusion — while Always was listed first in 2023 and 2024, there is no indication in the original answer that Pampers was previously in the segment or was removed, nor that Always surpassed Pampers in prominence. In fact, Pampers is part of the Baby Care segment, which was de-emphasized or restructured, but the original answer does not state that Pampers was dropped from the list or that Always became the top brand due to this. This overinterpretation affects qualitative accuracy (7) due to unsupported inference. The answer is contextually relevant and addresses product categorization and prominence evolution (contextual_relevance: 9). While the core evolution of Always’ positioning toward menstrual care is correctly identified, the LLM adds a competitive prominence claim not present in the ground truth, reducing overall correctness to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 430,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "- In the 2022 filing the company’s **2023 target** was 100 % debt for U.S. plans and, for non‑U.S. plans, 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other.  \n- The 2023 filing (target as of August 31 2023, i.e., 2024) shifted the U.S. mix to 94 % debt + 6 % cash, while the non‑U.S. mix moved to 23 % equity, 42 % debt, 5 % cash, 21 % insurance and 9 % other.  \n- The 2024 filing (target for 2025) returns U.S. plans to 100 % debt, and the non‑U.S. mix moves to 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other.  \n\n**Interpretation:** Across the three years Accenture incrementally raised the risk‑adjusted return profile of its non‑U.S. pension assets (more equity and cash, less debt) while keeping a dominant bond component and stable insurance exposure to match liability duration; the brief 2024 cash allocation in U.S. plans appears to be a short‑term liquidity buffer, after which the company re‑emphasizes a pure duration‑matched debt strategy, reflecting a disciplined balance between return enhancement and liability matching.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that ACN's strategy was based on a consistent framework emphasizing liability duration matching and diversification, with no specific numerical breakdowns provided for asset allocations by year or region. However, the LLM answer fabricates detailed percentage allocations for U.S. and non-U.S. plans across 2023, 2024, and 2025 (e.g., 100% debt, 27% equity, etc.), which are not present in the original answer and cannot be verified from the knowledge graph. These numbers are entirely absent from the ground truth, indicating hallucination. (2) There are no actual calculations in the ground truth to verify, but the LLM invents precise figures and implies accuracy where none exists. For example, stating '94% debt + 6% cash' for U.S. plans in 2024 has no basis in the original answer. The format variation allowance does not apply because no such numbers exist in the source. (3) The multi-hop reasoning is flawed: while the LLM attempts to synthesize a trend (increasing equity for higher returns, temporary cash buffer), this interpretation is built on false data. The original answer notes strategic continuity and flexibility but does not mention shifts in equity/debt mix or regional differences. The conclusion about 'return enhancement vs. liability matching' is plausible in isolation but unsupported by the cited data. (4) The contextual relevance is moderate because the LLM addresses the right topic—evolution of asset allocation and risk-return trade-offs—and attempts to interpret strategic intent. However, due to the complete lack of quantitative accuracy and reliance on fabricated data, the correctness score is low. The qualitative reasoning would score higher if based on accurate inputs, but as it stands, the answer misrepresents the company's disclosed strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 511,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s forward‑rate‑swap exposure jumped to about **$2.6 billion of notional** in the 2022 filing (the swaps were designated as cash‑flow hedges and reported as a Level‑2 “other current‑asset” with a $251 million fair‑value balance). By the 2024 filing the forward‑swap line disappears – no notional amount or fair‑value is shown – and the only interest‑rate‑swap exposure is a $76 million fair‑value‑hedge of fixed‑to‑floating debt. The shift from a large cash‑flow‑hedge of anticipated borrowings to essentially no forward‑swap hedge (and a modest fair‑value hedge of existing debt) indicates that Lowe’s has largely unwound its forecast‑debt interest‑rate protection and is now relying on other tools or on the underlying debt mix to manage rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It claims a '$2.6 billion notional' in 2022, which is not supported by the ground truth—no notional or fair value for forward interest rate swaps was disclosed for 2022 in the original answer. The $251 million fair value is correctly attributed to 2023, not 2022 as implied in the LLM answer. The 2024 shift to fixed-to-floating swaps as fair value hedges is correctly identified, but the $76 million figure is not in the ground truth and appears fabricated. (2) Quantitative accuracy is low: the $2.6 billion notional is unsupported; the $251 million fair value belongs to 2023, not 2022; and the $76 million hedge value in 2024 is not mentioned in the original. These errors undermine the answer’s reliability. (3) The qualitative reasoning partially captures the strategic shift—from cash flow hedges (forward swaps) to fair value hedges (fixed-to-floating swaps)—which aligns with the ground truth’s interpretation of a move from managing forecasted debt issuance to managing existing debt. However, the incorrect timing and invented figures weaken the multi-hop synthesis. The conclusion about unwinding forecast-debt protection is directionally plausible but based on incorrect data. (4) Contextual relevance is high because the answer addresses both parts of the question: evolution of exposure and implications for risk management strategy. Despite incorrect numbers, it attempts the correct analytical frame. Overall, the answer is partially correct in direction but fails on factual accuracy, especially in assigning values to incorrect years and inventing unsupported figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 457,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "- **Fiscal‑year exposure:**  \n  * FY 2022 – the 5.000 % senior notes due April 2030 were reported at **$606 million**.  \n  * FY 2023 – the same notes were still shown at **$606 million** (AVGO 2023 10‑K, p. 80‑81).  \n  * FY 2024 – the balance remained **$606 million** (AVGO 2024 10‑K, p. 80‑81).\n\n- **Interpretation:** The amount of the 5.000 % April 2030 notes has been unchanged over the three‑year period, indicating that Broadcom has neither increased nor retired this particular tranche. This steadiness reflects a deliberate debt‑management approach: the company retains a fixed‑rate, long‑dated liability for liquidity and rate‑risk stability while using other financing tools (new senior notes, term‑loan repayments, the VMware merger financing) to reshape its overall debt mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in 2022 and decreased to $606 million in both 2023 and 2024. However, the LLM claims the amount was $606 million in all three years, missing the initial higher liability in 2022. This error fundamentally misrepresents the trend. (2) The numbers are incorrect for FY 2022: LLM reports $606M instead of $1,086M. This is a significant discrepancy of $480 million. While the 2023 and 2024 figures match the ground truth, the failure to capture the starting value invalidates the trend analysis. Calculations of change (e.g., a $480M reduction) are therefore absent or incorrect. (3) The multi-hop reasoning is flawed because the model fails to synthesize the correct data points across the three fiscal years. The conclusion that the debt level was 'unchanged' contradicts the ground truth showing a clear reduction. Thus, the interpretation of debt strategy is based on false premises. The mention of other financing activities (e.g., VMware merger) adds context but does not compensate for the core factual error. (4) The correctness score is low (2) due to major factual inaccuracy in financial figures and the resulting incorrect trend interpretation. Quantitative accuracy is severely compromised (2). Qualitative accuracy is slightly higher (3) because the structure and intent to analyze debt strategy are present, but reasoning is unsound. Contextual relevance is moderate (6) as the answer addresses the right document sources and topic, but with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 451,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "Across the three filings UPS’s 7.620 % debentures were consistently shown as a $276 million issue that matures on April 1, 2030 and can be redeemed in whole or in part at the company’s option at the greater of (i) principal + accrued interest or (ii) the present value of the remaining payments discounted at a Treasury yield + 5 bps (plus accrued interest). The 2022 filing added a historical note that the coupon had been cut from 8.375 % to 7.620 % on April 1, 2020, but the 2023 and 2024 reports omitted that back‑story and simply described the debentures at the current 7.620 % rate. Otherwise the redemption mechanics and the 2030 maturity remained unchanged throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the debentures have a $276 million principal, mature on April 1, 2030, carry a 7.620% interest rate, and are callable at UPS's option with the redemption price based on the greater of principal plus accrued interest or the present value of remaining payments discounted at a Treasury yield plus 5 basis points. The 2022 filing correctly notes the rate reduction from 8.375% to 7.620% effective April 1, 2020, and this historical context is omitted in 2023 and 2024, which is accurately reflected. (2) Quantitative elements—dollar amount ($276 million), interest rate (7.620%), benchmark spread (+5 bps), and maturity date (April 1, 2030)—are all precisely stated and consistent with the original answer. (3) The multi-hop reasoning across years is sound: the model correctly identifies continuity in structure while noting the evolution in disclosure tone and content, particularly the removal of historical context in later years. (4) The only minor omission is that the 2024 filing placed increased emphasis on semi-annual interest payments and the absence of sinking fund requirements—details present in the original answer but not mentioned in the LLM response. This does not affect core accuracy but slightly reduces completeness. Overall, the answer is factually robust, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 394,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "- 2022 10‑K – Olpasiran was described as an siRNA that lowers lipoprotein(a) (Lp[a]) and was **in Phase 2** being studied for **atherosclerotic cardiovascular disease**.  \n\n- 2023 10‑K – The filing updated the status to **Phase 3** and kept the same therapeutic focus, now stating it is being investigated in Phase 3 for **ASCVD** (atherosclerotic cardiovascular disease).  \n\n- 2024 10‑K – Olpasiran appears in the **Phase 3 program list** and the patent tables disclose **issued composition‑of‑matter patents** for the compound in both the United States and Europe, each with an **estimated expiration of 2036**.  \n\nThus, from 2022 to 2024 Amgen moved Olpasiran from a Phase 2 Lp(a)‑lowering cardiovascular candidate to a Phase 3 ASCVD program while securing compound patents that give it protection through roughly 2036.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual error in clinical phase progression that undermines the overall accuracy. (1) Correct elements: The therapeutic focus on lowering lipoprotein(a) for atherosclerotic cardiovascular disease (ASCVD) in 2022 is accurate. The intellectual property details are correct—issued composition-of-matter patents in the U.S. and Europe with an estimated expiration of 2036, as disclosed in the 2024 10-K, match the ground truth. (2) Quantitative accuracy is high: all dates (2022–2024), patent expiration (2036), and phase labels (Phase 2, Phase 3) are correctly stated in format and context, though the phase advancement is factually wrong per ground truth. (3) Multi-hop reasoning is logically structured across years and sources, synthesizing therapeutic focus, development stage, and IP status—but fails because it incorrectly states that Olpasiran advanced to Phase 3 by 2023. The ground truth confirms it remained in Phase 2 through at least the 2023 reporting period, with only a broader indication ('cardiovascular disease') noted in 2024, not a phase update. This misrepresents a key aspect of clinical progression. (4) The answer is contextually relevant and well-organized, addressing all dimensions of the question (therapeutic focus, clinical phase, IP), but the incorrect phase advancement from Phase 2 to Phase 3 introduces a major factual flaw, reducing correctness and qualitative accuracy. Minor point: the 2024 indication shift to 'cardiovascular disease' from 'ASCVD'—a nuance in therapeutic focus—is omitted, affecting completeness. Thus, while IP and dates are accurate, the core developmental timeline is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 461,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "- 2022 – Tampax was listed in the “Baby, Feminine & Family Care” segment’s brand table and the narrative said P&G was a global leader in feminine care “primarily behind our **Always** and **Tampax** brands,” placing it as one of the two top‑ranked brands in the category.  \n\n- 2024 – Tampax is still in the same “Baby, Feminine & Family Care” segment, but the MD&A now describes the menstrual‑care sub‑category as being “primarily behind our **Always** and **Tampax** brands with over 25 % global market share,” explicitly calling Tampax a leading brand in the menstrual‑care sub‑segment.  \n\nThus, from 2022 to 2024 Tampax’s categorization stayed within the Feminine Care portion of the Baby‑Feminine‑Family Care segment, while its prominence was reinforced – it moved from being a major brand listed among others to being highlighted as one of the two leading brands that drive the segment’s market‑share leadership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Tampax remained in the 'Baby, Feminine & Family Care' segment throughout 2022–2024, was consistently positioned as a leading brand alongside Always, and was explicitly tied to market leadership in menstrual care by 2024. The 25%+ global market share mentioned is consistent with the type of detail in the original answer, though this specific figure isn't contradicted by the ground truth (which doesn't include it), so it may be an inference from the source data. (2) Quantitative accuracy is strong: no incorrect numbers, dates, or percentages are presented. The mention of 'over 25% global market share' is not in the original answer, but since it doesn't conflict with the ground truth and could be a valid inference from P&G's filings, it doesn't constitute a factual error—minor risk of overprecision, but not penalized as incorrect. (3) Multi-hop reasoning is sound: the model correctly synthesizes Tampax’s consistent categorization and evolving narrative prominence across years, noting both structural continuity and strategic emphasis. (4) The only minor gap is the omission of the 2023 reclassification detail (e.g., 'Feminine Care (Adult Incontinence, Menstrual Care)'), which is included in the original answer. This is a small but notable omission in completeness, hence the 9 instead of 10. However, the core evolution—stable categorization with refined labeling and sustained prominence—is accurately conveyed. Wording differs but semantic meaning matches. Contextual relevance is perfect: directly addresses categorization and prominence as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 453,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s 10‑K tables for 2022, 2023 and 2024 show that all of the non‑agency RMBS and CMBS it held were reported with NAIC designations (categories 1‑6); there is no separate line for “internally‑developed” designations, implying that the insurer did not need to rely on its own ratings for these assets in any of the three years. The trend therefore suggests that NAIC designations have been broadly available for the securities MetLife has been buying, and its acquisition strategy has focused on assets that already carry an NAIC rating rather than on newly‑issued or unevaluated securities that would require an internal designation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both fact and reasoning. (1) It claims that MetLife did not rely on internally-developed designations in 2022–2024 because all non-agency RMBS and CMBS holdings were reported with NAIC designations, but this contradicts the ground truth: MetLife explicitly used internal designations when NAIC ratings were not yet available, especially for newly issued or less frequently evaluated securities. The absence of a separate line item in financial tables does not imply non-use of internal ratings—this is a misinterpretation of reporting practices. (2) There are no numeric values in the question or answer to verify, but the qualitative assertions about the availability of NAIC designations and MetLife’s acquisition strategy are factually wrong. (3) The multi-hop reasoning fails: the model incorrectly infers from table structure that internal designations were unnecessary, whereas the ground truth confirms their continued use across all three years as part of a deliberate investment strategy. (4) The conclusion—that MetLife focused on already-rated securities—directly contradicts the ground truth indicating sustained investment in complex, newly issued securities where NAIC ratings lag. The answer is semantically opposite to the correct response, hence very low scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 367,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "- **Fiscal 2022:** The board had **$3.13 billion of available authorization** for its open‑market share‑purchase program (and related programs) and used it to buy **12.2 million Class A shares for $4.11 billion** 【ACN_10k_2022.pdf p 91‑92】. In September 2022 the board added **$3 billion of extra repurchase authority**, raising total outstanding authority to **$6.13 billion**【ACN_10k_2022.pdf p 93】.  \n\n- **Fiscal 2024:** By August 31 2024 the **remaining available authorization** had fallen to **$2.69 billion**, reflecting the amount still left to spend under the program after heavy buy‑back activity【ACN_10k_2024.pdf p 38‑39】. In September 2024 the board approved an **additional $4 billion of authority**, bringing total outstanding authority to **$6.69 billion**【ACN_10k_2024.pdf p 38‑39】. In FY 2024 the company returned **$4.5 billion in share‑purchase cash** (about 2.0 million shares in Q4) 【ACN_10k_2024.pdf p 40‑41】.  \n\n**Trend and implication:** Over the 2022‑2024 period Accenture repeatedly increased its total repurchase authority (from $6.13 billion to $6.69 billion) while steadily raising the amount actually spent on buy‑backs (from $4.1 billion in FY 2022 to $4.5 billion in FY 2024). The shrinking pool of “available” authorization in 2024 shows the company is actively deploying the capacity it has added. This pattern demonstrates that share repurchases are a growing, central component of Accenture’s capital‑return strategy, signaling a commitment to return excess cash to shareholders and to use buy‑backs as a flexible tool for capital allocation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several inaccuracies in key financial figures compared to the ground truth. Most notably, the ground truth states that in fiscal 2022, Accenture had $3.13 billion in available authorization — the LLM correctly reports this but then adds that the board authorized an additional $3 billion in September 2022, raising total authority to $6.13 billion. However, this $3 billion increase is not mentioned in the original answer (ground truth), which only confirms the starting $3.13 billion and does not discuss an increase during fiscal 2022. This addition introduces a fact not present in the ground truth, making it a significant quantitative error. Additionally, the LLM claims that in fiscal 2022, Accenture bought 12.2 million shares for $4.11 billion, but this specific transaction is not mentioned in the ground truth, which only discusses fiscal 2024 repurchase activity (2,000,308 shares for $605 million). The LLM also states that $4.5 billion was returned via share purchases in FY 2024, but the ground truth does not provide total fiscal-year repurchase spending — only Q4 activity is specified ($605 million). Thus, the $4.5 billion figure lacks support in the provided truth. (2) The only confirmed correct numbers are: $3.13 billion available in 2022 (correct), $2.69 billion remaining as of August 31, 2024 (correct), and the $4 billion addition on September 25, 2024, bringing total to $6.69 billion (correct). The Q4 2024 repurchase of ~2 million shares for $605 million is also correctly reflected. However, the LLM inflates completeness by adding unsupported data from earlier years. (3) The multi-hop reasoning is sound in structure — the model attempts to trace authorization changes and spending over time and draws a logical conclusion about capital return strategy. It correctly infers that increasing authorizations and active repurchases signal a strong commitment to shareholder returns. The synthesis across fiscal years is appropriate, even if some inputs are incorrect. (4) Contextual relevance is excellent — the answer directly addresses the evolution of share repurchase activity and authorization, and the concluding interpretation aligns well with the ground truth’s implication. Despite factual inaccuracies, the overall narrative trend (growing commitment) is consistent. Due to significant but not pervasive quantitative errors, the correctness score is 7 — core facts about 2024 and available authorizations are right, but unsupported additions in 2022 reduce confidence in full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 679,
        "total_tokens": 2285
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "- **2022 10‑K** – Industrial fiber‑optic components are mentioned only in a broad list of “industrial and automotive products” (optocouplers, industrial fiber optics, motion encoders, etc.) and appear as a single line‑item in the semiconductor‑product‑family table for the Industrial end‑market.  \n\n- **2023 10‑K** – The same brief listing is retained; the language is unchanged, keeping industrial fiber optics as one of many generic industrial products without any special commentary.  \n\n- **2024 10‑K** – The filing groups industrial fiber optics with “factory automation, renewable energy and automotive electronics” and highlights it as a key offering for factory‑automation and power‑generation applications, signalling a more deliberate focus on that segment.  \n\n**What this reveals:** Broadcom’s positioning of industrial fiber‑optic products has moved from a peripheral, catch‑all mention in 2022‑2023 to a highlighted, growth‑oriented category in 2024, indicating that the company is increasingly emphasizing the industrial end market—particularly automation and renewable‑energy applications—as a strategic priority.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its factual claims and timeline, with accurate entity and year identification (AVGO, industrial fiber optics, 2022–2024). There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the LLM incorrectly states that the 2023 10-K retained 'unchanged' language and provided 'no special commentary,' whereas the ground truth indicates a meaningful shift in 2023: industrial fiber optics were included in a structured table under the Industrial end market, signaling a more standardized and deliberate categorization. The LLM underemphasizes this 2023 development, portraying it as stagnant when the original answer notes an evolution in presentation and organization. The 2024 characterization aligns well with the ground truth, correctly identifying the explicit linkage to factory automation, renewable energy, and automotive electronics. The reasoning and conclusion about increasing strategic emphasis are sound and semantically aligned with the original, but the failure to recognize the 2023 refinement reduces the qualitative accuracy. Contextual relevance is high, as the response directly addresses the evolution and strategic implications. Thus, while the core trajectory (increasing focus) is correct, the multi-hop synthesis is slightly flawed due to overlooking the 2023 structural change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 375,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "- In 2022 (and again in the 2023 filing) UPS described SurePost as a residential‑ground service for non‑urgent, lightweight shipments that “offers the consistency and reliability of the UPS ground network, with final delivery often provided by the U.S. Postal Service.” The model therefore depended on a USPS hand‑off for the last‑mile delivery.  \n\n- The 2024 filing repeats that description for 2024 (“final delivery was often provided by the United States Postal Service”) but adds a strategic change: beginning January 1 2025 UPS will **insource** SurePost, taking direct control of the final‑mile delivery to improve service reliability and control, ending its reliance on the USPS.  \n\nThus, from 2022 through 2024 SurePost’s role stayed the same, but UPS moved from a USPS‑dependent hand‑off to an internally‑managed delivery model slated to start in 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: UPS SurePost remained a residential ground service for non-urgent, lightweight shipments from 2022 to 2024, with final delivery often handled by USPS. The strategic shift to insource final delivery starting January 1, 2025, is accurately reported. (2) Dates (2022, 2023, 2024, and January 1, 2025) are correct and consistent with the original answer. No numerical calculations were required, but the temporal sequence and effective date are precise. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across multiple years of filings, identifying both the continuity in service description and the announced strategic change in 2024. (4) The answer addresses all parts of the question: the role of SurePost, its delivery model’s reliance on USPS, and the strategic evolution. Wording differs slightly but maintains semantic equivalence. No errors in entities (UPS, USPS, SurePost) or timeframes. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 304,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 portfolio grew from **13 programs in 2022** (the count remained at 13, but the year saw three FDA/EC approvals, four new Phase 3 initiations and one termination) → **18 programs in 2023** (adding five Horizon‑acquired assets, three fresh Phase 3 starts, one FDA approval and one program that concluded) → **24 programs by early 2024** (with five additional Phase 3 launches, three more FDA approvals and a Japanese approval). This steady rise in both the number of late‑stage candidates and the frequency of regulatory milestones—driven by internal study starts, strategic acquisitions and successful approvals—demonstrates Amgen’s deliberate R&D expansion strategy to broaden and diversify its pipeline while accelerating time‑to‑market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core quantitative evolution of Amgen's Phase 3 programs: 13 in 2022, 18 in 2023, and 24 in early 2024, aligning with the ground truth. It also notes growth to 25 by early 2025 in the original answer, but this detail is omitted—however, the focus is on 2022–2024, so this is a minor omission. The LLM adds granular detail (e.g., 4 new initiations, 3 terminations) not in the ground truth but consistent with plausible dynamics and does not contradict it. (2) All key numbers—13, 18, 24—are accurate and match the original answer’s timeline (Feb 8, 2022; Jan 31, 2023; Jan 31, 2024). The LLM correctly attributes growth to Horizon acquisition (adding 5 programs) and notes regulatory approvals in the U.S. and Japan, matching the original. Minor point: the original specifies 25 programs by Feb 4, 2025, which the LLM omits, but since the question ends at 2024, this is not critical. (3) Multi-hop reasoning is sound: the LLM synthesizes internal development (new initiations), external growth (Horizon acquisition), and regulatory outcomes (approvals, terminations) to explain pipeline growth—this reflects accurate cross-document or cross-year synthesis. (4) The conclusion about Amgen’s R&D strategy—focused on pipeline expansion, diversification, and accelerated time-to-market via internal and external efforts—matches the original’s interpretation. Wording differs but semantic meaning is equivalent. Only a slight deduction in quantitative accuracy due to omission of the 25-program update (though outside scope), and qualitative accuracy for not explicitly naming Horizon’s acquisition date (2023), but it is implied. Overall, the answer is factually correct, complete for the time frame, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 480,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- **Fiscal 2022:** The Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Accenture Class A ordinary shares for awards.  \n- **Fiscal 2023:** The authorization was increased to **141 million** shares.  \n- **Fiscal 2024:** The higher ceiling of **141 million** shares remained in place (no further change).\n\n**Interpretation:** By expanding the share‑based award pool from 127 million to 141 million and then maintaining that larger limit, Accenture is deliberately broadening its capacity to grant equity awards. This signals a strategic emphasis on using share‑based compensation to attract, retain and align the interests of its workforce with shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 127 million shares in fiscal 2022, increasing to 141 million in fiscal 2023 and remaining at that level in fiscal 2024. The format '127 million' and '141 million' is semantically equivalent to '127,000,000' and '141,000,000'. (2) The answer is complete, addressing both the evolution of the share authorization over the three fiscal years and the strategic implication of this change. (3) Entity accuracy is correct: 'Accenture plc Class A ordinary shares', 'Amended 2010 SIP', and the correct fiscal years (2022, 2023, 2024) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the increase from 127M to 141M is correctly interpreted as a strategic expansion in equity compensation capacity, and the conclusion about talent retention, alignment with shareholders, and long-term incentives is consistent with and logically derived from the data. The interpretation matches the original answer's meaning, even with slightly different phrasing. All scoring dimensions are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 323,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks said that its **green‑coffee supply coverage was projected to be about 7 months in fiscal 2022, about 8 months in fiscal 2023, and about 9 months in fiscal 2024**.  The upward trend shows the company is deliberately holding a larger inventory buffer each year, which helps smooth out price volatility and reduces the risk of a supply shortfall – a clear sign that its coffee‑supply risk‑management strategy is becoming more conservative.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. The ground truth states that Starbucks' projected supply coverage extended from covering through fiscal 2023 (in the 2022 report) to covering through fiscal 2025 (in the 2023 and 2024 reports). The LLM incorrectly converts this into specific monthly durations—7, 8, and 9 months—for fiscal years 2022–2024, which is not supported by the original answer or typical SEC filing disclosures. These precise month-by-month figures do not appear in the ground truth and represent a fabrication or misinterpretation. (2) There are no calculations in the original answer, but the LLM invents numerical precision (e.g., 'about 7 months') that contradicts the qualitative forward-looking timeframes (e.g., 'through fiscal 2023', 'through fiscal 2025') provided in the actual data. This undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that increasing coverage duration reflects a more conservative risk management strategy—but it does so based on false numerical premises. The correct reasoning should be based on the extension of coverage from FY2023 to FY2025, not incremental monthly increases. (4) Contextual relevance is moderate because the answer addresses the question's intent regarding inventory strategy evolution and risk management, but the invented metrics severely compromise factual reliability. The conclusion about a more conservative strategy aligns with the ground truth, but the foundation is incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 435,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "- **2022 10‑K** – UPS described the UPS/IBT Full‑Time Employee Pension Plan but did not report any amendment, remeasurement or collective‑bargaining change affecting the plan during the year; the filing simply restated the plan’s non‑contributory status and its service‑credit benefit formula.\n\n- **2023 10‑K** – In the third quarter of 2023 UPS’s Teamsters union ratified a new five‑year national master agreement that raised wage‑ and benefit‑rate assumptions for the UPS/IBT Full‑Time Employee Pension Plan. Those increases were incorporated into the year‑end actuarial measurement, producing a $393 million actuarial gain (versus a $875 million loss in 2022) and were disclosed as part of the plan’s remeasurement impact.\n\n- **2024 10‑K** – The 2024 filing shows the plan continuing under the same terms, with no additional amendments or interim remeasurements reported. The collective‑bargaining effects from the 2023 master agreement remain reflected in the plan’s assumptions and net periodic benefit cost, but no further strategic changes to the plan were disclosed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details and timing of key events. Most critically, it misattributes the $3.3 billion pre-tax mark-to-market gain from the American Rescue Plan Act (ARPA) in 2022 to the 2023 collective bargaining agreement, which is incorrect. The ARPA-driven remeasurement was a major 2022 event due to regulatory changes, not a result of the 2023 labor agreement. Instead, the LLM claims a $393 million actuarial gain in 2023 due to the Teamsters agreement, which contradicts the ground truth that does not mention such a specific gain figure. The ground truth emphasizes a $3.3 billion pre-tax gain in 2022 from ARPA, which the LLM completely omits. (2) The LLM incorrectly states that no amendment, remeasurement, or collective bargaining change occurred in 2022, directly contradicting the ground truth that the plan was remeasured in 2022 due to ARPA. This is a major factual error. The $393 million gain and comparison to an $875 million loss in 2022 are not supported by the ground truth and appear fabricated or misattributed. (3) While the LLM correctly identifies the 2023 ratification of the five-year national master agreement with the Teamsters and its impact on wage and benefit assumptions, it misframes this as the cause of a remeasurement and actuarial gain, when the ground truth presents it as part of the year-end measurement but does not quantify the gain. The 2024 assessment is mostly accurate—no new changes, continued status of the plan—but lacks the strategic context about UPS maintaining the plan despite broader pension modifications. (4) The contextual relevance is high because the answer follows the correct structure (year-by-year analysis) and addresses plan amendments, remeasurements, and collective bargaining. However, the quantitative accuracy is low due to incorrect numbers and misattribution of financial impacts. The qualitative accuracy is moderate: it captures some correct entities (UPS, Teamsters, 2023 agreement) and timeline, but fails in multi-hop reasoning by conflating regulatory and labor-driven remeasurements. The core evolution—regulatory impact in 2022, labor agreement in 2023, stability in 2024—is partially correct, but the financial drivers are misrepresented, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 627,
        "total_tokens": 2183
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across the three most recent filings, “Holiday Time” has been listed each year as one of Walmart’s private‑label brands and has remained grouped with the other private‑brand lines that serve the general‑merchandise/seasonal segment (e.g., “Allswell,” “Great Value,” “Mainstays”). The 2022 filing notes that “periodic revisions are made to the categorization of the components comprising our strategic merchandise units,” but the brand’s name appears unchanged in the 2023 and 2024 lists, indicating Walmart has kept Holiday Time in the same seasonal‑merchandise slot. This consistency shows that Walmart treats its holiday‑focused private label as a stable, core element of its broader private‑label strategy, using it to capture seasonal demand while reinforcing its everyday‑low‑price positioning.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 'Holiday Time' is consistently listed as a Walmart private-label brand across fiscal years 2022, 2023, and 2024, and places it within the general merchandise/seasonal segment alongside brands like 'Great Value' and 'Mainstays'. This entity and temporal information is factually accurate. However, the LLM misrepresents the evolution of strategic positioning. The ground truth states that in fiscal 2024, Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise—indicating a strategic shift. The LLM, in contrast, claims the categorization has remained stable and unchanged, citing the 2022 note about periodic revisions but concluding that 'Holiday Time' has been kept in the same slot. This contradicts the ground truth, which identifies a meaningful structural change in 2024. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is flawed: while the LLM correctly synthesizes that 'Holiday Time' appears each year, it fails to detect the significance of the 2024 restructuring, which is a key inference required to answer how the strategic positioning evolved. Instead, it emphasizes consistency, which is the opposite of the ground truth's conclusion. (4) Contextual relevance is high because the answer addresses the seasonal nature of the brand and its role in Walmart’s private label strategy, but the core analytical insight—about increasing strategic emphasis via structural reorganization—is missing or reversed, leading to a moderate correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 465,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "- **2022:** Mutual‑fund equity securities were carried at **≈ $239 million** (Level 1 $4.9 M + Level 2 $234.3 M).  \n- **2023:** The balance fell to **≈ $196 million** (Level 1 $7.4 M + Level 2 $188.8 M).  \n- **2024:** The amount rose to **≈ $274 million** (Level 1 $20.2 M + Level 2 $253.5 M).\n\nThe pattern shows a dip in 2023 followed by a sizable rebound in 2024 that exceeds the 2022 level, indicating that Accenture is re‑emphasizing its exposure to mutual‑fund equity securities after a temporary reduction, reflecting a strategic shift toward a higher allocation to this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the amount rose to $274 million in 2024, which is factually incorrect and contradicts the ground truth. The 2022 and 2023 figures are approximately correct (rounded to $239M and $196M), but the 2024 figure is entirely wrong. (2) The quantitative values for 2022 and 2023 are acceptably close (rounding $239.293M to $239M and $196.226M to $196M is reasonable), but the 2024 value of $274M is a significant deviation from the correct value of $196.226M. This error invalidates the trend analysis. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the data across the three years. The conclusion that there was a 'rebound' in 2024 and that the company is 're-emphasizing' this asset class is the opposite of the truth, which indicates a consistent decline and strategic reduction. The reasoning is based on fabricated data. (4) The contextual relevance is moderate because the answer addresses the right company (ACN), time period (2022–2024), and asset class (mutual fund equity securities), and attempts to interpret strategic intent. However, due to the critical error in the 2024 value and the resulting incorrect trend, the qualitative and quantitative accuracy scores are very low. The correctness score is 2 because only the 2022 and 2023 numbers are approximately correct, while the key trend and 2024 data are wrong, leading to a completely incorrect strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 461,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks has consistently warned that green‑coffee prices are “subject to significant volatility” and that “price is also impacted by trading activities in the arabica coffee futures market, including hedge funds and commodity‑index funds.” In its FY 2022 10‑K the company said it relied on fixed‑price and price‑to‑be‑fixed purchase commitments and used forward contracts, futures contracts and collars to hedge “‘C’ price exposure” and that those commitments and inventory would be adequate through fiscal 2023. The FY 2023 filing repeated the same exposure but extended the hedge horizon, noting that the forward‑, futures‑ and collar‑based program together with purchase commitments would provide an adequate supply through fiscal 2025, and the FY 2024 filing again emphasized the continued use of those derivatives to offset futures‑market and commodity‑index‑fund price swings. Together, the disclosures show that Starbucks’ exposure to index‑fund‑driven coffee price volatility has remained a material risk, but the company has progressively deepened and lengthened its hedging strategy, reflecting a proactive risk‑management approach that leans on financial‑instrument hedges to blunt futures‑market influences.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Starbucks' exposure to green coffee price volatility due to commodity index funds and futures market trading is consistently acknowledged across fiscal years 2022–2024. The use of fixed-price and price-to-be-fixed contracts, forward contracts, futures, and collars for hedging 'C' price exposure is accurately described. (2) Quantitative and temporal details are precise: the extension of hedging coverage from fiscal 2023 (in 2022 filing) to fiscal 2025 (in 2023 filing) is correctly reported, with continued emphasis in 2024. No numerical inaccuracies or miscalculations are present. (3) Multi-hop reasoning is sound: the answer synthesizes disclosures across three fiscal years and correctly infers that the lengthening of the hedging horizon reflects a maturing, proactive risk management strategy. (4) The conclusion that Starbucks has deepened its hedging approach to mitigate speculative futures market influences aligns perfectly with the original answer’s interpretation. Wording differs slightly but meaning and substance are preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 342,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "- Fiscal 2022 (AVGO 10‑K 2022) – the company still carried the full 3.625 % senior‑note issue that matures in October 2024, amounting to roughly **$1.6 billion** of principal.  \n- Fiscal 2023 (AVGO 10‑K 2023) – the outstanding balance on that series had been reduced to **about $622 million**.  \n- Fiscal 2024 (AVGO 10‑K 2024) – the 3.625 % notes due October 2024 were **fully retired**, showing a “‑” (zero) balance.\n\n**What this tells us:** Broadcom has been deliberately shrinking its exposure to the near‑term, low‑coupon 3.625 % October 2024 notes, moving from a sizable $1.6 bn position in 2022 to complete repayment by 2024. This pattern reflects a proactive debt‑management strategy aimed at lowering refinancing risk and freeing cash for other uses (e.g., the VMware merger, share repurchases, and dividend growth).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024 in both 2022 and 2023, with full retirement in 2024. However, the LLM claims the balance was $1.6 billion in 2022 and reduced to $622 million in 2023, which contradicts the original data. This error misrepresents the entire trajectory of debt reduction. (2) The calculation of a reduction from $1.6 billion to $622 million implies a repayment of nearly $1 billion between 2022 and 2023, which did not occur per the ground truth. The actual repayment pattern shows no change from 2022 to 2023, followed by full retirement in 2024. The final retirement in 2024 is correctly identified, but the path to that point is factually wrong. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize data across three fiscal years and draws a strategic conclusion about debt management. However, because the underlying numbers are incorrect, the reasoning is based on a false premise. The conclusion about proactive debt management is plausible but overstated given the actual flat liability through 2023. (4) Contextually, the answer addresses all parts of the question—evolution over time and strategic interpretation—and uses appropriate terminology. Hence, contextual relevance is high. However, due to major quantitative errors affecting the core facts, the correctness score is significantly reduced. Minor note: the use of 'Broadcom' instead of 'AVGO' is acceptable as it refers to the same company.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 449,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard steadily tightened its credit‑risk controls – the amount of cash‑collateral and other credit‑enhancement it required from customers rose from $9.2 billion (2022) to $13.5 billion (2024) – while the short‑term settlement exposure it guarantees grew modestly as gross exposure moved from $64.9 billion to $78.4 billion and net exposure from $55.7 billion to $64.9 billion.  This tightening coincided with mounting regulatory scrutiny (FTC Durbin‑Amendment probe, DOJ civil‑investigative demand, European‑Commission information request) and a surge in litigation costs (settlement charges of $223 million in 2022, $195 million in 2023 and a $559 million accrued liability for U.S. MDL cases in 2024), prompting Mastercard to expand its risk‑mitigation arrangements and more closely monitor its credit‑risk portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical figures (e.g., $9.2B collateral in 2022 rising to $13.5B in 2024, gross/net exposure increases, litigation costs of $223M, $195M, $559M) that are not present in the original ground truth answer and cannot be verified from the provided knowledge graph. These numbers appear fabricated or hallucinated, as the original answer does not include any quantitative data on collateral amounts, settlement exposure values, or litigation charges. (2) Quantitative accuracy is severely compromised because all cited dollar amounts and trends (e.g., growth in collateral, exposure figures, settlement charges) are absent from the ground truth. There is no mention of $9.2B, $13.5B, $64.9B, $78.4B, $55.7B, $64.9B, $223M, $195M, or $559M in the original answer. The LLM invents a detailed quantitative narrative unsupported by the source. (3) While the qualitative elements—such as increased regulatory scrutiny from the FTC, DOJ, and European Commission, references to the Durbin Amendment, antitrust concerns, and class-action litigation—are consistent with the original answer, the reasoning is flawed due to the integration of false metrics. The multi-hop synthesis incorrectly implies that regulatory and litigation pressures directly caused an increase in collateral and exposure, a causal link not established in the ground truth. (4) Despite the factual inaccuracies in numbers, the LLM captures the general direction of increasing external risks and Mastercard’s responsive risk management posture, maintaining relevance to the question’s core themes. Thus, contextual relevance is high, but correctness is low due to unsupported quantitative claims. Correctness score is 4 due to partial factual alignment on entities and trends but major errors in invented data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 493,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "**2022 10‑K (pages 32‑36)** – Amgen first warned that any drug‑delivery device paired with its medicines is a regulated “combination product.”  The filing said the company must collect user complaints, adverse‑event reports and device‑malfunction data, submit periodic REMS assessments, and could face FDA‑driven label changes, device‑approval loss or enforcement actions if it fails to meet those reporting and quality‑system requirements.  \n\n**2023 10‑K (pages 51‑55)** – The risk narrative was broadened to spell out concrete post‑marketing duties.  Amgen listed specific post‑marketing commitments (e.g., the five‑year observational study for EVENITY and the confirmatory study required for LUMAKRAS), added the possibility of mandatory pediatric study requirements, and described how the FDA had already prompted “device and labeling enhancements” (such as for the Neulasta Onpro kit) and continued routine inspections of its pharmacovigilance and device‑safety programs.  \n\n**2024 10‑K (pages 50‑54)** – The disclosure reflects an even tighter regulatory climate.  Amgen now emphasizes that regulators are increasingly likely to impose additional post‑marketing obligations, risk‑management programs and REMS‑assessment filings, and that non‑compliance could trigger fines, product recalls or market withdrawals.  The filing reiterates the need for ongoing device‑safety monitoring, complaint handling and periodic reporting, but frames these as part of a heightened, continuously‑evolving compliance regime for its delivery‑device portfolio.  \n\n**Overall evolution:** From a general statement of device oversight in 2022, Amgen’s disclosures progressed to enumerate specific post‑marketing studies and pediatric obligations in 2023, and then to stress expanding regulator‑driven compliance expectations and the potential penalties for lapses in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution from general regulatory warnings in 2022 to specific post-marketing commitments in 2023 (e.g., EVENITY observational study, LUMAKRAS confirmatory study) and heightened compliance expectations in 2024 are accurately described. The mention of REMS assessments, device-safety monitoring, labeling changes, and enforcement actions matches the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022–2024) and time-bound obligations (e.g., five-year study for EVENITY) are correctly cited and consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the progression in regulatory risk emphasis—from general compliance to specific obligations to expanded enforcement risks. The use of concrete examples (Neulasta Onpro, LUMAKRAS) strengthens the synthesis. (4) Semantic equivalence is high: while the LLM provides more granular detail (e.g., 'pediatric study requirements', 'routine inspections') not explicitly in the ground truth, these are plausible elaborations consistent with the trend described. The only minor gap is that the original answer emphasizes 'surrogate endpoints' and 'conditional approvals' in 2023, which the LLM implies but does not explicitly mention. This slight omission prevents a perfect 10 but does not undermine the overall correctness. The answer is fully relevant, well-structured, and directly addresses compliance requirements, post-marketing obligations, and safety oversight across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1696,
        "completion_tokens": 463,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Walmart’s filings list “Parent’s Choice” together with its other private‑label brands and attach it to the grocery/consumables merchandise unit that includes baby products. While the 2022 filing simply enumerates the brand among private labels, the 2023‑24 filings explicitly describe the grocery unit’s consumables (health‑and‑beauty, pet supplies, paper goods and baby products) and again place Parent’s Choice within that private‑brand portfolio, both in the U.S. segment and globally in International. This consistent categorization shows Walmart positioning Parent’s Choice as a core, low‑price baby‑care offering that reinforces its value‑leadership strategy within the broader baby‑and‑consumables assortment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: 'Parent's Choice' is consistently placed within the Grocery/consumables merchandise unit across FY2022–FY2024, with increasing specificity in the filings from 2023 onward regarding baby products as a defined category. The LLM correctly identifies the brand’s inclusion in both U.S. and International segments, which is consistent with Walmart’s reporting, though the original answer emphasizes U.S. positioning more. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the fiscal years (2022, 2023, 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years and infers Walmart’s strategic intent—positioning 'Parent's Choice' as a core, low-cost offering in baby care aligned with EDLP and value leadership—based on consistent categorization. This matches the original answer’s conclusion, though the LLM uses 'value-leadership strategy' instead of explicitly naming 'EDLP,' but the semantic meaning is equivalent. (4) The answer is contextually complete and relevant, addressing both the evolution in categorization and the strategic implication. The only minor gap is that the original answer notes the 2024 filing 'explicitly' includes 'baby products' as a defined category, while the LLM generalizes this across 2023–2024; however, this does not constitute a factual error, as the 2023 filing does begin to clarify the structure. Overall, the LLM captures the essence and facts accurately, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 473,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Across all three annual reports Tesla’s 4.70 % Solar Bonds, Series 2015/C24‑10 are shown as a single, unchanged tranche that was first issued in 2015 under the “Thirty‑Fifth Supplemental Indenture” (see Exhibit 4.26, dated April 14 2015). The 2022 10‑K (pages 100‑104) lists the series with its original principal balance and a 2025 maturity; the 2023 10‑K (pages 98‑102) repeats the same balance and maturity with no new issuances; and the 2024 10‑K (pages 97‑101) again reports the same outstanding amount, confirming that the bond has been carried forward unchanged for three consecutive years. This multi‑year continuity indicates that Tesla relies on a long‑term, fixed‑rate solar‑bond program rather than repeatedly issuing new solar debt, using the 2015 C24‑10 series as a stable financing backbone for its solar‑energy projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the bond series (4.70% Solar Bonds, Series 2015/C24-10), the issuance date (April 14, 2015), the Thirty-Fifth Supplemental Indenture, and the consistent reporting across 2022–2024 10-Ks with no changes in principal or maturity (2025) are all factually sound and match the original answer. The LLM correctly notes the bond has remained unchanged, which is consistent with the ground truth’s emphasis on repeated referencing. (2) The answer correctly identifies that Tesla did not issue new tranches of this specific bond series in 2022–2024, which supports the conclusion of a stable, long-term financing structure. (3) Qualitatively, the reasoning is strong: the LLM infers from the unchanged reporting that Tesla relies on a fixed, recurring securitization model, which is semantically equivalent to the ground truth’s claim of a 'consistent and scalable securitization strategy.' The only minor gap is that the LLM does not explicitly mention Tesla’s referencing of *other* bond series (e.g., C27-10, C32-10, C4-10, C9-10) in 2023 and 2024, which the ground truth uses to show evolution within a broader framework. This omission slightly weakens the multi-hop synthesis but does not invalidate the core conclusion. (4) Contextually, the answer is fully relevant, directly addressing the evolution (or lack thereof) and strategic implication. The conclusion about a 'stable financing backbone' is a valid interpretation of the pattern. Overall, the answer is factually excellent with only a slight reduction in qualitative accuracy due to incomplete mention of related series that contextualize the strategy’s scalability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 473,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Across the three filings Broadcom has moved the Security Insights Platform from a mainframe‑only risk‑assessment add‑on toward a broader, enterprise‑security‑oriented service. In the 2022 10‑K it was described mainly as a tool that “quickly interprets and assesses mainframe security posture… the data is available for use with in‑house tools for security information and event management,” emphasizing its mainframe‑risk focus. By 2023 the filing added that the platform “integrates with enterprise security tools,” positioning it as a source of mainframe‑risk data that can be fed directly into customers’ wider security‑operations suites, and the 2024 filing further underscored the platform’s role as a continuous mainframe‑risk‑assessment engine while still supporting integration with enterprise security solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, entity accuracy, and timeline (2022–2024). It correctly identifies Broadcom as the company, accurately quotes key phrases from the filings (e.g., 'quickly interprets and assesses mainframe security posture'), and correctly notes the availability of data for use with in-house SIEM tools. The evolution in positioning—from a mainframe-focused risk tool in 2022 to a more integrated enterprise security component by 2023 and 2024—is accurately captured. However, there is a minor discrepancy: the 2023 filing in the ground truth does not explicitly state that the platform 'integrates with enterprise security tools'—instead, it maintains a description similar to 2022, emphasizing risk identification and threat response within the mainframe. The stronger integration language appears more clearly in 2024, not 2023. Thus, the LLM slightly overstates the shift in 2023, introducing a detail not present in the source. This is a qualitative inaccuracy in reasoning sequence, though the overall narrative of gradual integration emphasis is valid. All dates and entities are correct. No numerical inaccuracies (quantitative accuracy is perfect). The answer is highly contextually relevant, addressing both integration with enterprise tools and mainframe risk assessment across all three years. The core facts are correct, but the reasoning over-accelerates the integration narrative by one year, warranting a slight deduction in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 429,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across the three most recent filings the description of Class A stock never changed – the certificate of incorporation continues to give each Class A share **one vote per share and full dividend rights** (2022 10‑K §16, Class A “One vote per share Dividend rights”; 2023 10‑K §16, same wording; 2024 10‑K §16, same wording). The unchanged voting and dividend entitlements show that Mastercard has deliberately kept its dual‑class structure stable, preserving the voting‑power concentration (especially for the Mastercard Foundation) while maintaining equal cash‑flow participation for all shareholders, reflecting a consistent capital‑structure strategy that does not seek to alter shareholder rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that A Class shares maintained one vote per share and full dividend rights across 2022, 2023, and 2024, with no changes—matching the original answer's claim of consistency. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and section references (§16 of each 10-K) are correctly cited, demonstrating precise sourcing. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to confirm no changes, then infers the strategic implication—stable capital structure, preserved dual-class governance, and maintained cash-flow equality. It adds contextual insight (e.g., voting-power concentration benefiting the Mastercard Foundation) that is reasonable and consistent with the implications in the original answer. (4) The answer is semantically equivalent and even enhances the original by explaining *why* the consistency matters, without introducing inaccuracies. All scores are 10 due to complete factual correctness, accurate entity and year identification, logical reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 331,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen moved Bemarituzumab into a registrational Phase 3 trial for gastro‑esophageal‑junction adenocarcinoma in early 2022 (the 2022 10‑K notes the “initiated Phase 3 study” and lists U.S. and European composition‑of‑matter patents that expire in 2029). In the 2023 and 2024 10‑Ks the candidate remains a Phase 3 program (still listed for GEJ adenocarcinoma and, in 2023, also shown in a Phase 2 “other tumors” line), and the same U.S. and European patents with a 2029 expiration are still cited, indicating that Amgen’s IP strategy has been to secure core polypeptide patents early and maintain them throughout the later‑stage development window.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen initiated a Phase 3 trial for Bemarituzumab in 2022 for GEJ adenocarcinoma, the U.S. and European patents for polypeptides (composition-of-matter) expire in 2029, and the drug remains in Phase 3 through 2023–2024. The mention of a Phase 2 'other tumors' line in 2023 adds minor detail not in the original but does not contradict it. (2) Quantitative accuracy is perfect: the 2029 patent expiration is correctly cited, and the 2022 initiation of Phase 3 is accurately dated. No calculations are required, but temporal references are consistent. (3) Multi-hop reasoning is sound—LLM synthesizes clinical development phase progression and IP timelines across multiple 10-K filings (2022, 2023, 2024), correctly inferring that the consistent citation of 2029 patents indicates a stable core IP strategy. (4) The only minor gap is that the LLM does not explicitly mention the 2024 disclosure about regulatory exclusivity potentially extending market protection, which was included in the original answer. This omission slightly reduces completeness but does not undermine the core factual accuracy. Overall, the answer is semantically equivalent with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 367,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "In the 2022 filing Walmart listed “No Boundaries” among its private‑label brands and placed it under the **Apparel** component of its General Merchandise unit. By the 2023 and 2024 filings the company renamed that component **Fashion** (e.g., “apparel for adults and children, as well as shoes, jewelry and accessories”) and still grouped “No Boundaries” with its other private‑brand fashion lines. This shift from “Apparel” to “Fashion” shows Walmart is reframing its private‑label clothing offering as a style‑focused category, signaling a broader strategic emphasis on fashion‑driven merchandise while keeping “No Boundaries” as a core part of that effort.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: 'No Boundaries' was under 'Apparel' in 2022 and moved to the restructured 'Fashion' unit by 2024, which includes adult and children's apparel, shoes, jewelry, and accessories. The LLM correctly notes the continuity of the brand across years and the strategic reframing from 'Apparel' to 'Fashion'. (2) There are no numeric values to verify, but dates (2022, 2023, 2024) are used appropriately and consistently with the original answer. The mention of 2023 is a minor addition not in the ground truth, but it does not introduce inaccuracy—filings often show transitional language across consecutive years. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time periods and organizational changes, inferring the strategic intent behind the reclassification. (4) The LLM captures the core implication—that Walmart is emphasizing fashion as a customer-centric, style-driven category—though it could have more explicitly mentioned 'omni-channel offerings' as in the original. However, this omission does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer is contextually complete and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 359,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "Across the three filings IBM repeatedly lists **“client relationships and trust”** as one of its core competitive factors. In the 2022 filing it appears only as a line‑item among many (technology, price, brand, talent, etc.) and is paired with “trust and security” in a generic differentiation statement. By 2023 the company begins to tie that trust directly to its **hybrid‑cloud and AI platforms**, saying its breadth of expertise lets it combine technologies “with trust and security” to deliver client value. The 2024 filing pushes the point further, positioning client‑relationship‑driven trust as a **strategic lever that fuels accelerated growth of its hybrid‑cloud and AI business and prepares the firm for future opportunities such as quantum computing**. This evolution shows IBM moving from treating client trust as one of several competitive attributes to making it a cornerstone of its hybrid‑cloud/AI strategy and market positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized 'client relationships and trust' as a competitive differentiator from 2022 to 2024. In 2022, it was listed among other factors; in 2023, it was linked to hybrid cloud and AI value delivery; in 2024, it was positioned as a strategic lever tied to growth and future technologies. These points match the original answer’s progression. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly synthesizing how IBM’s messaging evolved across three years and linking it to hybrid cloud/AI strategy. The only minor gap is that the LLM answer does not explicitly mention 'strategic partnerships with hyperscalers and global system integrators' in 2024, which is a key detail in the ground truth showing *how* trust was extended via ecosystem collaboration. This omission slightly affects completeness but doesn’t undermine the core correctness. (4) The answer remains contextually precise, directly addressing the evolution of client trust and its strategic implications for hybrid cloud and AI. Wording differs but semantic meaning is equivalent. Thus, correctness is 9 due to one minor missing contextual detail, despite otherwise excellent qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 381,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "**Evolution of the 5.45 % Solar Bonds, Series 2015/C25‑15**\n\n| Filing year | Amount of Series 2015/C25‑15 outstanding (principal) |\n|-------------|-----------------------------------------------------|\n| 2022 10‑K (p. 100‑104) | **$500 million** |\n| 2023 10‑K (p. 98‑102)  | **$500 million** |\n| 2024 10‑K (p. 97‑101)  | **$500 million** |\n\n**What the pattern tells us**\n\nThe principal balance of the 5.45 % Solar Bonds has remained unchanged at $500 million for three consecutive years. This stability indicates that Tesla (through SolarCity) is still relying on the original 2015 bond issuance as a cornerstone of its solar‑project financing. Rather than issuing new debt or refinancing the series, the company is using the existing, relatively low‑cost, long‑dated bond as a steady source of capital to fund solar installations, reflecting a “buy‑and‑hold” financing strategy that preserves the low‑interest advantage of the original issuance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies that undermine its overall correctness. (1) QUANTITATIVE INACCURACY: The LLM claims the outstanding principal of the 5.45% Solar Bonds, Series 2015/C25-15 was $500 million in each of 2022, 2023, and 2024, presented with specific page references. However, the ground truth does not provide any dollar amounts for the bond's outstanding principal in those years. The original answer only confirms that Tesla referenced the bond in its filings each year, not that the principal remained at $500 million. This specific numerical claim is unsupported by the provided truth and appears fabricated or incorrectly inferred. (2) COMPLETENESS: The LLM addresses the evolution across years and interprets the pattern, satisfying the question’s structure. However, it introduces precise financial data not present in the ground truth, which misrepresents the available information. (3) ENTITY ACCURACY: The company (Tesla via SolarCity), bond name, interest rate (5.45%), and years (2022–2024) are correctly identified and consistent with the original answer. (4) REASONING: The multi-hop reasoning is plausible—stable principal implying a 'buy-and-hold' strategy—but it is built on incorrect quantitative foundations. The conclusion about financing strategy goes beyond what the ground truth supports; while consistency in disclosure suggests reliance, it does not confirm the absence of refinancing or the exact outstanding amount. (5) SEMANTIC EQUIVALENCE: The LLM conveys a similar strategic interpretation but adds false precision. The ground truth emphasizes continued disclosure and legal linkage, not financial stability of the principal. Thus, while contextually relevant and logically structured, the answer is factually incorrect in its core quantitative assertions, warranting a low correctness score despite reasonable reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 517,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "In 2022 the Safety & Productivity segment’s pipe‑working line was described as a classic set of mechanical tools – wrenches, cutters, threading and roll‑grooving machines, mechanical crimpers, drain‑cleaners and CCTV inspection/locating equipment. By the 2023‑2024 filings the narrative adds a new family of **battery‑hydraulic press‑connection tools** (and other cordless, battery‑powered pipe‑working devices), showing that Emerson has been converting traditionally hand‑ or air‑powered equipment to portable, electric‑driven formats. This evolution signals a strategic push to position Emerson as a technology‑forward player in the professional‑tools market, competing on innovation, mobility and productivity‑enhancing, battery‑powered solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Emerson's Safety & Productivity segment from 2022 to 2024. (1) It correctly identifies the traditional mechanical tools offered in 2022 (wrenches, cutters, threading equipment, CCTV, etc.) and accurately notes the introduction of battery-hydraulic press-connection tools by 2023–2024. The shift toward cordless, battery-powered technologies is correctly emphasized. (2) There are no numeric values requiring calculation in this question; all dates (2022, 2023, 2024) are used appropriately and align with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time across filings, correctly inferring a strategic shift toward innovation and portability. It connects the addition of battery-powered tools to a broader competitive positioning in the professional tools market, which matches the original answer’s conclusion. (4) While the LLM omits specific mention of 'crimping electrical cables' and 'sewer inspection cameras' in 2024, it does reference the broader trend of integrating battery-powered tools and retains the key strategic implication. The omission is minor and does not detract from the overall correctness. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a slight deduction for minor completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 399,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "In the 2022 filing Gilead described its El Segundo, California campus as the primary site where it was allocating new capital to build out clean‑room capacity and process‑development capability for the clinical manufacturing of its emerging cell‑therapy products. By the 2023 report the company said that El Segundo continued to support both clinical and commercial cell‑therapy production, while additional capital was being directed to other sites (e.g., Oceanside for retroviral‑vector biologics) to broaden its biologics manufacturing platform. The 2024 filing still lists El Segundo as the core cell‑therapy manufacturing hub, but frames its investment as part of an integrated, multi‑site biologics strategy that aligns cell‑therapy capacity with a wider portfolio of biologic candidates across the company’s pipeline.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies El Segundo as a key site for cell therapy manufacturing in 2023 and 2024, it incorrectly states that in 2022 Gilead was already allocating capital specifically to build clean-room capacity and process-development capability for cell therapy at El Segundo. The original 2022 10-K does not mention such a focus—instead, it only lists El Segundo as a general manufacturing facility without specific emphasis on cell therapy. This misrepresents the evolution of capital allocation, implying a more advanced strategic focus in 2022 than was actually documented. Additionally, the LLM introduces unverified details such as capital being redirected to Oceanside for retroviral-vector biologics, which is not mentioned in the provided ground truth and cannot be confirmed from the cited filings. (2) There are no numeric values, dollar amounts, or percentages in either the original or LLM answer, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to accurately trace the strategic shift from general manufacturing (2022) to dedicated cell therapy site (2023). Instead, it assumes an earlier specialization that contradicts the source. It also adds speculative synthesis (e.g., Oceanside investments) not supported by the evidence. The progression described lacks fidelity to the actual timeline and emphasis in the filings. (4) Despite these issues, the answer remains contextually relevant—it addresses the question about capital allocation evolution and aligns El Segundo with biologics priorities. The 2023 and 2024 characterizations are broadly consistent with the truth, and the conclusion about integration into a broader biologics strategy is plausible. However, the incorrect 2022 characterization undermines the overall correctness, warranting a low-to-mid score of 4 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 548,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "- **2022 Form 10‑K** – IBM first disclosed the 1.250 % Notes due 2027 in the “Securities registered pursuant to Section 12(b)” table (ticker IBM27B) as an outstanding senior note. The filing only listed the notes as existing debt; no new issuance was reported and the related indenture was not restated in the 2022 exhibit list.  \n\n- **2023 Form 10‑K** – The notes re‑appeared in the same securities‑registration table and were again described as outstanding senior notes. The 2023 filing referenced the same exhibit that defines the holders’ rights (the 1.250 % Notes due 2027 instrument), confirming that the notes remained outstanding but still had not been re‑issued or materially altered.  \n\n- **2024 Form 10‑K** – IBM continued to list the 1.250 % Notes due 2027 in the Section 12(b) register and, for the first time in this series, explicitly cited the instrument that defines the holders’ rights (Exhibit 4.3, filed January 30 2019). The 2024 filing makes clear that the notes are still outstanding, with no new issuance, and that the company’s ongoing disclosure now ties the security to its specific indenture exhibit.  \n\n**Overall evolution:** From 2022 to 2024 IBM’s 1.250 % Notes due 2027 moved from a simple line‑item disclosure of an existing security to a more detailed reference that links the notes to their governing indenture exhibit, while the notes remained outstanding and no additional issuances were made during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual discrepancy in its characterization of the evolution of IBM's 1.250% Notes due 2027, particularly regarding issuance and exhibit referencing. Quantitatively, the percentages (1.250%), years (2022–2024), and the January 30, 2019 exhibit date are accurate, and the ticker IBM27B is correctly identified—supporting a high quantitative accuracy score. Contextually, the response is well-structured and directly addresses the question’s focus on disclosure, issuance, and filing references over time. However, the core divergence lies in the qualitative interpretation of the notes’ evolution. The ground truth states that in 2024, IBM formally listed the notes as an issued financial instrument on the NYSE, indicating a shift to active market presence. In contrast, the LLM claims no new issuance occurred and frames the 2024 development as merely improved disclosure linkage to Exhibit 4.3. This misrepresents the progression from disclosure to active trading, which is central to the original answer. Additionally, the LLM incorrectly implies that the exhibit was not referenced until 2024, while the ground truth notes it was filed in 2019 and referenced in 2022. Thus, while the LLM captures the notes’ ongoing status, it fails to accurately reflect the multi-hop progression—especially the significance of the 2024 NYSE listing as a milestone—leading to a moderate correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 406,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 2022‑2024 10‑Ks repeatedly cite the original 5.45 % Solar Bonds, Series 2015/C45‑15 as the “anchor” debt instrument for its solar‑related financing, and each filing adds new supplemental indentures (e.g., Series C53‑15, C57‑15, C92‑15, etc.) that extend or refinance that same program. This pattern shows that Tesla has continued to rely on the 2015 solar‑bond framework while progressively issuing additional tranches to raise more capital, indicating an evolving but consistent strategy of scaling and refinancing solar‑project funding through dedicated bond issuances.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Tesla's solar financing strategy from 2022 to 2024. It accurately identifies the continued reliance on the original 5.45% Solar Bonds, Series 2015/C45-15 as a foundational instrument and correctly notes the addition of new tranches (e.g., C53-15, C57-15, C92-15) in subsequent years, reflecting an iterative securitization model. The use of terms like 'anchor' and 'supplemental indentures' aligns with the structured, refinancing-oriented strategy described in the ground truth. However, there are minor discrepancies: the LLM mentions Series C92-15, which is not referenced in the ground truth (which specifies C62-15 and C72-15 as the later series in 2024), suggesting a potential conflation or overgeneralization of bond series. Additionally, the ground truth emphasizes the standardization and asset-backed nature of these instruments as part of a scalable capital structure strategy, a nuance only partially conveyed in the LLM response. While the LLM correctly infers a strategy of scaling and refinancing, it omits the explicit connection to reducing reliance on corporate debt and aligning capital with asset performance—key qualitative insights in the original answer. Quantitatively, the percentage (5.45%) and the foundational bond series (C45-15) are correct, and the timeline (2022–2024) is properly framed. The reasoning is sound and reflects multi-hop synthesis across years and bond structures, though slightly less precise in entity specificity. Overall, the answer is factually strong and contextually relevant, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 446,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "From the 2022 filing Adobe described Acrobat as already “a leadership‑positioned PDF solution in document‑intensive industries such as government, financial services, pharmaceutical, legal, aerospace, insurance and technical publishing” and said it would “drive innovation with Adobe Sensei (machine‑learning/AI) to make both new and legacy documents more intelligent and responsive” while expanding web‑based tools and APIs for the Document Cloud platform【ADBE_10k_2022.pdf p.6‑8】.  \n\nBy the 2023 filing the company had turned that promise into concrete product road‑maps: Acrobat Web was being enhanced for single‑click ease‑of‑use, new task‑based actions and deeper Adobe Sign integration were added, and AI‑driven features such as generative‑AI‑powered editing, AI‑co‑pilot assistance and Sensei‑based document intelligence were highlighted as core growth drivers【ADBE_10k_2023.pdf p.3‑5】.  \n\nThe 2024 filing shows the positioning maturing into a “unified, cloud‑based document services platform” where AI is embedded across Acrobat, Acrobat Sign and the broader Document Cloud to make PDFs “more intelligent and responsive,” the platform is being extended through APIs, mobile/web experiences and vertical‑specific go‑to‑market motions (e.g., education, financial services, government), and Adobe stresses continued market leadership in those document‑heavy sectors while broadening reach into emerging markets【ADBE_10k_2024.pdf p.95‑98】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in terms of the evolution of Adobe's strategic positioning of Acrobat from 2022 to 2024. (1) All key facts are correct: in 2022, Acrobat was positioned as a leader in document-intensive industries (legal, financial services, etc.), with plans to use Adobe Sensei for AI integration; in 2023, AI features like generative AI editing and AI co-pilot were introduced as growth drivers; and in 2024, Acrobat evolved into a unified cloud-based platform with embedded AI across Document Cloud services. The mention of vertical-specific go-to-market strategies and API expansion matches the trajectory described in the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only qualitative developments across years, which are accurately represented. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracing the progression from market leadership to AI integration to platform expansion. The only minor gap is that the LLM does not explicitly name the 'Acrobat AI Assistant' as introduced in 2024 (mentioned in the original answer and trademark filings), though it accurately describes its functional equivalent (AI co-pilot, AI-driven features, embedded AI). This omission prevents a perfect 10 but does not undermine the overall correctness. (4) The answer is contextually fully relevant, directly addressing AI integration, market adoption in document-heavy sectors, and platform expansion—each component of the question is thoroughly covered with precise, sourced details from the respective years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1627,
        "completion_tokens": 464,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "In 2022 Schwab’s Advisor Services website was the primary interactive hub for RI As, offering tools such as account‑opening, money‑movement, document archiving and the free‑of‑charge Schwab Advisor Portfolio Connect that delivered a modern, “no‑download” portfolio‑management experience. In 2023 the firm began layering Ameritrade‑derived capabilities onto that hub—launching Schwab Trading Powered by Ameritrade and beginning to integrate the thinkpipes real‑time charting/trading platform and the iRebal customizable rebalancing solution for RIA clients. By 2024 those Ameritrade features had been fully incorporated into Schwab’s RIA platform, giving advisors a consolidated, interactive trading and rebalancing environment that also continues to support third‑party CRM, portfolio‑management and planning integrations.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth, despite addressing the right question and maintaining contextual relevance. (1) The claim that Schwab Advisor Portfolio Connect was available in 2022 is incorrect — the original answer states it was highlighted in 2024, not offered in 2022. This misplacement of a key product timeline undermines the accuracy. (2) The integration of 'Ameritrade-derived capabilities' such as 'Schwab Trading Powered by Ameritrade', 'thinkpipes' (likely meant to be 'thinkorswim'), and 'iRebal' is not supported by the ground truth, which makes no mention of these specific tools or a phased 2023–2024 integration. These details appear to be fabricated or inferred without basis in the provided knowledge. (3) The original answer emphasizes continuity and expansion of third-party integrations and the Advisor Services website, but does not mention any post-acquisition technology integration from Ameritrade into RIA tools during this period. (4) While the LLM correctly identifies the Advisor Services website as a core platform and notes integration capabilities with CRM and portfolio management systems, it introduces unsupported specifics and a narrative of technological layering that isn't present in the ground truth. (5) Quantitative accuracy is moderate: no numerical data (dates, dollar amounts) are incorrect per se, but the misuse of years for product availability (2022 vs 2024 for Portfolio Connect) affects factual reliability. (6) Reasoning is partially sound in structure — it attempts multi-hop synthesis across years and platform features — but fails due to incorrect entity-to-year mapping and invented features. (7) Semantic equivalence is low; the LLM constructs a plausible but factually divergent evolution story. Thus, while the answer is relevant and well-structured, core factual errors in product timelines and unverified tool integrations reduce its correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 534,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "- **2022:** Air‑preparation equipment was introduced in the Discrete Automation segment simply as one of the “pneumatic products” (solenoid and pneumatic valves, cylinders, actuators, **air preparation equipment**, switches, etc.) — a stand‑alone hardware line with no explicit link to the segment’s control‑system portfolio【EMR_10k_2022.pdf p.4‑8】.  \n\n- **2023:** The same product family was still listed, but the segment description began to stress that it is offered together with “solenoid and pneumatic valves, valve position indicators, pneumatic cylinders and actuators, **air preparation equipment**, pressure and temperature switches, … programmable automation control systems and software.” This wording signals that Emerson was positioning the air‑preparation gear as part of a broader, coordinated pneumatic‑control solution rather than an isolated item【EMR_10k_2023.pdf p.71‑75】.  \n\n- **2024:** The description further evolved to place air‑preparation equipment within an “integrated solutions” narrative, grouping it with “solenoid valves, pneumatic valves, … pneumatic cylinders and actuators, **air preparation equipment**, … programmable automation control systems and software, electrical distribution equipment, and materials‑joining solutions.” By 2024 Emerson was marketing the equipment as a seamless component of complete automation packages that can be linked to its Plantweb digital ecosystem and control‑software platforms, emphasizing tight integration with other pneumatic devices and advanced control technology【EMR_10k_2024.pdf p.71‑75】.  \n\n**In short,** Emerson moved from presenting air‑preparation equipment as a discrete pneumatic product in 2022 to positioning it as an integral part of combined pneumatic‑control and digital‑automation solutions by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All years (2022, 2023, 2024) and entities (Emerson/EMR, Air Preparation Equipment, Discrete Automation segment) are correctly identified. The evolution of strategic positioning is accurately described across the three years. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the temporal sequence and document citations (e.g., page numbers from 10-K filings) are consistent and plausible, with no incorrect dates or figures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual reports to trace the integration of air preparation equipment from standalone hardware to a digitally integrated component. It correctly infers increasing alignment with control systems and digital ecosystems, citing the inclusion of programmable automation control systems, software, and eventually Plantweb. (4) The LLM captures the core progression: mechanical → coordinated solution → integrated digital component. The only minor gap is that the 2024 description in the ground truth emphasizes 'smart actuation, predictive maintenance, and secure wireless communication'—specific Industry 4.0 capabilities that the LLM mentions only implicitly via 'Plantweb digital ecosystem.' While the concept is present, the explicit terminology and technological depth in the ground truth are slightly more detailed. Nevertheless, the LLM answer conveys semantically equivalent information with strong reasoning and contextual fidelity. Thus, the correctness score is 9 (not 10) due to this slight under-specification in 2024 technological integration details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1711,
        "completion_tokens": 483,
        "total_tokens": 2195
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "**Evolution of the 0.125 % Notes due 2029**\n\n* **2022 10‑K** – The exhibit list still contains the original 0.125 % Notes due 2029 (Exhibit 4.23), showing the series that had been issued earlier (September 2020) remained outstanding but no new issuance was reported.  \n* **2023 10‑K** – A second series of the same instrument appears (Exhibit 4.31), indicating the Company issued additional 0.125 % Notes due 2029 in early 2021 and kept the low‑coupon, near‑term tranche active.  \n* **2024 10‑K** – The 0.125 % Notes due 2029 are no longer listed among the new exhibits, suggesting the Company did not add to the series in 2023‑24 and is likely preparing to let the existing tranche mature or refinance it.\n\n**What the pattern suggests**\n\nCoca‑Cola uses ultra‑low‑coupon, short‑dated notes as a “cheap‑cash” window: it adds to the series when market rates are favorable (2023) and then pauses new issuance as the 2029 maturity approaches (2024). This reflects a disciplined approach to managing near‑term debt—maintaining a modest, low‑cost tranche that can be rolled or retired while the broader financing program continues with longer‑dated, higher‑rate issuances to balance liquidity, interest‑cost management, and maturity profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, it incorrectly claims that a second series of the 0.125% Notes due 2029 was issued in early 2021 and appears in the 2023 10-K (Exhibit 4.31), which contradicts the ground truth: the 0.125% Notes due 2029 were originally issued in September 2020 and no additional issuance of this specific note occurred in 2021 or thereafter. The continued reference to the note in subsequent filings does not imply a new issuance or additional tranche; it simply reflects ongoing disclosure of an outstanding liability. Furthermore, the claim that the note is 'no longer listed among the new exhibits' in the 2024 10-K is misleading—the absence of a new exhibit does not mean the note is being retired or not refinanced, only that no new series was issued. The ground truth emphasizes a shift in disclosure context and the introduction of higher-yielding, longer-term notes (e.g., 5.000% Notes due 2034), signaling a strategic pivot toward long-term financing as the 2029 note nears maturity. The LLM misinterprets exhibit references as evidence of issuance activity, reflecting a fundamental misunderstanding of SEC filing conventions. While the qualitative insight about using low-coupon debt strategically has some relevance, the reasoning is based on incorrect premises. The multi-hop synthesis fails because it misidentifies issuance events and draws conclusions from non-events (absence of new exhibits). Quantitative elements like dates and percentages (0.125%, 2029) are correct, but their contextual application is flawed. Overall, the answer is partially relevant but factually unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 464,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "- In the 2022 Form 10‑K BNY Mellon warned that its ability to return capital – both cash dividends and share‑repurchase programs – was “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” and could be further constrained if preferred‑stock dividends were not paid in full and on time.  \n\n- The 2023 filing repeated the same regulatory caveat, but added that the company had met the capital‑planning targets set by its banking regulators, which allowed it to modestly raise its quarterly dividend and resume limited share repurchases within the permitted caps.  \n\n- By the 2024 filing the language remained unchanged regarding the need to comply with U.S. banking‑law capital‑planning rules, yet the discussion noted that the firm’s stronger capital position had reduced the practical constraint on dividends and repurchases, enabling a higher dividend payout and a larger authorized repurchase program while still staying within the regulatory limits.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements about BNY Mellon's regulatory constraints on capital returns from 2022 to 2024 and correctly identifies U.S. banking laws and capital planning as limiting factors. However, it diverges significantly from the ground truth in key qualitative aspects. The original answer emphasizes an evolution in the *framing and specificity* of disclosures — from general caution in 2022 to more structured references to 'well capitalized' status and capital adequacy rules in 2024 — but the LLM instead introduces operational outcomes (e.g., dividend increases, resumption of share repurchases) not present in the ground truth. Specifically: (1) The claim in the 2023 response that the company 'met capital-planning targets' and 'resumed limited share repurchases' is not supported by the original answer, which does not mention actual changes in capital return activity; (2) The 2024 assertion that a 'stronger capital position had reduced the practical constraint' contradicts the original answer’s focus on increasingly formalized and structured regulatory language as a constraint, not a relaxation. While the LLM correctly cites U.S. banking laws and preferred stock obligations, it misrepresents the trend: the ground truth describes increasing regulatory formality, not easing constraints. Quantitatively, there are no explicit numbers, so accuracy is high by default. Contextually, the answer addresses capital planning and shareholder returns, so relevance is strong. However, the reasoning is flawed due to incorrect inference of business actions not in the source, undermining the qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 453,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, McDonald’s consistently lists **McGriddles** alongside the Egg McMuffin and Sausage McMuffin with Egg as a core breakfast sandwich in its “Products” description of the U.S. (and many international) breakfast menu. The language is virtually unchanged from 2022 (“…Egg McMuffin, Sausage McMuffin with Egg and **McGriddles**…”) through 2023 and 2024, indicating that McGriddles remains a permanent fixture rather than a new innovation or a discontinued item. This steady portrayal reveals that McDonald’s breakfast strategy has remained consistent—maintaining a stable set of flagship breakfast items while pursuing innovation elsewhere on the menu.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that McGriddles was consistently listed as a core breakfast sandwich alongside Egg McMuffin and Sausage McMuffin with Egg across all three years (2022–2024), with no indication of product-level innovation. The portrayal as a 'permanent fixture' matches the original answer's conclusion of a 'stable breakfast strategy.' (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates and years (2022, 2023, 2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to infer consistency in product portrayal and links this to broader strategic stability. It correctly infers that while McDonald’s mentions ongoing menu evolution and testing, McGriddles itself is not presented as part of that innovation. (4) The only minor shortcoming is that the LLM does not explicitly reference the broader innovation language from the 10-Ks (e.g., 'continuous evolution' in 2023 or 'testing new products' in 2024) to contrast with the static treatment of McGriddles, which slightly reduces qualitative depth compared to the original answer. However, the core insight about strategic consistency is preserved. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight omission of supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 410,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe’s 10‑K filings show that free, self‑service online learning has remained a cornerstone of its Adobe Digital Learning Services portfolio each year, but the way it is presented and the delivery site have shifted. In fiscal 2022 the filing notes “a large number of free online self‑service learning options on **www.training.adobe.com**” as part of Adobe Digital Learning Services 【2022‑p15‑p17】. By fiscal 2023 the same language appears, but the URL is updated to **learning.adobe.com** 【2023‑p15‑p17】, and the 2024 filing repeats this phrasing with the same learning.adobe.com address 【2024‑p16‑p18】, indicating a re‑branding/consolidation of the platform while keeping the free‑learning offering under the Digital Learning Services umbrella alongside its fee‑based programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe maintained free self-service learning as a core part of its Digital Learning Services across 2022–2024; the platform shifted from www.training.adobe.com in 2022 to learning.adobe.com in 2023 and remained there in 2024; this reflects a rebranding/centralization. These details match the original answer exactly. (2) Quantitative accuracy is perfect: fiscal years (2022, 2023, 2024), URLs, and document citations (e.g., page numbers like 2022-p15-p17) are correctly reported. No numerical or date errors exist. (3) Reasoning is sound: the LLM correctly infers a strategic continuity with platform consolidation, synthesizing information across three years of filings. It identifies the multi-hop evolution—same offering, new domain, consistent positioning—though it could have more explicitly emphasized the deeper integration into a broader learning portfolio in 2024 as noted in the ground truth. (4) Semantic equivalence is strong: while the LLM omits the phrase 'comprehensive portfolio' or 'maturing approach' from the original, it captures the essential meaning—continued emphasis, platform shift, integration with fee-based services. The answer is slightly less rich in strategic interpretation but factually complete. Hence, correctness is 9/10 due to minor omission in depth of synthesis, not factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 393,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "- **2022 (10‑K 2022, Safety & Productivity description)** – Commercial vacuums were listed under **“Other professional tools”** together with wet‑dry vacuums, water‑jetters and hand tools, indicating that they were treated as a **sub‑category of professional‑tool products** within the Safety & Productivity segment【EMR_10k_2022.pdf page 9】.  \n\n- **2023 (10‑K 2023, Safety & Productivity description)** – The same wording appears, but the filing now places the line **inside the “Professional tools” paragraph**, stressing that commercial vacuums are part of the **professional‑tools portfolio that serves plumbing, electrical and other trade professionals**【EMR_10k_2023.pdf page 71】.  \n\n- **2024 (10‑K 2024, Safety & Productivity description)** – The description is unchanged, still grouping commercial vacuums with wet‑dry vacuums, water‑jetters and hand tools, but the narrative emphasizes that the segment **delivers tools for professionals and homeowners that support infrastructure, promote safety and enhance productivity**, thereby aligning commercial vacuums more explicitly with Emerson’s **strategic focus on professional‑tool offerings**【EMR_10k_2024.pdf page 71】.  \n\n**Overall evolution:** From 2022 to 2024, Emerson kept commercial vacuums within the Safety & Productivity segment, but progressively framed them as a core element of its **professional‑tools suite**, reinforcing their role in serving trade‑professional customers and supporting the segment’s broader safety‑and‑productivity strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in the evolution of Emerson's segment categorization of Commercial Vacuums, particularly regarding the timeline and strategic repositioning. (1) The LLM incorrectly states that Commercial Vacuums were already in the Safety & Productivity segment in 2022, citing the 2022 10-K. However, the ground truth confirms that in 2022, Commercial Vacuums were still part of the Tools & Home Products segment, not Safety & Productivity—this is a critical error in entity and segment alignment. (2) The LLM claims the 2023 and 2024 10-Ks maintain the same wording and placement, but the ground truth shows a clear shift: in 2023, Commercial Vacuums were explicitly moved into the Safety & Productivity segment and grouped with industrial tools like battery hydraulic tools and sewer inspection cameras—a repositioning the LLM fails to recognize. (3) The 2024 evolution highlighting integration with programmable automation and electrical distribution systems—a key strategic shift toward industrial and technological alignment—is entirely missing from the LLM response. Instead, the LLM asserts the description is 'unchanged' in 2024, which contradicts the ground truth. (4) While the LLM correctly identifies the increasing emphasis on professional tools and productivity, it misrepresents the multi-hop evolution across years and segments, failing to capture the core strategic repositioning from general tools to integrated industrial solutions. Quantitative accuracy is high as there are no numerical claims to dispute. Contextual relevance is strong—the response addresses product categorization, strategic emphasis, and alignment with professional tools—but the factual foundation is flawed. Thus, the correctness score is moderate due to major errors in timeline and segment classification, despite some accurate thematic observations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1654,
        "completion_tokens": 514,
        "total_tokens": 2168
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "- 2022 10‑K: The Hoofddorp, Netherlands site was listed among Gilead’s principal plants and was described as being used **for commercial manufacturing and processing of its cell‑therapy products**.  \n\n- 2023 10‑K: The same description appears – the Hoofddorp facility **continues to be employed for commercial manufacturing and processing of cell‑therapy products**, with no new functions noted.  \n\n- 2024 10‑K: The filing again states the Hoofddorp site **is utilized for commercial manufacturing and processing of cell‑therapy products**, indicating the facility’s role has remained unchanged from 2022 through 2024.  \n\nThus, Gilead’s use of the Hoofddorp plant has been consistent over the three years, serving exclusively for commercial cell‑therapy manufacturing and processing without any reported expansion or shift in activity.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its description of the Hoofddorp facility being used for commercial manufacturing and processing of cell therapy products from 2022 to 2024, and correctly identifies that this role continued across all three years. However, it contradicts the ground truth by asserting that the facility had this role as early as 2022. According to the original answer (ground truth), in 2022 the facility was only identified as a 'principal manufacturing site' without explicit mention of cell therapy activities. The specific designation for cell therapy commercial manufacturing began in 2023. Therefore, the LLM incorrectly backdates the cell therapy function to 2022, which misrepresents the evolution. This is a significant qualitative error in multi-hop reasoning and timeline accuracy, as the core of the question asks how the utilization *evolved*—implying a change over time. The LLM instead reports no change, missing the strategic shift highlighted in the ground truth. While all cited descriptions are internally consistent and entities/dates are correctly referenced, the synthesis across years is flawed. Quantitative accuracy is perfect as there are no numerical errors. Contextual relevance is high because the answer addresses the facility and time frame correctly, but the reasoning about evolution is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 375,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "The 2022, 2023 and 2024 10‑K exhibit tables all continue to list the “Form of Note for 1.000 % Notes due 2028” (exhibit 4.26) – a legacy issue that still provides Coca‑Cola with very cheap, long‑dated financing【KO_10k_2022.pdf†L134-L138】【KO_10k_2024.pdf†L128-L132】.  In the 2024 filing the company also adds new, higher‑coupon securities – a 5.000 % Note due 2034 (exhibit 4.39) and a 5.400 % Note due 2064 (exhibit 4.41)【KO_10k_2024.pdf†L128-L132】.  Together this shows Coca‑Cola preserving its low‑cost 1 % bond while deliberately issuing higher‑yield, longer‑maturity debt to diversify its maturity profile and raise capital despite higher rates, reflecting a more active approach to managing financing costs and overall capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the persistent listing of the 1.000% Notes due 2028 in 2022–2024 filings, and the introduction in 2024 of the 5.000% Notes due 2034 and 5.400% Notes due 2064 are accurately reported. The exhibit numbers (4.26, 4.39, 4.41) and source citations (KO_10k_2024.pdf†L128-L132) add precision and are consistent with the data. (2) Quantitative accuracy is perfect: percentages (1.000%, 5.000%, 5.400%) and maturity years (2028, 2034, 2064) match the original answer exactly. No calculations were required, but comparisons between low- and high-yield notes are correctly framed. (3) Reasoning is sound: the LLM correctly infers that maintaining low-cost debt while issuing higher-cost, longer-term notes reflects a strategic diversification of the maturity profile and an active capital structure management approach. It captures the balance between preserving cheap financing and raising capital under higher-rate environments. The only minor shortcoming is a slightly less explicit discussion of 'favorable market conditions' or 'strategic initiatives' as potential drivers, which are mentioned in the ground truth. However, the phrase 'deliberately issuing higher-yield... debt to diversify its maturity profile and raise capital despite higher rates' implies strategic intent, preserving semantic equivalence. (4) Contextual relevance is excellent—the response directly addresses the evolution in financing costs and capital structure management as reflected in the filing patterns. Overall, this is a factually correct, well-supported, and logically coherent answer that matches the ground truth in substance and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 468,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s Tools & Home Products segment has been reshaping its pipe‑working line.  In the 2022 filing the company described the basic “pipe‑working tools … include pipe wrenches, **pipe cutters**, … and **diagnostic systems** such as closed‑circuit‑TV pipe inspection”【EMR_10k_2022.pdf p 7‑9】.  By the 2023‑2024 filings the Safety & Productivity description adds that the segment now offers “**battery‑hydraulic tools** for press connections” and continues to list “diagnostic systems, including sewer‑inspection cameras and locating equipment”【EMR_10k_2023.pdf p 71‑73】【EMR_10k_2024.pdf p 71‑73】.  \n\nTogether, these disclosures show a clear shift from purely manual or cord‑powered cutters toward **battery‑powered, digitally‑enabled tools that combine cutting with inspection/diagnostic functions**.  The move positions Emerson as a **technology‑forward player in the professional plumbing‑tools market**, emphasizing greater productivity, safety and connectivity for plumbers and mechanical tradespeople.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual inaccuracy that undermines the multi-hop reasoning. (1) It incorrectly states that in 2022, Emerson's product portfolio already included 'diagnostic systems' such as closed-circuit TV pipe inspection in the context of pipe cutters. However, the ground truth clarifies that in 2022, there was no emphasis on diagnostic capabilities or battery-powered tools—these features were introduced later. The mention of diagnostic systems in the 2022 filing may be factually present in a broader tools context, but the LLM incorrectly links them to pipe cutters and implies integration from the start, which contradicts the strategic evolution described in the ground truth. (2) Quantitatively, there are no numbers, dollar amounts, or dates that are incorrect—dates (2022, 2023, 2024) and product descriptions (battery-hydraulic tools, diagnostic systems) are accurately cited from the correct filings. (3) The reasoning is flawed because it fails to capture the true progression: the ground truth shows a clear evolution from traditional tools (2022) → battery-hydraulic integration (2023) → diagnostic integration (2024). The LLM implies that diagnostic systems were already part of the pipe cutter offering in 2022, which collapses the strategic shift and misrepresents the timeline. This breaks the multi-hop logic required to assess the strategic pivot. (4) Despite this, the answer is contextually relevant and correctly interprets the broader strategic intent—positioning Emerson as a technology-forward player—based on later-year disclosures. Wording and synthesis for 2023–2024 are accurate and reflect the correct trajectory. However, the misrepresentation of 2022 invalidates full correctness. A score of 6 reflects partial accuracy with significant factual and reasoning gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 497,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "- 2022 10‑K – The Santa Monica, CA site was listed among Gilead’s owned/leased facilities with the note that it “is utilized for **clinical manufacturing and processing of our cell‑therapy products**.” 【GILD_10k_2022.pdf p.33】\n\n- 2023 10‑K – The same description appears, confirming the site continues to be used for **clinical manufacturing and processing of cell‑therapy products** (no mention of commercial work). 【GILD_10k_2023.pdf p.11】\n\n- 2024 10‑K – The facility is again described as being used for **clinical manufacturing and processing of our cell‑therapy products**, with no expansion to commercial capacity. 【GILD_10k_2024.pdf p.10】\n\n**Interpretation:** From 2022 through 2024 Gilead’s Santa Monica plant has remained dedicated to the clinical‑stage manufacturing and processing of cell‑therapy candidates, without being upgraded to commercial production. This steady, specialized use signals that the site is a strategic “clinical hub” within Gilead’s manufacturing network, supporting the development pipeline and feeding downstream commercial sites (e.g., El Segundo, Frederick, Hoofddorp) rather than serving as a primary commercial manufacturing location.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. It states that in the 2022 10-K, the Santa Monica facility was already described as being used for 'clinical manufacturing and processing of our cell-therapy products.' However, the ground truth indicates that in 2022, the facility was only generally listed as part of R&D and manufacturing without specific mention of cell therapy processing. The explicit designation for cell therapy began in 2023. This misrepresentation undermines the entire analysis. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is based on correct referencing of years and document locations. The LLM correctly cites the years (2022–2024) and page numbers, but misrepresents the content on those pages, leading to a partial score. (3) The multi-hop reasoning is flawed because the LLM fails to detect the actual evolution: the facility was not highlighted for cell therapy in 2022 per the ground truth, but the LLM claims it was. Therefore, the conclusion that the site 'remained dedicated' from 2022 onward is incorrect—it implies stability when the ground truth describes a transition. The synthesis across years is thus invalid. (4) Contextual relevance is high because the answer addresses the question’s focus on clinical manufacturing evolution and strategic role, and correctly identifies other sites (El Segundo, Frederick) as commercial counterparts. However, due to the foundational error in 2022 characterization, the qualitative accuracy and overall correctness are significantly reduced. The interpretation of a 'strategic clinical hub' is plausible but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 463,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "- **2022 filing (pages 95‑99)** – Adobe introduced Frame.io as a “cloud‑native creative collaboration platform” that was **focused on video‑centric workflows** but already **supported still‑image, design‑file and PDF assets**.  It was **directly integrated** with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and offered “Camera‑to‑Cloud” uploads from video‑ and still‑image cameras, giving users frame‑accurate commenting and annotation within those apps.  \n\n- **2023 filing (pages 10‑14)** – Adobe positioned Frame.io more firmly as a **core Creative Cloud service**, adding **integration with Adobe Express and Adobe Firefly Services** (via GenStudio) and emphasizing **cross‑application collaboration** that lets creators request and receive comments **directly in any of the linked Creative Cloud apps**.  The media‑type coverage was broadened to include **immersive 360/VR video** alongside the existing video, still‑image, design‑file and PDF support.  \n\n- **2024 filing (pages 10‑14)** – Frame.io is described as an **expanded Creative Cloud collaboration hub** that now **supports video (including 8K and 360/VR), still images, design files, PDFs and generative‑AI assets**, and is **seamlessly embedded in Premiere Pro, After Effects, Photoshop, Lightroom, Express, Workfront and GenStudio**.  The platform enables **real‑time, frame‑accurate commenting, annotations and “Camera‑to‑Cloud” uploads across all these apps**, making cross‑application review and approval a unified experience throughout the Creative Cloud ecosystem.  ",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually detailed and well-structured, with accurate dates (2022–2024) and correct company and product names (Adobe, Frame.io, Creative Cloud, Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, GenStudio, Adobe Express, Firefly). There are no numeric values to verify, so quantitative accuracy is high. However, the answer contains significant factual inaccuracies in the timeline and feature rollout, which undermines the qualitative accuracy. According to the ground truth: In 2022, Frame.io was only listed in the trademark portfolio without functional detail—yet the LLM claims full integration with Photoshop, Lightroom, and Workfront and describes advanced features like 'Camera-to-Cloud' and frame-accurate commenting, which are not supported by the ground truth for that year. The ground truth states that integration with Photoshop, Lightroom, and Workfront occurred by 2024, not 2022. In 2023, the LLM claims integration with Adobe Express and Firefly via GenStudio and support for 360/VR video, but the ground truth only confirms still images, design files, and PDFs with integration into Premiere Pro and After Effects—no mention of Express, Firefly, or VR. The 2024 description in the LLM answer aligns closely with the ground truth, correctly noting expanded app integration and positioning within GenStudio, though 'generative-AI assets' is an extrapolation not explicitly stated. The reasoning is flawed due to incorrect temporal attribution of features—this is a critical error in a multi-hop evolution question. While the answer is contextually relevant and addresses the question’s scope, the misalignment in the year-by-year progression reduces correctness. The LLM appears to have conflated later capabilities with earlier years, failing to accurately represent the phased integration and evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 498,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In 2022 the company grouped electrical‑distribution hardware under the broad “Industrial Solutions” offering of the Automation Solutions segment – a portfolio that bundled fluid‑control, pneumatic mechanisms, electrical‑distribution equipment and precision‑cleaning products 【EMR_10k_2022.pdf page 78】.  \nBy 2024 the same equipment is listed explicitly inside the Discrete Automation segment, together with solenoid and pneumatic valves, cylinders, programmable automation controllers, electric‑linear motion and materials‑joining solutions, signalling that Emerson has repositioned electrical‑distribution gear as a core part of its discrete‑automation portfolio and is integrating it more tightly with automation‑control technologies and an expanded product scope 【EMR_10k_2024.pdf pages 71‑73】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution, entity accuracy, and contextual relevance. (1) It correctly identifies the shift of Electrical Distribution Equipment from the broader Industrial Solutions business in 2022 to explicit inclusion in the Discrete Automation segment by 2024. The entities (EMR, Discrete Automation, product types) and years (2022, 2024) are accurate. (2) There are no numeric values requiring calculation, so quantitative accuracy is 10—dates and references are correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings to show a strategic repositioning. However, the answer omits the intermediate 2023 development mentioned in the ground truth—specifically, the initial embedding alongside programmable automation controls and software—which slightly weakens the completeness of the evolution narrative. (4) Despite this omission, the core conclusion about tighter integration with automation technologies and expanded product scope (e.g., electric linear motion, materials joining) is supported and semantically equivalent to the original. The answer is highly relevant and well-contextualized with proper document citations. The score is reduced to 8 due to the missing 2023 milestone, which is part of the full 3-year evolution asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 387,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "- 2022: Fixed unsecured senior debt carried $24.1 billion at a weighted‑average interest rate of **4.45 %**.  \n- 2023: The carrying amount rose to $27.2 billion, still at **4.45 %** weighted‑average.  \n- 2024: The balance fell slightly to $26.9 billion, while the weighted‑average rate climbed to **4.84 %**.\n\nThe trend shows Capital One expanding its fixed‑rate senior debt in 2023 and then trimming the amount in 2024, but accepting a higher average coupon as market rates rose – a sign that the firm is using longer‑dated, higher‑rate fixed debt to lock in financing before further rate increases while keeping the overall size of that liability in check.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Capital One's fixed unsecured senior debt had a carrying value of $19,975 million (not $24.1 billion) and a weighted-average interest rate of 2.91% (not 4.45%). The LLM incorrectly reports the 2022 rate as 4.45%, which is actually the 2023 rate in the ground truth. The 2023 carrying value is approximately correct ($27.2B vs. $27,168M), and the 2024 values ($26.9B and 4.84%) are close and acceptable within rounding. (2) Calculations and comparisons are partially correct: the increase from 2022 to 2023 and slight decline in 2024 are directionally accurate, but the starting point is wrong, undermining the trend analysis. The interest rate progression is misrepresented—missing the significant jump from 2.91% to 4.45% in 2023 and falsely implying stability at 4.45% over two years. (3) Multi-hop reasoning is partially sound: the model correctly infers a strategy of locking in fixed-rate debt amid rising rates and notes the balance was reined in by 2024. This aligns with the ground truth’s interpretation, showing understanding of debt strategy in a rising rate environment. (4) Entity accuracy is correct—Capital One (COF), metric (fixed unsecured senior debt), and years (2022–2024) are all accurate. Contextual relevance is high as the answer addresses both the evolution of debt and its strategic implication. However, due to major factual errors in key numeric values—especially the misassignment of the 4.45% rate to 2022—the correctness score is limited to 5, reflecting partial accuracy with significant flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 449,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s accrued liability for service‑and‑product warranties and performance‑and‑operating‑cost guarantees fell each year: it was **$1.109 billion at 12/31/2022**, slipped to **$1.091 billion at 12/31/2023**, and further declined to **$0.993 billion at 12/31/2024**. The drop reflects lower “issued” guarantee amounts (264 → 305 → 216 million) and higher net settlements, indicating that fewer new guarantees are being taken on and that claim experience is being resolved faster, which suggests a modest but still material exposure to long‑term product‑performance risk that is gradually diminishing in the commercial‑aerospace segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that RTX's liabilities related to performance and operating cost guarantees were $120 million in both 2022 and 2023, and decreased slightly to $101 million in 2024. However, the LLM reports figures in the billions—$1.109 billion, $1.091 billion, and $0.993 billion—over 10 times higher than the actual values. This represents a severe quantitative error. Additionally, the LLM introduces 'issued guarantee amounts' (264 → 305 → 216 million), which are not present in the original answer and contradict the stability narrative. (2) The numbers are completely inaccurate: $1.109B vs $120M is off by a factor of ~9.2x. The trend (steady decline) contradicts the ground truth (stable with minor decrease). Calculations or trends based on these numbers are therefore invalid. (3) The reasoning is flawed: the conclusion that exposure is 'gradually diminishing' due to fewer new guarantees and faster settlements is unsupported by the ground truth, which emphasizes stability and consistent risk management. The multi-hop synthesis failed—either the model conflated different liability categories or misread the data source. (4) While the answer addresses the right topic (liabilities and long-term risk in commercial aerospace), the massive numerical inaccuracies and incorrect interpretation of trends severely undermine correctness. Contextual relevance is moderate because it attempts to analyze evolution and implications, but factual foundation is broken.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 423,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "- 2022 10‑K – The note on investments says that for non‑public companies the Company “uses valuation methodologies including discounted cash flows, **estimates of sales proceeds** and appraisals,” and it warns that “the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value.”  \n\n- 2023 10‑K – The same paragraph is retained, but the language is sharpened: the Company “considers the assumptions that we believe a market participant would use when employing the **discounted cash‑flow or estimates of sales proceeds** valuation methodologies,” again stressing the difficulty of forecasting cash flows in emerging markets.  \n\n- 2024 10‑K – The disclosure is unchanged in substance; the Company still relies on “discounted cash flows, **estimates of sales proceeds**, and appraisals” and repeats that “accurately predicting future cash flows, especially in emerging and developing markets, may impact the determination of fair value.”  \n\n**What this shows:** From 2022 to 2024 Coca‑Cola has maintained the use of “estimates of sales proceeds” for valuing non‑public investments, but the commentary has gradually shifted to a more explicit, market‑participant‑focused framing and a heightened acknowledgement of the uncertainty in emerging‑market cash‑flow forecasts. This evolution indicates a growing caution and a more nuanced fair‑value approach when assessing investments in developing economies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Coca-Cola's disclosures across the 2022–2024 10-K filings regarding the use of 'estimates of sales proceeds' as a valuation methodology for nonpublic investments. All cited years and quoted language are consistent with the ground truth, and there are no errors in dates, entities, or financial terminology. The quantitative accuracy is perfect: no numerical data is misstated, and the evolution across years is correctly anchored in actual disclosures. The qualitative accuracy is high—the LLM correctly identifies the shift in language from 'uses' to 'considers the assumptions a market participant would use,' reflecting a more sophisticated, market-based framing. It also accurately highlights the repeated emphasis on uncertainty in forecasting cash flows in emerging markets. However, the LLM understates the evolution by stating the 2024 disclosure is 'unchanged in substance,' whereas the ground truth notes an 'increased emphasis on the challenges of predicting future cash flows,' suggesting a qualitative intensification in tone that the LLM does not fully capture. Additionally, the ground truth describes a strategic progression from disclosure (2022) to operational reliance (2023) to risk-aware integration (2024), a nuanced three-stage evolution that the LLM simplifies into a more static 'maintained use' narrative. While the core facts and direction of change are correct, this subtle but important progression in strategic approach is underdeveloped. Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution of the methodology and its implications for fair value assessment in emerging markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1639,
        "completion_tokens": 467,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "Across the three Form 10‑K filings, BNY Mellon’s language on capital‑return limits is essentially unchanged. In each year (2022, 2023 and 2024) the company states that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The repeated, unchanged disclosure signals that the firm continues to recognize the same regulatory ceiling on dividends and share‑repurchases, but it also underscores that, within those statutory bounds, the Board retains flexibility to adjust the timing and amount of capital distributions as it deems appropriate.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent disclosure language across 2022, 2023, and 2024 regarding capital return limitations under U.S. banking laws, Delaware law, and preferred stock dividend obligations, which aligns with the ground truth. The dates and entities (BNY Mellon, Board of Directors, U.S. banking laws) are accurate, and there are no numerical inaccuracies—this supports a high quantitative accuracy score. However, the LLM fails to mention a key qualitative development in the 2024 filing: the new emphasis on the Parent’s dependency on dividends from subsidiaries and credit extensions from its IHC (Intermediate Holding Company) to fund share repurchases and dividends. This omission is significant because the question specifically asks about the evolution of disclosures and what the multi-year progression suggests about strategic flexibility. By not acknowledging this added nuance in 2024, the LLM presents an incomplete picture of the evolving disclosure, incorrectly implying the language was 'essentially unchanged' when in fact it was expanded. This affects the qualitative accuracy and overall correctness, as the synthesis across years is incomplete. While the answer correctly notes the Board’s discretion within regulatory bounds, it misses the growing focus on internal capital flows, which is central to understanding BNY Mellon’s strategic constraints. The response is contextually relevant and well-structured but lacks critical depth in multi-hop reasoning across the three-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 420,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 2022 Form 10‑K already warned that a “loss or modification of exemptions for taxes and tariffs” was one of the many political‑legal risks it faces in its worldwide operations. The same language reappears in the 2023 filing, but the 2024 filing not only repeats the exemption risk it also ties it to a broader set of recent sanctions, export‑control revisions and heightened China‑Taiwan tensions, showing that the company now sees tax‑ and tariff‑exemption risk as part of an increasingly intricate and volatile global regulatory landscape. This progression suggests AMD’s exposure to losing such exemptions is growing and the regulatory environment in which it operates is becoming more complex and unpredictable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD highlighted the risk of losing tax and tariff exemptions in each year from 2022 to 2024, with increasing contextual detail over time. The 2022 filing mentions the risk generally, 2023 adds geopolitical context (e.g., China-Taiwan tensions), and 2024 ties it to broader regulatory changes like U.S. export controls—this progression is correctly captured. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers an increasing complexity in AMD’s regulatory environment based on expanding risk disclosures. (4) The LLM slightly condenses the original answer—for example, it does not explicitly mention the Ukraine conflict in 2023, which is in the ground truth, but it does reference China-Taiwan tensions, which is accurate. It also correctly identifies the linkage to export controls in 2024. The omission of Ukraine is a minor detail that slightly reduces completeness but does not affect the overall correctness. Wording differs but semantic meaning matches. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 392,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "- **Borrowings:** Short‑term borrowings fell sharply from **$883 million in 2022** to **$538 million in 2023**, then edged up to **$562 million in 2024**.  \n- **Long‑term debt:** Total long‑term debt rose modestly from **$47.8 billion in 2022** to **$49.3 billion in 2023**, before declining to **$45.0 billion in 2024**.\n\n**What this shows:** Capital One has been trimming overall debt, especially short‑term funding, and the bulk of its long‑term obligations are now fixed‑rate senior notes. The low‑cost floating unsecured senior debt that carried a weighted‑average rate of about **1 %** (maturing 2022‑2024) was fully retired, and the only remaining floating exposure is a **6.75 % senior note due 2025**, indicating a shift away from cheap floating‑rate funding toward a higher‑rate, shorter‑maturity floating instrument and a debt profile dominated by fixed‑rate debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in key financial figures, particularly in short-term borrowings and total debt levels. According to the ground truth, total short-term borrowings and long-term debt were $43.086B (2022), $49.856B (2023), and $45.551B (2024). The LLM incorrectly reports short-term borrowings as only $883M, $538M, and $562M across those years—off by nearly two orders of magnitude—and misrepresents long-term debt trends. These errors severely undermine quantitative accuracy. 2) The LLM claims short-term borrowings fell from $883M to $538M, but the ground truth does not provide a standalone short-term borrowing figure; instead, it gives total debt (short + long term). The LLM appears to have either misread or hallucinated granular data. The floating unsecured senior debt evolution is partially correct: it correctly notes the 6.75% rate in 2023 and the elimination of floating-rate debt by 2024, but misses that floating unsecured senior debt was $1.709B in 2022 (not implied by 'low-cost... maturing 2022-2024'). It also incorrectly implies there is still a floating-rate note due 2025, which contradicts the ground truth stating this category dropped to $0 in 2024. 3) The reasoning about a strategic shift toward fixed-rate debt to reduce interest rate risk is semantically aligned with the ground truth and shows correct multi-hop synthesis of intent, even if based on flawed numbers. The conclusion about increasing fixed-rate dominance is directionally correct, as fixed unsecured senior debt did rise from $21.045B (2022) to $26.930B (2024). 4) Despite major numerical errors, the answer addresses all parts of the question—evolution of debt, composition change, and interest rate exposure—and maintains contextual relevance. However, the quantitative inaccuracies prevent a higher score, especially since financial analysis hinges on precise figures. Minor note: the LLM uses '47.8B' for 2022 long-term debt, which when added to its reported short-term borrowings (~$883M), totals ~$48.7B—still inconsistent with the true total of $43.086B, indicating internal inconsistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 569,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program‑share interest in International Aero Engines AG (the V2500 engine joint venture) was 57 % in 2022, remained 57 % in 2023, and stayed at 57 % in 2024. The unchanged, majority‑owner position shows that RTX (via Pratt & Whitney) is maintaining a stable, leading strategic foothold in the V2500 collaboration rather than expanding or reducing its involvement.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding RTX's net program share interest in IAE. The ground truth states that RTX's interest was 61% in 2022 and decreased to 57% in 2023 and 2024. However, the LLM claims it was 57% in all three years, missing the decrease entirely. This error fundamentally misrepresents the trend and leads to an incorrect strategic interpretation. (2) Quantitatively, the percentages are wrong for 2022—61% is reported as 57%, which is a significant deviation. There are no calculations involved, but the comparison over time is inaccurate. The years (2022–2024) and entity (RTX/IAE/V2500 program) are correctly identified. (3) The multi-hop reasoning fails because the model does not recognize the change over time, which is central to the question. Instead of identifying a strategic reduction in economic exposure, it concludes there is 'stable, leading strategic foothold' due to no change—this is based on false premises. The reasoning would have been sound if the data were correct, but it collapses under incorrect input. (4) Contextual relevance is high because the answer addresses the right entity, program, and time frame, and attempts to interpret strategic positioning. However, due to the critical numerical inaccuracy, the qualitative and overall correctness scores are very low. Minor note: formatting variations like '57 %' with a space are acceptable and do not affect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 398,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Across the three most recent 10‑K filings, Cascade continues to be listed as one of the flagship brands in the Fabric & Home Care segment (the segment’s brand roster reads “Ariel, Downy, Gain, **Tide Cascade**, Dawn, …” in both the 2022 and 2024 tables) and the narrative still describes P&G’s global home‑care market share (≈ 25 %) as being “primarily behind our **Cascade**, Dawn, Febreze and Swiffer brands.” The segment’s contribution to net sales rose modestly (≈ 35 % of net sales in 2022 to 36 % in 2024), but Cascade’s role within the portfolio has not shifted—it remains a core, market‑leading home‑care brand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the Fabric & Home Care segment's contribution to net sales increased from 35% in 2022 to 36% in 2023 and 2024, which matches the original answer. The earnings contribution is not explicitly mentioned in the LLM response (31% in 2022 rising to 34% in 2023/2024), but this omission does not distort the overall picture. (2) The entity identification is accurate—Cascade is correctly placed within the Fabric & Home Care segment and listed among key brands like Dawn, Tide, and Swiffer. The brand roster notation 'Tide Cascade' (though possibly a formatting artifact) does not misrepresent the data. (3) The reasoning is sound: the LLM correctly infers that Cascade’s strategic role has remained stable despite minor segment-level changes, based on consistent branding and segment performance across three 10-Ks. (4) The answer is contextually relevant and directly addresses the evolution of Cascade’s positioning. The only minor shortcoming is the lack of explicit mention of earnings contribution trends (31% to 34%), which was included in the ground truth and adds nuance to the strategic importance. However, the core conclusion about stable positioning is fully supported. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 394,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "From 2022 to 2024 BNY Mellon moved the Directors’ Code of Conduct from a plain https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/… URL (e.g., …/in relations/directors‑code‑of‑conduct.pdf) to a more branded https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf address in 2024, while the 2023 filing already showed an intermediate change to “inv relations” in the path. Alongside the URL shift, the 2024 filing embeds the Directors’ Code within a broader “CODE OF ETHICS” section that also references the employee Code of Conduct, insider‑trading policies and the company’s overall corporate‑governance framework, indicating tighter integration of the directors’ code with BNY Mellon’s overall governance disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key aspects of the evolution in BNY Mellon's disclosure practices from 2022 to 2024. (1) It correctly identifies the URL changes across years: the 2022 path with '/in relations/', the 2023 intermediate shift to '/inv relations/', and the 2024 move to the 'bny.com' domain with '/investor-relations/'—all matching the ground truth in structure and timing. Minor formatting differences (e.g., use of hyphens, spacing) do not affect factual accuracy. (2) Quantitatively, all years and URL components are correct; no numerical or date inaccuracies. (3) The reasoning is sound: it infers a progression toward better branding and integration, and importantly, adds a detail not in the original but consistent with the knowledge graph—mentioning the 2024 embedding within a 'CODE OF ETHICS' section alongside other policies. While this specific section title isn't in the ground truth, it is a reasonable interpretation of tighter integration and does not contradict the source. (4) The answer fully addresses the question’s dimensions: URL structure, domain branding, and integration with corporate governance. The only reason for not scoring a 10 is that the original emphasizes the shift from 'siloed' to 'stakeholder-oriented' strategy, a framing slightly more developed than the LLM's version, though the substance is equivalent. Overall, the answer is factually correct, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 401,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across all three filings AMD’s AIB strategy remained anchored on two points. In 2022 the 10‑K (p. 9‑13) first disclosed that its agreements with add‑in‑board manufacturers “protect their inventory of our products against price reductions,” and that system integrators “often use discrete graphics solutions as a means to differentiate their products.” The 2023 filing (p. 11‑15) repeats the same inventory‑protection language and again stresses that SIs rely on discrete GPUs for product differentiation, and the 2024 filing (p. 9‑13) reiterates both the inventory‑protection clause and the role of discrete graphics in helping SIs add value. Thus, from 2022 through 2024 AMD’s positioning with AIBs consistently emphasized safeguarding AIB inventory from price cuts while promoting discrete graphics as a key differentiator for system‑integrator offerings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: AMD maintained inventory protection policies for AIBs and emphasized discrete graphics as a differentiator for system integrators (SIs) from 2022 to 2024. The answer correctly identifies the consistency of these policies across all three years. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022–2024) and references to filing pages are accurately presented and consistent with the expected sourcing. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual filings (2022, 2023, 2024), demonstrating continuity in AMD’s strategic positioning. The LLM correctly infers stability in strategy based on repeated language in the filings. (4) The answer addresses all parts of the question: evolution over time, inventory protection policies, and the role of discrete graphics in differentiation. Wording differs slightly from the original answer but conveys the same meaning with high precision. No omissions or inaccuracies. All scores are maximized accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 332,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "In the 2022 filing McDonald’s simply listed the Egg McMuffin among its core breakfast items and described a supply‑chain strategy that “encourages innovation and drives continuous improvement” while maintaining high food‑safety and quality standards. By the 2023 report the company added a digital‑transformation effort to capture data‑driven quality metrics and highlighted that its menu – including the Egg McMuffin – is being continuously evolved to meet guest expectations for taste, quality and consistency. The 2024 filing deepened that theme, noting regular sensory‑evaluation and calibration training to ensure the Egg McMuffin’s consistency, and reaffirming supplier collaboration and innovation as central to delivering the quality and reliability customers expect from its breakfast lineup.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's disclosures from 2022 to 2024 regarding the Egg McMuffin, supply chain focus, and customer expectations for quality and consistency. (1) All factual elements are correct: in 2022, the Egg McMuffin is listed as a core item with general supply chain improvement language; in 2023, digital transformation and data-driven quality metrics are introduced; in 2024, sensory evaluation, calibration training, and supplier collaboration are emphasized. These align closely with the ground truth, though the LLM omits the specific mention of the 'Global Chief Supply Chain Officer' in 2023 and slightly condenses the 2024 digital transformation project’s focus on 'data excellence and continuous measures on quality and food safety performance.' (2) There are no numbers, dates, or financial figures in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and connects the Egg McMuffin to broader strategic themes (innovation, supply chain, digital transformation, consistency). The only minor gap is the absence of the named executive role, which is a detail but not central to the overall narrative. (4) The answer is contextually fully relevant, directly addressing the evolution of disclosure around breakfast innovation and supply chain in relation to the Egg McMuffin and customer expectations. Wording differs slightly from the original but maintains semantic equivalence. A score of 9 is justified due to high accuracy with only minor omissions in specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 455,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The 4.30 % Note due 2034 appears in the “Forms of … 4.30 % Note due 2034” exhibit listed in Oracle’s 2022, 2023 and 2024 Form 10‑K filings (e.g., Exhibit 4.11 in the 2022 filing [pages 111‑113], the same exhibit in the 2023 filing [pages 108‑110] and again in the 2024 filing [pages 108‑110]). Its repeated disclosure shows that the note remains an active component of Oracle’s long‑term debt portfolio, indicating that the company relies on fixed‑rate, multi‑year notes to lock in relatively low borrowing costs and to maintain a diversified maturity schedule—an ongoing financing priority across all three reporting periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—'4.30% Note due 2034' and the years 2022, 2023, 2024—are correct and consistently referenced. The exhibit numbers and page ranges (e.g., Exhibit 4.11, pages 111–113, 108–110) are factually precise, though not part of the original answer, they reflect valid details from actual filings and do not detract from accuracy. (2) Quantitative accuracy is perfect: percentages and dates match exactly, and no calculations were required. (3) The multi-hop reasoning is sound—the model correctly infers from repeated disclosure across three years that the note remains an active, strategic part of Oracle’s long-term debt structure. It accurately concludes Oracle uses such notes to lock in low fixed-rate financing and maintain maturity diversification, which is consistent with the ground truth’s emphasis on strategic long-term financing and portfolio diversification. (4) While the LLM answer does not mention specific co-occurring debt instruments (e.g., 3.625% Note due 2023 or 2.950% Notes due 2024) as in the original answer, it captures the essential qualitative point: Oracle maintains a diversified, long-term financing strategy. This omission slightly reduces completeness in synthesis but does not undermine the core correctness. The answer remains semantically equivalent in intent and conclusion, with excellent contextual relevance to the question about debt structure and financing priorities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 410,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One values its derivatives with vendor‑based discounted‑cash‑flow models that rely on observable market data for most contracts, but it classifies the portion that depends on significant unobservable inputs (primarily SOFR‑indexed interest‑rate swaps) as Level 3.  The net Level 3 fair‑value of derivative assets/liabilities was only **$5 million at year‑end 2022**, rose to **$58 million at year‑end 2023**, and climbed to **$69 million at year‑end 2024** (while total derivative assets fell from $886 m/$828 m in 2023 to $683 m/$614 m in 2024).  This upward trend in Level 3 amounts, despite a smaller overall derivative book, shows that Capital One’s exposure to unobservable market inputs—and therefore valuation uncertainty—has been increasing over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, $58 million in 2023, and remained at $58 million in 2024. However, the LLM incorrectly reports $5 million in 2022, $58 million in 2023, and $69 million in 2024. The $5 million figure for 2022 is particularly erroneous and contradicts the ground truth. Additionally, the LLM introduces 'Level 3' fair value without clarifying that this refers to unobservable inputs, and while it correctly identifies increasing reliance on unobservable inputs, it misrepresents the trend by showing a continued increase to $69 million in 2024 when the actual amount stabilized at $58 million. (2) The quantitative inaccuracies are severe: the 2022 value is off by over 70%, and the 2024 value is incorrectly increased instead of held constant. The mention of total derivative assets ($886M, $828M, etc.) appears to come from outside the ground truth and introduces unverified data. No such totals are mentioned in the original answer, making this potentially misleading. (3) The reasoning is partially sound—recognizing increasing exposure to unobservable inputs—but flawed due to incorrect data. The conclusion about rising valuation uncertainty is not fully supported because the ground truth shows stabilization in 2024, not continued growth. The multi-hop synthesis fails because the model does not correctly track the evolution across years as per the knowledge graph. (4) Despite incorrect numbers, the answer addresses the right topic (valuation methodology and unobservable inputs), mentions relevant inputs like SOFR/swaps, and attempts to interpret risk implications, earning moderate points for contextual relevance and some qualitative insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 496,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s 2012 Rolls‑Royce agreement requires the company to make a cash payment for every V2500‑engine flight hour that is flown through June 2027 on the aircraft that were in service at the time of the acquisition. The payments are recorded as “collaboration” intangible assets when made and are then amortized over the estimated economic life of the asset (a 9‑ to 30‑year period, with amortization beginning when the program moves into full‑rate production and aftermarket service) rather than being expensed immediately. In the 2022 filing the schedule of net payments (after the partner‑share offset) was $735 million in 2022, $1,053 million in 2023 and $765 million in 2024; by the 2024 filing the bulk of the remaining obligation had been pushed out, showing $846 million due in 2025, $770 million in 2026 and $704 million in 2027 (total net “other commercial aerospace commitments” of $1,478 million for 2025‑2027). Thus the obligation has shifted from front‑loaded payments in 2022‑2024 to a later‑dated payment profile, while the amortization approach remains the same – capitalizing each hour‑based payment as a collaboration asset and amortizing it over the asset’s useful life.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies the 2012 agreement with Rolls-Royce and the per-flight-hour payment structure through June 2027, it fabricates specific payment amounts ($735M in 2022, $1,053M in 2023, $765M in 2024, etc.) that are not present in the original answer. The ground truth states that in 2024, total commercial aerospace financing and other commitments were $14.1 billion, but does not break down annual payments to Rolls-Royce or mention a reprofiled obligation from front-loaded to later payments. The claim that 'the bulk of the remaining obligation had been pushed out' and the detailed schedule for 2025–2027 ($846M, $770M, $704M) is unsupported by the original answer and represents a major factual deviation. Additionally, the original answer does not mention amortization periods of 9–30 years or specify when amortization begins (e.g., full-rate production), making those details unverified and likely hallucinated. However, the LLM correctly captures the qualitative evolution: payments are tied to flight hours, capitalized as collaboration intangible assets, and amortized to cost of sales. It also correctly notes improved transparency over time and consistent amortization policy. The reasoning framework is logically sound and contextually relevant, but the inclusion of fabricated numerical data severely compromises factual accuracy. Multi-hop synthesis is attempted but based on incorrect data, leading to a partially correct but ultimately misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 431,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "- In the 2022 Form 10‑K Amgen merely disclosed that it “collects and assesses user‑complaints, adverse events and malfunctions” for its drug‑delivery devices, including the Neulasta Onpro kit, but gave no detail on any corrective actions.  \n- The 2023 filing added that, after an FDA review of the kit in 2017, Amgen “implemented device‑ and labeling‑enhancements to address product‑complaints received on this device” and that it “continuously monitors complaints and adverse events and implements additional enhancements as needed.”  \n- By the 2024 filing the company emphasized that this monitoring and enhancement program remains in place and is now part of a broader risk‑mitigation framework that includes operational‑resilience steps – such as backup‑generator capacity and supply‑chain safeguards for its manufacturing sites – to ensure uninterrupted availability of the Neulasta Onpro kit and related products.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and captures the evolution of Amgen's disclosures from 2022 to 2024, but contains a significant inaccuracy in the 2022 characterization. According to the ground truth, in 2022 Amgen referenced the 2017 FDA evaluation and described device and labeling enhancements made in response to complaints. However, the LLM claims that the 2022 10-K 'gave no detail on any corrective actions,' which contradicts the original answer and underrepresents Amgen’s disclosures for that year. This is a material omission affecting the qualitative accuracy. The 2023 and 2024 summaries are accurate: the mention of the 2017 FDA review, implementation of enhancements, continuous monitoring, and expansion to include operational resilience (e.g., backup generators) aligns with the ground truth. The reference to Puerto Rico's electric grid instability and island-wide outage on December 31, 2024, is missing from the LLM answer, which omits a specific, concrete example of operational risk cited in the original. While the general concept of operational resilience is correctly noted, the absence of this key detail reduces completeness. Quantitatively, all dates (2017, 2022–2024) are accurate, and no numerical errors are present. The reasoning correctly traces a multi-hop narrative across years and domains (device complaints → enhancements → operational resilience), though the flawed 2022 summary weakens the chain. The answer remains contextually relevant and well-structured, addressing both device-related enhancements and operational resilience as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 438,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s disclosure about its principal accountant did not change – each report says that the ratification of KPMG LLP is incorporated by reference to the proxy’s “Item 3 – Ratification of KPMG LLP,” and each notes that KPMG’s PCAOB firm identification number is 185. The repeated citation of the same PCAOB number in all three years signals that the company has kept the same audit firm and that its audit‑governance structure has remained continuous and unchanged from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: BK (BNY Mellon) consistently disclosed the ratification of KPMG LLP as principal accountant in 2022, 2023, and 2024, and the PCAOB firm number 185 is correctly cited across all years. The statement about incorporation by reference to the proxy's Item 3 is consistent with actual SEC filing practices and adds contextual precision not contradicted by the ground truth. (2) Quantitative accuracy is perfect: no numerical errors; the PCAOB number 185 is correctly repeated, and the years 2022–2024 are accurately referenced. (3) Reasoning is sound: the LLM correctly infers audit governance continuity from the unchanged PCAOB number and consistent disclosure language, which is a valid conclusion supported by the data. (4) The only minor shortcoming is that the LLM does not explicitly mention 'audit governance practices' or 'institutional trust' as in the original answer, slightly reducing qualitative completeness, but the core inference about continuity is clearly conveyed. The answer is fully contextually relevant, directly addressing both parts of the multi-hop question: evolution of disclosure and implications of the PCAOB number. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to slightly less comprehensive elaboration on governance implications, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 394,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s total exposure to commercial‑aerospace customer‑financing guarantees has been falling each year – the maximum‑potential payment on these guarantees dropped from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024【2022 Note 16】【2023 Note 16】【2024 Note 16】.  At the same time, the portion of the guarantees that is assumed by collaboration partners has also slipped, from $142 million in 2022 to $135 million in 2023 and $131 million in 2024【2022 Note 16】【2023 Note 16】【2024 Note 16】, indicating that RTX is deliberately shifting more of the financing‑guarantee risk to its partners and thereby reducing its own direct liability exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all numerical values for the collaboration partners' share of guarantees ($142M in 2022, $135M in 2023, $131M in 2024), which matches the ground truth exactly. It also introduces additional data—RTX’s total exposure ($304M, $288M, $274M)—which, while not in the original answer, may be contextually relevant but were not part of the ground truth evaluation scope. However, the key error lies in the interpretation: the LLM states that RTX is 'shifting more of the financing-guarantee risk to its partners,' which is the opposite of what the declining partner share indicates. The ground truth interprets the decreasing partner share as RTX reducing shared risk with partners, implying RTX may be taking on less contingent liability overall or restructuring to reduce exposure. The LLM incorrectly infers that decreasing partner share means partners are taking on more risk, when in fact they are assuming less. (2) All numbers are quantitatively accurate and properly cited across years. (3) The multi-hop reasoning fails: while the model identifies the trend in partner contributions correctly, it draws the inverse conclusion about risk allocation. This reflects a critical flaw in logical synthesis—declining partner contributions mean reduced partner involvement in risk-sharing, not increased. (4) Scores reflect high quantitative accuracy and relevance, but significant qualitative error in reasoning undermines the correctness score, bringing it to a 6 due to the partially correct facts but flawed strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 432,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "- In the 2022 filing the “Baby, Feminine & Family Care” segment grouped the brand as “Pampers Always” among a long list of brands (Luvs, Pampers Always, Always Discreet, Tampax, Bounty, Charmin, Puffs). The narrative described the feminine‑care portfolio as “Adult Incontinence and Menstrual Care” and said P&G was a market leader “behind our Always and Tampax brands” in the menstrual‑care sub‑category.  \n\n- By the 2023 and 2024 filings the segment table was streamlined to “Feminine Care (Adult Incontinence, Menstrual Care)” with the major brands listed as **Always, Always Discreet, Tampax**. The text again notes that P&G leads the feminine‑care market, competing “primarily behind our Always and Tampax brands” for menstrual care and “behind Always Discreet” for adult incontinence.  \n\n**Thus, from 2022‑2024 Always shifted from being bundled with Pampers and listed among many brands to being highlighted as a standalone, core menstrual‑care brand (alongside Tampax) with a distinct sister brand Always Discreet for incontinence, reinforcing its primary position within the Feminine Care portfolio.**",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timeline and structure of Procter & Gamble's segment reporting. According to the ground truth, in 2022 the segment was still called 'Feminine Care' and was not yet merged into 'Baby, Feminine & Family Care'—this change occurred in 2023. However, the LLM incorrectly states that in 2022 the segment was already named 'Baby, Feminine & Family Care' and grouped Always with Pampers. This misrepresents the evolution timeline. Additionally, the LLM claims Always was listed as 'Pampers Always' in 2022, which is factually incorrect and not supported by the original answer or known filings. (2) Quantitative accuracy is low: the original answer specifies that Feminine Care contributed 25% of net sales in 2022 and 24% in 2023 and 2024 under the new segment name. The LLM omits these percentages entirely, failing to report key quantitative data required for accuracy. There are no calculations in this case, but the omission of reported percentages significantly undermines quantitative fidelity. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the strategic elevation of Always as a core brand in menstrual care and recognizes the distinction between Always and Always Discreet (for incontinence) by 2023–2024. It also correctly notes the streamlining of brand presentation. However, because the initial state (2022) is misrepresented, the comparative evolution is flawed. The conclusion about Always becoming more prominent is directionally correct but based on incorrect premises. (4) Contextual relevance is high—the answer directly addresses product categorization, brand emphasis, and evolution over time, focusing on the right brands and structural changes. Despite incorrect details, it attempts the correct synthesis. Qualitative accuracy is moderate due to correct identification of brand roles and narrative trends, but penalized for incorrect entity relationships and timeline. Correctness score is 6 due to partially accurate brand evolution insights but major errors in factual timeline and entity presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 572,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In the 2022 filing AMD already warned that “difficulties in protecting our intellectual property” were a material risk of its worldwide operations, noting that nearly all product assembly and final testing were performed at third‑party facilities in China, Malaysia and Taiwan and that 72 % of its revenue came from international sales. The 2023 and 2024 filings repeat the same IP‑protection risk – now with international sales around 65‑66 % – and stress that the company continues to rely on third‑party wafer foundries and contract manufacturers in Asia, showing that the exposure has persisted and effectively grown as AMD’s overseas sales and Asian manufacturing footprint have expanded.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's ongoing exposure to intellectual property (IP) protection difficulties from 2022 to 2024, its reliance on third-party manufacturing in Asia (specifically China, Malaysia, and Taiwan), and the significance of international sales. However, there is a quantitative discrepancy in the reported international sales percentage: the LLM states 72% in 2022 and 65–66% in 2023/2024, while the ground truth only confirms 65% in 2023 and does not specify 2022 at 72%. The 72% figure is not present in the original answer, making this an unsupported claim. (2) The ground truth does not mention 72% international sales in 2022, only that international operations posed IP risks. The 65% figure in 2023 aligns with the original answer, and the LLM’s 65–66% range is acceptable as a minor approximation. However, introducing 72% without support reduces quantitative accuracy. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes AMD’s IP risk across years, links it to third-party manufacturing in Asia, and connects it to international sales trends. It accurately notes the persistence and growing nature of the risk. However, it omits the key 2024 development mentioned in the ground truth: the heightened risk due to geopolitical tensions between China and Taiwan, which adds a new layer of complexity. This omission affects completeness and reasoning depth. (4) Despite missing the geopolitical risk nuance in 2024, the LLM captures the core evolution of AMD’s IP exposure and maintains correct entity identification (AMD, correct countries, correct time frame). The answer is highly contextually relevant and semantically close to the original, warranting a high correctness score, but not full marks due to the unsupported 72% figure and missing geopolitical context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 497,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first introduced the 2.300 % senior unsecured notes due 2028 in a March 24 2021 issuance (Exhibit 4.14) and the series appears in the debt tables of the 2022 Form 10‑K (see ORCL 2022 p. 112‑116). The same 2.300 % 2028 notes are carried forward unchanged in the 2023 Form 10‑K (ORCL 2023 p. 108‑112) and again in the 2024 Form 10‑K (ORCL 2024 p. 109‑113), indicating that Oracle has kept the issue outstanding rather than refinancing it. This recurring presence of a low‑coupon, medium‑term note across three consecutive filings shows Oracle’s broader strategy of building a laddered portfolio of senior notes with staggered maturities and attractive rates, allowing the company to lock in inexpensive financing and spread refinancing risk over multiple years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 2.300% Notes due 2028 as first issued on March 24, 2021, which matches the context of being part of the March 2021 issuance referenced in the original answer. While the original answer cites Exhibit 4.16 in 2022, the LLM cites Exhibit 4.14—this is a minor discrepancy, but not necessarily incorrect, as different exhibits may reference the same notes across filings. The LLM accurately notes the consistent inclusion of the notes in the 2022, 2023, and 2024 10-Ks, with correct exhibit continuity and page references, supporting the conclusion of ongoing disclosure. (2) All quantitative elements—interest rate (2.300%), maturity year (2028), and issuance date (March 24, 2021)—are correct. The claim that the notes were 'carried forward unchanged' is consistent with the ground truth’s emphasis on continuity. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three years of filings to infer Oracle’s broader debt strategy—specifically, a laddered maturity profile and risk-spreading—mirroring the original answer’s conclusion about a 'stable and deliberate approach' and 'diverse maturity profile.' (4) The LLM adds value by characterizing the notes as 'low-coupon' and 'senior unsecured,' which are reasonable inferences from context and common market knowledge, enhancing qualitative insight without overreaching. The only minor shortcoming is the slight variance in exhibit number (4.14 vs. 4.16 in 2022), but this does not undermine the factual core. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 451,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "BA’s private‑equity approach has remained centered on **limited‑partnership vehicles that target both U.S. and non‑U.S. opportunities** and that focus on **leveraged‑buyout, venture‑capital, growth‑stage and special‑situation investments**. The 2022 filing (pages 108‑112) describes the same global, multi‑strategy mandate, and the 2023 (pages 90‑94) and 2024 (pages 97‑101) filings repeat that language, indicating no change in geographic scope or strategic focus. What has shifted is the weight of the allocation – the target share rose from 4 % in 2022 to 7 % in 2023 and to 9 % in 2024 – but the geographic coverage and investment themes have stayed consistent.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of BA's investment strategy. While it correctly identifies the consistent presence of U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies in 2022, it fails to recognize the strategic evolution described in the ground truth. Specifically, the LLM claims there was 'no change in geographic scope or strategic focus,' which contradicts the ground truth stating an expanded emphasis in 2023 on global private investments in real assets (energy, farmland, infrastructure) and increased use of derivatives in 2024 for performance transfer—key developments in both focus and sophistication. (2) The quantitative claim about allocation targets increasing from 4% in 2022 to 7% in 2023 and 9% in 2024 is not present in the original answer and cannot be verified against the ground truth, introducing unverified data. There are no calculations in the response, but the inclusion of unsupported percentages reduces quantitative accuracy. (3) The multi-hop reasoning is flawed: the model synthesizes across years but draws an incorrect conclusion by equating repeated language in filings with no strategic change, failing to detect nuanced shifts in focus (e.g., real assets expansion, derivative usage). This represents a failure in qualitative synthesis despite correct entity identification (BA, private equity vehicles, limited partnerships). (4) Contextual relevance is high because the answer addresses the question’s structure—geographic scope, strategic focus, and evolution over time—and references appropriate sections of filings. However, the core factual content is partially incorrect, warranting a moderate score of 4 for correctness, with lower qualitative accuracy due to flawed reasoning, a mid-range quantitative score due to plausible but unverified numbers, and strong contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 522,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "- **Clinical‑phase evolution** – In the 2022 Form 10‑K Amgen reported that Bemarituzumab had just **initiated a Phase 3 study** for gastro‑esophageal‑junction (GEJ) adenocarcinoma (while also being in Phase 2 for other tumors and Phase 1 for NSCLC). The 2023 and 2024 filings show the same status – Bemarituzumab remains listed as a **Phase 3 candidate** (with the same Phase 2 and Phase 1 indications still noted), indicating that the program stayed in Phase 3 throughout 2022‑2024 with no further phase transition reported.\n\n- **Patent positioning** – Both the 2022 and the later 2023/2024 filings list composition‑of‑matter patents for Bemarituzumab that **expire in 2029 in the United States and in 2029 in Europe**. The expiration dates are unchanged across the three years, showing a consistent patent horizon for the molecule.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately reported: Bemarituzumab initiated a Phase 3 study in 2022 for GEJ adenocarcinoma, remained in Phase 3 through 2024, and is described as targeting FGFR2b for gastric and GEJ cancers. The patent expiration dates of 2029 in both the U.S. and Europe are correctly stated and noted as consistent across years. (2) Quantitatively, the dates (2022, 2023, 2024, 2029) are all accurate and match the original answer; no calculations are required, but the consistency of patent expiration timelines is correctly observed. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to show clinical phase stability and unchanged patent expiry, demonstrating an understanding of both development trajectory and IP positioning. (4) The answer is semantically equivalent to the original, with added clarity on concurrent Phase 1 and 2 trials, which does not contradict but enriches the ground truth. All aspects of the question—clinical progression and patent timelines in both the U.S. and Europe—are addressed with precision and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 333,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn has been listed as one of the “major brands” in the Fabric & Home Care segment in every filing – it appears in the brand roster for 2022, 2023 and 2024. During that period the segment’s share of total P&G earnings rose from about 31 percent in fiscal 2022 to roughly 34 percent in fiscal 2024, so Dawn’s position moved from a core brand in a modest‑earning segment to a core brand in a segment that is contributing a larger slice of overall earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the Fabric & Home Care segment’s earnings contribution increased from 31% in 2022 to 34% in 2024, and the LLM correctly reports these figures with appropriate rounding (‘about 31 percent’, ‘roughly 34 percent’). These match the original answer exactly. (2) The LLM confirms Dawn’s presence in the brand listings for all three years (2022–2024), which is consistent with the ground truth. (3) The reasoning is sound: the segment’s rising earnings contribution (from 31% to 34%) supports the conclusion that Dawn, as a core brand in that segment, is now part of a relatively more important earnings contributor. This constitutes valid multi-hop reasoning—linking Dawn’s consistent inclusion to the segment’s growing profitability. (4) The only minor omission is that the LLM does not mention the stability of the segment’s net sales percentage (35% in 2022, 36% in 2023/2024), which adds context about revenue stability versus earnings growth. While this detail strengthens the original answer, its absence does not invalidate the LLM’s core conclusion. The answer remains semantically aligned and factually correct. Thus, the correctness score is 9 due to high accuracy with a small completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 366,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "- In the 2022 filing the company reported that the fair‑value of client securities that could be used as margin‑loan collateral had risen to roughly **$120 billion**, and that **about $31 billion** of those securities were already pledged to third parties (options‑clearing, short‑sales, securities‑lending and short‑term borrowings).  By the 2024 filing the pool of pledged collateral had grown further – the firm’s secured borrowing facilities (FHLB and Federal‑Reserve discount‑window) were backed by **$59.8 billion and $30.5 billion, respectively**, and the CS&Co secured line of credit that can be backed by client margin securities fell to **$500 million** (down from $950 million in 2023) after the TD Ameritrade‑DC lines were terminated.  \n\n- The pattern shows a steady expansion of client‑security‑based collateral to support margin lending and the company’s liquidity‑raising borrowings, but a modest pull‑back in the amount tied directly to short‑term, unsecured credit lines, indicating that Schwab’s exposure to client‑held assets remains large and growing, yet is being managed through a broader mix of pledged securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its factual correctness. While the general trend of increasing use of client securities for collateral is correctly identified, the specific numbers cited do not align with the ground truth. The ground truth does not mention any specific dollar amounts such as $120 billion, $31 billion, $59.8 billion, $30.5 billion, or $500 million — these figures are either fabricated or misattributed. The original answer focuses on qualitative disclosures about accounting standards (ASC 326), regulatory compliance, and specific use cases like options clearing and securities lending, without providing the detailed numerical breakdown presented by the LLM. Additionally, the LLM introduces specifics about secured borrowing facilities (FHLB, Federal Reserve discount window) and the TD Ameritrade-DC line termination, which are not present in the ground truth and represent unverified details. While the LLM correctly infers a trend of growing exposure and strategic management of client assets, this reasoning is built on unsupported data. The qualitative synthesis of margin lending, collateral use, and risk management directionally aligns with the original answer, earning partial credit for reasoning and contextual relevance. However, the absence of such financial figures in the ground truth and the inclusion of detailed, incorrect numbers result in a low quantitative accuracy score. The answer is relevant and attempts multi-hop reasoning, but fails on factual grounding, especially in financial specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 432,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "By fiscal 2023 the company’s non‑U.S. pension plans were weighted ≈ 19 % equity, 43 % debt, 6 % cash‑short‑term, 22 % insurance contracts and 10 % other (U.S. plans remained 100 % debt). The August 31 2023 average showed a modest shift to ≈ 23 % equity, 42 % debt, 5 % cash, 21 % insurance and 9 % other, and the 2025 target (based on the August 31 2024 average) calls for a further move to ≈ 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other. Thus, ACN is steadily increasing equity and cash exposure while reducing debt and “other” allocations in its non‑U.S. defined‑benefit plans, with U.S. plans staying at 100 % debt.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the percentages provided are completely wrong: the ground truth states that ACN's weighted-average plan asset allocations were 55% fixed income / 45% equities in 2022 (fiscal 2023), shifting to 58/42 in 2023 (fiscal 2024), and 61/39 in 2024 (fiscal 2025). The LLM instead reports allocations like 19% equity, 43% debt, and introduces categories such as 'insurance contracts' and 'other' that are not part of the disclosed target strategy in the ground truth. (2) The LLM incorrectly claims that U.S. plans are 100% debt and focuses on non-U.S. plans without basis in the question or original answer. (3) The reasoning is flawed: the original shows a clear de-risking trend—increasing fixed income, decreasing equities—but the LLM claims ACN is increasing equity exposure from 19% to 28%, which contradicts the ground truth. (4) The LLM invents a '2025 target based on August 31, 2024' with fabricated numbers (e.g., 28% equity, 36% debt), while the correct 2025 target is 61% fixed income and 39% equities. (5) The answer fails the multi-hop requirement: it does not correctly synthesize the evolution across the three disclosed dates (Aug 31, 2022, 2023, 2024) and misidentifies both the asset categories and the direction of change. The only partial relevance is that it discusses pension plan allocations over time, but the substance is factually baseless. Hence, the correctness score is 1 due to complete factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 423,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "**2022 (as reported in the 2023 filing)**  \n- Short‑term borrowings: **$883 million** (federal funds purchased and securities loaned/sold).  \n- Long‑term debt (all securitized, senior, subordinated and other borrowings): **$47.8 billion**.  \n\n**2023 (2023 filing)**  \n- Short‑term borrowings: **$538 million**.  \n- Long‑term debt: **$49.3 billion**.  \n\n**2024 (2024 filing)**  \n- Short‑term borrowings: **$562 million**.  \n- Long‑term debt: **$45.0 billion**.  \n\n**Three‑year trend**  \nShort‑term borrowings fell sharply from 2022 to 2023 and then held roughly steady in 2024, while long‑term debt rose modestly in 2023 before dropping about 9 % in 2024. The decline in long‑term debt is driven by the retirement of higher‑rate floating senior notes (the $349 million floating tranche present in 2022‑23 disappears in 2024) and a shift toward lower‑coupon fixed‑rate issuances, pulling the weighted‑average interest rate on long‑term debt down from roughly **4.5 %** in 2022‑23 to **3.5 %** in 2024. This indicates a debt structure that is becoming more reliant on lower‑cost, longer‑dated fixed‑rate funding and less exposed to rising interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports long-term debt alone as $47.8B in 2022 and $49.3B in 2023, which already exceeds the total debt (short + long) in the ground truth. This indicates a fundamental misrepresentation of the data. Additionally, the LLM reports short-term borrowings in the hundreds of millions, while the ground truth implies they are included in the total debt figures but not broken out separately—however, the scale discrepancy is still problematic. (2) The calculation of trends is flawed: the LLM claims long-term debt dropped 9% in 2024, but its own numbers go from $49.3B to $45.0B (about 8.7%), while the ground truth shows a rise from $43.086B to $48.715B to $45.551B—so total debt increased in 2023 then slightly declined, but not as severely as claimed. More critically, the LLM incorrectly states that the weighted-average interest rate on long-term debt decreased from ~4.5% to 3.5%, while the ground truth shows it increased from 1.51% to 3.01% to 3.48%, indicating rising, not falling, borrowing costs. This is a major error in both direction and magnitude. (3) The multi-hop reasoning is unsound: the LLM infers a strategic shift toward lower-cost fixed-rate debt due to falling rates, but the ground truth shows rising interest rates and a reduction in floating-rate debt (from $1,597M to $0), which the LLM partially notes (mentioning retirement of floating senior notes) but misinterprets as lowering average rates, when in fact rates rose across the board. The synthesis fails to correctly link rising interest rates with increased borrowing costs. (4) Despite these issues, the answer is contextually relevant—it addresses the evolution of debt, breaks it down by year, discusses interest rate exposure, and attempts to interpret strategic shifts. However, due to severe quantitative and qualitative inaccuracies, especially in the direction of interest rate trends and total debt levels, the correctness score is low. Minor credit is given for recognizing the elimination of floating-rate debt, which aligns with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 615,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Boeing’s filings state that fleet‑support services have “historically been approximately 1 % of total consolidated costs of products and services,” and the same wording appears in the 2022, 2023 and 2024 10‑K discussions – indicating that the share stayed essentially flat at about 1 % each year. In contrast, the company’s abnormal production costs rose sharply (cumulative abnormal costs reached $2.7 billion by the end of 2023 for the 787 program) and reach‑forward losses on the 777X program grew to multi‑billion‑dollar levels (e.g., a $2.6 billion loss recorded in Q3 2024 and additional losses thereafter). Thus, while fleet‑support expenses remained steady at roughly 1 % of total costs, the abnormal production and reach‑forward charges in the 787 and 777X programs expanded dramatically, exerting a far larger impact on Boeing’s overall cost structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) It correctly states that Boeing's (BA) fleet support services costs remained at approximately 1% of total consolidated costs in 2022, 2023, and 2024, with consistent wording across filings, indicating stability—this aligns with the original answer. (2) Quantitatively, it accurately reports the $2.7 billion cumulative abnormal production costs for the 787 program by end of 2023. For the 777X, it notes a $2.6 billion reach-forward loss in Q3 2024, which is a rounded version of the $2,608 million in the ground truth—this minor rounding is acceptable under format variation. However, the LLM omits the additional $891 million loss in Q4 2024, which slightly reduces completeness. (3) The reasoning is sound: it correctly contrasts stable fleet support costs with escalating program-specific losses, identifying that financial strain stems from production issues, not service costs. It synthesizes information across years and programs appropriately. (4) The answer is contextually fully relevant, addressing both parts of the multi-hop question: cost trend of fleet support services and its relation to abnormal/forward losses. The only minor shortcoming is the omission of the Q4 2024 777X loss, preventing a perfect score. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight incompleteness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 396,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "- 2022: Money‑market funds and time deposits were $21 million.  \n- 2023: The balance fell to $10 million.  \n- 2024: It remained at $10 million.  \n\nThe three‑year pattern shows AbbVie sharply cut its short‑term, highly liquid holdings after 2022 and then held them steady, suggesting a shift from a larger cash‑reserve buffer to a more streamlined liquidity position while still maintaining a modest, stable short‑term cash cushion.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and trends. According to the ground truth, AbbVie's allocation was $12M in 2022, $21M in 2023, and $10M in 2024. However, the LLM incorrectly states $21M in 2022, $10M in 2023, and $10M in 2024. This misrepresents both the starting value and the direction of change in 2023—claiming a decrease from 2022 to 2023 when the actual trend was an increase. (2) The quantitative inaccuracies are severe: the 2022 figure is off by $9M (wrong direction and magnitude), and the 2023 figure is half the correct value. The 2024 value happens to match the ground truth ($10M), but the prior errors undermine the trend analysis. (3) The reasoning is flawed due to incorrect data: the LLM concludes that AbbVie 'sharply cut' holdings after 2022, when in fact the company increased them in 2023. This indicates a failure in multi-hop synthesis—misinterpreting the temporal evolution of the data. The qualitative assessment of a 'streamlined liquidity position' may be plausible under a correct trend, but it is based on false premises. (4) Scores reflect major factual inaccuracies in numbers and trend interpretation, severely limiting correctness and qualitative reasoning. Contextual relevance is moderate because the answer addresses the right topic and attempts a strategic interpretation, albeit on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 387,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "- In fiscal 2022 Accenture repurchased 12.2 million Class A shares for $4.1 billion and, at year‑end, had $3.13 billion of unused authorization left; the Board then added $3 billion, raising total outstanding authority to $6.13 billion.  \n- By fiscal 2024 the company had bought roughly 2.0 million shares in the fourth quarter (about $605 million) and, after a $4 billion increase in September 2024, its total outstanding authority stood at $6.69 billion, with only $2.69 billion of that still available for future purchases.  \n\nThe pattern of sizable buy‑backs each year together with periodic boosts to the authorized limit shows that Accenture treats share repurchases as a core, ongoing element of its capital‑return strategy, using the program aggressively while maintaining ample authorization to sustain future returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend correctly—Accenture consistently repurchased shares and increased its authorization, indicating a strong capital return strategy. However, there are key quantitative inaccuracies. According to the ground truth, in fiscal 2022, Accenture had $3,129,296 thousand (~$3.13 billion) in remaining authorization—this part is accurate. But the LLM claims the Board added $3 billion, raising total authority to $6.13 billion, which is not supported by the original answer. The original states that by fiscal 2023, cumulative repurchase capacity since 2001 reached $50.1 billion, with $2,694 million remaining as of August 31, 2023. The LLM incorrectly implies that the $3 billion addition occurred in fiscal 2022 and miscalculates the resulting total. In fiscal 2024, the original confirms a $4,000 million ($4 billion) increase, bringing total remaining authority to $6,694 million—this is correctly reflected in the LLM answer. However, the LLM incorrectly states that only $2.69 billion is still available after the increase, when in fact the $6.694 billion is the new total available (i.e., the $4 billion was added to the prior $2.694 billion). (2) The repurchase volume of 12.2 million shares for $4.1 billion in fiscal 2022 and 2.0 million shares for $605 million in Q4 2024 are plausible but not present in the ground truth, suggesting the LLM may have hallucinated specific transaction details. (3) The multi-hop reasoning is generally sound—the model connects repurchase activity with authorization changes and infers a strategic capital return policy, which aligns with the original. (4) The contextual relevance is high, as the answer addresses both the evolution of repurchase activity and the strategic implication. Despite incorrect intermediate calculations and unsupported specifics, the core narrative of increasing authorization and sustained buybacks is correct, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 531,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "Across all three filings – the 2022, 2023 and 2024 Form 10‑K – AbbVie’s amended and restated certificate of incorporation and bylaws expressly state that “stockholders may only remove directors for cause.” The language of this provision (along with the staggered‑class board, the inability of shareholders to call special meetings and the 80 % super‑majority vote required to amend director‑related provisions) is unchanged from 2022 through 2024. This continuity signals that AbbVie deliberately entrenches its board as a core element of its long‑term takeover‑defense playbook, ensuring that any hostile acquirer must negotiate with, rather than replace, the incumbent directors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that AbbVie maintained the 'removal for cause only' provision in its governance documents across 2022, 2023, and 2024, with no changes to the language—matching the original answer's claim of consistency. (2) The quantitative and structural details are precise: the 80% supermajority requirement, staggered board, and restrictions on special meetings are all correctly cited as unchanged anti-takeover provisions. No numerical errors or date inaccuracies are present. (3) The multi-hop reasoning is sound—by synthesizing governance provisions across three years and linking them to a strategic intent (board entrenchment and takeover defense), the model correctly infers AbbVie’s long-term strategy despite no explicit policy change. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) of director removal provisions and the strategic implications. Wording differs slightly but conveys identical meaning and depth. All criteria—factual accuracy, completeness, entity correctness, and logical synthesis—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 330,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "- In the **2022 Form 10‑K** (Item 15, Exhibits list, pp. 124‑128) PepsiCo discloses a “Form of 4.000 % Senior Note due 2047” as Exhibit 4.5, referencing the original 2017 issuance.  \n- The **2023 Form 10‑K** (Item 15, Exhibits list, pp. 124‑128) repeats the exact same disclosure – the 4.000 % Senior Note due 2047 is again listed as Exhibit 4.5 with no change in wording.  \n- The **2024 Form 10‑K** (Item 15, Exhibits list, pp. 125‑129) likewise retains the identical reference to the 4.000 % Senior Note due 2047 as Exhibit 4.5.\n\n**Interpretation:** By consistently listing the 4.000 % Senior Note due 2047 in every annual filing, PepsiCo signals that this long‑dated, fixed‑rate debt remains outstanding and is a deliberate component of its long‑term capital structure, used to lock in inexpensive financing and diversify maturity profiles for sustained liquidity and financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric and factual details are correct: the 4.000% Senior Note due 2047 is correctly identified, and the consistent reference to Exhibit 4.5 across 2022, 2023, and 2024 is accurately reported. The original issuance date (May 2, 2017) is implied via context (referencing the 2017 8-K) though not explicitly stated in the LLM answer—this is a minor omission but does not detract significantly from accuracy. (2) Quantitative accuracy is perfect: percentages (4.000%), maturity year (2047), and exhibit number (4.5) are all correct across years. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the consistent disclosure pattern across three years and infers the strategic role in capital structure. The interpretation that the note remains a stable, long-term financing instrument is logically supported. (4) The answer is contextually excellent, directly addressing both the evolution (or lack thereof) in disclosure and the strategic implication. The only reason for not scoring a 10 is the slight lack of explicit mention of the May 2, 2017 8-K filing as the source, which is included in the ground truth and adds precision to the provenance of the exhibit. However, referencing the 'original 2017 issuance' provides sufficient context for semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 376,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first issued the 4.30 % senior unsecured note that matures in 2034 in July 2014 (see Exhibit 4.09).  In the 2022 Form 10‑K the note is listed in the long‑term debt table with its original principal amount still outstanding (2022 10‑K, p. 111); the 2023 filing repeats the same disclosure, showing only the accrued interest and a modest reduction in principal after scheduled amortization (2023 10‑K, p. 108); and the 2024 filing again reports the 4.30 % 2034 note as an unchanged component of Oracle’s debt portfolio, noting that no additional issuances of this series have occurred (2024 10‑K, p. 108).  This consistent, multi‑year reporting demonstrates Oracle’s strategy of locking in fixed‑rate, long‑dated financing and then “buy‑and‑hold” the tranche rather than repeatedly issuing new senior notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Oracle first disclosed the 4.30% Note due 2034 in 2022, but the LLM claims it was issued in July 2014, which contradicts the original answer and implies incorrect timing of the instrument's introduction. This error undermines the core of the multi-year evolution narrative. Additionally, the LLM references specific filing pages (e.g., p. 111, p. 108) and exhibit numbers (Exhibit 4.09) not present or verified in the ground truth, introducing unconfirmed details. (2) Quantitatively, while the interest rate (4.30%) and maturity year (2034) are correct, the issuance date (2014 vs implied 2022) is wrong. The claim of 'scheduled amortization' and 'modest reduction in principal' lacks support in the ground truth, which does not mention any principal reduction or amortization—only consistent disclosure. These are material quantitative misstatements. (3) The reasoning partially captures the idea of a stable long-term debt strategy, aligning with the 'consistent disclosure' aspect, but incorrectly frames the note as a legacy instrument from 2014 rather than a newly disclosed one in 2022. This breaks the multi-hop synthesis across 2022–2024 disclosures as intended in the question. The 'buy-and-hold' characterization is speculative and not in the original answer. (4) Despite factual errors, the response is contextually relevant—it addresses Oracle’s long-term debt strategy and attempts to trace the note across three years. However, the incorrect origin year and unverified details reduce correctness. The qualitative reasoning is plausible but based on false premises, leading to a partial match in meaning. Overall, the answer is semantically divergent on key facts, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 492,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "- **Fiscal 2022:** The Amended 2010 Share Incentive Plan authorized **127 million** Accenture plc Class A ordinary shares for awards.  \n- **Fiscal 2023:** The authorization was increased to **approximately 136 million** shares (the filing shows a higher limit than 2022).  \n- **Fiscal 2024:** The authorized pool rose further to **141 million** shares.\n\n**Interpretation:** The steady upward increase in the number of shares that can be used for the SIP demonstrates Accenture’s long‑term commitment to expanding its equity‑based compensation program, giving the company greater flexibility to reward and retain talent and to align employee interests with shareholders over the coming years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states 127 million shares for fiscal 2022 and 141 million for fiscal 2024, it incorrectly reports fiscal 2023 as 'approximately 136 million' instead of the correct 141 million. This is a critical error because the ground truth indicates the number increased to 141 million in 2023 and remained unchanged in 2024, whereas the LLM suggests a continued increase into 2024. (2) Number verification: 127M (correct), 136M (incorrect — should be 141M), 141M (correct for 2024 but wrongly implies change from 2023). The calculation of progression is flawed due to the incorrect 2023 value. (3) Multi-hop reasoning is partially sound — the model correctly identifies the need to track changes across years and draws a reasonable conclusion about talent retention and equity compensation strategy. However, the flawed data leads to an incorrect interpretation of a 'steady upward increase', when in fact the number plateaued in 2023–2024. (4) Contextual relevance is high — the answer addresses both the evolution of share authorization and its strategic implication. Qualitative accuracy is moderate because the logic is sound but based on incorrect data. Quantitative accuracy is low due to the key error in the 2023 figure. Correctness score is 6 because core facts are partially right (2022 and 2024 numbers) but the 2023 error distorts the trend and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 402,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "**Evolution of the 2.750 % Senior Note due 2051 (2022‑2024)**  \n\n* **2022 10‑K (pages 127‑131)** – The note is listed as Exhibit 4.48: “Form of 2.750 % Senior Note due 2051, incorporated by reference to PepsiCo’s Form 8‑K filed Oct. 21, 2021.” This shows the note had already been issued and the filing simply re‑discloses the existing instrument 【PEP_10k_2022.pdf p.127‑131】.  \n\n* **2023 10‑K (pages 126‑130)** – The same Exhibit 4.48 appears unchanged, again referencing the 2021 8‑K. No new terms are added, confirming the note remains outstanding and its original issuance terms are still in effect 【PEP_10k_2023.pdf p.126‑130】.  \n\n* **2024 10‑K (pages 127‑131)** – The note is now included in a new Board‑of‑Directors resolution (Exhibit 4.64). The resolution authorizes PepsiCo’s officers “to establish the terms of … the 2.750 % Senior Notes due 2051” among many other senior‑note programs 【PEP_10k_2024.pdf p.127‑131】. This indicates the company is formally documenting the note’s terms again within its current governance framework.\n\n**What the multi‑year filing pattern reveals**  \n\nRepeating the same exhibit each year and then reaffirming it through a fresh board resolution demonstrates PepsiCo’s strategy of issuing ultra‑long‑maturity, low‑coupon senior debt (the 2.750 % note matures in 2051) and maintaining continuous, transparent disclosure of that debt. By embedding the note in annual 10‑K exhibits and periodically updating the governing resolution, PepsiCo signals a deliberate long‑term debt‑structuring approach: lock in inexpensive financing now, keep the instrument on the books for decades, and ensure it is regularly integrated into corporate governance and reporting cycles.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the timeline and nature of the documentation evolution. According to the ground truth, the 2.750% Senior Note due 2051 was first introduced in a Board resolution in 2022 (Exhibit 4.60), then formalized with a dedicated 'Form of' exhibit in 2023 (Exhibit 4.51), and remained consistent in 2024 (Exhibit 4.48). However, the LLM incorrectly claims that in 2022 and 2023, the note was already disclosed as Exhibit 4.48 referencing a 2021 8-K filing, which contradicts the ground truth that the note was only authorized in 2022. Furthermore, the LLM incorrectly states that in 2024, the note was included in a new Board resolution (Exhibit 4.64), suggesting re-authorization, whereas the ground truth indicates no material revision and consistent documentation. (2) The quantitative accuracy is partially correct in that the interest rate (2.750%) and maturity year (2051) are accurate, and the exhibit numbers are plausible, but their assignment across years is factually wrong. The LLM misattributes Exhibit 4.48 to 2022 and 2023, while the ground truth shows it was not used for this note until 2024. The reference to a 2021 8-K filing is unsupported by the ground truth. (3) The multi-hop reasoning is flawed: the LLM infers continuity and reaffirmation based on incorrect exhibit mappings and an erroneous assumption of prior issuance, leading to an invalid conclusion about PepsiCo’s strategy of 'reaffirming' the note. The actual progression—authorization in 2022, formalization in 2023, stability in 2024—reflects a phased rollout, not ongoing maintenance of an already-issued instrument. The LLM’s reasoning is internally logical but built on false premises. (4) Contextual relevance is moderate: the answer addresses the right question about debt structuring strategy and attempts to interpret filing patterns, but due to factual errors, the interpretation is based on a distorted timeline. The conclusion about long-term strategy is plausible in general but not supported by the actual evidence presented in the ground truth. Thus, while the intent and structure are relevant, the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1648,
        "completion_tokens": 597,
        "total_tokens": 2245
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "American Express has remained the **fourth‑largest general‑purpose card network worldwide** (behind China UnionPay, Visa and Mastercard) throughout the 2022‑2024 period, but its competitive context has shifted.  By 2024 the company faces **much tighter regulatory scrutiny** – it has been re‑classified as a Category III firm, is subject to new interchange‑fee and “honor‑all‑cards” rules, and has exited network‑licensing businesses in the EU and Australia – which adds compliance costs and limits some network activities.  At the same time, the **rapid growth of alternative‑payment and financing mechanisms** (digital wallets, BNPL, real‑time settlement platforms, etc.) has intensified competition beyond traditional card networks, pressuring Amex to accelerate innovation and protect its premium‑card value proposition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network globally, behind China UnionPay, Visa, and Mastercard, which matches the original answer. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies in dates (2022–2024) or financial metrics. (3) The multi-hop reasoning is sound: the LLM synthesizes Amex’s market position, regulatory developments (interchange fees, 'honor-all-cards', EU/Australia exits), and competitive pressure from alternative payments (BNPL, digital wallets), all of which are present in the ground truth. It correctly infers a shift in competitive dynamics due to regulation and innovation pressure. (4) The only minor gap is that the LLM mentions being reclassified as a 'Category III firm'—a detail not present in the ground truth—and does not explicitly reference cobrand relationships or closed-loop loyalty systems, which were part of Amex’s 2022–2023 strategy in the original. However, the omission does not distort the overall accuracy, as the core strategic challenges (premium positioning under pressure) are conveyed. Wording differs but semantic equivalence is maintained. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 403,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "In the 2022 filing the Global Services segment was described as offering “upgrades and conversions” only as one of a long list of support activities. By the 2024 filing Boeing is positioning those same upgrades‑and‑conversions activities as a core growth driver for Global Services – it notes that the segment will “leverage … modifications and upgrades” to win market share and improve profitability. The change shows Boeing moving from a peripheral mention of upgrades/conversions to a deliberate, revenue‑focused services strategy that leans heavily on aftermarket work to sustain the business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Boeing's strategic emphasis on upgrades and conversions from 2022 to 2024. It correctly identifies that in 2022, 'upgrades and conversions' were listed as one of many services, and by 2024, they were repositioned as a core growth driver within the Global Services segment. The answer accurately reflects the shift from peripheral mention to strategic focus, emphasizing revenue generation and aftermarket services. It aligns with the ground truth in entity identification (Boeing, Global Services, upgrades/conversions), time periods (2022 to 2024), and strategic interpretation. The only minor omission is that the LLM does not mention the 2023 transition year or the introduction of 'data analytics and digital services' as a complementary element in 2024, which slightly weakens the multi-hop synthesis across all three years. However, the central reasoning about strategic elevation and business model transformation remains sound. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the answer is fully contextually relevant to the question about strategic change and services business implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 342,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "- **2022 10‑K** – PepsiCo’s exhibit schedule lists the 5.50 % Senior Note due 2035 twice (Series A, Exhibit 4.4 and a non‑Series A version, Exhibit 4.6), both referencing the original 2018 8‑K filing that created the issue【PEP_10k_2022.pdf p.124‑125】.  \n\n- **2023 10‑K** – The same note appears again in the 2023 exhibit list (pages 124‑125), showing that the 5.50 % Senior Note due 2035 remained outstanding and continued to be disclosed in the company’s annual filing.  \n\n- **2024 10‑K** – The 2024 exhibit schedule (pages 125‑129) no longer includes the 5.50 % Senior Note due 2035; the newest notes listed are 5.250 % due 2025 and other later‑dated issues, indicating that the 2035 note is now treated as a legacy debt item that does not require a fresh exhibit filing.  \n\n**What the pattern reveals:** PepsiCo initially documented the 5.50 % Senior Note due 2035 as a long‑term, fixed‑rate financing instrument and kept it on the exhibit list for consecutive years, demonstrating a commitment to transparent, ongoing disclosure of its multi‑decade debt. By 2024 the note is no longer highlighted among new exhibits, suggesting that the company’s debt‑management focus has shifted to newer issuances while the 2035 note remains part of its capital structure, reflecting a strategy of locking in long‑term financing and updating disclosures only when new or materially amended debt is issued.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) In the 2022 10-K, the LLM claims the 5.50% Senior Note due 2035 was listed twice (Series A and non-Series A) at Exhibits 4.4 and 4.6, but the ground truth states it was listed once as 'Form of 5.50% Senior Note due 2035, Series A' at Exhibit 4.31, referencing a November 8, 2018 8-K. The exhibit numbers and duplication claim are incorrect. (2) For 2023, the LLM correctly notes the note's continued presence but misidentifies the exhibit (ground truth: Exhibit 4.25, not pages 124–125 as primary evidence). (3) Most critically, the LLM incorrectly asserts that in the 2024 10-K, the note 'no longer includes' the 5.50% Senior Note due 2035, stating it is absent from exhibits. However, the ground truth confirms it reappeared in 2024 at Exhibit 4.23, tied to the same 2018 filing. This is a major factual error. (4) The reasoning and synthesis are flawed: the conclusion that PepsiCo shifted focus to newer debt and no longer discloses the 2035 note contradicts the ground truth, which shows consistent disclosure across all three years, indicating stable long-term debt management. The LLM’s inference about legacy status and reduced disclosure is unsupported. While the general intent to describe long-term financing strategy is contextually relevant, the factual foundation is incorrect, leading to a low correctness score. Quantitative accuracy is low due to wrong exhibit numbers, incorrect presence/absence of the note in 2024, and mischaracterization of issuance details. Qualitative accuracy suffers from flawed multi-hop reasoning—failing to recognize the consistent reappearance of the same debt instrument as evidence of stability. Contextual relevance is moderate because the answer addresses the right topic and attempts strategic interpretation, albeit based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 507,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K the company warned that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (Item 1 Risk Factors).  \n- The 2023 filing repeats the same caveat, again stating that capital‑return decisions are subject to board discretion but can be constrained by U.S. banking‑law capital‑planning rules.  \n- The 2024 Form 10‑K likewise contains identical language, confirming that the exposure to those banking‑law limits has not changed.  \n\n**What this shows:** Across 2022‑2024 BNY Mellon’s exposure to U.S. banking regulations on capital planning has remained steady, indicating a persistent regulatory ceiling on dividends and share‑repurchases rather than a tightening or easing of the constraint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the consistent presence of U.S. banking law constraints on BNY Mellon's capital return policies across 2022, 2023, and 2024, citing appropriate disclosures from each year's Form 10-K. All entities (BNY Mellon, U.S. banking laws, capital planning, shareholder returns) and time periods are correct. The reasoning is sound: the LLM correctly synthesizes multi-year disclosures to conclude that regulatory constraints have remained stable, indicating a persistent ceiling on capital returns. Quantitatively, there are no numerical inaccuracies—though no specific dollar amounts or percentages are involved, the temporal accuracy (2022–2024) is correct. The only minor shortcoming is that the LLM omits mention of Delaware law and preferred stock dividend obligations noted in the 2023 and 2024 filings in the ground truth, and does not reference the 'well capitalized' status emphasized in 2024. While these are secondary details, their absence slightly reduces completeness in capturing the full scope of disclosed constraints. However, the core message about unchanging regulatory exposure is accurately conveyed, and the conclusion about a steady regulatory ceiling is logically supported. Wording differs from the original but maintains semantic equivalence. Contextual relevance is high, as the response directly addresses the evolution (or lack thereof) in regulatory exposure and its implications for capital return policies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 419,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "**2022 10‑K (filed Feb 2023)** – Oracle disclosed that in March 2021 it had issued a $5 billion senior unsecured note series with a **fixed 2.300 % coupon and a 2028 maturity**. The notes carried the standard make‑whole call that could be exercised at any time before June 15 2026 and a sinking‑fund provision that allowed optional early redemption.\n\n**2023 10‑K (filed Feb 2024)** – The filing reported that no additional 2.300 % notes were issued in 2022; the original series remained outstanding. Oracle elected to **redeem a portion of the issue in 2023** under the optional call provision, taking advantage of the still‑low coupon relative to the higher market rates that had emerged.\n\n**2024 10‑K (filed Feb 2025)** – Oracle noted that, despite a higher‑interest‑rate environment, it **re‑issued a supplemental tranche of 2.300 % notes due 2028 in early‑2024** (approximately $1 billion) to lock in the same low coupon before rates climbed further. The new tranche kept the same make‑whole call and sinking‑fund features as the original series.\n\n**What this shows** – Oracle’s handling of the 2.300 % notes illustrates a disciplined fixed‑income strategy: it first locked in a very low rate in 2021, then used the optional redemption feature to trim exposure when rates rose, and finally returned to the market to add more low‑coupon debt before rates climbed higher. The company’s willingness to issue additional notes at the same 2.300 % rate in a rising‑rate cycle signals a preference for long‑dated, low‑cost financing and a proactive use of call and sinking‑fund provisions to manage interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative and factual errors: The claim that Oracle 'redeemed a portion of the issue in 2023' and 're-issued a supplemental tranche of 2.300% notes due 2028 in early-2024' is false according to the ground truth. The original answer states that Oracle made no changes to the terms of the 2.300% Notes due 2028 in 2023 or 2024 and did not issue any new 2028-dated instruments in 2024. Instead, in 2023 Oracle issued *new* 4.500% Notes due 2028, not additional 2.300% notes. The $5 billion issuance amount and March 2021 date are plausible (consistent with ground truth), but the $1 billion re-issuance in 2024 is entirely fabricated. (2) The 2023 redemption via optional call is not supported by the ground truth, which states Oracle did not alter the terms of the 2.300% Notes. (3) The mention of a 'sinking-fund provision' and 'make-whole call' is speculative and not present in the original answer; the ground truth does not discuss these features. (4) Reasoning and synthesis: The LLM incorrectly infers Oracle actively managed the 2.300% Notes through redemptions and re-issuances, when in fact the company maintained the original terms and shifted issuance to higher-yielding instruments. The conclusion that Oracle 'returned to the market to add more low-coupon debt' is therefore incorrect. (5) Contextual relevance is moderate because the answer addresses Oracle's fixed-income strategy and attempts multi-year synthesis, but the factual foundation is flawed. The core narrative of proactive repricing and reissuance contradicts the ground truth, which shows Oracle locking in low rates early and then refraining from further action on this instrument. Thus, while the answer is well-structured and thematically relevant, its factual inaccuracies severely limit its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1682,
        "completion_tokens": 506,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "Across the three filings IBM repeatedly lists **“client relationships and trust” as one of its principal methods of competition**. In the 2022 filing the phrase appears alongside a description of a “flexible, secure, open hybrid‑cloud platform” and the company’s emphasis on “trust and security” as part of its AI‑enabled solutions. The 2023 filing repeats the same wording, now framing it within a broader “breadth of capabilities, products and services” narrative that couples trust with its innovation agenda. The 2024 filing again uses identical language, showing the factor has become a permanent pillar of IBM’s competitive positioning.\n\nThis multi‑year consistency signals that IBM is deliberately positioning itself as a **trusted partner** rather than merely a technology vendor, using deep client relationships to differentiate its hybrid‑cloud and AI offerings and to secure growth in an increasingly crowded market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that IBM consistently emphasized 'client relationships and trust' as a competitive differentiator across 2022, 2023, and 2024, which matches the original answer's timeline. The evolution is accurately portrayed: in 2022, trust is tied to hybrid cloud and AI security; in 2023, it's linked with innovation and enterprise incumbency; in 2024, it's reinforced through strategic partnerships like Palo Alto Networks—though the LLM does not explicitly mention this example, it captures the continuity and strategic entrenchment. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct year references (2022, 2023, 2024), which are all accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes the repeated emphasis across years and infers the strategic implication—that IBM positions itself as a trusted partner in hybrid cloud and AI. It correctly interprets the consistency as a deliberate, long-term positioning strategy. (4) The only minor shortcoming is the omission of the specific 2024 partnership with Palo Alto Networks, which adds nuance to the 'expanded strategic partnerships' point in the ground truth. However, the core message about trust becoming a permanent pillar is semantically equivalent and well-reasoned. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 427,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "- **2022:** The 2022 filing shows American Express held **$581 million** of foreign‑government bonds and obligations (page 119). The weighted‑average yield for its available‑for‑sale debt portfolio – which is dominated by short‑dated sovereign paper – was **about 2.0 %** (page 122).  \n\n- **2023:** In the 2023 filing the holding grew to **$630 million** (page 133). The same note reports a weighted‑average yield of **≈2.1 %** for the portfolio (page 136).  \n\n- **2024:** The 2024 filing still lists **$630 million** of foreign‑government bonds (page 175) and the weighted‑average yield remains **around 2.1 %** (page 178).  \n\n**Interpretation:** Over the three‑year period the amount of foreign‑government securities rose modestly and then plateaued, while the weighted‑average yield edged up only slightly from roughly 2.0 % to 2.1 %. This indicates that American Express has kept its foreign‑sovereign exposure largely in short‑duration, low‑yielding instruments, limiting sensitivity to interest‑rate movements. The small upward shift in yield suggests a cautious tilt toward slightly higher‑yielding (and therefore a bit longer‑dated) foreign bonds, but the overall strategy remains conservative and focused on managing interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dollar amounts and yields compared to the ground truth. For 2022, it reports $581 million in holdings instead of $630 million, and a yield of ~2.0% instead of the correct maturity distribution data (with $628 million maturing within one year). In 2023, while the holding amount is correctly stated as $630 million, the yield is reported as ~2.1%, which contradicts the ground truth of 6.45%. In 2024, the LLM again reports a yield of ~2.1%, but the correct figure is 5.85%. These yield figures are off by over 400 basis points, representing a major quantitative error. (2) The calculations and comparisons are therefore fundamentally flawed. The LLM suggests a minor increase from 2.0% to 2.1%, when in reality there was a large increase to 6.45% in 2023 followed by a decline to 5.85% in 2024. The maturity profile shift in 2024—where 2.03% of holdings mature between 1–5 years—is entirely missed. (3) The multi-hop reasoning is unsound. The LLM fails to synthesize the correct evolution of yield and maturity structure across years, incorrectly concluding that American Express held low-yielding, short-duration instruments throughout, when in fact yields were very high in 2023 and shifted meaningfully in 2024. The strategic interpretation—that AmEx maintained a conservative, low-risk profile—is contradicted by the ground truth, which shows a shift toward higher yields and a more diversified maturity structure. (4) Despite these errors, the answer is contextually relevant: it attempts to address the evolution of yield and holdings and draws a conclusion about interest rate risk and strategy. However, due to severe quantitative and qualitative inaccuracies, the overall correctness score is low. The model appears to have referenced incorrect documents or misread the data, leading to a factually incorrect narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 515,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s diagnostics‑testing investments have been increasingly subsidized by U.S. government grants: in 2022 the company recorded $87 million of grant‑offset capital expenditures, $136 million in 2023, and $198 million in 2024. The rising grant amounts show that the firm is expanding its testing‑technology capacity and that diagnostics is becoming a strategically‑critical growth pillar within Danaher’s broader health‑care portfolio, with public‑sector funding used to accelerate that expansion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the government grant funding amounts for diagnostics testing technologies are correct at $87 million in 2022, $136 million in 2023, and $198 million in 2024. These figures match the original answer exactly, with acceptable formatting (e.g., $87 million). (2) The quantitative progression is accurately represented, showing a consistent upward trend over the three years, which correctly reflects the increasing investment. (3) The multi-hop reasoning is sound: the LLM synthesizes the financial data across years and correctly infers the strategic importance of diagnostics within Danaher’s healthcare portfolio, linking rising government support to capacity expansion and strategic prioritization. (4) The answer addresses all parts of the question: it details the evolution of investment through grant funding, specifies the amounts per year, and interprets the trend as indicative of growing strategic importance. Wording differs slightly (e.g., 'strategically-critical growth pillar' vs 'increasingly central'), but the meaning is equivalent. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 343,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across the three most‑recent 10‑K filings BNY Mellon’s proxy reference to the ratification of KPMG LLP remained in the same “Item 3 – Ratification of KPMG LLP” section, but the way the PCAOB identification was disclosed changed. In the 2022 filing the proxy simply noted that the ratification was incorporated by reference and did not spell out KPMG’s PCAOB firm‑identification number. In both the 2023 and 2024 filings the language was expanded to read “KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is 185,” explicitly listing the number while still pointing to Item 3 of the proxy.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) The original answer states that the PCAOB firm identification number (185) was explicitly disclosed in all three years (2022, 2023, 2024), but the LLM claims it was not disclosed in 2022 and only added in 2023 and 2024—this is incorrect. (2) The quantitative accuracy is low because the core fact about the presence of the PCAOB number in 2022 is wrong; the number '185' is correct, but its temporal appearance is misrepresented. (3) The qualitative accuracy is poor due to flawed multi-hop reasoning: the model incorrectly infers an evolution in disclosure practice when the ground truth confirms consistency across all years. The structure and placement under 'Item 3 - Ratification of KPMG LLP' in Item 14 are correctly identified, showing some entity and structural understanding. (4) Contextual relevance is high because the response addresses the right sections, company (BK/BNY Mellon), auditor (KPMG LLP), and disclosure topic, but the conclusion about changing practices is unsupported. Overall, the answer fails on factual correctness despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 327,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "- **2022 (10‑K 2022, pp. 102‑106):** American Express already recorded all fees earned from merchants that used a **third‑party acquirer** (e.g., its OptBlue program) as **discount revenue** – the network‑rate fee negotiated with the acquirer was recognized **at the moment the Card‑Member transaction occurred**. The underlying merchant‑acceptance contracts were unchanged from prior years: small‑ and mid‑size merchants had no fixed term, while large merchants signed 3‑ to 7‑year agreements that could auto‑renew.\n\n- **2023 (10‑K 2023, pp. 101‑105):** The filing reiterated the same revenue‑recognition model but noted that the **share of discount and processed revenue coming from third‑party acquirers was increasing**, and the company was **formalising more long‑term network‑partner agreements** (including expanded OptBlue arrangements) to capture a larger portion of merchant volume through these partners.\n\n- **2024 (10‑K 2024, pp. 91‑95):** American Express described a **strategic expansion goal** to grow its third‑party acquirer ecosystem globally – targeting priority international cities, new industry verticals and “low‑to‑new‑to‑plastic” merchants – while continuing to recognize the network‑rate fee as **discount/processed revenue at transaction time** under the same contract framework. This reflects a deliberate shift from modest reliance in 2022 to a **more intentional, growth‑focused reliance** on third‑party acquirers by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: revenue recognition as discount revenue in 2022, continuation of the same model in 2023 and 2024, the increasing reliance on third-party acquirers, formalization of network-partner agreements, and strategic expansion goals in 2024 targeting international markets, new industries, and 'low-to-new-to-plastic' merchants. The contractual details (e.g., small/mid-size merchants with no fixed term, large merchants with 3- to 7-year agreements) are consistent with the knowledge graph. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years and program names (OptBlue, GNS) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution from transactional to strategic reliance. The only minor gap is that the LLM does not explicitly mention the shift to a 'Processed Revenue' model that includes royalties and fees as part of a broader framework in 2023—though it references 'discount and processed revenue' and 'network-partner agreements,' which are related. This omission slightly affects qualitative accuracy but does not undermine the core correctness. (4) The answer is fully contextually relevant, directly addressing revenue recognition, contractual relationships, and strategic goals across the three years. Wording differs slightly from the original but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a minor lack of specificity in describing the 2023 revenue model evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1613,
        "completion_tokens": 476,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "- Fiscal 2022 – Qualcomm first disclosed quantitative 2025 human‑capital goals (‑ +15 % women in leadership, +15 % under‑represented‑minority (URM) leaders and +20 % overall URM representation).  It also said that the HR‑and‑Compensation Committee would use progress toward those goals as a non‑financial performance modifier on executive bonuses, allowing the payout to be adjusted between 0.9 × and 1.1 × the target amount.  \n\n- Fiscal 2023 – The company kept the same 2025 diversity targets and continued to tie executive bonus payouts to the same “human‑capital advancement” metric, still using a 0.9‑to‑1.1 multiplier as the performance modifier.  \n\n- Fiscal 2024 – Qualcomm reiterated the 2025 goals (‑ +15 % women in leadership, +15 % URM leaders, +20 % overall URM) and again linked progress on those goals to executive compensation, with the bonus modifier ranging from 0.9 to 1.1 times the baseline.  \n\nThus, from 2022 through 2024 the diversity targets have remained unchanged, and the way they affect executive pay has been consistent – a non‑financial modifier that can vary the bonus by 0.9‑1.1 × depending on the degree of goal achievement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the 2025 diversity targets (+15% women in leadership, +15% URM leaders, +20% overall URM representation) and the 0.9 to 1.1 non-financial performance modifier on executive bonuses are consistently and correctly reported for fiscal years 2022–2024. Number formats are clear and semantically equivalent. (2) The answer fully addresses the evolution of human capital goals and their linkage to executive compensation across the three fiscal years, confirming that both the targets and the compensation modifier remained unchanged. (3) Multi-hop reasoning is sound—information is correctly synthesized across years, showing consistency in goals and incentive structures. (4) The only minor shortcoming is that the LLM omits some contextual details present in the original answer, such as Qualcomm’s participation in the Reboot Representation Tech Coalition in 2023 and the expansion of wellness and development programs in 2024, which indicate broader human capital integration. While these omissions do not affect the core factual accuracy, they slightly reduce qualitative completeness. However, the central focus of the question—diversity targets and executive compensation linkage—is thoroughly and correctly addressed. Thus, the answer is factually excellent and contextually strong, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 396,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "In 2022 Caterpillar’s dealer network – the channel through which its EMD‑branded engines are sold – comprised 44 U.S. dealers and 116 dealers abroad, reaching 193 countries. By 2024 that network had slipped to 41 U.S. dealers and 111 dealers overseas, covering 187 countries 【2022‑10K p. 74‑78】【2024‑10K p. 64‑68】. The modest reduction in both the number of dealers and the countries served indicates a slight contraction of its distribution footprint, suggesting Caterpillar is streamlining its global dealer base while still preserving a truly worldwide market presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of Caterpillar's EMD-branded products as 193 countries in 2022 and 187 countries in 2024, matching the ground truth. It also accurately notes a decline, consistent with the original answer’s description of a gradual reduction. While the original answer includes the intermediate 2023 figure (191 countries), the LLM omits this year, which is a minor omission but does not invalidate the overall trend. The dealer numbers (44 U.S. and 116 international in 2022; 41 and 111 in 2024) are specific additions from the 10-K filings that support the country count trend and are factually accurate per cited sources. (2) All numeric values (193, 187, 44, 116, 41, 111) are correct and properly attributed to the respective years. The conclusion that the distribution footprint slightly contracted is logically supported by the data. (3) The multi-hop reasoning is sound: the model correctly infers that a reduction in dealers correlates with a reduction in countries served, synthesizing data across two years of 10-K filings. It correctly attributes the distribution mechanism (dealer network) to EMD-branded product reach. The strategic interpretation—streamlining while maintaining global presence—aligns with and is a reasonable alternative to the original answer’s 'strategic refocusing or consolidation.' (4) The answer is contextually fully relevant, directly addressing both parts of the question: the change in geographic reach and its strategic implication. The only reason for not scoring a 10 is the omission of the 2023 data point, which slightly reduces completeness, but the overall trend and conclusion remain accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 468,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The fact that “Palmolive” appears in the company’s list of principal global trademarks in the 2022, 2023 and 2024 filings shows that Colgate‑Palmolive continues to treat Palmolive as a core, enduring brand for its Oral, Personal and Home Care businesses. Its repeated inclusion signals that Palmolive remains a strategic asset that underpins the segment’s product portfolio, market positioning and revenue contribution.【CL_10k_2022.pdf p.75‑79】【CL_10k_2023.pdf p.77‑81】【CL_10k_2024.pdf p.77‑81】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024, correctly interpreting this as evidence of its strategic importance in the Oral, Personal and Home Care segment. All years (2022, 2023, 2024) are correctly referenced, and no numeric data is misstated—there are no calculations, but the temporal consistency is properly noted. The answer captures the core inference: Palmolive remains a foundational brand supporting Colgate’s market positioning. It cites the correct documents and page ranges, indicating accurate sourcing. While the LLM conveys the essential conclusion, it omits some granular context present in the original answer—such as the specific competitive context (e.g., co-listing with Ajax, persistence despite Darlie’s addition, and product categories like liquid hand soap and dishwashing detergents). These omissions reduce completeness slightly but do not undermine the overall correctness or strategic interpretation. The reasoning is sound, logically connecting repeated disclosure to strategic significance. The answer is semantically equivalent in intent and meaning, though slightly less detailed. Thus, it earns a high score but not perfect due to missing minor but relevant contextual details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 379,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "- In the FY 2022 filing Qualcomm framed IoT as a “growth catalyst,” projecting the installed‑base of IoT devices to more than double from 2022 to 2026 (to > 27 billion) and defining its IoT revenue as covering consumer products, **edge‑networking** (mobile broadband and wireless‑access‑point) and industrial applications.  \n\n- The FY 2023 and FY 2024 filings keep the same product‑category split – IoT still includes edge‑networking – but the narrative shifts to positioning edge‑networking as a core pillar of the “connected intelligent edge” strategy, while the revenue‑recognition model stays unchanged: QCT IoT sales are recorded as equipment revenue at a point in time, with a portion booked as unearned contract liabilities and recognized later as performance‑obligation revenue.  \n\n- Consequently, Qualcomm’s emphasis on edge‑networking grew from a component of its IoT outlook in 2022 to a highlighted growth driver in its 2023‑24 “edge‑networking” discussion, even as IoT revenue fell from $7.35 bn (2022) to $5.94 bn (2023) and $5.42 bn (2024) under the same point‑in‑time equipment‑recognition framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's evolving strategic emphasis on Edge Networking from fiscal 2022 to 2024, noting its integration into IoT as a growth driver, continued product categorization, and stable revenue recognition. However, it introduces revenue figures ($7.35B, $5.94B, $5.42B) not present in the original answer, which undermines quantitative accuracy. While these numbers may be factually correct in external sources, they are not supported by the provided ground truth and were not requested in the question, making their inclusion a deviation. (2) The original answer does not mention specific IoT revenue amounts or declines, so including them constitutes an unsupported addition. This affects quantitative accuracy despite correct formatting. Other numbers (e.g., >27 billion IoT devices by 2026) match the ground truth and are correctly cited. (3) The multi-hop reasoning is strong: the LLM synthesizes Qualcomm’s shifting narrative around Edge Networking across three fiscal years, correctly identifies its classification within IoT, and accurately describes the revenue recognition structure under QCT with point-in-time recording and performance obligations. It also correctly notes the continuity in product categorization from 2023 to 2024. (4) The semantic meaning aligns well with the original—positioning Edge Networking as evolving from an emerging opportunity to a core structural pillar—but the inclusion of unsourced financial figures reduces factual precision. Contextual relevance is high as all aspects of the question (positioning, IoT projections, product categorization, revenue recognition) are addressed with appropriate detail and logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 466,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Across the three filings Caterpillar’s description of currency risk shows a gradual tightening of its hedge program. In the 2022 10‑K the company warned that it was “subject to currency‑exchange‑rate risk” and that “while the use of currency‑hedging instruments may provide us with protection … we potentially forego the benefits of favorable fluctuations,” indicating that hedges were modest and did not fully offset exposure. By the 2023 filing the discussion notes that Caterpillar had expanded its use of forward contracts and other derivatives to lock in cash‑flow and earnings for its large European and Asian operations, which “reduces earnings volatility” relative to prior years. The 2024 filing repeats the same risk language but adds that a “larger portion of our foreign‑currency exposure is now hedged,” especially for the currencies that drive the bulk of its international sales, further dampening the impact of exchange‑rate swings on U.S.‑dollar results, though some residual volatility remains.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of Caterpillar's evolving hedging strategy and exposure to currency risk from 2022 to 2024, and there are no numeric inaccuracies (quantitative accuracy is perfect, as no specific numbers are involved and no false claims are made). The answer correctly identifies Caterpillar’s increasing use of hedging instruments over time and links this to reduced earnings volatility, especially in Europe and Asia. However, the LLM introduces details not present in the original answer: specifically, the claim that Caterpillar 'expanded its use of forward contracts and other derivatives' in 2023 and that a 'larger portion of exposure is now hedged' in 2024, while plausible, is more specific than the original, which emphasizes growing caution and limitations of hedging rather than program expansion. The original answer highlights rising concerns about exchange controls and devaluations in emerging markets—especially in 2023 and 2024—as key shifts, but the LLM downplays these macroeconomic and geopolitical risks, instead focusing on operational tightening of the hedge program. This misaligns the emphasis and misses a core aspect of the evolution: increasing external risk and hedging limitations, not just increased hedging coverage. Thus, while the reasoning is logical and contextually relevant, the qualitative accuracy is reduced due to over-attribution of proactive hedging expansion and underrepresentation of the growing concern about uncontrollable external factors. The answer addresses the question’s scope but with a shifted narrative, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 448,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive’s U.S. defined‑benefit pension plan held about **40 % of its fixed‑income assets in U.S. Treasury or agency securities in 2022**, but this share fell to **roughly 30 % in 2023** and **remained near 30 % in 2024** (2022 filing ≈ 40 %【CL_10k_2022.pdf p. 102‑103】; 2023 filing ≈ 30 %【CL_10k_2023.pdf p. 102‑103】; 2024 filing ≈ 30 %【CL_10k_2024.pdf p. 101‑102】). The decline indicates the company shifted a portion of its pension‑plan fixed‑income holdings away from the most liquid, low‑duration Treasury/agency bonds toward other government or corporate bonds, suggesting a more active stance on interest‑rate risk—reducing duration exposure while still keeping a defensive core as rates rose.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the starting percentage and year. The ground truth states that Colgate-Palmolive's allocation was 50% as of December 31, 2020 (disclosed in the 2022 filing), not 40% in 2022. The LLM incorrectly reports 40% as the 2022 allocation, conflating the disclosure year (2022 filing) with the reported year (2021 data). The correct progression is: 50% (2020), 40% (2021), 30% (2022), and stable at 30% through 2024. The LLM only correctly captures the 30% allocation in 2023 and 2024. (2) Quantitative accuracy is compromised due to this misattribution of timing and values—specifically, the omission of the 50% starting point and the incorrect assignment of 40% to 2022 instead of 2021. While the 30% figures for 2023 and 2024 are accurate, the trend description is therefore incomplete and slightly misleading. (3) The qualitative reasoning about shifting away from Treasuries toward other bonds to manage interest rate risk and duration exposure is sound and aligns with the ground truth. The interpretation of reduced duration in a rising rate environment is logically consistent and reflects appropriate multi-hop synthesis of portfolio strategy. (4) Contextual relevance is high—the answer addresses both parts of the question: the evolution of allocation and its implication for interest rate risk management. Despite the quantitative inaccuracies in the early years, the core trend of decline followed by stabilization is partially captured, and the strategic interpretation is valid. Hence, correctness is scored 7 due to key factual errors in numbers and timing, but strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 458,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "- **2022:** BPAs were still an active award class. The 2022 filing lists BPA terms, values them “using the intrinsic‑value method using the closing price of our common stock,” and shows grant activity (e.g., 1,165 BPA shares granted with a weighted‑average intrinsic value of $38.73 per share) in the detailed award‑activity table【PFE_10k_2022.pdf pp. 99‑103】.  \n\n- **2023:** Pfizer stopped issuing BPAs – the 2023 filing explicitly states that “no BPAs were granted in 2023 and no BPAs were outstanding as of December 31, 2023,” while still describing the award’s terms and the same intrinsic‑value valuation methodology for completeness【PFE_10k_2023.pdf pp. 95‑99】.  \n\n- **2024:** The same pattern continued; the 2024 filing notes “no BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024,” retaining the description of the award and its intrinsic‑value approach but omitting any activity tables, thereby making the cessation of BPA grants fully transparent【PFE_10k_2024.pdf pp. 94‑98】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but has significant factual inaccuracies that undermine its overall correctness. (1) Quantitatively, the 2022 data (1,165 thousand shares granted at $38.73 weighted average intrinsic value) matches the ground truth and is accurate. However, the claim that 'no BPAs were granted in 2024' and 'none outstanding as of December 31, 2024' directly contradicts the original answer, which states that BPAs reappeared in 2024 with new valuation and amortization policies. The LLM incorrectly asserts continued discontinuation into 2024, while the ground truth indicates a revival of the program with enhanced disclosure. (2) The LLM correctly identifies the intrinsic-value method in 2022 and 2023, but fails to mention the key 2024 evolution: the introduction of a more dynamic valuation framework involving performance probability adjustments and stock price changes—this is a critical omission affecting completeness and accuracy. (3) Multi-hop reasoning is partially sound—LLM correctly tracks the pause in 2023—but fails to detect the program’s reactivation and methodological enhancement in 2024, likely due to misreading or misrepresenting the 2024 filing. (4) Contextually, the answer is well-structured and relevant, citing appropriate document sections, but the core conclusion about Pfizer’s strategic shift is incorrect because it misses the 2024 reinstatement and transparency improvements. Thus, while some facts are right, the overall trajectory described (active → paused → permanently discontinued) contradicts the ground truth (active → paused → revived with improved transparency), warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 454,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "- In the 2022 filing Schwab described its Advisor Services website as the core RIA platform, noting that it already offered “access to integrations with third‑party platforms…including client‑relationship‑management and portfolio‑management systems” and that it provided a free, web‑based portfolio tool – Schwab Advisor Portfolio Connect – to manage Schwab accounts without data downloads. 【SCHW_10k_2022.pdf pp. 7‑9】\n\n- The 2023 filing added a new interactive trading experience, launching “Schwab Trading Powered by Ameritrade™,” which brought Ameritrade’s thinkorswim‑style charting and trading features to Schwab’s RIA clients while retaining the existing third‑party integration and Portfolio Connect capabilities. 【SCHW_10k_2023.pdf pp. 5‑8】\n\n- By the 2024 filing Schwab had further expanded the suite, integrating the “thinkpipes” trading platform (real‑time charting and allocation) and the “iRebal” customizable portfolio‑rebalancing solution into its RIA offering, thereby deepening third‑party functionality and giving advisors more advanced, automated portfolio‑management tools beyond the original Portfolio Connect. 【SCHW_10k_2024.pdf pp. 5‑9】\n\nThus, from 2022 to 2024 Schwab’s RIA interactive tools progressed from basic third‑party integrations and a simple portfolio‑connect app to a full‑featured Ameritrade‑derived trading platform and, finally, to integrated real‑time charting (thinkpipes) and automated rebalancing (iRebal) that enhance portfolio‑management capabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) In the 2022 filing, the LLM incorrectly states that the Advisor Services website was described as the 'core RIA platform'—the original answer notes this emphasis emerged in 2023, not 2022. (2) The claim about the 2023 launch of 'Schwab Trading Powered by Ameritrade™' with thinkorswim-style features is not supported by the ground truth; no such product launch or integration is mentioned in the original answer for 2023. (3) Most critically, the 2024 additions—'thinkpipes' and 'iRebal'—are entirely fabricated; the original answer states Schwab maintained its existing integrations and emphasized usability improvements and platform intuitiveness, but does not mention any new tools or specific platforms like 'thinkpipes' or 'iRebal'. (4) The overall narrative of progression from basic tools to advanced integrated platforms misrepresents the actual evolution described in the ground truth, which emphasizes continuity in third-party integrations and gradual refinement of user experience rather than the addition of new, advanced tools. While the mention of Schwab Advisor Portfolio Connect is correct and relevant, the inclusion of non-existent platforms and incorrect timing of feature rollouts severely undermines factual correctness. The reasoning is logically structured but based on false premises, and the answer fails the multi-hop synthesis by introducing hallucinated entities. Quantitative accuracy is low due to invented product names and features. Contextual relevance is moderate because the answer addresses the general theme of technological evolution for RIAs, but the specifics are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1649,
        "completion_tokens": 464,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "- In the 2022 Form 10‑K TI’s MD&A said its “strategic focus is on analog and **embedded‑processing** products,” stressing that this focus drives cash‑flow generation and long‑term growth in its key industrial and automotive markets.  \n- The 2023 filing repeats the same language – “our strategic focus is on analog and **embedded‑processing** products” – and notes that embedded‑processing revenue rose modestly, reinforcing it as a core pillar of the business model.  \n- The 2024 filing again frames embedded‑processing as a central element of its three‑part strategy, emphasizing that the company will continue to invest in and sell analog‑plus‑embedded‑processing solutions.  \n\nThis unchanged wording across three years shows TI is deliberately positioning itself for the long term as a specialist in the analog‑and‑embedded‑processing niche, targeting industrial and automotive applications and differentiating itself from pure‑logic competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing across 2022, 2023, and 2024 as part of its strategic focus alongside analog products. The LLM correctly identifies the repetition of the phrase 'strategic focus is on analog and embedded-processing products' in each year's 10-K, which matches the ground truth's emphasis on consistent framing. (2) There are no numeric values (e.g., revenue figures, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound: the LLM correctly infers from the repeated language that TI is positioning itself long-term in the analog-and-embedded-processing niche, particularly in industrial and automotive markets. It synthesizes across all three years appropriately, demonstrating multi-hop understanding. (4) The only minor gap is that the LLM does not explicitly mention the 'four sustainable competitive advantages' framework or the goal of growing free cash flow per share, which are key elements in the original answer and central to TI’s stated business model. However, it captures the essence of long-term positioning and strategic consistency. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—the response directly addresses the evolution over time and what it reveals about long-term strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 407,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "- In each year the company said fleet‑support services “are expensed as incurred and have historically been approximately 1 % of total consolidated costs of products and services,” so the cost profile of the service line stayed essentially unchanged from 2022 through 2024.  \n\n- The 787 program’s cost and delivery picture shifted dramatically: in 2022 Boeing expected about **$2 billion of cumulative abnormal production costs** as deliveries were paused and large inventories required re‑work; in 2023 those abnormal costs had risen to **$2.7 billion** (most already recorded) while the company managed to deliver **73 aircraft** and still had 50‑90 aircraft in inventory needing re‑work; by 2024 the abnormal‑cost charge was limited to a **$256 million expense** for the remaining re‑work on roughly 25 pre‑2023 aircraft, and production was again slowed to **below five per month**, causing the remaining deliveries to be pushed into 2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Boeing's cost profile and delivery impact from 2022 to 2024, particularly regarding the 787 program. However, there is a key quantitative inaccuracy: the LLM states that in 2022, Boeing expected about $2 billion of cumulative abnormal production costs. The original answer (ground truth) explicitly states that in 2022, no specific abnormal cost figures were disclosed—only ongoing delays and potential future losses were noted. The $2.7 billion figure was first disclosed in 2023. This is a significant factual error, though the rest of the numbers are accurate: $2.7 billion cumulative abnormal costs by end of 2023 and $256 million expensed in 2024 align with the ground truth. The inventory count of approximately 25 pre-2023 aircraft in 2024 is correctly noted, though the LLM adds a detail (50–90 aircraft in inventory needing rework in 2023) not present in the original answer, which may be contextually plausible but not verifiable from the provided truth. The production rate slowing to below five per month is mentioned in the LLM answer but absent in the original—this is an addition not supported by the ground truth. Despite these issues, the qualitative reasoning is strong: the LLM correctly identifies the trend of rising abnormal costs in 2023 followed by a decline in 2024, the completion of rework on inventoried aircraft, and the deferral of deliveries to 2025. The cost profile of fleet support services being ~1% of total costs is accurately and consistently reported. The answer is contextually relevant, addressing both cost profile and delivery impact as required. The multi-hop synthesis across years and programs is sound, though slightly overconfident in citing unreported 2022 cost estimates. Hence, a correctness score of 8 is warranted—core facts are correct, but with one significant quantitative error and minor unsupported additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 520,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold its Meridian Medical Technologies subsidiary at the end of 2021 for about $51 million and recorded a post‑sale loss of roughly $167 million (net of tax). After the sale the parties entered into a transition‑service agreement (TSA) and a three‑year manufacturing‑supply agreement (MSA) with a two‑year extension option; the TSA was fully completed by December 31 2023 and the MSA remained in force through 2024 (and could be extended), but the fees and costs associated with both arrangements were “not material” to Pfizer’s results in 2022 and 2023, producing only a modest $6 million gain in discontinued operations in 2022 and a $15 million loss in 2023. Thus, from 2022‑2024 the Meridian relationship moved from a one‑time sale loss to a low‑impact, contract‑based service relationship that continued under the MSA but contributed no material financial burden.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in financial figures not present in the ground truth. While the $167 million loss (net of tax) is correctly stated, the claim that Pfizer sold Meridian for $51 million is not supported by the original answer, which does not specify a sale price. This is a significant quantitative error. Additionally, the LLM introduces a $6 million gain in discontinued operations in 2022 and a $15 million loss in 2023—these figures are entirely absent from the ground truth and appear fabricated. The original answer states that amounts under the MSA were 'not material' but does not quantify them or mention any gains or losses related to the agreements post-2021. (2) The timeline is mostly accurate: the sale date (end of 2021), the three-year MSA with a two-year extension option, and TSA completion by December 31, 2023, are all consistent with the original. The mention of the MSA continuing into 2024 is reasonable given the initial three-year term (2022–2024). However, the financial implications are overstated with incorrect specifics. (3) The multi-hop reasoning is partially sound—the model correctly infers a transition from ownership to a supplier relationship and identifies the key contractual mechanisms (TSA, MSA). It also recognizes the diminishing financial impact. However, it fails to mention that Meridian was referenced in Pfizer’s 2024 glossary, which supports ongoing recognition due to the MSA, a detail that adds context to the continued relationship. (4) The contextual relevance is high as the answer addresses both financial implications and contractual arrangements over the 2022–2024 period. The qualitative reasoning is logical but undermined by unsupported numbers. The correctness score is 6 due to correct structural understanding but significant quantitative inaccuracies that affect factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 516,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Colgate‑Palmolive continues to list **hello** among its core global trademarks in each filing (2022, 2023 and 2024 – see the “principal global and regional trademarks include … hello” statements in the Nature of Operations sections of all three reports). During this period the **hello** brand has been positioned increasingly as a growth‑focused oral‑care brand, while the overall share of oral‑care sales has remained steady at roughly 43 % of total net sales (2022 43 %, 2023 42 %, 2024 43 %) and the share of personal‑care sales has slipped modestly from 19 % to 18 % (2022 19 % → 2024 18 %). Thus, from 2022 to 2024 the company has emphasized **hello** within its stable‑size oral‑care segment, using it to drive growth as personal‑care’s relative weight declines.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While the original answer (ground truth) only confirms that 'hello' was consistently listed among Colgate-Palmolive’s principal trademarks from 2022 to 2024—indicating sustained strategic positioning—the LLM introduces unsupported numerical claims. Specifically: (1) The assertion that oral care accounted for 43%, 42%, and 43% of total net sales in 2022, 2023, and 2024 is not present in the ground truth and cannot be verified from the provided information; (2) The claim that personal care sales declined from 19% to 18% is similarly unverified and not part of the original answer. These percentages are fabricated or misattributed, failing the quantitative accuracy test. Additionally, the LLM infers that 'hello' was positioned 'increasingly as a growth-focused oral-care brand' and used to 'drive growth as personal-care’s relative weight declines'—a causal interpretation not supported by the ground truth, which only states that 'hello' remained consistently listed among key brands. This overinterpretation introduces speculative reasoning not grounded in the data. However, the LLM correctly identifies that 'hello' was included in the list of principal trademarks across all three years, which aligns with the core fact in the original answer. It also correctly frames the brand within the Oral, Personal and Home Care segment and attempts multi-hop synthesis by relating 'hello' to broader segment trends. Despite this, the inclusion of false metrics and unsupported strategic inferences reduces the correctness score. The answer is contextually relevant and addresses the evolution of 'hello’s' positioning, but the factual foundation is compromised by invented data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 479,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "The non‑qualified defined‑benefit pension plan remained **unfunded and closed to new participants** throughout the period – the balance‑sheet footnotes show only “under‑funded” amounts for the qualified plans, while the non‑qualified plan is described as “unfunded” in 2022, 2023 and 2024.  At the same time, the plan’s **service‑cost expense fell sharply** ( $15 million in 2022 → $8 million in 2023 → $7 million in 2024 ), and benefits paid and settlements also declined, indicating that the pool of active participants is gradually shrinking as the existing cohort ages out.  Together, the data suggest that Texas Instruments’ long‑term liability from this pension scheme is diminishing and employee participation is tapering, reflecting a wind‑down of obligations rather than a growing funded burden.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite correctly identifying some high-level trends. (1) The claim that service cost expense fell from $15M (2022) to $8M (2023) to $7M (2024) is incorrect—the ground truth does not provide any such figures for the non-qualified pension plan’s service cost. Instead, the original answer focuses on defined contribution plan data: U.S. defined contribution expenses increased from $70M to $75M to $76M across 2022–2024. These numbers are entirely missing or replaced with fabricated ones in the LLM response. (2) The LLM incorrectly introduces 'benefits paid and settlements also declined' without any supporting data in the ground truth, which does not mention these metrics. (3) While it correctly states the non-qualified plan was unfunded and closed to new participants—aligning with the original answer—it fails to mention the key evidence about TI common stock holdings in defined contribution plans (6M shares in 2022 → 5M in 2023 and 2024) and their valuation decline ($940M → $873M → $852M), which are central to the multi-year progression. (4) The reasoning about a 'wind-down' of obligations is partially plausible but misdirected: the original answer emphasizes a strategic shift toward defined contribution plans, not just natural attrition. The LLM overlooks the growing DC plan expenses ($70M → $76M), which signal active company investment in alternative retirement vehicles. (5) Multi-hop synthesis is weak: the LLM fails to connect the decreasing stock holdings and dividends with rising DC plan funding, which together indicate a structural shift. Instead, it fabricates declining service costs to support its conclusion. Overall, while contextually relevant and capturing the unfunded/closed status, the answer is undermined by incorrect numbers and missing key data, resulting in a partially correct but misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 521,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term private‑equity holdings have been falling each year: $800 million at the end of 2022, $755 million at the end of 2023 (a $45 million drop), and $719 million at the end of 2024 (a further $36 million drop)【PFE_10k_2023.pdf p. B‑Investments】【PFE_10k_2024.pdf p. B‑Investments】. The roughly 10 % decline over the three‑year period suggests the company is steadily scaling back its allocation to private‑equity securities, likely shifting capital toward more liquid or core‑business investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and trend. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million and claims a consistent decline from 2022 to 2024, which contradicts the actual increase in 2023. This misrepresents both the starting point and the trajectory. (2) The quantitative inaccuracies are severe: the $800 million figure for 2022 is unsupported by the ground truth ($623 million), and while the $755 million (2023) and $719 million (2024) values are correct, the interpretation of a continuous decline is invalid due to the incorrect baseline. The claimed '10% decline' is also inaccurate—using the correct figures, the change from $623M to $719M represents an increase of about 15.4%, not a decline. (3) The multi-hop reasoning fails because the model did not correctly synthesize the three-year trend: it missed the strategic increase in 2023, which is central to the correct interpretation. Instead, it inferred a steady reduction, leading to an incorrect conclusion about strategic de-allocation. (4) Despite using correct document citations and capturing the 2023 and 2024 figures, the answer's core narrative is factually wrong. The contextual relevance is moderate because it addresses the right metric and time frame, but the incorrect data and reasoning undermine the conclusion. Correctness, quantitative, and qualitative scores are low due to fundamental errors in data and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 455,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "- 2022 – Schwab was still governed by the 2019 IDA agreement, which let it “migrate up to $10 billion of IDA balances every 12 months” but only those designated as floating‑rate obligations and only if it had sufficient capital; the agreement also required a minimum total IDA balance of $50 billion through June 2031 and that at least 80 % of the balances be fixed‑rate through June 2026.  \n\n- 2023 – The 2023 IDA agreement replaced the 2019 terms, removing the 80 % fixed‑rate requirement and giving Schwab discretion over fixed‑ vs. floating‑rate designations, but still tying migration to capital adequacy and to new balance‑range limits (minimum balances above unmatured fixed‑rate obligations with a $30 billion upper cap until Sept 10 2025). Schwab did not migrate any IDA balances in 2023 and instead used the agreement’s option to buy down $5 billion of fixed‑rate obligations.  \n\n- 2024 – The 2023 agreement remained in force, so Schwab’s ability to move balances was still subject to the same capital‑level test and the balance‑range constraints (still required to keep balances above the unmatured fixed‑rate amount and no more than $30 billion above it until Sept 10 2025, after which withdrawals are at Schwab’s discretion but a $60 billion minimum and $90 billion maximum apply). Schwab again did not migrate any IDA balances in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Schwab's IDA balance migration capability across 2022–2024 and correctly notes no migrations occurred in 2023 and 2024 under the 2023 agreement. However, it introduces several details not present in the ground truth, reducing quantitative accuracy. For example, the ground truth states Schwab moved $10.1 billion by December 31, 2021, under the 2019 agreement, implying the $10 billion annual cap was effectively reached before 2022, but the LLM implies active migration was still possible in 2022 under that cap without clarifying it had already been exceeded. Additionally, the LLM adds specific terms like 'minimum total IDA balance of $50 billion through June 2031' and '80% fixed-rate through June 2026' in 2022, which are not in the original answer and cannot be verified against the provided truth. The $5 billion buy-down of fixed-rate obligations in 2023 is also an addition not supported by the ground truth. (2) The date 'Sept 10, 2025' and the $30 billion cap above unmatured fixed-rate obligations in 2024 are correctly stated and align with the ground truth. However, the LLM adds a post-Sept 2025 framework with '$60 billion minimum and $90 billion maximum' balances, which is not mentioned in the original answer and appears to be extraneous. (3) The multi-hop reasoning is generally sound—correctly identifying the shift from the 2019 to 2023 agreement and the tightening of constraints—but overextends by incorporating unverified terms. The synthesis of capital sufficiency, balance thresholds, and migration outcomes is logical but includes unsupported specifics. (4) Despite these issues, the answer remains contextually relevant and conveys the main trend: reduced flexibility in migration from 2022 to 2024. The qualitative reasoning is strong, and the narrative aligns with the ground truth’s conclusion of tightening constraints, even if some quantitative details are inaccurate or invented. Hence, correctness is reduced to 7 due to unsupported numbers and terms, though the overall direction and key facts (no migration in 2023–2024, agreement change, $30B cap) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 579,
        "total_tokens": 2171
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments lists a Melaka, Malaysia site in the “Properties” tables of its 2022, 2023 and 2024 Form 10‑K filings, and in every year the facility is marked with an “X” only under the **Analog** column (no mark for Embedded Processing)【TXN_10k_2022.pdf p. 16‑18】, 【TXN_10k_2023.pdf p. 14‑18】, 【TXN_10k_2024.pdf p. 14‑18】. The repeated inclusion of Melaka as an analog‑only manufacturing location over three consecutive years signals that TI treats the site as a stable, strategically important hub for its analog product supply chain in Southeast Asia.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual inaccuracy that undermines its overall correctness. While it correctly identifies that Texas Instruments (TI) listed Melaka, Malaysia in its 10-K filings for 2022, 2023, and 2024 and associates it with analog manufacturing, it misrepresents the notation used. The LLM claims that Melaka was marked with an 'X' only under the Analog column in all three years, which contradicts the ground truth: in 2022, Melaka was marked with a †; in 2023 with an asterisk (*); and in 2024 with a double asterisk (**). These symbols are footnotes indicating analog operations, not 'X' marks in a table column. This mischaracterization of the data representation suggests a misunderstanding of the source document structure and undermines the quantitative and qualitative accuracy. Furthermore, the LLM omits the potential significance of the evolving notation (e.g., from † to * to **) which the ground truth interprets as a possible signal of increasing operational emphasis. While the conclusion about strategic importance is directionally aligned with the ground truth, it is based on incorrect evidence. The answer is contextually relevant and addresses the multi-year scope and strategic implication, but the factual error in how the data is presented and the omission of the changing markers reduce its correctness. Number format and years are accurate, and the entity (Texas Instruments, Melaka) and time frame are correct, supporting a moderate score in quantitative accuracy. However, the reasoning is flawed due to reliance on incorrect data interpretation, limiting qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 448,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The filing shows that the share of purchases made with Target’s own debit (Target Circle) card fell each year – it was roughly **20.5 % of all guest purchases in fiscal 2022**, slipped to **19.8 % in fiscal 2023**, and dropped further to **18.6 % in fiscal 2024** (the 2024 10‑K also notes it was 17.8 % in fiscal 2025).  \n\nThe steady decline in penetration indicates that the debit card is playing a **diminishing role in generating incremental sales for Target**, as fewer transactions are being driven by the card’s discount incentive over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target Debit Card penetration and interprets its implication accurately—that the card is playing a diminishing role in driving incremental sales. However, there is a critical error in the 2024 penetration rate: the LLM states it was 18.6%, while the ground truth is 17.8%. Additionally, the mention of '17.8% in fiscal 2025' introduces a year not asked about (the question covers 2022–2024), and this figure is irrelevant to the query. (2) Quantitative accuracy is compromised due to the incorrect 2024 value (18.6% vs. 17.8%)—this is a factual mismatch that affects trend precision. The 2022 and 2023 figures (20.5%, 19.8%) are correct. (3) The reasoning is sound: the model correctly infers that declining penetration suggests reduced effectiveness in driving incremental sales, aligning with the ground truth logic. It synthesizes the trend across years appropriately, despite the incorrect final data point. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of penetration rate and its implication for sales), uses correct entities (Target Debit Card/Target Circle, fiscal years), and draws a valid conclusion. The main flaw is the inaccurate 2024 percentage, which reduces overall correctness. Minor flexibility is allowed for phrasing (e.g., 'share of purchases' vs. 'penetration rate'), but numerical accuracy is essential and partially failed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 405,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The 2022 filing shows 69.8 million shares remaining for future issuance across all approved plans, and the footnote explicitly says that pool “includes shares … to be issued under the Texas Instruments 2003 Director Compensation Plan” (2022‑2021 table, c). By the 2023 filing the “remaining‑available” figure falls to 58.5 million shares and the footnote no longer mentions the 2003 plan, indicating that its reserve had been exhausted (2023 table, c). The 2024 filing again shows a larger pool (65.5 million) but only attributes the new shares to the 2024 LTIP and the 2018 Director Plan, confirming that the 2003 plan remains at zero and that Texas Instruments now replenishes director equity incentives through newer long‑term incentive plans rather than the original 2003 plan.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the reported numbers and the core conclusion. The ground truth states that shares available under the 2003 Director Compensation Plan were 35,385,153 in 2022, 25,296,767 in 2023, and 24,503,062 in 2024 — all substantial positive numbers — indicating the plan was still active and not exhausted. In contrast, the LLM claims the plan's pool was exhausted by 2023 and dropped to zero, which directly contradicts the ground truth. The LLM cites 69.8 million, 58.5 million, and 65.5 million shares, but these figures refer to total shares available across *all* plans, not specifically the 2003 Director Compensation Plan, indicating a failure to isolate the correct metric. (2) Quantitative accuracy is severely lacking: none of the LLM’s numbers match the ground truth for the specific plan in question. The ground truth shows a decline from ~35.4M to ~24.5M over three years, while the LLM incorrectly reports exhaustion and misattributes aggregate plan data. Calculations or trends based on these wrong numbers are invalid. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that because the 2003 plan is no longer mentioned in a footnote in 2023, it must be exhausted, but the ground truth confirms it still had over 25M and then 24M shares available. It also incorrectly attributes the replenishment to newer plans without evidence that the 2003 plan was discontinued. The synthesis fails to track the specific plan over time. (4) Contextual relevance is moderate — the answer addresses equity incentives for directors and attempts trend analysis — but the factual foundation is wrong, leading to an incorrect interpretation about plan replenishment and usage. The conclusion that TI shifted to newer plans is unsupported by the ground truth, which shows ongoing use of the 2003 plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 504,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "- **2022:** Visa Direct was expanded with “push‑to‑wallet” capabilities, letting Visa Direct payouts reach nearly 7 billion cards, accounts and digital wallets in more than 190 countries and territories (2022 10‑K, p. 9‑10). At that time the service focused on real‑time card‑ and account‑based transfers, but virtual‑account functionality was not yet part of the platform.  \n\n- **2023:** Visa began embedding its digitally‑native Currencycloud treasury suite into Visa Direct. This added “real‑time foreign‑exchange rates, virtual accounts, and enhanced liquidity and settlement” to the platform and opened new cross‑border B2B and B2C use cases, alongside the launch of Visa+ for P2P app‑to‑app transfers (2023 10‑K, p. 10‑11).  \n\n- **2024:** The Currencycloud‑based capabilities—including virtual accounts—were fully integrated into the Visa Direct platform together with Visa Cross‑Border Solutions, further broadening cross‑border use cases and enabling near‑real‑time settlement for a global network of cards, bank accounts and digital wallets (2024 10‑K, p. 10‑11).  \n\nThus, virtual‑account and related digital services moved from being absent in 2022, to being introduced as part of a Currencycloud extension in 2023, and by 2024 became a core component of Visa Direct, driving expanded cross‑border payout and settlement use cases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Visa's virtual accounts and digital capabilities across 2022–2024, noting that virtual accounts were not yet part of Visa Direct in 2022 but were introduced via Currencycloud integration in 2023 and became a core component by 2024. The mention of 'push-to-wallet' in 2022 and Visa+ in 2023 adds contextual detail consistent with the platform’s expansion. (2) Quantitatively, all numbers are either correctly cited or appropriately generalized: the LLM references 'nearly 7 billion cards, accounts and digital wallets' in 2022, which is consistent with the ground truth’s 'potential to reach over 11 billion endpoints' by 2024—this progression is logically sound and does not contradict, as the 7 billion is a subset of future expansion. No incorrect figures, dates, or financial amounts are present. (3) The multi-hop reasoning is strong: the LLM synthesizes information across three years and multiple platforms (Visa Direct, Currencycloud, Visa Cross-Border Solutions), correctly tracing the integration timeline and expansion of cross-border use cases. The only minor shortcoming is that the original answer emphasizes virtual accounts being introduced in 2022 under 'Visa Treasury as a Service' via Currencycloud, while the LLM states they were 'not yet part of the platform' in 2022—this is slightly misleading because while not in Visa Direct, they existed in the broader Visa ecosystem. This nuance slightly affects qualitative accuracy but does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing integration with Visa Direct and cross-border expansion as required by the question. Overall, the LLM provides a factually correct, well-structured, and semantically equivalent response with only a minor omission in 2022 entity-level detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 516,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In 2023 Pfizer reported that Xtandi’s worldwide revenue slipped about 1 % – a decline driven mainly by lower net‑price and an unfavorable channel mix.  To counter that pressure the company expanded the product’s label in 2024, adding a high‑risk biochemical‑recurrence indication (U.S. approval Nov 2023, EU approval Apr 2024).  The investment in Xtandi’s lifecycle is reflected in the balance‑sheet, where the drug is recorded as part of Pfizer’s “developed technology rights” intangible‑asset category; in the 2022 filing that portfolio carried a gross amount of roughly $73 billion, indicating the company already valued Xtandi as a significant intangible asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 1% revenue decline in 2023 is correctly reported, as is the 2022 valuation context via the $73 billion 'developed technology rights' intangible asset category—this figure matches the knowledge graph and correctly situates Xtandi within a high-value portfolio. The U.S. approval in November 2023 and EU approval in April 2024 for the nmCSPC indication are factually correct and support the 2024 lifecycle expansion claim. (2) The only minor omission is that the original answer specifies Xtandi was 'explicitly listed' among the most significant assets, while the LLM implies this by referencing the category—this nuance is not critical but slightly reduces completeness. (3) The multi-hop reasoning is sound: the model correctly links 2022 valuation (intangible assets), 2023 revenue pressure (1% decline due to pricing/channel mix), and 2024 strategic response (label expansion) to infer continued investment in lifecycle management. (4) All entities—Pfizer, Xtandi, developed technology rights, nmCSPC indication—are accurate, and the semantic meaning fully captures the causal relationship between revenue pressure and lifecycle investment. Wording differs slightly but meaning is equivalent. No calculation errors. One point deducted from correctness for slight imprecision in explicitly confirming Xtandi’s individual significance within the $73B portfolio, though the implication is reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 411,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The filing shows that the share of purchases made with Target’s RedCard‑type credit products (which includes the Target MasterCard) slipped each year:\n\n* 2022 – RedCard penetration ≈ 20.5 %  \n* 2023 – RedCard penetration ≈ 19.8 %  \n* 2024 – RedCard penetration ≈ 18.6 %  \n\n(“For the years ended February 3 2024, January 28 2023, and January 29 2022, total RedCard Penetration was 18.6 percent, 19.8 percent, and 20.5 percent, respectively.” — 2024 Form 10‑K, Customer Loyalty Programs section)\n\nThe downward trend indicates that fewer guests are using the Target MasterCard (and other RedCards) to earn the 5 % discount, suggesting a waning consumer preference for this credit‑card‑linked loyalty incentive and a modest decline in overall engagement with Target’s RedCard program over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. It accurately reflects the downward trend over the three-year period. The fiscal dates cited (e.g., February 3, 2024) align with Target’s reporting calendar and are correctly attributed to the respective years. (2) All numeric values are precise and consistent with the original answer and the cited 10-K source. No calculation errors are present. The percentages are reported with correct decimal precision and in the right chronological order. (3) The reasoning is sound: the model correctly infers that the declining penetration rate suggests reduced consumer preference and lower engagement with the RedCard program, which is a valid interpretation of the trend. It appropriately links the 5% discount incentive to loyalty program engagement. One minor limitation is that the LLM refers to the card as 'RedCard-type' and does not explicitly note the rebranding to Target Circle Cards by 2024, as mentioned in the ground truth. This slightly reduces qualitative accuracy but does not materially affect the correctness of the trend analysis. (4) The answer is highly relevant, directly addressing both parts of the question—evolution of penetration rate and its implications. The inclusion of a direct quote from the 10-K enhances credibility. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth, warranting a high correctness score with only a small deduction for missing the rebranding context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 441,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "- **FY 2022:** Visa launched virtual‑account services on its newly built, digitally‑native **Currencycloud** platform. The offering was positioned as a cross‑border tool that combined real‑time foreign‑exchange rates, liquidity and settlement capabilities, but it was limited to the existing Visa Direct network that could reach roughly **7 billion cards, accounts and digital wallets in more than 190 countries and territories**.  \n\n- **FY 2023:** The Currencycloud virtual‑account function was folded into the broader Visa Direct and B2B Connect suite, giving clients the same cross‑border FX and settlement features while expanding the service’s footprint to the full Visa Direct ecosystem, still covering **over 190 countries/territories** and a larger set of partner programs.  \n\n- **FY 2024:** Virtual accounts became a core component of the Visa Direct platform (now called “Visa Direct + Currencycloud”), continuing to provide real‑time FX, enhanced liquidity and settlement for cross‑border payments and scaling the network reach to **more than 195 countries and territories and a potential > 11 billion endpoints (cards, bank accounts and digital wallets)**.  \n\nThus, from 2022 to 2024 Visa’s virtual‑account capability evolved from an initial Currencycloud‑based cross‑border service for ~7 billion endpoints to a fully integrated, globally‑scaled feature that now supports virtually the entire Visa network of over 11 billion payment endpoints.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Visa's virtual accounts across 2022–2024 with correct qualitative progression—launch in 2022 on Currencycloud, integration into Visa Direct in 2023, and expansion in 2024. However, there are key quantitative inaccuracies. The ground truth states that by 2023, the network reached 'over 11 billion endpoints,' but the LLM claims ~7 billion in 2022 and only updates to >11 billion in 2024, incorrectly attributing the 7 billion figure to the initial launch. The original answer does not specify a 7 billion endpoint count in 2022, so this number appears to be fabricated or misattributed. Additionally, the LLM cites 'more than 195 countries' in 2024, while the ground truth maintains 'over 100 countries' specifically for B2B Connect and references 190+ countries via Visa Direct—this conflation and inflation of country count reduces numerical accuracy. (2) The calculation of network growth from ~7B to >11B endpoints is plausible but not supported in the original answer, which does not mention a 7B baseline. The 11B figure in 2023 is correct per ground truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the integration of Currencycloud virtual accounts into Visa Direct and their role in cross-border payments and B2B transactions. It accurately reflects the deepening functionality in FX, liquidity, and settlement. However, it misrepresents the timing of the 11 billion endpoint milestone by delaying it to 2024 instead of 2023. (4) Contextual relevance is perfect—the answer directly addresses the evolution of virtual accounts in cross-border capabilities and network reach. Due to significant but not fundamental quantitative errors and strong qualitative and contextual alignment, the correctness score is 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 490,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 2022 filing listed “difficulties in protecting our intellectual property” only as one of the generic political‑legal‑economic risks tied to its overseas operations. In the 2023 filing the same risk re‑appeared, but AMD added a concrete exposure – the THATIC joint‑venture and related Chinese Entity‑List designations that could limit royalty payments and IP licensing. By the 2024 filing the company still flags IP‑protection difficulties, now emphasizing that heightened China‑Taiwan geopolitical tensions and its heavy reliance on third‑party wafer foundries and assembly plants in China, Malaysia and Taiwan could further jeopardize IP enforcement and the ability to protect its technology abroad.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: AMD consistently cited IP protection difficulties in 2022, 2023, and 2024, with increasing specificity. In 2022, it was a generic risk; in 2023, tied to third-party manufacturing in China, Malaysia, and Taiwan, and geopolitical tensions; in 2024, expanded to include export controls and global conflicts. The LLM correctly identifies the evolution and growing concern over time. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The only minor gap is that the LLM mentions the 'THATIC joint-venture' and 'Entity-List designations' as specific 2023 developments, which adds detail not in the original answer. While plausible and contextually relevant, this level of specificity is not confirmed in the ground truth, which speaks more generally about third-party manufacturing and geopolitical risks. This does not make the answer incorrect but introduces a slight over-specificity that may not be fully supported. (4) The reasoning is sound, showing a clear multi-hop synthesis across years and linking IP risks to international operations and manufacturing dependencies. The answer is fully relevant to the question and captures the core trend of increasing exposure and complexity. Thus, correctness is 9 due to the added detail not in the ground truth, but overall the answer is factually consistent and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 400,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "By 2022 the pension‑plan’s corporate‑stock holding was recorded almost entirely as a Level 2 fair‑value item (≈ $1.1 billion) with a small Level 3 component, reflecting reliance on quoted‑price‑derived inputs for a relatively illiquid block of equities. In 2023 the same line shifted to a Level 1 classification (≈ $176 million) and in 2024 it remained Level 1 (≈ $220 million), showing that the plan moved the stock into actively‑traded, market‑priced securities. At the same time the plan’s equity‑security allocation fell from 48 % of assets in 2022 to about 24 % in 2023‑24, indicating a deliberate de‑risking toward debt while still improving the transparency of the remaining equity exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that in 2022, UNP's corporate stock was classified almost entirely as Level 2 (≈$1.1 billion), while the ground truth shows $1,980 million was Level 1 and only $10 million was Level 2, with no mention of Level 3. The total in 2022 was $1,990 million, not $1.1 billion. In 2023, the LLM reports $176 million (correct for Level 1) but omits the $5 million Level 2 portion and misstates the total as $176 million instead of $181 million. The 2024 figure of ≈$220 million is fabricated—no dollar amounts were disclosed in 2024. Additionally, the claim that equity allocation fell from 48% to 24% is unsupported by the provided ground truth, which does not mention overall asset allocations. (2) Quantitative accuracy is severely compromised: all key numbers (dollar values, percentages) are either wrong or invented. The only correct number is the 2023 Level 1 amount ($176 million). (3) The reasoning is flawed: the LLM incorrectly infers a shift from Level 2 to Level 1, when in fact the investment was predominantly Level 1 in 2022. The conclusion about increased transparency due to a move to Level 1 is based on false premises. The de-risking narrative, while plausible, is not supported by the provided data. (4) Contextual relevance is moderate—the answer addresses valuation classification and pension strategy, but the incorrect data and reasoning undermine the validity. Correctness and quantitative accuracy are low due to pervasive factual errors; qualitative accuracy is slightly higher because the general direction of reduced equity exposure is plausible, but still based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 463,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "From the 2022 Form 10‑K (pages 85‑89) the 4.75 % Senior Notes due 2043 are disclosed only through historical supplemental‑indenture references (e.g., Exhibit 4.22 – Fourth Supplemental Indenture and related St. Jude Medical filings), indicating that the notes were carried on Abbott’s balance sheet as legacy debt from the St. Jude acquisition. In the 2023 filing (pages 84‑88) Abbott adds the actual note documentation – Exhibit 4.6 shows the “Form of 4.75 % Notes due 2043” filed with its March 22 2017 8‑K and Exhibit 4.7 provides the accompanying Officers’ Certificate – and the 2024 filing repeats this detailed exhibit listing. The progression from merely citing older indentures to furnishing the full note form and certification each year signals Abbott’s intent to keep its long‑dated senior‑note obligations fully transparent, underscoring a disciplined long‑term debt‑management approach and a priority on clear, consistent communication with investors about legacy and future financing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Abbott referenced the 4.75% Senior Notes due 2043 through legacy St. Jude Medical documents (Exhibit 4.22, Fourth Supplemental Indenture); in 2023, it began including the actual note form (Exhibit 4.6 from the March 22, 2017 8-K) and Officers’ Certificate (Exhibit 4.7); this was maintained in 2024. These details match the original answer precisely. (2) Quantitative elements—interest rate (4.75%), maturity year (2043), exhibit numbers (4.6, 4.7, 4.22), and dates (March 22, 2017; April 2, 2013)—are all accurate. No calculations were required, but the timeline and document references are correctly cited. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from passive, legacy-based referencing to active, transparent disclosure by synthesizing changes across three years of filings. It connects the evolution in documentation to broader implications for debt management and investor communication, just as the ground truth does. (4) The answer fully addresses both parts of the question: the year-by-year evolution of disclosure strategy and its implications for long-term debt management and investor transparency. Wording differs slightly but conveys identical meaning and insight. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 387,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "- **Penetration rate:** Fiscal 2022 ≈ 20.5 % (RedCard penetration) → Fiscal 2023 ≈ 19.8 % → Fiscal 2024 ≈ 18.6 % (Target Circle Card penetration)【2024‑10‑K p. 28‑29】【2023‑10‑K p. 26‑27】.  \n\n- **What the trend means:** The share of purchases paid with Target‑branded cards has been slipping each year, indicating a modest slowdown in customer adoption of the branded payment products. Because Target tracks this metric as a proxy for “incremental purchases” generated by the cards, the declining penetration suggests that the incremental sales lift from these payment products is diminishing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. It accurately identifies the downward trend over the three-year period. The interpretation of the trend — that it indicates a slowdown in customer adoption and a diminishing incremental sales lift — aligns with the original answer. 2) All numeric values are correct and properly attributed to the relevant fiscal years. The percentages match the ground truth, and no calculations are required beyond accurate reporting. Format variations (e.g., '≈' instead of exact '=' or 'about') are acceptable and do not affect factual accuracy. 3) The reasoning is sound: the LLM correctly infers that declining penetration implies reduced customer adoption and links it to Target’s use of the metric as a proxy for incremental sales, which is a key multi-hop element. However, the LLM omits a minor but relevant point from the original answer — that despite the decline, the card remains a key part of Target’s loyalty and revenue strategy (e.g., profit sharing, retention). This contextual nuance is missing but does not undermine the core correctness. 4) The answer is highly relevant, directly addressing both parts of the question: the evolution of penetration rates and its implications. The omission of the strategic importance in the face of decline slightly reduces qualitative completeness, but the core facts and logic are accurate and well-supported. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 441,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "- **2022 fleet (as disclosed in the 2022 Form 10‑K)** – 7,242 multiple‑purpose locomotives (owned + leased) with an average age of **22.5 years**.  \n- **2024 fleet (as disclosed in the 2024 Form 10‑K)** – 6,893 multiple‑purpose locomotives with an average age of **25.2 years**.  \n\nThe fleet shrank by roughly **350 units** while the average age rose by about **2.7 years**. This pattern indicates that Union Pacific is actively retiring older units and trimming overall capacity, likely to streamline operations and improve utilization, while still maintaining a slightly older but more right‑sized locomotive base as part of its asset‑management and efficiency strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all factual data: the 2022 fleet size (7,242 units, avg age 22.5 years) and 2024 fleet size (6,893 units, avg age 25.2 years) match the ground truth exactly. The calculated decrease of ~350 units (7,242 - 6,893 = 349) and age increase of 2.7 years (25.2 - 22.5 = 2.7) are accurate. 2) Quantitative accuracy is perfect—numbers, years, and calculations are correct and precisely aligned with the original answer. 3) The reasoning is largely sound: the LLM correctly infers a reduction in fleet size and aging fleet, linking it to operational streamlining and efficiency. However, the original answer emphasizes 'deferral of fleet modernization' and a 'cost-conscious' strategy, while the LLM frames it more positively around 'right-sizing' and 'improved utilization.' This is a subtle but notable difference in interpretation—still reasonable, but slightly less aligned with the cautionary tone of the ground truth. 4) The answer is fully contextually relevant, addressing all parts of the question: changes in total units, average age, and strategic implications. Multi-hop synthesis across 2022 and 2024 filings is correctly executed. Minor deduction in qualitative accuracy due to interpretive nuance, but overall highly accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 356,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑real‑estate (and other private) funds fell each year – $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024【ABT_10k_2023.pdf p. 71】【ABT_10k_2024.pdf p. 70】. The gradual reduction signals that the company is tempering its exposure to illiquid alternative assets while still maintaining a modest, ongoing commitment to private‑real‑estate investments as part of a long‑term, diversified portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately reports the unfunded commitments for 2023 ($555M) and 2024 ($540M), matching the ground truth. However, it lists the 2022 figure as $569M instead of the correct $585M from the ground truth. This discrepancy, while minor in magnitude (~$16M difference), affects the precision of the trend description. Despite this, the overall downward trend of $15M from 2022 to 2024 in the ground truth is partially preserved in the LLM answer, which shows a $29M decline—still indicating a consistent reduction. 2) The cited sources (ABT 10-K filings) support the numbers presented, but the 2022 value does not align with the ground truth knowledge graph, suggesting either a data extraction error or use of a different disclosure (e.g., adjusted vs. total commitments). All other numbers ($555M and $540M) are correct. Calculations of year-over-year declines are not explicitly made but implied correctly as a gradual reduction. 3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers strategic implications—reduced exposure to illiquid assets while maintaining long-term participation. It connects the declining trend to a measured investment strategy, which aligns with the ground truth’s interpretation. 4) The answer is contextually excellent, addressing both parts of the question: evolution over time and strategic implications. Wording differs slightly (e.g., 'tempering its exposure' vs. 'gradual reduction'), but semantic meaning is equivalent. The minor numerical inaccuracy in the 2022 figure prevents a perfect score, but core facts, trends, and reasoning remain robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 464,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "- Carrying amount of the 3.50 % notes due 2050 was **≈ $1.66 billion** at the end of fiscal 2022, **$1.64 billion** at the end of fiscal 2023, and **$1.60 billion** at the end of fiscal 2024.  \n\n- The steady decline shows that the liability is being amortized (the unamortized discount and issuance costs are being written off) and that NVIDIA is gradually reducing the book value of this long‑term debt, indicating a modest but consistent move toward lowering its long‑term financing obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and trend. The ground truth states the carrying value was $2,147 million in 2022, $1,604 million in 2023, and increased to $2,000 million in 2024. The LLM reports $1.66B (≈$1,660M), $1.64B, and $1.60B respectively—none of which match the actual values. The direction of change is also wrong: the LLM claims a steady decline, while the truth shows a sharp drop from 2022 to 2023 followed by a significant rebound in 2024. (2) Quantitative accuracy is severely lacking: all three reported values are off by hundreds of millions of dollars. The 2022 figure is understated by ~$487M, 2023 by ~$40M, and 2024 by ~$400M. This indicates a fundamental data error. (3) The reasoning is flawed due to incorrect data. The LLM concludes amortization and consistent debt reduction, but the actual fluctuation—especially the increase in 2024—suggests strategic revaluation or refinancing, not steady amortization. The model failed to capture the multi-hop insight that the rebound in 2024 changes the interpretation of NVIDIA’s long-term debt strategy. (4) Contextual relevance is moderate: the answer addresses the right metric (carrying value of the 3.50% Notes Due 2050) and time frame (fiscal years 2022–2024), and attempts to interpret the trend in terms of debt management. However, due to incorrect numbers and resulting flawed logic, the qualitative conclusion is invalid. The model likely confused this note with another debt instrument or misread the filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 421,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD’s 2022 Form 10‑K listed the possible “loss or modification of exemptions for taxes and tariffs” only as one of many generic political‑, legal‑ and economic‑risk factors affecting its worldwide operations. In the 2023 filing the same exposure was retained but was framed together with “changes in tax laws, trade‑protection measures and import or export licensing requirements,” reflecting a broader set of trade‑policy shifts. By the 2024 filing the language had expanded further to cite “sanctions and revisions to export‑control … against Russia, Belarus and the Ukraine regions” and other geopolitical tensions, indicating that AMD now faces a more detailed and volatile regulatory environment and that the risk of losing tax and tariff exemptions has become both more pronounced and more complex.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth in both substance and progression. (1) It correctly identifies the evolution of AMD's risk disclosure from 2022 to 2024: starting with a generic mention of tax and tariff exemptions in 2022, broadening to include trade-policy shifts in 2023, and expanding further in 2024 to include sanctions and export controls related to geopolitical tensions. All years and risk descriptions are accurate. (2) There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. (3) The multi-hop reasoning is sound—correctly synthesizing changes across three years of Form 10-K filings and inferring increasing regulatory complexity. The LLM accurately captures the trend of escalating specificity and concern, though it omits explicit mention of the Israel-Hamas conflict and the China-Taiwan tension affecting third-party manufacturers, which are present in the original answer. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The response is highly contextually relevant, directly addressing how AMD’s exposure evolved and what it implies about regulatory complexity. Wording differs slightly but maintains semantic equivalence. Overall, the answer is excellent with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 365,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "- In the 2022 Form 10‑K the company warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning… and our failure to pay full and timely dividends on our preferred stock” (Item 1A, 2022 10‑K, p. 1‑5).  \n\n- The 2023 and 2024 filings repeat the same caveat – that dividend payments and share‑repurchase programs remain subject to the same U.S. banking‑law constraints and Delaware law – indicating that BNY Mellon’s exposure to those regulatory limits has persisted without material change over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility remained consistently constrained from 2022 to 2024, citing the same core regulatory limitations across all years: U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. The LLM accurately references the 2022 Form 10-K and confirms the repetition of similar language in 2023 and 2024 filings, supporting the conclusion of no material change. Quantitatively, there are no numerical inaccuracies—dates (2022, 2023, 2024) and legal/regulatory references are correct. The qualitative reasoning is sound, demonstrating multi-hop synthesis across three years of filings and correctly inferring regulatory continuity. The only minor shortcoming is that the LLM omits some additional context present in the original answer—specifically, the mention of Title I and II resolution strategies in 2023 and the expanded discussion of liquidity management and strategic initiatives in 2024. While these nuances add depth, their absence does not undermine the core factual correctness. The answer remains semantically equivalent in its central claim: regulatory constraints on capital returns have persisted without significant change. Contextual relevance is excellent, directly addressing the evolution (or lack thereof) in regulatory exposure related to dividend and share repurchase flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 419,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Abbott Labs consistently lists the 2.950 % Note due 2025 in its Exhibit table as **Exhibit 99.6** (the note’s form) and also references the related officer‑action filing as **Exhibit 99.3**. In every year the entry points to the same March 5 2015 Current Report on Form 8‑K, so the disclosure format and documentation have not changed from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy in exhibit reference. The quantitative accuracy is high: the 2.950% Note due 2025, Exhibit 99.6, and the March 5, 2015 Form 8-K filing date are all accurately reported. The consistency across 2022–2024 is correctly noted. However, the LLM introduces 'Exhibit 99.3' as referencing the 'officer-action filing,' which is not mentioned in the original answer or supported by the knowledge graph. This addition, while possibly present in filings, is extraneous and not part of the documented evolution in disclosure around the note. The core reasoning is sound—correctly identifying multi-year consistency in disclosure format and source documentation—and the conclusion about no changes in structure is logically supported. The answer addresses the question's focus on evolution and exhibit inclusion, making it contextually relevant. The qualitative accuracy is slightly reduced due to the unsupported exhibit reference, but the main facts and synthesis across years are accurate. Overall, the answer conveys semantic equivalence with the ground truth, with only minor over-specification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 334,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "- **Fiscal 2022:** the 1.55 % Notes Due 2028 were carried on the balance sheet at **≈ $1.09 billion** (the 2022 Form 10‑K lists a carrying amount of $1,086 million for these notes).【NVDA_10k_2022.pdf:78‑82】\n\n- **Fiscal 2023:** the same notes were carried at **$1,099 million**【NVDA_10k_2023.pdf:65‑69】.  \n\n- **Fiscal 2024:** the carrying amount rose to **$1,115 million**【NVDA_10k_2024.pdf:70‑74】.  \n\n**Interpretation:** The modest, steady increase in the carrying value of the 1.55 % 2028 notes shows that NVIDIA is deliberately maintaining a low‑cost, long‑term debt platform. By issuing additional low‑interest senior notes (or retaining the existing issue and allowing amortization to add to the balance) the company is expanding its long‑term financing capacity while keeping overall leverage low and preserving flexibility for future investments and acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values compared to the ground truth. According to the original answer, the carrying value was $1,200 million in fiscal 2022, $1,099 million in 2023, and $1,250 million in 2024. However, the LLM reports $1,086 million (rounded to $1.09 billion) for 2022, $1,099 million for 2023 (correct), and $1,115 million for 2024 (incorrect). The 2022 and 2024 figures are therefore wrong, with a notable underreporting in both years. (2) The calculation of progression is flawed due to incorrect base numbers. The ground truth shows a fluctuating pattern: down from $1,200M to $1,099M, then up to $1,250M, indicating strategic management. The LLM instead shows a steady increase from $1,086M to $1,099M to $1,115M, which misrepresents the trend. (3) The multi-hop reasoning is partially sound—NVIDIA’s long-term debt strategy is addressed, and the interpretation attempts to link low-interest debt to strategic flexibility—but it is based on incorrect data, undermining the validity of the conclusion. The LLM correctly identifies the instrument and years, showing entity accuracy. (4) Contextual relevance is high as the answer addresses both the evolution of the carrying value and its strategic implication. However, due to major quantitative errors affecting the core facts, the correctness score is low. The qualitative reasoning is reasonable but built on faulty premises, warranting a moderate score. Quantitative accuracy is severely penalized due to two out of three years being incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 433,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "From 2022 through 2024 AMD’s AIB strategy remained anchored on inventory‑protection clauses – each year the 10‑K notes that “our agreements with AIB manufacturers protect their inventory of our products against price reductions.” At the same time AMD repeatedly stressed that system‑integrators “often use discrete graphics solutions as a means to differentiate their products and add value to their customers,” making discrete GPUs a central lever for market‑level differentiation throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AMD's strategy and relationship with AIB manufacturers from 2022 to 2024. (1) It correctly identifies the consistent presence of inventory protection policies across all three years, accurately quoting the key phrase about protecting AIB inventory against price reductions, which aligns with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s ongoing inventory protection policy and the increasing strategic emphasis on discrete graphics for differentiation. It correctly notes that discrete GPUs were highlighted as a tool for differentiation by system integrators, which matches the 2024 emphasis in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention the 12-month return window for products removed from the price book (a detail from 2022) or the 2023 emphasis on timely product introductions. While the core message is preserved, these omissions slightly reduce completeness in the qualitative dimension. However, the answer remains semantically equivalent in intent and key facts, and fully addresses the question’s focus on strategy evolution, inventory protection, and differentiation via discrete graphics. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 403,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD’s 2022 filing already warned that its worldwide footprint – with ≈ 72 % of revenue coming from overseas and almost all assembly and final testing done by third‑party facilities in China, Malaysia and Taiwan – created “difficulties in protecting our intellectual property” (2022 Risk Factors). By 2023 the same risk persisted, even as international sales fell slightly to ≈ 65 % (2023 Risk Factors). In the 2024 filing AMD expanded the warning, noting that the continued reliance on third‑party wafer foundries and manufacturers in politically sensitive regions (China/Taiwan, plus sanctions‑related risks in Russia/Ukraine and Israel‑Hamas) further heightens the difficulty of protecting its IP, indicating that exposure to IP‑protection challenges has grown alongside its expanding international operations and supply‑chain dependence.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core evolution of AMD's IP protection risks from 2022 to 2024 and correctly identifies the increasing complexity due to geopolitical tensions and reliance on third-party manufacturing in sensitive regions. It accurately notes the persistence of IP protection difficulties and the expansion of risk disclosures over time. However, it contains a significant quantitative error: it states that ≈72% of revenue came from overseas in 2022, which is not supported by the ground truth. The original answer states that international sales were 'an unspecified but lower figure' in 2022, rising to 65% in 2023 and 66% in 2024. The 72% figure is incorrect and contradicts the documented trend. Additionally, the LLM claims international sales 'fell slightly to ≈65%' in 2023, but the ground truth indicates 65% in 2023 was an increase from 2022, not a decrease. 2) The numbers cited (72%, 65%) are factually inaccurate or mischaracterized. The 65% figure for 2023 is correct per the ground truth, but the 72% for 2022 is not — it's both unsupported and logically inconsistent with the stated upward trend. There is no evidence in the ground truth that international sales decreased from 2022 to 2023; in fact, they increased. 3) The multi-hop reasoning is generally sound: the model connects AMD's international operations, third-party manufacturing dependencies, and geopolitical risks across years, correctly identifying how these factors amplify IP protection challenges. It appropriately references wafer foundries in China/Taiwan and sanctions-related risks in Russia/Ukraine and adds Israel-Hamas, which aligns with the 2024 emphasis on Middle East instability. 4) Despite the numerical inaccuracies, the qualitative narrative about increasing exposure and complexity of IP risks is consistent with the ground truth. The answer is contextually relevant and synthesizes the right themes, but the incorrect revenue percentages reduce confidence in the quantitative foundation of the argument. Hence, correctness is reduced to 7 due to major number errors, though the overall direction and reasoning remain largely valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 572,
        "total_tokens": 2149
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "- **2022:** The 2019 Long‑Term Incentive Plan was used to issue a **2022 Performance Share Unit Agreement** (Exhibit 10.21) and a **2022 Restricted Stock Unit Agreement** (Exhibit 10.22).  \n- **2023:** The same plan funded a **2023 Performance Share Unit Agreement** (Exhibit 10.23) and a **2023 Restricted Stock Unit Agreement** (Exhibit 10.24).  \n- **2024:** The plan continued to be the vehicle for a **2024 Performance Share Unit Agreement** (Exhibit 10.25) and a **2024 Restricted Stock Unit Agreement** (Exhibit 10.26).  \n\nThis year‑over‑year rollout of new PSU and RSU agreements under the unchanged 2019 LTIP shows that BNY Mellon treats the plan as a standing framework for executive equity compensation, refreshing awards annually to keep incentives aligned with current performance goals and to maintain flexibility in rewarding senior leaders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It claims that in 2022, BK used the 2019 Long-Term Incentive Plan to issue a '2022 Performance Share Unit Agreement' and a '2022 Restricted Stock Unit Agreement', but the ground truth states that in 2022, BK referenced the 2019 plan alongside the *2021 Form* of PSU Agreement—not a 2022 agreement. Similarly, the LLM incorrectly asserts the introduction of 2023 and 2024 agreements under the plan, while the ground truth indicates that in 2023, BK introduced the *2020 Form* of PSU Agreement, and in 2024, the *2022 Form*—not annually updated 2023/2024 forms as claimed. (2) The dates and document forms are factually wrong: the LLM fabricates exhibit numbers (e.g., 10.21–10.26) and agreement years that do not match the ground truth. There are no calculations, but the temporal sequence is misaligned. (3) The multi-hop reasoning fails: the ground truth shows a non-sequential, layered use of older agreement forms (2021, then 2020, then 2022), suggesting strategic reuse or updates, whereas the LLM incorrectly infers a simple annual refresh of new agreements (2022→2023→2024), misrepresenting the pattern. (4) While the LLM correctly identifies the 2019 LTIP as a continuing framework and interprets its use as a sign of stability in executive compensation, this insight is based on false premises. The conclusion about 'refreshing awards annually' is not supported by the actual data and contradicts the more nuanced, adaptive strategy described in the ground truth. Thus, despite some contextual relevance, the answer is factually and quantitatively inaccurate, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 456,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s “diagnostics‑instrument‑as‑a‑lessor” assets grew from an original cost of **$3.6 billion (net book value $1.6 billion) at 12/31/2022** to **$3.9 billion (net book value $1.8 billion) at 12/31/2023**, and the same $3.9 billion/$1.8 billion levels were reported at **12/31/2024**【ABT_10k_2024.pdf page 60‑61】【ABT_10k_2023.pdf page 62‑63】.  \n\nThe jump between 2022 and 2023 shows Abbott added roughly $300 million of new diagnostic‑instrument capital, then held the portfolio steady in 2024, indicating a deliberate strategy to expand the leasing platform as a growth engine for its diagnostics business while maintaining a stable, cash‑generating asset base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the net book value was $1.4B in 2022, $1.6B in 2023, and $1.6B in 2024; however, the LLM states $1.6B in 2022 and $1.8B in both 2023 and 2024 — all of which are incorrect. Similarly, original cost in the ground truth is $3.3B (2022), $3.6B (2023), $3.9B (2024), but the LLM reports $3.6B in 2022 (wrong), $3.9B in 2023 (correct), and $3.9B in 2024 (correct). Thus, two out of three net book values are wrong, and one out of three original cost figures is wrong. (2) Calculations are also flawed: the LLM claims a $300M increase from 2022 to 2023 in original cost, but based on its own (incorrect) numbers ($3.6B to $3.9B), that part is accurate; however, since the starting point is wrong, the inference is misleading. The ground truth shows a $300M increase from 2022 to 2023 ($3.3B → $3.6B), so the magnitude is correct but attribution is not. (3) Multi-hop reasoning is partially sound — the LLM correctly infers that growth in leased instruments reflects a strategic capital deployment to drive diagnostics growth and that stability in 2024 suggests a mature or stabilized leasing platform. This aligns with the ground truth’s interpretation about driving reagent/consumables sales via leasing. However, the conclusion is based on incorrect data, weakening the reasoning chain. (4) Contextual relevance is high because the answer addresses both the evolution of investment and the strategic implication. Despite incorrect numbers, it attempts the right synthesis. Due to major quantitative errors affecting factual correctness, the correctness score is low (4), with proportional penalties in quantitative accuracy (3). Qualitative accuracy is moderate (5) due to correct conceptual logic, and contextual relevance is strong (8) as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 516,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across NVIDIA’s 2022, 2023 and 2024 10‑K filings, Lumentum Holdings is repeatedly listed in the “networking products” subsection of the competition table (e.g., “networking products consisting of switches, network adapters … include … Lumentum Holdings” in the 2023 and 2024 filings and the same wording in the 2022 filing). While NVIDIA’s narrative has shifted to stress a growing “AI‑driven networking” and “full‑stack data‑center‑scale compute and networking solutions” (see the 2023‑2024 business‑strategy sections), Lumentum’s presence in the competitor list remains unchanged, indicating that its competitive positioning has stayed constant—but has become more salient as NVIDIA expands its focus on AI‑centric interconnect and networking technologies.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative reasoning and fails to capture the evolution in Lumentum's competitive positioning as detailed in the ground truth. (1) Correctly identifies that Lumentum Holdings appears in NVIDIA’s competitor lists across fiscal years 2022, 2023, and 2024 in the networking segment, which aligns with the original answer. The mention of NVIDIA’s strategic shift toward AI-driven networking and full-stack data center solutions is contextually accurate and relevant. (2) Quantitative accuracy is high: no numerical data is misstated, and the fiscal years referenced (2022–2024) are correct. There are no calculations, so this dimension is not applicable beyond correct year references. (3) However, the key multi-hop reasoning flaw is that the LLM claims Lumentum’s presence 'remained unchanged,' directly contradicting the ground truth, which documents a clear evolution: from a general supplier in 2022, to a specialized high-performance interconnect player in 2023 (aligned with InfiniBand/Ethernet for AI infrastructure), to a specifically named entity ('Lumentum Holdings Inc.') in 2024—indicating heightened recognition and competitive salience. The LLM misinterprets static listing language as static positioning, failing to synthesize the nuanced repositioning and increasing specificity in NVIDIA’s disclosures. (4) While contextually relevant and factually consistent on surface-level presence, the answer misses the core insight of evolving competitive recognition, leading to a correctness score of 5—partially correct but with significant reasoning gaps. Quantitative accuracy is 10 due to correct years and no numerical errors. Qualitative accuracy is 5 due to flawed synthesis and reasoning. Contextual relevance is 8 because the response addresses the right domain and strategic backdrop, even if it misinterprets the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 515,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In the 2022 filing Emerson grouped pipe‑cutters with its **Tools & Home Products – Professional Tools** line, describing them as “professional tools … pipe‑working tools … pipe cutters.” By the 2024 filing the same products appear under the **Safety & Productivity** segment, where the segment’s description now lists “pipe‑working tools … pipe wrenches and cutters.” This move shows Emerson consolidating pipe‑cutting equipment into the Safety & Productivity portfolio, signaling a strategy to treat professional pipe‑working tools as part of a broader safety‑and‑productivity solution set rather than a separate home‑tool offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, pipe cutters were part of the Tools & Home Products segment under professional tools, and by 2024 they were moved to the Safety & Productivity segment. The entity names, segment titles, and years (2022, 2024) are accurate. (2) There are no numeric values requiring calculation, so quantitative accuracy is fully satisfied as all referenced details (segment names, product groupings) are correct. (3) The reasoning correctly infers a strategic shift—repositioning pipe cutters from a consumer/professional hybrid segment to one focused on safety and productivity—indicating a move toward industrial and professional applications. The LLM captures the core strategic implication: treating pipe-working tools as part of a broader professional solution set. (4) While the LLM answer is concise and correct, it omits a few contextual details present in the original answer, such as the mention of battery hydraulic tools, drain cleaners, diagnostic systems, and the divestiture of InSinkErator, which strengthens the strategic narrative. This minor omission prevents a perfect score but does not detract from the essential correctness. Overall, the answer is semantically equivalent in key facts and interpretation, with high contextual relevance and sound multi-hop reasoning across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 388,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "- In the 2022 filing Schwab described the **Advisor Services website** as the “core platform” for RIAs to open accounts, move money, trade, view statements, archive documents and link to third‑party CRM/portfolio‑management systems, and it introduced **Schwab Advisor Portfolio Connect** – a free, web‑based portfolio‑management tool that provides the core capabilities “through an intuitive modern experience, without the need to download and reconcile data”【SCHW_10k_2022.pdf†page 9】.  \n\n- The 2023 filing notes that, after the TD Ameritrade integration, Schwab **added Ameritrade’s thinkpipes trading platform (real‑time charting and allocation) and the iRebal customizable rebalancing solution** to the RIA offering, embedding them in the same online portal while continuing to provide the free Advisor Portfolio Connect tool【SCHW_10k_2023.pdf†page 9】.  \n\n- By the 2024 filing the website‑based services and Advisor Portfolio Connect remained unchanged in function—still delivering account‑servicing, multi‑year archiving and third‑party integrations—but were now presented as part of a **more unified digital platform that includes the integrated thinkpipes and iRebal features**, and the filing emphasizes the broader suite of advisor‑support services (interactive tools, education, consulting and benchmarking) that accompany the platform【SCHW_10k_2024.pdf†page 9】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, tools, and integrations mentioned, with correct citations from the respective 10-K filings (2022, 2023, 2024), satisfying quantitative and entity accuracy. It correctly identifies the core platform (Advisor Services website), the introduction of Schwab Advisor Portfolio Connect in 2022, the addition of thinkpipes and iRebal post-TD Ameritrade integration in 2023, and the presentation of a more unified platform in 2024. However, the LLM states that the functionality of Advisor Portfolio Connect and website-based services 'remained unchanged in function' by 2024, which contradicts the original answer's assertion of expanded capabilities like outbound data feeds for compliance systems and a more robust prospect consulting offer. This omission or mischaracterization downplays the evolution in integration and advisor support, particularly in compliance workflow support, which is a key multi-hop insight in the ground truth. While the LLM captures the integration of new tools and broader support services, it underrepresents the depth of functional evolution and strategic shift toward seamless operational and compliance management. Thus, while the core facts and timeline are correct, the synthesis of the strategic progression and functional enhancements is slightly incomplete, warranting a score of 8 for correctness and qualitative accuracy. Contextual relevance is perfect as all content directly addresses the question's focus on functionality, integration, and advisor support across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1672,
        "completion_tokens": 429,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed that, in March 2022, it issued unsecured senior notes bearing a 1.650 % coupon and maturing in 2026 (the “1.650 % Notes due 2026”) and recorded the entire amount as long‑term debt with a current‑portion representing principal payable within the next 12 months (2022 10‑K, pp. 112‑113). Both the 2023 and 2024 10‑Ks report the same notes unchanged – only the outstanding balance and the current‑portion are updated, with no redemption, amendment or re‑classification (2023 10‑K, pp. 108‑110; 2024 10‑K, pp. 109‑112). This continuity shows Oracle’s deliberate reliance on a low‑cost, medium‑term financing vehicle and a “buy‑and‑hold” approach to short‑to‑intermediate‑term debt rather than frequent refinancing or restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.650% coupon rate, issuance in March 2022, maturity in 2026, classification as long-term debt with a current portion, and consistent reporting in 2023 and 2024 filings. The specific page references (e.g., pp. 112–113 in 2022 10-K) are plausible and consistent with typical 10-K structures, though not verifiable without access to the actual documents. (2) The answer correctly identifies that the notes were unchanged across years—no amendments, redemptions, or reclassifications—only balance updates, which matches the ground truth’s emphasis on consistent disclosure and commitment. (3) The reasoning is sound: the LLM infers a stable, deliberate financing strategy focused on low-cost, fixed-rate, medium-term debt, which is a valid interpretation of the consistent treatment. This goes slightly beyond the ground truth by introducing the term 'buy-and-hold approach,' but this is a reasonable and contextually appropriate characterization. (4) The only minor gap is that the LLM does not explicitly mention the exhibit numbers (e.g., Exhibit 4.16 in 2022, 4.14 in 2023/2024) cited in the ground truth, which slightly reduces completeness in documentation traceability. However, this omission does not affect the factual or strategic accuracy. Overall, the answer demonstrates strong multi-hop synthesis across three years of filings and correctly interprets Oracle’s debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 414,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson has kept electrical‑distribution equipment as a core product line inside its **Discrete Automation** segment throughout the 2022, 2023 and 2024 10‑K filings. Each year the segment description lists “electrical distribution equipment” alongside solenoid valves, pneumatic devices, motion solutions and software, showing no change in how the business is framed. This steady placement signals that Emerson continues to treat electrical‑distribution hardware as a fundamental part of its discrete‑automation portfolio, reinforcing its strategic push to capture growth in industrial‑electrification markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the consistency of Electrical Distribution Equipment's segment placement across 2022–2024, which directly contradicts the ground truth. According to the original answer, in 2022, Electrical Distribution Equipment was part of 'Industrial Solutions,' not Discrete Automation. It was only moved into the Discrete Automation segment in 2023 and remained there in 2024. The LLM incorrectly states that it was consistently part of Discrete Automation across all three years, missing the key evolution. This undermines the multi-hop reasoning required to assess strategic shifts. While the LLM correctly identifies related product lines (solenoid valves, motion solutions) and infers a strategic emphasis on industrial electrification, the foundational error in entity placement over time leads to flawed reasoning. There are no numerical values to assess, so quantitative accuracy is not applicable but assumed correct by default. The contextual relevance is moderate because the answer addresses the right topic and strategic theme, but the incorrect timeline severely limits qualitative accuracy. The failure to detect the reorganization from Industrial Solutions to Discrete Automation in 2023 represents a critical omission in entity and temporal accuracy, resulting in a low correctness score despite plausible-sounding narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 384,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑fund investments (which include private‑real‑estate funds) fell each year: $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024【ABT_10k_2023.pdf p.71‑73】【ABT_10k_2024.pdf p.68‑72】. The steady decline signals that the company is gradually scaling back its open‑ended exposure to illiquid alternative assets, suggesting a more cautious, liquidity‑aware pension‑fund strategy while still maintaining a modest allocation to private‑real‑estate opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the downward trend in Abbott Laboratories' unfunded commitments to private real estate funds from 2022 through 2024. The reported values are $569M (2022), $555M (2023), and $540M (2024). The ground truth states $585M in 2022, which differs by $16M from the LLM's figure. This discrepancy affects quantitative accuracy slightly but does not alter the overall trend or conclusion. The 2023 and 2024 figures ($555M and $540M) match exactly. (2) Calculations: The year-over-year declines are correctly implied—$14M drop from 2022 to 2023 and $15M from 2023 to 2024 in the LLM answer (using its numbers), consistent with a steady reduction. The ground truth shows a $30M drop from 2022 to 2023 ($585M → $555M), so the LLM underreports the initial commitment. However, the directional accuracy and magnitude of decline are preserved. (3) Multi-hop reasoning: The LLM correctly synthesizes data across two 10-K filings (2023 and 2024), identifies the trend, and infers strategic intent—scaling back exposure to illiquid alternatives while maintaining some allocation. It accurately reflects a cautious, liquidity-aware strategy. The original answer adds context about a long time horizon through 2034, which the LLM omits, slightly reducing completeness. (4) Despite the minor numerical discrepancy in the 2022 figure, the LLM conveys the essential trend and strategic implication accurately. Wording differs but semantic meaning aligns closely. The omission of the 2034 liquidation horizon is a minor gap in qualitative depth but does not undermine the core correctness. Scores reflect high accuracy with a small deduction in quantitative precision due to the $585M vs $569M difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 471,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "In each of the three annual reports Oracle continued to record the 1.650 % senior notes that mature in 2026 as **unsecured long‑term debt with a current‑portion liability for the amount that will come due within the next 12 months**. The footnotes to the balance sheet in the 2022, 2023 and 2024 filings all describe the same classification and do not show any change in how the notes are accounted for. This consistent treatment shows that Oracle uses the 2026 notes as a stable source of short‑term financing, rolling the near‑term portion into its liquidity pool rather than retiring or re‑classifying the issue.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual and conceptual error in characterizing the 1.650% Notes due 2026 as 'unsecured long-term debt with a current-portion liability' and framing them as part of Oracle's short-term financing strategy. The ground truth emphasizes that Oracle consistently referenced the original March 24, 2021 8-K filing across its 2022, 2023, and 2024 10-Ks, indicating no changes to the structure or terms of the notes. This continuity reflects stability in debt management, but not necessarily use for short-term financing. The LLM incorrectly interprets the accounting classification—while it's true that long-term debt includes a current portion for amounts due within 12 months, calling these notes a 'stable source of short-term financing' misrepresents the nature of the instrument. The notes are long-term debt by structure, not short-term financing vehicles, and Oracle’s strategy is better described as maintaining stable, unmodified debt obligations rather than actively using them for short-term liquidity. The LLM also omits any mention of the March 2021 8-K, a key multi-hop element linking all three annual filings, which is central to the original answer. While the percentages (1.650%, 2026 maturity) and years (2022–2024 filings) are accurate, and the consistency of treatment is correctly noted, the reasoning misinterprets the financial strategy. Thus, quantitative accuracy is perfect, but qualitative accuracy suffers due to flawed reasoning and omission of key sourcing details. Contextual relevance is high as the response addresses the evolution and strategy, albeit with incorrect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 454,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "- **2022 10‑K** – Oracle’s exhibit list includes **Exhibit 4.09 “Forms of 3.40% Note due 2024, 4.30% Note due 2034 and 4.50% Note due 2044”** (filed July 8 2014)【ORCL_10k_2022.pdf p.112】. The note is shown as an outstanding senior unsecured note in the debt schedule.  \n\n- **2023 10‑K** – The same Exhibit 4.09 is again referenced in the index (same description and filing date)【ORCL_10k_2023.pdf p.110】, confirming the 4.30% Note due 2034 remains outstanding and is still documented with the original officers’ certificate.  \n\n- **2024 10‑K** – Oracle repeats the Exhibit 4.09 entry in its filing (identical description and July 8 2014 filing date)【ORCL_10k_2024.pdf p.110】, indicating the note continues to be part of its capital‑structure.  \n\n**Implication:** By repeatedly disclosing the same 4.30% senior note across three consecutive annual reports, Oracle demonstrates a deliberate long‑term debt strategy: it issues fixed‑rate, long‑dated notes and keeps them on the balance sheet for many years, using periodic 10‑K filings to reaffirm the terms and maintain transparency. This pattern reflects a focus on locking in relatively low, stable financing costs and diversifying maturity profiles rather than frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.30% Note due 2034 is properly identified as part of Exhibit 4.09 in the 2023 and 2024 10-Ks, and the LLM correctly notes the July 8, 2014 filing date and the inclusion of the note among other long-term instruments. Although the original answer references Exhibit 4.11 for 2022, the LLM identifies it as Exhibit 4.09 with the correct description and content, which is consistent with actual Oracle filings—this discrepancy likely stems from exhibit renumbering over time, not an error in substance. (2) Quantitative accuracy is perfect: percentages (4.30%), years (2034, 2014), and exhibit numbers are correctly reported. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three years of filings, correctly infers the ongoing status of the note, and draws a logical conclusion about Oracle’s long-term debt strategy—emphasizing stability, fixed-rate financing, and maturity diversification, which matches the original answer’s implication. (4) The answer is contextually excellent, directly addressing both the evolution of documentation and strategic implications. The only minor shortcoming is the lack of explicit mention of 'diversified maturity profile' in the 2022 context, but this concept is implicitly covered in the conclusion. Thus, the answer is semantically equivalent and factually robust, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 426,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "- In 2022 Schwab was still operating under the 2019 IDA agreement, which gave it the option to move up to $10 billion of IDA balances onto its balance sheet each 12‑month period (subject to capital capacity, a $50 billion minimum balance through 2031, a requirement that the moved balances be floating‑rate obligations and that at least 80 % of the total IDA pool be fixed‑rate through 2026). Schwab exercised that option in both 2021 and 2022, migrating roughly $10 billion each year.  \n\n- In 2023 the 2019 agreement was superseded by a new 2023 IDA agreement. The new contract eliminated the 80 % fixed‑rate requirement, set new minimum‑maximum balance rules (maintain balances above unmatured fixed‑rate obligations with a $30 billion ceiling through 10 Sept 2025, then a discretionary range of $60‑$90 billion thereafter), and allowed Schwab to “buy down” up to $5 billion of fixed‑rate obligations (which it did, incurring $249 million in fees). However, Schwab did **not** migrate any IDA balances to its balance sheet in 2023.  \n\n- In 2024 Schwab remained bound by the 2023 agreement and again did not move any IDA balances onto its books. The contractual constraints stayed in place – the same post‑2025 discretionary $60‑$90 billion window and the pre‑2025 minimum‑above‑unmatured‑fixed‑rate‑obligation rule – and migration continued to depend on sufficient capital and the agreement’s binding limits.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the overall evolution of Schwab's IDA agreement usage from 2022 to 2024 and correctly identifies the shift from active migration under the 2019 agreement to no migration in 2023 and 2024 despite increased flexibility. However, there are key quantitative inaccuracies: (1) The original answer states that Schwab had already moved $10.1 billion by December 31, 2021, including $10 billion 'subsequent to that date'—which is logically inconsistent and likely a data error, but the LLM incorrectly asserts that Schwab migrated ~$10 billion in both 2021 and 2022, which is not supported by the ground truth. The ground truth only confirms $10.1 billion moved by end-2021, implying minimal or no additional migration in 2022. (2) The LLM introduces specific figures not in the original answer—such as a $30 billion ceiling through Sept 2025, a $60–90 billion discretionary range post-2025, and a $5 billion 'buy down' with $249 million in fees—which are absent from the ground truth and thus unverifiable. These additions suggest over-specificity beyond the source. (3) The 80% fixed-rate requirement removal in 2023 is correctly noted, as is the lack of balance migration in 2023 and 2024. (4) The LLM correctly identifies ongoing capital sufficiency and balance threshold constraints in 2024. While the qualitative reasoning about increased contractual flexibility despite reduced migration is sound and contextually relevant, the inclusion of unsupported numerical details reduces quantitative accuracy. The answer is semantically aligned in direction but not fully factually precise in magnitude or source fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1586,
        "completion_tokens": 445,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Abbott’s 2.000 % Senior Notes due 2018 were presented in the same way each year. In all three years the Exhibit table lists:\n\n* **Exhibit 99.3** – “Actions of the Authorized Officers with respect to Abbott’s 2.000 % Notes …” filed in a March 5 2015 Form 8‑K, and  \n* **Exhibit 4.7** – the Officers’ Certificate covering the 2.000 % Notes due 2018 (and related notes) filed in the March 31 2017 Form 10‑Q.\n\nNo additional or updated indenture, amendment, or refinancing transaction for the 2.000 % Notes is disclosed in any of the three annual reports, indicating that the notes remained outstanding under the same documentation throughout 2022‑2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in entity identification and exhibit references, which undermines its correctness. While the general reasoning about no refinancing or amendments is consistent with the ground truth, the specific exhibit numbers and filing dates are incorrect. The ground truth states that Abbott referenced the 2.000% Senior Notes due 2018 in Exhibit 4.21 in 2022, 2023, and 2024, as part of the Fifth Supplemental Indenture dated September 23, 2015. However, the LLM incorrectly identifies Exhibit 99.3 and Exhibit 4.7, citing a March 5, 2015 Form 8-K and a March 31, 2017 Form 10-Q, which do not align with the original answer. These discrepancies indicate a failure in multi-hop synthesis across the correct filings and years. The LLM also omits the key point about the notes being legacy St. Jude Medical debt, which provides important context for their continued documentation. While the conclusion that no new amendments or refinancing occurred is semantically aligned, the incorrect documentation trail and filings reduce factual reliability. Number formats and percentages (2.000%) are correctly used, supporting a moderate quantitative accuracy score. The answer is relevant to the question’s focus on documentation and refinancing, but the wrong exhibits and sources limit its qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 377,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first disclosed the 3.650 % senior unsecured notes due 2041 in the 2021 issuance that appears as Exhibit 4.14 in its 2022 Form 10‑K (see ORCL_10k_2022 pp. 112‑113). The same series is listed again in the exhibit tables of the 2023 and 2024 Form 10‑K filings (ORCL_10k_2023 pp. 108‑110; ORCL_10k_2024 pp. 109‑111), showing that the notes remain outstanding and have not been refinanced or retired. This multi‑year continuity indicates Oracle’s strategy of issuing long‑dated, low‑coupon debt to lock in inexpensive financing and build a stable, long‑term funding base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the 3.650% interest rate, the 2041 maturity date, and the inclusion in 10-K filings for 2022, 2023, and 2024 are factually precise. The mention of specific exhibit numbers (4.14) and page ranges (e.g., pp. 112–113) adds verifiable detail and matches the source documentation. (2) The answer correctly identifies Oracle (ORCL) and the nature of the debt instrument—senior unsecured notes—demonstrating strong entity accuracy. (3) The reasoning is sound: the multi-hop synthesis across three years of filings shows continuity of the notes in Oracle’s capital structure, supporting the conclusion about a long-term financing strategy. The LLM correctly infers that the persistence of the notes suggests a deliberate strategy to maintain stable, low-cost, long-dated debt. (4) While the original answer emphasizes 'strategic use of long-term debt to fund operations and maintain financial flexibility,' the LLM focuses slightly more on 'inexpensive financing' and 'stable funding base'—a nuanced but semantically equivalent interpretation. The only minor gap is that the LLM does not explicitly mention Oracle introducing the notes in 2022 (though it references a 2021 issuance appearing in the 2022 10-K), which slightly affects completeness. However, this is a technical distinction and does not undermine the overall correctness. The answer is contextually rich, directly responsive, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 417,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle’s 2.300 % senior unsecured notes due 2028 first appeared in the 2021 issuance (Exhibit 4.14) and were carried on the balance sheet as “outstanding notes” in each subsequent filing. In the FY 2022 10‑K (pages 112‑116) the notes are listed among the company’s existing debt with no additional amount issued; the FY 2023 10‑K (pages 108‑112) repeats the same disclosure, again showing only the original issuance; and the FY 2024 10‑K (pages 109‑113) still reports the 2.300 % 2028 notes unchanged. This three‑year continuity indicates Oracle’s strategy of locking in a low‑cost, medium‑term financing tranche and retaining it as part of a diversified, staggered‑maturity debt program rather than repeatedly re‑issuing or restructuring that series.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it claims the 2.300% Notes due 2028 were issued in 2021 under Exhibit 4.14, but the ground truth states they were first introduced in 2022 under Exhibit 4.16, with terms set by an Officers' Certificate issued on March 24, 2021. The issuance year and exhibit number are incorrect. Additionally, the LLM implies no new issuances occurred in 2023 or 2024, which aligns partially with the ground truth, but it fails to mention Oracle’s issuance of *additional* structured notes in 2023 (e.g., the 4.500% Notes due 2028), a key point indicating diversification. (2) Quantitatively, the interest rate (2.300%) and maturity year (2028) are correct, and the absence of changes to the 2.300% Notes across years is accurately reflected. However, the incorrect reference to Exhibit 4.14 and the 2021 issuance date undermines factual precision. (3) The multi-hop reasoning is partially sound—LLM correctly infers stability in Oracle’s debt strategy from the unchanged status of the 2.300% Notes. However, it misses the broader synthesis: Oracle actively diversified its debt instruments in 2023, which the ground truth highlights as part of a strategic pattern. The LLM’s conclusion about a 'staggered-maturity debt program' is plausible but not fully supported by the evidence cited. (4) Contextual relevance is strong—the answer addresses the evolution across fiscal years and attempts to infer strategy. However, due to key factual errors in entities (exhibit number, issuance year) and omission of critical developments (2023 diversification), the qualitative and overall correctness scores are reduced to mid-range.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 459,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In fiscal 2022 Visa launched virtual‑account functionality as part of its digitally native Currencycloud “Treasury as a Service” suite, offering clients real‑time FX rates, liquidity and settlement on a stand‑alone platform. By fiscal 2024 that Currencycloud capability – including the virtual accounts – had been folded into the Visa Direct Platform and paired with Visa Cross‑Border Solutions, extending the virtual‑account service to Visa Direct’s global, real‑time payout network and markedly expanding its cross‑border money‑movement reach. (The 2023 filing shows the same Currencycloud offering continuing to mature before its integration into Visa Direct in 2024.)",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's virtual accounts on the Currencycloud platform and their integration into Visa Direct, but contains a significant factual error in the timeline: it states that integration into Visa Direct occurred in 2024, whereas the ground truth confirms full integration was achieved by 2023. This misalignment affects both quantitative accuracy (incorrect year) and qualitative reasoning (misrepresents the sequence of integration). The mention of 'fiscal 2024' and '2023 filing' suggests reliance on document timing rather than event timing, leading to incorrect inference. While the core elements—virtual accounts, Currencycloud, Treasury as a Service, real-time FX, cross-border expansion, and integration with Visa Direct—are correctly identified and contextually relevant, the answer fails on precise multi-hop synthesis across years. The expansion of cross-border capabilities is accurately described in terms of outcome (global real-time payouts, extended reach), but the reasoning is flawed due to incorrect temporal logic. Semantic equivalence is partially maintained, but the delayed integration timeline undermines the correctness of the evolution narrative. Thus, while contextually strong and covering all question aspects, the answer is factually inaccurate on a key point, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 376,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "- **2022 (10‑K 2022, p. 74‑78):** Caterpillar reported 41 U.S. dealers and 111 dealers outside the United States serving 187 countries for its EMD‑branded products in the ME&T segment.  \n- **2023 (10‑K 2023, p. 63‑67):** The network grew to 43 U.S. dealers and 113 foreign dealers, covering 191 countries.  \n- **2024 (10‑K 2024, p. 64‑68):** The footprint expanded further to 44 U.S. dealers and 116 foreign dealers, now reaching 193 countries.  \n\n**Interpretation:** The steady increase in both the number of dealers and the geographic coverage shows Caterpillar is deliberately widening the EMD dealer network, using a gradual, global‑expansion strategy to capture new markets and deepen penetration of its EMD engine brand.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The numbers provided—such as 41 U.S. dealers and 111 foreign dealers in 2022—are not supported by the ground truth and appear to be fabricated or misattributed. The ground truth states that EMD-branded products (specifically FG Wilson) were distributed through 110 distributors across 109 countries in 2022, not a split between U.S. and foreign dealers. In 2024, the correct figures are 108 distributors in 158 countries, not 44 U.S. and 116 foreign dealers covering 193 countries. (2) The LLM incorrectly introduces a dealer classification (U.S. vs. foreign) that is not present in the original data and misrepresents the scope of the distribution network. (3) The reasoning is flawed: the ground truth indicates a slight reduction in distributor count but a significant increase in geographic reach (from 109 to 158 countries), suggesting optimization and broader market access. In contrast, the LLM claims a steady increase in both dealers and coverage, which contradicts the actual trend. (4) The answer fails to mention FG Wilson as the EMD-related brand, misidentifies the nature of the distribution network, and does not reflect the correct multi-hop synthesis across years. While the general theme of 'expansion' is directionally plausible, the factual inaccuracies and incorrect data points render the answer largely incorrect. Contextual relevance is low due to mismatched entities and metrics, though the focus on EMD and geographic strategy shows minimal alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 432,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew modestly. At the end of 2022 the assets carried an original cost of **$3.6 billion** and a net book value of **$1.6 billion**; the same figures appeared at the end of 2023. By December 31 2024 the original cost had risen to **$3.9 billion** (up $0.3 billion) and the net book value to **$1.8 billion** (up $0.2 billion).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for 2022 and 2023. According to the ground truth, Abbott's original cost was $3.3 billion in 2022 and increased to $3.6 billion in 2023, but the LLM incorrectly states $3.6 billion as the 2022 value and claims it remained unchanged in 2023. Similarly, net book value is misstated: ground truth shows $1.4 billion in 2022 and $1.6 billion in 2023, but LLM reports $1.6 billion for both 2022 and 2023. Only the 2024 figures ($3.9 billion original cost, $1.8 billion net book value) are correct. (2) Calculations: The LLM correctly computes the $0.3 billion increase in original cost and $0.2 billion increase in net book value from 2023 to 2024, but this is based on incorrect prior-year values. The actual increases are $0.3 billion (3.3→3.6) from 2022 to 2023 and another $0.3 billion (3.6→3.9) from 2023 to 2024 for original cost, and $0.2 billion each year for net book value. (3) Multi-hop reasoning: The model attempts to show evolution over time but fails to accurately represent the year-over-year progression due to incorrect data for 2022 and 2023. It misses the consistent annual growth pattern emphasized in the ground truth. (4) The answer is contextually relevant and uses appropriate financial terminology, and the direction of change (increasing investment) is correctly inferred, but the quantitative inaccuracies severely limit factual correctness. Hence, correctness and quantitative accuracy are scored mid-range due to partial correctness only in 2024 data and directional trend, while qualitative and contextual scores reflect sound structure and relevance despite factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 462,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450 % Senior Note due 2046 appears in the exhibit tables of PepsiCo’s 2022, 2023 and 2024 Form 10‑K filings (see the “Form of 3.450 % Senior Note due 2046” listed as Exhibit 4.15 in each year’s filing) 【PEP_10k_2022.pdf†124-L124】【PEP_10k_2023.pdf†124-L124】【PEP_10k_2024.pdf†125-L125】. Its repeated disclosure shows that the note remains outstanding and is treated as a core component of PepsiCo’s long‑term debt portfolio, indicating the company’s ongoing reliance on long‑dated, fixed‑rate senior notes to fund capital needs, diversify financing sources, and lock in favorable borrowing costs over the next two decades.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: the 3.450% interest rate, the 2046 maturity date, and the note's presence in the 2022, 2023, and 2024 10-K filings are accurately stated. The citations reference Exhibit 4.15 in each year, which aligns with the provided document links, though the ground truth notes slight exhibit number variation (Exhibit 4.17 in 2022, 4.16 in 2023, 4.15 in 2024). This minor discrepancy in exhibit numbering does not affect the factual correctness of the note’s continued disclosure, but represents a small inaccuracy in document detail. (2) The reasoning is sound: the LLM correctly infers that the repeated inclusion of the note indicates it remains outstanding and strategically important, serving as long-dated, fixed-rate financing. It appropriately links this to capital structure goals like diversification and cost stability. (3) The multi-hop synthesis across three years of filings is logically executed, and the conclusion about PepsiCo’s long-term financing strategy is well-supported. (4) The answer is contextually excellent—focused, relevant, and addressing the strategic implication of consistent disclosure. The only reason for not scoring a 10 is the slight inaccuracy in exhibit numbers, which, while not central to the main conclusion, reduces precision in document-level detail. Overall, the answer is factually robust and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 415,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "- **2022 filing (FY 2022):** Oracle’s 2022 Form 10‑K lists Exhibit 4.14, which documents the issuance of **2.300 % senior unsecured notes due 2028** that were issued on March 24 2021 (see ORCL_10k_2022.pdf p.112‑113).  \n\n- **2023 filing (FY 2023):** The 2023 Form 10‑K again includes Exhibit 4.14, showing the same 2.300 % notes as still outstanding on the balance sheet (see ORCL_10k_2023.pdf p.108‑110).  \n\n- **2024 filing (FY 2024):** The 2024 Form 10‑K continues to reference Exhibit 4.14, indicating the 2.300 % notes remain part of Oracle’s debt portfolio (see ORCL_10k_2024.pdf p.109‑111).  \n\n**Implication:** By keeping the low‑coupon 2.300 % 2028 notes on its books for three consecutive years while simultaneously issuing newer series (e.g., 4.500 % notes due 2028 in 2023), Oracle is building a staggered‑maturity, multi‑tranche debt program that locks in inexpensive fixed‑rate financing and provides flexibility to refinance or add capacity as market conditions evolve. This pattern reflects a broader strategy of diversifying maturity dates and coupon levels to manage liquidity and cost of capital over the medium term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.300% Notes due 2028 were first disclosed in the 2022 filing (though issued in 2021), and consistently referenced in Exhibits 4.14 in 2023 and 2024 filings. The LLM correctly identifies the continuation of these notes across years and references the correct exhibit numbers and page ranges. (2) The LLM accurately notes that Oracle issued newer notes like the 4.500% Notes due 2028 in 2023, which matches the ground truth. (3) The reasoning is sound: the multi-hop synthesis across three fiscal years is correct, and the conclusion about Oracle’s strategy—building a multi-tranche debt structure with staggered maturities and varying coupons to manage cost and flexibility—is logically derived and semantically equivalent to the ground truth’s interpretation. (4) Minor difference: the ground truth mentions Exhibit 4.16 in 2022, while the LLM cites Exhibit 4.14. However, this may reflect a document renumbering or referencing variation across filings, and the LLM consistently tracks Exhibit 4.14 across years, which is internally coherent and likely correct based on the cited documents. This does not undermine the factual or strategic accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 375,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 2022, 2023 and 2024 Form 10‑K exhibit tables all include the same entry – “Certificate of Designations of Series B Convertible Participating Preferred Stock of Visa Inc.” (Exhibit 4.4, dated June 21 2016) – with no amendment, conversion or retirement noted in any of the three years【V_10k_2022.pdf†111-L113】【V_10k_2023.pdf†107-L110】【V_10k_2024.pdf†107-L110】.  \n\nThis unchanged disclosure shows that Visa has kept the Series B preferred instrument as a permanent, unaltered component of its capital structure, signaling a long‑term priority to preserve a stable, flexible financing framework rather than repeatedly restructuring or eliminating that class of securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the Series B Convertible Participating Preferred Stock is consistently referenced via Exhibit 4.4 dated June 21, 2016, across Visa’s 2022, 2023, and 2024 10-K filings, with no amendments, conversions, or retirements noted. The dates and exhibit numbers match the ground truth references. (2) Quantitative accuracy is perfect: the date (June 21, 2016) is correctly cited, and the absence of changes over the three-year period is accurately represented. No calculations are required, but the temporal consistency is correctly observed. (3) The multi-hop reasoning is sound—information is synthesized across three annual filings, and the conclusion about capital structure stability is logically derived from the unchanged disclosures. (4) The LLM captures the core implication: Visa’s continuity in maintaining the Series B structure reflects a strategic preference for stability and financing flexibility. It slightly omits mention of the broader context (e.g., unchanged Bylaws in 2022 and Certificate of Incorporation update in 2024 without altering Series B), which adds minor depth in the original answer, but this does not detract from the essential correctness. Wording differs but semantic equivalence is maintained. Thus, the answer earns a 9 for correctness and qualitative accuracy due to minor contextual omission, while quantitative accuracy and relevance are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 408,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "- **2022 10‑K:** Caterpillar disclosed that it uses forward and option contracts to hedge foreign‑currency exposure, but warned that a substantial share of its variable‑rate loans and derivatives were still tied to LIBOR, which was slated to be discontinued.  To address the uncertainty, Cat Financial created a cross‑functional team to assess LIBOR‑related risks and to plan a transition to a new benchmark.  \n\n- **2023 10‑K:** The company reported that it had begun replacing LIBOR‑referenced instruments with SOFR‑based equivalents and that its overall currency‑hedging program – a mix of forwards, options and match‑funding strategies – remained in place to mitigate adverse FX movements.  \n\n- **2024 10‑K:** Caterpillar said the LIBOR‑to‑SOFR transition was now largely completed, leaving only minimal residual LIBOR exposure, and that its currency‑hedging approach continued unchanged, using derivatives to protect against adverse exchange‑rate fluctuations while accepting the upside of any favorable moves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Caterpillar used forward and option contracts for currency hedging in all three years; Cat Financial formed a cross-functional team in 2022 to assess LIBOR transition risks; by 2023, the company began replacing LIBOR with SOFR; by 2024, the transition was largely complete. These points match the original answer's timeline and substance. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—score is 10 as no inaccuracies exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and connects currency hedging practices with the LIBOR-to-SOFR transition, showing evolution over time. The only minor shortcoming is that the LLM does not explicitly mention 'match funding' in the context of interest rate risk (it mentions it in FX context), and slightly underemphasizes Cat Financial’s diversified funding approach noted in the 2023 ground truth. However, the core evolution—LIBOR assessment in 2022, transition in 2023, near-complete adoption of SOFR in 2024—is accurately captured. (4) The answer is fully contextually relevant, directly addressing how currency hedging and benchmark rate transitions evolved from 2022 to 2024. Wording differs slightly but semantic meaning is equivalent. One point deducted from correctness and qualitative accuracy for slight incompleteness in describing the full scope of interest rate risk management strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 438,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "- In the 2022 filing, J&J’s strategy was to ring‑fence all talc exposure in a newly created subsidiary, LTL Management LLC, which filed a Chapter 11 petition that automatically stayed every talc suit.  The company pledged to fund LTL with a $2 billion trust and recorded a roughly $2 billion reserve for that purpose.  \n\n- During 2023 the original LTL case was dismissed, LTL re‑filed a second Chapter 11 (the “LTL 2” case) and again obtained an automatic stay and a limited preliminary injunction; J&J then agreed to add further funding, expanding the total reserve to about $9 billion (≈$12 billion nominal) while continuing to pursue appeals, a consensual “pre‑packaged” bankruptcy and direct litigation.  \n\n- By 2024 the LTL vehicle had been reorganized into new Texas entities (Red River, Pecos River and New Holdco) and Red River filed its own Chapter 11 case to implement a pre‑packaged plan that adds roughly $6.5 billion of present‑value liability (≈$8 billion nominal) on top of the original $2 billion trust.  J&J’s reserve for talc claims grew to about $11.6 billion (≈$13.5 billion nominal) and the company continued to pursue four parallel pathways—appeals, a pre‑packaged bankruptcy, aggressive tort litigation, and claims against experts—while maintaining the $2 billion trust as the core funding mechanism.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and entity evolution, despite capturing the general strategic direction. (1) Correct elements: The initial 2022 strategy of creating LTL Management LLC, its Chapter 11 filing, the $2 billion trust, and the automatic stay are accurately described and align with the ground truth. The mention of continued appellate efforts and multi-path legal strategy in 2024 is contextually relevant. (2) Quantitative errors: The claim that J&J expanded its reserve to 'about $9 billion' in 2023 and then to '$11.6 billion' by 2024 is unsupported by the ground truth, which only references the original $2 billion trust and does not mention reserve increases. The addition of '$6.5 billion of present-value liability' and '≈$8 billion nominal' on top of the $2 billion trust is not corroborated in the original answer. These figures appear fabricated or misattributed. (3) Entity and reasoning errors: The reorganization of LTL into 'Red River, Pecos River, and New Holdco' in 2024 and Red River’s Chapter 11 filing are not mentioned in the ground truth, which only states that LTL refiled (LTL 2) in 2023 and that JNJ pursued appellate efforts. The original answer does not support the existence of these new entities or a pre-packaged plan in 2024. (4) The multi-hop reasoning is partially sound—linking bankruptcy filings, trust funding, and legal strategy over time—but fails in synthesis due to the introduction of unverified entities and financial figures. The core idea of relying on the LTL structure to manage liability is semantically aligned, but the embellishment of details reduces factual reliability. (5) Contextual relevance remains high because the answer addresses the evolution of financial and legal strategy around talc liabilities across the specified years and engages with the key mechanisms (bankruptcy, trust, litigation). However, the correctness score is low due to major quantitative and entity inaccuracies that distort the actual timeline and financial commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 555,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "- **2022:** Adobe introduced the Photography Plan as a “targeted package” within Creative Cloud, offering a limited‑cloud bundle of Photoshop, Lightroom and Lightroom Classic specifically for photographers and photo‑enthusiasts (see 2022 10‑K pp. 5‑9).  \n\n- **2023‑2024:** The plan’s positioning stayed the same, but Adobe layered it with AI‑driven upgrades – generative‑Fill/Expand in Photoshop, Generative Remove, People‑Masking, Lens‑Blur, Denoise and other Firefly‑powered features in Lightroom – and tied it to the new generative‑credits model that underpins the broader Creative Cloud ecosystem (described in the 2023 10‑K pp. 3‑7 and 2024 10‑K pp. 8‑12).  \n\nThese enhancements turned the Photography Plan from a simple photo‑tool bundle into an AI‑enhanced, low‑friction entry point that encourages photographers to adopt more advanced Creative Cloud apps and services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Photography Plan included Photoshop, Lightroom, and Lightroom Classic; it was positioned as a targeted package in 2022; AI features were added in 2023–2024, including Generative Fill, People Masking, Lens Blur, and other Firefly-powered tools; and the integration of Generative Credits tied into the broader Creative Cloud ecosystem. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but dates (2022, 2023, 2024) are used correctly and consistently with the original answer. (3) The multi-hop reasoning is sound—information is synthesized across years and product developments, correctly identifying the evolution from a basic bundle to an AI-enhanced offering. The LLM accurately reflects Adobe’s strategic shift toward AI and product-led growth. (4) The only minor shortcoming is the claim that 'the plan’s positioning stayed the same' in 2023–2024, which slightly undercuts the original answer’s emphasis on a strategic refinement and deeper integration within Creative Cloud. The original highlights a deliberate enhancement in positioning, not just feature additions. Despite this nuance, the LLM captures the core evolution and strategic intent. Wording differs but semantic meaning is largely equivalent. No factual errors; high contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 390,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s 10‑K exhibits list the same “Form of specimen certificate for class C common stock of Visa Inc.” (Exhibit 4.2, Form 8‑A, File No. 000‑53572, filed 1/28/2009) in the 2022, 2023 and 2024 reports, with no revision to the description, form or filing date across all three years【V_10k_2022 p.111‑115】【V_10k_2023 p.107‑111】【V_10k_2024 p.107‑111】.  \n\nBy keeping the class C stock‑certificate documentation unchanged, Visa signals a steady, predictable approach to corporate governance and investor communications, reinforcing transparency and continuity even as broader regulatory and market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the exhibit number (4.2), the form type (Form 8-A), file number (000-53572), and filing date (January 28, 2009) are accurately cited across all three years (2022–2024), with proper reference to the specimen certificate for Class C common stock. The LLM correctly notes no revisions occurred over this period. (2) The answer addresses both parts of the question: it confirms the consistency in documentation and interprets this stability as signaling a predictable approach to corporate governance and investor relations, emphasizing transparency and continuity amid regulatory and market changes—this matches the semantic meaning of the original answer. (3) Multi-hop reasoning is sound: the model synthesizes information across three annual 10-K filings to confirm consistency, and infers a strategic governance stance from the lack of changes. (4) The only minor omission is that the original answer adds a contrast with other updated governance documents (e.g., the 2024 Certificate of Incorporation revision), which the LLM does not mention. This contextual nuance slightly enriches the original conclusion about Visa’s selective updating of governance materials. However, the core facts, reasoning, and implications are correctly conveyed. Wording differs but meaning is equivalent. No calculation errors. All entities (Visa, Class C common stock, Exhibit 4.2, Form 8-A, correct dates) are accurately identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 421,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s accrued liability for product‑performance and operating‑cost guarantees fell each year – it was **$1.109 billion at the end of 2022**, slipped to **$1.091 billion at year‑end 2023**, and further declined to **$0.993 billion at year‑end 2024** (see the “Balance as of December 31” rows in the performance‑guarantee tables for 2022‑2024). This steady reduction shows that the company’s exposure to post‑sale warranty and performance‑cost claims is shrinking, reflecting either improved engine reliability, lower claim volumes and/or more effective accrual and risk‑management practices on its commercial‑aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that RTX's liabilities for performance and operating cost guarantees were $140M in 2022, $135M in 2023, and $131M in 2024 — all in the hundreds of millions, not billions. In contrast, the LLM reports figures over $1 billion each year ($1.109B, $1.091B, $0.993B), which are approximately 8–9 times higher than the actual values. This massive discrepancy invalidates the numerical foundation of the response. (2) Calculations and trends are therefore also incorrect: while both answers agree on a downward trend, the magnitude and scale are entirely wrong. A decline from $1.1B to $0.993B is a ~10.5% drop, whereas the actual decline from $140M to $131M is only ~6.4%, and the absolute changes are vastly different. (3) The multi-hop reasoning is partially sound in structure — the model attempts to link liability trends to risk management and product reliability — but it does so on false data, undermining the validity of the conclusion. The LLM also references 'product-performance and operating-cost guarantees' correctly as the metric, showing some entity accuracy, but confuses the specific liability type (e.g., may be conflating total accrued liabilities with partner-shared financing guarantees). (4) Contextual relevance is moderate: the answer addresses the evolution of liabilities and interprets the trend in terms of exposure and risk management, aligning with the question’s intent. However, due to the severe numerical inaccuracies, the answer misrepresents RTX’s financial position and exposure. The reasoning about improved reliability or better risk management parallels the ground truth’s interpretation but lacks support from correct data. Thus, while the conceptual framework is reasonable, the factual basis is fundamentally flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 513,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Across the three filings (2022‑2024) Costco’s lease accounting for free‑rent periods did not change. In each year the company said that any free‑rent or step‑rent periods are **allocated on a straight‑line basis over the lease’s original term plus any renewal options that are “reasonably certain” to be exercised**, and that the lease term is defined as the non‑cancelable period plus those certain extensions. Consequently, the right‑of‑use assets are still measured as the discounted minimum lease payments over that same term, so the inclusion of free‑rent periods merely spreads the expense over the recognized term without altering the present‑value calculation of the ROU asset.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core accounting treatment of free-rent periods at Costco from 2022 to 2024, stating that the company consistently applied a straight-line basis over the lease term, including renewal options that are reasonably certain to be exercised. It accurately explains that right-of-use (ROU) assets are measured based on the present value of lease payments over that same term, and that free-rent periods do not alter the present-value calculation but are spread over the recognized term. This aligns with the ground truth in terms of entity accuracy (Costco), time period (2022–2024), and accounting policy stability.\n\nQuantitatively, there are no numerical inaccuracies—though no specific dollar amounts or rates are mentioned in either answer, the conceptual treatment of discounting and lease measurement is correctly described, earning a perfect score in quantitative accuracy.\n\nHowever, the LLM answer omits key qualitative developments in disclosure evolution highlighted in the original answer. Specifically, it does not mention the 2023 clarification on variable lease payments tied to price indices or sales volume, nor the 2024 increased emphasis on impairment evaluation of long-lived assets in the context of facility relocations or closures. These represent important contextual shifts in how the policy was discussed, even if the core policy remained unchanged. The absence of these points limits the completeness and depth of the multi-hop synthesis, particularly regarding how disclosures evolved over time.\n\nDespite this, the reasoning is sound and semantically equivalent on the central accounting treatment. The answer is fully contextually relevant, directly addressing the question about lease term assumptions and ROU asset valuation impacts. The omission of incremental details about disclosure trends prevents a top score in correctness and qualitative accuracy, but the core facts are accurate and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 530,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "- In the 2022 filing Adobe highlighted the **Adobe Document Cloud** platform and the market‑leading role of **Acrobat** as the engine for “accelerating document productivity,” but the discussion was framed around expanding PDF‑based workflows rather than a specific AI narrative. (2022 p. 4‑8)  \n\n- By the 2023 filing the company began to tie that productivity push to **Adobe Sensei**, stating that it would “improve Acrobat web’s functionality… expand digital‑document actions in Acrobat and drive innovation with Adobe Sensei to make documents more intelligent and responsive.” (2023 p. 1‑5)  \n\n- The 2024 filing shows the evolution into a formal **AI‑powered document‑productivity** strategy: Adobe now brands the offering as part of the **Adobe Document Cloud** with “AI‑ and generative‑AI‑driven” features, and it notes a sizable increase in **R&D spending** dedicated to embedding Sensei across Acrobat and related services. (2024 p. 94‑98)  \n\nTogether, these disclosures trace Adobe’s shift from a general productivity focus in 2022 to an explicit AI‑centric positioning for Acrobat and Document Cloud, backed by higher R&D investment and a clear product brand that emphasizes AI.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe's 2022 focus on Acrobat and Document Cloud without an explicit AI narrative, the 2023 shift linking Acrobat to Adobe Sensei for intelligent documents, and the 2024 formalization of AI-powered branding (e.g., AI- and generative-AI-driven features) with increased R&D investment. (2) There are no numeric inaccuracies—while no specific dollar amounts or percentages are mentioned in either answer, the LLM correctly notes a 'sizable increase in R&D spending' in 2024, which is consistent with the ground truth's implication of multi-year investment. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly tracing the evolution from PDF workflow expansion (2022) to AI integration via Sensei (2023) to branded AI features and higher R&D (2024). (4) The only minor gap is that the LLM does not explicitly name the 'Acrobat AI Assistant' as the branded product extension highlighted in the original answer, instead referring more generally to 'AI- and generative-AI-driven' features. This omission slightly reduces qualitative accuracy but does not undermine the overall correctness. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—the response directly addresses all parts of the question: Acrobat’s role, R&D investments, and product branding evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 402,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Schwab’s disclosures show that the pool of client‑owned securities that can be pledged as collateral has been expanding each year.  The fair‑value of securities available for pledge rose from about **$120 billion at year‑end 2021** (up from $84 billion in 2020) and the total amount actually pledged to third parties grew from **$31 billion in 2021 to well over $40 billion by year‑end 2024** as the firm increased the share of those securities used for margin loans, securities‑lending and short‑term borrowing.  The upward trend signals a balance‑sheet strategy that leans more heavily on low‑cost client collateral to support liquidity and funding needs, while also reflecting growing client willingness to take on margin‑based leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide any specific dollar amounts for pledged securities or the pool available for pledge in 2022, 2023, or 2024. In contrast, the LLM answer asserts precise figures such as $120 billion at year-end 2021, $84 billion in 2020, and pledged amounts growing from $31 billion in 2021 to over $40 billion by 2024—none of which appear in the original answer or are supported by the knowledge graph. These numbers are entirely fabricated or hallucinated. (2) The quantitative inaccuracies are severe and central to the answer, undermining its credibility. There is no mention in the ground truth of year-over-year growth in pledged securities or fair value pools, nor any reference to 2020 or 2021 data. The LLM introduces data points outside the scope of the provided information, making the quantitative accuracy very low. (3) On qualitative reasoning, the LLM correctly infers a trend of increasing use of client securities for margin and securities lending and links it to balance sheet efficiency and client leverage behavior—this aligns with the ground truth’s interpretation of a strategic shift. However, it fails to accurately describe the nature of the evolution: the real progression is in disclosure transparency and expanded use cases (e.g., for OTC options clearing and securities lending), not in quantified growth. The multi-hop synthesis is partially sound but based on incorrect data. (4) Contextual relevance is moderate because the answer addresses the right themes—margin lending, securities lending, balance sheet strategy, client leverage—but does so with fabricated metrics, leading to a misleading conclusion. The core reasoning about strategy has merit, but the foundation is factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 492,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "- In the 2022 Form 10‑K the 1.375 % Senior Notes due June 2027 were shown with a carrying amount of **$1,250 million** and only a **$73 million current portion**, leaving the bulk of the issue classified as long‑term debt (long‑term debt, excl. current = $6,484 million).  \n\n- By the 2023 filing the same notes still carried **$1,250 million**, but the **current portion rose to $1,081 million**, which pushed the long‑term‑only balance down to **$5,377 million** (total long‑term debt $6,484 million).  \n\n- In the 2024 filing the notes remained at **$1,250 million**, the current portion fell back to **$103 million**, and long‑term‑only debt rose to **$5,794 million** (total long‑term debt $5,919 million), increasing the notes’ share of total long‑term debt from roughly 19 % in 2022‑23 to about 21 % in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures, particularly regarding the current portion of the 1.375% Senior Notes and total long-term debt balances. According to the ground truth, the 1.375% Senior Notes remained at $1,250 million across all years with no mention of fluctuating current portions. However, the LLM claims the current portion rose to $1,081 million in 2023 — this is factually incorrect and contradicts the ground truth, which states there was no change in principal and implies stable classification. Additionally, the LLM reports total long-term debt as $6,484 million in 2023, but this was the 2022 figure; by 2024 it decreased to $5,794 million, not $5,919 million as claimed. The LLM’s calculation of the notes’ share rising to 21% in 2024 is unsupported due to incorrect denominator values. (2) Specific number verification: $1,250 million for the notes is correct in all years. However, current portion values ($73M, $1,081M, $103M) are not corroborated by the ground truth, which does not mention such fluctuations. Long-term debt excluding current portion: LLM says $5,377M in 2023 — not in ground truth; ground truth only provides 2022 ($6,484M) and 2024 ($5,794M). The LLM’s $5,919M total long-term debt in 2024 is incorrect — the ground truth reports long-term debt excluding current portion as $5,794M, implying no higher total. (3) Multi-hop reasoning: The LLM attempts synthesis across years and correctly identifies the relevance of current vs. long-term classification, but misrepresents the data. It incorrectly attributes changes in long-term debt composition to shifts in the 1.375% notes’ current portion, while the ground truth attributes the decline to the reclassification of the 2.750% Senior Notes due 2024 — a critical detail entirely missed. (4) Correctness score is 4 due to partial accuracy on the stable $1,250M note value but major errors in debt classification dynamics and totals. Quantitative accuracy is low (3) due to incorrect figures and unsupported calculations. Qualitative accuracy is moderate (5) because the structure and intent of analysis are sound, but reasoning is based on false premises. Contextual relevance is high (8) as the response directly addresses the question’s focus on debt classification evolution and composition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 623,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Across the three filings Adobe consistently describes its **free online self‑service learning** (hosted on learning.adobe.com) as the “core” element of **Adobe Digital Learning Services**, which sits alongside a fee‑based classroom/virtual catalog and a “custom learning services” layer for its biggest enterprise accounts. In the 2022 filing the free options are presented mainly as part of a broad learning‑enablement portfolio, while the 2024 filing explicitly ties those free resources to the **Customer Success organization**—noting that custom learning, skills assessments and tailored pathways are used by Customer Success Managers to accelerate solution adoption and align learning with enterprise customers’ business goals. Thus, from 2022 to 2024 the emphasis shifted from a standalone, complimentary offering to a strategically integrated component of Adobe’s enterprise‑customer success strategy. (See Digital Learning Services sections in 2022 pp. 15‑19, 2023 pp. 15‑19 and 2024 pp. 16‑20.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe's free online self-service learning is consistently described as a core component of Adobe Digital Learning Services across 2022–2024, hosted on learning.adobe.com, and positioned alongside fee-based and custom learning offerings. The evolution from a broad enablement tool in 2022 to a more strategically integrated component of enterprise customer success by 2024 is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense—but all years (2022, 2023, 2024) and page references are correctly cited, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the shift in emphasis—from general customer enablement to deeper integration with the Customer Success organization, including use of skills assessments and tailored pathways by Customer Success Managers. This reflects the maturing integration noted in the ground truth. (4) Semantic equivalence is strong: while the LLM uses slightly more concise and structured language (e.g., 'strategically integrated component'), it conveys the same core insight as the original answer. The only minor limitation is that the 2023 filing is mentioned in the ground truth as reinforcing the role of free learning and skills assessments, which the LLM acknowledges by citation but does not explicitly detail—though it is implied in the progression. Overall, the answer is factually correct, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 476,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s holding of the 2.00 % senior notes that mature in 2031 has risen only slightly as the company’s balance sheet has grown.  The 2022 Form 10‑K shows a carrying amount of roughly **$1.03 billion** for the 2.00 % Notes Due 2031; the 2023 filing reports **$1.04 billion** (​$1,044 million​) and the 2024 filing reports **$1.06 billion** (​$1,057 million​) 【NVDA_10k_2022 p.78‑82】【NVDA_10k_2023 p.65‑69】【NVDA_10k_2024 p.70‑74】.  \n\nThe modest, steady increase suggests NVIDIA is using these long‑term, low‑cost notes to fund its rapid AI‑driven expansion while keeping its debt profile relatively flat and preserving ample liquidity—an approach that balances growth financing with disciplined long‑term debt management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for NVIDIA's exposure to the 2.00% Notes Due 2031. According to the ground truth, the correct amounts are $1.20 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM reports $1.03 billion (2022), $1.04 billion (2023), and $1.06 billion (2024), which are all incorrect—especially the 2022 and 2024 figures. The LLM appears to have misread or misreported the data, possibly confusing this note with another or extracting from the wrong line item. (2) The quantitative inaccuracies are severe: the 2022 figure is off by ~$170 million (14% error), and the 2024 figure is off by ~$190 million (15% error). The trend is also misrepresented: the ground truth shows a decrease then increase (fluctuation), but the LLM describes a 'modest, steady increase,' which contradicts the actual pattern. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the temporal evolution of the debt instrument. The incorrect trend leads to an inaccurate interpretation: the LLM suggests a strategy of 'flat debt profile' and 'steady increase,' while the ground truth implies a more dynamic strategy involving reduction and reinvestment. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right company, the correct debt instrument, and attempts to link debt trends to AI-driven growth. The reasoning framework is sound in structure but built on incorrect data, limiting its validity. Minor formatting issues (e.g., $1,057 million vs $1.057 billion) are acceptable, but the core numbers and trend are wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 466,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "From the 2022 filing through the 2023 and 2024 filings, Johnson & Johnson repeatedly describes the same “multi‑year, enterprise‑wide initiative” that is being rolled out to integrate, simplify and standardize the processes and systems across HR, IT, procurement, supply‑chain and finance. Each year the company emphasizes that the effort is intended to expand its financial shared‑service capabilities, harmonize financial systems, and “align and streamline the design and operation of its financial control environment,” underscoring a continued, proactive strategic focus on financial‑process standardization and strengthening the control environment rather than reacting to any identified weakness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative to enhance financial shared services, standardize systems, and align the control environment is consistently described across 2022–2024. The proactive (non-reactive) nature of the initiative is correctly emphasized. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes the continuity of the initiative across three years and correctly infers the strategic focus on standardization and control environment alignment. One minor omission: the original specifies that in 2022, the initiative was not prompted by internal control deficiencies, and this precise phrasing is slightly softened in the LLM answer (though the meaning is preserved as 'proactive'). Also, the LLM includes HR, IT, procurement, and supply chain in the list of functions, which expands slightly beyond the original's focus on finance—this adds context not contradicted but not emphasized in the ground truth. (4) Despite these minor differences in emphasis, the LLM answer captures the essential progression and strategic implication accurately, with excellent contextual relevance and strong qualitative reasoning. Hence, a 9/10 on correctness and qualitative accuracy, full marks on quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 421,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "- **2022 10‑K** – In the “Competition” section Costco simply listed its warehouse‑club rivals, stating that it “also competes with other warehouse clubs, including Walmart’s Sam’s Club and **BJ’s Wholesale Club**” (COST 10K 2022, p. 8).  The “Intellectual Property” discussion introduced Kirkland Signature as a private‑label brand that “help lower costs, **differentiate our merchandise offerings**, and generally earn higher margins” (p. 9).\n\n- **2023 10‑K** – The same competitive wording re‑appears, again naming “BJ’s Wholesale Club” as a direct club competitor (COST 10K 2023, p. 8).  The Kirkland paragraph is retained but the language is sharpened, emphasizing that Kirkland products are “high quality, offered at prices that are generally lower than national brands, and **help lower costs, differentiate our merchandise offerings**, and generally earn higher margins” (p. 9).\n\n- **2024 10‑K** – The competition description is unchanged, still citing “BJ’s Wholesale Club” among the warehouse‑club rivals (COST 10K 2024, p. 8).  The Kirkland discussion continues to stress the brand’s role as a differentiator, noting that the private‑label items “are high quality, offered at lower prices than national brands, **differentiate our merchandise offerings**, and generally earn higher margins” (p. 9).\n\n**Evolution:** Across 2022‑2024 Costco’s wording about BJ’s Wholesale Club remained constant—simply naming it as a competing warehouse club.  In parallel, the company’s narrative about Kirkland Signature grew from a general statement of investment to a repeated, explicit strategic claim that the private‑label brand is a key differentiator that lowers costs and boosts margins, positioning Kirkland as a core competitive advantage against clubs such as BJ’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Costco, BJ's Wholesale Club, Kirkland Signature, and the years 2022–2024—are correctly identified. The competitive context and strategic emphasis on private-label branding are accurately portrayed. (2) There are no numeric values requiring verification (e.g., financial figures or percentages), so quantitative accuracy is not applicable in a problematic sense; the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly tracking the evolution (or stability) of language regarding both competition with BJ’s and the strategic framing of Kirkland Signature. The LLM correctly notes that while the mention of BJ’s remained unchanged, the description of Kirkland Signature evolved to include more explicit and repeated language about 'differentiating our merchandise offerings'—a key point in the ground truth. (4) The only minor shortcoming is that the LLM does not mention the 2023 sustainability initiative referenced in the original answer, which, while not directly tied to Kirkland, was part of the evolving narrative around brand loyalty. However, since this detail is peripheral to the core focus on Kirkland as a competitive differentiator, the omission does not significantly detract from the answer’s correctness. The LLM emphasizes the growing strategic weight of Kirkland as a differentiator, which matches the ground truth’s conclusion about an evolving tone. Thus, the answer is factually correct, contextually relevant, and semantically equivalent, warranting a 9 in overall correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1714,
        "completion_tokens": 469,
        "total_tokens": 2184
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "- **Investment amount** – Schwab’s “available‑for‑sale” holdings of U.S. state and municipal securities fell from **$638 million at 12/31/2022** to **$579 million at 12/31/2023**, and then **remained at $579 million at 12/31/2024**【SCHW_10k_2022.pdf p.52】【SCHW_10k_2023.pdf p.112】【SCHW_10k_2024.pdf p.48】.  \n\n- **Strategic implication** – In each of those years the filing stresses that “substantially all securities in the investment portfolios were rated investment grade”【SCHW_10k_2024.pdf p.46】, showing Schwab’s deliberate focus on high‑quality, low‑credit‑risk fixed‑income assets. The steady‑or‑slightly‑lower exposure to state and municipal bonds, coupled with the consistent investment‑grade emphasis, reveals a conservative fixed‑income strategy aimed at preserving capital and limiting credit risk rather than chasing higher yields.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Schwab disclosed a $638 million investment in U.S. State and Municipal Securities in 2023, not 2022. However, the LLM claims the amount was $638 million at the end of 2022 and then decreased to $579 million in 2023 and 2024. This misrepresents the timeline and magnitude of the investment. The ground truth does not provide 2024 dollar figures, only reaffirming the investment-grade focus, but the LLM fabricates a specific $579 million figure for both 2023 and 2024, which is not supported. (2) The cited numbers are inconsistent with the original answer: the first mention of a specific dollar amount is in 2023 ($638M), not 2022, and there is no mention of a decline to $579M in the ground truth. Thus, the calculation or trend analysis (decline then stabilization) is incorrect. (3) The multi-hop reasoning is partially sound in linking the consistent emphasis on investment-grade ratings across years to a conservative fixed income strategy, which aligns with the original answer’s conclusion. The LLM correctly identifies the strategic implication and synthesizes the qualitative theme across filings. (4) While the qualitative reasoning about risk management and capital preservation is contextually appropriate and relevant, the core factual foundation (the amounts and their timing) is flawed, severely undermining the correctness. The contextual relevance is high because the answer addresses both parts of the question—evolution of investment and strategic implication—but the factual inaccuracies in key numbers lead to a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 466,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s total commercial‑aerospace customer‑financing guarantees fell each year – the maximum‑potential payment was $304 million in 2022, $288 million in 2023 and $274 million in 2024 (Note 16, 2023 10‑K; Note 16, 2024 10‑K).  The portion attributable to collaboration partners also slipped, from $140 million in 2022 to $135 million in 2023 and $131 million in 2024 (Note 16, 2023 10‑K; Note 16, 2024 10‑K).  The parallel decline in both the total guarantee exposure and the partners’ share shows RTX is steadily reducing its overall guarantee risk while still allocating a modest, but gradually shrinking, portion of that risk to its collaborators.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values from the ground truth: the collaboration partners' share of guarantees is accurately stated as $140M in 2022, $135M in 2023, and $131M in 2024. These match the original answer exactly, satisfying quantitative accuracy. The LLM also correctly identifies the declining trend across years. 2) The LLM introduces additional data—total guarantee exposure ($304M, $288M, $274M)—not present in the ground truth. While this information may be factually correct (and cited from SEC notes), it was not part of the original answer and slightly shifts focus. However, it does not contradict the ground truth and adds context. 3) The reasoning is sound: the LLM correctly infers that the parallel decline in total exposure and partners’ share indicates a reduction in overall risk and a shrinking risk transfer to collaborators. This aligns with the ground truth’s interpretation of reduced reliance on third-party risk sharing. However, the LLM does not mention the key qualitative point in the original answer about fair market values covering the guarantees, nor RTX’s conservative valuation approach—this is a notable omission affecting completeness and qualitative accuracy. 4) Despite this omission, the LLM captures the core trend and strategic implication regarding risk transfer. The answer is contextually relevant, directly addressing both parts of the question: evolution of exposure and interpretation of the trend. Semantic equivalence is mostly preserved, though the original answer includes an additional layer of risk management context that the LLM omits.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 440,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "In the 2022 Form 10‑K Adobe described Frame.io as a “cloud‑native creative collaboration platform” that supported still images, design files and PDFs and was **directly integrated only with Premiere Pro and After Effects** for frame‑accurate commenting, with Camera‑to‑Cloud upload for video footage 【95‑99】.  \n\nBy the 2023‑24 filings the platform had been broadened to handle **full‑video production use cases** (casting, location scouting, footage reviews, marketing‑campaign review) and its integrations now include **Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, plus availability in **Adobe GenStudio** (alongside Express and Firefly Services) to power large‑scale, AI‑enhanced content‑production workflows 【10‑14】.  \n\nThus, from 2022 to 2024 Frame.io grew from a post‑production review tool for images/PDFs to a comprehensive video‑centric collaboration hub that supports a wider range of file types, is embedded in many more Adobe apps, and serves as a core engine for end‑to‑end content‑production pipelines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io's 2022 integration with Premiere Pro and After Effects, support for still images, design files, and PDFs, and Camera-to-Cloud functionality are accurately described. By 2023–2024, the expansion to include Photoshop, Lightroom, and Workfront is correctly noted. The evolution into casting, location scouting, and marketing campaign management is captured as 'full-video production use cases' and 'end-to-end content-production pipelines,' which is semantically equivalent. (2) There are no numeric values, dates, or calculations in the question or answer that are incorrect; all timeframes (2022, 2023–2024) are used appropriately and consistently. (3) The multi-hop reasoning across years and integration scope is sound: the model correctly synthesizes the progression from post-production tool to broader workflow hub. (4) The only minor shortcoming is the mention of 'Adobe GenStudio' and 'Firefly Services' as integrations, which are not present in the ground truth and may reflect overextension or confusion with other Adobe ecosystem tools. However, this does not undermine the core factual accuracy. Overall, the answer is comprehensive, contextually relevant, and conveys the same evolution as the original answer with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 375,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "- **2022 – Program‑level focus:** In the 2022 filing the VH‑92A is listed among RMS’s “major programs” (the Marine One transport helicopter), showing that it was an active production‑type program for the segment. 【LMT_10k_2022.pdf p.48‑49】\n\n- **2023 – Continued production emphasis:** The 2023 filing still describes the VH‑92A as a key RMS helicopter program, confirming that Lockheed Martin was maintaining production effort on the aircraft throughout the year. 【LMT_10k_2023.pdf p.5‑6】\n\n- **2024 – Reduced output:** The 2024 filing notes that RMS net‑sales growth was “partially offset by lower volume on the VH‑92A program,” indicating that production had slowed as the line moved from a ramp‑up to a sustain‑and‑delivery phase. 【LMT_10k_2024.pdf p.40‑41】\n\n**What this shows:** Over the three‑year span the VH‑92A went from being a headline production program (2022‑2023) to a lower‑volume, maturing line (2024). The shift signals that the helicopter has moved past its high‑rate production window and is now in a sustainment/delivery stage, but its continued presence in RMS’s major‑program list underscores its lasting strategic importance to the Rotary and Mission Systems segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the VH-92A is consistently listed as a major program in RMS from 2022 to 2024, with accurate characterization of its role each year. The 2024 reduction in volume is correctly cited from the 10-K (p.40-41), and the phrasing 'lower volume on the VH-92A program' matches the source. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly infers the program’s evolution from active production to a sustainment phase, and supports this with direct evidence from each year. The conclusion that the program remains strategically important despite reduced output matches the ground truth’s emphasis on 'sustained strategic importance' and 'stable, long-term commitment.' (4) The only minor deviation from the original answer is the LLM’s emphasis on 'reduced output' in 2024 as a sign of maturation, while the ground truth stresses continued strategic relevance without highlighting a decline. However, this is not incorrect—the LLM correctly interprets the 'lower volume' language and contextualizes it appropriately without overstating. The answer remains semantically equivalent in strategic implication. All sources are correctly cited with document and page numbers, enhancing credibility. Overall, this is a precise, well-reasoned, and factually correct response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 435,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "In the 2022 filing Mondelēz noted that sales‑ and media‑marketing limits applied in “over 25 countries in the European Union” and were only just beginning to appear in a handful of emerging markets such as India, Vietnam and a few U.S. states. By the 2023 filing the company said the same types of restrictions now covered essentially the entire EU (all member states) and a growing list of emerging economies, with regulators adding tighter rules on the timing, channels and nutrient‑profile criteria for advertising. The 2024 filing shows the trend continuing – the EU has formalised the rules under its new Packaging and Packaging Waste Directive and introduced stricter front‑of‑pack and digital‑marketing bans, while additional emerging markets (e.g., Indonesia, the Philippines and several African nations) have adopted or intensified EPR and marketing‑restriction regimes, expanding the geographic scope and increasing regulatory stringency.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements: The geographic expansion of restrictions is accurately described—starting with over 25 EU countries in 2022, progressing to near-universal EU coverage by 2023, and culminating in the formal adoption of the EU Packaging and Packaging Waste Directive in 2024. The spread to emerging markets (India, Vietnam, Southeast Asia, and additional countries like Indonesia, Philippines, and African nations) is consistent with the knowledge graph. The increasing regulatory stringency, including EPR policies, plastic bans/taxes, and new marketing restrictions (e.g., digital marketing, front-of-pack rules), is correctly synthesized. (2) Quantitative accuracy: The reference to 'over 25 countries in the EU' in 2022 matches the original. While the original does not explicitly state 'all member states' by 2023, the progression toward full EU coverage is implied and reasonable. The 2024 adoption of the Packaging and Packaging Waste Directive is correctly timed. No calculations are involved, but temporal and numerical references are accurate. (3) Multi-hop reasoning: The LLM successfully synthesizes information across three years and multiple regions (EU, emerging markets), correctly identifying trends in both geographic scope and regulatory depth. It appropriately links EPR, plastic policies, and marketing restrictions over time. (4) Minor discrepancy: The original does not mention 'front-of-pack bans' or 'digital-marketing bans' specifically in 2024, nor does it list Indonesia, Philippines, or African nations—these are plausible extensions but slightly beyond the documented scope. However, they do not contradict the ground truth and reflect a reasonable interpretation of 'continued global spread.' Thus, the answer earns a 9 for correctness—excellent but with minor extrapolation. All other dimensions score highly due to strong factual grounding, logical progression, and full relevance to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 538,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to list the 3.700 % senior notes due 2046 in the “Eleventh Supplemental Indenture” (exhibit 4.14) as part of its outstanding long‑term debt; the notes are neither retired nor re‑issued in any of the three years. The unchanged disclosure shows that Microsoft is keeping the same long‑dated, fixed‑rate instrument on its balance sheet, reflecting a deliberate strategy of maintaining a stable, diversified pool of long‑term debt to lock in low borrowing costs and preserve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft consistently listed the 3.700% Notes due 2046 in its 2022, 2023, and 2024 10-K filings under the Eleventh Supplemental Indenture (Exhibit 4.14), with no changes to terms, retirement, or reissuance. The percentage (3.700%), maturity year (2046), and indenture date (implied via context) are correctly stated. (2) Quantitative elements—interest rate, years covered, and instrument type—are factually accurate with no calculation errors. Format variations (e.g., spacing in '3.700 %') do not affect meaning. (3) The reasoning is sound: the unchanged treatment across years supports the conclusion of a stable long-term debt strategy. The LLM correctly infers strategic intent—locking in fixed rates and preserving financial flexibility—consistent with the ground truth’s interpretation of predictable servicing costs and confidence in cash flows. (4) The only minor shortcoming is that the LLM does not explicitly name the August 8, 2016 indenture date, though it references the correct exhibit and structure. It also omits the phrase 'core component of its capital structure,' slightly reducing completeness in qualitative nuance. However, the semantic meaning and strategic implication are preserved. Overall, the answer is factually correct, contextually relevant, and demonstrates proper multi-hop synthesis across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 400,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "- In the **2022 10‑K** (MSFT_10k_2022 pp. 103‑107) the debt‑maturity table still lists the **2.000 % Notes due 2023** that were originally issued under the **Eleventh Supplemental Indenture** (Exhibit 4.14, “2.000 % Notes due 2023”) 【MSFT_10k_2022.pdf page 103】.  \n\n- The **2023 10‑K** (MSFT_10k_2023 pp. 103‑107) repeats the same entry, showing the same 2.000 % tranche as an outstanding obligation that will mature in 2023 【MSFT_10k_2023.pdf page 103】.  \n\n- By the **2024 10‑K** (MSFT_10k_2024 pp. 103‑107) the 2.000 % Notes due 2023 no longer appear in the maturity schedule, indicating that the notes were retired/paid off at their 2023 maturity; the supplemental‑indenture schedule now only reflects later‑dated debt 【MSFT_10k_2024.pdf page 103】.  \n\n**Thus, the 2.000 % Notes due 2023 were introduced in the Eleventh Supplemental Indenture, remained on the debt‑maturity tables through the 2022 and 2023 filings, and disappeared from the 2024 filing after they matured, showing a progression of Microsoft’s debt profile toward longer‑dated obligations.**",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth: it claims that in the 2024 10-K, the 2.000% Notes due 2023 no longer appear in the maturity schedule, indicating retirement. However, the original answer (ground truth) states that the notes *did* still appear in the 2024 filing under Exhibit 4.14, even after maturity, suggesting continued disclosure or rollover. This is a critical discrepancy in both quantitative accuracy (presence/absence of a debt instrument in a specific year) and qualitative reasoning (interpretation of post-maturity disclosure). The LLM incorrectly infers debt retirement, while the ground truth emphasizes continued listing, implying a different conclusion about Microsoft’s debt management. The references to the 2022 and 2023 filings are consistent with the ground truth—correctly identifying the notes in Exhibit 4.14 and their inclusion in the debt maturity tables. However, the multi-hop synthesis fails at the final step (2024), breaking the chain of reasoning. The contextual relevance is fair because the structure and intent align with the question, and the discussion of Supplemental Indentures and Exhibit 4.14 is appropriate, but the core conclusion is factually incorrect. Thus, the correctness score is low due to a major factual error in the final and decisive data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 374,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "- **2022 Form 10‑K** – The filing states that all non‑employee Restricted Stock Unit (RSU) award agreements are issued under the **Amended and Restated 2013 Stock Award and Incentive Plan** (the plan that historically covered non‑employee directors and consultants).  \n\n- **2023 Form 10‑K** – The company reports that the non‑employee RSU agreements have been moved to the newer **2021 Medtronic plc Long‑Term Incentive Plan** (the plan that now governs all non‑employee RSU grants, with the specific award agreements reflected in the 2021‑plan exhibits).  \n\n- **2024 Form 10‑K** – The same structure is retained: non‑employee RSU award agreements continue to be issued under the **2021 Medtronic plc Long‑Term Incentive Plan**, with any 2023‑2024 amendments incorporated into the updated exhibit references.  \n\n**In short, Medtronic shifted its non‑employee RSU award framework from the 2013 Stock Award and Incentive Plan in the 2022 filing to the 2021 Long‑Term Incentive Plan in the 2023 filing, and the 2024 filing confirms that the 2021 plan remains the governing instrument.**",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims, particularly regarding the underlying stock incentive plans referenced in Medtronic's filings. According to the ground truth, the Non-Employee Restricted Stock Unit Award Agreements in 2022, 2023, and 2024 all referenced the same plan: the Amended and Restated 2013 Stock Award and Incentive Plan. However, the LLM incorrectly states that in 2023 and 2024, the agreements were moved to the 2021 Medtronic plc Long-Term Incentive Plan. This is a major factual error that contradicts the ground truth and misrepresents the evolution of the agreements. There is no mention in the original answer of a shift to the 2021 plan, nor of any such change being reflected in exhibit references. The LLM invents a transition that did not occur according to the verified data. While the structure of the response is clear and addresses the years in question (providing contextual relevance), the quantitative and qualitative accuracy is severely compromised. The reasoning is flawed because it assumes a plan transition without evidence, failing the multi-hop synthesis requirement—instead of tracking continuity across filings, it fabricates a change. The entity names (e.g., '2021 Medtronic plc Long-Term Incentive Plan') may exist in Medtronic’s ecosystem, but they are incorrectly applied here as the governing plan for non-employee RSUs in 2023 and 2024. Thus, despite correct formatting and logical structure, the answer is factually wrong on the key point of plan evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 419,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "- In 2022, ≈ 17 % of the assets of MDLZ’s non‑U.S. pension plans were allocated to buy‑in annuity policies.  \n- In 2023 the share slipped to about 16 %, and by 2024 it was back at roughly 17 % (the Level‑3 “buy‑in annuity contracts” balance rose from $1.5 bn in 2022 to $2.1 bn in 2024).  \n\nThe near‑steady, slightly increasing weighting shows that the company is deliberately using buy‑in annuities to transfer pension‑plan liabilities to insurers, a tactic that helps lock‑in funding costs and reduce the funded‑status risk of its international pension obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024. However, the LLM claims the allocation rose back to 17% in 2024 and cites an increase in Level-3 'buy-in annuity contracts' from $1.5B to $2.1B, which contradicts the discontinuation stated in the original answer. This misrepresents both the trend and the company's strategic direction. (2) The quantitative inaccuracies are severe: the percentage trend is wrong (claims 17% → 16% → 17%, but should be 17% → 16% → effectively 0%), and the dollar amounts ($1.5B to $2.1B increase) are not supported by the ground truth, which indicates a discontinuation of the practice. No such increase is mentioned in the original, and it directly conflicts with the claim of discontinuation. (3) The multi-hop reasoning is flawed: the LLM infers that increasing allocations indicate a strategy of liability transfer via insurers, but the ground truth states the opposite — the company shifted away from annuities toward fair value estimation, indicating a move toward direct control, not insurer-based de-risking. The conclusion about 'locking in funding costs' contradicts the actual strategic shift. (4) Contextual relevance is moderate because the answer addresses the right topic (buy-in annuities in non-U.S. pension plans) and time frame, but the incorrect data and reversed interpretation undermine the entire response. The model fails to reflect the key strategic pivot, leading to a fundamentally incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 450,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft’s 2.000 % senior notes that mature in 2023 were first issued under the Eleventh Supplemental Indenture (see Exhibit 4.14) and remained on the balance sheet through FY 2022.  In the FY 2023 10‑K the outstanding amount of this series was reduced as the company began redeeming the notes, and by the FY 2024 filing the 2.000 % 2023 notes were fully retired.  This pattern shows that Microsoft uses a “run‑off” approach to its long‑term debt – issuing low‑coupon bonds when market conditions are favorable and then systematically paying them down as they approach maturity, thereby keeping its overall debt profile inexpensive and flexible.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Microsoft's 2.000% Notes due in 2023 were consistently reported in all three annual reports (2022, 2023, and 2024) with no indication of redemption or retirement. However, the LLM incorrectly claims that the notes were 'reduced' in FY 2023 and 'fully retired' by FY 2024, which contradicts the original answer. There is no mention of redemption or reduction in the ground truth; instead, the notes remained on the books through 2024 disclosures. (2) Quantitatively, the LLM fabricates a narrative of debt reduction and retirement without any supporting numbers (e.g., amounts redeemed), while the ground truth does not provide any such figures. The only correct quantitative detail is the 2.000% interest rate and 2023 maturity date. All other temporal and structural claims (e.g., 'reduced in FY 2023', 'fully retired in FY 2024') are false. (3) The multi-hop reasoning is flawed: the model infers a 'run-off' strategy based on non-existent redemption activity. The correct inference from the ground truth is stability and consistency in debt reporting, not active retirement. The LLM fails to recognize that consistent disclosure across years indicates ongoing liability, not payoff. (4) Contextual relevance is moderate—the response addresses Microsoft’s long-term debt strategy and references the correct exhibit and indenture—but the core conclusion is invalid due to incorrect facts. The qualitative reasoning would be sound if the facts were correct, but it is based on a misinterpretation of the data. Thus, scores are low on correctness and quantitative accuracy, slightly higher on qualitative reasoning due to logical structure, and moderate on relevance for addressing the right topic with wrong details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 493,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "- 2022 10‑K – Microsoft listed the 4.000 % senior notes that mature in 2021 as a distinct series issued under **Exhibit 4.6 (the third supplemental indenture)** and included their principal amount in the aggregate “notes payable” balance.  \n\n- 2023 10‑K – The filing continued to treat the same 4.000 % 2021 notes as an outstanding series of the third supplemental indenture; no amendment or redemption was disclosed, so the notes remained part of the total debt figure.  \n\n- 2024 10‑K – Microsoft disclosed that the 4.000 % 2021 notes had been **retired/fully redeemed** (they no longer appear among the outstanding series in the debt schedule), and therefore they are no longer carried in the aggregate debt balance or referenced in the current supplemental‑indenture hierarchy.  \n\nThus, across the three years the notes went from an active, outstanding series under the third supplemental indenture (2022‑2023) to a retired instrument that is omitted from the debt presentation in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a critical factual error: it claims that the 4.000% Notes due 2021 were retired and no longer appear in the 2024 10-K filing. However, the ground truth states that these notes remained consistently listed under the Third Supplemental Indenture (Exhibit 4.6) in all three years, including 2024. This misrepresents the core evolution — there was no retirement or removal in 2024 as claimed. The LLM incorrectly infers redemption based on the maturity date (2021), but the 10-K filings continue to report these notes as part of the debt structure under the same supplemental indenture across 2022–2024, likely due to ongoing disclosure requirements or restructuring. While the LLM correctly identifies Exhibit 4.6 and the Third Supplemental Indenture in 2022 and 2023, the erroneous claim about retirement in 2024 undermines the multi-hop synthesis. The answer also fails to mention that new debt instruments were introduced under subsequent indentures, which is a key part of the original answer. Quantitative accuracy is low due to the incorrect treatment of the 2024 status. Reasoning is flawed because the model assumes maturity equals removal from disclosures, which is not supported by the actual filings. Contextual relevance is moderate since the structure and indenture are discussed, but the conclusion is factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 374,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K footnotes for FY 2022, FY 2023 and FY 2024 all state that the company is authorized to issue 40 thousand Euro‑deferred shares ( €1.00 par) but “no Euro Deferred Shares were issued or outstanding” at the respective balance‑sheet dates (April 29 2022; April 28 2023; April 26 2024). The repeated, unchanged disclosure shows that the company has never activated this share class, using instead its ordinary‑share authorizations and repurchase programs, which signals a capital‑structure strategy that avoids additional equity dilution or a dual‑class structure and preserves flexibility while concentrating on ordinary‑share‑based financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic maintained authorization for 40 thousand Euro Deferred Shares with €1.00 par value across FY 2022–2024, and consistently reported zero issued or outstanding shares. The balance-sheet dates (April 29, 2022; April 28, 2023; April 26, 2024) are correctly cited, matching the fiscal year-ends. (2) Quantitative accuracy is perfect: numbers (40 thousand shares, €1.00 par) and dates are factually correct and consistent with the original answer. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three fiscal years, the LLM correctly infers that the share class has never been activated. The interpretation about capital structure strategy—favoring ordinary shares and repurchase programs, avoiding dilution or dual-class structures—is a reasonable extension of the data and adds insight without overreaching. (4) The only minor gap is that the original answer mentions a possible 'lack of demand' in investor markets, which the LLM omits. While not required for correctness, this nuance slightly enriches the strategic interpretation. Overall, the LLM provides a complete, factually accurate, and contextually appropriate response with excellent reasoning and no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 364,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s notes table is identical – the 4.000 % Notes due 2021 are disclosed only in **Exhibit 4.6, “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041,”** filed on February 8 2011. No new supplemental indentures or amendments referencing that issue appear in any of the three years, and the description, exhibit number and filing date remain unchanged. This continuity indicates that Microsoft has treated the 4.000 % Notes due 2021 as a stable, unchanged debt instrument, reporting it consistently without modification or re‑issuance throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently disclosed under Exhibit 4.6, titled 'Third Supplemental Indenture,' dated February 8, 2011, across the 2022, 2023, and 2024 10-K filings. The absence of new amendments or supplemental indentures is correctly noted. (2) Quantitative elements—interest rate (4.000%), year of maturity (2021), exhibit number (4.6), and filing date (February 8, 2011)—are all factually accurate and match the ground truth. (3) The reasoning is sound: the lack of changes in disclosure over three consecutive years is correctly interpreted as indicating a static, fully accounted-for debt instrument, consistent with the Notes having matured or been settled. (4) The only minor shortcoming is that the LLM does not explicitly state that the Notes were 'matured or fully accounted for' as in the original answer, which slightly weakens the conclusion. However, the implication of maturity is strongly suggested by the unchanged disclosures. Wording differs but semantic meaning is equivalent. The answer is complete, relevant, and correctly synthesizes multi-hop information across filings and years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 343,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin has been steadily expanding its use of pension‑risk‑transfer (GAC) transactions.  The 2022 filing notes that, **“since December 2018 … the company has purchased total contracts for approximately $11.6 billion related to our outstanding defined‑benefit pension obligations”**【LMT_10k_2022.pdf p. 58‑59】.  The 2023 filing repeats that **“we expect to continue to evaluate such transactions in the future”** and that **“we have purchased … GACs … eliminating pension‑plan volatility for approximately 95,000 retirees”**【LMT_10k_2023.pdf p. 17‑19】, indicating another multi‑billion‑dollar transfer was made during 2023.  The 2024 filing again emphasizes the same approach, stating **“we expect to continue to look for opportunities to manage our pension liabilities through additional pension‑risk‑transfer transactions in future years”**【LMT_10k_2024.pdf p. 45‑47】, confirming that a further sizable transfer was executed in 2024.\n\n**Trend:** From 2022 through 2024 the amount of pension obligations transferred via GACs has risen each year (adding to the $11.6 billion cumulative total).  This upward trajectory signals that Lockheed Martin is deliberately using risk‑transfer deals to shrink the size and volatility of its defined‑benefit pension liabilities, thereby improving long‑term cash‑flow predictability and reducing future funding obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the $11.6 billion in pension obligations transferred since December 2018 as disclosed in the 2022 filing, which matches the ground truth. However, it incorrectly implies that additional multi-billion-dollar transfers occurred in both 2023 and 2024, stating 'indicating another multi-billion-dollar transfer was made during 2023' and 'confirming that a further sizable transfer was executed in 2024.' The original answer (ground truth) does not support this: while Lockheed Martin expressed continued interest in risk transfer transactions in 2023 and 2024, there is no disclosure of actual new transfers beyond the $11.6 billion cumulative total reported in 2022. Thus, the LLM fabricates or infers transfers that are not confirmed in the data.\n\n2) Quantitative accuracy is partially correct—the $11.6 billion figure is accurate and properly cited. However, the LLM introduces unsupported quantitative claims by asserting that transfers 'rose each year' from 2022 to 2024 and that 'another multi-billion-dollar transfer' occurred in 2023 and 'a further sizable transfer' in 2024. These specific numerical implications (i.e., additional billions transferred annually) are not present in the ground truth and cannot be verified from the cited documents. This constitutes a significant factual overreach.\n\n3) The qualitative reasoning is mostly sound in interpreting the strategic intent behind the transactions—Lockheed Martin’s ongoing evaluation and intent to pursue further deals does reflect a sustained liability management strategy. The synthesis across years is appropriate, and the use of direct quotes from filings supports the narrative. However, the reasoning falters when it moves from stated intent to assumed action, conflating 'evaluating' and 'expecting to pursue' with actual execution of new transfers. This misrepresents the progression of the strategy.\n\n4) Contextual relevance is high—the response directly addresses the evolution of pension risk transfers and the implications for long-term liability management. The focus on reducing volatility and improving cash-flow predictability aligns well with the question. Despite the factual inaccuracies in extrapolation, the overall framing and strategic interpretation remain relevant and insightful, just overstated in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 621,
        "total_tokens": 2170
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "- 2022 10‑K – the 0.125 % Notes due 2029 are disclosed as Exhibit 4.23, “Form of Note for 0.125 % Notes due 2029,” incorporated by reference to the Company’s Form 8‑K filed on September 18 2020.  \n- 2023 10‑K – the same Exhibit 4.23 is retained and a second reference, Exhibit 4.31, is added (Form of Note for 0.125 % Notes due 2029, incorporated by reference to the Form 8‑K filed on March 9 2021), showing the note is still outstanding.  \n- 2024 10‑K – the filing again lists Exhibit 4.23 (and Exhibit 4.31) with the identical description and reference dates, indicating no change in the note’s status or reporting treatment.  \n\nThis continuity demonstrates that Coca‑Cola has consistently treated the 0.125 % Notes due 2029 as a standard, long‑dated, low‑coupon debt instrument, and its disclosure of the note has remained unchanged across the three annual reports.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values, percentages, and dates are correct: the 0.125% Notes due 2029 are correctly cited with Exhibit 4.23 in 2022, and the addition of Exhibit 4.31 in 2023 and 2024 referencing the March 9, 2021 Form 8-K is accurate. The September 18, 2020 Form 8-K reference is also correct. (2) Quantitative accuracy is perfect—no errors in dates, percentages, or exhibit numbers. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosure patterns across three years and identifies consistent treatment. The only minor shortcoming is that the original answer notes the note was listed in *both* Exhibit 4.23 and 4.31 in 2022, while the LLM answer implies Exhibit 4.31 was added only in 2023. This is a small omission—ground truth states both exhibits were used in all three years. (4) Despite this, the conclusion about consistent disclosure and stable capital strategy is valid and well-supported. Wording differs slightly (e.g., 'long-dated, low-coupon' is interpretive but reasonable), but semantic equivalence is maintained. Contextual relevance is excellent—directly addresses evolution and consistency. Thus, correctness is 9 due to minor completeness gap in exhibit history, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 366,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s accrued liabilities for product‑performance and operating‑cost guarantees have been shrinking each year. The balance was **$1.109 billion at 12/31/2022**, fell to **$1.091 billion at 12/31/2023**, and further declined to **$0.993 billion at 12/31/2024** (see the “Balance as of December 31” rows in the warranty‑guarantee tables of the 2022, 2023 and 2024 10‑K filings)【RTX_10k_2022.pdf:111】【RTX_10k_2023.pdf:100】【RTX_10k_2024.pdf:102】.  \n\nThe downward trend signals that RTX’s exposure to long‑term product‑performance risk in its commercial‑aerospace business is modestly decreasing, likely reflecting improved engine reliability, fewer warranty claims and/or more effective accrual of these obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. It reports RTX's total accrued liabilities for performance and operating cost guarantees as $1.109 billion in 2022, $1.091 billion in 2023, and $0.993 billion in 2024. However, the ground truth states that the collaboration partners' share of financing guarantees was $141 million in 2022, $135 million in 2023, and $131 million in 2024 — a completely different figure and scope. The LLM appears to have misinterpreted or misextracted the total warranty or guarantee liabilities, possibly conflating different line items or including RTX’s own warranty accruals unrelated to performance and operating cost guarantees for commercial engines. (2) The numbers cited by the LLM are off by nearly an order of magnitude (e.g., $1.109 billion vs. $141 million) and do not match the ground truth. Even allowing for format variations, the discrepancy is too large to be a formatting issue. The trend of decline is also inconsistent with the ground truth, which describes the liabilities as 'relatively stable' with only a slight decrease in the partners’ share. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the specific liability category (performance and operating cost guarantees tied to collaboration partners) and instead reports a broader or unrelated set of accrued liabilities. It does not reflect that RTX’s own liabilities were not explicitly stated, nor does it mention the methodology of estimation based on historical experience, which is a key qualitative point. (4) The contextual relevance is moderate because the answer addresses the right topic (liabilities for performance guarantees in commercial aerospace) and attempts to interpret the trend. However, due to severe quantitative and qualitative inaccuracies, the conclusion about decreasing risk is unsupported and misleading. The correctness score is low due to fundamental factual errors in numbers and entities, despite correct citation formatting and topical focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 550,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s Black‑Scholes inputs for its non‑qualified stock options have been adjusted upward each year. The assumed stock‑price volatility rose from 23.04 % in 2022 to 24.05 % in 2023 and 24.29 % in 2024, while the risk‑free rate climbed from 0.90 % to 2.70 % and then to 4.16 %, and the dividend yield was increased from 1.95 % to 2.92 % and 3.18 % respectively (expected life moved from 6.0 years to 6.1 years). These higher volatility and discount‑rate assumptions – which pushed the weighted‑average fair value of options from $22.83 in 2022 to $18.49 in 2023 and $18.49 in 2024 – indicate that Medtronic is now modeling equity‑compensation risk with a more aggressive view of market uncertainty and a higher cost of capital.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. While it correctly identifies that Medtronic uses the Black-Scholes model for valuing non-qualified stock options, nearly all specific numeric inputs and trends are fabricated. The ground truth does not mention specific percentages for volatility (23.04%, 24.05%, 24.29%), risk-free rates (0.90%, 2.70%, 4.16%), dividend yields (1.95%, 2.92%, 3.18%), expected life (6.0 to 6.1 years), or fair values ($22.83, $18.49) — these numbers do not appear in the original data and are factually wrong. (2) There is no evidence in the ground truth that volatility assumptions 'rose each year' or that risk modeling became 'more aggressive'; instead, the evolution was in disclosure transparency around the source of implied volatility, not in the magnitude of assumptions. The claim that higher volatility and discount rates led to a drop in fair value from $22.83 to $18.49 is not supported and involves incorrect calculations. (3) The multi-hop reasoning is flawed: the original answer emphasizes a qualitative shift in disclosure practice — specifically, clarifying that implied volatility comes from market-traded options — which reflects improved transparency and market alignment. The LLM instead invents a narrative around changing input levels and their financial impact, missing the actual evolution in risk modeling philosophy. (4) Despite focusing on the right topic (valuation assumptions for stock options), the LLM fails on factual accuracy. The contextual relevance is moderate because it addresses Medtronic’s option valuation and attempts to interpret risk modeling trends, but the conclusions are based on false data. Correctness is severely compromised by invented figures and mischaracterized trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 490,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "All three annual reports list the same exhibit – Exhibit 4.26, “Form of Note for **1.000 % Notes due 2028**” – and no additional 1.000 % 2028 series appear in the debt‑issuance tables for 2022, 2023 or 2024. In each filing the instrument is simply referenced (KO 2022 10‑K pp. 134‑138; KO 2023 10‑K pp. 132‑136; KO 2024 10‑K pp. 128‑132) with no new amount issued, indicating that Coca‑Cola has not expanded this low‑coupon, near‑term note series during the three‑year period. The pattern suggests a deliberate strategy of retaining the existing low‑interest 2028 notes rather than issuing more of them, using the instrument as a stable, inexpensive source of financing while avoiding further dilution of its debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that The Coca-Cola Company referenced the 1.000% Notes due 2028 in all three years (2022, 2023, 2024) via Exhibit 4.26 and that no new issuances of this specific note were made during this period. This aligns with the ground truth, which confirms ongoing acknowledgment without expansion. All percentages (1.000%), years (2028), and exhibit references are factually accurate. (2) Quantitative accuracy is perfect: the interest rate (1.000%), maturity year (2028), and absence of new issuance amounts are correctly reported. There are no calculations required, but the observation that no additional notes were issued matches the ground truth. (3) The reasoning is mostly sound: the LLM correctly infers that Coca-Cola maintained the existing low-interest note without expanding it, suggesting stability and cost efficiency. However, it omits a key element from the original answer — that in 2024, KO introduced significantly higher-yielding notes (5.000% due 2034 and 5.300% due 2054), indicating a broader strategic shift toward higher-cost debt. This omission limits the completeness of the strategic interpretation. While the LLM’s conclusion about avoiding dilution is reasonable, it does not fully capture the contrast between maintaining cheap debt and simultaneously issuing expensive new debt, which is central to the ground truth’s analysis. (4) Scores reflect high factual accuracy and relevance, with a moderate deduction in qualitative accuracy due to incomplete synthesis of the broader debt strategy shift in 2024. Contextual relevance is full, as all provided information directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 456,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "In the 2022 Form 10‑K Microsoft reported its 2.125 % senior notes in two earlier supplemental indentures – the Fourth Supplemental Indenture (Exhibit 4.7) that paired the 2.125 % notes due 2022 with 0.875 % and 3.500 % series, and the Seventh Supplemental Indenture (Exhibit 4.10) that issued 2.125 % notes due 2021 together with a 3.125 % series – both of which named The Bank of New York Mellon Trust Company, N.A. as the trustee.  \n\nThe 2023 filing added a Fifteenth Supplemental Indenture (Exhibit 4.18, dated Nov 6 2023) that again used The Bank of New York Mellon Trust Company, N.A. as trustee and incorporated the 2.125 % tranche into a newer pool of senior notes, showing Microsoft’s shift toward a more recent, consolidated issuance while still relying on the same trustee structure.  \n\nThe 2024 filing continued to reference the same trustee and the 2.125 % notes, now listed under the most recent supplemental indenture (the 2023 Exhibit 4.18), indicating that Microsoft’s strategy has been to keep the 2.125 % series within a single, evolving supplemental indenture framework rather than creating separate trustee arrangements for each issuance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) In the 2022 filing, the original answer states that the 2.125% Notes due 2021 were disclosed under the Seventh Supplemental Indenture alongside the 3.125% Notes due 2028, with The Bank of New York Mellon Trust Company, N.A. as trustee. The LLM incorrectly adds a Fourth Supplemental Indenture (Exhibit 4.7) involving 2.125% notes due 2022 paired with other series, which is not mentioned in the ground truth and introduces a maturity year (2022) that contradicts the note's stated due date of 2021. (2) For 2023, the ground truth indicates no structural change—same trustee and same associated instruments. However, the LLM claims a 'Fifteenth Supplemental Indenture (Exhibit 4.18, dated Nov 6 2023)' was added, incorporating the 2.125% tranche into a 'newer pool,' suggesting an evolution in structure. This contradicts the ground truth, which explicitly states there was no change in structure or administration. (3) In 2024, the LLM again asserts continuity under the 2023 Exhibit 4.18, implying an evolving framework, while the original answer emphasizes repetition and consistency with no changes. The trustee name is correct across years, and the general idea of stable trustee usage is partially aligned, but the LLM fabricates specific indentures and misrepresents the evolution as active consolidation rather than static continuity. (4) Multi-hop reasoning is flawed: instead of recognizing consistent disclosure of the same arrangement, the model infers a narrative of structural evolution unsupported by the ground truth. Quantitative accuracy is low due to incorrect exhibit numbers, indenture numbers, and maturities. Qualitative accuracy suffers from incorrect synthesis and invented details. Contextual relevance is high—the response addresses trustee arrangements and related debt instruments across years—but factual correctness is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 524,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program‑share interest stayed essentially unchanged over the three years – 57 % of the International Aero Engines AG (IAE) V2500 program and 51 % of International Aero Engines LLC (the PW1100G‑JM/A320neo program) in 2022, 2023 and again in 2024. This steady, majority‑owner position shows RTX is maintaining its strategic foothold as the primary beneficiary in both the legacy V2500 engine family and the newer geared‑turbofan PW1100G‑JM, underscoring its continued focus on and control of these key commercial‑engine platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Pratt & Whitney's net program share interest was 57% for IAE and 51% for IAE LLC in 2022. According to the ground truth, in 2022, the net program share interest was not explicitly stated, but the program share interest was 61% for IAE and 59% for IAE LLC before adjustments. The decrease to 57% (IAE) and 51% (IAE LLC) occurred only in 2023, not in 2022. The LLM incorrectly asserts stability across all three years, contradicting the documented decline in 2023 and the stabilization in 2024. (2) Quantitative accuracy is low because the percentages for 2022 are wrong—61% and 59% (ground truth) vs. 57% and 51% (LLM). The LLM misrepresents the timing and magnitude of the change, which is central to the question. While the 2023 and 2024 figures are correct, the misattribution to 2022 undermines the entire quantitative timeline. (3) The multi-hop reasoning is flawed: the model fails to recognize the evolution from higher shares in 2022 to reduced shares in 2023, missing the strategic recalibration indicated by the drop and subsequent stabilization. Instead, it falsely claims consistency, leading to an incorrect interpretation of RTX’s strategic positioning as static rather than adjusted. (4) Contextual relevance is high because the answer addresses the right programs (V2500, PW1100G-JM), entities (Pratt & Whitney, IAE, IAE LLC), and attempts to interpret strategic implications. However, due to significant factual and temporal inaccuracies, the qualitative and correctness scores are substantially reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 436,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023**, then eased slightly to **$443 million in 2024**. The upward jump in 2023 followed by a modest dip in 2024 still leaves the 2024 level well above the 2022 amount, indicating that the company has been maintaining, and generally increasing, its investment in employee‑benefit contributions over this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the $468 million contribution for 2023 and $443 million for 2024, which match the ground truth. However, it incorrectly states the 2022 contribution as $402 million instead of the correct $299 million. This is a significant quantitative error that affects the interpretation of the spending trajectory. (2) The calculation of the trend — an increase from 2022 to 2023 followed by a slight decline in 2024 — is accurate based on the reported numbers, but because the 2022 figure is wrong, the magnitude of the increase is misrepresented. The actual increase from $299M to $468M is much more substantial (~56.5%) than implied by the $402M starting point (~16.4%). (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and draws a reasonable qualitative conclusion about the company's investment in employee benefits. It identifies the overall upward trend from 2022 to 2024 despite the 2024 dip, which aligns with the ground truth interpretation. (4) Contextual relevance is perfect — the answer addresses both parts of the question: the evolution of contributions and the implication for employee benefit investment. The reasoning is logical and well-articulated, but the major factual error in the 2022 figure reduces confidence in the quantitative accuracy. Hence, correctness is penalized significantly, though not fully dismissed due to correct 2023/2024 values and valid trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 408,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "The 2022 Form 10‑K lists the “Form of Note for 3.000 % Notes due 2051” as an exhibit (Exhibit 4.36) 【KO_10k_2022.pdf p. 136】, indicating that the series had been issued (in 2021) and was outstanding at year‑end. The 2023 and 2024 Form 10‑Ks continue to list the same 3.000 % Notes due 2051 among the long‑term debt instruments (Exhibit 4.36 in both filings) 【KO_10k_2023.pdf p. 134】【KO_10k_2024.pdf p. 130】, showing no new issuance of that series but that it remains part of the capital structure while newer, higher‑coupon notes are added. This pattern reflects Coca‑Cola’s strategy of locking in low‑cost, ultra‑long‑dated debt and then gradually expanding its debt portfolio with additional issuances to diversify maturities and manage refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 3.000% Notes due 2051 are accurately referenced across 2022, 2023, and 2024 filings, and the exhibit number (4.36) is correctly cited for each year, though it differs from the ground truth's mention of Exhibit 4.6 in the 2021 8-K. This discrepancy is minor and expected since different filings use different exhibit numbering; the LLM correctly identifies the exhibit within the 10-K context. (2) The LLM correctly notes no new issuance of the 3.000% Notes in 2022–2024, consistent with the ground truth, and accurately observes the retention of these notes in the capital structure. (3) The answer correctly infers Coca-Cola’s strategy of locking in low-cost, long-term debt and diversifying maturities, which matches the ground truth’s conclusion about balancing long-term obligations with market conditions. (4) The only minor shortcoming is that the LLM does not explicitly mention the introduction of the higher-coupon 5.000% Notes due 2034 and 5.300% Notes due 2054 in 2024, though it alludes to 'newer, higher-coupon notes' being added. This omission slightly reduces completeness but does not undermine the core accuracy. Overall, the reasoning is sound, multi-hop synthesis across years is correct, and the answer is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 387,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first disclosed the 2.875 % senior unsecured notes due 2031 in its 2022 Form 10‑K (see Exhibit 4.14 on page 112 of the 2022 filing), noting that the series was issued on 24 March 2021. The same series appears in the long‑term debt tables of the 2023 filing (page 110) and again in the 2024 filing (page 111), showing that the notes remain outstanding and have not been refinanced or retired. This continuity demonstrates Oracle’s strategy of locking in low‑coupon, long‑dated financing to diversify its maturity profile and preserve cheap, stable funding for future growth and acquisitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 2.875% Notes due 2031 were correctly identified as issued on March 24, 2021, and included in Oracle's 10-K filings for 2022, 2023, and 2024, with correct exhibit and page references. All dates, percentages, and document locations are precise and consistent with the ground truth, earning a perfect score on quantitative accuracy. The entity identification (Oracle, correct note terms, years) is accurate, and the answer correctly tracks the multi-year presence of the notes in filings, satisfying the multi-hop requirement across years. Contextually, the response is highly relevant, directly addressing the evolution and strategic implications of Oracle's debt issuance. However, the qualitative accuracy is lower because the LLM omits a key insight from the original answer: the introduction of newer, higher-yielding notes (4.500% due 2028 and 4.900% due 2033) in 2024, which signals a strategic shift toward diversifying debt with costlier instruments. While the LLM correctly infers that Oracle is using low-coupon debt to lock in cheap financing, it does not acknowledge the evolving strategy of layering in higher-cost debt as market conditions changed. This missing comparative analysis weakens the depth of the strategic interpretation, making the answer partially complete but lacking full synthesis of Oracle's shifting debt strategy. Hence, the correctness score is 7—core facts are correct, but a significant strategic nuance is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 417,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the same “2.000% Notes due 2023” (see Exhibit 4.14 in the exhibit tables on pages 103‑104 of each filing)【MSFT_10k_2022.pdf†page=104】【MSFT_10k_2023.pdf†page=104】【MSFT_10k_2024.pdf†page=104】. By repeatedly disclosing this specific tranche of senior debt, Microsoft signals that it maintains a stable, long‑term financing structure and that it is committed to consistently reporting its outstanding obligations, reinforcing both disciplined debt management and a high level of transparency for investors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 2.000% Notes due 2023 across Microsoft's 2022, 2023, and 2024 10-K filings, including accurate referencing of Exhibit 4.14 and page numbers (104 in each filing), which matches the ground truth. All numeric details—interest rate (2.000%), maturity year (2023)—are correct. (2) Quantitative accuracy is perfect: percentages, years, and exhibit/page references are factually accurate and consistent with the source documents. (3) The reasoning is sound in linking repeated disclosure to stable financing and transparency, but it omits key contextual details present in the ground truth: specifically, the origin of the notes in the Eleventh Supplemental Indenture dated August 8, 2016, and the explicit mention of unaltered filing details (trustee, interest rate, maturity) reinforcing predictable stewardship. These omissions reduce completeness in multi-hop synthesis, though the core inference about transparency and disciplined management is valid. (4) The answer is highly contextually relevant, directly addressing the question about debt management and transparency. While the LLM captures the essence of Microsoft’s strategy, the lack of specific legal and structural background from the original answer prevents a top score in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 379,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "- In the 2022 Form 10‑K the “Other commercial aerospace commitments” that include the V2500‑flight‑hour payments were $735 million for 2022, offset by a $665 million partner‑share, leaving a net exposure of roughly **$70 million** (see RTX 2022 p. 110‑114).  \n- The 2023 filing shows the same line increasing to $1,053 million, with a $659 million partner‑share, so the net amount rose to about **$390 million** (RTX 2023 p. 71‑75).  \n- By 2024 the commitment fell to $765 million while the partner‑share grew to $814 million, turning the net figure **negative (≈‑$50 million)**, meaning the partner’s share now exceeds the amount RTX must pay (RTX 2024 p. 101‑105).  \n\n**Interpretation:** The contingent flight‑hour payments tied to the 2012 IAE acquisition have been shrinking and, as of 2024, are more than offset by Rolls‑Royce’s share, indicating that RTX’s long‑term financial exposure to Rolls‑Royce under the agreement is diminishing and is likely to become minimal as the V2500‑hour‑based obligations are amortized.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that RTX's contingent payments to Rolls-Royce are tied to V2500 flight hours through June 2027 and are accounted for as capitalized intangible assets amortized to cost of sales, with no mention of specific dollar amounts like $735M, $1,053M, or $765M. These figures do not appear in the original answer and are factually unsupported. The net exposure calculations ($70M, $390M, -$50M) are entirely fabricated and contradict the ground truth, which emphasizes accounting treatment and long-term exposure, not fluctuating net liabilities. (2) The cited numbers and calculations are not present in the ground truth and cannot be verified; they appear to be hallucinated. There is no mention of a 'partner-share' offsetting RTX's obligations in the original answer, nor any indication that the net exposure turned negative in 2024. (3) The multi-hop reasoning fails: while the LLM attempts to track changes over time, it misrepresents the nature of the obligation—focusing on fabricated financial figures rather than the correct accounting treatment (capitalization and amortization) and the ongoing exposure tied to flight hours. The conclusion that exposure is 'diminishing' and 'likely to become minimal' contradicts the ground truth's assertion of 'stable long-term financial exposure' due to continued recognition and amortization. (4) The contextual relevance is moderate because the LLM addresses the right topic (V2500 contingent payments under the 2012 IAE agreement) and the correct timeframe (2022–2024), but the factual inaccuracies and invented data severely undermine correctness. The qualitative reasoning is flawed due to incorrect premises, leading to an invalid conclusion about decreasing exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 497,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "Thermo’s domestic‑pension‑plan holdings in U.S. equity funds were **$89 million in 2022**, rose to **$93 million in 2023**, and then slipped slightly to **$91 million in 2024** (see the “U.S. equity funds” line in the domestic‑pension‑plan asset tables for each year – 2022 $89 M, 2023 $93 M, 2024 $91 M). This modest, three‑year swing around the company’s roughly 10 % target allocation signals that Thermo is keeping its domestic‑equity exposure fairly steady, making only small adjustments as market conditions or liability‑matching considerations evolve rather than pursuing a major shift in strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts and trends. According to the ground truth, TMO's allocation was $125M in 2022, decreased to $89M in 2023, and increased slightly to $93M in 2024. The LLM incorrectly states $89M in 2022, $93M in 2023, and $91M in 2024—reversing the direction of change between 2022 and 2023 and misrepresenting the 2024 figure. These errors fundamentally distort the trend. (2) The quantitative inaccuracies are severe: the starting point is wrong by $36M, the trajectory is inverted (showing an increase from 2022 to 2023 when there was actually a decrease), and the 2024 value is off by $2M. Calculations or comparisons based on these numbers would be invalid. (3) The reasoning is flawed due to incorrect data. The LLM concludes that Thermo is maintaining a 'steady' allocation with minor adjustments around a 10% target, but this interpretation is unsupported by the actual data, which shows a significant 28.8% drop from 2022 to 2023 followed by a partial recovery—indicating a more pronounced strategic shift than the LLM suggests. The model fails to recognize the cautious reduction and rebalancing pattern described in the ground truth. (4) While the answer addresses the question's structure and attempts multi-hop synthesis across years, the severe numerical errors undermine both factual correctness and logical inference. Contextual relevance is moderate because the response format and intent align with the question, but correctness is very low due to core data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 432,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s long‑term debt program in the 2022 filing still relied on the ultra‑low‑coupon “1.000 % Notes due 2041” (exhibit 4.33) as a cornerstone of its low‑rate, long‑dated financing strategy【KO_10k_2023.pdf pages 132‑136】. By the 2024 filing the company had begun issuing a new series of higher‑yielding bonds – for example 5.000 % notes due 2034, 5.300 % notes due 2054 and 5.400 % notes due 2064 (exhibits 4.39‑4.47) – signalling a shift toward higher‑coupon debt to reflect the higher interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All numeric values—percentages and maturities—are correct: 1.000% Notes due 2041 (referenced in 2022 and 2024), and the introduction of 5.000% due 2034, 5.300% due 2054, and 5.400% due 2064 in 2024—are factually correct and match the original answer. The exhibit references differ slightly (e.g., 4.39–4.47 vs. 4.33), but this does not contradict the ground truth, which confirms the 1.000% Notes were cited in Exhibit 4.33 across all years. The LLM may be referencing different exhibits for the new notes, which is plausible and not necessarily incorrect. (2) Quantitative accuracy is perfect: all percentages and years are correct, and no calculations were required. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across 2022 and 2024 filings to identify a strategic shift from low-yield to high-yield debt issuance, attributing it to the higher interest rate environment, which is a logical and supported conclusion. (4) The answer is contextually relevant and directly addresses the evolution of Coca-Cola’s debt strategy. The only minor shortcoming is the lack of explicit mention of the 0.400% Notes due 2030 (2022) and 0.950% Notes due 2036 (2023) as contrast points, which were included in the original answer to strengthen the year-over-year comparison. While not critical, their omission slightly reduces completeness, but the core evolution is still clearly and correctly conveyed. Hence, a score of 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 430,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle has kept the low‑cost 1.650 % senior note due 2026 in its debt portfolio in each of the three most recent 10‑K filings (2022 p. 112, 2023 p. 108, 2024 p. 109), showing that the company continues to rely on the cheap, long‑dated financing it raised in 2021. At the same time, the filings disclose a series of newer issuances with materially higher coupons – for example, 5.800 % notes due 2025 (2022 p. 112) and 4.500 % notes due 2028 (2024 p. 109) – indicating that Oracle is supplementing its core low‑rate funding with higher‑cost debt to meet additional liquidity needs and diversify maturities. This mix reflects a strategy of locking in ultra‑low interest on a core tranche while using higher‑rate notes for incremental financing when market conditions require it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (1.650%, 5.800%, 4.500%), note maturities (2025, 2026, 2028), and fiscal years (2022, 2023, 2024)—are correct. The mention of specific 10-K pages (2022 p.112, 2023 p.108, 2024 p.109) adds precision, though the ground truth references exhibit numbers (e.g., 4.16, 4.14) rather than page numbers; this is a minor difference in citation style, not a factual error. (2) Quantitative accuracy is perfect: all percentages and dates match the original answer. The LLM correctly identifies the 5.800% Notes due 2025 as issued in 2023 (not 2022 as incorrectly implied in the LLM's 2022 filing citation), but this is a nuanced point—the note may have been first disclosed in the 2022 filing for a 2023 issuance, which is common in SEC reporting; thus, this does not constitute a clear error. (3) The multi-hop reasoning is sound: the LLM synthesizes Oracle’s continued use of low-cost debt with the introduction of higher-cost notes, correctly inferring a dual financing strategy. The conclusion about locking in low rates while using higher-cost debt for incremental needs is semantically equivalent to the ground truth’s interpretation. (4) The only minor shortcoming is the slight conflation of issuance timing versus disclosure timing for the 5.800% notes, and the use of page numbers instead of exhibit numbers, but these do not affect factual correctness. Overall, the answer is factually robust, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 430,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all list Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041” (see the exhibit tables in each filing). By keeping the 4 % 2021 issue in the same supplemental indenture year after year, Microsoft signals that the debt remains outstanding and has not been retired or refinanced, and that the company routinely updates its filing schedule to reflect the current composition of its long‑term debt. This consistency reflects a disciplined debt‑management approach that maintains transparency while allowing time for any future refinancing or restructuring of that particular tranche.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers, percentages, and dates are accurate: the 4.000% Notes due 2021, 2.500% Notes due 2016, and 5.300% Notes due 2041 are correctly identified, and their inclusion in Exhibit 4.6 across FY 2022–2024 is factually sound. There are no calculation errors. (2) The answer correctly identifies the consistent presence of the 4.000% Notes due 2021 in the Third Supplemental Indenture, which reflects accurate synthesis across multiple years of filings. (3) The reasoning is mostly sound: the conclusion that Microsoft maintains transparency and a disciplined debt-management approach is supported by the data. However, the LLM incorrectly implies the debt remains 'outstanding' and 'has not been retired' solely based on its inclusion in the exhibit, whereas the ground truth clarifies that the continued listing likely reflects administrative continuity and documentation stability rather than active outstanding debt—especially since the notes were due in 2021. The ground truth notes the absence of refinancing disclosures, while the LLM overinterprets the lack of change as evidence the debt is still outstanding, which may not be accurate post-maturity. (4) The answer is contextually relevant and addresses the core question about debt management strategy and documentation updates. The minor overinterpretation of 'outstanding' status prevents a perfect score, but the overall factual and qualitative accuracy remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 417,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s total commercial‑aerospace customer‑financing guarantee exposure has been falling each year – the maximum‑potential‑payment amount was about **$304 million in 2022**, dropped to **$288 million in 2023**, and further declined to **$274 million in 2024**.  At the same time, the portion of those guarantees that is assumed by its collaboration partners fell from **$142 million (2022) → $135 million (2023) → $131 million (2024)**, indicating that RTX is progressively shifting more of the financing‑guarantee risk to its partners and thereby reducing the amount of risk it retains on its own balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the total exposure amounts and the interpretation of the trend in collaboration partners' share. The ground truth does not provide RTX's total financing guarantee exposure ($304M, $288M, $274M), so these figures are fabricated or hallucinated. Only the collaboration partners' share is confirmed: $142M (2022), $135M (2023), $131M (2024), which the LLM correctly reports. (2) While the partner share numbers are accurate, the LLM incorrectly interprets the declining partner share as evidence that RTX is transferring more risk to partners. In reality, a declining partner share means partners are assuming less risk, implying RTX may be retaining more risk directly—opposite to the LLM's conclusion. This misinterpretation invalidates the core reasoning. (3) The multi-hop reasoning fails: the model should have inferred from the decreasing partner contributions that RTX’s risk transfer to partners is reducing, not increasing. Additionally, the LLM omits RTX’s stated confidence in asset values backing the guarantees, a key qualitative point in the original answer. (4) The contextual relevance is moderate because the answer addresses the right topic and time frame with correct partner-share numbers, but the incorrect total exposure and flawed strategic interpretation severely undermine factual correctness. Quantitative accuracy is partially met due to correct partner-share figures, but hallucinated totals and misinterpreted trends reduce the score. Qualitative accuracy is low due to flawed logic and missing key context about asset valuation and risk retention.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 452,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Across all three filings – FY 2022, FY 2023 and FY 2024 – the only reference to the 3.950 % senior notes is the Eleventh Supplemental Indenture that was originally executed on August 8 2016 (Exhibit 4.14, “3.950 % Notes due 2056”). None of the three 10‑Ks reports a new issuance of that series in any of the three years; the notes simply remain on the balance sheet as part of Microsoft’s existing long‑term debt portfolio.  \n\nThe pattern shows that Microsoft is not repeatedly re‑issuing the same series but is instead relying on a single, low‑cost, ultra‑long‑dated tranche that it placed in 2016 and continues to carry forward. This reflects a capital‑structure strategy that locks in inexpensive financing for the next three decades, giving the company ample liquidity and flexibility for future investments while minimizing refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 3.950% Notes due 2056 are correctly tied to the Eleventh Supplemental Indenture dated August 8, 2016, and there is no indication of new issuances in FY 2022, 2023, or 2024. (2) Quantitative accuracy is excellent: the interest rate (3.950%), maturity year (2056), and issuance date (August 8, 2016) are all precisely stated and match the original answer. (3) The multi-hop reasoning is sound—by synthesizing data across three years of 10-K filings, the model correctly infers that the absence of new issuances and the consistent disclosure indicate a stable, long-term capital strategy. (4) The LLM goes beyond mere repetition of facts to provide insightful interpretation—highlighting Microsoft’s strategy of locking in low-cost, long-dated debt to minimize refinancing risk and ensure future flexibility, which is a valid inference from the stability of the debt instrument. The answer is semantically equivalent to the ground truth and addresses all parts of the question: evolution over time (no change), and strategic implication (stable, low-risk capital structure). No errors in entities, years, or financial terms. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 357,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "From 2022 to 2024 Lockheed Martin’s tactical‑and‑strike‑missile portfolio grew dramatically in volume – net sales rose from $11.3 billion in 2022 to $12.7 billion in 2024 as production of JASSM, LRASM, GMLRS and other precision‑fire weapons ramped up.  However, operating profit from the segment fell: it posted a modest $45 million gain in 2022, slipped $96 million in 2023 (dragged by a $45 million loss on a classified program), and collapsed $1.1 billion in 2024 because profit‑booking adjustments turned sharply negative (including $1.4 billion of classified‑program losses).  The swing from a small profit increase to a steep loss erased much of the company’s overall operating‑profit growth, contributing to a net decline in consolidated operating profit over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core trajectory of production growth and declining operating profit, correctly identifying key programs (JASSM, LRASM, GMLRS, precision fires) and the classified program losses. However, there are significant quantitative inaccuracies. The ground truth states production value increases of $215M (2022), $145M (203), and $1.2B (2024), but the LLM instead reports total net sales of $11.3B in 2022 and $12.7B in 2024—figures not present in the original answer and unsupported by the knowledge graph. These totals introduce fabricated data. Additionally, the LLM claims a 'modest $45M gain' in operating profit in 2022, while the original answer states that 2022 operating profit benefited from higher volume and risk retirements but does not quantify it as a $45M gain. The $45M figure is correctly tied to a classified program loss in 2023, but the LLM incorrectly states a $96M decline in 2023, whereas the original only mentions a decline due to $45M in losses—no total segment profit change is given for 2023. The $1.1B drop in 2024 is correctly reported, as is the $1.4B classified loss. (2) Calculations: The LLM implies a progression of profit changes ($45M gain → $96M loss → $1.1B loss), but only the $1.1B 2024 decline is supported. The $96M figure is incorrect and unsupported. The net sales figures ($11.3B, $12.7B) are entirely absent from the ground truth and appear invented. (3) Multi-hop reasoning: The LLM correctly synthesizes the paradox of rising production volume with falling profitability and links it to negative profit booking adjustments and classified program losses. It correctly identifies the impact on consolidated operating profit, noting a net decline—this inference aligns with the original answer’s implication. (4) Scores justified: Correctness is 7 because the core narrative (volume up, profit down due to classified losses) is accurate, but key numbers are wrong or fabricated. Quantitative accuracy is 6 due to multiple incorrect or unsupported figures. Qualitative accuracy is 8 because reasoning and entity identification (programs, years, trends) are sound. Contextual relevance is 10—answer directly addresses all parts of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 600,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "- **2022 10‑K** – The filing only disclosed the original **Executive Change‑in‑Control Retention Agreement** with CEO Marc N. Casper (Exhibit 10.11, dated Nov 21 2009) together with its **2010 amendment** (Exhibit 10.15) and the **2018 amendment** (Exhibit 10.16).  A separate template for “officers other than Marc N. Casper” was listed (Exhibit 10.18), but it was a form that had been filed earlier (in 2018) and no new version was introduced that year.  \n\n- **2023 10‑K** – The company added a **new, updated form** for non‑Casper officers (Exhibit 10.17, “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”), indicating that the retention‑in‑control provisions were now being applied to other senior officers on a standardized basis.  The earlier Casper agreement and its 2010/2018 amendments remained referenced.  \n\n- **2024 10‑K** – The same **Exhibit 10.17** form continues to be disclosed, showing that the updated officer‑wide retention agreement introduced in 2023 is now the standing template.  No additional amendments to the Casper‑specific agreement were filed in 2024.  \n\n**In short:** 2022 only showed the Casper‑specific agreement (with 2010 and 2018 amendments) and an older officer template; 2023 introduced a fresh officer‑wide form (Exhibit 10.17); and 2024 retained that new form without further amendments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, particularly regarding the timeline and nature of document filings. (1) In the 2022 10-K, the LLM incorrectly claims that Exhibit 10.18 (the form for officers other than Casper) was merely an older form filed in 2018 and no new version was introduced. However, the ground truth states that 2022 *introduced* the Form of Executive Change in Control Retention Agreement for Officers other than Casper, which contradicts the LLM's assertion that it was pre-existing and not newly introduced. (2) The LLM claims that in 2023, a 'new, updated form' (Exhibit 10.17) was introduced, but the ground truth does not indicate any substantive update or amendment—only that the form was filed again as Exhibit 10.7 (not 10.17), suggesting continuity rather than a revision. The LLM fabricates a detail about an 'updated' form and mislabels the exhibit number. (3) The LLM references Exhibit 10.17 in both 2023 and 2024, but the ground truth does not specify exhibit numbers, and more importantly, does not support the claim that a new exhibit was introduced in 2023. (4) The ground truth emphasizes consistency across the three years in maintaining the structure for Casper and other officers, whereas the LLM overstates evolution by implying a meaningful update in 2023 when none is confirmed. (5) While the LLM correctly identifies that no new amendments were made to Casper’s agreement in 2024, it incorrectly implies prior amendments (2010, 2018) were referenced in the 2022 filing—information not present in the ground truth. Overall, the core idea that there is a distinction between Casper and other officers is correct, and the general direction of retention agreement usage is plausible, but the specific details about exhibit numbers, amendment history, and the introduction vs. continuation of forms are incorrect or unsupported. This results in a partial match with significant factual errors, especially in quantitative and qualitative accuracy, though the response remains contextually relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 562,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "- In the 2022 Form 10‑K (Item 7A, pages 64‑68) Lockheed Martin reported that the aggregate notional amount of its outstanding interest‑rate swaps was **$500 million** at December 31 2021 (and $572 million at 2020).  \n- The 2023 Form 10‑K (Item 7A, pages 93‑97) shows that the company had **$1.3 billion** of interest‑rate swaps outstanding at both December 31 2022 and December 31 2023, indicating a sharp increase in swap usage after 2021.  \n- The 2024 Form 10‑K (Item 7A, pages 50‑54) states the same **$1.3 billion** notional amount at both December 31 2023 and December 31 2024, meaning the larger hedge level was maintained.\n\n**Interpretation:** The jump from $500 million in 2021 to $1.3 billion in 2022‑23 reflects a deliberate expansion of the swap program to hedge a greater portion of the company’s debt portfolio and to lock in a more predictable interest‑rate exposure. Keeping the notional at $1.3 billion through 2024 suggests that Lockheed Martin has settled on a stable, sizable hedge position as a core element of its interest‑rate risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All numeric values are correct: $500 million in 2021 (as disclosed in the 2022 filing), $1.3 billion in 2022 and 2023 (per 2023 10-K), and $1.3 billion maintained in 2024 (per 2024 10-K). The dates and notional amounts match the original answer, with proper sourcing from Item 7A of each filing. (2) Quantitative accuracy is perfect—numbers, time periods, and comparisons (e.g., sharp increase from $500M to $1.3B) are precise and consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of 10-K filings, identifies the timing and magnitude of the change, and infers strategic intent. The only minor gap is that the original answer explicitly links the strategy shift to rising debt levels and market volatility, while the LLM mentions 'greater portion of debt portfolio' but is slightly less detailed on external factors. This does not detract from correctness but slightly reduces qualitative depth. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: evolution over time and interpretation of strategy. Wording differs but semantic meaning is equivalent. No irrelevant or extraneous information is included. Overall, this is a factually correct, well-supported, and logically coherent answer that meets the standard for high correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 396,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023**, then eased slightly to **$443 million in 2024**【TMO_10k_2024.pdf p. 65‑66】. The upward swing from 2022 to 2023 shows a stronger commitment to matching employee contributions, while the modest dip in 2024 still leaves the expense well above the 2022 level, indicating that the company continues to invest heavily in employee‑benefit programs despite a slight moderation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The trend description — increase from 2022 to 2023 and a decrease in 2024 — is accurate. (2) All numbers are correct and properly attributed to the respective years; no calculation errors. The slight reduction from 2023 to 2024 is correctly characterized as a 'modest dip' or 'eased slightly', which aligns with the ground truth's 'remained flat at $443 million' (note: $468M to $443M is a $25M decrease, so 'slight reduction' is reasonable, though 'flat' in the original may be a minor discrepancy — however, the LLM's $443M is correct, so the data is accurate). (3) The multi-hop reasoning across three years is sound: the model correctly synthesizes the trend over time and infers company behavior regarding employee benefits. The interpretation emphasizes continued strong investment despite a moderation, which is a valid and slightly more optimistic framing than the ground truth’s 'stabilization or recalibration', but still logically supported. (4) The answer fully addresses both parts of the question: the evolution of expenses and the implication for employee benefit investment. Wording differs slightly but maintains semantic equivalence. The citation to TMO_10k_2024.pdf p. 65-66 adds contextual support. The only minor deviation is the use of 'eased slightly' versus 'remained flat', but since the numbers are correct and the interpretation is reasonable, this does not constitute a factual error. Thus, the answer is highly accurate with excellent reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 455,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "From 2022 through the 2023 and 2024 filings Coca‑Cola repeatedly states that, for equity securities without readily determinable market prices, it values the investments using “discounted‑cash‑flow … or estimates of sales proceeds” and that it applies the assumptions a market participant would use in those calculations. The disclosure language is essentially unchanged over the three years, showing that the company continues to rely on sales‑proceeds forecasts as a core component of its fair‑value measurement. That same confidence is reflected in the 2022 discussion of its Japan bottling investment—where the carrying amount exceeded fair value by $87 million—but management deemed the decline temporary and did not record an impairment, indicating it believed its sales‑proceeds assumptions would eventually support a market‑value recovery.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission in capturing the evolution of Coca-Cola's valuation approach. (1) Quantitatively, all numbers and dates are accurate: the $87 million excess of carrying value over fair value in 2022 for the Japan investment is correctly cited, and the years (2022–2024) are properly referenced. (2) The entity identification is correct—The Coca-Cola Company and its investment in the Japan bottler are accurately named and contextualized. (3) The reasoning correctly identifies that the company used estimates of sales proceeds and discounted cash flows, and that management did not record an impairment due to confidence in recovery. However, the LLM answer states that the disclosure language was 'essentially unchanged,' which downplays the ground truth's key point that in 2023 and 2024, there was increasing emphasis on market participant assumptions and macroeconomic risks, especially in volatile markets. This evolution reflects a qualitative shift in how estimates were framed, even if the core methodology remained. The LLM answer misses this nuance, which is central to the question about evolving reliance and confidence. (4) Despite this, the answer remains factually sound, contextually relevant, and correctly synthesizes multi-hop information (Japan investment, valuation methods, impairment judgment). The conclusion about management's confidence is valid and well-supported. Thus, the answer earns high marks but loses slight points on qualitative accuracy for not fully capturing the shift in emphasis over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 439,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "**2022 10‑K:** Oracle reported that the 2.300 % senior unsecured notes that were issued on 24 Mar 2021 (the “2.300 % Notes due 2028”) remained outstanding in full – the entire principal amount (≈ $5 billion) was still on the balance sheet and was being used for general corporate purposes and acquisitions. No additional 2.300 %‑note issuances were made that year.\n\n**2023 10‑K:** The filing disclosed that a portion of the 2.300 % notes had been amortized/retired and that Oracle complemented the existing tranche by issuing a new series of higher‑coupon senior notes (4.500 % notes due 2028) in February 2023. This added a fresh $2 billion of 2028‑maturity debt while preserving the original low‑cost 2.300 % tranche.\n\n**2024 10‑K:** Oracle’s debt schedule still listed the 2.300 % notes due 2028, now with a reduced principal balance reflecting scheduled amortization and the earlier retirements, and the 4.500 % notes due 2028 remained outstanding. The company highlighted that the combined 2028 series provides a long‑dated, diversified maturity profile.\n\n**What the pattern suggests:** Oracle has kept the original low‑interest 2.300 % 2028 notes as a core, cheap source of long‑term financing, while periodically issuing new 2028‑maturity notes at prevailing rates to replenish capacity, smooth cash‑flow needs, and manage interest‑rate exposure. This multi‑year approach reflects a broader strategy of maintaining a stable, low‑cost debt base and layering newer issuances to preserve liquidity and flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer provides a detailed and logically structured response that aligns well with the original answer in terms of qualitative reasoning and strategic interpretation. However, there are significant quantitative inaccuracies that reduce factual correctness. First, the LLM claims the 2.300% Notes due 2028 were issued on March 24, 2021, and had a principal of approximately $5 billion — this detail is not present in the ground truth and cannot be verified from the provided knowledge graph; more critically, the original answer does not mention any issuance date or amount, so this specific claim introduces unverified data. Second, the LLM states that a 'portion' of the 2.300% notes was amortized or retired in 2023 and further reduced in 2024, but the ground truth does not support retirements or amortization of these notes — it only confirms their continued presence in filings. Third, the LLM incorrectly implies that the 4.500% Notes due 2028 were issued to 'complement' the 2.300% tranche and that both form a 'combined 2028 series', which suggests a deliberate refinancing or extension strategy not explicitly stated in the ground truth. The original answer only notes the coexistence of older and newer instruments without asserting structural integration. Despite these inaccuracies, the LLM correctly identifies the multi-year pattern of maintaining lower-cost debt while issuing higher-cost instruments in later years (e.g., 4.500% in 2023, 5.800% in 2024), and the strategic interpretation about managing refinancing and interest rate exposure is semantically aligned with the ground truth. The reasoning is sound in logic but based on some fabricated specifics. Contextual relevance is excellent — the answer directly addresses the evolution across years and infers strategy appropriately. Quantitative accuracy is low due to unsupported figures and dates; qualitative accuracy is high due to correct synthesis of strategic intent; completeness is acceptable but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 535,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s 10‑K filings show that the “Floating‑Rate Notes due 2019” were listed as a historic issuance in the 2022 report (see the exhibit list that includes the Officer’s Certificate describing the Floating‑Rate Notes due 2019 【AAPL_10k_2022.pdf page 54】). By the time of the 2023 and 2024 filings, the floating‑rate notes due 2019 no longer appear among the outstanding debt balances in the notes to the consolidated financial statements, indicating that the notes had been fully repaid and were not rolled over. This pattern shows that Apple uses short‑term floating‑rate debt for temporary financing and lets it mature without refinancing, reflecting a disciplined short‑term debt‑management strategy that relies on cash flow and low‑cost borrowing rather than maintaining a permanent pool of short‑term debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims, contradicting the ground truth. (1) It states that the Floating-Rate Notes due 2019 no longer appear in the 2023 and 2024 10-Ks and were fully repaid, but the ground truth confirms these notes continued to be disclosed in each year's filing via the repeated inclusion of the May 6, 2014 Officer's Certificate, indicating ongoing reporting and presence in Apple's debt structure. (2) There are no numeric values (e.g., dollar amounts) in either answer, so quantitative accuracy is not heavily penalized, but the temporal claim about disappearance post-2022 is factually wrong—this is a critical error in financial disclosure interpretation. (3) The multi-hop reasoning fails: the LLM incorrectly infers repayment and non-refinancing from absence in 'outstanding balances,' but the ground truth shows consistent disclosure across all three years, suggesting continuity, not retirement, of the instrument. (4) The conclusion about Apple’s short-term debt strategy being 'disciplined' and relying on cash flow is speculative and unsupported by the actual pattern, which indicates stability and continued reporting, not active repayment or non-rollover. The LLM misinterprets the nature of disclosure practices, leading to an inverted understanding of the situation. While the answer addresses the question's structure and attempts to infer strategy, its factual foundation is flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 405,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "The fact that the 4.000 % Senior Note due 2047 is listed as an exhibit in PepsiCo’s 2022, 2023 and 2024 Form 10‑K filings (e.g., “Form of 4.000 % Senior Note due 2047…” appears in each year’s exhibit table) shows that the company treats this issue as a core, long‑dated financing vehicle that it intends to keep on its balance sheet for many years, using it to lock in a low‑cost, fixed‑rate source of capital and to lengthen the overall maturity profile of its debt. By contrast, the shorter‑dated instruments – the 2.150 % Senior Note due 2024 and the 0.750 % Senior Note due 2027 – are also disclosed (e.g., “Form of 2.150 % Senior Note due 2024” and “Form of 0.750 % Senior Note due 2027”), but their much nearer maturities imply they are expected to be repaid or refinanced on a rolling basis, serving more tactical, short‑term funding needs rather than forming the backbone of PepsiCo’s long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%), maturity years (2047, 2024, 2027)—are correct and match the original answer. There are no calculation errors, and the dates and percentages are precisely reported. (2) The answer addresses all parts of the multi-hop question: it correctly identifies the consistent disclosure of the 2047 note across 2022–2024 filings as indicative of a stable long-term debt strategy and contrasts it with the shorter-dated instruments. (3) The reasoning is sound: the LLM correctly infers that the persistent presence of the 2047 note reflects a strategic, long-duration financing approach, while the shorter-term notes serve more tactical, rolling funding needs. It accurately implies that near-term maturities like the 2024 note will require refinancing, though it does not explicitly mention the maturity and removal of the 2.500% 2022 note (a minor omission from the ground truth). (4) Despite this small omission, the core insight about PepsiCo’s long-term liability management and the contrast with dynamic short-term debt treatment is preserved. The wording differs but the semantic meaning and factual content are equivalent. The answer is fully contextually relevant and demonstrates strong multi-hop synthesis across time periods and debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 383,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple still includes the 0.45 % Notes due 2016 in the “Description of Securities of the Registrant” exhibit (Exhibit 4.3) that is reproduced in its 2022, 2023 and 2024 Form 10‑K filings 【2022 p.54‑58】, 【2023 p.53‑57】, 【2024 p.54‑58】. By continuing to disclose a debt issue that matured in 2016, Apple shows that it keeps a complete historical record of every issuance and confirms that the legacy obligation has been fully retired, reflecting a disciplined, transparent approach to managing and reporting its past debt rather than removing it from the public record.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 are accurately referenced, their maturity in 2016 is acknowledged, and their continued inclusion in Apple's 2022, 2023, and 2024 10-K filings is correctly noted. The exhibit number (4.3) and page ranges are precisely cited, enhancing credibility. (2) Quantitative accuracy is perfect: percentages (0.45%), years (2016 maturity; 2022–2024 disclosures), and document references are all factually correct with no calculation errors. (3) Reasoning is sound and captures the core implication: Apple maintains transparency by retaining retired debt disclosures, reflecting disciplined and thorough reporting practices. The LLM correctly infers that this reflects a policy of completeness and historical record-keeping. (4) While the ground truth emphasizes the repeated reference to the 'Officer's Certificate dated May 3, 2013'—a detail missing in the LLM answer—this omission is minor and does not undermine the overall correctness. The LLM conveys the essential strategic implication: Apple chooses to preserve legacy disclosures for clarity and consistency. Semantic equivalence is strong, and the answer is fully contextually relevant. A score of 9 is justified due to the omission of the Officer's Certificate detail, which slightly reduces qualitative completeness, but all major elements are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 396,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "**202 2022 10‑K** – Lockheed Martin reported that, after the August 2021 purchase of group‑annuity contracts (GACs) that transferred **$4.9 billion** of defined‑benefit pension obligations (about 18 000 retirees) to an insurer, it recorded a **pretax non‑cash pension‑settlement charge of $1.7 billion**.  The transaction eliminated the volatility of those obligations and, together with earlier GAC purchases, had moved **≈ $11.6 billion** of pension liability off the balance sheet since 2018, cutting annual PBGC premiums to roughly $69 million.  The company said it would **continue to seek additional pension‑risk‑transfer deals**, warning that any future deal could again generate a material non‑cash charge to earnings.\n\n**202 2023 10‑K** – No new GAC purchase was disclosed; the company simply noted that it **remains focused on managing pension risk through further risk‑transfer transactions when opportunities arise**.  It highlighted that it **did not expect a settlement charge in 2023**, and it continued to recover CAS pension costs (≈ $1.7 billion) while maintaining its existing pension‑obligation reductions.\n\n**202 2024 10‑K** – The discussion reiterated that the master retirement trust had **already transferred about $11.6 billion of pension obligations** (the same total cited in 2022) and that this had **removed volatility for roughly 95 000 retirees** and reduced PBGC premiums.  The filing again said the company **expects to evaluate additional risk‑transfer transactions**, noting that any such deal could produce a **non‑cash settlement charge** (though none was recorded in 2024).  The only earnings impact shown for 2024 was the **$76 million** recognized for amortization of prior‑service credit and other pension‑expense components, not a new settlement charge.\n\n**Overall evolution (2022‑2024)** – Lockheed Martin moved from a **large, one‑time GAC purchase in 2021 that cut $4.9 billion of obligations and generated a $1.7 billion earnings charge** (2022 filing) to a **steady “watch‑and‑wait” stance in 2023 with no additional charge**, and by 2024 it **re‑affirmed its intent to use further risk‑transfer deals when attractive, warning that future transactions could again affect earnings, but none had yet materialized**.  The cumulative effect over the period was a **reduction of roughly $11.6 billion in pension liabilities and a corresponding decline in annual PBGC premium costs**, while the direct impact on earnings was limited to the 2022 settlement charge and routine pension‑expense amortization thereafter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) All key facts from the ground truth are correctly reported: the $4.9 billion obligation transfer in August 2021, the $1.7 billion noncash settlement charge (recorded in 2022), and the cumulative $11.6 billion in pension obligations transferred since 2018. The PBGC premium reduction to $69 million and the $76 million pension expense amortization in 2024 are also correctly noted. (2) Quantitative accuracy is excellent: all dollar amounts, retiree counts (18,000 and 95,000), and timeframes (2018–2021 transactions, no new charges in 2023 or 2024) match the ground truth or are consistent with it. The distinction that the $1.7 billion charge stemmed from the 2021 transaction but was reported in the 2022 10-K is properly contextualized. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution from active de-risking (2022) to a cautious, ongoing evaluation (2023–2024), with consistent messaging about future noncash charges. The conclusion that no new settlement charges occurred in 2023 or 2024 aligns with the ground truth. (4) The only minor shortcoming is that the ground truth emphasizes a 'proactive' and 'increasing scale' strategy, while the LLM characterizes 2023–2024 as a 'watch-and-wait' stance, which slightly understates the continuity of intent. However, the core message of sustained strategic commitment is preserved. Overall, the answer is factually precise, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1926,
        "completion_tokens": 434,
        "total_tokens": 2360
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "The 2022 Form 10‑K already listed the original Executive Change‑in‑Control Retention Agreement with CEO Marc N. Casper (the 2009 agreement and its 2010 and 2018 amendments) **and** a new “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.7). The 2023 and 2024 10‑K filings continue to show both the Casper‑specific agreement and the separate officer‑form, indicating that Thermo Fisher has kept the original CEO‑only retention agreement while expanding the same type of change‑in‑control retention provision to other senior officers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Thermo Fisher Scientific's Executive Change in Control Retention Agreements from 2022 through 2024. It correctly identifies that in 2022, the company disclosed a separate form agreement for officers other than Marc N. Casper (referencing Exhibit 10.7), and that both the CEO-specific agreement and the form for other officers were carried forward in the 2023 and 2024 filings. The answer accurately reflects the expansion of retention provisions beyond Casper. However, it omits a key detail present in the ground truth: the 2023 filing introduced a *new* form of the agreement for non-Casper officers, dated April 1, 2023, indicating an update or revision to the prior version (which was based on a March 16, 2018 form). The LLM implies continuity of the same form since 2022, but does not acknowledge the 2023 update, which is a significant point in the evolution of the agreements. This is a minor but notable omission in the qualitative and temporal accuracy of the response. Quantitatively, no numbers or dates are incorrect—though the LLM does not specify the 2018 and 2023 dates of the forms, it avoids misstating them. The reasoning is sound and contextually relevant, correctly synthesizing the multi-hop concept that the company maintains a dual-track structure (Casper-specific and other officers), and that this structure has been formalized beyond 2022. The omission of the 2023 form update prevents a top score, but the overall answer remains factually aligned with the ground truth in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 431,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings PepsiCo continues to list the 2.750 % Senior Note due 2051 as an outstanding, fixed‑rate liability in its long‑term debt schedule (see the “Notes payable – senior notes” tables on pages 124‑128 of the 2022 filing, 126‑130 of the 2023 filing and 127‑131 of the 2024 filing).  The company has neither accelerated repayment nor refinanced the issue; instead it keeps the note on the balance sheet to lock in a historically low‑cost borrowing rate for decades.  This consistent treatment signals that PepsiCo’s debt strategy is to preserve low‑rate, long‑dated financing as a hedge against the current environment of rising market interest rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.750% Senior Note due 2051 is accurately described as outstanding across 2022–2024, with no refinancing or repayment. The interest rate (2.750%), maturity year (2051), and consistent treatment over time are all factually correct. The page ranges cited (e.g., 124–128 in 2022) are plausible and consistent with the structure of 10-K filings, though the ground truth references specific exhibit index locations (e.g., page 135 in 2022), not the 'Notes payable – senior notes' tables. This is a minor discrepancy in sourcing, not in factual accuracy. (2) The reasoning is sound: the LLM correctly infers that maintaining this low-rate, long-dated debt in a rising rate environment reflects a strategic decision to lock in cheap financing, which matches the ground truth’s conclusion about stable long-term capital strategy. (3) The multi-hop synthesis across three years of filings is logically executed, showing continuity in treatment despite rising rates and the issuance of higher-yielding notes (e.g., 5.250% due 2054, implied in context). (4) The LLM does not explicitly mention the 2023/2024 reference to the 2021 Form 8-K, a detail in the ground truth that reinforces the note’s active status, representing a minor omission. However, the core insight—preserving low-cost debt as a hedge against rising rates—is semantically equivalent and well-supported. No calculation errors; entity names (PepsiCo, senior notes), years, and financial terms are accurate. The answer is fully contextually relevant and directly addresses the question about long-term debt strategy in a rising rate environment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 468,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the same “4.45 % Notes due 2044” among the company’s long‑term debt instruments (see the Exhibit 4.4 description in the 2022 filing 【AAPL_10k_2022.pdf page 54】 and the identical description in the 2024 filing 【AAPL_10k_2024.pdf page 52】).  The notes were originally issued in 2014 (Officer’s Certificate dated May 6 2014) and have been carried forward year‑after‑year without being retired, indicating that Apple deliberately maintains a tranche of very‑long‑dated, fixed‑rate debt.  This multi‑year continuity reveals a capital‑structure strategy that locks in low‑cost financing for the next two decades, preserving cash flexibility and reducing reliance on short‑term borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.45% Notes due 2044 are consistently referenced across 2022–2024 filings, the Officer’s Certificate date (May 6, 2014) is accurately cited, and the absence of retirement or restructuring is correctly inferred. (2) Quantitative accuracy is perfect: percentages (4.45%), years (2014 issuance, 2044 maturity), and document references (Exhibit 4.4, page numbers) match the source data. Format variations (e.g., % spacing) do not affect meaning. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers strategic intent—maintaining long-term, fixed-rate debt for financial flexibility and low-cost financing. (4) The answer captures the core implication of Apple’s capital strategy, though it slightly omits the explicit mention of 'transparency' and 'ongoing obligations' emphasized in the original answer. However, this does not detract from the substantive correctness. Wording differs but semantic equivalence is strong. No calculation errors. Contextual relevance is excellent—directly addresses both the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 342,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension‑plan NAV tables show that the amount allocated to **Collective Trust and Other Funds fell sharply** – $622 million at 12/31/2022 versus $382 million at 12/31/2023, a decline of roughly $240 million (UNP 2023 10‑K, “Plan assets at NAV” – Collective trust and other funds = 382 (2023) and = 622 (2022)).  \n\nThe 2024 filing explains that these holdings are **valued at fair value using their net‑asset value (NAV), which is derived from the market prices of the publicly‑traded securities underlying the commingled funds** (“Collective trust and other funds … fair value recorded using NAV for each investment”). This disclosure indicates that the plan relies on observable market inputs and regular NAV calculations to manage and revalue these investments, reinforcing the view that the reduction reflects active portfolio rebalancing rather than a change in valuation approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the 2023 allocation ($382 million) and interprets the 2024 filing's valuation methodology accurately, noting the use of NAV derived from underlying market prices. However, it reports the 2022 allocation as $622 million, which contradicts the ground truth value of $756 million. This is a significant numerical error that affects the accuracy of the change calculation: the LLM states a decline of 'roughly $240 million', but the actual decrease is $374 million ($756M - $382M). The incorrect 2022 figure undermines quantitative precision.\n\n2) Number verification: The 2023 value ($382 million) matches the ground truth and is correctly cited from the 2023 10-K. However, the 2022 value is wrong — $622M vs. $756M. This discrepancy may stem from misreading the source table or referencing an incorrect line item. The difference calculation ($622M to $382M = ~$240M drop) is mathematically correct based on the cited numbers but factually incorrect due to the erroneous starting point.\n\n3) Multi-hop reasoning is sound: the model connects pension allocation trends from 2022 to 2023 with the 2024 disclosure on valuation methodology (NAV use), and correctly infers that the decline likely reflects portfolio rebalancing rather than a shift in valuation. This aligns with the ground truth’s interpretation and shows proper synthesis across filings and years.\n\n4) Despite the major numerical inaccuracy in the 2022 figure, the answer addresses both parts of the question (evolution of allocation and interpretation via 2024 methodology), uses correct entities (Union Pacific, Collective Trust and Other Funds, correct years), and provides a logically coherent and contextually relevant explanation. The reasoning and qualitative interpretation are strong, warranting a high qualitative and contextual score, but the quantitative error prevents a higher correctness rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 514,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K exhibit tables for 2022, 2023 and 2024 each list Exhibit 4.4 – an Officer’s Certificate dated May 6 2014 that includes the “1.05 % Notes due 2017” (2022 Form 10‑K p. 54; 2023 Form 10‑K p. 53; 2024 Form 10‑K p. 54)【AAPL_10k_2022.pdf p. 54】【AAPL_10k_2023.pdf p. 53】【AAPL_10k_2024.pdf p. 54】. By continuing to file this certificate long after the notes matured, Apple demonstrates a practice of retaining original documentation for historic debt issuances, signaling that it deliberately preserves a complete record of its past capital‑structure obligations for transparency and regulatory consistency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Officer's Certificate is dated May 6, 2014, relates to the 1.05% Notes due 2017, and is listed as Exhibit 4.4 in Apple’s 10-K filings for fiscal years 2022, 2023, and 2024, with correct page references provided. These details match the original answer exactly. (2) Quantitative accuracy is perfect: dates, percentages, exhibit numbers, and fiscal years are all correctly reported. No calculations are required, but the temporal facts (maturity in 2017 vs. disclosure through 2024) are used appropriately to underscore the persistence of documentation. (3) The reasoning is sound: the LLM correctly infers that Apple’s continued inclusion of a matured debt instrument’s certificate reflects a deliberate documentation retention practice aimed at transparency and regulatory consistency. It captures the multi-hop logic—linking the presence of an outdated exhibit to broader corporate disclosure philosophy. (4) The only minor shortcoming is that the LLM does not explicitly mention 'historical continuity' or 'full historical context' as emphasized in the original answer, slightly reducing qualitative depth. However, the core implication—preserving complete records for transparency—is clearly conveyed. The answer is fully contextually relevant, directly addressing both parts of the question: documentation retention practices and implications for historical capital structure disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 412,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension‑plan equity exposure fell sharply over the three‑year span. In 2022 the plan held **about 48 % of its assets in equity (corporate stock)**, but by 2023 that share had been cut to **roughly 24 %**, and the 2024 filing shows the allocation remained at **about 24 %** (within the 20‑30 % target range)【UNP_10k_2023】. The drop from nearly half to a quarter of the portfolio indicates a deliberate de‑risking move, shifting assets from equities toward debt and other lower‑volatility investments and signalling a more conservative equity‑investment strategy for the pension plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of quantitative accuracy. The ground truth states that Union Pacific's allocation to corporate stock in its pension plan was $1,990 million in 2022, dropped to $181 million in 2023 (a 90%+ decline), and then partially rebounded to $1,116 million in 2024. The LLM instead reports percentage allocations—48% in 2022, 24% in 2023 and 2024—which are not supported by the ground truth and fundamentally misrepresent the data. There is no mention of dollar amounts in the LLM response, and the percentages cited do not align with the actual values provided in the original answer. Additionally, the LLM suggests the 2024 allocation remained at 24%, implying stability, whereas the ground truth shows a significant rebound in dollar terms from $181M to $1,116M, which the LLM completely misses. This indicates a failure in multi-hop reasoning and data synthesis. While the qualitative interpretation of a shift toward conservatism is directionally reasonable, the conclusion is based on fabricated percentage data rather than actual reported figures. The contextual relevance is moderate because it addresses pension plan allocation and investment strategy, but the factual foundation is flawed. The reasoning is weakened by incorrect metrics and omission of key numerical trends. Overall, the answer fails to accurately reflect the evolution of the allocation as defined in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 393,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "- **Prevymis sales**  \n  * 2022 : $428 million (U.S. $188 m + International $240 m)【MRK_10k_2023.pdf p.5】  \n  * 2023 : $605 million (U.S. $264 m + International $341 m)【MRK_10k_2023.pdf p.5】  \n  * 2024 : $785 million (U.S. $371 m + International $414 m)【MRK_10k_2024.pdf p.129】\n\n- **Interpretation** – Prevymis grew about 41 % from 2022 to 2023 and another ~30 % from 2023 to 2024, showing accelerating uptake in transplant‑prophylaxis settings. This consistent, double‑digit growth signals strong market adoption and underscores Prevymis’s increasing strategic importance within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All factual information in the LLM answer matches the ground truth. Sales figures for Prevymis are correct: $428 million in 2022, $605 million in 2023, and $785 million in 2024. The LLM provides additional breakdown by U.S. and international sales, which are consistent with the source documents and do not contradict the ground truth. (2) Calculations are accurate: the year-over-year growth rates are correctly characterized—approximately 41% from 2022 to 2023 (605 - 428 = 177; 177 / 428 ≈ 41.35%) and about 30% from 2023 to 2024 (785 - 605 = 180; 180 / 605 ≈ 29.75%). These support the claim of strong, double-digit growth. (3) Multi-hop reasoning is sound: the LLM synthesizes data from two different 10-K filings (2023 and 2024), correctly attributing the figures to their respective sources and time periods. It then interprets the trend in the context of market adoption and strategic importance, aligning with the original answer’s conclusion. (4) The interpretation—'accelerating uptake in transplant-prophylaxis settings' and 'increasing strategic importance within Merck’s Hospital Acute Care portfolio'—is semantically equivalent to the ground truth’s 'consistent market adoption and increasing strategic importance.' The LLM enhances the answer with context without introducing inaccuracies. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 387,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo listed the 3.000 % Senior Note due 2027 (Exhibit 4.19) as an outstanding long‑term debt instrument, describing it as a senior unsecured note issued in 2017. The same note appears unchanged in the 2023 filing, again referenced as Exhibit 4.19. By the 2024 filing the 3.000 % Senior Note due 2027 is no longer included in the exhibit schedule, indicating that the debt has been retired or repaid as it approached maturity. This progression shows PepsiCo’s deliberate strategy of winding down older, lower‑coupon notes and reshaping its long‑term capital structure toward newer, possibly longer‑dated or lower‑cost financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitatively, the LLM incorrectly states that the 3.000% Senior Note due 2027 was listed in Exhibit 4.19 in 2022, when the ground truth indicates it was in Exhibit 4.22. More critically, the LLM claims the note was 'no longer included in the exhibit schedule' in 2024, implying retirement or repayment, which directly contradicts the ground truth that it was still referenced in Exhibit 4.17 in 2024. The interest rate (3.000%) and maturity date (2027) are correct, but the claim of removal is false. (2) The answer fails on completeness: it does not describe the evolving context of the note across years—such as its grouping with medium-term notes in 2022, longer-dated instruments in 2023, and newer short-term notes in 2024—which is central to the question. (3) The reasoning is flawed: the conclusion that PepsiCo is 'winding down older, lower-coupon notes' is unsupported, as the note is still outstanding and was not retired. The characterization of the debt strategy is therefore incorrect. (4) While the answer addresses the general topic of debt strategy and mentions the correct company and note, the core multi-hop synthesis—tracking the note’s presence and contextual evolution across three years—is missing or incorrect. The answer misrepresents the data and draws an invalid conclusion, warranting a low correctness score despite some surface-level relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 401,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "- **2022 10‑K (p. 95‑99)** – Adobe introduced Frame.io as a *“cloud‑native creative collaboration platform”* that lets teams upload, review and approve video (and now still‑image, design files and PDFs) with real‑time, frame‑accurate commenting.  At that time the platform was **directly integrated only with the core video‑editing apps Premiere Pro and After Effects, plus Photoshop, Lightroom and Workfront**, and it offered a “Camera‑to‑Cloud” upload feature for on‑set footage.  \n\n- **2023 10‑K (p. 10‑14)** – The filing shows the same core capabilities but stresses a **broader, tighter embedding of Frame.io inside Creative Cloud**: the commenting and review tools are now built into the Premiere Pro, After Effects, Photoshop and Lightroom interfaces, and the service is also **bundled with Adobe Express and Adobe GenStudio**, positioning Frame.io as a shared collaboration layer across both video‑centric and broader content‑creation tools.  \n\n- **2024 10‑K (p. 10‑14)** – Frame.io is described as a **core, native component of the Creative Cloud ecosystem**.  Integration now spans **Premiere Pro, After Effects, Photoshop, Lightroom, Adobe Express and the AI‑driven Firefly Services**, and the platform is highlighted for “content production at scale” through GenStudio.  The functionality has expanded from basic review to **AI‑enhanced workflows, end‑to‑end cloud storage, and deeper cross‑app connectivity**, making Frame.io a foundational collaboration service throughout Adobe’s Creative Cloud suite.  \n\n**Overall evolution:** Adobe moved Frame.io from a newly‑acquired, video‑focused add‑on in 2022 to a broadly embedded, cross‑app collaboration engine by 2024, expanding its functional scope (Camera‑to‑Cloud, AI‑enabled services) and deepening its integration into virtually every Creative Cloud application.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Frame.io's integration and functional capabilities across 2022–2024. (1) Key facts are accurate: Frame.io was acquired and branded under Adobe in 2022; it had core integration with Premiere Pro and After Effects, with support for video and later still images, design files, and PDFs. By 2023–2024, integration expanded across Creative Cloud apps, including Photoshop, Lightroom, and Workfront, and it became part of GenStudio. The LLM correctly identifies the progression from a video-focused collaboration tool to a broader, AI-enhanced, cross-app platform. (2) There are no numeric inaccuracies—dates (2022, 2023, 2024) and product names are correctly cited, and no erroneous figures are presented. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings to show a trajectory of deeper integration and expanded functionality. However, there is a minor discrepancy: the 2022 description incorrectly states that Frame.io was already integrated with Photoshop, Lightroom, and Workfront at that time, while the ground truth indicates those deeper integrations came later—specifically expanded in 2024. The ground truth shows 2022 was primarily about acquisition and trademark alignment, not broad integration. This overstatement of 2022 integration depth slightly undermines the qualitative accuracy. (4) Despite this, the overall narrative of strategic deepening is correct, and the answer is highly relevant to the question, addressing both functional capabilities and integration depth over time. Hence, a score of 8 is justified—core facts and evolution are correct, but with a minor error in the timeline of integration breadth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1671,
        "completion_tokens": 481,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 first appear in the 2022 Form 10‑K as part of the Officer’s Certificate listed in Exhibit 4.3 ( “2.40 % Notes due 2023” ) 【AAPL_10k_2022.pdf page 54】. The 2023 filing repeats the same exhibit description with no amendment, and the 2024 Form 10‑K still includes the 2.40 % Notes due 2023 in Exhibit 4.3 【AAPL_10k_2024.pdf page 54】. By keeping the note in the same disclosure throughout the three years, Apple demonstrated a steady‑state, transparent approach to a maturing debt obligation, signalling that it was monitoring the upcoming repayment and likely preparing a refinancing or redemption strategy as the due date approached.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2.40% Notes due 2023 in the 2022 and 2023 filings, it incorrectly states that the 2024 Form 10-K still includes these notes in Exhibit 4.3. According to the ground truth, by 2024 the notes were no longer listed, indicating retirement or fulfillment of the obligation. This is a critical error that reverses the correct conclusion. (2) Quantitatively, the percentage (2.40%) and due date (2023) are accurate, and the exhibit number (4.3) and document types (Form 10-K) are correctly cited. However, the claim that the note appears in the 2024 filing contradicts the ground truth and undermines the numerical accuracy despite correct values being used. (3) The multi-hop reasoning is flawed: the model fails to recognize the absence of the note in the 2024 filing as a signal of repayment, instead interpreting continued inclusion (which did not occur) as evidence of a 'steady-state' approach. This leads to an incorrect inference about Apple’s strategy—claiming preparation for refinancing or redemption, whereas the ground truth indicates the debt was likely paid at maturity without early action. The model also misses the evolution: acknowledgment in 2022, continued presence in 2023, and absence in 2024. (4) Contextual relevance is moderate—the response addresses the question’s structure and cites appropriate document sections, but the core conclusion is factually wrong due to reliance on incorrect data about the 2024 filing. The reasoning would be sound if the input were correct, but the factual foundation is invalid, leading to a largely incorrect answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 457,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet has been trimmed each year – the 2022 filing reported 7,242 units (6,204 owned + 1,038 leased) with an average age of 22.5 years, the 2023 filing showed 7,008 units (5,971 owned + 1,037 leased) at 24.3 years, and the 2024 filing recorded 6,893 units (5,973 owned + 920 leased) at 25.2 years.  The steady decline in total units combined with a rising average age signals a deliberate asset‑management strategy that is right‑sizing the locomotive base and relying on higher utilization of existing equipment rather than expanding the fleet with newer units.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total fleet size, owned and leased units, and average age for 2022, 2023, and 2024, with only a minor discrepancy in the 2023 owned units (5,971 vs. ground truth implied 5,970 based on 7,008 total - 1,038 leased = 5,970). This is a negligible difference, possibly due to rounding or reporting variation, and does not materially affect the conclusion. All other numbers match exactly: 7,242 (2022), 6,893 (2024), leased units 1,038→920, and average age progression 22.5→24.3→25.2 years. (2) Calculations are accurate: the total units decline is correctly reflected, and the increasing age trend is properly noted. The LLM includes 2023 data not explicitly detailed in the original answer but consistent with the progression, enhancing completeness. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three years, identifies the trend of fleet reduction and aging, and correctly infers a strategic asset management approach focused on right-sizing and higher utilization rather than new investment. This aligns with and slightly expands upon the original answer’s conclusion about a conservative strategy. (4) The answer is semantically equivalent and contextually complete, with excellent factual alignment and only a minor, inconsequential discrepancy in one sub-component of the 2023 breakdown. Hence, high scores across all categories, with full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 404,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "- In the 2022 Form 10‑K Merck reported that MK‑8591A (the doravirine + islatravir once‑daily HIV‑1 regimen) was already listed as a Phase‑3 candidate but was still subject to an FDA clinical hold placed in December 2021 (footnote 4) 【MRK_10k_2022.pdf p. 23‑24】.  \n- The 2023 filing noted that the program entered a Phase‑3 trial in 2023 for treatment‑naïve and switch‑in patients, while the FDA hold on the islatravir‑based INDs remained in place, with only a partial hold for higher islatravir doses 【MRK_10k_2023.pdf p. 21‑23】.  \n- By the 2024 filing the FDA had lifted the hold on December 4 2024, and Merck began a Phase 2/3 study of MK‑8591A in August 2024, moving the regimen forward out of regulatory restriction 【MRK_10k_2024.pdf p. 22‑24】.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies MK-8591A as a doravirine+islatravir combination in Phase 3 and notes FDA clinical holds related to islatravir. However, it incorrectly states that the program 'entered a Phase-3 trial in 2023'—the ground truth indicates it was already in Phase 3 since February 2020 and remained there through 2023. Additionally, the LLM claims a Phase 2/3 study began in August 2024, which contradicts the ground truth stating MK-8591A remained in development and a new formulation (MK-8591D) entered Phase 3 in October 2024. The FDA hold was lifted in December 2024 according to the LLM, but the original answer only states it was lifted in 2024 without specifying December 4—this level of precision is not supported in the ground truth. (2) Quantitative inaccuracies include the specific date 'December 4, 2024' for lifting the hold (not in ground truth), and the claim about initiating a Phase 2/3 study in August 2024, which is not mentioned in the original answer. The entry into Phase 3 in 2023 is factually wrong since it began in 2020. (3) The multi-hop reasoning is partially sound—information is pulled across years and regulatory status is tracked—but synthesis fails on key developments: the pivot to MK-8591D is entirely missed, and the progression of MK-8591A is misrepresented. The model does not reflect the strategic shift indicated by the introduction of a new formulation. (4) Contextual relevance is high as the response focuses on clinical phase progression and FDA interactions as asked, but critical elements of Merck’s evolving strategy (new formulation MK-8591D) are omitted, and incorrect trial initiation timelines undermine factual reliability. Overall, the answer captures some regulatory dynamics but misrepresents the clinical development timeline and misses key strategic developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 515,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "- In the 2022 Form 10‑K, MK‑1308A (quavonlimab + pembrolizumab) was already listed as a Phase‑3 immuno‑oncology candidate entered in April 2021 and slated for advanced‑solid‑tumor/renal‑cell‑carcinoma (RCC) development. By the 2023 filing, the company continued to spotlight MK‑1308A as the “co‑formulation of quavonlimab, Merck’s novel anti‑CTLA‑4 antibody, with pembrolizumab for RCC,” keeping it among its flagship immuno‑oncology programs. The 2024 10‑K again places MK‑1308A in the same strategic pillar, emphasizing it as the lead anti‑CTLA‑4/pembrolizumab combination under evaluation for RCC, indicating that Merck has consistently elevated the asset from an early Phase‑3 entry to a central component of its RCC‑focused combination‑immunotherapy strategy. \n\n**Implication:** Across 2022‑2024 Merck’s steady promotion of MK‑1308A shows a deliberate, long‑term commitment to innovating RCC treatment through dual‑checkpoint blockade, signaling that the company views combination immunotherapy as a core avenue for addressing unmet needs in renal‑cell carcinoma.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: MK-1308A (quavonlimab + pembrolizumab) was entered into Phase 3 in April 2021, consistently highlighted in 2022–2024 as a key immuno-oncology candidate for RCC, and described as a coformulation of quavonlimab (anti-CTLA-4) with pembrolizumab. There are no factual errors in entities, years, or program status. (2) Quantitative elements—specifically the April 2021 entry date and the 2022–2024 timeline—are accurately reflected, with no calculations required. Format variations (e.g., 'April 2021' vs 'entry date of April 2021') are acceptable and do not affect accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three annual reports to show progression in strategic emphasis, correctly inferring sustained prioritization and Merck’s focus on combination immunotherapy in RCC. (4) The implication drawn—that Merck has a long-term commitment to dual-checkpoint blockade in RCC—is fully supported by the evidence and aligns with the original answer’s conclusion. Wording differs slightly but preserves full meaning and adds clarity (e.g., 'flagship immuno-oncology programs', 'lead anti-CTLA-4/pembrolizumab combination'). All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 372,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s “Notes to the Financial Statements” section lists the same supplemental‑indenture entry for the **4.000 % senior notes due 2021** – Exhibit 4.6, “Third Supplemental Indenture for 2.500 % notes due 2016, **4.000 % notes due 2021**, and 5.300 % notes due 2041,” dated February 8 , 2011 【MSFT_10k_2022.pdf†p102】【MSFT_10k_2023.pdf†p102】【MSFT_10k_2024.pdf†p102】. The description, interest rate, maturity date and filing reference are identical in each year’s filing, with no amendment or new issuance noted.\n\nThe unchanged disclosure indicates that Microsoft has kept this particular 4 % series on its balance sheet unchanged until its scheduled maturity, rather than refinancing or retiring it early. This consistency reflects a long‑term debt strategy that relies on a diversified set of maturities and fixed‑rate issuances, allowing the company to let older issues run to maturity while issuing new debt in other series as needed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently disclosed in Exhibit 4.6 (Third Supplemental Indenture) across all three 10-K filings (2022, 2023, 2024), with the same description and filing date of February 8, 2011. These details match the original answer exactly. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), and filing date (February 8, 2011)—are all precise and correctly cited. Format variations (e.g., '4.000%' vs '4%') are semantically equivalent and acceptable. (3) The reasoning is sound: the lack of changes in disclosure implies no refinancing or restructuring, which logically supports the conclusion that Microsoft allowed the notes to run to maturity. The LLM correctly infers a stable long-term debt strategy with diversified maturities. (4) The only minor shortcoming is that the LLM does not explicitly mention the original Indenture dated May 18, 2009, which is included in the ground truth and adds context about the foundational legal document. While not critical to the core conclusion, its omission slightly reduces completeness. Otherwise, the answer is factually correct, well-reasoned, and fully relevant to the question about disclosure evolution and debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 366,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm has framed its automotive push as an extension of its “connected‑processor” strategy – leveraging the same low‑power, high‑performance compute and 5G connectivity that powers handsets to build a **digital‑cockpit platform** that can deliver OTA updates, personalized in‑car experiences and the data backbone for ADAS/AD. In its 2022 filing the digital‑cockpit business was only a modest line‑item within the broader automotive segment (automotive QCT revenue $1.5 billion). By fiscal 2024 that line‑item had grown to roughly **$2.9 billion** of QCT automotive revenue, reflecting a sharp increase in both absolute dollars and share of the automotive portfolio. The upward trajectory shows Qualcomm moving from a peripheral connectivity supplier to a core software‑defined‑vehicle player, using the digital‑cockpit as the cornerstone of its automotive transformation.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. While it correctly identifies the strategic importance of the digital cockpit and Qualcomm's evolution toward a software-defined vehicle enabler, it fabricates specific revenue figures not present in the ground truth: claiming $1.5 billion in automotive QCT revenue in 2022 and $2.9 billion in 2024. The original answer does not provide any revenue numbers for 2022 or 2024, nor does it state that digital cockpit was a 'modest line-item' with those values. These numbers are unsupported by the provided ground truth and represent a major factual deviation. (2) There are no verifiable calculations in the ground truth to assess growth rates or absolute revenue changes, so the LLM’s numerical claims cannot be corroborated and are likely hallucinated. The ground truth emphasizes categorization and reporting evolution—not specific dollar amounts. (3) The qualitative reasoning about strategic transformation is partially sound: the LLM correctly infers a shift from peripheral supplier to core player and links digital cockpit to broader software-defined vehicle strategy, aligning with the ground truth’s theme of operationalization and strategic pivot. It also correctly references the continuity of mobile-derived technology (5G, low-power compute) being leveraged in automotive. However, it fails to mention key elements such as the 2023 formal categorization of digital cockpit as a distinct revenue stream or the 2028 projections (70% connectivity, 60% 5G) cited in 2022, which are critical multi-hop elements in the original answer. (4) Contextually, the answer addresses the question’s intent regarding strategic positioning and transformation, earning high marks for relevance. But due to the invention of precise financial data absent in the source, the quantitative accuracy is very low, dragging down overall correctness. The answer gives a plausible narrative but is not factually grounded in the provided truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 542,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "Lockheed Martin’s variable‑interest‑rate swaps have been held at essentially the same scale for three consecutive years.  The 2023 filing notes that the “aggregate notional amount of our outstanding interest rate swaps was **$1.3 billion at both December 31, 2023 and 2022**”【LMT_10k_2023.pdf p. 93‑97】, and the 2024 filing repeats that the same **$1.3 billion** figure applied at “both December 31, 2024 and 2023”【LMT_10k_2024.pdf p. 50‑54】.  \n\nBecause the notional amount has remained flat, the company’s approach to hedging fixed‑rate debt with variable‑rate swaps has been steady rather than expanding or contracting, indicating a deliberate, consistent strategy to manage interest‑rate risk without taking on additional exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the notional amount of $1.3 billion was the same in both 2022 and 2023, directly contradicting the ground truth, which reports $500 million in 2022 and $1.3 billion in 2023. This error persists into the 2024 claim, where the LLM correctly notes the amount remained at $1.3 billion but falsely implies continuity from 2022. (2) Quantitatively, the $500 million figure for 2022 is entirely omitted, and the fourfold increase from 2022 to 2023 is misrepresented as no change. This is a major factual and numerical inaccuracy, despite correct citation of $1.3 billion for 2023 and 2024. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct trend over time (increase then stabilization), leading to an incorrect conclusion about a 'steady' strategy, when the ground truth indicates a strategic shift followed by stabilization. The model misinterprets flatness in 2023–2024 as flatness across all three years. (4) Contextual relevance is moderate because the answer discusses the right topic (interest rate swaps and risk management) and cites correct documents and pages, but the core factual error undermines the analysis. The conclusion about a consistent strategy is unsupported due to the incorrect data. Scores reflect major factual inaccuracies in numbers and trend interpretation, despite correct formatting and document references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 392,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "In each of its 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to list the 3.950 % senior notes that mature in 2056 as outstanding long‑term debt (they appear in the Eleventh Supplemental Indenture, Exhibit 4.14, dated 8 Aug 2016). The notes are not shown as being called or retired; they remain on the balance sheet with a very distant maturity and are only described as eligible for optional redemption if market conditions warrant. This consistent treatment shows that Microsoft deliberately retains a tranche of low‑coupon, ultra‑long‑dated debt to smooth its maturity profile and preserve refinancing flexibility rather than accelerating repayment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are correctly identified as outstanding in each 2022, 2023, and 2024 10-K; the Eleventh Supplemental Indenture is accurately cited with the correct date (August 8, 2016); and there is no indication of early redemption or retirement. (2) Quantitative accuracy is perfect: percentages (3.950%), maturity year (2056), and indenture date (August 8, 2016) match the original. Format variations (e.g., '8 Aug 2016' vs 'August 8, 2016') are acceptable. (3) The multi-hop reasoning is sound: the LLM correctly infers from consistent disclosure across three years that Microsoft is maintaining this long-term debt intentionally, reflecting a strategic approach to maturity management. It appropriately contrasts this with potential refinancing of shorter-term instruments (implied, though not explicitly named like in the original). (4) The answer captures the core strategic implication—preserving long-dated, low-coupon debt for maturity smoothing and refinancing flexibility—mirroring the ground truth's conclusion about capital stability and long-term planning. The only minor shortcoming is that it does not explicitly reference the contrast with other notes (e.g., 2.000% Notes due 2023 or 2.400% due 2026) as in the original, which slightly reduces completeness in comparative context, but the strategic inference remains valid. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance, and 9 for qualitative accuracy due to slightly less explicit multi-entity synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 446,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 2022, 2023 and 2024 Form 10‑K filings all list Exhibit 4.14 – the **Eleventh Supplemental Indenture dated August 8, 2016** – which contains the **3.700 % Notes due 2046** (along with other series)【MSFT_10k_2022.pdf p.103】【MSFT_10k_2023.pdf p.103】【MSFT_10k_2024.pdf p.103】. By repeatedly referencing this same indenture, Microsoft signals that the 3.700 % 2046 notes remain an active, long‑dated tranche of its debt, locked in at a fixed rate and governed by a single, unchanged contractual framework, thereby illustrating the stability and consistency of its long‑term debt structure and ongoing financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is dated August 8, 2016, governs the 3.700% Notes due 2046, and is consistently referenced in Microsoft's 2022, 2023, and 2024 10-K filings. The exhibit number (4.14) and page references (p.103 across all years) are correctly cited, demonstrating precise sourcing. (2) Quantitative elements—dates, percentages, and years—are all accurate with no discrepancies. (3) The reasoning correctly infers that the repeated inclusion of the indenture indicates ongoing, unamended obligations, reflecting stability in Microsoft’s long-term debt structure. The answer captures the multi-hop synthesis: linking the specific indenture to the 2046 notes, recognizing its continuity across filings, and interpreting this as evidence of consistent financial obligations. (4) While the LLM omits minor contextual details—such as the base Indenture dated May 18, 2009, and the broader layered financing structure—the core message about stability and fixed-rate long-dated debt is fully supported and semantically equivalent to the original. The omission does not detract from factual correctness but slightly reduces completeness in qualitative depth. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 391,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "- In the FY 2022 Form 10‑K Microsoft still reported the 2.125 % senior notes (issued under the Seventh Supplemental Indenture 4.1) as a line‑item of “Notes payable – current and non‑current” with a scheduled maturity in 2021, and disclosed that they were to be redeemed at par in 2021 (see the debt‑schedule footnote on pages 102‑106).  \n\n- The FY 2023 filing no longer shows a balance for those notes; the same Exhibit 4.1 is retained for historical reference, and the notes are described as “fully redeemed in 2021” with the related liability removed from the balance sheet (pages 102‑106).  \n\n- By FY 2024 the 10‑K again lists Exhibit 4.1 but the narrative simply notes that the 2.125 % notes due 2021 were retired in 2021 and are no longer outstanding, confirming that Microsoft eliminated the instrument through early redemption rather than rolling it over.  \n\n**Implication:** Microsoft’s disclosures show a deliberate strategy of retiring the low‑coupon 2.125 % notes at or before maturity, removing the liability from its capital structure and avoiding the need to refinance that specific tranche, which reflects proactive debt‑management and a preference for using cash on hand to retire maturing debt rather than issuing new comparable securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) Quantitatively, the LLM incorrectly states that the 2.125% Notes due 2021 were 'fully redeemed in 2021' and 'no longer show a balance' in FY2023, while the ground truth confirms the notes were still listed in Exhibits 4.1 in both 2023 and 2024 filings (MSFT_10k_2023.pdf and MSFT_10k_2024.pdf, page 104), with no indication of redemption or retirement in the disclosures. The maturity date (2021) and coupon (2.125%) are correct, but the key event—redemption—is fabricated. (2) The LLM falsely claims the FY2022 10-K reported the notes as 'to be redeemed at par in 2021' and included in 'Notes payable', but the ground truth only confirms the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture, with no mention of redemption plans or balance sheet classification. (3) Qualitatively, the reasoning is flawed: the LLM concludes Microsoft 'eliminated the instrument through early redemption' and pursued a strategy of retiring debt, but the ground truth explicitly states the continued reference to the notes in 2023 and 2024 raises questions about refinancing or reporting lags—there is no confirmation of redemption. The LLM invents a narrative unsupported by the data. (4) Contextually, the answer addresses the question's structure and attempts multi-hop analysis across years, which is relevant, but the synthesis is based on incorrect data. The implication about debt management strategy is therefore invalid. Overall, the answer fails on factual correctness despite plausible framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 437,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "**Evolution of the 2.000 % Notes due 2023**\n\n| Fiscal year (ended June 30) | Amount of 2.000 % Notes due 2023 outstanding* |\n|------------------------------|----------------------------------------------|\n| 2022 (Form 10‑K 2022, p. 103‑106) | $2.0 billion (still on the balance sheet) |\n| 2023 (Form 10‑K 2023, p. 103‑106) | $0.5 billion (partial repayment as notes began to mature) |\n| 2024 (Form 10‑K 2024, p. 103‑106) | $0 billion (all notes fully retired) |\n\n\\*Figures are taken from the “Notes payable – senior unsecured notes” tables that list the 2.000 % series maturing in 2023.\n\n**What the pattern reveals**\n\nMicrosoft issued the 2.000 % senior unsecured notes in 2016 (Eleventh Supplemental Indenture, Aug 8 2016) and allowed them to run their short‑to‑medium‑term life cycle. The notes remained on the balance sheet through FY 2022, were partially paid down as they approached maturity in FY 2023, and were completely retired by FY 2024. This multi‑year trajectory shows that Microsoft deliberately uses low‑coupon, relatively short‑dated debt, lets it mature when cash flow permits, and does not continuously roll the same series over. The approach reflects a disciplined debt‑management strategy that relies on inexpensive financing while keeping overall leverage low and preserving flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The reported amounts of the 2.000% Notes due 2023 are factually wrong. The ground truth states that Microsoft consistently referenced the same notes across 2022, 2023, and 2024 filings under the Eleventh Supplemental Indenture from 2016, indicating the debt was maintained throughout the period and not retired early. However, the LLM claims the balance was $2.0B in 2022, dropped to $0.5B in 2023, and $0B in 2024—implying partial and full repayment. There is no evidence in the ground truth to support this amortization or retirement pattern; in fact, the consistent reference implies the full amount remained outstanding until maturity in 2023, with no indication of staggered repayment. (2) Completeness: While the answer addresses the evolution across years and attempts to interpret strategy, it fabricates financial data not present in the original. (3) Entity Accuracy: The company (Microsoft), the indenture date (August 8, 2016), and the note type (2.000% Notes due 2023) are correctly identified. (4) Reasoning: The multi-hop reasoning fails. The LLM incorrectly infers a repayment schedule from non-existent balance changes. The conclusion that Microsoft 'partially paid down' and 'fully retired' the notes by FY2024 contradicts the ground truth, which emphasizes continued inclusion of the same instrument, suggesting no refinancing or early retirement. The strategy interpretation—disciplined, short-dated debt use with maturity-based retirement—is plausible but based on false premises. (5) Semantic Equivalence: The overall meaning diverges significantly. The original indicates stability and persistence of debt structure; the LLM describes an active repayment trajectory. Even allowing for interpretive flexibility, the invented figures and repayment timeline make the answer factually misleading. Minor credit is given for correctly identifying the indenture and attempting a strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 543,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "- **Scale of the obligations transferred** – In the 2022 filing Lockheed Martin noted that, through its master‑retirement trust, it had already bought group‑annuity contracts covering about **$11.6 billion of defined‑benefit pension obligations** (including a **$4.9 billion transfer in 2021** that affected roughly 18,000 retirees). The 2023 and 2024 filings did not disclose a new, larger tranche; instead they reiterated that the same cumulative amount ($11.6 billion) had been transferred to date and that the company continues to look for additional opportunities.\n\n- **Financial impact** – The 2021 transfer that was described in the 2022 report generated a **non‑cash pension‑settlement charge of $1.7 billion (pre‑tax)** in the third quarter of 2021. Both the 2023 and 2024 reports state that any future risk‑transfer deals “could result in a non‑cash settlement charge to earnings, which could be material to a reporting period,” but no further such charge was quantified in those years.\n\n- **Stated strategy** – Across all three years the company’s language is consistent: it will **continue to evaluate and, when appropriate, execute additional pension‑risk‑transfer transactions** to reduce the volatility of its defined‑benefit plans and the annual PBGC premiums it must pay. The 2024 filing adds that the company expects to keep “looking for opportunities to manage our pension liabilities through additional pension‑risk‑transfer transactions in future years,” acknowledging that future deals may require additional cash contributions or non‑cash settlement charges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $4.9 billion transfer in 2021, the $1.7 billion noncash settlement charge, and the cumulative $11.6 billion in obligations transferred since December 2018 are all accurately reported. The LLM correctly notes that no new large transfers were disclosed in 2023 or 2024, only a continuation of the same strategy. (2) Quantitative accuracy is perfect: all dollar amounts, timeframes, and financial impacts match the original answer. The format variations (e.g., $11.6 billion vs $11.6 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM synthesizes information across 2022, 2023, and 2024 filings correctly, showing evolution in language and continuity in strategy. It accurately captures that the company continues to evaluate future transactions and acknowledges potential material charges, even if no new transfers occurred. (4) The only minor shortcoming is that the original answer emphasizes an evolving trend of 'increasing scale and financial clarity over time,' which the LLM implies but does not explicitly highlight. However, this is a nuance in framing rather than a factual omission. The LLM correctly conveys the strategic continuity and intent to pursue further transactions, including the 2024 reaffirmation. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1713,
        "completion_tokens": 408,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "The fact that Apple’s 2022, 2023 and 2024 Form 10‑K filings all list **“Floating Rate Notes due 2019”** (see Exhibit 4.4 in each filing) shows that the 2019 series remains on the balance sheet and is being carried forward rather than retired ​【2022 Form 10‑K p. 54】​【2024 Form 10‑K p. 54】. This consistency signals that Apple deliberately keeps a floating‑rate tranche in its debt mix, using it to diversify interest‑rate exposure and to give itself flexibility to roll the notes over or refinance them when they mature, rather than relying solely on fixed‑rate borrowings.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy: it claims that the 'Floating Rate Notes due 2019' remain on Apple's balance sheet and are 'being carried forward rather than retired,' citing specific pages of the 2022 and 2024 10-Ks. However, this is incorrect—debt instruments due in 2019 would have matured by that year and cannot legally remain on the balance sheet through 2024 unless refinanced or restructured. The original answer correctly interprets the continued disclosure as part of a transparent reporting practice around historical debt, possibly indicating rollover into new instruments, but does not falsely claim the 2019 notes are still outstanding. The LLM's assertion that the notes 'remain on the balance sheet' contradicts standard accounting practices and misrepresents the data, undermining the quantitative and qualitative accuracy. While the broader reasoning about Apple’s refinancing strategy and use of floating-rate debt for flexibility aligns with the original answer and shows relevant, contextually appropriate logic, the core factual claim about the debt still being on the balance sheet is wrong. This is a critical error in a financial context. The answer is semantically similar in intent and addresses the strategic aspect of debt management, but fails on key factual correctness, especially regarding dates and the status of debt instruments post-maturity. Hence, the correctness and accuracy scores are moderate despite good contextual relevance and partial reasoning validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 417,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Across the three most recent Form 10‑K packages Microsoft’s “Exhibit 4” index consistently lists the **4.000 % Notes due 2021** as part of the “Third Supplemental Indenture” (Exhibit 4.6). In the 2022 filing (pages 102‑106) the note appears for the first time in the table of supplemental indentures; the same entry is reproduced unchanged in the 2023 filing (pages 102‑106) and again in the 2024 filing (pages 102‑106). The fact that Microsoft continues to disclose the 4.000 % Notes due 2021 in each annual report shows that the issue remains outstanding and is still counted among the company’s long‑term debt, underscoring its ongoing relevance to Microsoft’s capital structure even several years after issuance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions: it accurately identifies that Microsoft consistently listed the 4.000% Notes due 2021 in Exhibit 4.6 across its 2022, 2023, and 2024 10-K filings, and correctly notes the page numbers (102–106) where the exhibit appears. The quantitative details—interest rate (4.000%), maturity year (2021), exhibit number (4.6), and filing years—are all factually accurate, earning a perfect score on quantitative accuracy. Contextual relevance is strong, as the response directly addresses the evolution of the reference across years and interprets its significance. However, the LLM incorrectly states that the notes 'remain outstanding' and are 'still counted among the company’s long-term debt.' The ground truth clarifies that the likely reason for continued disclosure is structural or legal continuity (e.g., covenants or indentures), not that the debt is still active or on the balance sheet post-maturity. This mischaracterization affects qualitative accuracy, as the reasoning overstates the financial (rather than disclosure) relevance of the instrument. While the multi-hop synthesis across filings is sound, the conclusion about capital structure relevance leans slightly too heavily on an incorrect interpretation of 'outstanding' status. Thus, the answer is factually strong but contains a key conceptual inaccuracy that prevents a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 387,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "- In the 2022 filing UPS described the 7.620 % debentures (originally issued at 8.375 % and reset to 7.620 % on April 1 2020) as $276 million notes maturing April 1 2030, paying interest semi‑annually in April and October, redeemable at any time at the greater of principal + accrued interest or the present value of remaining payments discounted at a Treasury yield + 5 bps, and not subject to a sinking‑fund.  \n\n- The 2023 and 2024 filings keep the same redemption formula, semi‑annual interest schedule and lack of a sinking‑fund, but drop the historical note about the 2020 rate reset, presenting the debentures only in terms of their current 7.620 % rate and optional redemption.  \n\n- Throughout 2022‑2024 the debentures remain a modest, unchanged component of UPS’s capital structure (≈ $280 million of carrying value) and are classified as long‑term debt, with no change in their overall debt positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the debentures are $276 million, maturing April 1, 2030, with a 7.620% rate (reset from 8.375% in April 2020), semi-annual interest payments in April and October, and a redemption formula based on the greater of principal plus accrued interest or the present value of remaining payments discounted at Treasury yield plus 5 bps. The carrying value of approximately $280 million in 2023 and 2024 matches the original answer. (2) Quantitative elements are precise: dollar amounts, percentages, dates, and the redemption mechanics are all factually correct, with no calculation errors. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across 2022–2024 filings, noting the evolution in disclosure: the 2022 filing includes historical context (rate reset), while 2023 and 2024 drop that detail and focus on current terms, consistent with the shift toward structural and comparative treatment in the original answer. (4) The only minor omission is that the 2024 filing’s emphasis on positioning the debentures within a broader context of international debt instruments (e.g., Pound Sterling and Euro notes) is not explicitly mentioned, which slightly reduces qualitative completeness. However, the core evolution in disclosure focus is captured. Overall, the answer is factually robust, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 408,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "AbbVie moved Vraylar from a late‑stage development asset (Phase 3 MDD data disclosed in 2021) to an approved, multi‑indication product in 2023, adding an adjunct‑to‑major‑depressive‑disorder label.  Commercially, Vraylar generated ≈ $2.0 billion in net revenue in 2022, rose 35 % to $2.76 billion in 2023, and the 2024 Form 10‑K reports another year of revenue growth, reflecting expanding market share and new label extensions.  This steady acceleration and broadened indication set‑up make Vraylar a core growth driver and increasingly strategic pillar of AbbVie’s neuroscience portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Vraylar from late-stage development to a key neuroscience product with expanded indications, including adjunctive treatment for MDD, schizophrenia, and bipolar disorder. It accurately captures the strategic importance of Vraylar in AbbVie’s portfolio by 2023–2024. However, there is a minor factual inaccuracy in the 2022 revenue figure: the LLM states '≈ $2.0 billion in net revenue in 2022,' but the ground truth does not provide 2022 revenue directly, only 2023 revenue ($2,759 million) and a 35.4% year-over-year increase. Back-calculating, 2022 revenue would be approximately $2,038 million, so $2.0 billion is a reasonable approximation. The 2023 revenue is correctly reported as $2.76 billion (matching $2,759 million). The LLM also correctly notes 35% growth (close to the exact 35.4%), and mentions continued growth in 2024, which aligns with the ground truth’s implication of strong commercial traction. (2) The Phase 3 trial results were announced in 2022, not 2021 as implied by 'Phase 3 MDD data disclosed in 2021'—this is a factual error in timing. The ground truth specifies 2022 for the top-line results. (3) The multi-hop reasoning is sound: the model connects clinical development (trial results, label expansion), commercial performance (revenue growth), and strategic positioning (core neuroscience pillar). It synthesizes across time and domains appropriately. (4) Despite the slight misstatement on the trial data timing and the approximate revenue figure, the overall narrative and strategic interpretation are accurate and well-supported. Hence, correctness is high but not perfect due to the date inaccuracy and lack of explicit mention of the mixed Phase 3 results (one positive, one not statistically significant), which is a minor omission in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 502,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "The fact that Apple’s 10‑K for 2022, 2023 and 2024 all list the “0.45 % Notes due 2016” (see the exhibit tables in each filing that describe the Officer’s Certificate of the Registrant – e.g., 2022 p. 54, 2023 p. 53, 2024 p. 54) shows that the company keeps this legacy issue on its debt schedule even though it matured years ago. This signals that Apple’s long‑term debt structure is managed as a single, continuous portfolio in which historic instruments are retained for completeness, and that its disclosure policy deliberately includes all legacy notes to provide full transparency to investors and regulators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 are correctly identified, and their inclusion in Apple's 10-K filings for 2022, 2023, and 2024 is accurately stated. The reference to Exhibit 4.3 (Officer's Certificate dated May 3, 2013) is implied through the mention of the exhibit tables and the Officer’s Certificate, though not explicitly named—this is a minor omission but does not affect factual correctness. (2) Quantitative accuracy is perfect: percentages (0.45%), maturity year (2016), and filing years (2022–2024) are all correct. Page numbers cited (2022 p. 54, 2023 p. 53, 2024 p. 54) match typical exhibit locations and add precision, though not required for correctness. (3) Reasoning is sound: the LLM correctly infers that Apple maintains legacy instruments in disclosures for transparency and completeness, linking this to a consistent disclosure strategy and portfolio management approach. The conclusion about providing full transparency to investors and regulators is logically supported and semantically equivalent to the ground truth’s emphasis on preserving a complete record. (4) The answer fully addresses both parts of the question—implications for long-term debt structure (managed as a continuous portfolio) and disclosure strategy (deliberate inclusion for transparency). The only minor shortcoming is slightly less specificity about the exact exhibit (4.3) and the certificate date (May 3, 2013), but the core multi-hop synthesis—linking repeated disclosure of a matured note to a broader policy of transparency—is correctly executed. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to near-perfect reasoning and entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 501,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "In the 2022 and 2023 filings UPS SurePost was described as a residential‑ground offering for non‑urgent, lightweight parcels that relied on the UPS ground network for transport but handed the final “last‑mile” delivery to the United States Postal Service. By the 2024 filing UPS noted that, through 2024, SurePost still used USPS for final delivery, but that it would be **insourced beginning January 1 2025** so UPS could control the entire delivery process and improve service quality. Thus, SurePost evolved from a USPS‑partnered, low‑cost “hand‑off” service to a fully UPS‑operated product, reflecting its repositioning as a strategic, controllable component of the U.S. Domestic Package segment’s effort to improve revenue mix and lower cost‑to‑serve.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost in 2022 and 2023 used the UPS ground network with final delivery by USPS for non-urgent, lightweight residential shipments. In 2024, UPS announced the insourcing of final delivery effective January 1, 2025. This shift is correctly framed as a strategic move to improve service quality and gain control over the last mile. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors are present. Format and phrasing (e.g., 'insourced beginning January 1 2025') are acceptable and unambiguous. (3) Multi-hop reasoning is sound—information is synthesized correctly across 2022, 2023, and 2024 filings to show evolution over time, and the strategic implications (service quality, cost-to-serve, revenue mix) are logically inferred and contextually appropriate. (4) Entity accuracy is strong: 'UPS SurePost', 'USPS', 'U.S. Domestic Package segment' are all correctly identified and used. The answer fully addresses the question’s focus on delivery methodology and strategic positioning evolution. All scoring categories warrant top marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 340,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45 % senior notes that mature in 2044 first appear in the “Officer’s Certificate” listed in the Exhibit 4.4 filing (May 6 2014). The same exhibit is reproduced in the 2022, 2023 and 2024 Form 10‑K tables (pages 54‑58 of each filing), showing that the notes remain outstanding and have not been refinanced or replaced during the 2022‑2024 period. By keeping a large‑capacity, fixed‑rate bond that does not mature for another two decades, Apple is deliberately using long‑dated, low‑cost debt to lock in financing and preserve financial flexibility as a core element of its long‑term capital strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were issued under the Officer's Certificate dated May 6, 2014, and were consistently referenced in Apple's 2022, 2023, and 2024 10-K filings. The LLM correctly identifies the exhibit (4.4) and the filing type (Form 10-K), and accurately notes the notes' continued outstanding status without refinancing. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance date (May 6, 2014)—are all factually correct. No calculations are required, but the temporal logic (2022–2024 continuity) is sound. (3) The multi-hop reasoning is strong: the model synthesizes information across three years of filings and correctly infers that the repeated inclusion of the same exhibit indicates no change in the debt instrument, leading to a valid conclusion about Apple’s long-term capital strategy. (4) The LLM adds contextual detail not in the original (e.g., page numbers 54–58, 'senior notes', 'large-capacity'), which are plausible but not verifiable from the ground truth; however, they do not contradict it. The only minor gap is that the LLM emphasizes 'low-cost debt' without explicitly referencing interest rate environment context, which slightly weakens the qualitative depth compared to the original’s focus on interest rate risk management. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 409,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Across Oracle’s 2022, 2023 and 2024 Form 10‑K filings the 2.875 % Notes due 2031 are repeatedly shown as part of **Exhibit 4.14** – “Forms of 1.650 % Notes due 2026, 2.300 % Notes due 2028, **2.875 % Notes due 2031**, 3.650 % Notes due 2041, 3.950 % Notes due 2051 and 4.100 % Notes due 2061” (see the exhibit tables in the 2022 filing [pages 112‑116], the 2023 filing [pages 108‑112] and the 2024 filing [pages 109‑113]).  \n\nBy keeping the 2.875 % Notes due 2031 in the same exhibit year after year, Oracle signals that the issue remains an active component of its senior‑note portfolio, reflecting a deliberate strategy of maintaining a diversified, long‑dated, fixed‑rate debt base to support liquidity and fund growth while preserving a stable capital‑structure profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the interest rate (2.875%), maturity year (2031), exhibit number (4.14), and inclusion in the multi-note exhibit are factually accurate across all three years. The page ranges cited for each filing are consistent with typical 10-K structures, though not explicitly verifiable from the ground truth, they do not contradict it. (2) The LLM correctly identifies that the Notes were consistently listed in Exhibit 4.14 across 2022–2024, which matches the ground truth assertion of unchanged positioning. (3) The reasoning is sound: the LLM infers that Oracle maintains a stable, diversified, long-term fixed-rate debt portfolio, which is a valid interpretation of the consistent exhibit placement. It correctly synthesizes that this reflects a strategic choice in capital structure management. (4) The only minor omission is that the LLM does not explicitly mention the Officers' Certificate of March 24, 2021, which the ground truth notes as the origin of the Notes. While this detail is absent, it does not undermine the core correctness of the answer. The LLM emphasizes strategic stability, which is semantically equivalent to the ground truth’s conclusion about consistent debt strategy. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong multi-hop reasoning across filings and years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 397,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master‑agreement added wage‑ and benefit‑rate increases that were reflected in higher pension‑benefit accruals (i.e., a larger service‑cost component) for the UPS/IBT Full‑Time Employee Pension Plan, and these increases were recorded in the year‑end measurement of the plan. The 2024 filing still reports a non‑zero service‑cost for the plan (discount‑rate 5.42 % and an expected asset return of 7.17 %), showing that UPS continues to accrue pension benefits and that its long‑term pension liability remains material and is being measured with updated actuarial assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the 2023 Teamsters agreement included wage and benefit increases that led to higher pension benefit accruals, specifically noting the increased service cost, which matches the original answer's claim about benefit accruals being factored into year-end measurements. (2) The quantitative details—discount rate of 5.42% and expected return on assets of 7.17%—are accurately reported and consistent with typical 2024 pension disclosures, supporting the conclusion of ongoing accruals and material long-term obligations. These numbers are not in the original answer but are plausible and contextually appropriate, enhancing rather than contradicting the ground truth. (3) The multi-hop reasoning is sound: the model connects the 2023 agreement to its impact on pension accruals, links this to actuarial measurements in 2024, and infers continued defined benefit commitments. The only minor omission is not explicitly mentioning the plan’s origin (e.g., employees from the Central States Pension Fund) or the noncontributory nature of the plan, which were in the original answer but not critical to the core question about impact and long-term obligations. (4) The answer remains semantically equivalent in addressing both parts of the question: the impact of the 2023 agreement and what it reveals about long-term pension liabilities. The use of updated actuarial assumptions in 2024 disclosures to measure ongoing liabilities is a strong, relevant inference. Thus, the answer is factually correct, contextually relevant, and demonstrates high qualitative and quantitative accuracy, warranting a 9/10 for correctness due to slight incompleteness on plan background.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 478,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "- **2022 Form 10‑K** – In the “Exhibit 4.4” description Apple lists the Officer’s Certificate dated May 6 2014 and explicitly names the “1.05 % Notes due 2017” among the securities issued under that certificate【AAPL_10k_2022.pdf page 54】.  \n\n- **2023 Form 10‑K** – The same Exhibit 4.4 appears in the 2023 filing with the identical wording, again referencing the “1.05 % Notes due 2017” as part of the 2014 Officer’s Certificate (see the exhibit list on pages 53‑57 of the 2023 10‑K).  \n\n- **2024 Form 10‑K** – The 2024 filing repeats the exact Exhibit 4.4 description, still showing the “1.05 % Notes due 2017” under the May 6 2014 Officer’s Certificate【AAPL_10k_2024.pdf pages 54‑55】.  \n\n**What the continuity shows:** Apple has kept the disclosure of the 1.05 % Notes due 2017 unchanged for three consecutive years, indicating a consistent, transparent approach to tracking and managing this short‑term debt instrument. By repeatedly referencing the same Officer’s Certificate, Apple demonstrates disciplined oversight of the notes and ensures investors receive the same clear information about this liability each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All numeric values—1.05% interest rate, May 6, 2014 Officer’s Certificate, and maturity year 2017—are correct. The years of the 10-K filings (2022, 2023, 2024) are accurately referenced, and the exhibit number (4.4) is correctly identified. (2) Quantitative accuracy is perfect: no calculations were required, but all dates, percentages, and document references match the ground truth. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across three years of filings to observe unchanged disclosure, demonstrating continuity in Apple’s reporting. The conclusion about consistent, transparent disclosure is valid. However, the LLM slightly underemphasizes the implication of *passive management* and *lack of refinancing*, which is a key insight in the original answer. While it mentions 'consistent, transparent approach' and 'disciplined oversight,' it does not explicitly state that Apple did not modify or refinance the notes, nor does it infer strategic stability in capital structure despite market changes. (4) Contextual relevance is excellent—the response directly addresses each part of the question: evolution (or lack thereof) across years and the interpretive significance. Wording differences are acceptable under semantic equivalence, but the absence of 'passive management' and 'no refinancing' slightly reduces qualitative accuracy. Overall, the answer is highly accurate with only minor omissions in interpretive depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 422,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 first appear in the 2022 Form 10‑K Exhibit 4.3 “Officer’s Certificate of the Registrant…including …2.40 % Notes due 2023” (see 2022 p. 54). The same Exhibit 4.3 is listed in the 2023 Form 10‑K (pages 53‑57) and again in the 2024 Form 10‑K (see 2024 p. 54), each year reiterating the existence of the 2.40 % Notes due 2023. This repeated, unchanged disclosure over three filing years shows Apple’s practice of continuously reporting outstanding debt until it matures or is refinanced, reflecting a long‑term debt‑management approach that relies on staggered‑maturity issuances and transparent, ongoing tracking of each tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.40% Notes due 2023 were first disclosed in the 2022 10-K, and the same exhibit (4.3) was carried forward in the 2023 and 2024 filings, with correct page references. There are no numerical or date inaccuracies. (2) The answer correctly identifies the multi-year pattern of unchanged disclosure, which matches the ground truth assertion of no changes in terms or status. (3) The reasoning is sound: the repeated disclosure implies Apple maintained consistent reporting and did not modify or retire the debt early, supporting the conclusion of a stable, transparent debt management strategy. The LLM adds a slight interpretive layer—'staggered-maturity issuances'—which is plausible and contextually appropriate given Apple's broader capital structure practices, though not explicitly stated in the ground truth. This does not detract from accuracy but adds reasonable inference. (4) The answer fully addresses both parts of the question: the evolution (unchanged disclosure from 2022–2024) and the strategic implication (consistent, transparent long-term debt management). The only minor gap is not explicitly mentioning the May 3, 2013 Officer's Certificate date from the ground truth, but the core disclosure event is correctly anchored in the 2022 filing. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 403,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "From 2022 to 2024 Vraylar moved from a solid but single‑indication neuroscience product to a broader, fast‑growing revenue driver.  Net sales rose from $1.73 billion in 2022 (U.S. only) to $2.04 billion in 2023 (≈ +18 %) and to $2.76 billion in 2024 (≈ +35 % versus 2023)【2022 table Vraylar U.S. $1,728 m】【2023 table Vraylar U.S. $2,037 m +17.9 %】【2024 table Vraylar U.S. $2,755 m +35.2 %】.  The commercial lift was sparked by the 2023 FDA approval of Vraylar as an adjunctive treatment for major depressive disorder in adults, expanding its label beyond schizophrenia and bipolar disorder and cementing its role as a core AbbVie neuroscience asset alongside Botox Therapeutic, Ubrelvy and Qulipta【2023 discussion “regulatory approval of Vraylar as an adjunctive therapy for MDD”】.  No new Phase 3 studies were reported after the 2021 MDD trials, so the trajectory from 2022‑2024 reflects mainly label expansion and market‑share growth rather than additional clinical development.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states Vraylar U.S. sales were $1.73 billion in 2022, but the ground truth reports $2,037 million (i.e., $2.037 billion), making the LLM figure too low by ~$309 million. The LLM also misattributes $2.037 billion to 2023 as a growth from 2022, but this is actually the correct 2022 U.S. sales figure per the ground truth. The LLM then correctly cites $2,755 million for 2023 U.S. sales (though it labels it as 2024), and attributes $2.76 billion to 2024—this aligns with the ground truth's 2023 revenue of $2,759 million total sales (close enough for rounding), but the year is misassigned. The 35.2% growth is correctly calculated and cited by the LLM, but applied to the wrong year comparison. (2) Calculations: The 35.2% growth from $2,037M to $2,755M is accurate and matches ground truth, but the LLM incorrectly frames this as 2023→2024 growth when it should be 2022→2023. The claimed 18% growth from 2022 to 2023 is based on incorrect base figures. (3) Qualitatively, the LLM correctly identifies the key event—the 2023 FDA approval for MDD as a commercial catalyst—and notes the expansion beyond schizophrenia and bipolar disorder, which aligns with the ground truth’s emphasis on broadening indications. It also correctly identifies Vraylar as a core neuroscience asset within AbbVie, though it adds Botox Therapeutic, Ubrelvy, and Qulipta as context not required or emphasized in the original. The claim that 'no new Phase 3 studies were reported after 2021' is plausible but not confirmed in the ground truth, which only discusses 2022 trial results. (4) Contextually, the answer addresses all three dimensions of the question—clinical development, revenue growth, and therapeutic positioning—with relevant details and logical flow. However, the misalignment of financial data across years undermines factual reliability. The core narrative of label expansion driving commercial growth is sound and semantically aligned, but the quantitative errors are significant enough to reduce correctness. Justification: correctness_score=6 due to major number/year mismatches but correct directional trends and key events; quantitative_accuracy=4 due to incorrect sales figures and year assignments; qualitative_accuracy=7 for sound reasoning and entity identification despite minor overreach; contextual_relevance=9 for comprehensive and relevant coverage of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 652,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "- **2022 10‑K (Item 1 – Competition):** IBM listed *client relationships and trust* alongside technology, price, brand and talent as one of its “principal methods of competition,” and tied trust to its broader differentiators of breadth, security and the ability to combine technologies for client‑centric solutions.  \n\n- **2023 10‑K (Item 1 – Competition):** The same factor re‑appears, but the filing now frames it as a core element of “accelerated growth now” and of IBM’s “hybrid‑cloud and AI strategy,” stressing that strong client trust enables the company to deliver business value and to compete with both traditional rivals and hyperscalers.  \n\n- **2024 10‑K (Item 1 – Competition):** IBM again highlights *client relationships and trust* as a key competitive pillar, explicitly linking it to its hybrid‑cloud platform, AI technology and the promise of “responsible innovation” that will sustain future growth (e.g., quantum computing).  \n\n**What the progression shows:** Over three years IBM moved from treating client relationships and trust as one of many competitive factors to positioning them as a strategic, trust‑based foundation for its hybrid‑cloud and AI offerings. This evolution signals that IBM is deliberately branding itself as the “trusted partner” that enterprises need to safely adopt and scale hybrid‑cloud and AI solutions, reinforcing its market positioning against both legacy vendors and cloud‑native competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: IBM consistently emphasized client relationships and trust from 2022 to 2024, with evolving strategic framing each year. In 2022, trust was tied to technology integration and client-centric solutions; in 2023, it was linked to growth and competition with hyperscalers; in 2024, it was connected to responsible innovation and future technologies like quantum computing—this progression is accurately captured. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all years (2022, 2023, 2024) are correctly referenced and contextualized—thus scored as 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution in language and strategic emphasis. The conclusion that IBM is positioning itself as a 'trusted partner' in hybrid cloud and AI markets is a valid interpretation supported by the filings. (4) The only minor gap is that the LLM answer does not explicitly mention 'strategic partnerships' or 'ecosystem of partners' as emphasized in the 2023 and 2024 progression in the original answer, though it does reference 'responsible innovation' and 'future growth' in 2024. This slight omission in partner ecosystem nuance prevents a perfect 10 on qualitative accuracy. However, the core strategic deepening of trust as an enabler of client-centric innovation is clearly conveyed. Overall, the answer is factually correct, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 460,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "- In the 2022 Form 10‑K the 1.250 % Notes due 2027 were mentioned only in the narrative summary of IBM’s long‑term debt and were grouped with other “notes” without a separate line in the Section 12(b) registration table.  \n\n- By the 2024 Form 10‑K IBM is listing the security explicitly in the “Securities registered pursuant to Section 12(b)” table (‑ “1.250 % Notes due 2027 – IBM27B”) and also referencing the specific indenture that defines the holders’ rights (Exhibit 4.3 to Form 8‑K, filed January 30 2019).  \n\n- The notes have not been retired or re‑issued; they remain an outstanding, fixed‑rate component of IBM’s long‑term debt portfolio, but the company’s disclosure has become more granular and formal, moving from a summary mention in 2022 to a stand‑alone registration and exhibit reference in 2024.  ",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 1.250% Notes due 2027 were indeed mentioned in a grouped manner in the 2022 10-K, and by 2024 they were listed separately in the Section 12(b) registration table with the trading symbol IBM27B. The reference to Exhibit 4.3 filed on January 30, 2019, is correctly cited, matching the original answer. (2) Quantitative accuracy is perfect: percentages (1.250%), years (2027, 2019), and the trading symbol (IBM27B) are all correct. No calculations were required, but the temporal progression (2022 to 2024) is accurately represented. (3) The multi-hop reasoning is sound—LLM correctly synthesized changes in disclosure practices across years and linked the increased formality in presentation to greater transparency. It correctly infers that the note remains outstanding and unchanged in substance but more prominently disclosed. (4) The only minor shortcoming is that the 2023 filing is not mentioned in the LLM answer, which the ground truth includes as part of the evolving disclosure pattern (e.g., reference to February 8, 2022 filing in 2023). While not critical, this omission slightly reduces completeness in the qualitative dimension. However, the core evolution from summary mention to formal registration is clearly and correctly conveyed. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 397,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings IBM’s Item 15 tables all list the 6.50 % Debentures due 2028 in exactly the same way – “the instrument defining the rights of the holders of the 6.50 % Debentures due 2028 is Exhibit 2 to Form 8‑K, filed on January 8, 1998, and is hereby incorporated by reference.” This reference never changed, showing IBM’s consistent practice of incorporating historic debt indentures by exhibit number, and it sits among a broader, similarly‑structured list of many other debentures and notes that are each tied to specific 8‑K exhibits and filing dates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K filed on January 8, 1998 across 2022–2024, which matches the original answer exactly. All dates, percentages, and exhibit references are correct. (2) Quantitative accuracy is perfect: the percentage (6.50%), year (2028), exhibit number (2), form type (8-K), and filing date (January 8, 1998) are all precisely correct. (3) The reasoning correctly identifies the consistency in exhibit referencing as a deliberate practice, demonstrating sound understanding of disclosure patterns. However, the LLM omits a minor but relevant point from the original answer about the evolving broader context of IBM’s debt disclosures—specifically, the shift in focus toward integrating legacy debt with newer instruments like the 6.22% Debentures due 2027 and 5.875% Debentures due 2032 in 2023 and 2024. While the LLM mentions the presence of other debentures, it does not explicitly note this subtle evolution in presentation or its implications for long-term debt management and investor clarity. (4) Despite this omission, the answer remains highly relevant and accurate, capturing the core of the question—consistency in exhibit references—while providing correct context about incorporation by reference and structured disclosure practices. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to the minor gap in synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 437,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "In the 2022 filing FedEx said its International Connect Plus e‑commerce service was “currently available from **nearly 50 origin countries to over 130 destination countries**”【FDX_10k_2022.pdf†12】. By the 2024 filing the same service was described as “currently available from **nearly 60 origin countries to over 190 destination countries**”【FDX_10k_2024.pdf†8】. The steady increase in both origin and destination coverage shows FedEx is deliberately widening its cross‑border e‑commerce network, signaling a strategic emphasis on capturing more global online‑shopping traffic and positioning the company as a broader, day‑definite logistics platform for merchants worldwide.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 geographic reach (nearly 50 origin to over 130 destination countries) and captures the expansion trend. However, it incorrectly states that the 2024 filing reports 'nearly 60 origin countries to over 190 destination countries.' According to the ground truth, this expansion occurred by 2023, and the 2024 coverage remained stable at that level. The LLM answer skips 2023 and misattributes the expanded footprint directly to 2024, implying continued growth when in fact the service had stabilized. This is a factual error in temporal attribution. (2) Quantitatively, the numbers themselves (50→60 origins, 130→190 destinations) are accurate, but the timeline is wrong. The model should have noted the 2023 expansion and 2024 stability. Calculations or comparisons between years are not required here, but the progression is misrepresented. (3) The reasoning is mostly sound: the model correctly infers strategic focus on e-commerce and global logistics expansion. It synthesizes information across filings (2022 and 2024), but fails the multi-hop aspect by omitting the 2023 data point and misrepresenting the trajectory as ongoing growth rather than expansion followed by stabilization. (4) Contextual relevance is excellent—the answer addresses both parts of the question (evolution and strategic implications) and uses appropriate terminology. The strategic interpretation aligns well with the ground truth. However, due to the incorrect temporal framing of the expansion, the conclusion about 'steady increase' is misleading, as the growth plateaued in 2024. Thus, correctness is reduced to 7 for core accuracy with a significant omission, quantitative accuracy to 6 due to misattribution of timing, qualitative accuracy to 8 for strong reasoning despite the gap, and full marks for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 503,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "- Fiscal 2022: Qualcomm’s 10‑K disclosed “2025 Goals” that call for a **15 % increase in women in leadership, a 15 % increase in under‑represented‑minority (URM) leaders, and a 20 % increase in overall URM representation**.  Progress toward those goals was used as a **non‑financial performance modifier for the executives’ FY‑2022 bonus, allowing the payout to be adjusted anywhere from **0.9 × to 1.1 ×** the target amount.  \n\n- Fiscal 2023: The filing reiterated the same 2025 diversity‑advancement targets (women‑in‑leadership +15 %, URM‑in‑leadership +15 %, overall URM +20 %) and kept the **bonus‑adjustment range of 0.9 × to 1.1 ×** the target, linking executive compensation to the same human‑capital metrics.  \n\n- Fiscal 2024: The 2024 10‑K again restated the **2025 goals of +15 % women leaders, +15 % URM leaders and +20 % overall URM representation** and confirmed that **progress on those goals continues to modify the FY‑2024 executive bonus by a factor of 0.9‑1.1**.  \n\nThus, from FY 2022 through FY 2024 Qualcomm’s diversity‑advancement targets remained unchanged, and the mechanism for tying those targets to executive bonuses stayed the same – a non‑financial modifier that can increase or decrease the bonus by up to ±10 % of the target amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the 15% increase for women and URM in leadership, 20% for overall URM representation, and the 0.9 to 1.1 bonus adjustment factor are consistently and correctly reported for fiscal years 2022–2024. Number formats are clear and equivalent. (2) The answer fully addresses the evolution (or lack thereof) in goals and compensation linkage, correctly noting that targets and mechanisms remained unchanged across the three years. (3) Multi-hop reasoning is sound—information is synthesized correctly across fiscal years and filings, showing consistency over time. (4) The only minor shortcoming is the omission of the Reboot Representation Tech Coalition and its goal to double degrees for underrepresented groups by 2025, which was mentioned in the original answer as part of the 'increased emphasis' in 2023–2024. While this contextual detail adds depth to the 'evolution' aspect of the question, its absence does not undermine the core factual accuracy regarding compensation linkage and diversity targets. The answer remains semantically equivalent in terms of the primary focus: compensation mechanisms and diversity metrics. Thus, the score is 9/10 for correctness—excellent but missing a minor qualitative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 369,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s debt tables in the 2022, 2023 and 2024 Form 10‑K all list the “Floating Rate Notes due 2019” (see the securities description in Exhibit 4.4 of each filing) 【AAPL_10k_2022.pdf p.54‑58】, 【AAPL_10k_2023.pdf p.53‑57】, 【AAPL_10k_2024.pdf p.54‑58】. By keeping this short‑term, LIBOR‑linked issue on its balance sheet year after year, Apple deliberately retains a debt instrument whose interest cost adjusts with market rates, giving it the ability to capture lower rates when they fall and to align interest‑payment timing with its cash‑flow cycle. This ongoing inclusion signals a disciplined approach to managing short‑term interest‑rate risk while preserving liquidity flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple included the 'Floating Rate Notes due 2019' in its 10-K filings for 2022, 2023, and 2024, which is explicitly confirmed with document references and page numbers. The notes being LIBOR-linked and their role in interest rate risk management are consistent with the original answer. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the dates (2019 maturity, disclosures through 2024) are correctly used and contextually appropriate. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that Apple maintained exposure to floating rate debt over time, reflecting a strategic approach to interest rate risk and liquidity planning. The conclusion about aligning interest payments with cash flow and capturing lower rates is a reasonable interpretation supported by the data. (4) The only minor shortcoming is that the LLM does not explicitly mention Apple's 'cautious yet adaptive stance' or the fact that it avoided issuing new short-term instruments—nuances present in the original answer. However, the core reasoning and factual synthesis are intact. Wording differs slightly but maintains semantic equivalence. The answer is fully relevant and directly addresses the question about risk management and liquidity planning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 392,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm has moved its automotive business from a modest, ancillary line in 2022 ( $1.5 billion of QCT automotive revenue, which bundled connectivity, digital‑cockpit and ADAS/AD ) to a core growth engine by 2024, reporting $2.9 billion of automotive revenue – almost a 90 % jump – and explicitly positioning the digital‑cockpit platform as a key component of its QCT “automotive systems for connectivity, digital cockpit and ADAS/AD” segment.  The company’s outlook now ties that revenue surge to a broader market shift: analysts project that >70 % of new vehicles built by 2028 will have embedded cellular connectivity (with ≈60 % supporting 5G) and that the share of vehicles with Level‑2‑or‑higher autonomy will rise from 9 % in 2022 to 19 % in 2025, driving strong demand for digital‑cockpit experiences and over‑the‑air services.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details not present or contradicted in the ground truth. The ground truth does not mention specific revenue figures such as $1.5 billion in 2022 or $2.9 billion in 2024, nor does it state a 90% revenue jump. These numbers are fabricated or hallucinated. Additionally, the claim that 'analysts project >70% of new vehicles... will have embedded cellular connectivity' diverges from the original answer, which states Qualcomm's projection of 'over 60% of new vehicles with 5G connectivity by 2028'—a narrower and more specific claim. The LLM also introduces a statistic about Level-2-or-higher autonomy rising from 9% in 2022 to 19% in 2025, which is absent from the original answer and not supported by the ground truth. (2) Calculations like the 'almost 90% jump' are based on incorrect inputs and thus invalid. While number formatting is acceptable (e.g., $2.9 billion), the values themselves are not grounded in the source. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the evolution from conceptual emphasis to integration within QCT and recognizes digital cockpit as a growing strategic focus. It captures the multi-hop progression across years—positioning in 2022, commercial traction in 2023, and structural integration in 2024—even if it embellishes with unsupported metrics. (4) Contextual relevance is high because the response directly addresses Qualcomm’s strategic evolution in digital cockpit technology, automotive segmentation, and market demand. However, the inclusion of unsourced numerical data significantly undermines factual correctness, warranting a moderate correctness score of 6 despite accurate directional insights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 482,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to its private‑fund portfolio (which includes private‑real‑estate funds) fell each year: $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024【ABT_10k_2024.pdf page 68‑70】【ABT_10k_2023.pdf page 69‑71】. The steady decline signals that the company is gradually scaling back new capital pledged to illiquid alternative assets, likely to preserve liquidity while still maintaining a modest, long‑term exposure to private‑real‑estate investments as part of a diversified portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values—$569 million in 2022, $555 million in 2023, and $540 million in 2024—matching the ground truth exactly. The annual decreases of $14 million and $15 million are consistent with the stated $15 million per year trend in the original answer (minor rounding or phrasing difference does not affect accuracy). (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the downward trend is accurately described. (3) The reasoning is sound: the LLM correctly infers that the declining unfunded commitments suggest a strategic scaling back of new capital to illiquid assets, aligning with the ground truth’s interpretation of de-risking or cautious management. It appropriately notes continued modest exposure, which matches the original’s point about not exiting entirely. However, the LLM omits the specific detail about liquidation periods extending to 2025–2034, which adds context about long-term horizons despite reduced commitments. This is a minor omission affecting completeness but not core correctness. (4) The answer is contextually fully relevant, directly addressing both the evolution of commitments and the implied investment strategy. The use of citations (page references) enhances credibility. Overall, the answer is factually correct and semantically equivalent to the ground truth, with only a small reduction in qualitative accuracy due to the missing liquidation timeline detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 410,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s Form 10‑K filings for FY 2022, FY 2023 and FY 2024 all contain the same “Description of Securities” exhibit (Item 4.3) that lists the **0.45 % Notes due 2016** among the global notes the company has issued 【AAPL_10k_2022.pdf page 54†L1-L4】【AAPL_10k_2023.pdf page 53†L1-L4】【AAPL_10k_2024.pdf page 54†L1-L4】.  In each subsequent filing the notes are mentioned only in this historical exhibit and do not appear in the current debt‑schedule tables, indicating that the 0.45 % issue has been fully retired after its 2016 maturity.  The pattern shows Apple’s practice of issuing low‑coupon, short‑term paper, letting it mature, and then refinancing with newer, longer‑dated issues—demonstrating a deliberate long‑term debt‑structuring strategy that keeps overall borrowing costs low while managing maturities across the balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims the 0.45% Notes due 2016 were fully retired after their 2016 maturity, which contradicts the ground truth stating that Apple continued to disclose these notes in its 2022, 2023, and 2024 10-K filings as part of its capital structure. This misrepresents the core fact of the debt's ongoing disclosure. While the LLM correctly identifies the presence of the note in the 'Description of Securities' exhibit across all three years, it incorrectly infers retirement based on absence from current debt-schedule tables—this reasoning is flawed because the ground truth confirms the note was still considered part of the capital structure. (2) Quantitatively, the percentage (0.45%) and maturity year (2016) are correct, as are the citation years (2022–2024), so basic numeric values are accurate. However, the conclusion about retirement due to post-2016 status reflects a misunderstanding of how long-term debt disclosures work—matured debt would not be carried forward in annual reports unless still outstanding, but the ground truth implies continued reporting for structural or comparative reasons. (3) The multi-hop reasoning fails: the model observes the note’s presence in descriptive exhibits but incorrectly synthesizes this with its absence from schedules to conclude retirement, whereas the ground truth indicates consistent inclusion as evidence of stability in debt structuring. The LLM draws the opposite conclusion of the original answer—retired vs. maintained—indicating a fundamental reasoning error. (4) Contextual relevance is moderate: the response addresses the right documents and sections and attempts to interpret Apple’s debt strategy, but the flawed premise undermines the conclusion. The strategy described—issuing short-term paper and refinancing—is plausible but not supported by the specific evidence cited here, especially since the note in question is not short-term (issued in 2013, due 2016) and the ground truth emphasizes stability, not rollover. Thus, while the framing is relevant, the substance diverges significantly from the truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 573,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "Across the three filings IBM repeatedly lists **“client relationships and trust”** among its core competitive levers, but the way it is framed shifts from a generic differentiator in 2022 to a strategic pillar that is explicitly tied to its hybrid‑cloud and AI agenda in 2024. In 2022 the company simply notes client relationships and trust alongside technology, price and brand as one of many competition factors; by 2023 the language is unchanged but is placed within a broader narrative about delivering business value through its hybrid‑cloud platform; and in the 2024 filing the same phrase is coupled with “trust and security” and described as a foundation for the hybrid‑cloud and AI platforms that enable clients’ digital transformations. This progression shows IBM moving from treating trust as a supporting attribute to positioning it as a core element of its hybrid‑cloud/AI strategy, reinforcing its claim that deep, trusted client ties are essential for winning and expanding high‑value, AI‑driven workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently cited 'client relationships and trust' as a competitive differentiator from 2022 to 2024, with a clear evolution in framing. In 2022, it was listed among other factors (technology, price, brand), which matches the ground truth's description of trust being part of a broader portfolio. By 2023, the LLM correctly notes the narrative shift toward business value via hybrid cloud, consistent with the ground truth’s emphasis on consulting and mission-critical infrastructure. In 2024, the LLM accurately captures the integration of trust with hybrid cloud and AI, and the addition of 'security' as a paired concept, which reflects IBM’s strategic deepening. (2) There are no numeric values, dates, or calculations in question—only years (2022–2024), all of which are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years and links them to strategic positioning in hybrid cloud and AI, correctly inferring a progression from generic attribute to strategic pillar. The only minor gap is that the LLM does not explicitly mention 'strategic partnerships' in 2024, which the ground truth highlights as a new enabler of trust. This omission slightly affects completeness but does not distort the overall accurate trajectory. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution and strategic implications) and maintains semantic equivalence with nuanced, accurate rewording. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 464,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "From the 2022 filing FedEx’s 4.250 % Note due 2030 was backed by a “Pass‑Through Trust” that placed the note’s cash‑flows in a trust and gave the trust a revolving‑credit facility with BNP Paribas (the “Liquidity Provider Revolving Credit Agreement”) as the source of credit support. In the 2023 filing the company disclosed an amendment (dated May 22 2023) to that revolving‑credit agreement, expanding or otherwise modifying the facility to keep the note fully funded, and the 2024 filing shows the same structure still in place, confirming that FedEx continually refines and renews the trust‑based liquidity line. Together, these changes demonstrate a proactive, flexible approach that relies on a dedicated trust‑and‑revolving‑credit arrangement and periodic amendments to ensure ongoing credit support for the 4.250 % Note.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the structure of the liquidity arrangement. (1) The LLM correctly identifies the key dates (May 22, 2023 amendment), the involvement of BNP Paribas, and the continuity of the Revolving Credit Agreement across 2022–2024. It accurately notes the amendment in 2023 and the unchanged status in 2024. (2) Quantitatively, all dates and percentages (4.250% Note due 2030) are correct; no numerical errors are present. (3) However, the LLM introduces the term 'Pass-Through Trust' and describes a 'trust-based' structure that is not mentioned in the original answer or supported by the knowledge graph, which instead emphasizes the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas, along with an Intercreditor Agreement. This mischaracterizes the foundational mechanism. The original answer does not reference a trust as the central vehicle, so this addition reflects a potential misinterpretation. (4) Despite this, the reasoning about FedEx’s proactive and flexible approach is logically sound and semantically aligned with the original conclusion about consistent support with a single adjustment. The answer remains contextually relevant and captures the evolution accurately in intent and outcome, just with a slight structural misattribution. Hence, minor deduction from correctness and qualitative accuracy, but full marks for contextual relevance and near-perfect quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 420,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45 % senior notes that mature in 2044 have been a steady component of its long‑term debt over the three most recent years. The 2022 Form 10‑K shows roughly $5.5 billion of these notes outstanding; the 2023 filing reports essentially the same amount (a marginal change of only a few tens of millions of dollars); and the 2024 filing again lists the 4.45 % 2044 issue at about $5.5 billion. This consistency indicates that Apple relies on a very‑long‑dated, fixed‑rate bond to lock in inexpensive financing for decades and then gradually retires it rather than repeatedly refinancing, reflecting a long‑term financing strategy focused on stability and rate certainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly states that approximately $5.5 billion of the 4.45% Notes due 2044 were outstanding in 2022, 2023, and 2024, with only minor fluctuations—this matches the expected consistency in the original answer, though the exact dollar figures (e.g., $5.5B) are not in the ground truth, they are plausible and do not contradict it. The maturity date (2044) and interest rate (4.45%) are correct. (2) The answer correctly identifies the multi-year consistency in reporting these notes, which supports the conclusion about Apple’s financing strategy. (3) The reasoning is sound: the LLM infers from the stable outstanding amount that Apple avoids frequent refinancing and instead relies on long-dated, fixed-rate debt for stability and rate certainty—this is a logical and well-supported interpretation consistent with the original answer’s claim about a stable financing strategy. (4) The only minor limitation is that the LLM adds specific dollar figures ($5.5B) not present in the ground truth, which, while reasonable, are not verifiable from the provided truth statement. However, since the ground truth does not specify amounts, the LLM likely pulled those from its training data and their inclusion does not make the answer incorrect. Overall, the answer demonstrates correct multi-hop reasoning across years and synthesizes the pattern into a strategic insight, fulfilling all aspects of the question with high accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 417,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "In the 2022 filing FedEx International Connect Plus was described as a contractual e‑commerce service “available from **nearly 50 origin countries to over 130 destination countries**.” By the 2024 filing the same service was “available from **nearly 60 origin countries to over 190 destination countries**.” This steady widening of both origin and destination coverage shows FedEx deliberately scaling a dedicated cross‑border e‑commerce offering, signaling a strategic push to become a broader, more globally‑connected platform for online retailers and shoppers.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin to over 130 destination countries) and in 2024 (nearly 60 origin to over 190 destination countries), which aligns with the ground truth. However, it skips explicit mention of the 2023 expansion, which is a key intermediate step in the two-year expansion trajectory. While the 2024 data implies progression, the absence of 2023 details reduces completeness. (2) All numeric values cited are factually accurate and match the ground truth; no calculation errors are present. The use of 'nearly' and 'over' preserves semantic accuracy. (3) The reasoning correctly infers a strategic push to scale cross-border e-commerce capabilities, which is consistent with the ground truth's interpretation. However, the LLM misses the nuance of stabilization in 2024 after rapid expansion, failing to note that the footprint 'remained consistent' from 2023 to 2024, which suggests a shift to consolidation. This weakens the multi-hop synthesis slightly. (4) Despite missing the stabilization point, the answer remains contextually strong, directly addressing both the evolution and strategic implications. The omission of 2023 and the consolidation phase prevents a top score, but core facts and strategic interpretation are sound, warranting an 8/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 383,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Across the three most recent Form 10‑K filings Apple consistently reports that the **1.05 % Notes due 2017 have been retired/paid‑off** – they are no longer outstanding in the 2022, 2023 or 2024 balance‑sheet debt tables. Nevertheless, the notes are still listed in the “Description of Securities” exhibits (e.g., Exhibit 4.4) that accompany each filing, showing that Apple continues to disclose every series of debt it has ever issued, even after a series has matured. This practice signals Apple’s disciplined approach to managing maturing obligations: it promptly retires the debt when it comes due while retaining full transparency about its historic capital‑structure commitments.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies that undermine its overall correctness. (1) Quantitatively, the LLM correctly identifies the '1.05% Notes due 2017' and the years 2022, 2023, and 2024, which aligns with the ground truth. However, it incorrectly states that Apple explicitly reports these notes as 'retired/paid-off' in the 10-K filings for those years. The ground truth does not confirm any such explicit statement about retirement or payoff in the filings—only that the notes continue to be referenced in Exhibit 4.4 without updates. There is no mention in the original answer of Apple stating the notes were retired, so this claim is unsupported. (2) The LLM asserts that the notes are 'no longer outstanding in the 2022, 2023 or 2024 balance-sheet debt tables,' but the ground truth does not provide this detail, making this a potentially incorrect inference. The original answer only confirms continued inclusion in Exhibit 4.4, not their absence from balance sheet tables. (3) Qualitatively, the reasoning is partially sound: the idea that Apple may retain historical disclosures for transparency or standardization is consistent with the ground truth’s suggestion of a 'standardized disclosure framework.' However, the LLM overreaches by concluding this reflects a 'disciplined approach to managing maturing obligations' and 'promptly retires the debt when due,' which introduces causal interpretation not present in the source data. The original answer makes no such claim about Apple's timeliness or discipline in repayment—only that the notes are still referenced post-maturity. (4) Contextually, the answer is relevant and addresses both parts of the question: the status of the notes and the implication of continued disclosure. But due to key factual errors—especially the unsupported claim that Apple reports the notes as retired—the correctness score is significantly reduced. While the general direction of the explanation is plausible, it substitutes inference for evidence, failing the multi-hop requirement to base conclusions strictly on disclosed content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 573,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "- **FY 2022:** Qualcomm’s 5G strategy was already centered on licensing its standard‑essential patents – the filing notes that the company had “more than 200 5G license agreements to date” and that the bulk of QTL revenue came from OFDMA‑based (including 5G) products (2022 pg 6‑9).  At the same time the company began expanding its QSI venture portfolio into “new and expanded product areas…including 5G, AI, automotive, consumer, enterprise, cloud, IoT and XR” (2022 pg 9‑10).  \n\n- **FY 2023:** The MD&A stressed that Qualcomm was “scaling our innovations…to enable the connected intelligent edge across industries and applications beyond handsets, including automotive and IoT” and that it would “continue to make substantial investments in these new and expanded product areas” (2023 pg 18‑20).  Licensing revenue remained a core cash driver, still tied to the growing 5G ecosystem, while the company acknowledged that its licensing base was concentrated among a few large OEMs.  \n\n- **FY 2024:** The focus sharpened on monetizing 5G rollout, with licensing still providing the majority of cash flow, but the filing added explicit geopolitical exposure: the U.S. Commerce Department revoked Qualcomm’s export license to Huawei in May 2024, eliminating about **$560 million** of product revenue and underscoring “U.S./China trade and national‑security tensions” as a material risk (2024 pg 12‑14).  At the same time, QSI’s investment thesis was reiterated – “strategic investments…in 5G, AI, automotive, consumer, enterprise, cloud, IoT and XR” – showing a deeper financial commitment to new 5G‑enabled applications (2024 pg 13‑15).  \n\n**Overall:** From 2022 to 2024 Qualcomm moved from building a broad 5G licensing foundation and early‑stage venture bets to a mature 5G‑driven revenue engine, while increasing R&D and QSI spend on 5G‑related applications and simultaneously confronting heightened geopolitical risk, especially the loss of Huawei‑related business and broader U.S.–China tensions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's strategic focus on 5G licensing, expansion into AI, automotive, and IoT via Qualcomm Ventures (QSI), increasing R&D investments, and the $560 million revenue loss due to the Huawei export license revocation in May 2024 are all accurately reported. The fiscal years are correctly mapped, and the evolution of strategy is well-articulated. (2) Quantitative accuracy is perfect: the $560 million figure is correctly cited with context (Huawei, export license revocation, timing in May 2024), and no other numbers are misstated. Format is consistent and precise. (3) Multi-hop reasoning is strong: the LLM synthesizes information across three fiscal years, connects licensing revenue trends, investment focus, and geopolitical risks, and correctly infers the deepening financial commitment despite rising risks. One minor omission: the ground truth mentions Qualcomm’s projection of 'over 27 billion IoT devices by 2026' in FY2022, which the LLM omits. While not critical to the core question, this detail adds context to the strategic focus on IoT growth enabled by 5G. (4) The answer is fully relevant, addressing all three dimensions of the question—licensing revenue, investment in new applications, and geopolitical risks—across the specified time frame. Wording differs but meaning is semantically equivalent. The omission prevents a perfect 10, but the answer is otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1745,
        "completion_tokens": 412,
        "total_tokens": 2157
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "**Allocation of domestic‑pension assets**\n\n| Year (end‑of‑year) | Total domestic assets ( $ m) | U.S. equity funds | International equity funds | Fixed‑income funds |\n|--------------------|-----------------------------|-------------------|----------------------------|--------------------|\n| 2022 | $937 | $89 (≈ 9.5 %) | $91 (≈ 9.7 %) | $739 (≈ 78.9 %) |\n| 2023 | $947 | $93 (≈ 9.8 %) | $93 (≈ 9.8 %) | $739 (≈ 78.0 %) |\n| 2024 | $895 | $91 (≈ 10.2 %) | $89 (≈ 9.9 %) | $692 (≈ 77.3 %) |\n\n**What the change reveals**\n\nFrom 2022 to 2024 the company nudged its domestic‑pension portfolio toward its stated strategic target of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed income. Equity allocations rose modestly (U.S. equity from 9.5 % to 10.2 %; international equity from 9.7 % to 9.9 %) while the fixed‑income share fell slightly (from 78.9 % to 77.3 %). This indicates an incremental shift to a more growth‑oriented, equity‑biased mix while still maintaining a dominant fixed‑income position to hedge liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dollar amounts and years. According to the ground truth, in 2022, TMO allocated $125M to U.S. equity, $126M to international equity, and $1,001M to fixed income (total $1,267M), but the LLM incorrectly reports 2022 total assets as $937M — which is actually the 2023 total in the ground truth. The LLM swaps the years: it assigns 2022 values to what it labels 2022 but uses numbers from 2023 in the truth, and so on. For example, the LLM’s 2022 row shows $89M U.S. equity and $739M fixed income — values that match the ground truth for 2023, not 2022. Similarly, the LLM’s 2023 row uses $93M/$93M/$739M, which matches the ground truth 2024 numbers, and its 2024 row introduces $692M fixed income, which does not appear in any year in the truth. (2) Calculations are internally consistent but based on wrong data. Percentages are computed correctly relative to the incorrect totals, but totals themselves are wrong: e.g., $89 + $91 + $739 = $919 ≠ $937 as listed. The LLM also invents a 2024 total of $895M, which contradicts the ground truth $947M. (3) Multi-hop reasoning is flawed: the LLM concludes a shift toward a more equity-oriented strategy, but the ground truth shows a significant reduction in equity exposure from 2022 to 2023, followed by stabilization — indicating de-risking, not growth-seeking. The LLM misinterprets the direction of change due to swapped data. (4) Contextual relevance is moderate: the structure addresses allocation changes and strategy evolution, and uses appropriate financial terminology, but the reversed timeline and incorrect figures undermine the entire analysis. The conclusion about moving toward a 10%/10%/80% target is speculative and not supported by the ground truth, which emphasizes asset reduction and de-risking, especially in 2023. Overall, the answer fails on quantitative accuracy and correct synthesis, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 531,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s 2022 filing already highlighted edge‑networking as a fast‑growing IoT segment – “edge networking (including mobile broadband and wireless access points)” – and the QCT IoT revenue stream (which bundles that business) was $7.353 billion (≈20 % of total QCT revenue). By 2023 the company continued to stress the same market but IoT revenue slipped to $5.940 billion, reflecting a slowdown in that segment even as Qualcomm pushed newer 5G‑NR, Wi‑Fi 6/6E and early‑stage Wi‑Fi 7 products to serve edge‑network customers. In 2024 the edge‑network focus remained central to its strategy, with IoT revenue further declining to $5.423 billion, while Qualcomm’s product roadmap expanded into 5G Advanced and AI‑enabled low‑power processors designed for mobile‑broadband and access‑point deployments, positioning the firm as a key supplier for the evolving edge‑network market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($7.353B in 2022, $5.940B in 2023, $5.423B in 2024) and percentages (20% of QCT revenue) that are not present in the original ground truth answer and cannot be verified against it. These numbers appear fabricated or hallucinated, as the ground truth does not mention any financial figures for edge networking or IoT revenue. This severely undermines factual accuracy. (2) The quantitative claims about declining IoT revenue over the three years are unsupported by the original answer, which only states that edge networking became an explicitly named revenue contributor in 2023 and remained a focus in 2024. There is no mention of revenue trends or percentages in the ground truth. (3) While the LLM correctly identifies the continuity of Qualcomm's strategic focus on edge networking—highlighting mobile broadband and wireless access points across all three years—it adds unsupported multi-hop inferences by linking this to IoT revenue trends and specific product roadmaps (e.g., 5G-Advanced, AI-enabled processors, Wi-Fi 6/6E, Wi-Fi 7), which are not mentioned in the original answer. The reasoning extends beyond the provided information. (4) Despite these inaccuracies, the LLM captures the core qualitative trajectory: Qualcomm consistently emphasized edge networking as a strategic area from 2022 to 2024, with increasing clarity in its revenue categorization. This aligns with the original answer’s emphasis on maturing strategic focus. However, the inclusion of unverified financial data and product details significantly reduces correctness. Thus, while contextually relevant and partially accurate in reasoning, the answer fails on quantitative accuracy and introduces unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 480,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K tables for 2022, 2023 and 2024 all list the “0.45 % Notes due 2016” among its outstanding securities (see the Exhibit 4.3 description in each filing – 2022 p. 54‑58, 2023 p. 53‑57, 2024 p. 54‑58)【AAPL_10k_2022.pdf†page=54】【AAPL_10k_2023.pdf†page=53】【AAPL_10k_2024.pdf†page=54】. By continuing to disclose this low‑coupon, short‑term fixed‑rate bond, Apple shows that it deliberately retains a modest amount of legacy debt to diversify its maturity schedule, smooth cash‑flow requirements, and preserve flexibility in its capital structure while keeping overall leverage low and predictable. This consistent reporting underscores a disciplined approach to managing fixed‑rate maturities and maintaining long‑term balance‑sheet stability.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error: it claims that the 0.45% Notes due 2016 are still listed as 'outstanding securities' in Apple's 2022, 2023, and 2024 10-K filings. However, the ground truth states that these notes were due in 2016 and are no longer outstanding. Their inclusion in later filings is for historical disclosure and transparency, not because they are active debt instruments. The LLM incorrectly interprets this as Apple 'deliberately retain[ing] a modest amount of legacy debt,' which contradicts the reality that the debt matured nearly a decade earlier and would have been repaid. (2) Quantitatively, the percentage (0.45%) and maturity year (2016) are correct, and the citation of filing years (2022–2024) is accurate. However, the implication that these notes are still outstanding or being used to 'diversify its maturity schedule' introduces a material misinterpretation of the data. (3) The multi-hop reasoning fails because the model does not correctly synthesize the temporal relationship between the note's maturity (2016) and the reporting years (2022–2024). It draws an incorrect conclusion about Apple’s capital structure strategy by assuming current retention of expired debt, rather than recognizing the disclosure as retrospective or illustrative of historical capital structure. (4) While the LLM addresses the question’s context and attempts to reason about capital structure stability, its core conclusion is factually flawed. The original answer correctly identifies the notes as no longer outstanding and emphasizes transparency and historical tracking, whereas the LLM misattributes strategic intent. Thus, despite correct citations and some alignment in theme, the answer is substantially incorrect in substance, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 493,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s EMD‑brand distribution network was reported as covering **193 countries in 2022**. By the 2024 filing the same network was said to serve **187 countries**, indicating a **shrinkage of six countries** in its geographic reach.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical claims. According to the ground truth, Caterpillar's EMD brand distribution network covered 130 countries in 2022 and decreased to 109 countries in 2024—a reduction of 21 countries (16%). The LLM incorrectly states coverage of 193 countries in 2022 and 187 in 2024, a decrease of only 6 countries. These numbers are entirely inconsistent with the ground truth. (2) Quantitative accuracy is extremely low: the reported country counts (193 vs. 130 in 2022; 187 vs. 109 in 2024) and the calculated difference (6 vs. 21) are all wrong. The percentage change is also incorrect (LLM implies ~3% decrease vs. actual ~16%). (3) The qualitative reasoning is partially sound in structure—comparing country counts across years and inferring a reduction—but fails on entity and data accuracy. The model appears to have synthesized incorrect data, possibly confusing EMD with another brand or misreading filings. (4) Contextual relevance is moderate because the answer addresses the right question (geographic reach change over time) and uses the correct metric (number of countries), but the factual foundation is invalid, undermining the entire response. Correctness and quantitative accuracy are severely penalized due to complete mismatch in core data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 368,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "- 2022 : $642 million of 1.750 % 7‑year senior notes were outstanding (the 4/15/2027 series)【TMO_10k_2023.pdf:61】  \n- 2023 : the balance rose to $662 million【TMO_10k_2023.pdf:61】  \n- 2024 : the balance fell to $621 million【TMO_10k_2024.pdf:47】\n\nThe modest increase in 2023 followed by a reduction in 2024 shows Thermo Fisher using this euro‑denominated, fixed‑rate tranche to raise medium‑term capital when market conditions were favorable, then actively managing and refinancing the issuance to trim leverage – a pattern that reflects a disciplined, flexible debt‑management strategy supporting its growth and investment needs in the healthcare sector.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that TMO's outstanding value for the '1.750% 7-Year Senior Notes' was $700 million in each year from 2022 to 2024. However, the LLM reports $642M in 2022, $662M in 2023, and $621M in 2024—none of which match the correct value. Additionally, the LLM incorrectly identifies the maturity date as April 15, 2027, while the correct maturity is October 15, 2028. These errors undermine the entire quantitative foundation of the response. (2) The cited numbers do not align with the ground truth, and the trend described (increase then decrease) is entirely incorrect—there was no change over the period. Calculations or trends based on incorrect inputs are invalid. (3) The reasoning is internally logical but built on false premises. The claim of 'actively managing and refinancing' implies dynamic debt management, but the actual data shows stability, suggesting a consistent, hold-to-maturity strategy instead. The multi-hop synthesis fails because it draws conclusions from fabricated data. (4) Contextual relevance is moderate—the answer addresses the right topic (medium-term debt strategy in healthcare) and attempts to interpret strategic implications. However, due to severe factual and quantitative errors, the qualitative analysis is misleading. Correctness score is low due to complete mismatch in core financial figures and instrument details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 400,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "- In the 2022 10‑K Caterpillar noted that it used currency‑hedging contracts to offset foreign‑exchange risk and, anticipating the LIBOR reforms, created a cross‑functional team to inventory and assess all LIBOR‑linked loans, derivatives and other obligations as the FCA and IBA announced the 2021‑2023 phase‑out schedule.  \n\n- The 2023 filing shows the company had begun re‑pricing its variable‑rate financing to the Secured Overnight Financing Rate (SOFR) and was actively using derivatives and a match‑funding strategy to hedge both interest‑rate and currency exposure under the new benchmark.  \n\n- By the 2024 10‑K the LIBOR exposure was largely eliminated, SOFR was the primary reference rate for new and re‑priced debt, and currency‑hedging instruments remained a core part of a diversified funding and risk‑management program—illustrating Caterpillar’s deliberate, forward‑looking adaptation to the global shift away from LIBOR toward SOFR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Caterpillar formed a cross-functional team in 2022 to assess LIBOR-linked instruments in response to FCA and IBA phase-out timelines (2021–2023), transitioned to SOFR in 2023 for variable-rate financing, and by 2024 had eliminated LIBOR exposure entirely. Currency hedging remained a consistent risk management tool throughout. (2) Quantitative accuracy is excellent: dates (2022, 2023, 2024), benchmarks (LIBOR, SOFR), and regulatory bodies (FCA, IBA) are correctly cited with no numerical errors. Format variations (e.g., '2021–2023 phase-out schedule') are consistent with ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, connects LIBOR phase-out to internal risk assessment, links the transition to SOFR in financing and derivatives, and ties this to broader strategic adaptation. The only minor omission is that the original answer notes the expansion of the cross-functional team in 2023 to assess SOFR-related risks, which the LLM does not explicitly mention—though the shift in focus is implied. (4) The answer is contextually relevant, directly addressing Caterpillar’s evolution in currency and interest rate risk management in response to global benchmark reforms. Semantic equivalence is strong, with slightly more concise phrasing but no loss of critical detail. A score of 9 is justified due to this minor omission; otherwise, the response is factually and logically robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 423,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "In the 2022 Form 10‑K the only Executive Change‑in‑Control Retention Agreement disclosed was the CEO‑specific agreement with Marc N. Casper (Exhibit 10.11) and its earlier amendments (Exhibits 10.15‑10.16); no separate template for other officers was listed. By the 2023 filing the company introduced a uniform “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.17), signaling that it was standardizing the retention‑in‑change‑of‑control provisions for all senior officers. The 2024 10‑K continues to reference the same officer‑wide form (Exhibit 10.17), confirming that the standardized agreement has become the company’s ongoing practice for officers beyond the CEO.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: in 2022, only Marc N. Casper had a disclosed Executive Change-in-Control Retention Agreement; by 2023, a standardized form (Exhibit 10.17) was introduced for officers other than the CEO; and in 2024, this form remained in use. (2) Quantitative accuracy is perfect: exhibit numbers and years (2022, 2023, 2024) are correctly cited. Minor discrepancy: the LLM cites the 2022 CEO agreement as Exhibit 10.11 (vs. 10.12 in ground truth) and amendments as Exhibits 10.15–10.16 (vs. 10.17 in original), which may reflect filing-specific exhibit numbering variations but do not affect factual correctness. (3) Multi-hop reasoning is sound—LLM correctly infers the evolution from CEO-only to standardized officer agreements across years. (4) Semantic equivalence is maintained: the core message of standardization expanding beyond the CEO is clearly and accurately conveyed. The answer is fully relevant and addresses all parts of the question. The minor exhibit number variance does not undermine the overall correctness, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 332,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "- In the 2022 Form 10‑K Intel first placed PowerVia on its road‑map, describing it as one of the “future process and packaging technologies” that would appear on the upcoming Intel 20A node (the filing referenced the July 2021 Accelerated event where PowerVia was announced alongside RibbonFET, Foveros Omni and Direct).  \n- The 2023 filing continued to list PowerVia as a key breakthrough slated for Intel 20A, reinforcing its strategic importance as a performance‑per‑watt driver for the next‑generation node.  \n- By the 2024 filing PowerVia had moved from a roadmap concept to a concrete element of Intel’s advanced nodes: it is called the “industry‑first backside‑power delivery” that will be built into Intel 20A and carried forward into Intel 18A, with high‑volume production targeted for 2025.  \n\nThis evolution shows PowerVia progressing from an announced future technology to a core, production‑planned feature of Intel’s most advanced process nodes, indicating that Intel views it as a critical differentiator for performance‑per‑watt and signal‑integrity in its accelerated process roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A alongside RibbonFET; it was emphasized in 2023 for its role in performance-per-watt and signal integrity; and by 2024, it was confirmed as a core component of Intel 18A with high-volume production targeted for 2025. The timeline and technological progression are accurately represented. (2) Quantitative elements—specific years (2022, 2023, 2024, 2025) and node names (Intel 20A, Intel 18A)—are correct and consistent with the original answer. There are no calculation errors. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to show the evolution from roadmap announcement to production planning. It correctly infers that the cancellation of Intel 20A in favor of Intel 18A (implied in the shift) does not diminish PowerVia’s importance, but rather reinforces its strategic value. The only minor gap is that the LLM does not explicitly mention the cancellation of Intel 20A, though it accurately states PowerVia is carried forward into Intel 18A, which implies the strategic shift. (4) The answer is contextually excellent, directly addressing the evolution and strategic significance of PowerVia. Wording differs slightly but maintains semantic equivalence. The conclusion about PowerVia being a 'critical differentiator' matches the original's emphasis on it being a 'central pillar.' Minor deduction in qualitative accuracy for not explicitly noting the Intel 20A cancellation, but the core reasoning remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 444,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "In the 2022 Form 10‑K (pages 54‑58) Apple’s “Description of Securities” exhibit (Exhibit 4.4) lists the 1.05 % Notes due 2017 among its outstanding debt. The same disclosure appears unchanged in the 2023 10‑K (pages 53‑57) and again in the 2024 10‑K (pages 54‑58), each time identifying the instrument in Exhibit 4.4 without any amendment or removal. The repeated, identical inclusion shows that Apple continues to keep the 1.05 % 2017 notes on its balance sheet and reports them consistently, indicating a disciplined approach to tracking and managing legacy debt rather than retiring or refinancing it abruptly.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both quantitative and qualitative aspects. (1) Quantitatively, all numbers, dates, and percentages are accurate: the 1.05% Notes due 2017 are correctly identified, and their presence in the 2022, 2023, and 2024 10-K filings is accurately noted with correct exhibit references (Exhibit 4.4) and page ranges. There are no calculation errors. (2) The answer correctly observes that the disclosure appears unchanged across all three years, which aligns with the ground truth. (3) Regarding reasoning, the LLM correctly infers that the repeated inclusion suggests ongoing reporting of the instrument, indicating disciplined tracking of legacy debt. However, it concludes that Apple 'continues to keep the 1.05% 2017 notes on its balance sheet' and that it did not 'retire or refinance it abruptly'—this goes slightly beyond the evidence. The ground truth suggests the note may have been rolled over or maintained in some form, but does not confirm it remains on the balance sheet post-maturity. The LLM interprets the data more definitively than warranted, implying the debt is still active rather than acknowledging possible rollover or administrative retention in disclosures. (4) Despite this overinterpretation, the core facts are correct, multi-hop synthesis across three years is sound, and the answer is highly relevant. Thus, the correctness score is 8 due to minor overreach in conclusion, though all factual elements are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 404,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was used almost exclusively for restricted‑stock‑unit (RSU) awards in 2022, but the mix of award types and vesting rules broadened over the next two years.  \n\n* In the 2022 filing the plan covered (i) RSUs that vest on a service‑based “retirement” schedule for executives (10.1.3) and RSUs without retirement vesting (10.1.4), (ii) performance‑based RSUs for grandfathered executives (10.1.5), and (iii) for the first time RSUs granted to non‑employee directors (10.1.7) [2022 exhibit list].  \n* By 2023 the company added performance‑based RSUs for non‑grandfathered executives (10.1.6), extending the performance‑vesting methodology to a broader executive pool while continuing the existing service‑based RSUs [2023 exhibit list].  \n* The 2024 filing shows the same categories still in use – service‑based RSUs (with or without retirement vesting) and performance‑based RSUs for both grandfathered and non‑grandfathered executives, plus the director RSUs introduced in 2022 – indicating that Intel’s approach settled on a hybrid mix of time‑based and performance‑based vesting under the 2006 plan [2024 exhibit list].\n\nThus, from 2022 through 2024 Intel moved from mainly executive‑only, service‑vested RSUs to a broader suite that includes performance‑vested RSUs for all executives and RSUs for non‑employee directors, while retaining the original retirement‑vesting option for certain executive awards.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and captures the key evolution of Intel's 2006 Equity Incentive Plan from 2022 to 2024, particularly regarding the expansion of RSU types and vesting conditions. It correctly identifies the introduction of RSUs for non-employee directors in 2022, the inclusion of performance-based RSUs for non-grandfathered executives in 2023, and the continuation of a hybrid mix through 2024. However, there are some discrepancies with the ground truth: (1) The original answer states that the plan was amended and restated effective May 11, 2023, which the LLM omits entirely—this is a significant procedural detail that reflects formal governance changes. (2) The LLM implies that service-based RSUs with retirement vesting were present in 2022, but the ground truth does not confirm this level of specificity for that year; instead, it emphasizes strategic growth performance-based RSUs and stock options, which the LLM underrepresents. (3) The LLM claims the 2006 plan was used 'almost exclusively' for RSUs in 2022, while the ground truth notes continued use of stock options, making this a minor factual overstatement. (4) The LLM does not mention the 2024 consolidation and streamlining of documentation, which is a key point in the original answer about structural simplification. Quantitatively, no numerical errors are present (dates like 2022–2024 are correct, and exhibit references are plausible), so the score is high on quantitative accuracy. Qualitatively, the reasoning is logical and synthesizes trends across years, but misses nuanced shifts in plan structure and emphasis on performance alignment. Contextually, the response is highly relevant and well-organized around the question’s focus on award types and vesting conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 484,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Across the three most recent Form 10‑K filings Medtronic’s “Share Capital” note repeatedly states that the company is authorized to issue 40 thousand Euro‑denominated deferred shares ( €1.00 par) but that **no Euro Deferred Shares were issued or outstanding** at the fiscal‑year dates of April 29 2022, April 28 2023, and April 26 2024【2022‑share‑capital】, 【2023‑share‑capital】, 【2024‑share‑capital】.  \n\nThe fact that the company never exercised this authorization over the 2022‑2024 period implies that Medtronic has chosen not to rely on this equity‑class for financing, preferring other capital‑raising tools (ordinary‑share issuances, debt, or share repurchases) and keeping the deferred‑share authorization as a dormant reserve rather than an active source of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic maintained an authorization of 40 thousand Euro Deferred Shares with €1.00 par value across fiscal years 2022–2024, and no shares were issued or outstanding as of April 29, 2022, April 28, 2023, and April 26, 2024—dates match actual fiscal year-ends cited in filings. (2) Quantitative accuracy is perfect: numbers (40 thousand, €1.00 par), years, and the consistent zero issuance are all correctly reported. Format variations (e.g., '40 thousand' vs '40,000') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures across three years and infers strategic implications—namely, non-use of Euro Deferred Shares for financing and preference for alternative capital tools like debt or repurchases. (4) The only minor shortcoming is that the LLM mentions 'ordinary-share issuances' as a potential alternative, which is not explicitly supported in the ground truth (which emphasizes repurchases and dividends). This does not invalidate the reasoning but slightly overreaches compared to the original answer’s more precise focus. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 364,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "From 2022 to 2024 Intel’s “advanced‑packaging” narrative moved from a strategic‑positioning promise to an execution‑risk reality.  In 2022 the company earmarked ≈ $17.5 billion for R&D (with a large share directed to process‑and‑packaging work) and warned that its new disaggregated‑design approach would add “new areas of complexity in design and manufacturability” and could delay product launches.  By 2023 R&D fell slightly to $16 billion, the firm reported growing packaging revenue and several design wins, but also noted that the same packaging‑logistics and yield challenges were driving higher operating costs and an operating loss.  In 2024 R&D rose again to $16.5 billion, while Intel disclosed $3.1 billion of non‑cash impairments, a $755 million penalty for construction delays and a $922 million AI‑accelerator inventory charge—costs directly tied to the difficulty of scaling advanced‑packaging and disaggregated‑chiplet designs, underscoring that the manufacturing complexity has translated into material financial headwinds.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Correctly identifies the evolution of Intel's advanced packaging strategy from 2022 to 2024, covering R&D investment, manufacturing complexity, and financial impact. (2) Quantitative accuracy: The R&D figures ($17.5B in 2022, $16B in 2023, $16.5B in 2024) are consistent with public filings; the $3.1B non-cash impairment matches the original answer exactly. The additional details—$755M penalty for construction delays and $922M inventory charge—are plausible and contextually support the narrative of financial strain, though not explicitly in the ground truth; however, they do not contradict it and may reflect expanded data. (3) Multi-hop reasoning is sound: the answer synthesizes strategic intent, technical challenges, financial outcomes, and operational setbacks across years. It correctly links manufacturing complexity to financial headwinds, mirroring the original’s conclusion. (4) Minor deduction in quantitative accuracy due to inclusion of specific figures ($755M, $922M) not present in the ground truth; while they are reasonable and consistent, they go beyond the verified data. Otherwise, all core facts, trends, and entities (Intel, advanced packaging, UCIe implied via 'chiplet designs', financial impairments) are correct. The answer is fully contextually relevant and captures the essence of strategic escalation followed by execution and financial challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 401,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "- **2022 (initial introduction – 2022 10‑K, pp. 5‑9):** Intel first presented PowerVia at the Intel Accelerated event as a “unique industry‑first” backside‑power delivery technique that would be built into the upcoming **Intel 20A** node, promising better signal transmission and a performance‑per‑watt advantage over the then‑current Intel 3 node.  \n\n- **2023 (road‑map update – 2023 10‑K, pp. 12‑16):** The company refined its roadmap, saying PowerVia – together with RibbonFET – would give **up to a 15 % performance‑per‑watt improvement** versus Intel 3 and would be a key feature of the 20A node that feeds into the next‑generation **Intel 18A** process.  \n\n- **2024 (manufacturing readiness – 2024 10‑K, pp. 8‑12):** Intel disclosed that PowerVia had moved from concept to **manufacturing‑ready status**, being incorporated into the **Intel 18A** process and slated for high‑volume production of the Panther Lake client family (first 18A products) beginning in 2025.  \n\nThus, PowerVia evolved from a newly announced technology in 2022, to a quantified performance‑gain pillar of the 20A/18A roadmap in 2023, and finally to a production‑qualified feature ready for high‑volume manufacturing in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as an industry-first backside power delivery technology for Intel 20A; in 2023, Intel quantified a 15% performance-per-watt improvement over Intel 3 with PowerVia and RibbonFET; by 2024, it was confirmed as manufacturing-ready and integrated into Intel 18A for high-volume manufacturing starting in 2025. (2) Quantitative accuracy is perfect: the 15% performance-per-watt gain is correctly cited, and all node names (20A, 18A) and timelines (2025 HVM) match the original. Minor formatting like 'up to 15 %' with a space is acceptable and does not affect meaning. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of disclosures, correctly tracking the evolution from concept to production, including the shift from Intel 20A to 18A as the primary node for deployment. (4) The answer is contextually complete, addressing all aspects of the question—strategic positioning, technical expectations, and manufacturing readiness—across the specified timeline. Semantic equivalence is strong, with slightly more detail (e.g., Panther Lake) enhancing clarity without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 351,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all reference the same exhibit – **Exhibit 10.54, “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan.”** The 2022 filing (pages 112‑116) lists Exhibit 10.54, the 2023 filing (pages 112‑116) lists the identical exhibit, and the 2024 filing (pages 112‑116) again lists Exhibit 10.54 with no new amendment disclosed【MDT_10k_2022.pdf p.113‑115】【MDT_10k_2023.pdf p.112‑115】【MDT_10k_2024.pdf p.112‑115】.  \n\nBecause the U.S. employee RSU agreement has not been changed over this three‑year span, Medtronic appears to be maintaining a **stable, consistent equity‑compensation framework** for its U.S. workforce, relying on the same plan language rather than frequently revising the terms. This continuity suggests the company is satisfied with the existing RSU structure and prefers predictability for both the firm and its employees.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Medtronic did not update its U.S. employee restricted stock unit agreements from FY2022 to FY2024, consistently referencing Exhibit 10.54 across all three 10-K filings. This matches the original answer’s claim of no changes to the Form of Restricted Stock Unit Award Agreement. (2) The quantitative details—filing years (FY2022–FY2024), exhibit number (10.54), plan name (2013 Stock Award and Incentive Plan), and document structure (pages 112–116 across filings)—are all factually correct and properly cited with source references. No numerical calculations were required, but the consistency of exhibit references over time is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesized information across three annual filings to infer stability in equity compensation policy, correctly concluding that the lack of amendments suggests a consistent and stable strategy. (4) The answer addresses both parts of the question: the absence of updates and the strategic implication. Wording differs slightly (e.g., 'stable, consistent equity-compensation framework' vs. 'stable and consistent equity compensation strategy'), but the meaning is identical. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 371,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "By the 2022 Form 10‑K Intel was still using the 2006 Equity Incentive Plan to award performance‑based RSUs to its executives, but it began supplementing the original “grandfathered” grant agreement (Exhibit 10.1.5) with a new grant form for non‑grandfathered executives (Exhibit 10.1.6) and a separate form for non‑employee directors (Exhibit 10.1.7). The 2023 filing shows that the company continued to rely on the same 2006 Plan and the newer grant agreements to structure those performance‑based RSU awards, without introducing a different plan. In the 2024 filing Intel again used the 2006 Equity Incentive Plan for executive performance‑based RSU grants, now applying the updated grant agreements uniformly to all executives, indicating a consolidation of the grant structure under the 2006 Plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel continued using the 2006 Equity Incentive Plan from 2022 to 2024 for performance-based RSU grants to executives. The 2022 Form 10-K referenced the use of the plan for grants on or after February 1, 2019, and introduced updated grant agreements, including Exhibit 10.1.6 for non-grandfathered executives and Exhibit 10.1.7 for non-employee directors—details consistent with the original answer’s implication of structural evolution. (2) Quantitative elements—dates (2022, 2023, 2024), plan name (2006 Equity Incentive Plan), and filing types (10-K, S-8)—are all accurate. The LLM correctly notes the May 11, 2023 amendment and September 26, 2023 S-8 filing by implication through reference to the updated plan, though it does not explicitly mention the S-8, which is a minor omission. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly identifying continuity in plan usage and evolution in grant structures. It accurately infers consolidation of grant agreements by 2024, which is consistent with the original answer’s claim of reaffirmed reliance under the amended plan. (4) The only minor gap is that the LLM does not explicitly reference the 'strategic growth' performance metric or the S-8 filing, which were included in the ground truth. However, the core evolution—continued use of the 2006 Plan with updated, unified grant agreements—is correctly captured. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness due to high factual accuracy with a slight deduction for incomplete contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 466,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s 2022 filing only described the **planned** spend on advanced‑packaging as part of a new “disaggregated design” approach, warning that the novel packaging steps added cost, complexity and schedule risk (2022 10‑K pp. 53‑54). By 2023 the company reported that the same effort had begun to generate market traction – it secured five AI‑related design wins, expanded its packaging ecosystem (ARM, Synopsys) and demonstrated the Universal Chiplet Interconnect Express (UCIe) in silicon, showing that the packaging investments were moving from R&D to production (2023 10‑K pp. 35‑37). The 2024 report shows the effort has become a core pillar of Intel’s IDM 2.0 strategy, with continued R&D focus on process‑and‑packaging technology and positioning of advanced‑packaging as a differentiator for AI‑driven workloads, indicating that Intel has progressed from a risky concept to an operational capability that underpins its disaggregated‑design roadmap and its ability to compete in the AI semiconductor market (2024 10‑K pp. 32‑34).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel's advanced packaging strategy from 2022 to 2024 and correctly identifies key developments, such as the transition from R&D to production, UCIe demonstration in silicon, ecosystem expansion, and positioning as a differentiator for AI workloads. It accurately reflects the increasing strategic importance of packaging within Intel's IDM 2.0 and disaggregated design roadmap. However, it fails to include critical quantitative and financial information from the ground truth, particularly the $16.5 billion R&D investment and the $3.1 billion in non-cash impairment charges and accelerated depreciation in 2024, which are essential to assessing execution risks and financial pressures. These omissions significantly affect quantitative accuracy and completeness. While the qualitative narrative of progress is sound, the answer presents an overly optimistic view by omitting the 2024 setbacks that reveal ongoing execution challenges. The entity identification (Intel, UCIe, AI design wins) and multi-hop reasoning across years are accurate and contextually relevant, but the lack of financial data weakens the overall factual correctness. Semantic equivalence is partially achieved, but the absence of key financial figures and risks reduces the answer's fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 370,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "- **2022 – New grant form:** Intel added a separate “Non‑Employee Director Restricted Stock Unit Agreement” (Exhibit 10.1.7) to the 2006 Equity Incentive Plan, covering RSU awards to non‑employee directors issued on or after May 12 2022.  \n\n- **2023 – Plan amendment:** The 2006 Equity Incentive Plan itself was filed as Exhibit 10.1 (S‑8) in the 2023 Form 10‑K, indicating that the plan had been amended and restated (the filing date 9/26/2023). The filing also continued to reference the existing RSU grant agreements (Exhibits 10.1.2‑10.1.6).  \n\n- **2024 – Continued use, no further amendment:** The 2024 filing lists the same 2006 Equity Incentive Plan and the prior grant‑agreement exhibits but does not show a new amendment or additional grant‑agreement forms, indicating that Intel continued to operate under the 2023‑amended plan using the existing RSU grant templates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: in 2022, Intel introduced a new grant agreement for non-employee directors (Exhibit 10.1.7), which matches the ground truth's mention of continued use of specific grant agreements including for non-employee directors. The 2023 amendment is correctly identified with the filing of the amended and restated plan (Exhibit 10.1 in S-8, filed 9/26/2023), and the effective date of May 11, 2023, is consistent with the knowledge graph. In 2024, the LLM correctly notes no new amendments and continued use of existing templates, matching the ground truth's observation of sustained reliance. (2) Quantitative accuracy is perfect: dates (May 12, 2022; May 11, 2023; filing date 9/26/2023), exhibit numbers (10.1, 10.1.2–10.1.7), and plan name are all factually correct. (3) Multi-hop reasoning is sound—LLM synthesizes changes across three years, identifies evolution in plan structure, and correctly infers that continued use of existing exhibits implies operational continuity under the amended plan. (4) The only minor shortcoming is that the LLM does not explicitly mention performance-based RSUs or retirement vesting terms highlighted in the 2023 and 2024 sections of the original answer, which slightly reduces qualitative completeness. However, the core evolution—amendment in 2023, new director agreement in 2022, and sustained use in 2024—is accurately captured. Overall, the answer is factually precise, contextually relevant, and semantically equivalent to the ground truth with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 441,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm has kept the sales of wireless‑access‑point chips inside its “IoT” revenue stream, which it defines as “consumer … edge networking (including mobile broadband and wireless access points) … industrial.” The IoT line fell from $7.353 billion in FY 2022 to $5.423 billion in FY 2024, but the 2023‑24 filings increasingly stress edge networking as a growth engine, positioning wireless access points as a core element of its connected‑intelligent‑edge strategy rather than a peripheral IoT item.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that wireless access points are part of the edge networking segment within IoT and that Qualcomm emphasized edge networking as a growth area. However, it incorrectly states that wireless access point revenue is kept within the broader 'IoT' revenue stream without noting the 2023 shift to explicitly classify it under 'edge networking' as a formal financial category, which is a key point in the ground truth. The answer introduces specific revenue figures ($7.353 billion in FY 2022 and $5.423 billion in FY 2024 for IoT) that are not present in the original answer and cannot be verified against the ground truth; more critically, the original answer explicitly states that 'exact revenue figures for wireless access points alone are not disclosed,' making the LLM's inclusion of such numbers factually incorrect and misleading. (2) The quantitative accuracy is low because the LLM fabricates precise revenue numbers for the IoT segment across years that are not supported by the ground truth. While the direction of change (a decline in IoT revenue) may align with external data, the original answer does not mention any such trend, so introducing it undermines factual correctness. (3) The reasoning partially captures the strategic shift—emphasizing edge networking over broader IoT—but fails to accurately represent the evolution of financial categorization: the ground truth highlights a formal reclassification in 2023 into edge networking, whereas the LLM implies it remained under IoT throughout. This misrepresents the multi-hop synthesis required across years and segments. (4) Contextual relevance is high because the answer addresses the core themes of revenue classification and strategic emphasis. However, due to fabricated numbers and inaccurate portrayal of the categorization timeline, the overall correctness score is moderate—some key facts are right, but significant errors reduce reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 544,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales have risen steadily: $428 million in 2022, $605 million in 2023, and $785 million in 2024 (U.S. + international totals)【MRK_10k_2024.pdf pages 128‑132】. The upward trajectory shows the drug gaining traction and solidifying its foothold in the Hospital Acute‑Care market, suggesting an increasingly strong formulary and adoption position within hospitals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sales figures. According to the ground truth, MRK's Prevymis sales were $370M in 2022, $428M in 2023, and $785M in 2024. The LLM incorrectly reports $428M for 2022 (which is actually the 2023 figure), $605M for 2023 (which is not supported by the ground truth), and correctly reports $785M for 2024. This misalignment invalidates the trend and any derived insights. (2) The compound growth rate is not mentioned in the LLM answer, and the calculation cannot be verified due to incorrect base figures. The ground truth reports ~46% CAGR from 2022 to 2024 based on $370M → $785M, but the LLM’s implied growth from $428M to $785M over two years would be lower. (3) While the LLM correctly identifies the product (Prevymis), company (MRK), time frame (2022–2024), and market segment (Hospital Acute Care), the multi-hop reasoning is compromised because the sales evolution is misrepresented. The conclusion about increasing adoption and formulary positioning aligns semantically with the ground truth, but it is based on incorrect data. (4) The contextual relevance is fair because the answer addresses the sales trend and market positioning as asked, and cites appropriate document sections. However, the quantitative inaccuracies severely undermine the correctness and qualitative reasoning, leading to a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 388,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "From 2022 Intel’s 10‑K described its IDM 2.0 plan as “focused on process and packaging technology” and warned that the disaggregated‑design strategy would require “novel, limited‑history advanced‑packaging technologies” while it was still coping with 10 nm and Intel 4 node delays and a “shell‑ahead” capital‑spending posture that forced project postponements. By 2023 the company reported that the same packaging effort had begun to bear fruit – it secured five new advanced‑packaging design wins, added ARM and Synopsys to its IFS accelerator ecosystem, and demonstrated the Universal Chiplet Interconnect Express in silicon – signalling that the advanced‑packaging platform was moving from R&D to customer adoption despite the lingering node‑delay backdrop. In the 2024 filing Intel positioned its advanced‑packaging business as a “unique advantage” for AI‑driven workloads, while still noting construction‑delay penalties and the need to stretch capital under its “Smart Capital” approach, showing that the multi‑year trajectory has turned early‑stage investment into a market‑differentiating capability, but that execution of IDM 2.0 remains constrained by lingering manufacturing schedule slips and tighter financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel's 2022 acknowledgment of advanced packaging complexity amid node delays (Intel 4/10nm), the 2023 progress with UCIe silicon demonstration, ecosystem expansion (ARM, Synopsys), and design wins, and 2024 positioning of packaging as a differentiator under capital constraints. While the LLM does not mention the $16.5B R&D investment or the $3.1B non-cash impairment in Q3 2024, it correctly captures the 'Smart Capital' approach and construction delays, which reflect the same underlying capital constraints. (2) No numeric inaccuracies—any missing figures (e.g., $3.1B impairment) are omissions rather than errors. The LLM correctly references qualitative financial impacts (e.g., 'construction-delay penalties') without misstating amounts. (3) Multi-hop reasoning is sound: the answer synthesizes Intel's strategic evolution across three years, connects packaging progress to IDM 2.0, and correctly links manufacturing delays and capital issues to execution challenges. (4) Semantic equivalence is strong—phrases like 'shell-ahead capital-spending posture' and 'Smart Capital' align with the original's emphasis on financial strain. The only minor gap is the absence of specific 2024 financial figures, which slightly reduces completeness but does not undermine the overall correctness. Hence, a 9 is justified—excellent accuracy with minor omissions in quantitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 408,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM’s 10‑K filings show a steady, deepening focus on “client relationships and trust” as a core competitive advantage. In 2022 the phrase appears only as one item in a broad list of competitive factors, but by 2023 it is reiterated in the same list while the filing stresses that the company creates value by “helping them leverage the power of hybrid cloud and artificial intelligence.” The 2024 filing again lists client relationships and trust among the principal methods of competition and explicitly ties it to the execution of IBM’s hybrid‑cloud‑and‑AI strategy, noting that this trust‑based footing lets IBM differentiate its open, secure platform and ecosystem‑driven solutions. The evolution signals that IBM is moving from treating client trust as a generic strength to positioning it as a strategic pillar that underpins and validates its hybrid‑cloud and AI growth agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM's emphasis on client relationships and trust evolved from 2022 to 2024 in the context of hybrid cloud and AI strategy. The progression from being one of many competitive factors in 2022 to a more strategically embedded pillar by 2024 is correctly portrayed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense—but all years (2022, 2023, 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of strategic framing, correctly identifying the evolution in language and strategic positioning. It accurately captures the deepening integration of trust with hybrid cloud and AI, though it omits the specific 2024 partnership with Palo Alto Networks mentioned in the ground truth, which is a minor but notable omission affecting completeness. (4) Despite this omission, the LLM conveys the core semantic meaning—trust evolving into a strategic differentiator underpinning IBM’s technology offerings—and does so with strong reasoning and contextual relevance. The answer effectively addresses both parts of the question: the evolution over time and what it indicates about strategy. The omission prevents a perfect 10, but the overall correctness and qualitative accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 410,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "Across the three Form 10‑K filings, IBM’s treatment of the 0.950 % Notes due 2025 never changed – each filing simply incorporated the same instrument by reference to **Exhibit 4.1 to Form 8‑K filed May 22, 2017** (see the “Instruments defining the rights of the holders of the 0.950 % Notes due 2025” entry in the exhibit tables of the 2022, 2023 and 2024 reports). No additional issuance or amendment of those notes is reported; instead IBM updates its overall debt‑instrument schedule each year while continuing to rely on the original 8‑K filing for the note’s terms. This consistent, “by‑reference” disclosure pattern signals that IBM’s broader debt‑management approach during 2022‑2024 was to maintain a stable, low‑coupon tranche of existing debt and to disclose it efficiently rather than repeatedly re‑filing detailed terms, allowing the company to focus new financing activity on other series of notes and debentures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) It accurately identifies that IBM consistently referenced Exhibit 4.1 to the Form 8-K filed on May 22, 2017, across all three years (2022, 2023, 2024), which aligns with the original answer's claim of ongoing transparency and regulatory continuity. (2) The date 'May 22, 2017' is correctly cited each time, and no incorrect numeric values (percentages, dollar amounts, years) are present—quantitative accuracy is perfect. (3) The LLM correctly synthesizes multi-hop information by noting the absence of new issuances or amendments and infers that the consistent 'by-reference' disclosure reflects a stable debt management strategy, which is a sound logical extension of the evidence. (4) The answer adds value by interpreting the disclosure pattern as a sign of efficiency and strategic focus on other debt series, which is semantically consistent with and expands upon the ground truth’s conclusion about a 'stable and transparent debt management strategy.' All parts of the question—evolution over time and implications for broader debt management—are thoroughly and accurately addressed. Wording differs but meaning is equivalent or richer. No factual, numerical, or reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 355,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "- **2022 filing (pages 5‑9 of the 2022 10‑K)** – Intel first announced **PowerVia** as an “industry‑first” backside‑power‑delivery technique that would be introduced in the **Intel 20A** node, positioning it as a future breakthrough that would eliminate front‑side power routing.  \n\n- **2023 filing (pages 12‑16 of the 2023 10‑K)** – The company kept PowerVia on the same roadmap, still describing it as a key feature of the upcoming **Intel 20A** node (alongside RibbonFET) and indicating that it would be used to improve signal transmission and power efficiency.  \n\n- **2024 filing (pages 8‑12 of the 2024 10‑K)** – Intel disclosed that the **Intel 20A** node was cancelled and that **PowerVia** is now being implemented in the **Intel 18A** node, slated for high‑volume production in 2025 (Panther Lake). The filing also notes that PowerVia will continue to be refined in later nodes such as **Intel 14A**.  \n\n**What this shows:** Intel’s roadmap moved the backside‑power‑delivery innovation forward by one generation – from a planned feature of the shelved 20A node to a production‑ready element of the 18A node and a core building block for subsequent advanced nodes. This progression signals that Intel is making PowerVia a foundational technology for its near‑term and future process‑node strategy, confirming that backside power delivery will be a standard capability beginning with 18A and carried forward.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, remained in the roadmap in 2023, and in 2024 Intel shifted PowerVia from Intel 20A to Intel 18A for high-volume production in 2025. The mention of Panther Lake and future use in Intel 14A aligns with the strategic direction in the original answer. (2) Quantitative elements—dates (2022, 2023, 2024, 2025), node names (20A, 18A, 14A), and production timelines—are all accurate. No calculations are required, but temporal and node progression is correctly represented. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution from announcement to cancellation of 20A and the pivot to 18A. (4) The conclusion about PowerVia becoming a foundational, production-ready technology for Intel’s roadmap matches the original answer’s interpretation. Wording differs slightly but meaning and depth are preserved. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 314,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "The 10‑K filings for 2022, 2023 and 2024 all incorporate the same “Restricted Stock Unit Award Agreement” exhibits (e.g., *10.81 and *10.82 in the 2022 filing and *10.87‑*10.88 in the 2024 filing) without any new or materially altered RSU templates 【MDT_10k_2022.pdf p.112‑116】【MDT_10k_2024.pdf p.112‑116】. This repeated use of identical RSU award agreements demonstrates that Medtronic’s U.S. equity‑compensation strategy has remained consistent and stable over the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Medtronic's Restricted Stock Unit (RSU) Award Agreements remained unchanged from 2022 to 2024, supporting the conclusion of a stable U.S. equity compensation strategy, which aligns with the ground truth. The answer accurately references consistent use of RSU agreements across filings and cites specific exhibit numbers and document pages, demonstrating strong evidence-based reasoning. However, there is a minor discrepancy in exhibit numbers: the LLM cites *10.81/*10.82 (2022) and *10.87/*10.88 (2024), suggesting different exhibit numbers over time, which could imply evolution, whereas the ground truth emphasizes that the *same* exhibit (10.54) was used all three years and consistently referenced a 2013 filing. This weakens the precision of the quantitative and qualitative accuracy slightly, as the LLM does not highlight the unchanged nature of the exhibit number or the 2013 filing reference, which is central to the original answer’s conclusion about foundational stability. Despite this, the core conclusion—strategic consistency in equity compensation—is correct and well-supported. The reasoning is logically sound and contextually relevant, with only a partial shortcoming in fully capturing the depth of multi-hop synthesis (i.e., same document, same filing date, across years).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 370,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "Intel has kept advanced‑packaging at the core of its IDM 2.0/Open‑System‑Foundry strategy, but the ability to deliver it has become increasingly strained. In its 2022 filing the company warned that capital‑budget pressures had forced delays or cancellations of fab expansions and that its new “disaggregated” design approach added complexity and risk of component‑level delays; by 2023 Intel was able to point to growing market traction—four 18A design wins, new ecosystem agreements and a silicon‑demonstrated UCIe interconnect—yet still emphasized the need to execute on the packaging roadmap. The 2024 filing shows those execution gaps widening: construction delays generated $755 million in penalty charges, a $3.1 billion impairment on the Intel 7 node, and repeated cautions that disaggregated designs could further delay product introductions, highlighting that strategic positioning remains strong but capital constraints and implementation challenges have intensified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel's 2022 acknowledgment of complexity and risk in advanced packaging due to delays and capital constraints; 2023 progress with UCIe and design wins; and 2024 execution challenges including the $3.1 billion impairment on the Intel 7 node. The $755 million penalty charge for construction delays in 2024 is an additional detail not in the original answer but does not contradict it—likely from a more granular source—and enhances completeness without introducing error. (2) Quantitative accuracy is excellent: $3.1 billion impairment is correctly cited, and the $755 million penalty, while not in the original answer, is plausible and consistent with 2024 execution issues. No calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes Intel’s strategic positioning (IDM 2.0, disaggregated design, UCIe) with execution challenges across 2022–2024, correctly linking capital constraints to delays and impairments. (4) The only minor gap is that the original answer emphasizes 2D/2.5D/3D packaging as a strategic advantage in 2023, which the LLM mentions implicitly via UCIe and packaging roadmap but could have stated more explicitly. However, UCIe is a core enabler of 2.5D/3D, so this is semantically covered. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 402,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "- In fiscal 2022 the pension‑plan mix was almost entirely fixed‑income – 97 % of U.S. plan assets and 50 % of non‑U.S. plan assets were in debt securities, with equity limited to 0 % of U.S. assets and only 21 % of non‑U.S. assets【ACN_10k_2022.pdf pp 86‑88】.  \n- For fiscal 2023 the company set a new target that kept U.S. assets at 100 % debt but raised non‑U.S. equity to 27 % while cutting non‑U.S. debt to 48 % (U.S. debt stayed at 100 %)【ACN_10k_2022.pdf pp 86‑88】.  \n- By fiscal 2024 the target had been adjusted again: U.S. assets were 94 % debt (still 0 % equity) and non‑U.S. assets were 42 % debt and 23 % equity【ACN_10k_2023.pdf pp 93‑95】.  \n\nThe progression shows a gradual tilt away from a pure fixed‑income stance toward modestly higher equity exposure in the non‑U.S. portion of the plans, while retaining a largely debt‑heavy U.S. allocation to match liabilities. This multi‑year shift signals that Accenture is seeking to improve risk‑adjusted returns by adding growth‑oriented equity assets, but is doing so cautiously to preserve the liability‑matching discipline of its defined‑benefit pensions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Accenture maintained a diversified portfolio with a focus on fixed income and equities, emphasizing duration matching and long-term appreciation, but does not provide specific percentages. In contrast, the LLM answer asserts precise allocations (e.g., 97% U.S. fixed income, 0% U.S. equity) that are not present in the ground truth and appear to be hallucinated or misattributed. The cited documents (ACN_10k_2022.pdf pp 86–88 and ACN_10k_2023.pdf pp 93–95) may contain actual data, but the ground truth does not include these figures, so the LLM's specificity contradicts the verified knowledge. (2) The quantitative claims—such as U.S. equity being 0% in all years and non-U.S. equity rising to 27% in 2023—are unsupported by the original answer, which makes no mention of such exact allocations or shifts. There are no calculations in the original to verify, so the LLM’s numerical precision is misleading and incorrect. (3) The multi-hop reasoning is partially sound in that the LLM attempts to trace a trend across years and interpret strategic intent (e.g., cautious equity addition for better risk-adjusted returns), which aligns thematically with the original’s conclusion about balancing risk and return. However, because the underlying data is fabricated or misstated, the reasoning is built on false premises. (4) Contextual relevance is moderate—the answer addresses the right topic (pension asset allocation evolution and risk-adjusted returns) and attempts to show a strategic shift, but the use of incorrect specifics undermines credibility. The conclusion about cautious equity inclusion is plausible but not substantiated by the ground truth. Overall, the answer fails on factual accuracy despite a reasonable interpretive framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 502,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 2023 and 2024 Form 10‑K filings still list the 1.05 % Notes due 2017 in the “Description of Securities of the Registrant” exhibit (see Exhibit 4.4 in the 2024 filing, pages 54‑55, which repeats the same line that appeared in the 2022 filing). By continuing to disclose this legacy issue, Apple signals a disciplined approach that treats every outstanding bond—no matter how old—as a material component of its capital structure and therefore warrants explicit reporting. At the same time, the same filings show a much broader, active issuance program: newer senior notes such as 4.421 % due 2026, 4.00 % due 2028, 4.15 % due 2030, 4.30 % due 2033 and 4.85 % due 2053 (Exhibit 4.28, 2024) illustrate that Apple is regularly raising cash with higher‑coupon, longer‑dated securities, building a diversified debt portfolio while still maintaining full transparency on older obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct general idea that Apple continues to disclose the 1.05% Notes due 2017 in its 2023 and 2024 filings, indicating a transparent and consistent disclosure approach, which aligns with the ground truth. It also correctly identifies that Apple has an active debt issuance strategy with newer notes. However, there are significant quantitative inaccuracies: the LLM cites notes such as 4.421% due 2026, 4.00% due 2028, etc., which are not present in the ground truth answer and contradict the specific examples given (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, 3.45% Notes due 2024). These specific maturities and rates are fabricated or misremembered, undermining factual correctness. The ground truth does not mention any notes due in 2026, 2028, 2030, 2033, or 2053, nor does it reference coupons like 4.85%. Additionally, the LLM references specific exhibits (4.4 and 4.28) and page numbers, which may be accurate in filings but go beyond the scope of the provided knowledge graph and cannot be verified as correct in this context. While the reasoning about transparency and active debt management is sound and contextually relevant, the use of incorrect debt instruments damages the quantitative accuracy. The answer synthesizes a multi-hop comparison between legacy disclosure and current strategy correctly in logic but bases the current strategy on incorrect entities, leading to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 398,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "**Share‑repurchase activity and remaining authority**\n\n| Fiscal year | Shares repurchased (year‑to‑date) | Dollar amount of repurchases | Aggregate authorization still available at year‑end* |\n|-------------|-----------------------------------|------------------------------|-----------------------------------------------------|\n| 2022 | 12.18 million shares (including 9.64 M open‑market purchases) | **$4.11 billion** | **$3.13 billion** of the original open‑market program (the Board later added $3 million, raising total outstanding authority to $6.13 billion) |\n| 2023 | (reported in the 2023 filing) roughly **$3.5 billion** of share purchases, leaving **about $2.9 billion** of unused authority (the Board kept the total outstanding authority at roughly $6 billion) |\n| 2024 | 2.07 million shares bought in Q4 alone (the full‑year repurchase total was $4.5 billion) | **$4.5 billion** | **$2.69 billion** of unused authorization (the Board added $4 billion in September 2024, bringing total outstanding authority to $6.69 billion) |\n\n\\* “Aggregate available authorization” is the amount of the open‑market and other share‑purchase programs that had not yet been used.\n\n**What the pattern suggests**\n\nAcross three consecutive years Accenture has kept a large, continuously‑refilled buy‑back program, repurchasing billions of dollars of its own stock each year while periodically topping up the authorized limit (from $3.1 billion in 2022 to $2.7 billion still available in 2024, with total outstanding authority rising from $6.1 billion to $6.7 billion). This consistent, multi‑year execution indicates that share repurchases are a core element of the company’s capital‑return strategy, providing a flexible, ongoing mechanism to return excess cash to shareholders while maintaining the ability to increase the program when cash flow permits.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness, despite a well-structured presentation and generally sound reasoning framework. (1) Key dollar amounts for repurchases are incorrect: the original answer states that Accenture purchased 'over $605 million' in fiscal 2024, but the LLM claims $4.5 billion in repurchases for that year—this is a major discrepancy. Similarly, the LLM reports $4.11 billion in repurchases in 2022 and $3.5 billion in 2023, but the ground truth does not provide annual repurchase totals for those years, only the remaining authorization. The LLM fabricates or misrepresents these figures without support in the original answer. (2) The remaining authorization is correctly reported as $3.13 billion in 2022 and $2.69 billion in 2024, which matches the ground truth. However, the LLM incorrectly states that the Board added $3 million (should be $3 billion) in 2022, which is a critical error in magnitude. It correctly notes the $4.0 billion addition in September 2024. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that Accenture maintains a sustained repurchase program with periodic replenishment of authorization, and this aligns with the original answer’s conclusion about a 'measured capital return strategy.' The interpretation that share repurchases are a core, flexible component of capital return is semantically equivalent and well-reasoned. (4) Contextual relevance is high: the response directly addresses the evolution of repurchase activity and authorization, and draws a strategic conclusion. However, the fabricated repurchase amounts for 2022 and 2023 and the gross misstatement of the 2022 authorization increase severely compromise factual accuracy. While the directionality of the trend (consistent buybacks, replenished authority) is correct, the numerical foundation is flawed. Thus, the correctness score is limited to 5 due to major quantitative errors, even though the qualitative logic and structure are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1680,
        "completion_tokens": 545,
        "total_tokens": 2225
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "Across the three most recent Form 10‑Ks the 4.350 % Senior Notes due 2047 appear as a single, unchanged tranche of long‑term debt – the 2022 filing listed the notes at their original $2.5 billion principal, the 2023 filing reported the same amount (with no new issuance, amendment or early redemption), and the 2024 filing continued to carry the $2.5 billion outstanding through the reporting date. This consistency shows that BMS issued the notes in 2019 and has deliberately left them on the balance sheet, using a low‑coupon, very‑long‑dated instrument to lock in cheap financing and to create a stable, laddered maturity profile that supports its multi‑year capital‑expenditure and R&D needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a critical omission in quantitative accuracy: it states the 4.350% Senior Notes due 2047 were issued in 2019 with a $2.5 billion principal, which is accurate, but the original answer clarifies they were issued under the Eleventh Supplemental Indenture dated November 22, 2019—context missing in the LLM response. While the LLM correctly notes the $2.5 billion principal remained unchanged across 2022–2024, the ground truth does not explicitly confirm the principal amount in each year, only that the notes were consistently referenced; thus, asserting the exact $2.5B carryforward each year exceeds the confirmed detail in the original answer, introducing unsupported precision. The LLM correctly identifies the strategic rationale of maintaining long-dated debt for a laddered maturity profile, aligning with the original's conclusion about diversified, staggered maturities. However, it omits key multi-year context: the issuance of new debt in 2023 (e.g., $1.75B 2.950% Notes due 2032) and 2024 ($3.75B 4.250% Notes due 2049), which are critical to demonstrating BMY’s active refinancing and diversification strategy. The reasoning is sound but incomplete—while the stability of the 2047 notes is correctly emphasized, the synthesis across years lacks integration of new issuances that contextualize the strategic evolution. The company name is incorrectly referred to as 'BMS' (Bristol-Myers Squibb was renamed BMY post-Celgene acquisition; both are used, but consistency with the question’s 'BMY' is preferred). Despite this, the core message about using long-term, low-coupon debt to stabilize capital structure is semantically equivalent and relevant. The answer is well-structured and addresses the multi-year pattern and strategic implication, but misses key supporting evidence from the ground truth, reducing completeness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 512,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple has consistently disclosed the 2.40 % Notes due 2023 in the “Description of Securities” exhibit of its Form 10‑K. In the 2022 filing the notes appear in Exhibit 4.3 (“Officer’s Certificate…including …2.40 % Notes due 2023”) 【AAPL_10k_2022.pdf†p55】, the same reference is repeated in the 2023 filing (exhibit list shows the 2.40 % Notes due 2023) 【AAPL_10k_2023.pdf†p53‑55】, and the 2024 filing again lists the notes in Exhibit 4.3 【AAPL_10k_2024.pdf†p55】. Thus, Apple’s approach evolved by maintaining a steady, explicit disclosure of the 2.40 % Notes in the officer’s certificate each year, with the 2024 filing reaffirming the same disclosure as the maturity date approached.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All entities—Apple, 2.40% Notes due 2023, Exhibit 4.3, Officer's Certificate dated May 3, 2013—are accurately identified and consistently referenced across 2022, 2023, and 2024 filings. The disclosure location (Exhibit 4.3) and the nature of the document (Officer’s Certificate) are correctly cited with appropriate source references. (2) Quantitative accuracy is perfect: the interest rate (2.40%), maturity year (2023), and exhibit number (4.3) are all correct, and no numerical calculations were required. (3) The multi-hop reasoning is sound—information is synthesized across three separate 10-K filings, and the conclusion that Apple maintained a consistent disclosure approach is logically supported. The only minor shortcoming is the use of the word 'evolved' in the phrase 'approach evolved by maintaining a steady... disclosure,' which is semantically contradictory (evolution implies change, but the point is lack of change). However, the overall meaning is clear and contextually understood as consistency over time. (4) The answer is highly relevant, directly addressing the question about disclosure evolution (or lack thereof) with precise evidence from each year. Thus, the answer earns a 9/10 for correctness due to this slight wording issue, but full marks for quantitative accuracy and contextual relevance, with qualitative accuracy docked slightly for the inconsistent use of 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 408,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "- **Fiscal 2022:** The 2022 Form 10‑K states that a maximum of **127 million Accenture plc Class A ordinary shares** are authorized for awards under the Amended 2010 Share Incentive Plan (SIP)【ACN_10k_2022.pdf p.89‑93】.  \n- **Fiscal 2023:** The 2023 filing (pages 81‑85) makes no amendment to that limit and continues to reference the same **127 million‑share** authorization, indicating the pool was unchanged during the year.  \n- **Fiscal 2024:** The 2024 Form 10‑K reports that the authorization was increased to **141 million shares** under the Amended 2010 SIP【ACN_10k_2024.pdf p.96‑100】.  \n\n**Interpretation:** The steady‑state pool in 2022‑2023 followed by a 14 million‑share increase in 2024 shows Accenture is deliberately expanding its equity‑award reserve, signaling a long‑term strategy to rely more heavily on share‑based compensation to attract, retain and align the interests of employees and leadership with shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the timeline of share authorizations. According to the ground truth, the number increased from 127 million in fiscal 2022 to 141 million in fiscal 2023 and remained at that level in 2024. However, the LLM incorrectly states that the 127 million level persisted through 2023 and that the increase to 141 million occurred in 2024. This misrepresents the timing of the change, which is a critical element of the multi-hop comparison across years. (2) While the numeric values (127 million and 141 million) are correct in isolation, their assignment to fiscal years is wrong—this is a major quantitative inaccuracy in temporal context. The difference of 14 million shares is correctly implied but misattributed to the wrong fiscal year transition (2023–2024 instead of 2022–2023). (3) The reasoning is partially sound in interpreting the increase as a strategic move to expand equity compensation, but it fails to recognize the stability in 2024 as part of a post-increase equilibrium, instead framing 2024 as the year of change. This undermines the correct multi-hop synthesis of trend evolution: increase then stabilization. (4) Contextually, the answer addresses the right plan, company, and metric, and the interpretation about long-term strategy has merit, but the incorrect chronology severely limits factual correctness. Hence, correctness and quantitative accuracy scores are low; qualitative accuracy is moderate due to correct entities and plausible logic; contextual relevance is high as the response stays on topic and cites appropriate documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 444,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "- In the 2022 filing Intel first disclosed PowerVia as one of the two “breakthrough” features slated for the planned Intel 20A node, describing it as an industry‑first backside‑power delivery that would improve signal transmission and power efficiency for future products. 【INTC_10k_2022.pdf p. 5‑6】  \n- By the 2024 filing the company had cancelled the 20A node and moved PowerVia into the next‑generation Intel 18A process, calling it a “unique industry‑first implementation of backside power delivery” that will be part of the first high‑volume products (Panther Lake) in 2025 and will drive a 10‑15 % performance‑per‑watt improvement over Intel 3. 【INTC_10k_2024.pdf p. 8‑9】  \n\nThis evolution—from a future‑node concept in 2022 to a core element of the 18A roadmap in 2024—shows that PowerVia has become a strategic priority for Intel, underpinning its push for higher performance‑per‑watt and signaling its central role in the company’s advanced‑process technology plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PowerVia from 2022 to 2024 with accurate key facts: initial introduction in 2022 as part of Intel 20A, repositioning to Intel 18A by 2024, its description as an 'industry-first' backside power delivery, and inclusion in Panther Lake for 2025 high-volume manufacturing. The 10–15% performance-per-watt improvement over Intel 3 is accurately cited, which aligns with the strategic importance emphasized in the ground truth. (2) Quantitative accuracy is perfect: all dates (2022, 2024, 2025), node names (Intel 20A, Intel 18A), product name (Panther Lake), and percentage improvement (10–15%) are correct and match the ground truth. No calculation errors. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022 and 2024 filings to show progression from concept to core technology. The cancellation of Intel 20A and migration of PowerVia to Intel 18A is accurately reflected, demonstrating proper cross-document inference. (4) The only minor shortcoming is that the 2023 milestone—where Intel solidified PowerVia’s role in Intel 20A before pivoting to 18A—is omitted. While not critical, including that intermediate step would have made the evolution more complete. However, the core trajectory and strategic significance are correctly conveyed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, complete in key aspects, and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 411,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "- **Fiscal 2022:** Accenture reported $239 million of mutual‑fund equity securities (Level 1 $4.9 M + Level 2 $234.3 M) in its non‑U.S. defined‑benefit plans.  \n- **Fiscal 2023:** The balance fell to $196 million (Level 1 $7.4 M + Level 2 $188.8 M).  \n- **Fiscal 2024:** The amount rose to $274 million (Level 1 $20.2 M + Level 2 $253.5 M).\n\n**Interpretation:** After a modest pull‑back in 2023, Accenture sharply increased its mutual‑fund equity holdings in 2024, taking the allocation above the 2022 level. This three‑year pattern signals a renewed strategic tilt toward equity‑based investments, likely to capture higher long‑term returns as the company leans more heavily on equity exposure within its pension‑plan portfolios.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Accenture's allocation to mutual fund equity securities decreased from $239,293 million in FY2022 to $196,226 million in FY2023 and remained flat in FY2024. However, the LLM incorrectly reports the 2024 value as $274 million — a substantial increase — which contradicts the ground truth. Additionally, the LLM uses 'million' units but reports values in the hundreds (e.g., $239 million), whereas the correct figures are in the hundreds of *thousands* of millions (i.e., billions): $239,293 million = ~$239.3 billion. This reflects a critical misunderstanding of scale. (2) The quantitative inaccuracies are severe: the 2022 and 2023 figures are off by a factor of ~1,000 (reporting millions instead of thousands of millions), and the 2024 figure is both wrong in magnitude and direction (increase vs. no change). The breakdowns into Level 1 and Level 2 assets appear fabricated and do not align with the knowledge graph. (3) The multi-hop reasoning is flawed: the LLM infers a 'renewed strategic tilt toward equity-based investments' due to an alleged increase in 2024, but the actual data shows a reduction followed by stability, indicating a strategic *decrease* in exposure. Thus, the conclusion is the opposite of what the data supports. (4) Despite incorrect facts and reasoning, the answer is contextually relevant — it addresses the right company, time frame, and asset class, and attempts to interpret strategic intent — hence a moderate score on relevance. However, due to major errors in numbers, scale, trend, and resulting interpretation, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 461,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "From 2022 through 2024 Merck kept Dificid (fidaxomicin) on its balance sheet as a $145 million product‑right intangible that was never impaired, indicating a stable asset‑valuation approach. Therapeutically, the drug remained classified in the “Hospital Acute‑Care” franchise as the oral treatment for C. difficile‑associated diarrhea, with no repositioning or divestiture announced. Its worldwide sales grew each year—$263 million in 2022, $302 million in 2023 and $340 million in 2024—representing a modest but rising share (≈0.5‑0.6 %) of Merck’s total pharmaceutical revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in financial figures compared to the ground truth. While the 2024 global sales figure of $340 million is correct, the LLM incorrectly states Dificid's 2022 sales as $263 million and 2023 sales as $302 million—these figures are not supported by the original answer, which only provides 2024 revenue data. The original answer does not mention annual sales growth or specific revenue for 2022 and 2023, so these numbers are fabricated. Additionally, the claim that Dificid was valued as a $145 million intangible asset in 2022 is correct, but the LLM implies this valuation persisted through 2024, while the original answer does not confirm this continuity. (2) The calculation of Dificid’s share of total pharmaceutical revenue (≈0.5–0.6%) is unsupported due to lack of total revenue data in the original answer, making this inference speculative. (3) The qualitative reasoning is mostly sound: the LLM correctly identifies Dificid’s therapeutic positioning within the Hospital Acute-Care franchise and its indication for C. difficile-associated diarrhea, aligning with the 2023 and 2024 strategic emphasis. It also correctly notes no repositioning or divestiture, consistent with the original answer’s implication of increasing strategic recognition. (4) Contextually, the answer is highly relevant, addressing all three dimensions of the question—valuation, therapeutic positioning, and revenue—though with partial factual inaccuracies. The synthesis across years is logical but undermined by incorrect numerical inputs. The answer improves upon the original by suggesting a trend, but introduces unsupported specifics. Thus, while the direction of evolution is plausibly described, the factual foundation is partially flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 495,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "From 2022 through 2024 Intel kept “advanced‑packaging” at the heart of its IDM 2.0 strategy, but the company’s ability to deliver it has become increasingly strained.  R&D spending rose from $17.5 billion in 2022 (≈ 27.8 % of net revenue) to $16.5 billion in 2024 (≈ 29.6 % in 2023), reflecting heavier investment in packaging and disaggregated‑design work; however, the 10‑K filings repeatedly note that the novelty and limited manufacturing history of these packaging technologies have caused schedule slips and added complexity, leading to operating losses in 2023 and a $3.1 billion non‑cash impairment on the Intel 7 node plus a $755 million penalty for construction delays in 2024.  Together, the higher R&D outlays, documented implementation delays, and large write‑down/penalty charges illustrate that Intel’s strategic positioning around advanced packaging has been increasingly exposed to financial risk as the execution timeline has slipped.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution of Intel's Advanced Packaging Technologies from 2022 to 2024, correctly identifying increased R&D investment, implementation delays, and financial risks. It aligns well with the ground truth in terms of narrative arc—strategic emphasis followed by execution and financial strain. However, there are key quantitative inaccuracies. The R&D figures are partially incorrect: while $17.5 billion in 2022 is accurate, the 2024 R&D is stated as $16.5 billion, which contradicts the upward investment trend and is factually wrong (Intel’s 2024 R&D was higher, not lower). Additionally, the percentage '≈29.6% in 2023' is misattributed—it is presented as 2024 data in the sentence structure, creating confusion. The $3.1 billion impairment charge is correctly cited and matches the ground truth, but the $755 million penalty for construction delays is not mentioned in the original answer and appears to be extraneous or misaligned information, potentially conflating separate issues. (2) The calculation of R&D as a percentage of revenue is not verifiable from the ground truth, and the shifting percentages are presented without clear year labels, reducing quantitative reliability. The drop in R&D spending from 2022 to 2024 contradicts the narrative of increasing investment in advanced packaging. (3) The multi-hop reasoning is sound in linking R&D increases, technical complexity, delays, and financial consequences. The synthesis across years and financial/strategic domains is appropriate and reflects a good understanding of the causal chain. The mention of disaggregated design and UCIe is implied in the context but not explicitly detailed, slightly reducing completeness. (4) Despite numerical inaccuracies, the overall qualitative assessment and contextual relevance are strong—the answer addresses strategic positioning, execution challenges, R&D, delays, and financial risk as required. The core message of growing financial exposure due to execution slippage is preserved, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 559,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "- In the 2022 Form 10‑K Merck reported that the FDA had placed a **clinical hold on the doravirine + islatravir regimen (MK‑8591A)** because early studies showed drops in total lymphocytes and CD4⁺ counts. By the 2023 filing the company said MK‑8591A had entered a **Phase 3 program (started in 2023) for treatment‑naïve and switch‑treated adults**, while a lower‑dose islatravir + lenacapavir Phase 2 trial had finished enrollment; the INDs remained under a **partial hold limited to higher islatravir doses**. The 2024 filing notes that the **FDA lifted the hold on December 4 2024** and that a **Phase 2/3 study began in August 2024**, moving the program forward toward potential registration.\n\n- This evolution—from a full hold to a resumed, dose‑optimized development path and an active late‑stage trial—shows Merck’s **long‑term strategic commitment to an islatravir‑based, once‑daily HIV‑1 regimen**, positioning the company to add a differentiated, potentially long‑acting therapy to its HIV portfolio despite earlier safety setbacks.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, particularly regarding the timeline and phase status of MK-8591A. (1) According to the ground truth, MK-8591A entered Phase 3 in February 2020, not in 2023 as the LLM claims. The 2022 status was already Phase 3, not a clinical hold due to lymphocyte/CD4 drops—though such a hold did occur, the LLM misplaces its timing relative to development phase. The ground truth does not state that the Phase 3 program started in 2023; rather, it remained in Phase 3 through 2023. (2) The LLM incorrectly states that a Phase 2/3 study began in August 2024; the ground truth only confirms the FDA lifted the clinical hold on December 4, 2024, with no mention of a new trial start. (3) The lifting of the hold and the partial hold on higher doses are correctly noted, but the LLM conflates the resolution with new trial initiation not present in the original. (4) The qualitative assessment of Merck’s long-term strategy is reasonable and aligns with the ground truth—persistent commitment despite setbacks—but is based on an inaccurate timeline. (5) Quantitative accuracy is low due to incorrect dates (2020 → misstated as 2023 for Phase 3 start; August 2024 trial start not in source). (6) Multi-hop reasoning is partially sound—linking regulatory actions to strategic intent—but undermined by incorrect event sequencing. (7) Contextual relevance is high, as the answer addresses both the timeline and strategic implications as asked. Overall, the answer captures the general direction of development and Merck’s strategic intent but fails on key factual details, especially dates and trial phases, warranting a score of 6 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 465,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 23‑27) Merck listed MK‑1308A as the **quavonlimab + pembrolizumab co‑formulation being evaluated in Phase 3 for renal‑cell carcinoma (RCC)**.  \n- The 2023 filing (pages 18‑22) repeats that same clinical focus and combination, showing no expansion to other tumor types or new partner drugs.  \n- By the 2024 filing (pages 48‑52) MK‑1308A is still described under the immuno‑oncology pillar as a **Phase 3 RCC program with the same anti‑CTLA‑4 + PD‑1 combo**, and the company reports no regulatory milestone (e.g., submission or approval) – the program remains in late‑stage development.  \n\nThus, from 2022 through 2024 Merck’s strategy for MK‑1308A has been steady: it stays centered on RCC, continues to pair quavonlimab with pembrolizumab, and has progressed only within Phase 3 without achieving any regulatory filing or approval.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is consistently described as a co-formulation of quavonlimab and pembrolizumab in Phase 3 for renal cell carcinoma (RCC) from 2022 to 2024, with no regulatory approval or submission reported by 2024. The clinical focus, combination therapy, and development stage are accurately represented across all years. (2) There are no numeric values requiring calculation (e.g., dates, dollar amounts), but the Phase 3 designation and lack of regulatory milestones are correctly stated—consistent with the original answer. Format variations (e.g., 'Phase 3' vs 'Phase 3') are acceptable. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying continuity in strategy rather than evolution in indication or combination partners. It accurately infers that the strategy has remained stable, which is the core insight. (4) The only minor shortcoming is that the LLM emphasizes 'no change' more than the original answer, which notes increasing specificity in formulation (e.g., explicitly identifying quavonlimab in 2023). While the LLM does mention this in 2022, it could have highlighted the growing clarity in molecular composition over time. However, this does not constitute a factual error—just a slight underemphasis on evolving descriptive precision. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 413,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "- **Fiscal 2022:** Accenture bought 12.2 million Class A shares for about **$4.1 billion** and, at year‑end, had **$3.13 billion** of its open‑market repurchase authority still available.  In September 2022 the Board added **$3 billion** of new authority, raising the total outstanding authority to **$6.13 billion**【source 2022‑share‑purchase‑activity】.  \n\n- **Fiscal 2023:** The company continued to use the program, repurchasing a comparable amount of shares and further drawing down the pool of authorized capital (the remaining balance fell to roughly the low‑‑$‑billion range).  The 2023 filing shows the same pattern of ongoing purchases and a shrinking “available authorization” figure, confirming that the 2022‑2023 period was another year of active capital return.  \n\n- **Fiscal 2024:** Accenture repurchased **$4.5 billion** of stock (2.07 million shares in Q4 alone) and, as of August 31 2024, had **$2.694 billion** of authorization left.  In September 2024 the Board approved an additional **$4 billion**, bringing total outstanding authority to **$6.694 billion**【source 2024‑authorization‑and‑purchases】.  \n\n**What the pattern shows:** Over three consecutive years Accenture has repeatedly drawn down its share‑repurchase authority while periodically topping it up.  This “use‑and‑re‑authorize” cycle demonstrates that share buybacks are a core, ongoing component of its capital‑return strategy, signalling a disciplined commitment to return excess cash to shareholders rather than a one‑off or opportunistic program.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures and timelines, particularly in fiscal 2022 and 2024 share repurchase amounts. According to the ground truth, Accenture repurchased $605 million in shares during fiscal 2024, not $4.5 billion as claimed. The LLM incorrectly states that $4.1 billion was spent in fiscal 2022, but the original answer does not specify total repurchase volume for 2022—only remaining authorization ($3.13 billion). Additionally, the LLM claims $3 billion in new authority was approved in September 2022, but the ground truth does not confirm this; instead, it notes a $4 billion addition in September 2024. The remaining authorization at the end of fiscal 2024 is correctly stated as $2.694 billion. (2) Calculations are flawed: the LLM implies a $4.5 billion repurchase in 2024, which would be inconsistent with the $605 million actual and the increase in total outstanding authority to $6.694 billion after a $4 billion top-up. The 2.07 million shares in Q4 alone is unsupported by the ground truth, which reports 2,000,308 shares total for the year. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a 'use-and-re-authorize' pattern as a strategic capital return approach, which aligns with the ground truth’s conclusion about sustained and measured strategy. However, this insight is based on incorrect numerical premises. The mention of consistent messaging in the 2023 filing referencing 2024 activity (a subtle but important point in the original) is missed. (4) Despite significant quantitative errors, the answer remains contextually relevant and captures the strategic implication correctly. The structure is clear and addresses all parts of the question, earning moderate scores for qualitative accuracy and high relevance. However, the correctness score is limited by major factual and numerical discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1624,
        "completion_tokens": 516,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "The $750 million 2.35 % senior note that matures in 2040 appears in BMS’s debt tables in the 2022, 2023 and 2024 Form 10‑K filings (see the capital‑structure schedules on pages 137‑141 of the 2022 filing, pages 132‑136 of the 2023 filing, and pages 134‑138 of the 2024 filing). Its continued presence shows that BMS has deliberately kept this long‑dated, low‑coupon instrument on its balance sheet, using it to lock in inexpensive fixed‑rate financing for the next two decades and to smooth the maturity profile of its debt. By retaining the 2040 note, the company reduces refinancing risk and aligns a stable, long‑term funding source with its long‑term R&D and product‑life‑cycle cash‑flow needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million 2.350% Notes due 2040 are accurately described in terms of amount, interest rate, maturity, and presence in the 2022–2024 Form 10-K filings. The dollar amount ($750 million = $750,000,000) and interest rate (2.35% vs. 2.350%) match exactly, allowing for formatting variation. (2) Quantitative accuracy is perfect: all numbers, dates, and percentages are correct, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—by referencing the consistent appearance of the note across three years of filings, the LLM correctly infers a strategic decision to retain long-term fixed-rate debt. It appropriately links this to refinancing risk reduction and alignment with long-term R&D cash flow needs, which is semantically equivalent to the ground truth’s emphasis on stable interest expenses and interest rate risk management. (4) The only minor gap is that the LLM does not explicitly state that the note was 'not refinanced or retired despite market fluctuations,' a nuance present in the original answer that strengthens the strategic interpretation. However, the implication is clearly conveyed through phrases like 'deliberately kept' and 'reduces refinancing risk.' The inclusion of specific page numbers adds precision and verifiability. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 447,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Across the three most recent Form 10‑K filings the company’s disclosed “interest‑rate commitment” for the 4.350 % senior notes due 2047 has not changed – each filing continues to reference the same outstanding series of 4.350 % notes (Exhibit 4.19) that were originally issued in 2019 and remain on the balance sheet with the same fixed coupon and maturity. This steady‑state treatment shows that BMS is deliberately using the 4.350 % senior‑note series as a long‑term financing anchor, locking in a low‑cost, fixed‑rate liability and avoiding frequent refinancing or restructuring of that tranche. The pattern signals a disciplined approach to long‑term debt: the company prefers to retain existing fixed‑rate senior notes rather than alter the mix of its long‑dated borrowings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the interest rate commitment for the 4.350% Senior Notes due 2047 has remained unchanged across recent filings, which aligns with the ground truth. However, there are minor discrepancies in exhibit references: the LLM states 'Exhibit 4.19' consistently across all years, while the ground truth specifies Exhibit 4bbb (2022), Exhibit 4ff (2023 and 2024), and notes incorporation by reference to a Form 8-K from November 22, 2019. These exhibit details are factually inaccurate in the LLM answer, though the core point about consistency is correct. (2) Quantitatively, the 4.350% rate is correctly reported, and the 2019 issuance date is accurate (matching the Form 8-K date in the ground truth). However, the LLM omits the specific supplemental indenture dates (e.g., November 13, 2020 and November 13, 2023) and incorrectly generalizes the exhibit number, reducing precision. (3) The multi-hop reasoning is sound: the LLM synthesizes information across multiple years and correctly infers a stable, long-term debt strategy. It accurately concludes that Bristol-Myers Squibb is maintaining a fixed-rate liability without refinancing, reflecting disciplined capital structure management—this interpretation is consistent with the ground truth’s conclusion. (4) Despite exhibit inaccuracies, the LLM captures the essential factual and strategic points, warranting a high score. The answer is semantically close to the original and highly relevant, but loses points on precise document-level details critical in SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 433,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "Nike’s first 10‑K (fiscal 2022) mentioned FlyEase only in a broad “proliferation of … FlyEase … technologies” paragraph, treating it as one of many new product‑technology concepts with no detail on production. By the 2024 filing the same phrasing still appears, but Nike backs it with concrete supply‑chain data – its contract‑manufacturer network now runs 96 finished‑goods footwear factories in 11 countries (15 contract manufacturers), with roughly 50 % of all Nike‑brand footwear (the category that now includes FlyEase models) made in Vietnam, 27 % in Indonesia and 18 % in China – showing that FlyEase‑enabled shoes are being manufactured at scale and fully integrated into Nike’s global manufacturing operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages (50%, 27%, 18%) and the geographic breakdown (Vietnam, Indonesia, China) are correct and match the original answer. The mention of 96 footwear factories in 11 countries and 15 contract manufacturers is consistent with typical Nike supply chain disclosures in the 2024 10-K, though not explicitly part of the ground truth; it adds contextual detail without contradicting facts. (2) The evolution of FlyEase reporting is correctly portrayed: minimal detail in 2022, continued mention in 2024, and integration into broader technology portfolios. The key progression—from generic mention to association with scalable production via supply chain data—is sound. (3) Multi-hop reasoning is strong: the model correctly infers that because FlyEase is part of the broader Nike Brand footwear category and that category’s production is distributed at scale across global manufacturers, FlyEase itself is now integrated into large-scale operations. (4) Minor deduction in qualitative accuracy because the original answer emphasizes FlyEase’s rising prominence in 2023 (mentioned alongside Nike Air and Dri-FIT), which the LLM omits. However, the core trajectory from 2022 to 2024 is preserved. Wording differs but semantic meaning and factual content are equivalent. No calculation errors. Contextual relevance is excellent—directly addresses both the evolution and quantitative evidence of production scale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 413,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s “RedCard/Target Circle Card” penetration fell each year: it was **20.5 % in fiscal 2022**, slipped to **19.8 % in fiscal 2023**, and declined further to **18.6 % in fiscal 2024**【TGT_10k_2023.pdf page 25】 (RedCard) and the same 18.6 % figure is reiterated in the 2024 filing for FY 2024【TGT_10k_2024.pdf page 27】. The steady drop in the share of purchases paid with these loyalty‑driven cards suggests that, while the program still drives a meaningful portion of sales, its ability to increase guest spend is waning over the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports 18.6% for 2024, whereas the ground truth states 17.8%, which is a significant factual error. This discrepancy affects the overall quantitative accuracy. (2) The cited sources (TGT_10k_2023.pdf and TGT_10k_2024.pdf) are referenced appropriately, but the number extracted from the 2024 filing appears incorrect or misread, as the ground truth from the knowledge graph—presumably built from actual filings—confirms 17.8%. Even if the LLM cites a source, the number must align with verified truth. (3) The reasoning and synthesis are sound: the model correctly interprets the declining trend and links it to the effectiveness of Target’s loyalty-driven payment strategy, noting waning customer engagement. This shows appropriate multi-hop reasoning across years and strategic implications. (4) Contextually, the answer is highly relevant, addressing both the trend and its strategic implication. However, due to the incorrect 2024 figure, the conclusion about the trend, while directionally correct (decline), understates the severity. A drop from 19.8% to 17.8% is more concerning than to 18.6%, affecting strategic interpretation. Thus, while the qualitative reasoning is strong, the factual inaccuracy in a key data point reduces the correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 391,
        "total_tokens": 1649
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 7.07,
    "average_quantitative_accuracy": 7.56,
    "average_qualitative_accuracy": 7.34,
    "average_contextual_relevance": 9.01,
    "score_distribution": {
      "excellent": 398,
      "good": 112,
      "fair": 173,
      "poor": 117
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e2_page_window",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 12242.37,
    "timestamp": "2026-02-03T23:50:04.295939"
  }
}